data_2rlf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rlf _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 2.7 m-20 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.3 Cg_endo -55.78 -15.54 13.17 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.714 2.276 . . . . 0.0 111.978 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.8 tp -46.29 -44.42 16.58 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.319 -0.863 . . . . 0.0 109.169 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.8 t -68.6 -45.26 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.273 -0.892 . . . . 0.0 108.997 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -48.93 -49.02 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.184 -0.947 . . . . 0.0 109.057 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.09 -34.47 78.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 0.0 109.387 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.74 -57.25 8.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 0.0 109.805 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.57 -36.14 66.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.733 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.7 mt -71.7 -42.51 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.338 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.4 mt -55.73 -34.63 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.128 -0.982 . . . . 0.0 108.511 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.09 -45.17 32.95 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.1 mt -55.67 -36.21 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.165 -1.197 . . . . 0.0 109.179 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.5 -61.91 1.67 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.353 -0.842 . . . . 0.0 109.236 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.401 ' NE2' ' ND1' ' B' ' 37' ' ' HIS . 4.2 t-80 -45.15 -39.9 6.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.416 -0.802 . . . . 0.0 110.061 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -66.23 -69.49 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.141 -0.974 . . . . 0.0 109.843 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.8 mt -48.19 -27.4 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 0.0 109.739 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.425 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 7.4 mt -72.24 -60.37 2.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.928 . . . . 0.0 109.945 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 40.7 t-105 -48.1 -48.53 33.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.055 -1.028 . . . . 0.0 109.784 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 45' ' ' ARG . 66.6 mt -63.28 -59.89 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.08 -1.013 . . . . 0.0 109.336 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.3 tp -44.27 -40.66 5.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.572 -0.705 . . . . 0.0 109.821 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 1.7 m-20 -69.75 -31.31 69.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -0.964 . . . . 0.0 109.217 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.5 ' NH1' ' OD2' ' D' ' 44' ' ' ASP . 0.4 OUTLIER -75.4 -16.05 60.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 110.181 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -90.04 -12.06 39.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.872 -1.142 . . . . 0.0 109.22 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.487 ' O ' ' N ' ' A' ' 49' ' ' LYS . 17.6 t80 -78.0 -60.73 2.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 109.306 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -50.23 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 109.066 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 47' ' ' PHE . 30.8 mtpt -91.65 -82.43 0.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.915 . . . . 0.0 109.634 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.1 m -87.35 170.07 11.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.635 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.3 mt -105.46 -21.66 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.569 -0.707 . . . . 0.0 109.626 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -55.02 -20.87 10.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.182 -0.949 . . . . 0.0 109.8 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.433 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 7.6 mmm180 -70.94 -42.59 69.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.062 -1.024 . . . . 0.0 109.553 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -66.79 -35.23 79.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.227 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -65.25 -48.85 71.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -0.866 . . . . 0.0 109.19 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -63.2 -29.18 70.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.348 -0.845 . . . . 0.0 109.526 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.433 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 18.5 m80 -66.2 -52.34 48.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.263 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.22 -60.89 7.8 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.46 ' O ' ' CB ' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -50.28 118.8 3.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.377 -1.072 . . . . 0.0 109.458 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 59' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.479 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.298 0.57 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.516 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 48.5 m-20 -157.72 51.23 0.46 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.472 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 13.0 Cg_endo -59.23 -12.02 14.92 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.759 2.306 . . . . 0.0 112.345 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 58.2 tp -47.98 -46.71 32.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 108.958 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.71 -44.93 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.113 -0.992 . . . . 0.0 108.774 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 71.2 t -48.97 -49.71 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 108.931 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.38 -32.87 74.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -0.837 . . . . 0.0 109.136 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.91 -58.08 6.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 0.0 109.66 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.77 -35.28 63.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 109.697 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 16.7 mt -73.29 -41.86 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 0.0 109.745 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 21.9 mt -55.86 -35.57 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.005 -1.059 . . . . 0.0 108.822 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.34 -44.18 43.55 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 48.6 mt -56.05 -33.07 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.226 -1.161 . . . . 0.0 109.204 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -65.19 0.79 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 109.1 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . 0.513 ' NE2' ' ND1' ' C' ' 37' ' ' HIS . 3.4 t-80 -45.43 -38.13 5.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.412 -0.805 . . . . 0.0 109.748 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 54.9 tp -66.38 -67.86 0.42 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 109.503 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.8 mt -48.91 -25.89 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 109.518 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mt -71.5 -64.07 0.99 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.851 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -46.11 -47.1 17.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 0.0 109.647 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 51.7 mt -63.27 -55.46 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.087 -1.008 . . . . 0.0 108.909 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 39.5 tp -47.13 -41.19 17.09 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.51 -0.744 . . . . 0.0 109.661 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' B' ' 44' ' ' ASP . 0.3 OUTLIER -69.79 -30.26 67.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.707 -179.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.97 -19.71 58.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.07 -1.018 . . . . 0.0 110.47 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -82.97 -8.46 59.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.631 -1.293 . . . . 0.0 108.973 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -138.11 106.93 5.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.525 -0.734 . . . . 0.0 109.569 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -171.15 3.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.216 -0.928 . . . . 0.0 109.556 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -71.89 -142.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.905 . . . . 0.0 109.302 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 20.8 m 51.54 75.74 0.19 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.166 -0.959 . . . . 0.0 109.568 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 50.9 mt -99.36 -31.21 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.463 -0.773 . . . . 0.0 109.385 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.494 ' CE2' ' NH1' ' B' ' 53' ' ' ARG . 0.1 OUTLIER -61.02 -32.93 72.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.0 109.781 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.494 ' NH1' ' CE2' ' B' ' 52' ' ' TYR . 19.5 mmt-85 -64.42 -33.84 76.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.085 -1.009 . . . . 0.0 109.42 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -75.3 -42.15 55.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.873 . . . . 0.0 109.17 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -58.34 -40.53 82.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.856 . . . . 0.0 109.55 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -72.78 -67.61 0.55 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . 0.45 ' O ' ' ND1' ' B' ' 57' ' ' HIS . 23.0 t-80 -41.22 -30.06 0.15 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.616 -0.678 . . . . 0.0 110.208 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.28 -70.25 1.31 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mt -66.35 82.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -1.113 . . . . 0.0 109.516 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 58.8 tttm . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.403 179.855 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 55.1 m . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' C' ' 26' ' ' LEU . 3.2 m-20 57.64 65.33 3.52 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 109.647 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -45.22 -11.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.921 2.414 . . . . 0.0 112.535 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' C' ' 24' ' ' ASP . 24.2 tp -47.74 -46.11 29.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 108.975 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 45.5 t -67.19 -45.32 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 108.769 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 71.5 t -50.3 -51.64 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.363 -0.836 . . . . 0.0 109.008 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.32 -32.58 73.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.502 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.8 -55.27 18.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.53 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.13 -37.51 69.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.843 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 23.1 mt -71.89 -42.81 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.072 -1.017 . . . . 0.0 109.602 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.25 -36.39 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 108.551 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.95 -45.04 64.76 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 63.5 mt -59.6 -41.59 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.347 -1.09 . . . . 0.0 108.832 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.77 -68.01 0.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.368 -0.832 . . . . 0.0 109.292 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . 0.513 ' ND1' ' NE2' ' B' ' 37' ' ' HIS . 2.3 t-80 -44.17 -39.95 4.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.389 -0.82 . . . . 0.0 110.24 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.76 -67.89 0.38 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.985 -1.072 . . . . 0.0 109.196 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 mt -47.67 -40.66 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.344 -0.847 . . . . 0.0 109.423 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mt -61.64 -54.31 44.54 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.45 -0.781 . . . . 0.0 109.581 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -46.31 -58.19 3.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.418 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.19 -47.8 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.055 -1.028 . . . . 0.0 109.339 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 6.3 tp -52.56 -27.52 17.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.417 -0.802 . . . . 0.0 110.43 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -91.03 -34.03 15.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.071 -1.018 . . . . 0.0 109.426 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' C' ' 47' ' ' PHE . 14.6 mmm180 -84.67 4.32 33.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.343 -0.848 . . . . 0.0 110.403 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . 0.476 ' C ' ' O ' ' C' ' 45' ' ' ARG . 34.8 mt -31.0 -34.95 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 CA-C-O 121.273 0.559 . . . . 0.0 110.299 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.55 ' N ' ' O ' ' C' ' 45' ' ' ARG . 0.2 OUTLIER 68.2 102.04 0.05 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.714 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -104.16 162.67 12.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.557 -0.714 . . . . 0.0 109.211 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' C' ' 50' ' ' SER . 20.4 tptt -92.37 -150.14 0.26 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.168 -0.958 . . . . 0.0 109.767 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' SER . . . . . 0.412 ' O ' ' O ' ' C' ' 49' ' ' LYS . 8.2 m 47.06 92.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 109.843 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 mt -92.65 -31.61 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.213 -0.93 . . . . 0.0 109.446 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . 0.463 ' CD2' ' N ' ' C' ' 53' ' ' ARG . 50.9 p90 -48.45 -44.26 35.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.382 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . 0.463 ' N ' ' CD2' ' C' ' 52' ' ' TYR . 3.7 mtp85 -46.73 -50.52 17.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.306 -0.871 . . . . 0.0 109.954 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -61.7 -41.5 97.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.112 -0.993 . . . . 0.0 109.76 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -60.79 -35.57 76.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 109.266 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -73.52 -37.62 65.58 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.275 -0.891 . . . . 0.0 109.239 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -41.22 94.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.914 . . . . 0.0 109.189 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.42 -62.43 4.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 57.6 mt -85.24 -147.99 0.11 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -1.125 . . . . 0.0 109.316 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.442 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.95 161.38 77.8 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.339 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -65.1 -21.52 62.84 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.511 2.14 . . . . 0.0 112.097 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 54.2 tp -46.8 -43.87 18.74 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -69.76 -43.23 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.329 -0.857 . . . . 0.0 108.803 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 70.4 t -51.04 -48.55 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.069 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.35 -33.91 76.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 0.0 109.26 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.35 -57.02 9.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 109.674 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -56.1 -35.99 67.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.746 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 12.3 mt -71.69 -41.41 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.208 -0.933 . . . . 0.0 109.352 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -56.64 -35.17 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.942 . . . . 0.0 108.796 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.79 -43.67 50.1 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 57.2 mt -59.17 -30.34 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.333 -1.098 . . . . 0.0 109.478 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.75 -67.5 0.63 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -0.944 . . . . 0.0 109.405 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -44.11 -35.71 2.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.23 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 45.8 tp -71.42 -63.13 1.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.031 -1.043 . . . . 0.0 109.803 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.7 mt -50.93 -34.38 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.96 . . . . 0.0 109.599 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' D' ' 43' ' ' LEU . 1.2 mt -67.17 -64.81 0.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.36 -0.838 . . . . 0.0 110.273 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -44.76 -48.61 10.84 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.398 -0.814 . . . . 0.0 109.682 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 93.3 mt -59.63 -37.52 71.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 108.601 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' D' ' 40' ' ' LEU . 0.1 OUTLIER -57.7 -43.38 85.14 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.488 -0.757 . . . . 0.0 109.36 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . 0.5 ' OD2' ' NH1' ' A' ' 45' ' ' ARG . 7.0 m-20 -71.71 -26.82 62.65 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.381 -0.825 . . . . 0.0 110.182 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -28.36 58.31 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.829 -1.169 . . . . 0.0 110.981 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' D' ' 48' ' ' PHE . 7.7 mt -58.4 -12.31 3.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.525 -1.359 . . . . 0.0 109.179 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -73.95 17.09 0.18 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.14 -0.975 . . . . 0.0 109.114 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . 0.506 ' H ' ' C ' ' D' ' 46' ' ' LEU . 0.4 OUTLIER -46.66 155.2 0.26 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 109.56 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 15.8 tttm 64.23 -146.45 0.29 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 73.3 m 47.96 59.44 4.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 38.8 mt -95.06 -29.59 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.347 -0.846 . . . . 0.0 109.39 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -37.94 74.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.545 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . 0.472 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 5.9 mtm180 -61.51 -36.63 81.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.247 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -69.99 -37.92 75.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 0.0 109.258 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -63.39 -53.79 46.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 109.677 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -62.61 -29.13 70.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.748 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . 0.472 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 1.4 m-70 -67.48 -45.14 76.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 109.431 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.29 -60.71 6.78 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.1 -166.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -1.15 . . . . 0.0 109.712 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 61.1 tttm . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.923 -1.036 . . . . 0.0 109.669 -179.969 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 5.5 p-10 . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 120.889 0.376 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 11.2 Cg_endo -58.02 -17.87 33.17 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.509 2.139 . . . . 0.0 112.269 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.8 tp -47.2 -45.02 22.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.189 -0.945 . . . . 0.0 108.826 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.98 -44.52 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.241 -0.912 . . . . 0.0 108.802 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -49.86 -50.25 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.163 -0.96 . . . . 0.0 109.068 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.54 -33.69 76.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.322 -0.861 . . . . 0.0 109.514 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.57 -56.78 8.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 109.784 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 m -55.55 -34.65 64.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.705 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.4 mt -74.81 -43.7 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.118 -0.989 . . . . 0.0 109.725 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.8 mt -54.02 -35.91 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.021 -1.05 . . . . 0.0 108.618 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.06 -45.43 41.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.7 mt -57.65 -37.27 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.192 -1.181 . . . . 0.0 108.907 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.15 -68.74 0.33 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -0.85 . . . . 0.0 109.373 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -43.19 -42.26 4.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.431 -0.793 . . . . 0.0 110.263 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.7 tp -61.05 -67.66 0.38 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.106 -0.996 . . . . 0.0 109.569 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 mt -49.15 -44.1 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 109.513 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt -55.77 -58.39 8.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 109.987 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -46.43 -59.1 3.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.322 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.467 ' O ' ' N ' ' A' ' 45' ' ' ARG . 48.0 mt -51.17 -52.44 18.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.276 -0.89 . . . . 0.0 108.978 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 42' ' ' ILE . 0.1 OUTLIER -41.89 -57.21 2.47 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.426 0.631 . . . . 0.0 109.503 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -59.15 -27.7 65.89 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.328 -0.858 . . . . 0.0 109.624 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.467 ' N ' ' O ' ' A' ' 42' ' ' ILE . 2.7 mmp_? -81.52 -13.82 57.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.071 -1.018 . . . . 0.0 110.714 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 mt -88.65 -18.88 27.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.652 -1.28 . . . . 0.0 109.198 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.48 ' O ' ' CB ' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -141.79 166.29 25.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.301 -0.875 . . . . 0.0 109.518 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.48 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 2.4 t80 75.96 97.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.57 -0.706 . . . . 0.0 109.539 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 50' ' ' SER . 10.1 tttp -150.23 -135.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.109 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 49' ' ' LYS . 0.9 OUTLIER 68.14 117.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.957 . . . . 0.0 109.51 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 mt -97.69 -29.25 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 109.625 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.485 ' CG ' ' N ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -57.32 -38.82 74.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.97 . . . . 0.0 109.44 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.485 ' N ' ' CG ' ' A' ' 52' ' ' TYR . 1.4 mtt180 -57.65 -37.21 72.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.044 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -70.67 -39.98 73.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.844 . . . . 0.0 109.233 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -65.55 -34.08 77.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.125 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -75.02 -31.66 61.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.824 . . . . 0.0 109.613 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -68.92 -37.93 79.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.256 -0.902 . . . . 0.0 109.152 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.63 -64.41 2.6 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.7 mt -75.78 150.95 37.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -1.112 . . . . 0.0 109.538 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.449 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.265 0.555 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.15 160.67 39.18 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 109.271 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' B' ' 26' ' ' LEU . 18.7 Cg_endo -63.16 -24.5 72.8 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.557 2.171 . . . . 0.0 112.165 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' B' ' 25' ' ' PRO . 56.9 tp -45.63 -40.89 9.55 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 52.3 t -70.98 -44.75 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.345 -0.847 . . . . 0.0 108.809 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 74.4 t -49.54 -48.71 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 108.953 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.55 -34.73 78.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.362 -0.836 . . . . 0.0 109.223 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.26 -56.75 12.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 109.665 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.04 -36.71 68.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 109.966 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 29.8 mt -72.05 -40.06 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.095 -1.003 . . . . 0.0 109.686 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 30.6 mt -58.05 -35.23 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.013 -1.054 . . . . 0.0 108.751 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.14 -44.0 45.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 55.9 mt -57.8 -35.83 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.288 -1.125 . . . . 0.0 109.162 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.44 -65.96 0.61 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.279 -0.888 . . . . 0.0 109.056 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -45.5 -39.18 7.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.46 -0.775 . . . . 0.0 109.895 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.79 -69.3 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 0.0 109.786 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.4 mt -51.21 -23.84 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.113 -0.992 . . . . 0.0 109.269 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 tt -68.67 -63.86 0.98 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.36 -0.837 . . . . 0.0 110.005 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 -52.34 -46.63 66.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.989 . . . . 0.0 109.907 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.95 -55.21 26.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.032 -1.042 . . . . 0.0 108.841 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 52.9 tp -46.8 -40.99 14.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.536 -0.728 . . . . 0.0 109.932 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.3 -25.32 61.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 109.865 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.6 -17.72 43.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.912 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -81.06 -27.78 35.57 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.631 -1.293 . . . . 0.0 109.338 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -147.46 116.93 7.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.223 -0.923 . . . . 0.0 109.668 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . 0.444 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 79.7 t80 -173.41 82.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 109.391 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -141.8 -129.97 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.43 -0.794 . . . . 0.0 109.176 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 7.4 t 49.57 84.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.419 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 27.5 mt -97.9 -26.78 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.272 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.574 ' CG ' ' N ' ' B' ' 53' ' ' ARG . 2.8 p90 -53.09 -40.26 63.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.453 -0.779 . . . . 0.0 110.362 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.574 ' N ' ' CG ' ' B' ' 52' ' ' TYR . 0.0 OUTLIER -64.91 -29.49 70.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.931 -1.106 . . . . 0.0 109.909 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -74.57 -41.44 60.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.143 -0.973 . . . . 0.0 109.414 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.44 -50.74 66.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.195 -0.941 . . . . 0.0 108.963 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.53 -32.56 71.6 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.303 -0.873 . . . . 0.0 109.12 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -61.37 -59.46 5.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.114 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.65 -58.07 12.33 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 56.4 mt -78.0 69.48 4.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.357 -1.084 . . . . 0.0 109.246 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.9 tptp . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.563 -179.811 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 37.6 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.313 0.578 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' C' ' 26' ' ' LEU . 2.0 m-20 48.81 64.81 8.02 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.754 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -46.06 -8.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.738 2.292 . . . . 0.0 112.435 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' C' ' 24' ' ' ASP . 39.0 tp -47.41 -45.91 25.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.163 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 32.8 t -67.84 -45.83 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 108.616 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -49.32 -49.26 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 109.013 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.01 -34.67 78.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.26 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.24 -55.53 15.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 109.701 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.86 -36.67 67.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.724 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 mt -72.34 -42.02 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 109.406 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.7 mt -54.76 -34.69 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.09 -1.006 . . . . 0.0 108.64 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.23 -44.28 23.19 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 59.9 mt -57.19 -32.38 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.184 -1.186 . . . . 0.0 108.971 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -71.27 -65.56 0.73 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 108.812 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -46.16 -38.24 7.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.815 . . . . 0.0 109.678 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.4 -69.95 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.216 -0.927 . . . . 0.0 109.696 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 15.7 mt -47.4 -25.45 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.16 -0.963 . . . . 0.0 109.398 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 5.9 mt -71.98 -61.05 1.93 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.482 -0.761 . . . . 0.0 109.755 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -47.79 -48.18 30.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.978 . . . . 0.0 109.61 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' C' ' 45' ' ' ARG . 53.4 mt -61.6 -59.8 3.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.193 -0.942 . . . . 0.0 108.826 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.4 tp -43.51 -44.6 6.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.756 -0.59 . . . . 0.0 109.913 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' C' ' 44' ' ' ASP . 0.7 OUTLIER -68.13 -27.25 66.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.22 -0.925 . . . . 0.0 109.64 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.464 ' N ' ' O ' ' C' ' 42' ' ' ILE . 14.0 mmt180 -82.6 -15.54 51.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.171 -0.955 . . . . 0.0 110.559 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 mt -86.58 -11.28 51.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.736 -1.227 . . . . 0.0 109.247 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -59.07 94.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.942 . . . . 0.0 109.156 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . 0.51 ' O ' ' CG ' ' C' ' 48' ' ' PHE . 0.1 OUTLIER -162.89 6.99 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -50.57 -31.36 15.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 3.1 p -164.41 131.95 3.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 5.1 mt -82.18 -22.77 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 108.996 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -45.8 -39.72 8.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 0.0 109.96 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -53.01 -48.57 67.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.117 -0.989 . . . . 0.0 110.171 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' D' ' 51' ' ' ILE . 10.1 m-85 -62.37 -40.48 96.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.095 -1.003 . . . . 0.0 109.562 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -60.19 -58.39 8.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.851 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -57.0 -37.19 71.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -48.04 82.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.063 -1.023 . . . . 0.0 109.748 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.4 -59.54 9.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 6.9 mt -75.63 87.68 2.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -1.163 . . . . 0.0 109.4 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.46 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' D' ' 26' ' ' LEU . 15.4 m-20 51.15 66.68 5.08 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.393 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -46.16 -10.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.754 2.303 . . . . 0.0 112.092 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' D' ' 24' ' ' ASP . 44.9 tp -47.58 -47.6 28.42 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.223 -0.923 . . . . 0.0 109.016 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.27 -44.79 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 108.73 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -48.58 -49.5 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 108.904 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.26 -37.14 86.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.507 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -57.1 10.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.231 -0.918 . . . . 0.0 109.916 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.4 -36.72 64.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.224 -0.923 . . . . 0.0 109.81 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 26.9 mt -72.54 -41.69 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.166 -0.958 . . . . 0.0 109.453 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -55.92 -36.98 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 108.702 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.11 -45.16 57.71 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 47.2 mt -56.05 -38.88 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.204 -1.174 . . . . 0.0 109.286 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.72 -61.78 1.72 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -0.866 . . . . 0.0 109.137 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -46.57 -44.02 17.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.61 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.0 tp -60.07 -69.18 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mt -46.95 -25.25 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.891 . . . . 0.0 109.403 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . 0.444 ' CD2' ' OD2' ' D' ' 44' ' ' ASP . 1.5 tt -69.96 -64.12 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.895 . . . . 0.0 109.716 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 19.0 t-105 -47.26 -49.06 24.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 109.523 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 36.2 mt -61.16 -50.93 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.176 -0.953 . . . . 0.0 109.228 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 53.2 tp -50.88 -37.7 45.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.835 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . 0.444 ' OD2' ' CD2' ' D' ' 40' ' ' LEU . 73.2 m-20 -75.9 -28.41 58.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 109.625 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -71.56 -27.02 62.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.951 . . . . 0.0 110.569 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.4 mt -71.27 -16.08 62.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.69 -1.256 . . . . 0.0 109.112 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -82.92 -7.55 59.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.248 -0.908 . . . . 0.0 108.935 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . 0.445 ' O ' ' CB ' ' D' ' 49' ' ' LYS . 0.9 OUTLIER -87.7 -153.86 0.24 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.405 -0.809 . . . . 0.0 109.737 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' D' ' 48' ' ' PHE . 5.9 ttpt 74.14 -62.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.365 -0.834 . . . . 0.0 109.593 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.85 106.42 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.196 -0.94 . . . . 0.0 109.594 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' C' ' 54' ' ' PHE . 4.0 mt -87.78 -23.3 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.574 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . 0.468 ' CD1' ' C ' ' D' ' 52' ' ' TYR . 0.0 OUTLIER -62.79 -49.25 75.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.145 -0.972 . . . . 0.0 110.181 -179.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . 0.419 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 0.7 OUTLIER -71.6 -28.48 63.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.536 -1.353 . . . . 0.0 110.19 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -75.66 -54.91 6.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.086 -1.009 . . . . 0.0 111.089 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.1 OUTLIER -75.58 -18.29 59.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.957 -1.089 . . . . 0.0 110.583 -178.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . 0.526 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 2.2 tm-20 -84.5 -33.7 23.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.856 -1.152 . . . . 0.0 108.063 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . 0.419 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 0.5 OUTLIER -69.0 -38.6 79.36 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' D' ' 60' ' ' LYS . . . -69.78 -61.5 4.34 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.1 77.61 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -1.159 . . . . 0.0 109.556 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' D' ' 58' ' ' GLY . 50.9 tttt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.479 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 26' ' ' LEU . 8.6 m-20 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -45.82 -11.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.778 2.319 . . . . 0.0 112.27 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 24' ' ' ASP . 37.2 tp -46.65 -46.31 19.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.234 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.6 t -68.51 -44.78 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 108.974 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -49.15 -49.39 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 0.0 109.08 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.83 -35.04 79.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 109.355 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.41 -56.98 10.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.69 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.456 ' H ' ' HG ' ' A' ' 31' ' ' SER . 0.9 OUTLIER -55.95 -36.98 68.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.194 -0.941 . . . . 0.0 109.866 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.8 mt -71.01 -40.91 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.107 -0.996 . . . . 0.0 109.441 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.9 mt -57.02 -36.05 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.141 -0.974 . . . . 0.0 108.59 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.29 -44.1 53.34 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.5 mt -61.81 -27.02 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.165 -1.197 . . . . 0.0 109.155 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.99 -66.6 0.65 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.333 -0.854 . . . . 0.0 109.441 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.31 -39.31 6.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 109.841 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.67 -69.0 0.3 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.419 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.5 mt -47.1 -34.34 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.514 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 mt -62.87 -55.8 22.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.464 -0.773 . . . . 0.0 109.943 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -52.03 -45.01 64.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mt -68.76 -28.29 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.108 -0.995 . . . . 0.0 109.279 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -44.26 97.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.563 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.507 ' OD1' ' NH2' ' B' ' 45' ' ' ARG . 2.6 m-20 -80.19 -24.45 40.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 109.97 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -93.31 0.97 57.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.122 -0.987 . . . . 0.0 111.25 -179.22 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.48 ' C ' ' O ' ' A' ' 45' ' ' ARG . 31.0 mt -31.3 -36.27 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.693 -0.63 . . . . 0.0 110.814 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 169.15 -10.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 109.267 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -46.21 103.8 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.383 -0.823 . . . . 0.0 109.42 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.455 ' CG ' ' H ' ' A' ' 50' ' ' SER . 12.6 tptm -145.44 -129.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.905 . . . . 0.0 109.713 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.455 ' H ' ' CG ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER 65.36 135.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.282 -0.886 . . . . 0.0 109.229 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.1 mt -102.17 -35.26 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.525 -0.735 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -35.39 69.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.612 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -64.24 -41.12 97.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 0.0 109.369 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -65.34 -29.11 69.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.434 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -75.34 -68.42 0.56 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.098 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -46.83 -31.27 2.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.243 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -69.85 -58.77 3.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.314 -0.866 . . . . 0.0 109.566 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.19 -60.45 9.0 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.08 97.17 1.44 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -1.1 . . . . 0.0 109.356 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.4 mttp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.511 -179.888 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 30.3 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' B' ' 26' ' ' LEU . 4.8 m-20 48.82 67.28 4.66 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.449 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -47.22 -9.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.763 2.309 . . . . 0.0 112.311 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.468 ' H ' ' C ' ' B' ' 24' ' ' ASP . 39.1 tp -47.22 -44.76 22.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.944 . . . . 0.0 108.871 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 38.7 t -68.66 -44.88 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 108.758 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.5 t -49.7 -50.62 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 109.176 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.39 -34.82 78.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 109.391 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.76 -55.99 14.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 109.685 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.72 -36.85 67.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 109.873 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 18.9 mt -72.42 -42.4 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.553 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 mt -55.85 -34.65 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.054 -1.029 . . . . 0.0 108.826 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.33 -43.89 36.55 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 67.7 mt -60.25 -26.29 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.243 -1.151 . . . . 0.0 109.234 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.58 -64.49 1.06 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.267 -0.896 . . . . 0.0 109.263 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -45.5 -43.56 11.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.4 tp -63.15 -64.57 0.87 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.311 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 8.2 mt -47.78 -28.36 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.471 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mt -67.44 -55.86 11.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 110.141 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -55.67 -39.72 71.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.944 . . . . 0.0 109.937 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 94.5 mt -70.58 -40.57 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.954 -1.091 . . . . 0.0 108.959 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 50.3 tp -57.51 -41.33 80.61 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.516 -0.74 . . . . 0.0 109.767 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.3 -23.73 43.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.154 -0.966 . . . . 0.0 109.84 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.507 ' NH2' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -89.01 -4.74 58.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.044 -1.035 . . . . 0.0 110.902 -179.19 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.497 ' C ' ' O ' ' B' ' 45' ' ' ARG . 28.0 mt -33.56 -35.9 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.693 -0.629 . . . . 0.0 110.166 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' B' ' 45' ' ' ARG . 3.3 t80 -172.59 136.08 0.73 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.943 . . . . 0.0 109.326 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . 0.413 ' CD2' ' O ' ' B' ' 47' ' ' PHE . 0.7 OUTLIER -167.85 98.58 0.46 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.216 -0.928 . . . . 0.0 109.43 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -141.79 -35.73 0.44 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 109.424 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 11.9 p -65.65 124.71 23.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.291 -0.88 . . . . 0.0 109.531 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 15.8 mt -111.39 -22.67 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.671 -0.643 . . . . 0.0 109.347 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -54.03 -21.43 8.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.663 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -69.87 -45.9 66.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.437 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -65.09 -34.4 78.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.476 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -65.65 -60.24 3.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 109.458 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -52.71 -30.96 35.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.459 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -62.63 -63.42 1.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 109.315 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.33 -59.29 9.77 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mt -50.77 143.96 9.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.358 -1.084 . . . . 0.0 109.683 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.5 mttm . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.33 179.854 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 50.9 p . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' C' ' 26' ' ' LEU . 1.7 p-10 -171.11 70.24 0.51 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.393 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.53 -9.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.814 2.343 . . . . 0.0 112.402 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . 0.46 ' H ' ' C ' ' C' ' 24' ' ' ASP . 48.3 tp -47.76 -46.97 30.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.189 -0.944 . . . . 0.0 109.033 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.78 -45.47 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.238 -0.914 . . . . 0.0 108.759 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -48.46 -46.48 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 0.0 109.139 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.93 -36.87 83.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -0.929 . . . . 0.0 109.46 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.36 -55.13 27.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 109.388 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.08 -36.2 67.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.392 -0.818 . . . . 0.0 109.894 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 18.4 mt -72.98 -41.57 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.109 -0.994 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 21.1 mt -56.78 -34.79 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.074 -1.016 . . . . 0.0 108.614 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.11 -45.17 42.03 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 54.4 mt -57.13 -31.81 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.21 -1.171 . . . . 0.0 108.869 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.98 -64.62 0.87 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.456 -0.778 . . . . 0.0 109.055 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -46.25 -39.08 9.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.876 . . . . 0.0 109.72 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -63.09 -70.13 0.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.956 . . . . 0.0 109.545 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 3.9 mt -47.14 -37.92 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.319 -0.863 . . . . 0.0 109.401 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mt -61.42 -61.79 2.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.343 -0.848 . . . . 0.0 110.101 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -45.85 -49.48 15.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.366 -0.834 . . . . 0.0 109.578 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 64.7 mt -60.57 -44.44 96.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.166 -0.959 . . . . 0.0 108.9 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.36 -55.28 11.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.536 -0.727 . . . . 0.0 109.583 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -64.4 -27.71 69.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 110.316 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -72.11 -25.25 61.67 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.861 -1.149 . . . . 0.0 110.798 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 47' ' ' PHE . 9.7 mt -68.95 -8.78 47.71 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.669 -1.27 . . . . 0.0 109.289 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' C' ' 49' ' ' LYS . 2.9 m-85 -47.23 -92.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -0.93 . . . . 0.0 109.35 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 46.09 19.63 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.762 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' C' ' 47' ' ' PHE . 16.4 mtpt -64.01 -148.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.153 -0.967 . . . . 0.0 109.483 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.7 162.83 14.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.174 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 13.4 mt -103.93 -22.76 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.536 -0.728 . . . . 0.0 109.442 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' C' ' 52' ' ' TYR . 6.5 t80 -63.55 -22.05 66.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.265 -0.897 . . . . 0.0 109.982 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -66.33 -46.99 74.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.072 -1.017 . . . . 0.0 110.0 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -66.02 -33.68 76.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 0.0 109.691 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -63.17 -58.65 6.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.378 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -57.14 -30.0 64.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 109.157 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -67.28 -45.83 75.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.298 -0.876 . . . . 0.0 109.127 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.25 -61.89 5.36 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 mt -48.7 140.08 8.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -1.153 . . . . 0.0 109.494 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.474 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' SER . . . . . 0.522 ' H ' ' HG ' ' D' ' 23' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.286 0.565 . . . . 0.0 109.521 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.37 160.11 0.38 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.328 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' D' ' 26' ' ' LEU . 19.5 Cg_endo -61.83 -24.42 77.24 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.567 2.178 . . . . 0.0 112.206 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' D' ' 25' ' ' PRO . 56.2 tp -45.59 -41.02 9.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 108.775 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 33.5 t -70.26 -45.27 76.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.303 -0.873 . . . . 0.0 108.697 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 74.1 t -49.76 -49.1 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 108.95 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.37 -33.47 76.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.307 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.23 -56.17 14.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.663 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -37.12 69.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.228 -0.92 . . . . 0.0 109.858 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 20.6 mt -71.36 -41.67 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.076 -1.015 . . . . 0.0 109.426 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 17.3 mt -56.48 -33.94 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.071 -1.018 . . . . 0.0 108.566 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.58 -44.55 32.38 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 61.9 mt -58.41 -29.66 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.343 -1.092 . . . . 0.0 109.218 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.13 -67.07 0.6 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.0 109.097 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -46.82 -37.29 8.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 0.0 109.732 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 59.4 tp -65.09 -69.2 0.31 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.133 -0.98 . . . . 0.0 109.507 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.1 mt -49.2 -26.51 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.483 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 tt -67.64 -63.03 1.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.924 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . 0.507 ' CH2' ' NE ' ' D' ' 45' ' ' ARG . 24.7 t-105 -53.04 -43.87 66.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.984 -1.072 . . . . 0.0 109.666 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.75 -51.2 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.152 -0.967 . . . . 0.0 108.782 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 58.1 tp -50.06 -39.73 43.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.608 -0.683 . . . . 0.0 109.931 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.79 -24.43 55.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 109.911 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . 0.507 ' NE ' ' CH2' ' D' ' 41' ' ' TRP . 0.6 OUTLIER -76.08 -25.24 55.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.106 -0.996 . . . . 0.0 110.21 -179.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -73.13 -28.88 62.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.796 -1.19 . . . . 0.0 109.338 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . 0.455 ' O ' ' CB ' ' D' ' 48' ' ' PHE . 7.5 m-85 -66.19 -170.4 0.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . 0.455 ' CB ' ' O ' ' D' ' 47' ' ' PHE . 2.4 t80 73.61 18.5 3.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . 0.525 ' CG ' ' H ' ' D' ' 50' ' ' SER . 0.0 OUTLIER -58.47 -97.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -0.869 . . . . 0.0 109.409 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.525 ' H ' ' CG ' ' D' ' 49' ' ' LYS . 1.1 t -57.76 139.52 53.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.44 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 19.8 mt -109.59 -26.83 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.661 -0.65 . . . . 0.0 109.522 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . 0.516 ' CZ ' ' OG ' ' D' ' 50' ' ' SER . 17.8 p90 -59.99 -43.82 94.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.93 . . . . 0.0 109.721 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . 0.407 ' N ' ' CD2' ' D' ' 52' ' ' TYR . 10.1 mtp85 -64.39 -35.93 82.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.089 -1.007 . . . . 0.0 109.339 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -63.48 -33.74 76.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.878 . . . . 0.0 109.334 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -71.21 -56.59 5.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -0.84 . . . . 0.0 109.215 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -51.56 -29.31 16.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.221 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -69.34 -55.79 9.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.913 . . . . 0.0 109.235 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -48.07 -57.17 8.16 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.73 121.6 13.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.345 -1.091 . . . . 0.0 109.445 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 23.6 tttt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.486 -179.981 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.532 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 5.1 m-20 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 12.8 Cg_endo -59.01 -12.67 16.09 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.744 2.296 . . . . 0.0 112.121 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.2 tp -47.22 -46.85 24.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 0.0 108.959 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.2 t -68.9 -44.74 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.34 -0.85 . . . . 0.0 108.792 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.3 t -49.36 -49.33 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.0 108.815 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.82 -33.39 75.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.374 -0.829 . . . . 0.0 109.35 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.52 -56.8 10.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.3 -0.875 . . . . 0.0 109.677 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.484 ' H ' ' HG ' ' A' ' 31' ' ' SER . 0.7 OUTLIER -55.98 -37.34 68.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 109.891 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 27.7 mt -71.59 -41.36 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.136 -0.977 . . . . 0.0 109.474 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.1 mt -55.67 -34.79 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.175 -0.953 . . . . 0.0 108.458 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.26 -44.96 32.69 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.2 mt -56.84 -34.07 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.175 -1.191 . . . . 0.0 109.248 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.96 -63.61 1.03 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 109.086 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.96 -38.39 7.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.475 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.71 -70.97 0.2 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.872 . . . . 0.0 109.392 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 mt -46.79 -25.52 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.278 -0.889 . . . . 0.0 109.505 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -74.24 -55.5 5.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.704 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.5 t-105 -50.84 -48.52 59.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.96 . . . . 0.0 109.613 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mt -65.78 -57.53 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.291 -0.881 . . . . 0.0 109.398 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.6 tp -48.78 -27.95 3.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.541 -0.725 . . . . 0.0 110.525 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 2.3 m-20 -90.3 -26.97 19.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.012 -1.055 . . . . 0.0 109.961 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -73.12 -26.12 61.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.628 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 48' ' ' PHE . 9.0 mt -64.91 -9.81 24.06 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.795 -1.191 . . . . 0.0 109.552 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -66.82 76.61 0.12 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.1 -1.0 . . . . 0.0 109.514 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -156.9 21.01 0.32 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -126.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.54 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.0 m -48.55 125.91 10.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 0.0 109.421 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.3 mt -94.62 -24.86 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.817 . . . . 0.0 109.428 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.505 ' CD2' ' OE1' ' A' ' 56' ' ' GLU . 0.5 OUTLIER -60.6 -23.23 64.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.878 . . . . 0.0 109.592 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.457 ' O ' ' CG ' ' A' ' 57' ' ' HIS . 21.3 mtt180 -70.36 -37.47 74.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.088 -1.008 . . . . 0.0 109.665 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -71.93 -36.52 69.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.154 -0.966 . . . . 0.0 109.298 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -65.62 -46.42 79.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 0.0 109.793 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.505 ' OE1' ' CD2' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -70.56 -28.16 64.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.245 -0.909 . . . . 0.0 109.708 -179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.457 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 1.9 m-70 -67.28 -46.32 73.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 109.196 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.86 -65.16 2.56 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mt -59.1 145.34 42.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -1.136 . . . . 0.0 109.492 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.457 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.561 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 28.9 m-20 -152.21 48.5 0.47 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 109.612 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 10.5 Cg_endo -56.52 -15.06 14.45 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.794 2.33 . . . . 0.0 112.235 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 29.6 tp -46.5 -46.1 18.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.247 -0.908 . . . . 0.0 109.096 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.53 -44.39 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.231 -0.918 . . . . 0.0 108.967 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 74.5 t -50.73 -50.22 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.302 -0.874 . . . . 0.0 109.089 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.42 -36.56 82.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.53 -56.08 16.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.336 -0.852 . . . . 0.0 109.806 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.22 -36.77 66.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 109.707 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.19 -40.33 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.108 -0.995 . . . . 0.0 109.613 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 17.1 mt -56.8 -36.0 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.019 -1.051 . . . . 0.0 108.803 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.63 -43.29 44.33 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 86.2 mt -63.11 -21.27 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.35 -1.088 . . . . 0.0 108.908 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.55 -69.77 0.54 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.838 . . . . 0.0 109.218 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -46.55 -33.69 4.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.332 -0.855 . . . . 0.0 109.453 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.7 tp -68.11 -68.76 0.36 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.358 -0.839 . . . . 0.0 109.446 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -48.64 -33.33 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -0.925 . . . . 0.0 109.433 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 tt -64.32 -54.74 28.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 109.444 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -48.83 -48.04 41.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.3 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 11.5 mt -66.27 -33.12 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.119 -0.988 . . . . 0.0 108.802 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -58.88 -34.5 71.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.507 -0.746 . . . . 0.0 110.316 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -87.71 -27.26 22.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.971 -1.081 . . . . 0.0 109.614 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -91.63 3.46 54.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 110.649 -179.481 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.481 ' C ' ' O ' ' B' ' 45' ' ' ARG . 34.1 mt -29.35 -37.02 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.976 -0.453 . . . . 0.0 110.915 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' B' ' 45' ' ' ARG . 0.4 OUTLIER -177.92 165.01 1.96 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.995 -1.066 . . . . 0.0 109.7 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -163.99 110.43 1.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.814 . . . . 0.0 109.432 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.586 ' N ' ' CD ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -144.02 -18.48 0.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.375 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.434 ' H ' ' HG ' ' B' ' 50' ' ' SER . 0.0 OUTLIER -93.4 97.22 10.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.214 -0.929 . . . . 0.0 109.35 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 5.8 mt -93.33 -23.84 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.255 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -34.94 74.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.588 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 12.3 mtp180 -64.66 -32.58 74.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.869 . . . . 0.0 109.395 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -72.69 -42.63 64.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -0.892 . . . . 0.0 109.27 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -60.48 -39.7 88.61 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.385 -0.822 . . . . 0.0 109.015 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -71.77 -30.87 66.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.408 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -65.18 -48.95 71.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.27 -0.894 . . . . 0.0 109.066 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.9 -62.34 5.32 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 3.9 mt -58.98 138.08 57.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.353 -1.087 . . . . 0.0 109.272 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 16.0 tttm . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.52 -179.896 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.324 0.583 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 10.8 t0 -167.6 48.77 0.16 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.9 . . . . 0.0 109.197 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 2.9 Cg_endo -44.98 -19.77 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.778 2.319 . . . . 0.0 112.011 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 32.3 tp -45.85 -40.73 10.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.404 -0.81 . . . . 0.0 109.172 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.44 -45.19 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.866 . . . . 0.0 108.959 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 70.8 t -51.18 -49.88 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 108.973 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.89 -32.99 74.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.839 . . . . 0.0 109.249 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.36 -55.88 13.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.865 . . . . 0.0 109.47 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.93 -36.47 70.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.352 -0.843 . . . . 0.0 109.672 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 15.4 mt -71.45 -40.23 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.159 -0.963 . . . . 0.0 109.402 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.4 mt -58.03 -35.69 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.139 -0.976 . . . . 0.0 108.665 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.42 -43.23 62.57 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 79.5 mt -63.76 -28.87 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.415 -1.05 . . . . 0.0 109.006 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.94 -58.86 4.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.412 -0.805 . . . . 0.0 108.98 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -54.36 -42.76 70.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.397 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 59.2 tp -58.81 -62.79 1.61 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.131 -0.98 . . . . 0.0 109.319 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mt -51.61 -40.98 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.215 -0.928 . . . . 0.0 109.495 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mt -60.86 -54.43 45.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.403 -0.81 . . . . 0.0 110.05 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -52.21 -44.61 64.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.366 -0.834 . . . . 0.0 109.813 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 36.4 mt -70.48 -28.17 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.236 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.82 -43.5 98.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.644 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.31 -24.6 32.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.111 -0.993 . . . . 0.0 109.688 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' C' ' 47' ' ' PHE . 1.6 mmt85 -89.42 -1.18 57.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.3 -0.875 . . . . 0.0 110.753 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . 0.491 ' C ' ' O ' ' C' ' 45' ' ' ARG . 29.0 mt -31.16 -36.23 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.851 -0.531 . . . . 0.0 110.805 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' C' ' 45' ' ' ARG . 2.3 m-85 -169.16 85.22 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.116 -0.99 . . . . 0.0 109.801 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 46.32 -132.87 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 109.686 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -170.07 -140.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.88 . . . . 0.0 109.256 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' SER . . . . . 0.441 ' O ' ' CZ ' ' C' ' 54' ' ' PHE . 40.5 t -147.9 120.52 8.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.319 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 17.1 mt -86.79 -23.12 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.243 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -23.85 64.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.352 -0.842 . . . . 0.0 109.499 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -70.39 -45.49 65.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.132 -0.98 . . . . 0.0 109.956 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' C' ' 54' ' ' PHE . 0.7 OUTLIER -69.1 -43.14 75.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.007 -1.058 . . . . 0.0 109.069 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -55.95 -56.72 17.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.407 -0.808 . . . . 0.0 109.354 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -26.8 68.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.664 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 37.0 t60 -67.16 -47.5 70.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.225 -0.922 . . . . 0.0 109.131 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.28 -59.6 9.21 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 62.4 mt -69.09 147.86 50.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.325 -1.103 . . . . 0.0 109.791 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 15.3 mttp . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.626 179.709 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' SER . . . . . 0.404 ' O ' ' OD1' ' D' ' 24' ' ' ASP . 69.4 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' D' ' 26' ' ' LEU . 62.0 m-20 -151.68 68.0 7.47 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -46.95 -11.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.659 2.239 . . . . 0.0 112.187 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' D' ' 24' ' ' ASP . 36.9 tp -47.36 -46.32 25.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.023 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 80.6 t -67.67 -45.5 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 0.0 108.852 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 72.6 t -49.42 -47.4 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.897 . . . . 0.0 108.912 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.53 -34.2 77.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.412 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.41 -56.63 10.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.194 -0.941 . . . . 0.0 109.634 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.94 -35.67 66.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 0.0 109.91 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 18.9 mt -73.25 -43.73 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.133 -0.979 . . . . 0.0 109.561 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 20.6 mt -54.56 -34.42 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.177 -0.952 . . . . 0.0 108.655 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.55 -44.41 26.82 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 50.0 mt -55.59 -31.04 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.087 -1.243 . . . . 0.0 109.356 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.11 -63.02 1.36 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.299 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -45.87 -38.94 7.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.367 -0.833 . . . . 0.0 109.854 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 53.7 tp -68.12 -67.85 0.43 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.123 -0.985 . . . . 0.0 109.642 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -47.31 -25.68 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.659 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.88 -65.67 0.67 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 109.818 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 21.3 t-105 -48.9 -45.19 40.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.212 -0.93 . . . . 0.0 109.879 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' D' ' 45' ' ' ARG . 84.9 mt -63.32 -56.86 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.131 -0.981 . . . . 0.0 108.875 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 61.2 tp -46.26 -45.82 17.42 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.539 -0.726 . . . . 0.0 109.422 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.79 -26.7 67.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.357 -0.839 . . . . 0.0 109.771 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . 0.49 ' CA ' ' HE ' ' D' ' 45' ' ' ARG . 0.0 OUTLIER -77.49 -21.15 53.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.13 -0.981 . . . . 0.0 110.151 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.1 mt -83.65 -34.13 25.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.776 -1.202 . . . . 0.0 108.926 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -95.43 118.09 31.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.458 -0.776 . . . . 0.0 109.389 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -158.85 -8.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.122 -0.986 . . . . 0.0 109.63 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.9 pttp -67.98 -152.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.191 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 11.4 p 44.09 59.53 3.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.334 -0.854 . . . . 0.0 109.65 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 12.4 mt -96.83 -22.89 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.338 -0.852 . . . . 0.0 109.606 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -67.73 -22.75 65.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.136 -0.977 . . . . 0.0 109.483 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . 0.435 ' O ' ' ND1' ' D' ' 57' ' ' HIS . 0.1 OUTLIER -69.93 -39.37 76.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 109.44 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -69.72 -37.62 76.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.92 . . . . 0.0 109.089 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.35 -43.69 96.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.341 -0.849 . . . . 0.0 109.288 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -68.99 -27.95 66.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.272 -0.892 . . . . 0.0 109.114 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . 0.435 ' ND1' ' O ' ' D' ' 53' ' ' ARG . 1.7 m-70 -67.37 -46.95 71.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.308 -0.87 . . . . 0.0 108.855 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.26 -60.99 7.38 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 114.81 6.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -1.061 . . . . 0.0 109.419 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.06 -0.972 . . . . 0.0 109.447 179.978 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 26' ' ' LEU . 13.3 m-20 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.123 0.487 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -45.72 -11.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.691 2.261 . . . . 0.0 112.076 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 24' ' ' ASP . 28.7 tp -47.37 -45.68 25.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.339 -0.851 . . . . 0.0 109.044 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.32 -45.64 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.288 -0.883 . . . . 0.0 108.803 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.5 t -49.53 -47.85 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.253 -0.904 . . . . 0.0 109.021 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.3 -33.58 76.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 109.339 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.18 -56.66 10.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.873 . . . . 0.0 109.685 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.95 -36.27 70.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.259 -0.9 . . . . 0.0 109.633 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.7 mt -70.87 -41.15 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 0.0 109.329 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.2 mt -57.48 -33.8 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.099 -1.001 . . . . 0.0 108.626 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.65 -44.38 39.92 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.1 mt -55.47 -34.98 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.321 -1.106 . . . . 0.0 109.097 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.82 -64.33 0.89 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.31 -0.869 . . . . 0.0 109.066 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.23 -41.01 8.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.445 -0.784 . . . . 0.0 110.072 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 35.4 tp -64.19 -68.04 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.111 -0.993 . . . . 0.0 109.6 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mt -47.9 -24.59 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.213 -0.93 . . . . 0.0 109.308 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.462 ' CD2' ' OD2' ' A' ' 44' ' ' ASP . 1.8 tt -71.35 -61.32 1.81 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 109.595 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 -51.16 -49.79 60.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.272 -0.892 . . . . 0.0 109.714 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' A' ' 45' ' ' ARG . 80.6 mt -60.23 -56.32 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.006 -1.059 . . . . 0.0 108.969 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.3 tp -46.34 -42.15 14.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.477 -0.764 . . . . 0.0 109.578 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.462 ' OD2' ' CD2' ' A' ' 40' ' ' LEU . 72.9 m-20 -67.71 -28.19 67.45 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.21 -0.931 . . . . 0.0 109.276 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 42' ' ' ILE . 7.0 mmt-85 -80.11 -17.72 51.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 110.42 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -87.14 -35.08 18.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.693 -1.255 . . . . 0.0 109.002 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -99.5 -154.58 0.47 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.462 -0.774 . . . . 0.0 109.255 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 t80 66.56 114.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 50' ' ' SER . 5.3 ptmm? -169.8 -148.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.315 -0.866 . . . . 0.0 109.3 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 49' ' ' LYS . 17.0 m 50.98 97.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.9 mt -86.5 -24.42 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 109.067 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -59.23 -21.7 59.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.272 -0.892 . . . . 0.0 109.867 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' A' ' 57' ' ' HIS . 17.7 mmm180 -74.43 -44.09 53.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.91 -1.119 . . . . 0.0 109.744 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.495 ' CD1' ' C ' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -73.71 -33.55 64.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.993 -1.067 . . . . 0.0 108.496 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -68.43 -52.12 36.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.351 -0.843 . . . . 0.0 109.861 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -71.17 -27.54 63.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.122 -0.986 . . . . 0.0 110.194 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.521 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 11.4 m170 -65.0 -52.91 53.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.966 -1.084 . . . . 0.0 109.124 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.05 -64.52 2.76 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.4 116.98 4.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.189 -1.183 . . . . 0.0 109.425 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.431 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.537 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 16.6 m-20 -159.96 50.22 0.34 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.212 -0.93 . . . . 0.0 109.376 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 12.3 Cg_endo -58.7 -15.8 27.79 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.928 2.418 . . . . 0.0 112.438 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 52.1 tp -47.22 -43.23 21.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.086 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.58 -45.25 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.91 . . . . 0.0 108.733 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 77.6 t -49.0 -46.34 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.282 -0.886 . . . . 0.0 108.989 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.95 -37.1 85.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 109.144 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.01 -55.37 29.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.339 -0.851 . . . . 0.0 109.651 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.0 -37.28 71.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 110.06 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 14.0 mt -70.84 -39.75 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.141 -0.974 . . . . 0.0 109.319 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 26.8 mt -57.77 -36.44 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.246 -0.909 . . . . 0.0 108.634 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.54 -44.55 63.6 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.2 -23.28 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.295 -1.12 . . . . 0.0 109.005 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.2 tp -76.78 -71.71 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.464 -0.773 . . . . 0.0 109.456 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . 0.47 ' CD2' ' ND1' ' C' ' 37' ' ' HIS . 2.9 t-80 -44.79 -35.42 2.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 109.774 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -66.58 -68.66 0.36 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.191 -0.943 . . . . 0.0 109.466 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 7.0 mt -48.69 -41.18 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.463 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.96 -61.72 2.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 110.066 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -46.82 -47.62 21.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.104 -0.998 . . . . 0.0 109.746 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 70.1 mt -62.0 -42.17 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.185 -0.947 . . . . 0.0 109.11 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.42 -43.39 64.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.625 -0.672 . . . . 0.0 109.918 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -77.83 -25.41 48.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.743 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -71.83 -30.47 65.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.84 -1.163 . . . . 0.0 110.614 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -55.85 -26.53 47.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.734 -1.228 . . . . 0.0 109.281 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.19 -166.17 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.071 -1.018 . . . . 0.0 109.255 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -134.36 -125.02 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.742 . . . . 0.0 109.358 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -149.74 -63.68 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 83.7 p -52.14 104.96 0.1 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.871 . . . . 0.0 109.493 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 10.7 mt -103.75 -20.18 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.435 -0.791 . . . . 0.0 109.355 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -57.51 -12.64 2.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.576 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -72.1 -42.17 66.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 109.724 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -70.09 -38.41 75.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.143 -0.973 . . . . 0.0 108.993 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -59.43 -47.91 83.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.512 -0.743 . . . . 0.0 109.593 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.8 -27.2 63.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.584 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -66.18 -50.48 63.74 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.885 . . . . 0.0 109.13 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.03 -63.54 3.77 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 7.2 mt -68.65 118.58 11.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -1.148 . . . . 0.0 109.511 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 mptt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.481 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.32 159.22 75.54 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 0.0 109.277 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -61.08 -20.35 67.34 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.36 2.04 . . . . 0.0 112.205 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 47.4 tp -47.22 -42.54 20.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.944 . . . . 0.0 108.581 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 35.0 t -69.09 -45.48 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 73.8 t -48.77 -47.55 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 108.853 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.86 -36.48 84.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.37 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.13 -57.27 10.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.393 -0.817 . . . . 0.0 109.832 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.48 -36.97 67.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.268 -0.895 . . . . 0.0 109.916 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 24.8 mt -70.99 -42.45 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.378 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.9 mt -55.41 -35.69 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 108.83 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.25 -45.22 40.44 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 51.5 mt -55.72 -30.27 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.157 -1.202 . . . . 0.0 109.066 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -64.01 1.09 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 109.069 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . 0.47 ' ND1' ' CD2' ' B' ' 37' ' ' HIS . 13.0 t-80 -43.4 -37.25 2.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.484 -0.76 . . . . 0.0 110.244 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 35.3 tp -71.99 -65.17 0.8 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.983 -1.073 . . . . 0.0 109.523 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.3 mt -46.94 -27.64 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.235 -0.916 . . . . 0.0 109.393 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.04 -63.24 1.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.338 -0.851 . . . . 0.0 109.688 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -45.94 -47.5 16.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 109.287 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 64.5 mt -58.49 -49.31 82.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.221 -0.924 . . . . 0.0 108.93 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.56 -50.43 13.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.653 -0.655 . . . . 0.0 109.411 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . 0.423 ' OD1' ' NH1' ' D' ' 45' ' ' ARG . 1.3 m-20 -62.76 -32.82 74.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.89 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -73.02 -19.12 61.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.07 -1.019 . . . . 0.0 110.416 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -83.75 -13.63 53.49 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.641 -1.287 . . . . 0.0 108.716 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.93 12.7 5.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 0.0 109.733 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.16 106.69 18.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.113 -0.992 . . . . 0.0 109.039 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -163.58 -90.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.152 -0.967 . . . . 0.0 109.72 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.34 103.61 0.25 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.913 . . . . 0.0 109.756 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 18.4 mt -90.99 -22.68 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.052 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.97 -23.42 66.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.026 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . 0.52 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 96.7 mtt180 -70.38 -36.51 74.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.068 -1.02 . . . . 0.0 110.125 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -72.35 -34.74 68.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.004 -1.06 . . . . 0.0 109.286 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.26 -45.8 79.29 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.338 -0.851 . . . . 0.0 109.679 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -71.6 -29.01 64.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.0 109.591 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . 0.521 ' O ' ' NZ ' ' D' ' 49' ' ' LYS . 2.7 m-70 -64.58 -43.05 95.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 109.068 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.44 -61.61 4.09 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 mt -75.07 107.2 6.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -1.117 . . . . 0.0 109.57 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 14.9 tttt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.515 179.824 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . 0.537 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 6.1 t70 66.21 48.4 0.56 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.353 -0.842 . . . . 0.0 109.595 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 0.9 OUTLIER -48.11 -19.72 1.81 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.634 2.223 . . . . 0.0 111.701 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 42.1 tp -46.26 -41.17 12.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.423 -0.798 . . . . 0.0 108.99 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 36.4 t -69.66 -45.67 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.237 -0.914 . . . . 0.0 108.795 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 77.5 t -49.2 -47.35 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 108.963 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.8 -34.33 77.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.873 . . . . 0.0 109.226 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.2 -55.44 18.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.849 . . . . 0.0 109.688 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -58.1 -36.21 72.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.324 -0.86 . . . . 0.0 109.892 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 25.7 mt -72.05 -42.52 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.145 -0.972 . . . . 0.0 109.438 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mt -56.2 -33.37 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.107 -0.996 . . . . 0.0 108.457 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.5 -44.78 25.84 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.85 -28.99 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.188 -1.184 . . . . 0.0 109.113 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.18 -65.33 0.76 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.335 -0.853 . . . . 0.0 108.883 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -45.75 -42.88 12.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.48 -0.763 . . . . 0.0 109.712 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.19 -67.79 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 0.0 109.558 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mt -47.13 -35.7 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.175 -0.953 . . . . 0.0 109.639 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mt -63.5 -57.39 10.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.937 . . . . 0.0 109.826 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -48.15 -45.38 33.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.04 -1.037 . . . . 0.0 109.472 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 67.4 mt -64.49 -50.17 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.156 -0.965 . . . . 0.0 109.012 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 14.3 tp -52.09 -37.14 53.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.638 -0.664 . . . . 0.0 110.39 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.67 -21.73 30.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.036 -1.04 . . . . 0.0 110.349 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . 0.423 ' NH1' ' OD1' ' C' ' 44' ' ' ASP . 0.0 OUTLIER -76.09 -28.95 57.73 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.984 -1.073 . . . . 0.0 110.712 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.25 -10.98 1.46 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.687 -1.258 . . . . 0.0 109.171 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -77.04 120.49 22.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.165 -0.96 . . . . 0.0 109.407 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.34 178.78 8.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.39 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . 0.558 ' CD ' ' H ' ' D' ' 50' ' ' SER . 6.0 tmtt? 54.83 -153.67 0.31 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.088 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.558 ' H ' ' CD ' ' D' ' 49' ' ' LYS . 2.6 m 47.01 54.7 8.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.945 -1.097 . . . . 0.0 110.023 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 47.4 mt -97.47 -28.64 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 0.0 109.297 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.44 -32.96 67.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.339 -0.85 . . . . 0.0 109.455 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -63.56 -34.76 78.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.114 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -72.55 -38.88 67.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.286 -0.884 . . . . 0.0 109.108 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -62.29 -49.39 75.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.411 -0.806 . . . . 0.0 109.208 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -67.87 -26.22 65.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.338 -0.851 . . . . 0.0 109.424 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -68.91 -34.71 75.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.87 . . . . 0.0 109.119 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.19 -62.89 2.36 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 7.5 mt -59.93 116.6 4.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -1.132 . . . . 0.0 109.337 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.474 179.886 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 26' ' ' LEU . 28.0 t70 . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -44.72 -12.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.677 2.251 . . . . 0.0 112.234 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' A' ' 24' ' ' ASP . 38.8 tp -48.92 -43.22 39.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.018 -1.052 . . . . 0.0 108.8 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 t -68.39 -46.01 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.232 -0.918 . . . . 0.0 108.588 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.6 t -49.08 -47.17 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 0.0 108.876 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.11 -33.39 75.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.316 -0.865 . . . . 0.0 109.345 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.44 -57.24 6.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.313 -0.867 . . . . 0.0 109.727 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.71 -37.14 65.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.968 . . . . 0.0 109.429 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.5 mt -71.11 -41.15 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 0.0 109.124 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.3 mt -56.03 -34.03 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.119 -0.988 . . . . 0.0 108.524 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.9 -45.84 31.7 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.9 mt -60.55 -23.13 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.265 -1.138 . . . . 0.0 108.845 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.6 tp -76.69 -70.8 0.43 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.518 -0.739 . . . . 0.0 109.082 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -47.31 -33.51 5.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 109.506 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.9 tp -66.59 -69.17 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 109.654 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 mt -48.45 -27.68 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.61 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.429 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 1.6 mt -68.61 -59.82 2.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -0.933 . . . . 0.0 109.914 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -53.36 -46.12 69.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.021 -1.049 . . . . 0.0 109.809 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 82.2 mt -61.78 -52.77 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.018 -1.051 . . . . 0.0 108.836 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.8 tp -51.25 -38.58 53.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.506 -0.746 . . . . 0.0 109.399 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 1.4 m-20 -72.38 -24.98 61.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 109.23 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.53 ' CA ' ' HE ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -77.96 -24.12 48.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.177 -0.952 . . . . 0.0 110.14 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 48' ' ' PHE . 9.3 mt -80.17 -13.93 58.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.77 -1.206 . . . . 0.0 109.043 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -75.03 29.78 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.655 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.49 ' H ' ' C ' ' A' ' 46' ' ' LEU . 78.0 t80 -83.04 77.14 9.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.134 -0.979 . . . . 0.0 109.369 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -85.71 -128.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.459 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.98 168.48 10.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.337 -0.852 . . . . 0.0 109.489 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.0 mt -104.2 -23.11 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.487 -0.758 . . . . 0.0 109.324 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -60.15 -21.82 62.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.097 -1.002 . . . . 0.0 109.734 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.7 mtt85 -69.39 -43.48 73.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.176 -0.952 . . . . 0.0 109.26 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -64.96 -36.56 84.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.476 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -70.68 -61.64 1.69 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -48.39 -29.72 4.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.348 -0.845 . . . . 0.0 109.646 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -71.13 -53.3 15.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.198 -0.939 . . . . 0.0 109.512 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.05 -60.28 9.33 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.8 mt -77.65 81.65 4.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -1.139 . . . . 0.0 109.604 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.7 tttt . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.379 179.864 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.86 160.86 66.62 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.301 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' B' ' 26' ' ' LEU . 18.7 Cg_endo -63.7 -21.08 69.9 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.525 2.15 . . . . 0.0 112.301 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' B' ' 25' ' ' PRO . 48.9 tp -46.63 -43.67 17.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 108.686 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 37.3 t -69.54 -44.76 79.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.306 -0.871 . . . . 0.0 108.801 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -48.6 -46.63 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.878 . . . . 0.0 108.827 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.15 -39.06 92.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.393 -0.817 . . . . 0.0 109.155 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.86 -57.51 11.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.458 -0.776 . . . . 0.0 109.948 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.78 -37.07 63.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.096 -1.003 . . . . 0.0 109.758 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 20.6 mt -71.38 -38.49 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.152 -0.967 . . . . 0.0 109.468 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 29.8 mt -57.51 -36.27 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.087 -1.008 . . . . 0.0 108.582 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.89 -46.53 52.18 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 69.0 mt -59.64 -25.76 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.306 -1.114 . . . . 0.0 108.891 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 14.0 tp -75.63 -67.88 0.62 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -42.59 -42.73 3.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.529 -0.732 . . . . 0.0 110.086 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 22.2 tp -64.37 -64.66 0.82 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.979 -1.076 . . . . 0.0 109.521 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.404 HG21 HD11 ' B' ' 39' ' ' ILE . 6.3 mt -48.02 -29.34 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.327 -0.858 . . . . 0.0 109.556 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 5.2 mt -75.98 -57.79 3.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.552 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -45.83 -54.97 7.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.365 -0.834 . . . . 0.0 109.663 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' B' ' 45' ' ' ARG . 58.5 mt -58.66 -60.38 2.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.155 -0.966 . . . . 0.0 109.036 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' B' ' 42' ' ' ILE . 57.3 tp -41.61 -38.84 1.46 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.674 -0.641 . . . . 0.0 110.347 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.74 -30.19 62.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.1 -1.0 . . . . 0.0 109.625 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' B' ' 42' ' ' ILE . 0.4 OUTLIER -80.9 -13.64 58.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.898 . . . . 0.0 110.596 -179.521 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -87.28 -33.15 19.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.661 -1.275 . . . . 0.0 109.015 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -63.62 -19.87 65.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 109.515 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.02 128.9 34.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.445 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.444 ' HZ3' ' CB ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -167.29 -54.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 109.504 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 78.1 p -93.32 138.39 31.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.959 . . . . 0.0 109.525 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 30.0 mt -110.33 -27.43 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.698 -0.626 . . . . 0.0 109.859 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -33.08 56.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.154 -0.966 . . . . 0.0 110.267 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -67.54 -39.71 85.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.861 -1.149 . . . . 0.0 109.595 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -66.28 -33.87 76.73 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.324 -0.86 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -68.24 -52.08 38.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 109.384 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -60.99 -30.92 70.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.676 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.26 -57.64 5.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 0.0 109.722 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.02 -58.93 11.76 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 5.2 mt -70.08 148.18 49.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.184 -1.186 . . . . 0.0 109.365 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 6.1 tptm . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.404 -179.936 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.352 0.596 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.502 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 4.9 p30 -166.71 51.84 0.24 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.391 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 12.4 Cg_endo -59.2 -9.54 8.52 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.633 2.222 . . . . 0.0 111.922 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 41.3 tp -47.5 -46.05 26.9 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.34 -0.85 . . . . 0.0 108.873 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 29.2 t -69.15 -45.58 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.213 -0.929 . . . . 0.0 108.686 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -49.2 -50.46 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.87 . . . . 0.0 109.071 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.77 76.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.872 . . . . 0.0 109.222 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.64 -55.84 15.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.448 -0.782 . . . . 0.0 109.659 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -54.92 -36.46 65.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 109.688 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.7 mt -72.41 -40.62 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.225 -0.922 . . . . 0.0 109.531 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 23.5 mt -56.27 -35.65 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.001 -1.062 . . . . 0.0 108.871 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.15 -42.72 35.1 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 58.0 mt -58.72 -36.84 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -1.158 . . . . 0.0 109.57 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.45 -60.97 1.99 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.183 -0.948 . . . . 0.0 109.305 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -44.34 -39.34 4.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 0.0 110.187 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 25.6 tp -69.22 -66.94 0.52 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 109.688 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mt -46.81 -27.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.311 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 tt -74.25 -52.42 12.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.359 -0.838 . . . . 0.0 109.762 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . 0.435 ' CH2' ' NE ' ' C' ' 45' ' ' ARG . 24.3 t-105 -58.31 -46.08 86.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -0.962 . . . . 0.0 109.46 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 69.6 mt -64.57 -39.24 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.144 -0.973 . . . . 0.0 109.185 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.12 -31.31 71.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.839 . . . . 0.0 109.678 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -82.81 -25.24 32.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 109.627 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.451 ' C ' ' H ' ' C' ' 47' ' ' PHE . 3.5 mmt-85 -79.27 -26.15 42.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 111.137 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 6.4 mt -55.86 -9.69 0.62 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.413 -1.429 . . . . 0.0 109.217 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.451 ' H ' ' C ' ' C' ' 45' ' ' ARG . 70.8 t80 -70.61 66.3 0.33 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 109.108 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -92.19 153.41 19.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.863 . . . . 0.0 109.797 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . 0.68 ' HZ1' ' H ' ' C' ' 50' ' ' SER . 1.4 ttpp 59.06 -150.47 0.44 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 109.474 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' SER . . . . . 0.68 ' H ' ' HZ1' ' C' ' 49' ' ' LYS . 6.2 t 47.06 59.9 3.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.935 . . . . 0.0 109.548 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 15.8 mt -102.01 -31.08 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.429 -0.795 . . . . 0.0 109.411 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . 0.434 ' CD1' ' C ' ' C' ' 52' ' ' TYR . 0.0 OUTLIER -55.25 -34.25 63.85 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.336 -0.853 . . . . 0.0 110.13 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -67.42 -36.74 81.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.098 -1.001 . . . . 0.0 109.472 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -68.78 -32.29 71.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -0.95 . . . . 0.0 108.808 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -68.95 -47.01 66.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.449 -0.782 . . . . 0.0 109.3 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -65.94 -27.28 68.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.277 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . 0.671 ' CE1' ' HZ3' ' D' ' 49' ' ' LYS . 82.3 t60 -71.18 -44.54 65.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.095 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.11 -63.3 4.67 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 41.1 mt -80.96 90.39 5.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.286 -1.126 . . . . 0.0 109.393 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 mttm . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.536 -179.846 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.24 0.543 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' D' ' 26' ' ' LEU . 11.1 m-20 -154.29 66.28 5.28 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.362 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -45.26 -11.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.738 2.292 . . . . 0.0 112.179 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' D' ' 24' ' ' ASP . 41.9 tp -47.61 -44.98 27.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.127 -0.983 . . . . 0.0 109.193 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.4 t -68.47 -44.99 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.22 -0.925 . . . . 0.0 108.812 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.3 t -49.12 -48.62 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 108.981 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.71 -33.19 75.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.327 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.36 -57.1 8.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.342 -0.849 . . . . 0.0 109.571 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.56 -37.09 70.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.812 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 16.2 mt -71.11 -43.11 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.155 -0.965 . . . . 0.0 109.52 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 27.2 mt -56.05 -35.11 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.071 -1.018 . . . . 0.0 108.681 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.95 -43.79 39.58 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -62.26 -26.45 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.304 -1.115 . . . . 0.0 108.869 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.49 -67.0 0.55 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.478 -0.764 . . . . 0.0 109.172 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -45.16 -47.27 12.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.35 -0.844 . . . . 0.0 109.954 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.2 tp -57.62 -63.54 1.2 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.166 -0.959 . . . . 0.0 109.614 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.406 HD12 HG22 ' D' ' 39' ' ' ILE . 10.3 mt -50.57 -36.1 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.122 -0.986 . . . . 0.0 109.558 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 mt -63.57 -57.54 9.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.798 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -47.24 -44.75 23.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.279 -0.888 . . . . 0.0 109.548 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 12.2 mt -69.38 -33.9 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 108.714 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -60.14 -42.15 94.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.438 -0.789 . . . . 0.0 109.936 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.97 -22.19 36.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 0.0 109.612 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' D' ' 47' ' ' PHE . 9.3 mmt180 -92.57 -0.71 57.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 0.0 110.875 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . 0.482 ' C ' ' O ' ' D' ' 45' ' ' ARG . 32.8 mt -31.01 -36.16 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.658 -0.651 . . . . 0.0 110.832 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' D' ' 45' ' ' ARG . 0.2 OUTLIER 178.23 15.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.139 -0.976 . . . . 0.0 109.547 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -49.95 101.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.449 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . 0.671 ' HZ3' ' CE1' ' C' ' 57' ' ' HIS . 0.0 OUTLIER -150.6 -29.16 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.964 . . . . 0.0 109.626 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 15.2 p -51.34 120.42 5.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 0.0 109.318 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 15.8 mt -101.07 -29.37 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.492 -0.755 . . . . 0.0 109.721 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -34.48 60.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.186 -0.946 . . . . 0.0 109.897 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -63.64 -39.6 94.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 109.551 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -67.55 -37.82 83.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 0.0 109.44 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.29 -64.43 0.88 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.437 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -51.27 -31.47 21.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.124 -0.985 . . . . 0.0 109.528 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . 0.414 ' ND1' ' C ' ' D' ' 57' ' ' HIS . 14.1 t-80 -69.26 -53.98 17.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.159 -0.963 . . . . 0.0 109.541 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.97 -62.29 6.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.35 109.94 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -1.13 . . . . 0.0 109.076 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.562 -179.958 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.6 m-20 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.8 Cg_endo -55.12 -14.92 9.54 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.837 2.358 . . . . 0.0 112.266 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.9 tp -47.5 -44.28 25.35 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.201 -0.937 . . . . 0.0 109.091 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.8 t -68.21 -45.08 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.186 -0.946 . . . . 0.0 108.665 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.6 t -50.89 -48.12 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 0.0 109.009 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.02 -32.72 74.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 109.464 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.52 -55.14 12.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.329 -0.857 . . . . 0.0 109.626 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.94 -36.21 67.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.744 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.1 mt -73.35 -43.34 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.509 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.4 mt -54.34 -32.95 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.029 -1.044 . . . . 0.0 108.595 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.41 -45.33 14.54 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.0 mt -56.64 -36.68 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.148 -1.207 . . . . 0.0 109.483 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.39 -59.51 2.94 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.236 -0.915 . . . . 0.0 109.203 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -44.3 -44.81 8.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.342 -0.849 . . . . 0.0 110.02 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.53 -68.83 0.31 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.084 -1.01 . . . . 0.0 109.639 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 mt -45.44 -29.76 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.418 -0.801 . . . . 0.0 109.653 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 mt -68.57 -61.5 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.947 . . . . 0.0 109.543 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.494 ' NE1' ' OD2' ' D' ' 44' ' ' ASP . 54.8 t-105 -44.33 -46.04 9.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.548 -0.72 . . . . 0.0 109.633 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.5 mt -71.59 -33.09 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.086 -1.009 . . . . 0.0 109.559 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.9 tp -61.52 -43.12 99.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 109.972 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.52 -20.74 36.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 110.588 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 46' ' ' LEU . 8.6 mmt180 -85.92 -16.56 38.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.711 -1.243 . . . . 0.0 111.515 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 45' ' ' ARG . 20.7 mt -39.61 -34.55 0.24 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.01 -1.056 . . . . 0.0 110.171 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.548 ' CG ' ' O ' ' A' ' 47' ' ' PHE . 1.6 p90 -55.05 126.73 25.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.014 -1.054 . . . . 0.0 109.394 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -173.76 32.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 109.235 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -148.7 -76.64 0.16 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 109.556 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.474 ' H ' ' HZ1' ' A' ' 49' ' ' LYS . 3.3 p -55.15 85.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.94 . . . . 0.0 109.597 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.52 ' N ' ' O ' ' A' ' 49' ' ' LYS . 26.3 mt -89.76 -21.29 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.648 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.54 -21.47 62.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.965 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -67.36 -40.87 85.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.966 . . . . 0.0 109.943 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -71.39 -37.65 71.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 0.0 109.32 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -59.08 -51.38 70.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.233 -0.917 . . . . 0.0 109.192 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -67.69 -26.29 66.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 109.452 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -67.25 -42.01 84.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.18 -0.95 . . . . 0.0 109.198 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.04 -62.58 3.49 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mt -52.9 159.7 1.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.392 -1.063 . . . . 0.0 109.503 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.9 mttt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.498 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' B' ' 26' ' ' LEU . 6.9 m-20 -156.55 65.29 3.82 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.605 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -45.61 -9.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.773 2.315 . . . . 0.0 112.182 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' B' ' 24' ' ' ASP . 29.1 tp -47.27 -46.9 25.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.263 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.96 -45.21 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.225 -0.922 . . . . 0.0 108.89 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 73.0 t -48.98 -48.88 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 108.999 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.22 -34.01 77.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.364 -0.835 . . . . 0.0 109.461 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.46 -56.63 10.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.26 -0.9 . . . . 0.0 109.599 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.11 -37.0 68.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.586 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 16.8 mt -71.0 -41.08 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 21.1 mt -56.4 -33.91 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.174 -0.954 . . . . 0.0 108.645 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.67 -43.13 24.48 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 66.9 mt -59.14 -39.4 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.115 -1.226 . . . . 0.0 109.308 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.12 -63.8 1.0 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.952 . . . . 0.0 109.076 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.08 -49.77 11.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.435 -0.79 . . . . 0.0 109.761 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 48.9 tp -56.5 -65.19 0.65 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 109.618 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.8 mt -46.44 -40.03 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 0.0 109.538 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.67 -63.24 1.37 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 110.095 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -45.06 -48.25 11.82 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.374 -0.828 . . . . 0.0 109.854 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 79.3 mt -61.53 -47.78 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.212 -0.93 . . . . 0.0 109.07 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 13.3 tp -51.78 -39.59 58.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.537 -0.727 . . . . 0.0 110.137 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.31 -26.45 55.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 109.953 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.495 ' CA ' ' HE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -73.58 -27.95 61.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.056 -1.027 . . . . 0.0 110.464 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -65.96 -31.06 71.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.688 -1.258 . . . . 0.0 109.179 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' B' ' 48' ' ' PHE . 60.3 t80 -78.19 -103.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 109.313 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . 0.48 ' N ' ' CG ' ' B' ' 47' ' ' PHE . 2.7 t80 48.04 -154.97 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.925 . . . . 0.0 109.747 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 6.6 tttt 68.73 -153.8 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.3 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.525 ' O ' ' CE2' ' B' ' 54' ' ' PHE . 13.8 m 44.77 75.53 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.215 -0.928 . . . . 0.0 109.401 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 27.3 mt -90.7 -20.25 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.15 -0.969 . . . . 0.0 109.712 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -20.97 58.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 0.0 109.581 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -71.49 -42.92 67.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 110.046 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . 0.525 ' CE2' ' O ' ' B' ' 50' ' ' SER . 4.0 m-85 -70.58 -35.08 72.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.059 -1.026 . . . . 0.0 109.492 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -63.55 -45.56 89.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.19 -0.944 . . . . 0.0 109.279 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -71.49 -25.49 62.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.514 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . 0.457 ' NE2' ' NZ ' ' C' ' 49' ' ' LYS . 15.1 t60 -65.97 -53.07 43.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.091 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.02 -60.52 7.12 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.12 148.96 16.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -1.168 . . . . 0.0 109.439 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 33.1 tttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.391 179.929 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.55 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 4.2 p30 -175.09 49.16 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.346 -0.846 . . . . 0.0 109.432 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 10.6 Cg_endo -56.34 -12.32 7.79 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.941 2.427 . . . . 0.0 112.249 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 35.5 tp -47.71 -44.65 27.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.129 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 38.6 t -68.99 -45.18 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.179 -0.95 . . . . 0.0 108.674 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.8 t -49.69 -49.19 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.0 108.889 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.17 -31.87 73.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.338 -0.851 . . . . 0.0 109.254 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.15 -57.27 7.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 109.686 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' SER . . . . . 0.443 ' H ' ' HG ' ' C' ' 31' ' ' SER . 1.2 m -55.68 -36.27 66.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.666 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.5 mt -71.79 -38.98 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.979 . . . . 0.0 109.548 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 23.7 mt -59.38 -35.51 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.015 -1.053 . . . . 0.0 108.73 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.47 -42.89 63.22 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 77.7 mt -63.63 -22.28 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.414 -1.05 . . . . 0.0 108.771 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.91 -70.84 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . 0.55 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 2.3 t-80 -45.92 -36.73 5.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.864 . . . . 0.0 109.67 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.95 -67.82 0.4 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.437 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.403 HD12 HG21 ' C' ' 39' ' ' ILE . 5.6 mt -48.54 -28.92 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.878 . . . . 0.0 109.672 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 mt -71.57 -59.79 2.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 110.01 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 51.9 t-105 -49.59 -47.75 49.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.084 -1.01 . . . . 0.0 109.811 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 73.2 mt -64.02 -58.74 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.102 -0.999 . . . . 0.0 109.273 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 59.2 tp -44.99 -54.46 6.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.47 -0.769 . . . . 0.0 109.679 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.79 -26.61 67.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.314 -0.867 . . . . 0.0 110.109 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.461 ' HE ' ' CA ' ' C' ' 45' ' ' ARG . 0.0 OUTLIER -79.19 -20.69 47.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.924 -1.11 . . . . 0.0 110.446 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -79.84 -32.14 40.56 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.701 -1.249 . . . . 0.0 109.058 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.451 ' O ' ' CB ' ' C' ' 48' ' ' PHE . 6.3 t80 -92.33 -144.91 0.21 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 0.0 109.31 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . 0.451 ' CB ' ' O ' ' C' ' 47' ' ' PHE . 1.1 t80 72.38 106.31 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 109.441 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . 0.457 ' NZ ' ' NE2' ' B' ' 57' ' ' HIS . 10.7 tttp -165.62 -154.03 0.19 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.366 -0.834 . . . . 0.0 109.094 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' SER . . . . . 0.42 ' O ' ' O ' ' C' ' 49' ' ' LYS . 34.6 m 42.55 91.14 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.333 -0.854 . . . . 0.0 109.917 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 10.3 mt -94.64 -19.09 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.411 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -67.53 -21.88 65.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.092 -1.005 . . . . 0.0 109.499 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -68.2 -42.33 80.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.895 . . . . 0.0 109.7 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -71.71 -45.13 62.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.112 -0.992 . . . . 0.0 109.036 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -54.29 -48.69 70.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 108.828 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -66.8 -26.95 67.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.397 -0.814 . . . . 0.0 109.032 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -66.95 -43.9 81.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.888 . . . . 0.0 108.746 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.47 -62.64 4.91 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.0 103.3 0.92 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -1.114 . . . . 0.0 108.925 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 31.9 tttm . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.079 -0.963 . . . . 0.0 109.542 179.97 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 66.1 p . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . 0.472 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 2.6 m-20 53.21 52.8 10.82 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.243 -0.911 . . . . 0.0 109.441 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 11.2 Cg_endo -58.57 -13.7 18.34 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.542 2.161 . . . . 0.0 112.116 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 35.6 tp -48.0 -44.23 30.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.947 . . . . 0.0 108.901 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.58 -45.36 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.16 -0.962 . . . . 0.0 108.668 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 67.9 t -48.94 -47.7 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.847 . . . . 0.0 108.957 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.89 -35.07 79.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.336 -0.853 . . . . 0.0 109.166 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.86 -56.93 11.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.849 . . . . 0.0 109.708 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.87 -36.16 67.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.147 -0.971 . . . . 0.0 109.79 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 11.2 mt -71.63 -39.57 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.192 -0.942 . . . . 0.0 109.494 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 16.5 mt -58.67 -35.29 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.988 -1.07 . . . . 0.0 108.576 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.88 -43.73 57.67 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.86 -23.61 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.225 -1.162 . . . . 0.0 108.919 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.69 -70.21 0.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.866 . . . . 0.0 109.032 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . 0.55 ' CE1' ' NE2' ' C' ' 37' ' ' HIS . 9.8 t-80 -46.46 -35.64 5.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.913 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 57.3 tp -65.75 -63.02 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.117 -0.989 . . . . 0.0 109.564 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 6.8 mt -54.7 -32.82 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.522 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.03 -58.04 4.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.816 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 -46.45 -51.94 14.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.819 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.06 -53.58 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.008 -1.057 . . . . 0.0 108.883 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 54.9 tp -46.13 -44.05 15.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.464 -0.772 . . . . 0.0 109.895 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . 0.494 ' OD2' ' NE1' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -68.7 -28.18 66.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.775 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -79.2 -19.69 50.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 0.0 110.687 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.4 mt -80.9 -33.81 33.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.666 -1.271 . . . . 0.0 109.167 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -67.88 114.0 6.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.426 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -157.75 -155.14 0.48 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.153 -0.967 . . . . 0.0 109.597 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt 48.43 -153.5 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.36 -0.837 . . . . 0.0 109.243 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 94.4 p 43.1 65.34 0.98 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.36 -0.837 . . . . 0.0 109.65 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 6.7 mt -89.96 -24.41 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 109.07 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.98 -27.92 65.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 109.893 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -71.94 -43.34 65.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.904 -1.122 . . . . 0.0 109.498 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -60.75 -37.03 80.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.383 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -68.57 -67.77 0.44 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.395 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -47.53 -40.16 18.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.893 . . . . 0.0 109.658 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -65.56 -54.37 28.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.305 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.83 -61.3 7.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.51 129.08 40.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -1.195 . . . . 0.0 109.413 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 37.8 tttp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.394 -179.9 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 26' ' ' LEU . 30.5 t0 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -46.06 -11.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.662 2.241 . . . . 0.0 112.031 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 24' ' ' ASP . 37.6 tp -47.78 -45.91 29.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.262 -0.899 . . . . 0.0 108.962 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.53 -45.29 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.207 -0.933 . . . . 0.0 108.721 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.3 t -49.12 -49.08 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 108.95 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.24 -32.55 74.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.316 -0.865 . . . . 0.0 109.157 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.81 -58.16 6.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.347 -0.845 . . . . 0.0 109.671 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.55 -36.85 67.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 109.743 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.4 mt -70.93 -39.74 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.361 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.3 mt -57.66 -34.51 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.027 -1.045 . . . . 0.0 108.415 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.96 -44.63 45.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.6 mt -57.0 -31.33 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.19 -1.182 . . . . 0.0 109.128 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.07 -64.69 0.86 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.305 -0.872 . . . . 0.0 109.208 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -44.96 -47.37 11.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.839 . . . . 0.0 110.223 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.8 tp -59.02 -63.92 1.13 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.997 -1.064 . . . . 0.0 109.693 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.3 mt -51.38 -25.74 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 109.601 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mt -74.74 -56.59 4.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.175 -0.953 . . . . 0.0 109.49 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -48.37 -51.3 27.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 109.377 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.75 -53.58 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.235 -0.916 . . . . 0.0 109.105 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.4 tp -46.49 -35.42 5.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.562 -0.711 . . . . 0.0 110.327 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 0.2 OUTLIER -79.2 -29.08 42.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.039 -1.038 . . . . 0.0 109.814 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.79 -19.48 57.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 0.0 110.873 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 47' ' ' PHE . 8.5 mt -77.6 -9.22 58.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.556 -1.34 . . . . 0.0 109.347 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.403 ' O ' ' O ' ' A' ' 46' ' ' LEU . 3.0 m-85 -47.41 -90.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 109.225 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 46.57 23.91 0.27 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 109.64 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -66.07 -144.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.495 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.3 m -80.51 141.48 35.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 109.629 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 mt -97.21 -32.19 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.514 -0.741 . . . . 0.0 109.432 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -56.2 -19.12 12.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -72.27 -41.04 67.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -0.987 . . . . 0.0 109.812 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -69.54 -33.3 72.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.088 -1.007 . . . . 0.0 109.377 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -69.7 -45.46 68.22 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.287 -0.883 . . . . 0.0 109.347 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -67.1 -27.05 67.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -69.12 -52.64 26.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.24 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.19 -60.56 8.73 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.1 mt -48.63 147.33 2.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.348 -1.089 . . . . 0.0 109.491 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.7 tttt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.35 179.829 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.51 162.68 28.98 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.279 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' B' ' 26' ' ' LEU . 23.4 Cg_endo -65.82 -28.31 51.18 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.51 2.14 . . . . 0.0 112.224 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' B' ' 25' ' ' PRO . 37.6 tp -45.73 -40.54 9.54 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.34 -44.53 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 71.0 t -49.94 -47.39 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.91 . . . . 0.0 108.774 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.69 78.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.237 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.38 -56.27 15.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -0.875 . . . . 0.0 109.832 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.41 -37.83 76.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -0.945 . . . . 0.0 110.018 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 18.4 mt -69.26 -42.97 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.107 -0.995 . . . . 0.0 109.191 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 mt -56.4 -34.46 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.242 -0.911 . . . . 0.0 108.783 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.33 -43.41 38.44 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 68.1 mt -60.38 -31.94 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.295 -1.12 . . . . 0.0 109.305 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.97 -66.52 0.6 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 109.248 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -44.96 -41.7 7.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 109.924 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.0 tp -62.7 -68.37 0.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.5 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 6.1 mt -46.93 -31.44 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.316 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -60.2 3.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.86 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . 0.404 ' NE1' ' OD2' ' A' ' 44' ' ' ASP . 37.7 t-105 -48.75 -43.94 38.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 109.664 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 25.8 mt -64.53 -40.01 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.99 . . . . 0.0 108.922 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 tp -56.48 -35.76 68.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.571 -0.706 . . . . 0.0 110.368 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.8 -22.98 27.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.071 -1.018 . . . . 0.0 110.382 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.478 ' C ' ' H ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -76.13 -27.97 57.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.912 -1.117 . . . . 0.0 110.517 -179.204 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -51.86 -11.47 0.15 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.6 -1.312 . . . . 0.0 108.99 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.478 ' H ' ' C ' ' B' ' 45' ' ' ARG . 24.6 t80 -67.28 126.45 29.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.493 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -147.95 -90.54 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.92 . . . . 0.0 109.425 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.407 ' O ' ' OG ' ' B' ' 50' ' ' SER . 1.8 pttt -61.85 -149.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.181 -0.949 . . . . 0.0 109.393 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' B' ' 49' ' ' LYS . 48.8 p 45.99 56.67 5.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 109.612 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 12.4 mt -92.74 -28.95 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.263 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.68 -25.6 4.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.403 -0.811 . . . . 0.0 109.788 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.461 ' O ' ' CG ' ' B' ' 57' ' ' HIS . 30.4 mtt180 -68.52 -38.33 80.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.765 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -71.37 -35.15 70.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.027 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -65.8 -53.1 44.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.691 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -65.23 -30.43 71.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.885 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . 0.461 ' CG ' ' O ' ' B' ' 53' ' ' ARG . 1.7 m-70 -68.04 -41.77 81.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.147 -0.971 . . . . 0.0 109.437 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.75 -66.2 1.69 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.74 108.24 6.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -1.144 . . . . 0.0 109.27 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.898 -1.048 . . . . 0.0 109.409 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.62 160.78 32.03 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.171 -0.956 . . . . 0.0 109.407 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' C' ' 26' ' ' LEU . 13.5 Cg_endo -60.05 -23.69 74.07 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.625 2.216 . . . . 0.0 112.2 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' C' ' 25' ' ' PRO . 39.9 tp -45.72 -42.08 11.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.294 -0.878 . . . . 0.0 108.86 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 46.9 t -70.0 -44.16 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.376 -0.828 . . . . 0.0 108.784 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 69.9 t -50.17 -47.63 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 0.0 108.918 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.06 86.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.567 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.62 -55.27 21.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 109.591 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.62 -36.76 67.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 109.83 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 25.9 mt -72.36 -42.64 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.511 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.1 mt -55.01 -34.26 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.12 -0.987 . . . . 0.0 108.805 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.8 -44.05 21.06 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 64.2 mt -58.35 -29.73 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.17 -1.194 . . . . 0.0 109.421 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.15 -59.42 2.75 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.235 -0.915 . . . . 0.0 109.015 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -47.24 -38.84 13.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.703 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.2 tp -68.68 -67.66 0.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.574 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.5 mt -46.09 -28.02 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 0.0 109.418 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 mt -69.95 -60.45 2.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.409 -0.807 . . . . 0.0 109.823 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -47.02 -43.61 19.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 6.4 mt -70.75 -40.44 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.112 -0.992 . . . . 0.0 109.326 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 57.9 tp -60.51 -35.5 76.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.339 -0.851 . . . . 0.0 110.091 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -87.54 -19.24 28.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.116 -0.99 . . . . 0.0 110.167 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' C' ' 47' ' ' PHE . 3.7 mmt180 -84.65 -20.88 30.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.027 -1.046 . . . . 0.0 111.119 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' C' ' 45' ' ' ARG . 38.8 mt -46.35 -17.73 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.825 -1.172 . . . . 0.0 109.108 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' C' ' 45' ' ' ARG . 22.6 m-85 -93.08 79.25 4.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.264 -0.897 . . . . 0.0 109.319 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -83.77 -57.36 3.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.33 -0.856 . . . . 0.0 109.476 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -76.94 -139.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.36 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 46.1 m 52.78 61.35 3.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.442 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 61.1 mt -95.33 -26.01 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.865 . . . . 0.0 109.518 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -58.81 -22.72 59.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.267 -0.895 . . . . 0.0 109.835 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . 0.517 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 0.0 OUTLIER -67.37 -42.32 83.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.83 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -71.01 -38.9 72.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.289 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -62.83 -45.97 90.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.28 -0.888 . . . . 0.0 109.071 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -69.15 -27.33 65.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.833 . . . . 0.0 109.62 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . 0.517 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 51.3 m170 -69.39 -38.54 78.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 0.0 109.188 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.6 -59.83 5.01 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mt -72.67 176.04 5.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -1.162 . . . . 0.0 109.496 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . 0.585 ' N ' ' CD ' ' C' ' 60' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.371 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' D' ' 26' ' ' LEU . 7.1 p30 -169.0 68.09 0.67 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.366 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -47.24 -9.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.754 2.302 . . . . 0.0 112.29 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' D' ' 24' ' ' ASP . 33.9 tp -47.48 -46.84 27.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.169 -0.957 . . . . 0.0 108.979 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.72 -45.79 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.262 -0.899 . . . . 0.0 108.728 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 66.2 t -48.45 -48.73 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -0.879 . . . . 0.0 108.881 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.81 -34.92 79.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.37 -0.831 . . . . 0.0 109.305 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.56 -56.37 12.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.0 109.755 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 2.5 m -55.65 -35.04 65.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 109.809 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 16.4 mt -73.89 -42.99 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.155 -0.966 . . . . 0.0 109.586 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 19.4 mt -55.14 -34.7 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.075 -1.016 . . . . 0.0 108.733 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.71 -44.83 37.68 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 56.6 mt -57.21 -35.02 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -1.134 . . . . 0.0 109.026 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -67.11 0.48 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.377 -0.827 . . . . 0.0 108.848 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -47.13 -37.95 10.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.378 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 59.3 tp -61.48 -70.7 0.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.23 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mt -49.35 -24.08 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.921 . . . . 0.0 109.577 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.54 -60.68 2.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -0.891 . . . . 0.0 109.759 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -52.26 -46.54 65.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.092 -1.005 . . . . 0.0 109.53 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 54.9 mt -62.63 -55.02 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.179 -0.95 . . . . 0.0 108.878 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 42.3 tp -47.93 -37.59 14.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.542 -0.724 . . . . 0.0 109.744 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -73.72 -28.44 61.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.144 -0.972 . . . . 0.0 109.544 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.37 -20.57 54.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.195 -0.941 . . . . 0.0 110.423 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -80.34 -8.84 59.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.777 -1.202 . . . . 0.0 108.968 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -141.38 100.22 3.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.444 -0.785 . . . . 0.0 109.125 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -151.68 5.68 0.45 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.188 -0.945 . . . . 0.0 109.618 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . 0.403 ' CG ' ' H ' ' D' ' 50' ' ' SER . 43.1 tttt -76.61 -140.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.447 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.403 ' H ' ' CG ' ' D' ' 49' ' ' LYS . 15.3 m 47.37 76.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.872 . . . . 0.0 109.486 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 24.2 mt -99.75 -23.94 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.437 -0.789 . . . . 0.0 109.442 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . 0.401 ' CG ' ' N ' ' D' ' 53' ' ' ARG . 25.6 p90 -57.95 -33.31 68.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.338 -0.851 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . 0.48 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 23.0 ptt180 -65.16 -30.72 71.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -75.12 -34.01 61.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.296 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.9 -44.23 64.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -0.826 . . . . 0.0 109.902 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -72.76 -27.74 62.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.14 -0.975 . . . . 0.0 109.525 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . 0.48 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 0.7 OUTLIER -70.24 -42.52 72.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.913 . . . . 0.0 109.251 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.45 -64.36 2.77 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 1.7 tt -56.43 108.58 0.5 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -1.179 . . . . 0.0 109.551 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.469 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.547 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.9 p30 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.7 Cg_endo -55.64 -17.89 18.86 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.813 2.342 . . . . 0.0 112.381 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.9 tp -46.25 -43.26 15.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 109.008 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 t -69.34 -45.67 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.328 -0.858 . . . . 0.0 108.888 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.4 t -48.97 -48.5 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.91 . . . . 0.0 109.015 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.95 -35.99 82.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.34 -0.85 . . . . 0.0 109.422 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.02 -56.48 14.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.903 . . . . 0.0 109.737 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -36.82 65.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.236 -0.915 . . . . 0.0 109.923 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.8 mt -72.35 -40.94 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.133 -0.98 . . . . 0.0 109.496 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.1 mt -56.36 -34.12 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.059 -1.025 . . . . 0.0 108.675 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.99 -44.19 24.64 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.7 mt -58.89 -30.86 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.154 -1.204 . . . . 0.0 109.226 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.77 -66.76 0.62 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.286 -0.884 . . . . 0.0 109.059 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -46.12 -37.95 7.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.706 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.2 tp -64.14 -70.24 0.23 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 109.382 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.3 mt -47.32 -35.25 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 0.0 109.693 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mt -63.95 -63.23 1.21 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 109.934 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -45.41 -47.94 13.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.29 -46.77 94.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.395 -0.816 . . . . 0.0 108.916 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.07 -50.02 29.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.582 -0.699 . . . . 0.0 109.327 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.68 -30.78 71.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.392 -0.817 . . . . 0.0 110.289 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -69.25 -26.93 65.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.902 -1.124 . . . . 0.0 110.39 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -71.52 -32.71 68.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.649 -1.282 . . . . 0.0 109.47 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -67.15 -88.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.033 -1.042 . . . . 0.0 109.559 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.2 -168.39 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.1 tttt 48.25 -152.41 0.11 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.142 -0.974 . . . . 0.0 109.271 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.7 p 45.22 59.41 3.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 109.773 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 mt -98.69 -22.95 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 0.0 109.606 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -55.61 -25.3 38.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.971 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.463 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 6.6 ptt180 -67.7 -40.21 84.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.124 -0.985 . . . . 0.0 109.977 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.439 ' N ' ' CG ' ' A' ' 53' ' ' ARG . 54.9 m-85 -71.35 -36.7 71.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.028 -1.045 . . . . 0.0 109.404 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -63.41 -44.74 93.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -0.899 . . . . 0.0 109.219 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -70.28 -28.1 64.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 109.625 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.463 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 20.1 m170 -66.06 -42.29 89.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -0.947 . . . . 0.0 109.272 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.82 -63.4 2.87 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 mt -70.98 119.51 15.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -1.161 . . . . 0.0 109.368 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.4 mttt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.441 -179.949 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' B' ' 26' ' ' LEU . 19.1 t70 50.97 67.36 4.38 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.523 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -46.1 -11.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.673 2.248 . . . . 0.0 112.19 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' B' ' 24' ' ' ASP . 43.6 tp -47.23 -48.25 24.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 108.991 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 45.7 t -67.56 -44.47 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.305 -0.872 . . . . 0.0 108.903 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 77.8 t -49.23 -48.55 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.264 -0.897 . . . . 0.0 109.019 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.7 78.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.912 . . . . 0.0 109.339 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.24 -57.71 6.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 0.0 109.927 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.92 -36.49 62.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 109.806 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 24.0 mt -72.31 -41.63 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 109.424 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 21.9 mt -55.43 -34.82 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.156 -0.965 . . . . 0.0 108.73 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.29 -45.26 31.33 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 47.9 mt -54.97 -37.99 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.199 -1.177 . . . . 0.0 109.496 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.31 -58.31 3.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.173 -0.955 . . . . 0.0 108.818 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -46.8 -41.36 15.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -0.86 . . . . 0.0 109.6 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 51.3 tp -65.78 -70.02 0.26 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.783 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mt -46.57 -26.64 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 109.684 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 6.0 mt -70.19 -62.82 1.24 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.99 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -48.19 -47.74 35.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.069 -1.02 . . . . 0.0 109.674 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.473 ' O ' ' N ' ' B' ' 45' ' ' ARG . 68.0 mt -63.9 -61.35 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.132 -0.98 . . . . 0.0 109.336 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 60.5 tp -43.74 -42.37 5.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.687 -0.633 . . . . 0.0 109.784 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -69.32 -28.97 66.71 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.257 -0.902 . . . . 0.0 109.469 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' B' ' 42' ' ' ILE . 11.0 mmm180 -78.23 -16.69 57.59 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.218 -0.926 . . . . 0.0 110.105 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -88.8 -9.54 51.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.851 -1.156 . . . . 0.0 109.07 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -47.72 -23.89 0.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.64 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . 0.463 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 2.1 t80 -47.91 106.88 0.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.598 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -160.09 -41.03 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 109.558 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.49 121.96 5.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.189 -0.944 . . . . 0.0 109.598 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 mt -102.72 -24.05 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.568 -0.707 . . . . 0.0 109.286 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' B' ' 52' ' ' TYR . 5.8 p90 -52.3 -28.27 18.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . 0.479 ' O ' ' CG ' ' B' ' 57' ' ' HIS . 7.4 mtt-85 -63.02 -42.56 99.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.978 -1.076 . . . . 0.0 109.564 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -68.18 -35.23 77.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 109.392 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.03 -55.73 15.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.127 -0.983 . . . . 0.0 108.951 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -56.83 -32.18 65.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.381 -0.825 . . . . 0.0 109.562 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . 0.479 ' CG ' ' O ' ' B' ' 53' ' ' ARG . 3.2 m-70 -64.3 -61.16 2.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 109.274 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.55 -59.53 9.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mt -80.06 81.53 6.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.364 -1.08 . . . . 0.0 109.658 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.347 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.551 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 2.3 p30 -165.5 48.84 0.2 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 109.406 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 11.0 Cg_endo -57.01 -14.18 13.75 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.808 2.339 . . . . 0.0 112.083 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 33.7 tp -47.34 -44.32 23.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 108.993 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 36.1 t -69.92 -45.16 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.113 -0.992 . . . . 0.0 108.77 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 54.6 t -49.75 -48.53 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 108.977 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.03 -32.99 74.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 109.376 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.96 -54.96 19.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.913 . . . . 0.0 109.698 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' SER . . . . . 0.401 ' H ' ' HG ' ' C' ' 31' ' ' SER . 0.7 OUTLIER -58.36 -37.37 75.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.972 . . . . 0.0 109.937 -179.652 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 20.5 mt -70.74 -42.27 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.107 -0.996 . . . . 0.0 109.118 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 23.1 mt -55.86 -33.67 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.191 -0.943 . . . . 0.0 108.555 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.08 -44.73 28.6 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 55.2 mt -57.26 -31.99 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.188 -1.184 . . . . 0.0 109.422 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.82 -64.28 1.0 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 108.988 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -45.61 -43.11 11.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.372 -0.83 . . . . 0.0 109.717 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 44.4 tp -60.77 -68.67 0.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 109.508 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.0 mt -47.45 -30.7 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.218 -0.926 . . . . 0.0 109.516 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mt -68.86 -65.61 0.68 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -0.949 . . . . 0.0 109.811 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . 0.414 ' CH2' ' NE ' ' C' ' 45' ' ' ARG . 19.5 t-105 -45.16 -49.38 12.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.858 . . . . 0.0 109.882 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 76.0 mt -61.7 -54.44 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.049 -1.032 . . . . 0.0 109.1 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 60.3 tp -47.91 -44.54 29.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 109.567 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' C' ' 44' ' ' ASP . 0.2 OUTLIER -67.33 -27.99 67.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.784 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.414 ' NE ' ' CH2' ' C' ' 41' ' ' TRP . 0.9 OUTLIER -75.98 -24.11 55.34 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.14 -0.975 . . . . 0.0 110.43 -179.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.4 mt -79.44 -25.53 41.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.759 -1.213 . . . . 0.0 109.224 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -56.42 95.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 109.733 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -156.96 -59.32 0.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.772 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . 0.429 ' CG ' ' H ' ' C' ' 50' ' ' SER . 21.8 tttp 54.3 -138.17 1.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.109 -0.994 . . . . 0.0 109.066 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' SER . . . . . 0.429 ' H ' ' CG ' ' C' ' 49' ' ' LYS . 1.8 t -78.68 170.94 15.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.102 -0.999 . . . . 0.0 109.036 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 9.9 mt -100.87 -26.23 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 0.0 109.802 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.82 -26.03 5.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.942 . . . . 0.0 110.038 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . 0.496 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 11.2 mmt180 -68.48 -43.79 76.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.938 -1.101 . . . . 0.0 109.735 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . 0.458 ' O ' ' CD1' ' D' ' 51' ' ' ILE . 8.0 m-85 -63.75 -36.98 85.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.928 . . . . 0.0 108.779 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.86 -53.73 51.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.469 -0.769 . . . . 0.0 109.158 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -61.6 -33.01 73.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.437 -0.789 . . . . 0.0 109.545 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 2.6 m-70 -59.44 -58.3 9.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 108.936 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.74 -59.99 7.97 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 49.6 mt -71.95 175.66 5.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.344 -1.092 . . . . 0.0 109.213 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.428 179.853 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.332 0.587 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.98 161.09 47.99 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.305 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' D' ' 26' ' ' LEU . 18.6 Cg_endo -63.1 -24.1 73.29 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.496 2.131 . . . . 0.0 112.1 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' D' ' 25' ' ' PRO . 45.3 tp -45.95 -42.63 13.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 108.675 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.9 t -69.76 -44.17 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.292 -0.88 . . . . 0.0 108.806 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 69.9 t -51.4 -50.74 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.061 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.46 -34.53 77.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.745 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.56 -54.55 22.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 109.664 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 2.5 m -57.23 -35.35 69.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -0.953 . . . . 0.0 109.657 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 13.9 mt -72.93 -44.5 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 0.0 109.377 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 30.8 mt -53.87 -35.42 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.133 -0.98 . . . . 0.0 108.735 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.52 -44.39 41.09 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 65.4 mt -59.34 -43.09 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.241 -1.152 . . . . 0.0 109.208 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.13 -62.64 1.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 109.024 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -45.14 -40.28 6.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.391 -0.818 . . . . 0.0 110.139 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 55.7 tp -65.79 -65.3 0.69 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.115 -0.99 . . . . 0.0 109.571 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 9.8 mt -49.65 -29.48 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.918 . . . . 0.0 109.711 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 6.1 mt -70.09 -56.78 6.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 109.555 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -47.38 -48.37 25.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.307 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 7.2 mt -65.75 -43.3 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.127 -0.983 . . . . 0.0 108.89 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 tp -52.01 -44.63 64.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.428 -0.795 . . . . 0.0 109.921 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -76.24 -24.69 54.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 110.239 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . 0.482 ' O ' ' N ' ' D' ' 47' ' ' PHE . 0.0 OUTLIER -88.69 -3.99 58.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 111.071 -178.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' D' ' 45' ' ' ARG . 27.3 mt -33.93 -35.04 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.696 -0.627 . . . . 0.0 110.449 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . 0.482 ' N ' ' O ' ' D' ' 45' ' ' ARG . 1.8 t80 -169.18 131.03 1.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.92 . . . . 0.0 109.276 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -166.57 97.9 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.112 -0.993 . . . . 0.0 109.708 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -160.58 -25.87 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.254 -0.904 . . . . 0.0 109.457 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t -48.02 110.19 0.3 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . 0.458 ' CD1' ' O ' ' C' ' 54' ' ' PHE . 4.1 mt -84.23 -17.81 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.289 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.83 -37.42 70.31 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.201 -0.937 . . . . 0.0 110.862 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . 0.5 ' O ' ' ND1' ' D' ' 57' ' ' HIS . 78.8 mtm180 -78.16 -41.1 35.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.266 -1.521 . . . . 0.0 111.007 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' D' ' 54' ' ' PHE . 8.3 t80 -71.34 -44.84 64.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.079 -1.013 . . . . 0.0 110.542 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.21 -24.29 47.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.036 -1.04 . . . . 0.0 110.792 -178.73 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . 0.572 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 88.3 tt0 -80.14 -28.89 38.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.597 -1.314 . . . . 0.0 108.017 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' D' ' 53' ' ' ARG . 11.8 m170 -70.37 -47.07 62.63 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.78 -61.15 6.76 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.35 140.1 55.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.328 -1.101 . . . . 0.0 109.427 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 57.0 tttm . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.477 179.984 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 26' ' ' LEU . 8.2 m-20 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -47.22 -10.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.904 2.403 . . . . 0.0 112.411 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 24' ' ' ASP . 36.7 tp -46.87 -45.55 20.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.13 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 t -70.21 -45.56 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.93 . . . . 0.0 108.715 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.0 t -48.58 -48.26 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.285 -0.884 . . . . 0.0 108.908 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.58 81.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.381 -0.825 . . . . 0.0 109.309 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.05 -55.48 21.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.337 -0.852 . . . . 0.0 109.729 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.16 -37.0 71.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.966 . . . . 0.0 110.005 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.6 mt -71.58 -42.13 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.145 -0.972 . . . . 0.0 109.438 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -56.67 -33.29 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.153 -0.967 . . . . 0.0 108.703 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.55 -43.59 29.47 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.0 mt -56.96 -32.23 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.287 -1.125 . . . . 0.0 109.363 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.26 -61.97 1.64 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.136 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -48.6 -39.17 22.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.354 -0.841 . . . . 0.0 109.728 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -66.41 -67.43 0.45 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.919 . . . . 0.0 109.602 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.7 mt -47.3 -27.55 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.529 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mt -67.9 -65.62 0.67 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.272 -0.893 . . . . 0.0 109.823 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.412 ' CH2' ' NE ' ' A' ' 45' ' ' ARG . 24.7 t-105 -48.03 -45.98 32.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.728 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.3 mt -61.6 -54.34 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.157 -0.964 . . . . 0.0 108.894 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.5 tp -47.13 -44.37 21.52 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.579 -0.7 . . . . 0.0 109.638 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.88 -26.16 64.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.222 -0.923 . . . . 0.0 110.089 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.412 ' NE ' ' CH2' ' A' ' 41' ' ' TRP . 0.2 OUTLIER -77.22 -23.42 51.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.978 -1.076 . . . . 0.0 110.387 -179.513 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.1 mt -77.77 -21.14 52.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.8 -1.188 . . . . 0.0 108.956 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 63.27 154.02 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.908 . . . . 0.0 109.39 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -158.65 43.56 0.27 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -0.876 . . . . 0.0 109.379 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.539 ' CD ' ' H ' ' A' ' 50' ' ' SER . 0.6 OUTLIER -163.34 -148.37 0.13 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 109.156 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.539 ' H ' ' CD ' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -132.85 166.26 22.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 0.0 109.368 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.2 mt -99.33 -44.0 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.38 -0.825 . . . . 0.0 109.642 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.423 ' OH ' ' OG ' ' A' ' 50' ' ' SER . 17.3 p90 -56.35 -24.41 43.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.959 . . . . 0.0 109.495 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -69.13 -44.23 72.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.969 . . . . 0.0 109.287 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -64.3 -29.67 70.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.223 -0.923 . . . . 0.0 109.115 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -72.63 -70.23 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.835 . . . . 0.0 109.332 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -46.23 -28.42 1.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 109.518 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -67.4 -61.98 1.64 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.18 -0.95 . . . . 0.0 109.618 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -50.7 -53.12 26.93 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.0 mt -68.72 100.49 1.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -1.186 . . . . 0.0 109.641 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 tttm . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.369 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.443 ' O ' ' O ' ' B' ' 24' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' B' ' 23' ' ' SER . 0.1 OUTLIER 57.38 160.91 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.344 -0.848 . . . . 0.0 109.445 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.36 -22.18 53.05 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.398 2.066 . . . . 0.0 112.017 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 37.1 tp -46.58 -43.87 17.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 108.653 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.43 -42.54 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.36 -0.837 . . . . 0.0 108.889 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 73.9 t -51.34 -50.19 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 109.018 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.83 85.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.311 -0.868 . . . . 0.0 109.38 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.64 -55.28 24.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.73 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' SER . . . . . 0.41 ' H ' ' HG ' ' B' ' 31' ' ' SER . 0.9 OUTLIER -56.56 -37.0 69.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.714 -179.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 24.5 mt -71.61 -39.74 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.158 -0.963 . . . . 0.0 109.526 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 34.0 mt -58.37 -34.23 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.157 -0.965 . . . . 0.0 108.742 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.88 -41.86 32.19 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 79.4 mt -62.74 -36.46 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.32 -1.106 . . . . 0.0 109.119 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.79 -62.47 1.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.023 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -46.42 -40.59 12.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 109.684 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 59.2 tp -63.19 -70.48 0.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.777 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 8.4 mt -47.0 -33.34 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.485 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mt -64.45 -58.69 5.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.425 -0.797 . . . . 0.0 109.535 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -46.28 -44.79 16.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 109.65 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 11.1 mt -70.53 -33.6 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.117 -0.989 . . . . 0.0 109.446 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 tp -59.11 -43.86 91.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 110.203 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -82.54 -22.76 34.84 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 110.514 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -82.05 -16.22 50.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.89 -1.131 . . . . 0.0 111.006 -179.212 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' B' ' 48' ' ' PHE . 21.9 mt -44.58 -19.16 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.904 -1.122 . . . . 0.0 109.472 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' B' ' 45' ' ' ARG . 93.7 t80 -49.77 97.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.122 -0.987 . . . . 0.0 109.355 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . 0.426 ' N ' ' O ' ' B' ' 46' ' ' LEU . 58.6 t80 -168.54 65.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.882 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.439 ' CG ' ' H ' ' B' ' 50' ' ' SER . 14.3 pttt -158.81 -107.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.83 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.439 ' H ' ' CG ' ' B' ' 49' ' ' LYS . 41.4 t -80.76 129.17 34.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 109.957 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 32.8 mt -106.04 -32.09 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.633 -0.667 . . . . 0.0 109.438 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -46.48 -27.78 1.2 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 0.0 109.934 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 43.4 mtt-85 -65.91 -41.93 90.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.119 -0.988 . . . . 0.0 109.69 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -68.4 -33.51 74.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 109.7 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.14 -46.67 76.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.946 . . . . 0.0 109.377 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -69.56 -33.87 73.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.608 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -64.37 -33.62 76.26 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.159 -0.963 . . . . 0.0 108.756 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.04 -63.9 2.01 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mt -55.42 126.34 24.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -1.159 . . . . 0.0 109.105 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.35 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.486 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 67.2 m-20 51.17 52.32 11.89 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.652 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 11.6 Cg_endo -58.36 -16.4 28.61 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.666 2.244 . . . . 0.0 112.254 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 31.4 tp -46.23 -44.44 16.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.214 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 40.4 t -69.16 -44.56 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.258 -0.901 . . . . 0.0 108.907 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -49.6 -49.14 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.153 -0.967 . . . . 0.0 108.96 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.55 -33.07 75.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.863 . . . . 0.0 109.27 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.08 -56.95 8.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 109.669 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.9 -35.46 69.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.887 . . . . 0.0 109.924 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 24.4 mt -72.78 -43.99 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 0.0 109.531 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 26.6 mt -54.83 -35.27 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.16 -0.963 . . . . 0.0 108.792 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.23 -44.75 42.55 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 58.1 mt -57.67 -27.22 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.273 -1.134 . . . . 0.0 109.203 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.93 -67.36 0.68 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.22 -0.925 . . . . 0.0 109.08 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -46.22 -43.17 15.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.491 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.88 -67.49 0.4 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 109.403 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -47.85 -28.75 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.326 -0.858 . . . . 0.0 109.864 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -67.92 -64.28 0.89 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.793 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . 0.519 ' CH2' ' NE ' ' C' ' 45' ' ' ARG . 30.5 t-105 -48.01 -45.58 31.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.22 -0.925 . . . . 0.0 109.634 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 82.7 mt -63.34 -48.53 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.174 -0.954 . . . . 0.0 108.936 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.7 tp -53.42 -33.28 53.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.635 -0.665 . . . . 0.0 110.126 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.3 -25.01 31.92 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.168 -0.958 . . . . 0.0 109.947 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.519 ' NE ' ' CH2' ' C' ' 41' ' ' TRP . 0.1 OUTLIER -75.36 -27.97 59.36 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.087 -1.008 . . . . 0.0 110.493 -179.311 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' C' ' 47' ' ' PHE . 9.8 mt -61.51 -30.71 70.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.612 -1.305 . . . . 0.0 108.946 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.408 ' O ' ' O ' ' C' ' 46' ' ' LEU . 54.8 m-85 -61.22 -111.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.101 -0.999 . . . . 0.0 108.833 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . 0.514 ' CG ' ' O ' ' C' ' 48' ' ' PHE . 8.6 t80 45.77 83.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -0.869 . . . . 0.0 109.667 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . 0.537 ' CD ' ' H ' ' C' ' 50' ' ' SER . 0.2 OUTLIER -85.07 -152.71 0.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.147 -0.97 . . . . 0.0 108.725 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' SER . . . . . 0.537 ' H ' ' CD ' ' C' ' 49' ' ' LYS . 0.2 OUTLIER -60.6 -173.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.84 -1.163 . . . . 0.0 109.436 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 45.5 mt -108.64 -27.66 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.59 -0.694 . . . . 0.0 109.272 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -36.29 70.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.996 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -65.83 -34.83 79.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.076 -1.015 . . . . 0.0 109.559 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -68.49 -35.98 78.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.391 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -69.99 -40.62 75.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.918 . . . . 0.0 109.478 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.48 -25.13 63.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 109.49 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.75 -46.5 45.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.195 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.43 -65.99 2.27 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mt -58.81 118.79 6.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -1.124 . . . . 0.0 109.73 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 11.5 tttm . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.602 -179.974 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 41.7 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' D' ' 24' ' ' ASP . 2.8 p-10 -165.51 68.17 1.21 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -46.14 -11.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.793 2.329 . . . . 0.0 112.34 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' D' ' 24' ' ' ASP . 34.2 tp -47.21 -46.3 23.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 109.212 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 43.9 t -69.48 -44.32 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 108.754 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 78.0 t -49.92 -48.08 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.348 -0.845 . . . . 0.0 109.054 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.2 -34.42 77.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 109.547 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.81 -55.4 17.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.649 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.37 -37.29 69.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.213 -0.929 . . . . 0.0 109.842 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 20.6 mt -71.58 -40.39 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.6 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 26.8 mt -57.71 -35.21 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 0.0 108.795 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.47 -42.69 47.65 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 74.6 mt -62.69 -30.49 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.362 -1.081 . . . . 0.0 109.45 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.53 -60.1 2.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 109.081 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -48.98 -40.57 31.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.959 . . . . 0.0 109.542 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.1 tp -62.9 -68.42 0.34 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.194 -0.942 . . . . 0.0 109.412 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 mt -47.15 -31.77 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.455 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt -68.26 -57.97 5.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.39 -0.819 . . . . 0.0 109.798 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -46.64 -44.52 18.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.403 -0.811 . . . . 0.0 109.621 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mt -72.25 -38.33 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.051 -1.031 . . . . 0.0 109.426 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 44.5 tp -57.85 -41.35 82.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.929 . . . . 0.0 110.106 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -82.64 -24.0 34.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.096 -1.003 . . . . 0.0 109.813 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' D' ' 47' ' ' PHE . 11.9 mmt180 -89.82 -1.66 58.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.171 -0.955 . . . . 0.0 110.83 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . 0.478 ' C ' ' O ' ' D' ' 45' ' ' ARG . 31.4 mt -31.99 -35.77 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.768 -0.583 . . . . 0.0 110.581 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' D' ' 45' ' ' ARG . 88.1 t80 -172.75 7.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.525 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.51 113.55 0.72 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.564 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -163.54 -37.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.377 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 44.5 m -54.53 134.94 46.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -0.85 . . . . 0.0 109.634 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 8.7 mt -104.06 -26.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.656 -0.652 . . . . 0.0 109.379 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -47.64 -42.05 23.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.871 . . . . 0.0 109.89 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -45.74 72.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 0.0 109.712 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -62.46 -36.48 82.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 109.591 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -63.27 -66.67 0.51 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.435 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -45.86 -34.91 4.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.347 -0.846 . . . . 0.0 109.863 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -63.55 -60.99 2.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.129 -0.982 . . . . 0.0 109.522 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -47.51 -59.77 5.71 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mt -70.11 118.53 13.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.274 -1.133 . . . . 0.0 109.577 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 24.1 mttm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.573 179.893 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.83 -11.85 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.66 2.24 . . . . 0.0 112.192 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -47.96 -47.16 32.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.13 -0.981 . . . . 0.0 108.899 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.0 t -67.93 -44.22 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.321 -0.862 . . . . 0.0 108.878 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.9 t -49.34 -50.66 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 108.951 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.39 80.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.406 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.32 -57.41 9.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.654 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.21 -36.08 63.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 110.013 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.6 mt -73.12 -41.51 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.006 . . . . 0.0 109.703 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.27 -36.68 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.987 -1.07 . . . . 0.0 108.641 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.38 -44.28 42.77 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.9 mt -56.31 -39.05 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.03 -1.276 . . . . 0.0 109.387 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.83 -54.64 14.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.126 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -48.61 -42.88 35.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.838 . . . . 0.0 109.881 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.2 tp -67.16 -65.47 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 109.684 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.9 mt -46.65 -27.41 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 109.43 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mt -69.48 -61.8 1.64 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.383 -0.823 . . . . 0.0 109.727 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.476 ' NE1' ' OD2' ' D' ' 44' ' ' ASP . 55.8 t-105 -47.84 -46.04 30.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 0.0 109.413 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.2 mt -64.17 -55.7 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.197 -0.939 . . . . 0.0 109.135 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.2 tp -45.27 -43.7 10.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.583 -0.698 . . . . 0.0 110.313 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.04 -27.63 54.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.034 -1.041 . . . . 0.0 110.556 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -72.47 -22.24 61.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.793 -1.192 . . . . 0.0 110.487 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.3 mt -68.64 -12.06 60.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.657 -1.277 . . . . 0.0 108.986 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -82.5 137.86 34.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.331 -0.856 . . . . 0.0 109.183 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -151.07 174.9 12.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.148 -0.97 . . . . 0.0 109.513 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.429 ' CG ' ' H ' ' A' ' 50' ' ' SER . 15.3 tttp 47.37 -143.28 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.364 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.429 ' H ' ' CG ' ' A' ' 49' ' ' LYS . 18.8 p 51.48 42.25 29.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.478 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 mt -80.67 -31.02 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 109.158 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.557 ' CG ' ' N ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -46.08 -42.69 13.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.789 . . . . 0.0 109.887 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.557 ' N ' ' CG ' ' A' ' 52' ' ' TYR . 1.2 mtp180 -50.61 -61.84 1.95 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 0.0 110.665 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -70.63 -26.58 63.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.885 -1.134 . . . . 0.0 110.061 -179.076 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -46.41 80.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.904 -1.122 . . . . 0.0 109.371 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -76.39 -27.5 56.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.673 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -61.97 -50.56 71.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.211 -0.93 . . . . 0.0 109.317 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.81 -59.51 3.7 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.9 mt -64.53 -167.85 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -1.169 . . . . 0.0 109.853 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.054 -0.975 . . . . 0.0 109.421 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 92.0 p . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.517 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 6.0 m-20 -153.61 50.4 0.57 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 109.532 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 11.7 Cg_endo -57.97 -14.47 18.66 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.793 2.329 . . . . 0.0 112.066 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 33.3 tp -46.17 -45.82 16.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.36 -0.837 . . . . 0.0 109.255 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 36.0 t -69.19 -44.72 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.24 -0.913 . . . . 0.0 108.927 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 72.5 t -49.18 -49.11 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 109.096 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.73 -33.73 76.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.289 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.86 -56.8 9.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.337 -0.852 . . . . 0.0 109.825 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.83 -37.2 70.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.877 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 33.4 mt -71.25 -41.22 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.058 -1.026 . . . . 0.0 109.499 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 24.0 mt -57.08 -34.14 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 108.559 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.11 -43.94 24.82 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 53.9 mt -56.11 -35.29 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.177 -1.19 . . . . 0.0 109.235 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -61.53 1.73 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.22 -0.925 . . . . 0.0 109.073 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . 0.455 ' NE2' ' ND1' ' C' ' 37' ' ' HIS . 1.8 t-80 -46.83 -41.91 16.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 109.771 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -62.3 -69.75 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.166 -0.959 . . . . 0.0 109.591 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.3 mt -46.11 -38.26 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.34 -0.85 . . . . 0.0 109.36 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mt -59.37 -62.4 1.91 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.45 -0.781 . . . . 0.0 109.967 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -44.99 -49.38 11.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.424 -0.798 . . . . 0.0 109.649 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 34.1 mt -59.79 -48.61 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.12 -0.988 . . . . 0.0 108.52 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.62 -57.41 4.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.55 -0.719 . . . . 0.0 109.453 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.0 -31.34 68.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.848 . . . . 0.0 110.41 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.438 ' CA ' ' HE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -71.92 -23.43 61.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.873 -1.142 . . . . 0.0 110.471 -179.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.0 mt -75.93 -34.01 59.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.699 -1.251 . . . . 0.0 108.887 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -48.42 101.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.912 . . . . 0.0 109.435 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -163.5 -3.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -67.21 -118.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.55 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 10.3 p -53.18 104.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.324 -0.86 . . . . 0.0 109.718 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 11.4 mt -102.21 -24.85 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.479 -0.763 . . . . 0.0 109.17 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -54.46 -24.94 22.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.854 . . . . 0.0 109.748 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 -65.87 -38.77 89.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.522 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -71.01 -36.65 72.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 109.166 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -69.46 -46.77 65.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.405 -0.809 . . . . 0.0 109.162 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -64.02 -27.88 69.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 108.933 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -69.38 -46.63 66.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.403 -0.811 . . . . 0.0 109.545 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.0 -61.22 6.0 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 73.0 mt -60.86 -178.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -1.127 . . . . 0.0 109.808 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.436 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' C' ' 24' ' ' ASP . 2.9 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.545 ' H ' ' HG ' ' C' ' 23' ' ' SER . 20.2 t0 -168.94 65.38 0.6 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.899 . . . . 0.0 109.463 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -45.18 -11.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.749 2.299 . . . . 0.0 112.14 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' C' ' 24' ' ' ASP . 22.2 tp -47.69 -46.33 29.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.144 -0.972 . . . . 0.0 109.107 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 41.5 t -68.15 -44.93 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.213 -0.929 . . . . 0.0 108.581 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.2 t -50.03 -49.39 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.334 -0.854 . . . . 0.0 108.788 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.28 -30.19 71.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.355 -0.841 . . . . 0.0 109.288 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.96 -56.83 6.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.0 109.602 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.31 -36.97 66.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.947 . . . . 0.0 109.525 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 36.3 mt -72.71 -42.5 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.16 -0.963 . . . . 0.0 109.412 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 20.3 mt -55.88 -34.33 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.122 -0.986 . . . . 0.0 108.629 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.26 -45.33 31.28 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 65.4 mt -58.38 -34.66 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.277 -1.131 . . . . 0.0 108.993 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.98 -67.89 0.41 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 108.908 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . 0.455 ' ND1' ' NE2' ' B' ' 37' ' ' HIS . 4.3 t-80 -45.83 -36.82 5.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.813 . . . . 0.0 109.656 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.89 -69.61 0.28 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 109.517 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 7.9 mt -48.11 -30.12 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 109.751 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt -68.1 -63.56 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.109 -0.995 . . . . 0.0 109.718 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 -44.45 -48.69 10.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.338 -0.851 . . . . 0.0 110.06 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.89 -58.28 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.046 -1.034 . . . . 0.0 109.108 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 54.1 tp -45.12 -40.19 6.72 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.533 -0.73 . . . . 0.0 109.99 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . 0.42 ' O ' ' CE2' ' C' ' 48' ' ' PHE . 0.4 OUTLIER -73.18 -28.39 62.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 109.638 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.423 ' HE ' ' CA ' ' C' ' 45' ' ' ARG . 0.0 OUTLIER -76.55 -18.76 58.51 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.212 -0.93 . . . . 0.0 110.196 -179.57 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' C' ' 47' ' ' PHE . 8.3 mt -83.93 -31.18 25.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.797 -1.189 . . . . 0.0 108.885 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.464 ' C ' ' CG ' ' C' ' 48' ' ' PHE . 2.4 m-85 -52.92 -174.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 109.652 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . 0.464 ' CG ' ' C ' ' C' ' 47' ' ' PHE . 0.8 OUTLIER 67.02 -66.51 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 0.0 109.811 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' C' ' 47' ' ' PHE . 10.8 tttp 52.33 -93.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.353 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' SER . . . . . 0.451 ' N ' ' O ' ' C' ' 48' ' ' PHE . 68.1 m -63.27 148.41 48.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.136 -0.977 . . . . 0.0 109.389 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 11.6 mt -103.31 -27.55 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.562 -0.711 . . . . 0.0 109.697 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -52.88 -18.66 2.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.934 . . . . 0.0 109.715 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . 0.49 ' O ' ' CD2' ' C' ' 57' ' ' HIS . 9.5 mtp180 -72.64 -42.16 64.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.865 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.7 -38.03 83.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.935 . . . . 0.0 109.37 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -64.15 -59.3 4.59 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.352 -0.843 . . . . 0.0 109.249 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -55.88 -29.4 59.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.547 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . 0.49 ' CD2' ' O ' ' C' ' 53' ' ' ARG . 10.9 m170 -69.01 -52.89 24.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.204 -0.935 . . . . 0.0 109.312 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.16 -63.93 4.0 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.71 105.17 3.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -1.187 . . . . 0.0 109.108 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.396 179.947 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . 0.526 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 2.8 m-20 -155.81 49.85 0.45 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.527 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 11.0 Cg_endo -57.65 -7.13 2.86 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.768 2.312 . . . . 0.0 112.138 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 33.7 tp -49.23 -48.8 45.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 108.924 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 98.5 t -67.11 -44.87 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 108.724 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 73.5 t -48.67 -50.03 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 108.974 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.75 -33.8 76.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -0.856 . . . . 0.0 109.173 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.25 -57.55 8.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 109.635 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.35 -35.86 65.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.189 -0.944 . . . . 0.0 109.949 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 21.8 mt -72.94 -42.45 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.123 -0.985 . . . . 0.0 109.485 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 mt -55.04 -35.85 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.974 -1.079 . . . . 0.0 108.573 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.67 -45.14 46.4 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 57.9 mt -56.79 -37.74 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -1.171 . . . . 0.0 109.129 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' D' ' 37' ' ' HIS . 0.7 OUTLIER -66.4 -68.47 0.37 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.902 . . . . 0.0 109.342 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' D' ' 36' ' ' LEU . 1.6 t-80 -42.76 -33.18 0.7 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.438 -0.789 . . . . 0.0 110.161 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.3 tp -70.36 -71.21 0.25 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.947 . . . . 0.0 109.672 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mt -49.16 -29.4 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 109.498 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.64 -59.66 2.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.457 -0.777 . . . . 0.0 109.648 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 17.0 t-105 -45.1 -54.28 6.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.71 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.62 -46.45 79.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.204 -0.935 . . . . 0.0 108.867 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.53 -48.77 14.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.588 -0.695 . . . . 0.0 109.722 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . 0.476 ' OD2' ' NE1' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -66.97 -33.87 76.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -0.873 . . . . 0.0 110.184 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -68.34 -23.86 64.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.091 -1.006 . . . . 0.0 110.577 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -75.82 -34.37 60.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.663 -1.273 . . . . 0.0 109.089 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -52.58 115.78 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.4 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -172.11 132.77 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 0.0 109.486 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . 0.418 ' O ' ' OG ' ' D' ' 50' ' ' SER . 6.8 ttpt -154.27 -42.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 109.708 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' D' ' 49' ' ' LYS . 4.5 m -165.77 159.18 15.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.655 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 9.2 mt -103.97 -25.27 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.613 -0.679 . . . . 0.0 109.369 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -52.01 -19.04 1.63 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.328 -0.857 . . . . 0.0 109.852 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -71.63 -41.03 69.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.069 -1.019 . . . . 0.0 109.682 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -70.71 -32.48 69.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.096 -1.003 . . . . 0.0 109.148 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -68.37 -42.84 78.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.265 -0.897 . . . . 0.0 109.401 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -72.73 -28.2 62.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.287 -0.883 . . . . 0.0 109.288 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -66.21 -44.3 84.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 108.761 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.33 -63.36 3.81 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.5 125.62 24.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.349 -1.089 . . . . 0.0 109.233 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 61.2 mttt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.889 -1.053 . . . . 0.0 109.425 -179.906 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 26' ' ' LEU . 1.3 m-20 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -47.99 -8.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.928 2.418 . . . . 0.0 112.476 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.469 ' H ' ' C ' ' A' ' 24' ' ' ASP . 36.4 tp -48.46 -47.48 38.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.099 -1.001 . . . . 0.0 108.923 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.2 t -67.54 -45.03 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.0 108.639 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.0 t -49.28 -46.8 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.5 81.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.241 -0.912 . . . . 0.0 109.228 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.64 -56.67 10.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 0.0 109.682 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -36.41 64.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.26 -0.9 . . . . 0.0 109.738 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.0 mt -72.7 -41.98 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 109.565 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 mt -56.13 -35.52 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.099 -1.001 . . . . 0.0 108.786 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.85 -44.99 45.48 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.3 mt -59.16 -33.9 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 121.297 -1.119 . . . . 0.0 109.376 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.56 -66.13 0.61 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.389 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -44.4 -45.39 8.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.325 -0.859 . . . . 0.0 110.235 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.5 tp -59.05 -66.07 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.097 -1.002 . . . . 0.0 109.598 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mt -48.8 -47.51 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.165 -0.96 . . . . 0.0 109.626 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 mt -56.45 -55.18 36.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 110.13 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -48.54 -49.54 35.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.038 -1.039 . . . . 0.0 109.691 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.3 mt -60.6 -57.27 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.244 -0.91 . . . . 0.0 109.126 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.0 tp -50.3 -21.56 1.44 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.675 -0.64 . . . . 0.0 110.247 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -90.77 -26.73 19.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.971 . . . . 0.0 110.009 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.9 mtp85 -81.63 -21.87 37.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.163 -0.96 . . . . 0.0 110.721 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -69.16 -31.8 70.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.667 -1.271 . . . . 0.0 108.91 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -98.1 124.35 42.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.433 -0.792 . . . . 0.0 109.212 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -168.44 -8.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.143 -0.973 . . . . 0.0 109.878 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.545 ' CG ' ' H ' ' A' ' 50' ' ' SER . 1.3 tpmt? -72.95 -149.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.176 -0.953 . . . . 0.0 109.312 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.545 ' H ' ' CG ' ' A' ' 49' ' ' LYS . 59.0 p 46.33 71.61 0.29 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.56 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.7 mt -94.45 -25.16 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.559 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -61.23 -26.18 67.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 109.466 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -68.62 -37.6 79.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.079 -1.013 . . . . 0.0 109.359 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -74.19 -41.29 61.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.151 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -62.34 -42.98 99.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.335 -0.853 . . . . 0.0 109.405 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -73.61 -26.34 60.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.185 -0.947 . . . . 0.0 109.276 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.476 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 12.3 t-80 -69.91 -31.19 68.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.17 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.32 -63.68 1.77 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mt -57.94 112.13 1.39 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -1.183 . . . . 0.0 109.234 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.593 -179.869 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' B' ' 24' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.552 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 23.9 m-20 -151.34 49.27 0.56 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.462 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 9.8 Cg_endo -56.16 -10.96 5.09 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.724 2.282 . . . . 0.0 112.02 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 28.6 tp -47.01 -47.24 22.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.063 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 41.0 t -67.69 -45.3 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.887 . . . . 0.0 108.937 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -48.79 -48.9 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 108.994 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.43 -33.46 75.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.4 -0.813 . . . . 0.0 109.184 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.91 -58.01 6.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.675 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -55.22 -35.5 64.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.797 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 36.8 mt -73.45 -41.26 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.121 -0.987 . . . . 0.0 109.745 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 24.1 mt -55.98 -35.41 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.992 -1.068 . . . . 0.0 108.661 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.76 -45.4 34.79 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mt -55.26 -30.58 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.23 -1.159 . . . . 0.0 109.096 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.07 -65.64 0.82 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.228 -0.92 . . . . 0.0 109.055 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -46.48 -34.87 5.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.619 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.75 -71.24 0.22 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 109.469 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.9 mt -46.78 -37.41 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.324 -0.86 . . . . 0.0 109.397 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.7 tt -58.92 -62.91 1.53 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.489 -0.757 . . . . 0.0 109.662 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 10.9 t-105 -47.41 -52.44 16.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.828 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 57.0 mt -55.02 -48.19 76.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.989 -1.069 . . . . 0.0 108.681 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.11 -50.63 11.0 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.39 0.614 . . . . 0.0 109.476 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.469 ' CG ' HH11 ' C' ' 45' ' ' ARG . 37.7 m-20 -62.16 -32.68 73.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.342 -0.849 . . . . 0.0 109.521 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.507 ' CA ' ' HE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -72.39 -20.52 61.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.115 -0.99 . . . . 0.0 110.183 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -85.83 -34.3 21.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.699 -1.251 . . . . 0.0 108.961 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . 0.491 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 59.1 t80 -59.01 96.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.286 -0.884 . . . . 0.0 109.378 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' B' ' 47' ' ' PHE . 8.5 m-85 -165.9 97.82 0.64 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.688 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -150.41 -80.9 0.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.935 . . . . 0.0 109.552 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 16.4 m -80.4 106.14 12.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.937 . . . . 0.0 109.548 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 13.7 mt -92.29 -23.48 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.897 . . . . 0.0 109.562 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.428 ' CD1' ' C ' ' B' ' 52' ' ' TYR . 1.4 p90 -64.64 -17.09 63.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 109.214 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -43.87 64.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 109.783 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -68.63 -32.93 73.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.511 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -70.66 -44.3 67.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.692 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.99 -29.39 68.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 109.512 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -68.67 -47.79 65.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.877 . . . . 0.0 109.177 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.0 -64.31 3.48 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.22 120.63 8.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.292 -1.122 . . . . 0.0 109.469 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.485 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 74.0 m . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.297 0.57 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' C' ' 26' ' ' LEU . 25.4 t0 55.27 66.81 3.55 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.508 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -46.51 -11.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.717 2.278 . . . . 0.0 111.974 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' C' ' 24' ' ' ASP . 40.5 tp -47.49 -45.04 25.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.423 -0.798 . . . . 0.0 109.059 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 51.5 t -69.85 -45.19 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 108.755 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 78.9 t -48.45 -48.22 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -0.865 . . . . 0.0 108.846 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.5 -35.45 80.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.355 -0.841 . . . . 0.0 109.107 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.29 -57.36 10.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.46 -0.775 . . . . 0.0 109.851 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -56.42 -35.71 68.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.757 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.4 mt -71.47 -39.76 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.114 -0.991 . . . . 0.0 109.355 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 32.2 mt -58.15 -35.14 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.012 -1.055 . . . . 0.0 108.423 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.64 -45.15 54.86 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 75.3 mt -61.69 -23.06 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.298 -1.119 . . . . 0.0 108.73 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.1 -70.83 0.39 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.385 -0.822 . . . . 0.0 109.404 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -45.36 -37.05 4.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.312 -0.868 . . . . 0.0 109.676 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.93 -68.05 0.37 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 0.0 109.412 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 5.4 mt -51.98 -27.69 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.947 . . . . 0.0 109.584 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.22 -61.49 1.76 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 0.0 109.598 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -46.91 -43.75 19.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 109.646 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 64.6 mt -67.68 -40.05 83.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.261 -0.899 . . . . 0.0 109.249 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 57.6 tp -58.68 -36.35 74.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.577 -0.702 . . . . 0.0 110.217 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -86.4 -20.44 28.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.106 -0.997 . . . . 0.0 110.158 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.469 HH11 ' CG ' ' B' ' 44' ' ' ASP . 1.6 mmp_? -78.45 -27.23 46.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.952 -1.093 . . . . 0.0 110.549 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -52.14 -12.9 0.27 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.563 -1.336 . . . . 0.0 108.864 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . 0.447 ' H ' ' C ' ' C' ' 45' ' ' ARG . 53.6 m-85 -93.13 101.75 14.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.887 . . . . 0.0 109.724 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -168.23 -20.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 0.0 109.559 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.74 -70.25 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.166 -0.959 . . . . 0.0 109.369 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 64.0 p -68.49 110.88 4.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.174 -0.954 . . . . 0.0 109.365 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 11.2 mt -105.95 -25.17 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.576 -0.703 . . . . 0.0 109.803 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -28.29 23.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.93 . . . . 0.0 109.752 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -65.91 -42.79 89.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 0.0 109.817 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -64.96 -34.96 79.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.309 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -63.69 -59.53 4.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.338 -0.851 . . . . 0.0 109.227 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -54.72 -31.01 57.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 109.732 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -65.73 -42.96 90.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -0.976 . . . . 0.0 109.335 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.13 -61.5 5.13 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 54.0 mt -74.91 156.8 35.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -1.147 . . . . 0.0 109.591 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.377 179.968 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.237 0.542 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' D' ' 26' ' ' LEU . 1.5 m-20 51.0 66.97 4.75 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.93 . . . . 0.0 109.617 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -46.44 -10.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.785 2.323 . . . . 0.0 112.353 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' D' ' 24' ' ' ASP . 26.3 tp -47.26 -45.89 24.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 109.079 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 39.0 t -69.29 -45.14 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.1 t -49.4 -48.92 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 108.78 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.93 -32.88 74.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.341 -0.85 . . . . 0.0 109.184 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.3 -56.89 10.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.388 -0.82 . . . . 0.0 109.741 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -56.1 -36.34 68.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.783 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.07 -40.54 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.114 -0.991 . . . . 0.0 109.395 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 25.0 mt -57.18 -34.06 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.124 -0.985 . . . . 0.0 108.543 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.46 -44.52 27.01 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 61.7 mt -57.9 -29.5 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.152 -1.204 . . . . 0.0 109.022 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.48 -66.62 0.67 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.427 -0.796 . . . . 0.0 109.252 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -46.53 -39.92 11.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.834 . . . . 0.0 109.927 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.7 -67.54 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.064 -1.022 . . . . 0.0 109.757 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mt -48.85 -40.48 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.152 -0.968 . . . . 0.0 109.541 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 tt -55.79 -55.4 32.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.844 . . . . 0.0 109.915 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -53.06 -48.69 67.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.074 -1.016 . . . . 0.0 110.077 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 68.2 mt -60.18 -49.48 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.107 -0.996 . . . . 0.0 109.152 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 tp -49.37 -40.29 35.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.497 -0.752 . . . . 0.0 110.093 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -74.01 -27.65 61.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.206 -0.934 . . . . 0.0 109.808 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -74.65 -24.25 58.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 110.494 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -74.48 -9.5 58.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.68 -1.262 . . . . 0.0 109.086 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -142.84 89.24 2.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.453 -0.779 . . . . 0.0 109.466 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . 0.415 ' O ' ' O ' ' D' ' 49' ' ' LYS . 2.7 t80 -151.76 -3.96 0.27 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 0.0 109.515 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' D' ' 48' ' ' PHE . 4.1 mtmt -63.02 -134.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.413 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.489 ' HG ' HH11 ' D' ' 53' ' ' ARG . 21.3 t 51.36 79.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 109.521 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 47.8 mt -95.74 -37.58 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.845 . . . . 0.0 109.334 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . 0.521 ' CD2' ' N ' ' D' ' 53' ' ' ARG . 21.2 p90 -52.23 -43.96 64.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.107 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . 0.521 ' N ' ' CD2' ' D' ' 52' ' ' TYR . 0.9 OUTLIER -62.84 -18.07 62.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 108.844 179.32 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -69.32 -46.86 66.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.367 -0.833 . . . . 0.0 109.128 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 1.1 m-85 -74.18 -52.96 10.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.062 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -49.2 -35.11 16.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.423 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . 0.496 ' CD2' ' O ' ' D' ' 53' ' ' ARG . 12.4 m170 -70.64 -57.69 4.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 109.642 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -50.46 -56.98 11.18 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 4.7 mt -70.91 124.01 23.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -1.127 . . . . 0.0 109.492 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 35.3 tttm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.461 179.834 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.66 -11.16 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.638 2.225 . . . . 0.0 112.439 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.2 tp -47.43 -47.88 26.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.039 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.9 -44.99 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -0.841 . . . . 0.0 108.824 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -49.38 -47.76 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.269 -0.895 . . . . 0.0 108.718 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.36 83.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.622 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.33 -53.7 39.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -0.915 . . . . 0.0 109.61 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -37.3 71.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.794 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.4 mt -72.29 -41.52 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.144 -0.972 . . . . 0.0 109.563 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.3 mt -56.88 -35.2 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.013 -1.055 . . . . 0.0 108.693 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.5 -42.98 46.5 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.2 mt -62.18 -27.17 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.336 -1.097 . . . . 0.0 109.148 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.92 -63.63 1.13 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.363 -0.835 . . . . 0.0 108.982 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -45.8 -40.64 9.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 0.0 109.94 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -64.3 -67.66 0.41 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.587 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.2 mt -47.36 -35.63 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.279 -0.888 . . . . 0.0 109.106 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 43' ' ' LEU . 2.5 mt -62.34 -61.61 2.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.615 -0.678 . . . . 0.0 109.682 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -43.3 -46.46 6.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.613 -0.679 . . . . 0.0 109.796 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.3 mt -71.88 -28.05 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 108.985 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 40' ' ' LEU . 6.6 tp -63.75 -41.93 97.93 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.274 -0.891 . . . . 0.0 109.907 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -83.95 -23.59 31.04 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.293 -0.88 . . . . 0.0 109.813 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' PHE . 8.4 mmt85 -95.47 3.17 54.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.252 -0.905 . . . . 0.0 110.865 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.488 ' C ' ' O ' ' A' ' 45' ' ' ARG . 34.4 mt -31.17 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.783 -0.573 . . . . 0.0 110.816 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 45' ' ' ARG . 2.2 m-85 -171.9 -170.86 0.81 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.114 -0.991 . . . . 0.0 109.74 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.528 ' O ' ' N ' ' A' ' 50' ' ' SER . 3.3 p90 -137.88 -1.93 1.96 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.467 -0.77 . . . . 0.0 109.552 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp 47.99 -91.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.88 . . . . 0.0 109.525 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -148.13 177.63 9.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -0.882 . . . . 0.0 109.43 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 mt -102.35 -24.29 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.491 -0.756 . . . . 0.0 109.489 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -52.63 -21.35 3.84 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.223 -0.923 . . . . 0.0 109.448 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -67.47 -43.48 80.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.36 -0.837 . . . . 0.0 109.9 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -69.98 -39.55 75.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.973 . . . . 0.0 109.371 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -55.01 -51.5 66.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.348 -0.845 . . . . 0.0 109.641 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -71.23 -25.11 62.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.31 -0.869 . . . . 0.0 109.794 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -67.44 -37.59 83.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 0.0 109.611 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.25 -62.83 1.77 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.4 mt -72.26 84.85 1.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -1.215 . . . . 0.0 109.622 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 pttt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.421 179.804 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 34.6 p . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' B' ' 26' ' ' LEU . 5.7 m-20 -149.42 64.88 7.54 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.589 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -44.54 -9.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.972 2.448 . . . . 0.0 112.524 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' B' ' 24' ' ' ASP . 42.7 tp -47.34 -46.13 25.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.123 -0.985 . . . . 0.0 109.261 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 35.1 t -68.14 -45.13 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 108.924 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 78.2 t -48.38 -47.65 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.877 . . . . 0.0 109.138 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.54 -37.45 86.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.35 -0.844 . . . . 0.0 109.4 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.07 -55.9 21.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 109.569 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' SER . . . . . 0.427 ' H ' ' HG ' ' B' ' 31' ' ' SER . 2.1 m -56.31 -34.74 66.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 109.887 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.41 HG23 HD12 ' B' ' 32' ' ' ILE . 5.2 mt -72.83 -43.48 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.14 -0.975 . . . . 0.0 109.323 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 11.7 mt -54.59 -35.3 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.067 -1.02 . . . . 0.0 108.547 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.59 -44.18 50.4 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 59.3 mt -59.3 -34.67 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.269 -1.136 . . . . 0.0 109.468 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.33 -67.77 0.47 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -0.962 . . . . 0.0 109.226 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -44.29 -34.08 1.81 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.47 -0.768 . . . . 0.0 109.788 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 54.8 tp -70.18 -70.44 0.29 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 14.2 mt -47.24 -24.02 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.216 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.7 tt -71.76 -63.48 1.12 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 109.688 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 16.6 t-105 -48.65 -47.03 40.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.558 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 82.2 mt -57.11 -44.68 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.93 -54.47 9.99 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.496 0.665 . . . . 0.0 109.38 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . 0.456 ' CG ' HH11 ' C' ' 45' ' ' ARG . 59.2 m-20 -61.82 -29.5 70.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.552 -0.717 . . . . 0.0 110.338 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -73.35 -24.32 60.33 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.949 -1.094 . . . . 0.0 110.871 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -75.0 -8.58 56.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.605 -1.309 . . . . 0.0 109.577 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -143.11 117.87 9.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.324 -0.86 . . . . 0.0 109.664 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -156.3 -3.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -0.873 . . . . 0.0 109.362 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -71.23 -146.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.601 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.513 ' O ' ' CE2' ' B' ' 54' ' ' PHE . 0.7 OUTLIER 46.92 72.27 0.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.364 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 22.1 mt -100.33 -24.42 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.405 -0.81 . . . . 0.0 109.532 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -70.79 -16.51 62.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.175 -0.953 . . . . 0.0 109.449 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -45.18 56.34 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . 0.513 ' CE2' ' O ' ' B' ' 50' ' ' SER . 4.6 m-85 -69.23 -30.96 69.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.349 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -69.49 -45.36 69.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 109.078 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -72.98 -29.18 62.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -0.858 . . . . 0.0 109.421 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -64.36 -60.04 3.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.232 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.98 -55.13 31.93 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.36 95.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.349 -1.089 . . . . 0.0 109.209 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 tttt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.459 -179.826 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' C' ' 26' ' ' LEU . 0.9 OUTLIER 50.9 70.37 2.04 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -47.36 -7.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.631 2.22 . . . . 0.0 112.313 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . 0.509 ' H ' ' C ' ' C' ' 24' ' ' ASP . 41.9 tp -49.31 -45.61 45.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.088 -1.007 . . . . 0.0 109.093 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.97 -45.53 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.067 -1.021 . . . . 0.0 108.534 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.5 t -49.28 -46.7 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.52 75.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.87 . . . . 0.0 109.285 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.07 -56.47 11.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.387 -0.82 . . . . 0.0 109.556 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.68 -37.27 68.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 109.559 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 12.2 mt -70.75 -40.34 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.517 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 26.2 mt -58.44 -35.31 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.054 -1.029 . . . . 0.0 108.79 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.56 -43.73 67.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.47 -27.19 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.45 -1.03 . . . . 0.0 108.999 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.5 tp -68.8 -68.89 0.36 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.0 109.111 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . 0.598 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 1.8 t-80 -45.97 -43.0 13.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 110.048 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 49.1 tp -58.39 -65.19 0.69 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.124 -0.985 . . . . 0.0 109.709 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.404 HD13 HG23 ' C' ' 39' ' ' ILE . 4.1 mt -49.09 -31.87 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.954 . . . . 0.0 109.523 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -70.31 -59.46 2.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.923 . . . . 0.0 110.277 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -48.83 -46.17 41.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.997 -1.064 . . . . 0.0 109.908 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 69.6 mt -64.88 -48.89 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.135 -0.978 . . . . 0.0 109.124 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 tp -54.46 -32.42 57.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.567 -0.708 . . . . 0.0 110.183 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' C' ' 44' ' ' ASP . 0.3 OUTLIER -84.54 -22.29 30.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.074 -1.016 . . . . 0.0 109.746 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . 0.456 HH11 ' CG ' ' B' ' 44' ' ' ASP . 0.2 OUTLIER -79.1 -25.09 43.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -0.936 . . . . 0.0 110.464 -179.236 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' C' ' 48' ' ' PHE . 10.5 mt -67.31 -31.2 71.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.706 -1.247 . . . . 0.0 108.893 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -47.45 98.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.943 . . . . 0.0 109.217 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . 0.429 ' N ' ' O ' ' C' ' 46' ' ' LEU . 2.5 t80 -162.05 18.66 0.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 109.341 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' C' ' 48' ' ' PHE . 1.5 pttm -61.11 -115.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.811 . . . . 0.0 109.647 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' SER . . . . . 0.403 ' H ' ' CG ' ' C' ' 49' ' ' LYS . 0.9 OUTLIER -87.26 148.59 25.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.664 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 18.5 mt -106.63 -24.23 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.648 -0.658 . . . . 0.0 109.407 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -52.39 -20.32 2.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.328 -0.857 . . . . 0.0 109.609 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -71.43 -41.8 69.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.18 -0.95 . . . . 0.0 109.578 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -67.14 -38.43 85.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 109.079 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -64.58 -64.62 0.83 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.407 -0.808 . . . . 0.0 109.146 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -50.52 -30.17 12.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.829 . . . . 0.0 109.855 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.79 -56.21 10.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.991 . . . . 0.0 109.571 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.4 -60.26 9.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.07 110.34 0.29 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -1.134 . . . . 0.0 109.426 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.46 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.6 p . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . 0.436 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 1.5 m-20 47.64 54.66 15.94 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.229 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 17.3 Cg_endo -60.88 -11.34 17.57 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.566 2.177 . . . . 0.0 112.453 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 20.6 tp -47.64 -46.17 28.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 0.0 108.977 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.5 t -70.1 -45.2 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 108.647 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 78.8 t -49.23 -48.1 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.148 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.49 -34.8 78.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.865 . . . . 0.0 109.285 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.81 -55.87 16.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.966 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.3 -37.47 72.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.115 -0.991 . . . . 0.0 109.919 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . 0.4 HG21 HD11 ' D' ' 32' ' ' ILE . 19.8 mt -70.33 -39.2 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 109.261 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 22.5 mt -58.9 -34.59 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.116 -0.99 . . . . 0.0 108.617 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.18 -44.9 58.51 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 63.8 mt -60.47 -28.55 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.472 -1.016 . . . . 0.0 109.121 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.39 -66.4 0.66 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.34 -0.85 . . . . 0.0 109.049 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . 0.598 ' CE1' ' NE2' ' C' ' 37' ' ' HIS . 11.6 t-160 -47.28 -37.27 10.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.952 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 42.8 tp -68.27 -62.99 1.15 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.097 -1.002 . . . . 0.0 109.67 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mt -46.64 -40.76 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 109.324 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 mt -59.78 -60.45 3.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.454 -0.779 . . . . 0.0 110.322 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . 0.424 ' CZ2' ' CG ' ' D' ' 45' ' ' ARG . 20.6 t-105 -49.93 -46.26 51.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.004 -1.06 . . . . 0.0 110.025 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.31 -47.04 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.14 -0.975 . . . . 0.0 109.362 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 tp -53.92 -39.85 66.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.426 -0.796 . . . . 0.0 109.744 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.35 -25.61 59.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.25 -0.906 . . . . 0.0 109.823 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . 0.424 ' CG ' ' CZ2' ' D' ' 41' ' ' TRP . 0.6 OUTLIER -74.47 -28.54 61.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.987 -1.071 . . . . 0.0 110.486 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 mt -69.13 -24.67 64.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.708 -1.245 . . . . 0.0 109.12 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -86.05 77.41 9.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.491 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -162.72 3.76 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.341 -0.849 . . . . 0.0 109.182 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . 0.53 ' CG ' ' H ' ' D' ' 50' ' ' SER . 0.8 OUTLIER -62.47 -98.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.53 ' H ' ' CG ' ' D' ' 49' ' ' LYS . 49.0 p -46.65 129.51 11.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.631 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 15.3 mt -104.91 -29.84 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.557 -0.715 . . . . 0.0 109.109 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -26.1 6.02 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.214 -0.929 . . . . 0.0 109.459 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -66.69 -45.05 80.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.119 -0.988 . . . . 0.0 109.55 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -65.01 -36.41 84.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.2 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.51 -66.64 0.53 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.383 -0.823 . . . . 0.0 109.068 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -46.74 -30.85 2.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.551 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -68.89 -56.7 7.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.936 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.8 -60.42 9.05 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mt -59.1 107.65 0.57 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -1.201 . . . . 0.0 109.322 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.274 -179.694 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.554 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 4.9 p-10 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.9 Cg_endo -56.15 -16.87 18.23 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.912 2.408 . . . . 0.0 112.152 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.8 tp -46.22 -43.42 15.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.262 -0.899 . . . . 0.0 109.17 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.06 -44.93 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.234 -0.916 . . . . 0.0 108.924 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.2 t -49.68 -49.59 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.192 -0.942 . . . . 0.0 109.174 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.09 -34.45 78.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.321 -0.862 . . . . 0.0 109.482 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.32 -56.48 12.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 109.615 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.452 ' H ' ' HG ' ' A' ' 31' ' ' SER . 0.7 OUTLIER -55.44 -37.56 67.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.307 -0.87 . . . . 0.0 109.908 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.1 mt -72.21 -41.13 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.966 . . . . 0.0 109.589 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.2 mt -55.87 -34.82 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.098 -1.001 . . . . 0.0 108.485 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.08 -45.01 33.59 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.4 mt -59.62 -27.27 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.256 -1.143 . . . . 0.0 109.187 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.15 -65.91 0.79 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 109.212 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -45.18 -37.89 4.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.363 -0.835 . . . . 0.0 109.79 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.7 tp -66.12 -68.99 0.33 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.943 . . . . 0.0 109.671 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.8 mt -46.69 -36.42 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.445 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mt -66.46 -58.06 6.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.271 -0.893 . . . . 0.0 109.708 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -49.1 -48.04 44.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.758 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.4 mt -63.1 -49.08 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -0.929 . . . . 0.0 109.315 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.6 tp -51.41 -34.65 35.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.535 -0.728 . . . . 0.0 110.318 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.0 m-20 -84.44 -26.42 28.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.12 -0.988 . . . . 0.0 110.272 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -71.78 -29.38 64.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.073 -1.017 . . . . 0.0 110.685 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -59.37 -26.11 64.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.714 -1.241 . . . . 0.0 109.593 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -57.26 111.07 0.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.07 -1.019 . . . . 0.0 109.43 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.481 ' CD1' ' C ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -169.54 16.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.241 -0.912 . . . . 0.0 109.471 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 48' ' ' PHE . 45.5 mtpt -62.44 -133.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 109.443 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.56 146.79 54.08 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 109.673 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.2 mt -106.31 -21.71 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -58.05 -15.13 8.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.399 -0.813 . . . . 0.0 109.755 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -69.58 -40.72 76.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 109.774 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -72.86 -42.84 63.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.079 -1.013 . . . . 0.0 109.158 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -56.51 -46.18 80.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.171 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -71.7 -25.43 62.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -0.843 . . . . 0.0 109.317 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -69.77 -32.51 71.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.17 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.22 -62.89 2.02 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.8 mt -72.66 138.8 46.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.193 -1.181 . . . . 0.0 109.498 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.389 -179.874 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' B' ' 26' ' ' LEU . 19.9 t0 -158.66 64.27 2.69 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.873 . . . . 0.0 109.476 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -44.61 -10.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.766 2.31 . . . . 0.0 112.367 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' B' ' 24' ' ' ASP . 30.2 tp -47.35 -46.43 25.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.023 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.5 -45.83 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.197 -0.939 . . . . 0.0 108.804 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 63.3 t -48.26 -48.18 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -0.837 . . . . 0.0 109.026 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.72 -34.15 77.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.219 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.89 -57.41 8.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 109.749 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 2.3 m -55.18 -35.64 65.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.93 . . . . 0.0 109.786 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 19.8 mt -72.89 -41.28 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.098 -1.001 . . . . 0.0 109.567 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -56.11 -33.88 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.037 -1.039 . . . . 0.0 108.574 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.13 -44.83 22.01 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 59.5 mt -56.77 -31.76 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.274 -1.133 . . . . 0.0 109.182 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.68 -64.11 1.02 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.193 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -44.4 -40.5 5.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.413 -0.805 . . . . 0.0 110.123 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 50.8 tp -66.87 -67.27 0.46 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.975 . . . . 0.0 109.636 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 mt -47.33 -26.02 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 109.429 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.66 -68.05 0.44 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.322 -0.861 . . . . 0.0 110.039 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -44.51 -46.54 9.83 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.437 -0.789 . . . . 0.0 109.953 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 56.7 mt -59.29 -47.28 90.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.123 -0.986 . . . . 0.0 108.644 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.1 -54.01 11.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.481 -0.762 . . . . 0.0 108.985 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -60.25 -29.89 69.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.493 -0.754 . . . . 0.0 110.389 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -21.39 57.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.909 -1.12 . . . . 0.0 110.745 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -79.04 -33.71 44.48 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.532 -1.355 . . . . 0.0 108.952 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -61.49 122.61 15.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.848 . . . . 0.0 109.682 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -156.39 52.85 0.54 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.374 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.44 -80.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 109.456 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.499 ' CB ' ' CZ ' ' B' ' 52' ' ' TYR . 0.0 OUTLIER -155.81 166.57 33.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.436 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 11.5 mt -96.9 -34.89 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.303 -0.873 . . . . 0.0 109.842 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.499 ' CZ ' ' CB ' ' B' ' 50' ' ' SER . 19.6 p90 -62.66 -19.14 63.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.036 -1.04 . . . . 0.0 109.654 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.7 mmt85 -68.56 -45.22 72.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.537 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -66.27 -32.61 74.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.277 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -69.67 -59.94 2.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.0 109.18 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -53.73 -28.12 32.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.897 . . . . 0.0 109.822 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -71.56 -53.87 12.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.104 -0.997 . . . . 0.0 109.305 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.31 -62.25 6.04 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.98 108.24 0.57 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -1.105 . . . . 0.0 108.985 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 17.9 tttm . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.471 -179.837 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' C' ' 26' ' ' LEU . 15.9 m-20 -149.52 66.06 8.12 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -46.22 -10.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.875 2.383 . . . . 0.0 112.237 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . 0.489 ' H ' ' C ' ' C' ' 24' ' ' ASP . 49.3 tp -47.32 -46.57 25.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.237 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.58 -44.51 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.077 -1.014 . . . . 0.0 108.847 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 69.5 t -49.15 -49.48 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 108.904 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.61 74.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.218 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.48 -57.54 8.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 109.6 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.43 -37.14 67.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.088 -1.008 . . . . 0.0 109.873 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 24.3 mt -71.4 -41.85 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 0.0 109.454 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 23.1 mt -55.55 -34.86 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.089 -1.007 . . . . 0.0 108.544 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.83 -45.24 28.2 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 50.0 mt -55.36 -31.51 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.261 -1.14 . . . . 0.0 109.379 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.0 -57.69 3.74 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.271 -0.893 . . . . 0.0 109.019 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -50.33 -37.62 37.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.217 -0.927 . . . . 0.0 109.436 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -67.02 -69.01 0.33 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.273 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.4 mt -46.7 -26.44 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.275 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mt -69.61 -64.98 0.77 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -0.875 . . . . 0.0 109.655 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -45.41 -47.5 13.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.497 -0.752 . . . . 0.0 109.635 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 70.1 mt -63.73 -56.8 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.145 -0.972 . . . . 0.0 109.074 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.3 tp -44.7 -48.92 10.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.492 -0.755 . . . . 0.0 110.129 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.66 -25.81 65.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.15 -0.969 . . . . 0.0 110.416 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 11.7 mmt-85 -77.84 -21.1 51.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.887 -1.133 . . . . 0.0 110.536 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.1 mt -77.17 -14.43 59.78 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.697 -1.252 . . . . 0.0 108.956 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -76.55 -3.9 39.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.574 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . 0.407 ' O ' ' CG ' ' C' ' 48' ' ' PHE . 0.2 OUTLIER -79.52 112.79 17.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.976 . . . . 0.0 109.579 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . 0.491 ' CG ' ' H ' ' C' ' 50' ' ' SER . 4.5 pttp -163.22 -92.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.475 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' SER . . . . . 0.491 ' H ' ' CG ' ' C' ' 49' ' ' LYS . 28.4 t -77.55 138.03 38.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.4 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 11.1 mt -102.89 -20.28 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.536 -0.727 . . . . 0.0 109.112 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -30.6 26.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.263 -0.898 . . . . 0.0 109.683 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -62.7 -46.03 90.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 109.636 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . 0.408 ' O ' ' CD1' ' D' ' 51' ' ' ILE . 2.7 m-85 -63.78 -37.11 86.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.242 -0.911 . . . . 0.0 109.375 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.07 -63.36 1.17 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.25 -0.906 . . . . 0.0 109.147 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -46.77 -34.07 4.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.795 . . . . 0.0 109.673 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -65.62 -49.72 67.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 0.0 109.137 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.7 -60.81 8.07 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.53 105.84 17.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -1.14 . . . . 0.0 108.963 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.384 -179.99 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.42 160.64 40.4 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.251 -0.906 . . . . 0.0 109.296 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.02 -21.99 73.43 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.578 2.185 . . . . 0.0 112.373 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 51.5 tp -46.25 -43.64 15.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 108.664 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.6 -44.4 79.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.339 -0.85 . . . . 0.0 108.731 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 74.4 t -50.19 -49.43 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 108.703 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.56 -32.83 74.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.412 -0.805 . . . . 0.0 109.251 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.37 -56.67 9.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 109.783 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.67 -36.4 69.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 0.0 109.775 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 15.7 mt -71.65 -42.3 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 109.475 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 24.0 mt -56.13 -34.83 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -0.999 . . . . 0.0 108.617 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.28 -43.62 37.91 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 58.7 mt -58.0 -38.57 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.204 -1.174 . . . . 0.0 109.037 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.0 -66.26 0.57 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -0.884 . . . . 0.0 109.089 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -45.3 -36.65 4.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 0.0 109.83 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 44.1 tp -66.42 -70.0 0.27 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.095 -1.003 . . . . 0.0 109.407 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 9.9 mt -48.01 -25.15 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.361 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . 0.471 ' CD2' ' OD2' ' D' ' 44' ' ' ASP . 2.8 tt -72.74 -55.61 6.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.334 -0.854 . . . . 0.0 109.658 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -53.27 -50.92 63.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.094 -1.003 . . . . 0.0 109.568 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 23.1 mt -59.0 -55.0 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.091 -1.006 . . . . 0.0 108.739 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 35.9 tp -47.52 -37.2 11.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.422 -0.799 . . . . 0.0 109.72 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . 0.471 ' OD2' ' CD2' ' D' ' 40' ' ' LEU . 94.6 m-20 -74.22 -26.05 60.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.223 -0.923 . . . . 0.0 109.67 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . 0.503 ' CA ' ' HE ' ' D' ' 45' ' ' ARG . 0.0 OUTLIER -82.12 -17.67 45.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.126 -0.984 . . . . 0.0 110.732 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -82.26 -34.89 28.59 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.64 -1.287 . . . . 0.0 109.691 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . 0.607 ' CG ' ' N ' ' D' ' 48' ' ' PHE . 0.1 OUTLIER -101.53 -167.66 1.45 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.423 -0.798 . . . . 0.0 109.694 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . 0.607 ' N ' ' CG ' ' D' ' 47' ' ' PHE . 2.5 t80 77.76 30.39 0.47 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.505 -0.747 . . . . 0.0 109.541 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' D' ' 50' ' ' SER . 7.9 tptt -93.3 -148.32 0.25 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 109.28 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 50' ' ' SER . . . . . 0.429 ' O ' ' O ' ' D' ' 49' ' ' LYS . 1.2 m 54.75 102.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.469 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . 0.408 ' CD1' ' O ' ' C' ' 54' ' ' PHE . 11.8 mt -91.12 -19.52 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 109.16 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -31.4 70.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -0.909 . . . . 0.0 109.777 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -47.35 66.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 0.0 110.413 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . 0.479 ' CD1' ' O ' ' D' ' 54' ' ' PHE . 0.0 OUTLIER -69.75 -28.8 66.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.044 -1.035 . . . . 0.0 109.211 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.08 -58.28 7.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.367 -0.833 . . . . 0.0 109.609 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -68.88 -26.99 65.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.121 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -59.94 -61.01 2.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.986 -1.071 . . . . 0.0 109.098 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.7 -59.48 8.13 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.7 110.12 2.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -1.141 . . . . 0.0 109.611 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 2.8 pttp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.46 179.94 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 26' ' ' LEU . 19.3 Cg_endo -61.72 -29.26 83.2 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.541 2.16 . . . . 0.0 112.055 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 25' ' ' PRO . 40.8 tp -45.13 -40.45 7.01 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.7 t -69.25 -43.51 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.0 t -53.12 -51.8 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.13 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.38 -34.95 76.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.52 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.39 -53.51 42.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 109.591 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.508 ' H ' ' HG ' ' A' ' 31' ' ' SER . 0.8 OUTLIER -58.2 -37.44 74.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.859 -179.687 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.3 mt -71.41 -42.47 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.389 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.9 mt -55.28 -36.37 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 0.0 108.789 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.31 -42.79 56.44 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.3 mt -61.83 -46.53 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.235 -1.156 . . . . 0.0 109.269 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.45 -44.69 80.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 109.142 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -57.88 -56.08 26.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 109.482 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.3 tp -54.0 -59.97 3.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.913 . . . . 0.0 109.533 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.2 mt -47.52 -48.36 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.299 -0.876 . . . . 0.0 109.311 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mt -51.93 -59.31 4.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -45.14 -65.83 0.48 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.459 -0.776 . . . . 0.0 109.572 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mt -48.58 -37.74 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.125 -0.984 . . . . 0.0 109.278 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.1 -49.31 63.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.47 -0.769 . . . . 0.0 110.084 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.67 -21.72 55.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.968 . . . . 0.0 110.401 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 47' ' ' PHE . 12.9 mmt180 -91.68 -1.15 57.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.013 -1.054 . . . . 0.0 110.841 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 45' ' ' ARG . 29.7 mt -35.79 -30.61 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.525 -0.734 . . . . 0.0 110.192 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 45' ' ' ARG . 7.4 p90 -170.92 167.13 7.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.161 -0.962 . . . . 0.0 109.486 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -164.15 99.68 0.85 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.252 -0.905 . . . . 0.0 109.578 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 51' ' ' ILE . 10.1 ttmt -151.64 -44.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.166 -0.959 . . . . 0.0 109.405 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.9 t -60.15 80.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 109.369 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 49' ' ' LYS . 40.7 mt -92.43 -27.76 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.89 . . . . 0.0 109.557 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.51 -44.84 65.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.751 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.29 -45.12 62.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.088 -1.008 . . . . 0.0 109.454 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -61.97 -37.28 84.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.286 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.0 -34.7 78.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.115 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -70.21 -38.14 75.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.353 -0.842 . . . . 0.0 109.476 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -62.66 -54.41 39.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 0.0 109.324 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -54.17 -63.08 5.49 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 60' ' ' LYS . 7.7 mt -72.93 21.85 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -1.143 . . . . 0.0 109.741 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.53 ' H ' ' C ' ' A' ' 58' ' ' GLY . 65.9 mttm . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.546 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ASP . . . . . 0.533 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 1.5 p30 -153.35 50.05 0.55 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.88 . . . . 0.0 109.399 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 9.2 Cg_endo -55.59 -11.26 4.55 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.802 2.334 . . . . 0.0 112.248 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 43.6 tp -47.62 -45.85 28.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.152 -0.967 . . . . 0.0 109.094 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.57 -46.14 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.145 -0.972 . . . . 0.0 108.808 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 74.0 t -47.98 -48.27 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.892 . . . . 0.0 108.99 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.54 84.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.452 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.39 -57.34 8.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.261 -0.9 . . . . 0.0 109.801 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -53.93 -35.83 62.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 0.0 109.69 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 18.4 mt -72.65 -41.68 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.179 -0.951 . . . . 0.0 109.411 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 18.6 mt -55.25 -34.5 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.087 -1.008 . . . . 0.0 108.691 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.94 -44.77 23.23 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 51.6 mt -55.49 -34.87 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.072 -1.252 . . . . 0.0 109.326 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.46 -58.97 2.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 108.971 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' HIS . . . . . 0.602 ' NE2' ' ND1' ' C' ' 37' ' ' HIS . 2.3 t-80 -47.83 -37.4 13.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 0.0 109.716 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 52.6 tp -69.88 -67.74 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 0.0 109.466 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mt -47.04 -25.14 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 109.316 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mt -69.03 -63.43 1.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.642 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 41.8 t-105 -47.72 -46.69 29.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.399 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' B' ' 45' ' ' ARG . 72.3 mt -62.02 -61.4 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 108.906 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 57.6 tp -42.53 -47.73 5.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.762 -0.587 . . . . 0.0 110.096 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.72 -27.78 68.57 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' B' ' 42' ' ' ILE . 2.3 mmt180 -81.19 -14.97 57.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.099 -1.001 . . . . 0.0 110.333 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -88.83 -16.08 32.93 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.763 -1.211 . . . . 0.0 109.289 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -47.23 -77.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.326 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 45.11 74.72 0.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 109.769 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -96.65 -88.21 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 109.49 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' SER . . . . . 0.492 ' HG ' ' N ' ' B' ' 51' ' ' ILE . 2.1 t -148.51 148.98 30.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.388 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . 0.492 ' N ' ' HG ' ' B' ' 50' ' ' SER . 20.2 mt -96.37 -22.55 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.325 -0.859 . . . . 0.0 109.566 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -67.01 -20.7 65.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.592 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -70.31 -43.74 69.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.246 -0.909 . . . . 0.0 109.833 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -67.12 -34.76 78.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -0.956 . . . . 0.0 109.632 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -66.35 -43.65 85.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.201 -0.937 . . . . 0.0 109.302 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -68.78 -27.54 65.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.085 -1.009 . . . . 0.0 108.72 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -70.69 -38.41 73.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.447 -0.783 . . . . 0.0 109.501 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.96 -62.4 3.17 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 50.5 mt -72.39 136.43 46.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -1.083 . . . . 0.0 109.367 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 48.5 mttm . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.463 179.92 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' ASP . . . . . 0.505 ' C ' ' H ' ' C' ' 26' ' ' LEU . 0.2 OUTLIER -161.5 68.35 2.34 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.923 . . . . 0.0 109.571 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -46.4 -9.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.692 2.261 . . . . 0.0 112.105 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' C' ' 24' ' ' ASP . 35.4 tp -47.2 -46.41 23.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 0.0 109.141 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 33.8 t -69.49 -45.19 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.191 -0.943 . . . . 0.0 108.631 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 71.6 t -49.32 -50.41 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.336 -0.853 . . . . 0.0 108.995 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.11 -30.9 71.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.363 -0.835 . . . . 0.0 109.228 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.74 -56.22 11.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 109.603 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.13 -37.55 74.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -0.946 . . . . 0.0 109.829 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 42.0 mt -71.02 -40.72 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 0.0 109.51 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 18.5 mt -58.53 -32.28 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.106 -0.996 . . . . 0.0 108.594 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.86 -44.03 26.01 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 52.4 mt -57.04 -31.46 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.301 -1.117 . . . . 0.0 109.186 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.25 -62.39 1.45 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 108.935 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' HIS . . . . . 0.602 ' ND1' ' NE2' ' B' ' 37' ' ' HIS . 10.5 t-80 -47.13 -34.46 6.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 109.586 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 40.2 tp -70.56 -66.77 0.56 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.661 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 5.8 mt -49.97 -26.19 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.623 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -72.38 -54.49 9.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.138 -0.976 . . . . 0.0 109.526 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -55.02 -49.08 72.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.722 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 59.4 mt -63.9 -55.14 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.203 -0.936 . . . . 0.0 109.117 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 40.1 tp -48.23 -40.37 24.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.794 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' C' ' 44' ' ' ASP . 4.5 m-20 -73.21 -25.84 60.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 109.843 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.64 -19.43 45.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.114 -0.991 . . . . 0.0 110.506 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -79.39 -32.22 42.99 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.631 -1.293 . . . . 0.0 109.109 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -92.31 103.47 15.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.437 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.55 -12.3 0.13 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.328 -0.857 . . . . 0.0 109.582 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -65.1 -156.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.187 -0.946 . . . . 0.0 109.304 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 60.6 p 45.91 76.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.956 -1.09 . . . . 0.0 109.656 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 10.8 mt -95.54 -27.68 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -59.4 -24.91 63.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.193 -0.942 . . . . 0.0 109.421 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -68.78 -37.19 79.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.421 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -72.2 -35.12 68.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 109.364 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -64.12 -56.51 14.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.792 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -65.11 -28.25 69.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.114 -0.991 . . . . 0.0 109.788 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -70.41 -43.74 69.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.431 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.86 -65.7 2.32 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.67 95.28 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -1.189 . . . . 0.0 109.054 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.326 -179.831 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 24' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' D' ' 26' ' ' LEU . 27.8 t0 51.13 69.36 2.61 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.936 . . . . 0.0 109.394 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -47.32 -10.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.663 2.242 . . . . 0.0 112.134 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 26' ' ' LEU . . . . . 0.46 ' H ' ' C ' ' D' ' 24' ' ' ASP . 35.2 tp -47.88 -47.03 32.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.244 -0.91 . . . . 0.0 108.902 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 42.3 t -68.66 -44.71 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.106 -0.996 . . . . 0.0 108.63 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 78.3 t -49.24 -49.44 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 108.687 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.44 77.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.379 -0.826 . . . . 0.0 109.236 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.12 -56.85 10.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.343 -0.848 . . . . 0.0 109.734 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.82 -37.12 65.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.162 -0.961 . . . . 0.0 109.763 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 17.2 mt -71.5 -41.95 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.42 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 27.6 mt -55.24 -35.32 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 108.69 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.47 -45.3 47.44 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 72.2 mt -60.99 -24.26 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.291 -1.123 . . . . 0.0 109.037 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 17.2 tp -76.16 -70.53 0.44 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.464 -0.772 . . . . 0.0 109.231 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -45.52 -33.38 2.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.873 . . . . 0.0 109.715 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 56.6 tp -68.19 -66.27 0.59 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.179 -0.951 . . . . 0.0 109.49 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mt -52.43 -28.23 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.842 . . . . 0.0 109.659 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mt -76.24 -59.24 2.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.84 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -45.97 -52.01 12.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.283 -0.886 . . . . 0.0 109.841 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 42' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' D' ' 45' ' ' ARG . 66.9 mt -60.46 -57.63 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.154 -0.966 . . . . 0.0 109.018 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 59.2 tp -43.89 -44.69 7.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.62 -0.675 . . . . 0.0 109.81 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 44' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' D' ' 44' ' ' ASP . 0.6 OUTLIER -67.46 -29.86 69.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.164 -0.96 . . . . 0.0 109.652 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 45' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' D' ' 42' ' ' ILE . 4.0 mmt180 -77.22 -17.43 58.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.2 -0.938 . . . . 0.0 110.208 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 mt -85.7 -17.13 36.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.82 -1.175 . . . . 0.0 109.236 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.35 -6.66 4.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.195 -0.941 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -71.41 70.97 0.64 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.52 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -96.65 -100.27 0.18 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.422 -0.799 . . . . 0.0 109.52 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 3.4 m -76.18 130.99 39.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 109.783 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 28.9 mt -93.37 -30.67 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.898 . . . . 0.0 109.318 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -25.68 61.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.925 . . . . 0.0 109.923 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 53' ' ' ARG . . . . . 0.426 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 12.5 mmt85 -63.6 -41.26 98.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.123 -0.986 . . . . 0.0 109.669 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -71.15 -41.39 70.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.151 -0.968 . . . . 0.0 109.435 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -58.84 -41.81 87.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.332 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -26.87 61.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.259 -0.901 . . . . 0.0 109.26 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 57' ' ' HIS . . . . . 0.426 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 2.5 m-70 -67.47 -39.65 85.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 108.905 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.82 -63.35 2.74 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.08 159.75 2.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.251 -1.146 . . . . 0.0 109.605 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 17.7 mttp . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.448 -179.967 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 2.7 m-20 57.11 49.28 3.67 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.53 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.3 Cg_endo -55.78 -15.54 13.17 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.714 2.276 . . . . 0.0 111.978 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.8 tp -46.29 -44.42 16.58 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.319 -0.863 . . . . 0.0 109.169 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.8 t -68.6 -45.26 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.273 -0.892 . . . . 0.0 108.997 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -48.93 -49.02 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.184 -0.947 . . . . 0.0 109.057 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.09 -34.47 78.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 0.0 109.387 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.74 -57.25 8.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 0.0 109.805 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.57 -36.14 66.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.733 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.7 mt -71.7 -42.51 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.338 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.4 mt -55.73 -34.63 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.128 -0.982 . . . . 0.0 108.511 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.09 -45.17 32.95 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.1 mt -55.67 -36.21 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.165 -1.197 . . . . 0.0 109.179 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.5 -61.91 1.67 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.353 -0.842 . . . . 0.0 109.236 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.401 ' NE2' ' ND1' ' B' ' 37' ' ' HIS . 4.2 t-80 -45.15 -39.9 6.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.416 -0.802 . . . . 0.0 110.061 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -66.23 -69.49 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.141 -0.974 . . . . 0.0 109.843 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.8 mt -48.19 -27.4 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 0.0 109.739 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.425 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 7.4 mt -72.24 -60.37 2.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.928 . . . . 0.0 109.945 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 40.7 t-105 -48.1 -48.53 33.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.055 -1.028 . . . . 0.0 109.784 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 45' ' ' ARG . 66.6 mt -63.28 -59.89 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.08 -1.013 . . . . 0.0 109.336 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.3 tp -44.27 -40.66 5.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.572 -0.705 . . . . 0.0 109.821 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.514 ' OD2' ' NC ' ' A' ' 199' ' ' RIM . 1.7 m-20 -69.75 -31.31 69.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -0.964 . . . . 0.0 109.217 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.5 ' NH1' ' OD2' ' D' ' 44' ' ' ASP . 0.4 OUTLIER -75.4 -16.05 60.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 110.181 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -90.04 -12.06 39.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.872 -1.142 . . . . 0.0 109.22 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.487 ' O ' ' N ' ' A' ' 49' ' ' LYS . 17.6 t80 -78.0 -60.73 2.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 109.306 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -50.23 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 109.066 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 47' ' ' PHE . 30.8 mtpt -91.65 -82.43 0.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.915 . . . . 0.0 109.634 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.1 m -87.35 170.07 11.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.635 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.3 mt -105.46 -21.66 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.569 -0.707 . . . . 0.0 109.626 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -55.02 -20.87 10.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.182 -0.949 . . . . 0.0 109.8 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.433 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 7.6 mmm180 -70.94 -42.59 69.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.062 -1.024 . . . . 0.0 109.553 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -66.79 -35.23 79.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.227 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -65.25 -48.85 71.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -0.866 . . . . 0.0 109.19 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -63.2 -29.18 70.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.348 -0.845 . . . . 0.0 109.526 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.433 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 18.5 m80 -66.2 -52.34 48.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.263 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.22 -60.89 7.8 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.46 ' O ' ' CB ' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -50.28 118.8 3.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.377 -1.072 . . . . 0.0 109.458 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 59' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.479 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.298 0.57 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.516 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 48.5 m-20 -157.72 51.23 0.46 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.472 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 13.0 Cg_endo -59.23 -12.02 14.92 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.759 2.306 . . . . 0.0 112.345 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 58.2 tp -47.98 -46.71 32.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 108.958 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.71 -44.93 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.113 -0.992 . . . . 0.0 108.774 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 71.2 t -48.97 -49.71 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 108.931 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.38 -32.87 74.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -0.837 . . . . 0.0 109.136 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.91 -58.08 6.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 0.0 109.66 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.77 -35.28 63.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 109.697 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 16.7 mt -73.29 -41.86 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 0.0 109.745 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 21.9 mt -55.86 -35.57 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.005 -1.059 . . . . 0.0 108.822 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.34 -44.18 43.55 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 48.6 mt -56.05 -33.07 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.226 -1.161 . . . . 0.0 109.204 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -65.19 0.79 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 109.1 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . 0.513 ' NE2' ' ND1' ' C' ' 37' ' ' HIS . 3.4 t-80 -45.43 -38.13 5.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.412 -0.805 . . . . 0.0 109.748 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 54.9 tp -66.38 -67.86 0.42 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 109.503 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.8 mt -48.91 -25.89 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 109.518 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mt -71.5 -64.07 0.99 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.851 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -46.11 -47.1 17.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 0.0 109.647 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 51.7 mt -63.27 -55.46 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.087 -1.008 . . . . 0.0 108.909 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 39.5 tp -47.13 -41.19 17.09 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.51 -0.744 . . . . 0.0 109.661 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' B' ' 44' ' ' ASP . 0.3 OUTLIER -69.79 -30.26 67.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.707 -179.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.97 -19.71 58.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.07 -1.018 . . . . 0.0 110.47 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -82.97 -8.46 59.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.631 -1.293 . . . . 0.0 108.973 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -138.11 106.93 5.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.525 -0.734 . . . . 0.0 109.569 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -171.15 3.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.216 -0.928 . . . . 0.0 109.556 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 14.2 mtpp -71.89 -142.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.905 . . . . 0.0 109.302 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 20.8 m 51.54 75.74 0.19 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.166 -0.959 . . . . 0.0 109.568 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 50.9 mt -99.36 -31.21 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.463 -0.773 . . . . 0.0 109.385 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.494 ' CE2' ' NH1' ' B' ' 53' ' ' ARG . 0.1 OUTLIER -61.02 -32.93 72.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.0 109.781 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.494 ' NH1' ' CE2' ' B' ' 52' ' ' TYR . 19.5 mmt-85 -64.42 -33.84 76.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.085 -1.009 . . . . 0.0 109.42 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -75.3 -42.15 55.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.873 . . . . 0.0 109.17 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -58.34 -40.53 82.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.856 . . . . 0.0 109.55 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -72.78 -67.61 0.55 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . 0.45 ' O ' ' ND1' ' B' ' 57' ' ' HIS . 23.0 t-80 -41.22 -30.06 0.15 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.616 -0.678 . . . . 0.0 110.208 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.28 -70.25 1.31 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mt -66.35 82.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -1.113 . . . . 0.0 109.516 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 58.8 tttm . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.403 179.855 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 55.1 m . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' C' ' 26' ' ' LEU . 3.2 m-20 57.64 65.33 3.52 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 109.647 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -45.22 -11.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.921 2.414 . . . . 0.0 112.535 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' C' ' 24' ' ' ASP . 24.2 tp -47.74 -46.11 29.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 108.975 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 45.5 t -67.19 -45.32 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 108.769 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 71.5 t -50.3 -51.64 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.363 -0.836 . . . . 0.0 109.008 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.32 -32.58 73.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.502 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.8 -55.27 18.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.53 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.13 -37.51 69.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.843 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 23.1 mt -71.89 -42.81 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.072 -1.017 . . . . 0.0 109.602 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.25 -36.39 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 108.551 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.95 -45.04 64.76 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 63.5 mt -59.6 -41.59 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.347 -1.09 . . . . 0.0 108.832 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.77 -68.01 0.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.368 -0.832 . . . . 0.0 109.292 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . 0.513 ' ND1' ' NE2' ' B' ' 37' ' ' HIS . 2.3 t-80 -44.17 -39.95 4.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.389 -0.82 . . . . 0.0 110.24 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.76 -67.89 0.38 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.985 -1.072 . . . . 0.0 109.196 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 mt -47.67 -40.66 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.344 -0.847 . . . . 0.0 109.423 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mt -61.64 -54.31 44.54 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.45 -0.781 . . . . 0.0 109.581 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -46.31 -58.19 3.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.418 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.19 -47.8 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.055 -1.028 . . . . 0.0 109.339 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 6.3 tp -52.56 -27.52 17.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.417 -0.802 . . . . 0.0 110.43 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -91.03 -34.03 15.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.071 -1.018 . . . . 0.0 109.426 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.699 HH21 HNC2 ' B' ' 299' ' ' RIM . 14.6 mmm180 -84.67 4.32 33.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.343 -0.848 . . . . 0.0 110.403 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . 0.476 ' C ' ' O ' ' C' ' 45' ' ' ARG . 34.8 mt -31.0 -34.95 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 CA-C-O 121.273 0.559 . . . . 0.0 110.299 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.55 ' N ' ' O ' ' C' ' 45' ' ' ARG . 0.2 OUTLIER 68.2 102.04 0.05 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.714 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -104.16 162.67 12.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.557 -0.714 . . . . 0.0 109.211 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' C' ' 50' ' ' SER . 20.4 tptt -92.37 -150.14 0.26 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.168 -0.958 . . . . 0.0 109.767 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' SER . . . . . 0.412 ' O ' ' O ' ' C' ' 49' ' ' LYS . 8.2 m 47.06 92.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 109.843 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 mt -92.65 -31.61 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.213 -0.93 . . . . 0.0 109.446 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . 0.463 ' CD2' ' N ' ' C' ' 53' ' ' ARG . 50.9 p90 -48.45 -44.26 35.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.382 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . 0.463 ' N ' ' CD2' ' C' ' 52' ' ' TYR . 3.7 mtp85 -46.73 -50.52 17.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.306 -0.871 . . . . 0.0 109.954 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -61.7 -41.5 97.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.112 -0.993 . . . . 0.0 109.76 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -60.79 -35.57 76.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 109.266 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -73.52 -37.62 65.58 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.275 -0.891 . . . . 0.0 109.239 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -41.22 94.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.914 . . . . 0.0 109.189 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.42 -62.43 4.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 57.6 mt -85.24 -147.99 0.11 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -1.125 . . . . 0.0 109.316 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.442 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.95 161.38 77.8 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.339 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -65.1 -21.52 62.84 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.511 2.14 . . . . 0.0 112.097 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 54.2 tp -46.8 -43.87 18.74 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -69.76 -43.23 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.329 -0.857 . . . . 0.0 108.803 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 70.4 t -51.04 -48.55 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.069 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.35 -33.91 76.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 0.0 109.26 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.35 -57.02 9.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 109.674 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -56.1 -35.99 67.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.746 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 12.3 mt -71.69 -41.41 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.208 -0.933 . . . . 0.0 109.352 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -56.64 -35.17 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.942 . . . . 0.0 108.796 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.79 -43.67 50.1 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 57.2 mt -59.17 -30.34 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.333 -1.098 . . . . 0.0 109.478 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.75 -67.5 0.63 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -0.944 . . . . 0.0 109.405 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -44.11 -35.71 2.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.23 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 45.8 tp -71.42 -63.13 1.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.031 -1.043 . . . . 0.0 109.803 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.7 mt -50.93 -34.38 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.96 . . . . 0.0 109.599 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' D' ' 43' ' ' LEU . 1.2 mt -67.17 -64.81 0.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.36 -0.838 . . . . 0.0 110.273 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -44.76 -48.61 10.84 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.398 -0.814 . . . . 0.0 109.682 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 93.3 mt -59.63 -37.52 71.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 108.601 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' D' ' 40' ' ' LEU . 0.1 OUTLIER -57.7 -43.38 85.14 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.488 -0.757 . . . . 0.0 109.36 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.5 ' OD2' ' NH1' ' A' ' 45' ' ' ARG . 7.0 m-20 -71.71 -26.82 62.65 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.381 -0.825 . . . . 0.0 110.182 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -28.36 58.31 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.829 -1.169 . . . . 0.0 110.981 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' D' ' 48' ' ' PHE . 7.7 mt -58.4 -12.31 3.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.525 -1.359 . . . . 0.0 109.179 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -73.95 17.09 0.18 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.14 -0.975 . . . . 0.0 109.114 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . 0.506 ' H ' ' C ' ' D' ' 46' ' ' LEU . 0.4 OUTLIER -46.66 155.2 0.26 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 109.56 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 15.8 tttm 64.23 -146.45 0.29 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 73.3 m 47.96 59.44 4.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 38.8 mt -95.06 -29.59 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.347 -0.846 . . . . 0.0 109.39 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -37.94 74.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.545 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . 0.472 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 5.9 mtm180 -61.51 -36.63 81.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.247 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -69.99 -37.92 75.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 0.0 109.258 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -63.39 -53.79 46.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 109.677 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -62.61 -29.13 70.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.748 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . 0.472 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 1.4 m-70 -67.48 -45.14 76.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 109.431 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.29 -60.71 6.78 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.1 -166.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -1.15 . . . . 0.0 109.712 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 61.1 tttm . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.923 -1.036 . . . . 0.0 109.669 -179.969 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' RIM . . . . . 0.514 ' NC ' ' OD2' ' A' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 299' ' ' RIM . . . . . 0.699 HNC2 HH21 ' C' ' 45' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 399' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 499' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 24' ' ' ASP . 12.9 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 5.5 p-10 41.13 54.36 7.42 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.69 -0.631 . . . . 0.0 110.047 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 11.2 Cg_endo -58.02 -17.87 33.17 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.509 2.139 . . . . 0.0 112.269 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.8 tp -47.2 -45.02 22.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.189 -0.945 . . . . 0.0 108.826 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.98 -44.52 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.241 -0.912 . . . . 0.0 108.802 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -49.86 -50.25 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.163 -0.96 . . . . 0.0 109.068 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.54 -33.69 76.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.322 -0.861 . . . . 0.0 109.514 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.57 -56.78 8.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 109.784 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 m -55.55 -34.65 64.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.705 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.4 mt -74.81 -43.7 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.118 -0.989 . . . . 0.0 109.725 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.8 mt -54.02 -35.91 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.021 -1.05 . . . . 0.0 108.618 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.06 -45.43 41.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.7 mt -57.65 -37.27 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.192 -1.181 . . . . 0.0 108.907 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.15 -68.74 0.33 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -0.85 . . . . 0.0 109.373 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -43.19 -42.26 4.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.431 -0.793 . . . . 0.0 110.263 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.7 tp -61.05 -67.66 0.38 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.106 -0.996 . . . . 0.0 109.569 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 mt -49.15 -44.1 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 109.513 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt -55.77 -58.39 8.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 109.987 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -46.43 -59.1 3.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.322 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.467 ' O ' ' N ' ' A' ' 45' ' ' ARG . 48.0 mt -51.17 -52.44 18.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.276 -0.89 . . . . 0.0 108.978 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 42' ' ' ILE . 0.1 OUTLIER -41.89 -57.21 2.47 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.426 0.631 . . . . 0.0 109.503 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.451 ' OD2' ' NC ' ' A' ' 199' ' ' RIM . 12.8 m-20 -59.15 -27.7 65.89 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.328 -0.858 . . . . 0.0 109.624 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.467 ' N ' ' O ' ' A' ' 42' ' ' ILE . 2.7 mmp_? -81.52 -13.82 57.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.071 -1.018 . . . . 0.0 110.714 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 mt -88.65 -18.88 27.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.652 -1.28 . . . . 0.0 109.198 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.48 ' O ' ' CB ' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -141.79 166.29 25.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.301 -0.875 . . . . 0.0 109.518 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.48 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 2.4 t80 75.96 97.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.57 -0.706 . . . . 0.0 109.539 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 50' ' ' SER . 10.1 tttp -150.23 -135.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.109 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 49' ' ' LYS . 0.9 OUTLIER 68.14 117.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.957 . . . . 0.0 109.51 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 mt -97.69 -29.25 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 109.625 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.485 ' CG ' ' N ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -57.32 -38.82 74.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.97 . . . . 0.0 109.44 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.485 ' N ' ' CG ' ' A' ' 52' ' ' TYR . 1.4 mtt180 -57.65 -37.21 72.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.044 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -70.67 -39.98 73.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.844 . . . . 0.0 109.233 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -65.55 -34.08 77.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.125 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -75.02 -31.66 61.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.824 . . . . 0.0 109.613 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -68.92 -37.93 79.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.256 -0.902 . . . . 0.0 109.152 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.63 -64.41 2.6 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.7 mt -75.78 150.95 37.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -1.112 . . . . 0.0 109.538 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.449 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.265 0.555 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.15 160.67 39.18 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 109.271 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' B' ' 26' ' ' LEU . 18.7 Cg_endo -63.16 -24.5 72.8 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.557 2.171 . . . . 0.0 112.165 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' B' ' 25' ' ' PRO . 56.9 tp -45.63 -40.89 9.55 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 52.3 t -70.98 -44.75 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.345 -0.847 . . . . 0.0 108.809 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 74.4 t -49.54 -48.71 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 108.953 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.55 -34.73 78.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.362 -0.836 . . . . 0.0 109.223 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.26 -56.75 12.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 109.665 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.04 -36.71 68.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 109.966 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 29.8 mt -72.05 -40.06 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.095 -1.003 . . . . 0.0 109.686 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 30.6 mt -58.05 -35.23 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.013 -1.054 . . . . 0.0 108.751 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.14 -44.0 45.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 55.9 mt -57.8 -35.83 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.288 -1.125 . . . . 0.0 109.162 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.44 -65.96 0.61 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.279 -0.888 . . . . 0.0 109.056 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -45.5 -39.18 7.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.46 -0.775 . . . . 0.0 109.895 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.79 -69.3 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 0.0 109.786 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.4 mt -51.21 -23.84 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.113 -0.992 . . . . 0.0 109.269 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 tt -68.67 -63.86 0.98 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.36 -0.837 . . . . 0.0 110.005 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 -52.34 -46.63 66.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.989 . . . . 0.0 109.907 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.95 -55.21 26.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.032 -1.042 . . . . 0.0 108.841 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 52.9 tp -46.8 -40.99 14.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.536 -0.728 . . . . 0.0 109.932 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.509 ' OD2' ' NC ' ' B' ' 299' ' ' RIM . 1.2 m-20 -72.3 -25.32 61.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 109.865 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.6 -17.72 43.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.912 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -81.06 -27.78 35.57 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.631 -1.293 . . . . 0.0 109.338 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -147.46 116.93 7.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.223 -0.923 . . . . 0.0 109.668 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . 0.444 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 79.7 t80 -173.41 82.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 109.391 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -141.8 -129.97 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.43 -0.794 . . . . 0.0 109.176 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 7.4 t 49.57 84.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.419 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 27.5 mt -97.9 -26.78 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.272 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.574 ' CG ' ' N ' ' B' ' 53' ' ' ARG . 2.8 p90 -53.09 -40.26 63.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.453 -0.779 . . . . 0.0 110.362 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.574 ' N ' ' CG ' ' B' ' 52' ' ' TYR . 0.0 OUTLIER -64.91 -29.49 70.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.931 -1.106 . . . . 0.0 109.909 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -74.57 -41.44 60.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.143 -0.973 . . . . 0.0 109.414 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.44 -50.74 66.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.195 -0.941 . . . . 0.0 108.963 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.53 -32.56 71.6 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.303 -0.873 . . . . 0.0 109.12 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -61.37 -59.46 5.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.114 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.65 -58.07 12.33 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 56.4 mt -78.0 69.48 4.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.357 -1.084 . . . . 0.0 109.246 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.9 tptp . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.563 -179.811 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 37.6 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.313 0.578 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' C' ' 26' ' ' LEU . 2.0 m-20 48.81 64.81 8.02 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.754 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -46.06 -8.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.738 2.292 . . . . 0.0 112.435 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' C' ' 24' ' ' ASP . 39.0 tp -47.41 -45.91 25.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.163 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 32.8 t -67.84 -45.83 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 108.616 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -49.32 -49.26 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 109.013 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.01 -34.67 78.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.26 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.24 -55.53 15.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 109.701 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.86 -36.67 67.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.724 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 mt -72.34 -42.02 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 109.406 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.7 mt -54.76 -34.69 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.09 -1.006 . . . . 0.0 108.64 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.23 -44.28 23.19 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 59.9 mt -57.19 -32.38 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.184 -1.186 . . . . 0.0 108.971 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -71.27 -65.56 0.73 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 108.812 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -46.16 -38.24 7.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.815 . . . . 0.0 109.678 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.4 -69.95 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.216 -0.927 . . . . 0.0 109.696 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 15.7 mt -47.4 -25.45 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.16 -0.963 . . . . 0.0 109.398 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 5.9 mt -71.98 -61.05 1.93 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.482 -0.761 . . . . 0.0 109.755 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -47.79 -48.18 30.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.978 . . . . 0.0 109.61 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' C' ' 45' ' ' ARG . 53.4 mt -61.6 -59.8 3.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.193 -0.942 . . . . 0.0 108.826 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.4 tp -43.51 -44.6 6.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.756 -0.59 . . . . 0.0 109.913 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . 0.446 ' OD2' ' NC ' ' C' ' 399' ' ' RIM . 0.7 OUTLIER -68.13 -27.25 66.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.22 -0.925 . . . . 0.0 109.64 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.464 ' N ' ' O ' ' C' ' 42' ' ' ILE . 14.0 mmt180 -82.6 -15.54 51.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.171 -0.955 . . . . 0.0 110.559 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 mt -86.58 -11.28 51.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.736 -1.227 . . . . 0.0 109.247 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -59.07 94.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.942 . . . . 0.0 109.156 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . 0.51 ' O ' ' CG ' ' C' ' 48' ' ' PHE . 0.1 OUTLIER -162.89 6.99 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -50.57 -31.36 15.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 3.1 p -164.41 131.95 3.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 5.1 mt -82.18 -22.77 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 108.996 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -45.8 -39.72 8.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 0.0 109.96 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -53.01 -48.57 67.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.117 -0.989 . . . . 0.0 110.171 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' D' ' 51' ' ' ILE . 10.1 m-85 -62.37 -40.48 96.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.095 -1.003 . . . . 0.0 109.562 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -60.19 -58.39 8.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.851 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -57.0 -37.19 71.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -48.04 82.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.063 -1.023 . . . . 0.0 109.748 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.4 -59.54 9.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 6.9 mt -75.63 87.68 2.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -1.163 . . . . 0.0 109.4 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.46 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' D' ' 26' ' ' LEU . 15.4 m-20 51.15 66.68 5.08 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.393 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -46.16 -10.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.754 2.303 . . . . 0.0 112.092 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' D' ' 24' ' ' ASP . 44.9 tp -47.58 -47.6 28.42 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.223 -0.923 . . . . 0.0 109.016 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.27 -44.79 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 108.73 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -48.58 -49.5 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 108.904 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.26 -37.14 86.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.507 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -57.1 10.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.231 -0.918 . . . . 0.0 109.916 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.4 -36.72 64.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.224 -0.923 . . . . 0.0 109.81 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 26.9 mt -72.54 -41.69 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.166 -0.958 . . . . 0.0 109.453 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -55.92 -36.98 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 108.702 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.11 -45.16 57.71 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 47.2 mt -56.05 -38.88 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.204 -1.174 . . . . 0.0 109.286 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.72 -61.78 1.72 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -0.866 . . . . 0.0 109.137 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -46.57 -44.02 17.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.61 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.0 tp -60.07 -69.18 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mt -46.95 -25.25 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.891 . . . . 0.0 109.403 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . 0.444 ' CD2' ' OD2' ' D' ' 44' ' ' ASP . 1.5 tt -69.96 -64.12 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.895 . . . . 0.0 109.716 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . 0.495 ' HE1' HNC2 ' C' ' 399' ' ' RIM . 19.0 t-105 -47.26 -49.06 24.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 109.523 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 36.2 mt -61.16 -50.93 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.176 -0.953 . . . . 0.0 109.228 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 53.2 tp -50.88 -37.7 45.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.835 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.476 ' OD2' ' NC ' ' D' ' 499' ' ' RIM . 73.2 m-20 -75.9 -28.41 58.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 109.625 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -71.56 -27.02 62.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.951 . . . . 0.0 110.569 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.4 mt -71.27 -16.08 62.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.69 -1.256 . . . . 0.0 109.112 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -82.92 -7.55 59.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.248 -0.908 . . . . 0.0 108.935 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . 0.445 ' O ' ' CB ' ' D' ' 49' ' ' LYS . 0.9 OUTLIER -87.7 -153.86 0.24 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.405 -0.809 . . . . 0.0 109.737 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' D' ' 48' ' ' PHE . 5.9 ttpt 74.14 -62.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.365 -0.834 . . . . 0.0 109.593 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.85 106.42 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.196 -0.94 . . . . 0.0 109.594 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' C' ' 54' ' ' PHE . 4.0 mt -87.78 -23.3 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.574 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . 0.468 ' CD1' ' C ' ' D' ' 52' ' ' TYR . 0.0 OUTLIER -62.79 -49.25 75.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.145 -0.972 . . . . 0.0 110.181 -179.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . 0.419 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 0.7 OUTLIER -71.6 -28.48 63.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.536 -1.353 . . . . 0.0 110.19 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -75.66 -54.91 6.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.086 -1.009 . . . . 0.0 111.089 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.1 OUTLIER -75.58 -18.29 59.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.957 -1.089 . . . . 0.0 110.583 -178.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . 0.526 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 2.2 tm-20 -84.5 -33.7 23.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.856 -1.152 . . . . 0.0 108.063 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . 0.419 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 0.5 OUTLIER -69.0 -38.6 79.36 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' D' ' 60' ' ' LYS . . . -69.78 -61.5 4.34 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.1 77.61 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -1.159 . . . . 0.0 109.556 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' D' ' 58' ' ' GLY . 50.9 tttt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.479 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' RIM . . . . . 0.451 ' NC ' ' OD2' ' A' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 299' ' ' RIM . . . . . 0.509 ' NC ' ' OD2' ' B' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 399' ' ' RIM . . . . . 0.495 HNC2 ' HE1' ' D' ' 41' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 499' ' ' RIM . . . . . 0.476 ' NC ' ' OD2' ' D' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.0 p . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 26' ' ' LEU . 8.6 m-20 -152.4 66.72 6.54 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 109.363 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -45.82 -11.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.778 2.319 . . . . 0.0 112.27 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 24' ' ' ASP . 37.2 tp -46.65 -46.31 19.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.234 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.6 t -68.51 -44.78 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 108.974 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -49.15 -49.39 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 0.0 109.08 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.83 -35.04 79.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 109.355 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.41 -56.98 10.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.69 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.456 ' H ' ' HG ' ' A' ' 31' ' ' SER . 0.9 OUTLIER -55.95 -36.98 68.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.194 -0.941 . . . . 0.0 109.866 -179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.8 mt -71.01 -40.91 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.107 -0.996 . . . . 0.0 109.441 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.9 mt -57.02 -36.05 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.141 -0.974 . . . . 0.0 108.59 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.29 -44.1 53.34 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.5 mt -61.81 -27.02 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.165 -1.197 . . . . 0.0 109.155 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.99 -66.6 0.65 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.333 -0.854 . . . . 0.0 109.441 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.31 -39.31 6.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 109.841 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.67 -69.0 0.3 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.419 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.5 mt -47.1 -34.34 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.514 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 mt -62.87 -55.8 22.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.464 -0.773 . . . . 0.0 109.943 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -52.03 -45.01 64.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mt -68.76 -28.29 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.108 -0.995 . . . . 0.0 109.279 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.69 -44.26 97.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.563 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.507 ' OD1' ' NH2' ' B' ' 45' ' ' ARG . 2.6 m-20 -80.19 -24.45 40.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 109.97 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -93.31 0.97 57.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.122 -0.987 . . . . 0.0 111.25 -179.22 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.48 ' C ' ' O ' ' A' ' 45' ' ' ARG . 31.0 mt -31.3 -36.27 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.693 -0.63 . . . . 0.0 110.814 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 169.15 -10.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 109.267 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -46.21 103.8 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.383 -0.823 . . . . 0.0 109.42 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.455 ' CG ' ' H ' ' A' ' 50' ' ' SER . 12.6 tptm -145.44 -129.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.905 . . . . 0.0 109.713 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.455 ' H ' ' CG ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER 65.36 135.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.282 -0.886 . . . . 0.0 109.229 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.1 mt -102.17 -35.26 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.525 -0.735 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -35.39 69.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.612 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -64.24 -41.12 97.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 0.0 109.369 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -65.34 -29.11 69.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.434 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -75.34 -68.42 0.56 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.098 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -46.83 -31.27 2.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.243 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -69.85 -58.77 3.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.314 -0.866 . . . . 0.0 109.566 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.19 -60.45 9.0 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.08 97.17 1.44 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -1.1 . . . . 0.0 109.356 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.4 mttp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.511 -179.888 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 30.3 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' B' ' 26' ' ' LEU . 4.8 m-20 48.82 67.28 4.66 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.449 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -47.22 -9.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.763 2.309 . . . . 0.0 112.311 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.468 ' H ' ' C ' ' B' ' 24' ' ' ASP . 39.1 tp -47.22 -44.76 22.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.944 . . . . 0.0 108.871 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 38.7 t -68.66 -44.88 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 108.758 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.5 t -49.7 -50.62 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 109.176 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.39 -34.82 78.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 109.391 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.76 -55.99 14.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 109.685 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.72 -36.85 67.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 109.873 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 18.9 mt -72.42 -42.4 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.553 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 mt -55.85 -34.65 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.054 -1.029 . . . . 0.0 108.826 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.33 -43.89 36.55 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 67.7 mt -60.25 -26.29 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.243 -1.151 . . . . 0.0 109.234 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.58 -64.49 1.06 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.267 -0.896 . . . . 0.0 109.263 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -45.5 -43.56 11.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.4 tp -63.15 -64.57 0.87 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.311 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 8.2 mt -47.78 -28.36 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.471 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.409 ' CD2' ' NC ' ' B' ' 299' ' ' RIM . 2.2 mt -67.44 -55.86 11.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 110.141 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -55.67 -39.72 71.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.944 . . . . 0.0 109.937 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 94.5 mt -70.58 -40.57 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.954 -1.091 . . . . 0.0 108.959 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 50.3 tp -57.51 -41.33 80.61 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.516 -0.74 . . . . 0.0 109.767 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.3 -23.73 43.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.154 -0.966 . . . . 0.0 109.84 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.507 ' NH2' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -89.01 -4.74 58.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.044 -1.035 . . . . 0.0 110.902 -179.19 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.497 ' C ' ' O ' ' B' ' 45' ' ' ARG . 28.0 mt -33.56 -35.9 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.693 -0.629 . . . . 0.0 110.166 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' B' ' 45' ' ' ARG . 3.3 t80 -172.59 136.08 0.73 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.943 . . . . 0.0 109.326 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . 0.413 ' CD2' ' O ' ' B' ' 47' ' ' PHE . 0.7 OUTLIER -167.85 98.58 0.46 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.216 -0.928 . . . . 0.0 109.43 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -141.79 -35.73 0.44 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 109.424 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 11.9 p -65.65 124.71 23.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.291 -0.88 . . . . 0.0 109.531 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 15.8 mt -111.39 -22.67 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.671 -0.643 . . . . 0.0 109.347 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -54.03 -21.43 8.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.663 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -69.87 -45.9 66.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.437 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -65.09 -34.4 78.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.476 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -65.65 -60.24 3.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 109.458 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -52.71 -30.96 35.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.459 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -62.63 -63.42 1.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 109.315 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.33 -59.29 9.77 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mt -50.77 143.96 9.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.358 -1.084 . . . . 0.0 109.683 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.5 mttm . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.33 179.854 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 50.9 p . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' C' ' 26' ' ' LEU . 1.7 p-10 -171.11 70.24 0.51 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.393 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.53 -9.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.814 2.343 . . . . 0.0 112.402 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . 0.46 ' H ' ' C ' ' C' ' 24' ' ' ASP . 48.3 tp -47.76 -46.97 30.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.189 -0.944 . . . . 0.0 109.033 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.78 -45.47 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.238 -0.914 . . . . 0.0 108.759 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -48.46 -46.48 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 0.0 109.139 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.93 -36.87 83.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -0.929 . . . . 0.0 109.46 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.36 -55.13 27.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 109.388 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.08 -36.2 67.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.392 -0.818 . . . . 0.0 109.894 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 18.4 mt -72.98 -41.57 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.109 -0.994 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 21.1 mt -56.78 -34.79 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.074 -1.016 . . . . 0.0 108.614 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.11 -45.17 42.03 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 54.4 mt -57.13 -31.81 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.21 -1.171 . . . . 0.0 108.869 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.98 -64.62 0.87 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.456 -0.778 . . . . 0.0 109.055 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -46.25 -39.08 9.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.876 . . . . 0.0 109.72 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -63.09 -70.13 0.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.956 . . . . 0.0 109.545 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 3.9 mt -47.14 -37.92 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.319 -0.863 . . . . 0.0 109.401 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mt -61.42 -61.79 2.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.343 -0.848 . . . . 0.0 110.101 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -45.85 -49.48 15.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.366 -0.834 . . . . 0.0 109.578 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 64.7 mt -60.57 -44.44 96.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.166 -0.959 . . . . 0.0 108.9 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.36 -55.28 11.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.536 -0.727 . . . . 0.0 109.583 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . 0.514 ' OD1' ' NC ' ' C' ' 399' ' ' RIM . 7.8 m-20 -64.4 -27.71 69.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 110.316 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -72.11 -25.25 61.67 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.861 -1.149 . . . . 0.0 110.798 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 47' ' ' PHE . 9.7 mt -68.95 -8.78 47.71 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.669 -1.27 . . . . 0.0 109.289 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' C' ' 49' ' ' LYS . 2.9 m-85 -47.23 -92.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -0.93 . . . . 0.0 109.35 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 46.09 19.63 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.762 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' C' ' 47' ' ' PHE . 16.4 mtpt -64.01 -148.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.153 -0.967 . . . . 0.0 109.483 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.7 162.83 14.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.174 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 13.4 mt -103.93 -22.76 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.536 -0.728 . . . . 0.0 109.442 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' C' ' 52' ' ' TYR . 6.5 t80 -63.55 -22.05 66.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.265 -0.897 . . . . 0.0 109.982 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -66.33 -46.99 74.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.072 -1.017 . . . . 0.0 110.0 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -66.02 -33.68 76.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 0.0 109.691 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -63.17 -58.65 6.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.378 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -57.14 -30.0 64.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 109.157 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -67.28 -45.83 75.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.298 -0.876 . . . . 0.0 109.127 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.25 -61.89 5.36 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 mt -48.7 140.08 8.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -1.153 . . . . 0.0 109.494 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.474 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' SER . . . . . 0.522 ' H ' ' HG ' ' D' ' 23' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.286 0.565 . . . . 0.0 109.521 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.37 160.11 0.38 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.328 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' D' ' 26' ' ' LEU . 19.5 Cg_endo -61.83 -24.42 77.24 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.567 2.178 . . . . 0.0 112.206 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' D' ' 25' ' ' PRO . 56.2 tp -45.59 -41.02 9.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 108.775 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 33.5 t -70.26 -45.27 76.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.303 -0.873 . . . . 0.0 108.697 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 74.1 t -49.76 -49.1 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 108.95 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.37 -33.47 76.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.307 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.23 -56.17 14.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.663 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -37.12 69.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.228 -0.92 . . . . 0.0 109.858 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 20.6 mt -71.36 -41.67 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.076 -1.015 . . . . 0.0 109.426 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 17.3 mt -56.48 -33.94 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.071 -1.018 . . . . 0.0 108.566 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.58 -44.55 32.38 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 61.9 mt -58.41 -29.66 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.343 -1.092 . . . . 0.0 109.218 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.13 -67.07 0.6 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.0 109.097 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -46.82 -37.29 8.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 0.0 109.732 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 59.4 tp -65.09 -69.2 0.31 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.133 -0.98 . . . . 0.0 109.507 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.1 mt -49.2 -26.51 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.483 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 tt -67.64 -63.03 1.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.924 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . 0.507 ' CH2' ' NE ' ' D' ' 45' ' ' ARG . 24.7 t-105 -53.04 -43.87 66.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.984 -1.072 . . . . 0.0 109.666 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.75 -51.2 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.152 -0.967 . . . . 0.0 108.782 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 58.1 tp -50.06 -39.73 43.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.608 -0.683 . . . . 0.0 109.931 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.524 ' OD1' ' NC ' ' D' ' 499' ' ' RIM . 0.5 OUTLIER -75.79 -24.43 55.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 109.911 -179.603 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.507 ' NE ' ' CH2' ' D' ' 41' ' ' TRP . 0.6 OUTLIER -76.08 -25.24 55.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.106 -0.996 . . . . 0.0 110.21 -179.596 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -73.13 -28.88 62.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.796 -1.19 . . . . 0.0 109.338 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . 0.455 ' O ' ' CB ' ' D' ' 48' ' ' PHE . 7.5 m-85 -66.19 -170.4 0.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . 0.455 ' CB ' ' O ' ' D' ' 47' ' ' PHE . 2.4 t80 73.61 18.5 3.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . 0.525 ' CG ' ' H ' ' D' ' 50' ' ' SER . 0.0 OUTLIER -58.47 -97.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -0.869 . . . . 0.0 109.409 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.525 ' H ' ' CG ' ' D' ' 49' ' ' LYS . 1.1 t -57.76 139.52 53.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.44 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 19.8 mt -109.59 -26.83 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.661 -0.65 . . . . 0.0 109.522 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . 0.516 ' CZ ' ' OG ' ' D' ' 50' ' ' SER . 17.8 p90 -59.99 -43.82 94.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.93 . . . . 0.0 109.721 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . 0.407 ' N ' ' CD2' ' D' ' 52' ' ' TYR . 10.1 mtp85 -64.39 -35.93 82.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.089 -1.007 . . . . 0.0 109.339 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -63.48 -33.74 76.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.878 . . . . 0.0 109.334 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -71.21 -56.59 5.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -0.84 . . . . 0.0 109.215 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -51.56 -29.31 16.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.221 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -69.34 -55.79 9.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.913 . . . . 0.0 109.235 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -48.07 -57.17 8.16 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.73 121.6 13.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.345 -1.091 . . . . 0.0 109.445 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 23.6 tttt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.486 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' RIM . . . . . 0.441 ' NC ' ' OD2' ' A' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 299' ' ' RIM . . . . . 0.409 ' NC ' ' CD2' ' B' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 399' ' ' RIM . . . . . 0.514 ' NC ' ' OD1' ' C' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 499' ' ' RIM . . . . . 0.524 ' NC ' ' OD1' ' D' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.5 p . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.532 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 5.1 m-20 -154.68 49.51 0.46 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.182 -0.949 . . . . 0.0 109.644 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 12.8 Cg_endo -59.01 -12.67 16.09 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.744 2.296 . . . . 0.0 112.121 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.2 tp -47.22 -46.85 24.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 0.0 108.959 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.2 t -68.9 -44.74 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.34 -0.85 . . . . 0.0 108.792 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.3 t -49.36 -49.33 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.0 108.815 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.82 -33.39 75.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.374 -0.829 . . . . 0.0 109.35 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.52 -56.8 10.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.3 -0.875 . . . . 0.0 109.677 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.484 ' H ' ' HG ' ' A' ' 31' ' ' SER . 0.7 OUTLIER -55.98 -37.34 68.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 109.891 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 27.7 mt -71.59 -41.36 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.136 -0.977 . . . . 0.0 109.474 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.1 mt -55.67 -34.79 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.175 -0.953 . . . . 0.0 108.458 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.26 -44.96 32.69 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.2 mt -56.84 -34.07 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.175 -1.191 . . . . 0.0 109.248 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.96 -63.61 1.03 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 109.086 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.96 -38.39 7.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.475 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.71 -70.97 0.2 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.872 . . . . 0.0 109.392 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 mt -46.79 -25.52 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.278 -0.889 . . . . 0.0 109.505 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -74.24 -55.5 5.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.704 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.5 t-105 -50.84 -48.52 59.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.96 . . . . 0.0 109.613 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mt -65.78 -57.53 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.291 -0.881 . . . . 0.0 109.398 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.6 tp -48.78 -27.95 3.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.541 -0.725 . . . . 0.0 110.525 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.511 ' OD2' ' NC ' ' A' ' 199' ' ' RIM . 2.3 m-20 -90.3 -26.97 19.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.012 -1.055 . . . . 0.0 109.961 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -73.12 -26.12 61.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.628 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 48' ' ' PHE . 9.0 mt -64.91 -9.81 24.06 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.795 -1.191 . . . . 0.0 109.552 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -66.82 76.61 0.12 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.1 -1.0 . . . . 0.0 109.514 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -156.9 21.01 0.32 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -126.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.54 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.0 m -48.55 125.91 10.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 0.0 109.421 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.3 mt -94.62 -24.86 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.817 . . . . 0.0 109.428 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.505 ' CD2' ' OE1' ' A' ' 56' ' ' GLU . 0.5 OUTLIER -60.6 -23.23 64.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.878 . . . . 0.0 109.592 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.457 ' O ' ' CG ' ' A' ' 57' ' ' HIS . 21.3 mtt180 -70.36 -37.47 74.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.088 -1.008 . . . . 0.0 109.665 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -71.93 -36.52 69.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.154 -0.966 . . . . 0.0 109.298 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -65.62 -46.42 79.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 0.0 109.793 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.505 ' OE1' ' CD2' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -70.56 -28.16 64.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.245 -0.909 . . . . 0.0 109.708 -179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.457 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 1.9 m-70 -67.28 -46.32 73.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 109.196 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.86 -65.16 2.56 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mt -59.1 145.34 42.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -1.136 . . . . 0.0 109.492 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.457 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.561 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 28.9 m-20 -152.21 48.5 0.47 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 109.612 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 10.5 Cg_endo -56.52 -15.06 14.45 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.794 2.33 . . . . 0.0 112.235 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 29.6 tp -46.5 -46.1 18.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.247 -0.908 . . . . 0.0 109.096 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.53 -44.39 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.231 -0.918 . . . . 0.0 108.967 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 74.5 t -50.73 -50.22 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.302 -0.874 . . . . 0.0 109.089 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.42 -36.56 82.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.53 -56.08 16.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.336 -0.852 . . . . 0.0 109.806 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.22 -36.77 66.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 109.707 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.19 -40.33 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.108 -0.995 . . . . 0.0 109.613 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 17.1 mt -56.8 -36.0 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.019 -1.051 . . . . 0.0 108.803 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.63 -43.29 44.33 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 86.2 mt -63.11 -21.27 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.35 -1.088 . . . . 0.0 108.908 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.55 -69.77 0.54 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.838 . . . . 0.0 109.218 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -46.55 -33.69 4.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.332 -0.855 . . . . 0.0 109.453 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.7 tp -68.11 -68.76 0.36 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.358 -0.839 . . . . 0.0 109.446 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -48.64 -33.33 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -0.925 . . . . 0.0 109.433 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 tt -64.32 -54.74 28.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 109.444 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -48.83 -48.04 41.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.3 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 11.5 mt -66.27 -33.12 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.119 -0.988 . . . . 0.0 108.802 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -58.88 -34.5 71.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.507 -0.746 . . . . 0.0 110.316 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -87.71 -27.26 22.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.971 -1.081 . . . . 0.0 109.614 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -91.63 3.46 54.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 110.649 -179.481 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.481 ' C ' ' O ' ' B' ' 45' ' ' ARG . 34.1 mt -29.35 -37.02 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.976 -0.453 . . . . 0.0 110.915 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' B' ' 45' ' ' ARG . 0.4 OUTLIER -177.92 165.01 1.96 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.995 -1.066 . . . . 0.0 109.7 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -163.99 110.43 1.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.814 . . . . 0.0 109.432 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.586 ' N ' ' CD ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -144.02 -18.48 0.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.375 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.434 ' H ' ' HG ' ' B' ' 50' ' ' SER . 0.0 OUTLIER -93.4 97.22 10.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.214 -0.929 . . . . 0.0 109.35 179.8 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 5.8 mt -93.33 -23.84 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.255 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -34.94 74.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.588 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 12.3 mtp180 -64.66 -32.58 74.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.869 . . . . 0.0 109.395 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -72.69 -42.63 64.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -0.892 . . . . 0.0 109.27 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -60.48 -39.7 88.61 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.385 -0.822 . . . . 0.0 109.015 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -71.77 -30.87 66.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.408 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -65.18 -48.95 71.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.27 -0.894 . . . . 0.0 109.066 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.9 -62.34 5.32 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 3.9 mt -58.98 138.08 57.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.353 -1.087 . . . . 0.0 109.272 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 16.0 tttm . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.52 -179.896 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.324 0.583 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 10.8 t0 -167.6 48.77 0.16 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.9 . . . . 0.0 109.197 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 2.9 Cg_endo -44.98 -19.77 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.778 2.319 . . . . 0.0 112.011 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 32.3 tp -45.85 -40.73 10.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.404 -0.81 . . . . 0.0 109.172 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.44 -45.19 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.866 . . . . 0.0 108.959 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 70.8 t -51.18 -49.88 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 108.973 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.89 -32.99 74.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.839 . . . . 0.0 109.249 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.36 -55.88 13.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.865 . . . . 0.0 109.47 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.93 -36.47 70.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.352 -0.843 . . . . 0.0 109.672 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 15.4 mt -71.45 -40.23 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.159 -0.963 . . . . 0.0 109.402 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.4 mt -58.03 -35.69 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.139 -0.976 . . . . 0.0 108.665 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.42 -43.23 62.57 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 79.5 mt -63.76 -28.87 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.415 -1.05 . . . . 0.0 109.006 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.94 -58.86 4.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.412 -0.805 . . . . 0.0 108.98 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -54.36 -42.76 70.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.397 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 59.2 tp -58.81 -62.79 1.61 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.131 -0.98 . . . . 0.0 109.319 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mt -51.61 -40.98 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.215 -0.928 . . . . 0.0 109.495 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . 0.485 ' CD2' ' NC ' ' C' ' 399' ' ' RIM . 2.6 mt -60.86 -54.43 45.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.403 -0.81 . . . . 0.0 110.05 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -52.21 -44.61 64.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.366 -0.834 . . . . 0.0 109.813 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 36.4 mt -70.48 -28.17 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.236 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.82 -43.5 98.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.644 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.31 -24.6 32.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.111 -0.993 . . . . 0.0 109.688 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' C' ' 47' ' ' PHE . 1.6 mmt85 -89.42 -1.18 57.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.3 -0.875 . . . . 0.0 110.753 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . 0.491 ' C ' ' O ' ' C' ' 45' ' ' ARG . 29.0 mt -31.16 -36.23 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.851 -0.531 . . . . 0.0 110.805 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' C' ' 45' ' ' ARG . 2.3 m-85 -169.16 85.22 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.116 -0.99 . . . . 0.0 109.801 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 46.32 -132.87 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 109.686 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -170.07 -140.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.88 . . . . 0.0 109.256 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' SER . . . . . 0.441 ' O ' ' CZ ' ' C' ' 54' ' ' PHE . 40.5 t -147.9 120.52 8.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.319 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 17.1 mt -86.79 -23.12 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.243 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -23.85 64.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.352 -0.842 . . . . 0.0 109.499 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -70.39 -45.49 65.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.132 -0.98 . . . . 0.0 109.956 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' C' ' 54' ' ' PHE . 0.7 OUTLIER -69.1 -43.14 75.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.007 -1.058 . . . . 0.0 109.069 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -55.95 -56.72 17.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.407 -0.808 . . . . 0.0 109.354 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -26.8 68.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.664 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 37.0 t60 -67.16 -47.5 70.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.225 -0.922 . . . . 0.0 109.131 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.28 -59.6 9.21 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 62.4 mt -69.09 147.86 50.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.325 -1.103 . . . . 0.0 109.791 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 15.3 mttp . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.626 179.709 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' SER . . . . . 0.404 ' O ' ' OD1' ' D' ' 24' ' ' ASP . 69.4 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' D' ' 26' ' ' LEU . 62.0 m-20 -151.68 68.0 7.47 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -46.95 -11.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.659 2.239 . . . . 0.0 112.187 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' D' ' 24' ' ' ASP . 36.9 tp -47.36 -46.32 25.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.023 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 80.6 t -67.67 -45.5 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 0.0 108.852 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 72.6 t -49.42 -47.4 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.897 . . . . 0.0 108.912 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.53 -34.2 77.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.412 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.41 -56.63 10.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.194 -0.941 . . . . 0.0 109.634 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.94 -35.67 66.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 0.0 109.91 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 18.9 mt -73.25 -43.73 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.133 -0.979 . . . . 0.0 109.561 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 20.6 mt -54.56 -34.42 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.177 -0.952 . . . . 0.0 108.655 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.55 -44.41 26.82 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 50.0 mt -55.59 -31.04 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.087 -1.243 . . . . 0.0 109.356 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.11 -63.02 1.36 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.299 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -45.87 -38.94 7.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.367 -0.833 . . . . 0.0 109.854 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 53.7 tp -68.12 -67.85 0.43 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.123 -0.985 . . . . 0.0 109.642 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -47.31 -25.68 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.659 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . 0.492 ' CD2' HNC1 ' D' ' 499' ' ' RIM . 4.3 mt -68.88 -65.67 0.67 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 109.818 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 21.3 t-105 -48.9 -45.19 40.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.212 -0.93 . . . . 0.0 109.879 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' D' ' 45' ' ' ARG . 84.9 mt -63.32 -56.86 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.131 -0.981 . . . . 0.0 108.875 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 61.2 tp -46.26 -45.82 17.42 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.539 -0.726 . . . . 0.0 109.422 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.477 ' OD1' ' NC ' ' D' ' 499' ' ' RIM . 1.2 m-20 -66.79 -26.7 67.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.357 -0.839 . . . . 0.0 109.771 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.49 ' CA ' ' HE ' ' D' ' 45' ' ' ARG . 0.0 OUTLIER -77.49 -21.15 53.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.13 -0.981 . . . . 0.0 110.151 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.1 mt -83.65 -34.13 25.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.776 -1.202 . . . . 0.0 108.926 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -95.43 118.09 31.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.458 -0.776 . . . . 0.0 109.389 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -158.85 -8.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.122 -0.986 . . . . 0.0 109.63 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.9 pttp -67.98 -152.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.191 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 11.4 p 44.09 59.53 3.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.334 -0.854 . . . . 0.0 109.65 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 12.4 mt -96.83 -22.89 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.338 -0.852 . . . . 0.0 109.606 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -67.73 -22.75 65.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.136 -0.977 . . . . 0.0 109.483 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . 0.435 ' O ' ' ND1' ' D' ' 57' ' ' HIS . 0.1 OUTLIER -69.93 -39.37 76.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 109.44 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -69.72 -37.62 76.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.92 . . . . 0.0 109.089 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.35 -43.69 96.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.341 -0.849 . . . . 0.0 109.288 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -68.99 -27.95 66.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.272 -0.892 . . . . 0.0 109.114 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . 0.435 ' ND1' ' O ' ' D' ' 53' ' ' ARG . 1.7 m-70 -67.37 -46.95 71.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.308 -0.87 . . . . 0.0 108.855 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.26 -60.99 7.38 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 114.81 6.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -1.061 . . . . 0.0 109.419 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.06 -0.972 . . . . 0.0 109.447 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' RIM . . . . . 0.511 ' NC ' ' OD2' ' A' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 299' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 399' ' ' RIM . . . . . 0.485 ' NC ' ' CD2' ' C' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 499' ' ' RIM . . . . . 0.492 HNC1 ' CD2' ' D' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 26' ' ' LEU . 13.3 m-20 56.23 65.3 4.31 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.693 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -45.72 -11.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.691 2.261 . . . . 0.0 112.076 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 24' ' ' ASP . 28.7 tp -47.37 -45.68 25.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.339 -0.851 . . . . 0.0 109.044 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.32 -45.64 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.288 -0.883 . . . . 0.0 108.803 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.5 t -49.53 -47.85 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.253 -0.904 . . . . 0.0 109.021 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.3 -33.58 76.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 109.339 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.18 -56.66 10.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.873 . . . . 0.0 109.685 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.95 -36.27 70.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.259 -0.9 . . . . 0.0 109.633 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.7 mt -70.87 -41.15 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 0.0 109.329 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.2 mt -57.48 -33.8 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.099 -1.001 . . . . 0.0 108.626 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.65 -44.38 39.92 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.1 mt -55.47 -34.98 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.321 -1.106 . . . . 0.0 109.097 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.82 -64.33 0.89 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.31 -0.869 . . . . 0.0 109.066 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.23 -41.01 8.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.445 -0.784 . . . . 0.0 110.072 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 35.4 tp -64.19 -68.04 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.111 -0.993 . . . . 0.0 109.6 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mt -47.9 -24.59 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.213 -0.93 . . . . 0.0 109.308 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.462 ' CD2' ' OD2' ' A' ' 44' ' ' ASP . 1.8 tt -71.35 -61.32 1.81 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 109.595 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 -51.16 -49.79 60.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.272 -0.892 . . . . 0.0 109.714 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' A' ' 45' ' ' ARG . 80.6 mt -60.23 -56.32 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.006 -1.059 . . . . 0.0 108.969 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.3 tp -46.34 -42.15 14.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.477 -0.764 . . . . 0.0 109.578 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.48 ' OD2' ' NC ' ' A' ' 199' ' ' RIM . 72.9 m-20 -67.71 -28.19 67.45 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.21 -0.931 . . . . 0.0 109.276 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 42' ' ' ILE . 7.0 mmt-85 -80.11 -17.72 51.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 110.42 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -87.14 -35.08 18.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.693 -1.255 . . . . 0.0 109.002 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -99.5 -154.58 0.47 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.462 -0.774 . . . . 0.0 109.255 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 t80 66.56 114.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 50' ' ' SER . 5.3 ptmm? -169.8 -148.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.315 -0.866 . . . . 0.0 109.3 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 49' ' ' LYS . 17.0 m 50.98 97.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.9 mt -86.5 -24.42 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 109.067 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -59.23 -21.7 59.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.272 -0.892 . . . . 0.0 109.867 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.521 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 17.7 mmm180 -74.43 -44.09 53.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.91 -1.119 . . . . 0.0 109.744 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -73.71 -33.55 64.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.993 -1.067 . . . . 0.0 108.496 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -68.43 -52.12 36.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.351 -0.843 . . . . 0.0 109.861 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -71.17 -27.54 63.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.122 -0.986 . . . . 0.0 110.194 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 11.4 m170 -65.0 -52.91 53.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.966 -1.084 . . . . 0.0 109.124 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.05 -64.52 2.76 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.4 116.98 4.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.189 -1.183 . . . . 0.0 109.425 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.431 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.537 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 16.6 m-20 -159.96 50.22 0.34 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.212 -0.93 . . . . 0.0 109.376 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 12.3 Cg_endo -58.7 -15.8 27.79 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.928 2.418 . . . . 0.0 112.438 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 52.1 tp -47.22 -43.23 21.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.086 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.58 -45.25 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.91 . . . . 0.0 108.733 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 77.6 t -49.0 -46.34 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.282 -0.886 . . . . 0.0 108.989 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.95 -37.1 85.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 109.144 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.01 -55.37 29.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.339 -0.851 . . . . 0.0 109.651 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.0 -37.28 71.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 110.06 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 14.0 mt -70.84 -39.75 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.141 -0.974 . . . . 0.0 109.319 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 26.8 mt -57.77 -36.44 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.246 -0.909 . . . . 0.0 108.634 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.54 -44.55 63.6 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.2 -23.28 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.295 -1.12 . . . . 0.0 109.005 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.2 tp -76.78 -71.71 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.464 -0.773 . . . . 0.0 109.456 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . 0.47 ' CD2' ' ND1' ' C' ' 37' ' ' HIS . 2.9 t-80 -44.79 -35.42 2.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 109.774 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -66.58 -68.66 0.36 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.191 -0.943 . . . . 0.0 109.466 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 7.0 mt -48.69 -41.18 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.463 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.96 -61.72 2.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 110.066 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -46.82 -47.62 21.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.104 -0.998 . . . . 0.0 109.746 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 70.1 mt -62.0 -42.17 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.185 -0.947 . . . . 0.0 109.11 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.42 -43.39 64.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.625 -0.672 . . . . 0.0 109.918 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.499 ' OD2' ' NC ' ' B' ' 299' ' ' RIM . 6.7 m-20 -77.83 -25.41 48.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.743 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.542 ' NE ' ' NC ' ' A' ' 199' ' ' RIM . 9.6 mmm180 -71.83 -30.47 65.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.84 -1.163 . . . . 0.0 110.614 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -55.85 -26.53 47.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.734 -1.228 . . . . 0.0 109.281 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.19 -166.17 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.071 -1.018 . . . . 0.0 109.255 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -134.36 -125.02 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.742 . . . . 0.0 109.358 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -149.74 -63.68 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 83.7 p -52.14 104.96 0.1 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.871 . . . . 0.0 109.493 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 10.7 mt -103.75 -20.18 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.435 -0.791 . . . . 0.0 109.355 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -57.51 -12.64 2.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.576 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -72.1 -42.17 66.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 109.724 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -70.09 -38.41 75.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.143 -0.973 . . . . 0.0 108.993 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -59.43 -47.91 83.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.512 -0.743 . . . . 0.0 109.593 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.8 -27.2 63.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.584 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -66.18 -50.48 63.74 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.885 . . . . 0.0 109.13 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.03 -63.54 3.77 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 7.2 mt -68.65 118.58 11.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -1.148 . . . . 0.0 109.511 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 mptt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.481 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.32 159.22 75.54 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 0.0 109.277 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -61.08 -20.35 67.34 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.36 2.04 . . . . 0.0 112.205 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 47.4 tp -47.22 -42.54 20.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.944 . . . . 0.0 108.581 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 35.0 t -69.09 -45.48 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 73.8 t -48.77 -47.55 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 108.853 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.86 -36.48 84.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.37 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.13 -57.27 10.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.393 -0.817 . . . . 0.0 109.832 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.48 -36.97 67.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.268 -0.895 . . . . 0.0 109.916 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 24.8 mt -70.99 -42.45 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.378 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.9 mt -55.41 -35.69 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 108.83 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.25 -45.22 40.44 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 51.5 mt -55.72 -30.27 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.157 -1.202 . . . . 0.0 109.066 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -64.01 1.09 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 109.069 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . 0.47 ' ND1' ' CD2' ' B' ' 37' ' ' HIS . 13.0 t-80 -43.4 -37.25 2.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.484 -0.76 . . . . 0.0 110.244 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 35.3 tp -71.99 -65.17 0.8 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.983 -1.073 . . . . 0.0 109.523 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.3 mt -46.94 -27.64 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.235 -0.916 . . . . 0.0 109.393 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.04 -63.24 1.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.338 -0.851 . . . . 0.0 109.688 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -45.94 -47.5 16.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 109.287 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 64.5 mt -58.49 -49.31 82.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.221 -0.924 . . . . 0.0 108.93 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.56 -50.43 13.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.653 -0.655 . . . . 0.0 109.411 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . 0.434 ' OD2' ' NC ' ' C' ' 399' ' ' RIM . 1.3 m-20 -62.76 -32.82 74.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.89 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -73.02 -19.12 61.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.07 -1.019 . . . . 0.0 110.416 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -83.75 -13.63 53.49 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.641 -1.287 . . . . 0.0 108.716 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.93 12.7 5.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 0.0 109.733 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.16 106.69 18.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.113 -0.992 . . . . 0.0 109.039 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -163.58 -90.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.152 -0.967 . . . . 0.0 109.72 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.34 103.61 0.25 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.913 . . . . 0.0 109.756 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 18.4 mt -90.99 -22.68 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.052 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.97 -23.42 66.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.026 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . 0.52 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 96.7 mtt180 -70.38 -36.51 74.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.068 -1.02 . . . . 0.0 110.125 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -72.35 -34.74 68.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.004 -1.06 . . . . 0.0 109.286 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.26 -45.8 79.29 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.338 -0.851 . . . . 0.0 109.679 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -71.6 -29.01 64.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.0 109.591 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . 0.521 ' O ' ' NZ ' ' D' ' 49' ' ' LYS . 2.7 m-70 -64.58 -43.05 95.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 109.068 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.44 -61.61 4.09 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 mt -75.07 107.2 6.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -1.117 . . . . 0.0 109.57 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 14.9 tttt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.515 179.824 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.537 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 6.1 t70 66.21 48.4 0.56 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.353 -0.842 . . . . 0.0 109.595 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 0.9 OUTLIER -48.11 -19.72 1.81 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.634 2.223 . . . . 0.0 111.701 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 42.1 tp -46.26 -41.17 12.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.423 -0.798 . . . . 0.0 108.99 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 36.4 t -69.66 -45.67 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.237 -0.914 . . . . 0.0 108.795 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 77.5 t -49.2 -47.35 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 108.963 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.8 -34.33 77.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.873 . . . . 0.0 109.226 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.2 -55.44 18.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.849 . . . . 0.0 109.688 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -58.1 -36.21 72.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.324 -0.86 . . . . 0.0 109.892 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 25.7 mt -72.05 -42.52 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.145 -0.972 . . . . 0.0 109.438 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mt -56.2 -33.37 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.107 -0.996 . . . . 0.0 108.457 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.5 -44.78 25.84 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.85 -28.99 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.188 -1.184 . . . . 0.0 109.113 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.18 -65.33 0.76 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.335 -0.853 . . . . 0.0 108.883 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -45.75 -42.88 12.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.48 -0.763 . . . . 0.0 109.712 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.19 -67.79 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 0.0 109.558 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mt -47.13 -35.7 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.175 -0.953 . . . . 0.0 109.639 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mt -63.5 -57.39 10.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.937 . . . . 0.0 109.826 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -48.15 -45.38 33.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.04 -1.037 . . . . 0.0 109.472 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 67.4 mt -64.49 -50.17 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.156 -0.965 . . . . 0.0 109.012 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 14.3 tp -52.09 -37.14 53.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.638 -0.664 . . . . 0.0 110.39 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.412 ' OD1' ' NC ' ' D' ' 499' ' ' RIM . 0.7 OUTLIER -84.67 -21.73 30.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.036 -1.04 . . . . 0.0 110.349 -179.189 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.423 ' NH1' ' OD1' ' C' ' 44' ' ' ASP . 0.0 OUTLIER -76.09 -28.95 57.73 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.984 -1.073 . . . . 0.0 110.712 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.25 -10.98 1.46 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.687 -1.258 . . . . 0.0 109.171 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -77.04 120.49 22.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.165 -0.96 . . . . 0.0 109.407 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.34 178.78 8.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.39 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . 0.558 ' CD ' ' H ' ' D' ' 50' ' ' SER . 6.0 tmtt? 54.83 -153.67 0.31 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.088 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.558 ' H ' ' CD ' ' D' ' 49' ' ' LYS . 2.6 m 47.01 54.7 8.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.945 -1.097 . . . . 0.0 110.023 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 47.4 mt -97.47 -28.64 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 0.0 109.297 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.44 -32.96 67.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.339 -0.85 . . . . 0.0 109.455 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -63.56 -34.76 78.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.114 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -72.55 -38.88 67.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.286 -0.884 . . . . 0.0 109.108 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -62.29 -49.39 75.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.411 -0.806 . . . . 0.0 109.208 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -67.87 -26.22 65.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.338 -0.851 . . . . 0.0 109.424 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -68.91 -34.71 75.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.87 . . . . 0.0 109.119 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.19 -62.89 2.36 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 7.5 mt -59.93 116.6 4.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -1.132 . . . . 0.0 109.337 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.474 179.886 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' RIM . . . . . 0.542 ' NC ' ' NE ' ' B' ' 45' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 299' ' ' RIM . . . . . 0.499 ' NC ' ' OD2' ' B' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 399' ' ' RIM . . . . . 0.434 ' NC ' ' OD2' ' C' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 499' ' ' RIM . . . . . 0.412 ' NC ' ' OD1' ' D' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 26' ' ' LEU . 28.0 t70 52.4 65.01 6.64 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.446 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -44.72 -12.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.677 2.251 . . . . 0.0 112.234 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' A' ' 24' ' ' ASP . 38.8 tp -48.92 -43.22 39.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.018 -1.052 . . . . 0.0 108.8 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 t -68.39 -46.01 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.232 -0.918 . . . . 0.0 108.588 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.6 t -49.08 -47.17 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 0.0 108.876 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.11 -33.39 75.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.316 -0.865 . . . . 0.0 109.345 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.44 -57.24 6.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.313 -0.867 . . . . 0.0 109.727 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.71 -37.14 65.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.968 . . . . 0.0 109.429 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.5 mt -71.11 -41.15 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 0.0 109.124 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.3 mt -56.03 -34.03 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.119 -0.988 . . . . 0.0 108.524 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.9 -45.84 31.7 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.9 mt -60.55 -23.13 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.265 -1.138 . . . . 0.0 108.845 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.6 tp -76.69 -70.8 0.43 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.518 -0.739 . . . . 0.0 109.082 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -47.31 -33.51 5.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 109.506 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.9 tp -66.59 -69.17 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 109.654 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 mt -48.45 -27.68 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.61 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.429 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 1.6 mt -68.61 -59.82 2.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -0.933 . . . . 0.0 109.914 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -53.36 -46.12 69.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.021 -1.049 . . . . 0.0 109.809 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 82.2 mt -61.78 -52.77 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.018 -1.051 . . . . 0.0 108.836 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.8 tp -51.25 -38.58 53.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.506 -0.746 . . . . 0.0 109.399 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 1.4 m-20 -72.38 -24.98 61.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 109.23 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.53 ' CA ' ' HE ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -77.96 -24.12 48.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.177 -0.952 . . . . 0.0 110.14 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 48' ' ' PHE . 9.3 mt -80.17 -13.93 58.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.77 -1.206 . . . . 0.0 109.043 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -75.03 29.78 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.655 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.49 ' H ' ' C ' ' A' ' 46' ' ' LEU . 78.0 t80 -83.04 77.14 9.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.134 -0.979 . . . . 0.0 109.369 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -85.71 -128.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.459 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.98 168.48 10.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.337 -0.852 . . . . 0.0 109.489 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.0 mt -104.2 -23.11 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.487 -0.758 . . . . 0.0 109.324 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -60.15 -21.82 62.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.097 -1.002 . . . . 0.0 109.734 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.7 mtt85 -69.39 -43.48 73.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.176 -0.952 . . . . 0.0 109.26 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -64.96 -36.56 84.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.476 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -70.68 -61.64 1.69 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -48.39 -29.72 4.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.348 -0.845 . . . . 0.0 109.646 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -71.13 -53.3 15.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.198 -0.939 . . . . 0.0 109.512 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.05 -60.28 9.33 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.8 mt -77.65 81.65 4.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -1.139 . . . . 0.0 109.604 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.7 tttt . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.379 179.864 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.86 160.86 66.62 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.301 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' B' ' 26' ' ' LEU . 18.7 Cg_endo -63.7 -21.08 69.9 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.525 2.15 . . . . 0.0 112.301 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' B' ' 25' ' ' PRO . 48.9 tp -46.63 -43.67 17.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 108.686 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 37.3 t -69.54 -44.76 79.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.306 -0.871 . . . . 0.0 108.801 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -48.6 -46.63 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.878 . . . . 0.0 108.827 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.15 -39.06 92.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.393 -0.817 . . . . 0.0 109.155 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.86 -57.51 11.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.458 -0.776 . . . . 0.0 109.948 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.78 -37.07 63.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.096 -1.003 . . . . 0.0 109.758 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 20.6 mt -71.38 -38.49 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.152 -0.967 . . . . 0.0 109.468 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 29.8 mt -57.51 -36.27 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.087 -1.008 . . . . 0.0 108.582 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.89 -46.53 52.18 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 69.0 mt -59.64 -25.76 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.306 -1.114 . . . . 0.0 108.891 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 14.0 tp -75.63 -67.88 0.62 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -42.59 -42.73 3.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.529 -0.732 . . . . 0.0 110.086 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 22.2 tp -64.37 -64.66 0.82 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.979 -1.076 . . . . 0.0 109.521 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.404 HG21 HD11 ' B' ' 39' ' ' ILE . 6.3 mt -48.02 -29.34 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.327 -0.858 . . . . 0.0 109.556 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 5.2 mt -75.98 -57.79 3.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.552 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -45.83 -54.97 7.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.365 -0.834 . . . . 0.0 109.663 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.478 ' O ' ' N ' ' B' ' 45' ' ' ARG . 58.5 mt -58.66 -60.38 2.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.155 -0.966 . . . . 0.0 109.036 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' B' ' 42' ' ' ILE . 57.3 tp -41.61 -38.84 1.46 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.674 -0.641 . . . . 0.0 110.347 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.403 ' CG ' ' NC ' ' B' ' 299' ' ' RIM . 1.0 OUTLIER -73.74 -30.19 62.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.1 -1.0 . . . . 0.0 109.625 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' B' ' 42' ' ' ILE . 0.4 OUTLIER -80.9 -13.64 58.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.898 . . . . 0.0 110.596 -179.521 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -87.28 -33.15 19.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.661 -1.275 . . . . 0.0 109.015 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -63.62 -19.87 65.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 109.515 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.02 128.9 34.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.445 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.444 ' HZ3' ' CB ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -167.29 -54.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 109.504 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 78.1 p -93.32 138.39 31.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.959 . . . . 0.0 109.525 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 30.0 mt -110.33 -27.43 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.698 -0.626 . . . . 0.0 109.859 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -33.08 56.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.154 -0.966 . . . . 0.0 110.267 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -67.54 -39.71 85.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.861 -1.149 . . . . 0.0 109.595 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -66.28 -33.87 76.73 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.324 -0.86 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -68.24 -52.08 38.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 109.384 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -60.99 -30.92 70.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.676 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.26 -57.64 5.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 0.0 109.722 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.02 -58.93 11.76 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 5.2 mt -70.08 148.18 49.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.184 -1.186 . . . . 0.0 109.365 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 6.1 tptm . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.404 -179.936 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.352 0.596 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.502 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 4.9 p30 -166.71 51.84 0.24 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.391 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 12.4 Cg_endo -59.2 -9.54 8.52 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.633 2.222 . . . . 0.0 111.922 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 41.3 tp -47.5 -46.05 26.9 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.34 -0.85 . . . . 0.0 108.873 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 29.2 t -69.15 -45.58 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.213 -0.929 . . . . 0.0 108.686 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -49.2 -50.46 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.87 . . . . 0.0 109.071 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.77 76.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.872 . . . . 0.0 109.222 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.64 -55.84 15.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.448 -0.782 . . . . 0.0 109.659 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -54.92 -36.46 65.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 109.688 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.7 mt -72.41 -40.62 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.225 -0.922 . . . . 0.0 109.531 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 23.5 mt -56.27 -35.65 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.001 -1.062 . . . . 0.0 108.871 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.15 -42.72 35.1 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 58.0 mt -58.72 -36.84 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -1.158 . . . . 0.0 109.57 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.45 -60.97 1.99 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.183 -0.948 . . . . 0.0 109.305 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -44.34 -39.34 4.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 0.0 110.187 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 25.6 tp -69.22 -66.94 0.52 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 109.688 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mt -46.81 -27.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.311 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 2.4 tt -74.25 -52.42 12.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.359 -0.838 . . . . 0.0 109.762 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . 0.435 ' CH2' ' NE ' ' C' ' 45' ' ' ARG . 24.3 t-105 -58.31 -46.08 86.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -0.962 . . . . 0.0 109.46 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 69.6 mt -64.57 -39.24 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.144 -0.973 . . . . 0.0 109.185 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.12 -31.31 71.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.839 . . . . 0.0 109.678 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -82.81 -25.24 32.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 109.627 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.451 ' C ' ' H ' ' C' ' 47' ' ' PHE . 3.5 mmt-85 -79.27 -26.15 42.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 111.137 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 6.4 mt -55.86 -9.69 0.62 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.413 -1.429 . . . . 0.0 109.217 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.451 ' H ' ' C ' ' C' ' 45' ' ' ARG . 70.8 t80 -70.61 66.3 0.33 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 109.108 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -92.19 153.41 19.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.863 . . . . 0.0 109.797 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . 0.68 ' HZ1' ' H ' ' C' ' 50' ' ' SER . 1.4 ttpp 59.06 -150.47 0.44 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 109.474 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' SER . . . . . 0.68 ' H ' ' HZ1' ' C' ' 49' ' ' LYS . 6.2 t 47.06 59.9 3.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.935 . . . . 0.0 109.548 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 15.8 mt -102.01 -31.08 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.429 -0.795 . . . . 0.0 109.411 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . 0.434 ' CD1' ' C ' ' C' ' 52' ' ' TYR . 0.0 OUTLIER -55.25 -34.25 63.85 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.336 -0.853 . . . . 0.0 110.13 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -67.42 -36.74 81.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.098 -1.001 . . . . 0.0 109.472 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -68.78 -32.29 71.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -0.95 . . . . 0.0 108.808 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -68.95 -47.01 66.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.449 -0.782 . . . . 0.0 109.3 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -65.94 -27.28 68.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.277 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . 0.671 ' CE1' ' HZ3' ' D' ' 49' ' ' LYS . 82.3 t60 -71.18 -44.54 65.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.095 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.11 -63.3 4.67 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 41.1 mt -80.96 90.39 5.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.286 -1.126 . . . . 0.0 109.393 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 mttm . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.536 -179.846 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.24 0.543 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' D' ' 26' ' ' LEU . 11.1 m-20 -154.29 66.28 5.28 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.362 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -45.26 -11.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.738 2.292 . . . . 0.0 112.179 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' D' ' 24' ' ' ASP . 41.9 tp -47.61 -44.98 27.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.127 -0.983 . . . . 0.0 109.193 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.4 t -68.47 -44.99 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.22 -0.925 . . . . 0.0 108.812 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.3 t -49.12 -48.62 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 108.981 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.71 -33.19 75.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.327 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.36 -57.1 8.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.342 -0.849 . . . . 0.0 109.571 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.56 -37.09 70.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.812 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 16.2 mt -71.11 -43.11 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.155 -0.965 . . . . 0.0 109.52 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 27.2 mt -56.05 -35.11 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.071 -1.018 . . . . 0.0 108.681 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.95 -43.79 39.58 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 78.6 mt -62.26 -26.45 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.304 -1.115 . . . . 0.0 108.869 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.49 -67.0 0.55 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.478 -0.764 . . . . 0.0 109.172 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -45.16 -47.27 12.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.35 -0.844 . . . . 0.0 109.954 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.2 tp -57.62 -63.54 1.2 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.166 -0.959 . . . . 0.0 109.614 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.406 HD12 HG22 ' D' ' 39' ' ' ILE . 10.3 mt -50.57 -36.1 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.122 -0.986 . . . . 0.0 109.558 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 mt -63.57 -57.54 9.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.798 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -47.24 -44.75 23.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.279 -0.888 . . . . 0.0 109.548 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 12.2 mt -69.38 -33.9 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 108.714 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -60.14 -42.15 94.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.438 -0.789 . . . . 0.0 109.936 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.501 ' OD1' ' NC ' ' D' ' 499' ' ' RIM . 0.7 OUTLIER -81.97 -22.19 36.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 0.0 109.612 -179.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' D' ' 47' ' ' PHE . 9.3 mmt180 -92.57 -0.71 57.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 0.0 110.875 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . 0.482 ' C ' ' O ' ' D' ' 45' ' ' ARG . 32.8 mt -31.01 -36.16 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.658 -0.651 . . . . 0.0 110.832 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' D' ' 45' ' ' ARG . 0.2 OUTLIER 178.23 15.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.139 -0.976 . . . . 0.0 109.547 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -49.95 101.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.449 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . 0.671 ' HZ3' ' CE1' ' C' ' 57' ' ' HIS . 0.0 OUTLIER -150.6 -29.16 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.964 . . . . 0.0 109.626 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 15.2 p -51.34 120.42 5.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 0.0 109.318 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 15.8 mt -101.07 -29.37 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.492 -0.755 . . . . 0.0 109.721 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -34.48 60.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.186 -0.946 . . . . 0.0 109.897 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -63.64 -39.6 94.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 109.551 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -67.55 -37.82 83.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 0.0 109.44 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.29 -64.43 0.88 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.437 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -51.27 -31.47 21.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.124 -0.985 . . . . 0.0 109.528 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . 0.414 ' ND1' ' C ' ' D' ' 57' ' ' HIS . 14.1 t-80 -69.26 -53.98 17.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.159 -0.963 . . . . 0.0 109.541 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.97 -62.29 6.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.35 109.94 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -1.13 . . . . 0.0 109.076 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 17.6 ttmt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.562 -179.958 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 299' ' ' RIM . . . . . 0.403 ' NC ' ' CG ' ' B' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 399' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 499' ' ' RIM . . . . . 0.501 ' NC ' ' OD1' ' D' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.6 m-20 58.23 49.66 3.25 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 109.449 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.8 Cg_endo -55.12 -14.92 9.54 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.837 2.358 . . . . 0.0 112.266 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.9 tp -47.5 -44.28 25.35 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.201 -0.937 . . . . 0.0 109.091 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.8 t -68.21 -45.08 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.186 -0.946 . . . . 0.0 108.665 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.6 t -50.89 -48.12 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 0.0 109.009 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.02 -32.72 74.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 109.464 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.52 -55.14 12.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.329 -0.857 . . . . 0.0 109.626 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.94 -36.21 67.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.744 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.1 mt -73.35 -43.34 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.509 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.4 mt -54.34 -32.95 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.029 -1.044 . . . . 0.0 108.595 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.41 -45.33 14.54 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.0 mt -56.64 -36.68 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.148 -1.207 . . . . 0.0 109.483 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.39 -59.51 2.94 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.236 -0.915 . . . . 0.0 109.203 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -44.3 -44.81 8.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.342 -0.849 . . . . 0.0 110.02 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.53 -68.83 0.31 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.084 -1.01 . . . . 0.0 109.639 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 mt -45.44 -29.76 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.418 -0.801 . . . . 0.0 109.653 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 mt -68.57 -61.5 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.947 . . . . 0.0 109.543 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.494 ' NE1' ' OD2' ' D' ' 44' ' ' ASP . 54.8 t-105 -44.33 -46.04 9.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.548 -0.72 . . . . 0.0 109.633 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.5 mt -71.59 -33.09 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.086 -1.009 . . . . 0.0 109.559 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.9 tp -61.52 -43.12 99.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 109.972 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.52 -20.74 36.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 110.588 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 46' ' ' LEU . 8.6 mmt180 -85.92 -16.56 38.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.711 -1.243 . . . . 0.0 111.515 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 45' ' ' ARG . 20.7 mt -39.61 -34.55 0.24 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.01 -1.056 . . . . 0.0 110.171 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.548 ' CG ' ' O ' ' A' ' 47' ' ' PHE . 1.6 p90 -55.05 126.73 25.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.014 -1.054 . . . . 0.0 109.394 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -173.76 32.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 109.235 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -148.7 -76.64 0.16 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 109.556 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.474 ' H ' ' HZ1' ' A' ' 49' ' ' LYS . 3.3 p -55.15 85.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.94 . . . . 0.0 109.597 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.52 ' N ' ' O ' ' A' ' 49' ' ' LYS . 26.3 mt -89.76 -21.29 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.648 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.54 -21.47 62.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.965 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -67.36 -40.87 85.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.966 . . . . 0.0 109.943 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -71.39 -37.65 71.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 0.0 109.32 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -59.08 -51.38 70.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.233 -0.917 . . . . 0.0 109.192 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -67.69 -26.29 66.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 109.452 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -67.25 -42.01 84.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.18 -0.95 . . . . 0.0 109.198 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.04 -62.58 3.49 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mt -52.9 159.7 1.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.392 -1.063 . . . . 0.0 109.503 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.9 mttt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.498 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' B' ' 26' ' ' LEU . 6.9 m-20 -156.55 65.29 3.82 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.605 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -45.61 -9.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.773 2.315 . . . . 0.0 112.182 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' B' ' 24' ' ' ASP . 29.1 tp -47.27 -46.9 25.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.263 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.96 -45.21 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.225 -0.922 . . . . 0.0 108.89 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 73.0 t -48.98 -48.88 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 108.999 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.22 -34.01 77.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.364 -0.835 . . . . 0.0 109.461 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.46 -56.63 10.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.26 -0.9 . . . . 0.0 109.599 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.11 -37.0 68.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.586 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 16.8 mt -71.0 -41.08 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 21.1 mt -56.4 -33.91 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.174 -0.954 . . . . 0.0 108.645 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.67 -43.13 24.48 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 66.9 mt -59.14 -39.4 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.115 -1.226 . . . . 0.0 109.308 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.12 -63.8 1.0 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.952 . . . . 0.0 109.076 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.08 -49.77 11.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.435 -0.79 . . . . 0.0 109.761 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 48.9 tp -56.5 -65.19 0.65 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 109.618 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.8 mt -46.44 -40.03 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 0.0 109.538 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.67 -63.24 1.37 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 110.095 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -45.06 -48.25 11.82 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.374 -0.828 . . . . 0.0 109.854 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 79.3 mt -61.53 -47.78 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.212 -0.93 . . . . 0.0 109.07 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 13.3 tp -51.78 -39.59 58.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.537 -0.727 . . . . 0.0 110.137 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.513 ' OD1' ' NC ' ' B' ' 299' ' ' RIM . 1.7 m-20 -76.31 -26.45 55.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 109.953 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.495 ' CA ' ' HE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -73.58 -27.95 61.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.056 -1.027 . . . . 0.0 110.464 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -65.96 -31.06 71.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.688 -1.258 . . . . 0.0 109.179 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' B' ' 48' ' ' PHE . 60.3 t80 -78.19 -103.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 109.313 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . 0.48 ' N ' ' CG ' ' B' ' 47' ' ' PHE . 2.7 t80 48.04 -154.97 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.925 . . . . 0.0 109.747 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 6.6 tttt 68.73 -153.8 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.3 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.525 ' O ' ' CE2' ' B' ' 54' ' ' PHE . 13.8 m 44.77 75.53 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.215 -0.928 . . . . 0.0 109.401 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 27.3 mt -90.7 -20.25 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.15 -0.969 . . . . 0.0 109.712 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -20.97 58.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 0.0 109.581 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -71.49 -42.92 67.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 110.046 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . 0.525 ' CE2' ' O ' ' B' ' 50' ' ' SER . 4.0 m-85 -70.58 -35.08 72.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.059 -1.026 . . . . 0.0 109.492 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -63.55 -45.56 89.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.19 -0.944 . . . . 0.0 109.279 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -71.49 -25.49 62.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.514 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . 0.457 ' NE2' ' NZ ' ' C' ' 49' ' ' LYS . 15.1 t60 -65.97 -53.07 43.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.091 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.02 -60.52 7.12 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.12 148.96 16.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -1.168 . . . . 0.0 109.439 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 33.1 tttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.391 179.929 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.55 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 4.2 p30 -175.09 49.16 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.346 -0.846 . . . . 0.0 109.432 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 10.6 Cg_endo -56.34 -12.32 7.79 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.941 2.427 . . . . 0.0 112.249 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 35.5 tp -47.71 -44.65 27.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.129 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 38.6 t -68.99 -45.18 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.179 -0.95 . . . . 0.0 108.674 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.8 t -49.69 -49.19 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.0 108.889 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.17 -31.87 73.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.338 -0.851 . . . . 0.0 109.254 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.15 -57.27 7.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 109.686 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' SER . . . . . 0.443 ' H ' ' HG ' ' C' ' 31' ' ' SER . 1.2 m -55.68 -36.27 66.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.666 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.5 mt -71.79 -38.98 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.979 . . . . 0.0 109.548 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 23.7 mt -59.38 -35.51 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.015 -1.053 . . . . 0.0 108.73 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.47 -42.89 63.22 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 77.7 mt -63.63 -22.28 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.414 -1.05 . . . . 0.0 108.771 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.91 -70.84 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . 0.55 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 2.3 t-80 -45.92 -36.73 5.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.864 . . . . 0.0 109.67 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.95 -67.82 0.4 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.437 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.403 HD12 HG21 ' C' ' 39' ' ' ILE . 5.6 mt -48.54 -28.92 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.878 . . . . 0.0 109.672 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 mt -71.57 -59.79 2.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 110.01 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . 0.437 ' HE1' HNC1 ' B' ' 299' ' ' RIM . 51.9 t-105 -49.59 -47.75 49.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.084 -1.01 . . . . 0.0 109.811 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 73.2 mt -64.02 -58.74 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.102 -0.999 . . . . 0.0 109.273 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 59.2 tp -44.99 -54.46 6.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.47 -0.769 . . . . 0.0 109.679 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.79 -26.61 67.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.314 -0.867 . . . . 0.0 110.109 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.461 ' HE ' ' CA ' ' C' ' 45' ' ' ARG . 0.0 OUTLIER -79.19 -20.69 47.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.924 -1.11 . . . . 0.0 110.446 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -79.84 -32.14 40.56 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.701 -1.249 . . . . 0.0 109.058 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.451 ' O ' ' CB ' ' C' ' 48' ' ' PHE . 6.3 t80 -92.33 -144.91 0.21 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 0.0 109.31 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . 0.451 ' CB ' ' O ' ' C' ' 47' ' ' PHE . 1.1 t80 72.38 106.31 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 109.441 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . 0.457 ' NZ ' ' NE2' ' B' ' 57' ' ' HIS . 10.7 tttp -165.62 -154.03 0.19 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.366 -0.834 . . . . 0.0 109.094 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' SER . . . . . 0.42 ' O ' ' O ' ' C' ' 49' ' ' LYS . 34.6 m 42.55 91.14 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.333 -0.854 . . . . 0.0 109.917 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 10.3 mt -94.64 -19.09 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.411 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -67.53 -21.88 65.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.092 -1.005 . . . . 0.0 109.499 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -68.2 -42.33 80.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.895 . . . . 0.0 109.7 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -71.71 -45.13 62.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.112 -0.992 . . . . 0.0 109.036 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -54.29 -48.69 70.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 108.828 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -66.8 -26.95 67.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.397 -0.814 . . . . 0.0 109.032 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -66.95 -43.9 81.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.888 . . . . 0.0 108.746 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.47 -62.64 4.91 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.0 103.3 0.92 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -1.114 . . . . 0.0 108.925 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 31.9 tttm . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.079 -0.963 . . . . 0.0 109.542 179.97 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 66.1 p . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.472 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 2.6 m-20 53.21 52.8 10.82 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.243 -0.911 . . . . 0.0 109.441 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 11.2 Cg_endo -58.57 -13.7 18.34 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.542 2.161 . . . . 0.0 112.116 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 35.6 tp -48.0 -44.23 30.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.947 . . . . 0.0 108.901 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.58 -45.36 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.16 -0.962 . . . . 0.0 108.668 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 67.9 t -48.94 -47.7 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.847 . . . . 0.0 108.957 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.89 -35.07 79.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.336 -0.853 . . . . 0.0 109.166 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.86 -56.93 11.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.849 . . . . 0.0 109.708 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.87 -36.16 67.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.147 -0.971 . . . . 0.0 109.79 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 11.2 mt -71.63 -39.57 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.192 -0.942 . . . . 0.0 109.494 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 16.5 mt -58.67 -35.29 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.988 -1.07 . . . . 0.0 108.576 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.88 -43.73 57.67 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.86 -23.61 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.225 -1.162 . . . . 0.0 108.919 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.69 -70.21 0.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.866 . . . . 0.0 109.032 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . 0.55 ' CE1' ' NE2' ' C' ' 37' ' ' HIS . 9.8 t-80 -46.46 -35.64 5.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.913 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 57.3 tp -65.75 -63.02 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.117 -0.989 . . . . 0.0 109.564 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 6.8 mt -54.7 -32.82 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.522 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.03 -58.04 4.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.816 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 -46.45 -51.94 14.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.819 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.06 -53.58 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.008 -1.057 . . . . 0.0 108.883 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 54.9 tp -46.13 -44.05 15.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.464 -0.772 . . . . 0.0 109.895 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.494 ' OD2' ' NE1' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -68.7 -28.18 66.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.775 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -79.2 -19.69 50.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 0.0 110.687 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.4 mt -80.9 -33.81 33.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.666 -1.271 . . . . 0.0 109.167 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -67.88 114.0 6.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.426 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -157.75 -155.14 0.48 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.153 -0.967 . . . . 0.0 109.597 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt 48.43 -153.5 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.36 -0.837 . . . . 0.0 109.243 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 94.4 p 43.1 65.34 0.98 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.36 -0.837 . . . . 0.0 109.65 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 6.7 mt -89.96 -24.41 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 109.07 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.98 -27.92 65.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 109.893 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -71.94 -43.34 65.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.904 -1.122 . . . . 0.0 109.498 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -60.75 -37.03 80.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.383 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -68.57 -67.77 0.44 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.395 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -47.53 -40.16 18.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.893 . . . . 0.0 109.658 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -65.56 -54.37 28.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.305 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.83 -61.3 7.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.51 129.08 40.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -1.195 . . . . 0.0 109.413 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 37.8 tttp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.394 -179.9 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 299' ' ' RIM . . . . . 0.513 ' NC ' ' OD1' ' B' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 399' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 499' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.275 0.559 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 26' ' ' LEU . 30.5 t0 52.77 66.84 4.42 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.166 -0.959 . . . . 0.0 109.516 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -46.06 -11.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.662 2.241 . . . . 0.0 112.031 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 24' ' ' ASP . 37.6 tp -47.78 -45.91 29.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.262 -0.899 . . . . 0.0 108.962 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.53 -45.29 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.207 -0.933 . . . . 0.0 108.721 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.3 t -49.12 -49.08 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 108.95 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.24 -32.55 74.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.316 -0.865 . . . . 0.0 109.157 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.81 -58.16 6.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.347 -0.845 . . . . 0.0 109.671 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.55 -36.85 67.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 109.743 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.4 mt -70.93 -39.74 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.361 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.3 mt -57.66 -34.51 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.027 -1.045 . . . . 0.0 108.415 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.96 -44.63 45.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.6 mt -57.0 -31.33 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.19 -1.182 . . . . 0.0 109.128 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.07 -64.69 0.86 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.305 -0.872 . . . . 0.0 109.208 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -44.96 -47.37 11.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.839 . . . . 0.0 110.223 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.8 tp -59.02 -63.92 1.13 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.997 -1.064 . . . . 0.0 109.693 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.3 mt -51.38 -25.74 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 109.601 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.453 ' CD2' HNC1 ' A' ' 199' ' ' RIM . 1.4 mt -74.74 -56.59 4.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.175 -0.953 . . . . 0.0 109.49 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -48.37 -51.3 27.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 109.377 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.75 -53.58 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.235 -0.916 . . . . 0.0 109.105 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.4 tp -46.49 -35.42 5.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.562 -0.711 . . . . 0.0 110.327 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.514 ' OD1' ' NC ' ' A' ' 199' ' ' RIM . 0.2 OUTLIER -79.2 -29.08 42.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.039 -1.038 . . . . 0.0 109.814 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.79 -19.48 57.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 0.0 110.873 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 47' ' ' PHE . 8.5 mt -77.6 -9.22 58.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.556 -1.34 . . . . 0.0 109.347 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.403 ' O ' ' O ' ' A' ' 46' ' ' LEU . 3.0 m-85 -47.41 -90.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 109.225 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 46.57 23.91 0.27 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 109.64 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -66.07 -144.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.495 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.3 m -80.51 141.48 35.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 109.629 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 mt -97.21 -32.19 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.514 -0.741 . . . . 0.0 109.432 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -56.2 -19.12 12.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -72.27 -41.04 67.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -0.987 . . . . 0.0 109.812 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -69.54 -33.3 72.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.088 -1.007 . . . . 0.0 109.377 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -69.7 -45.46 68.22 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.287 -0.883 . . . . 0.0 109.347 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -67.1 -27.05 67.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -69.12 -52.64 26.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.24 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.19 -60.56 8.73 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.1 mt -48.63 147.33 2.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.348 -1.089 . . . . 0.0 109.491 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.7 tttt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.35 179.829 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.51 162.68 28.98 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.279 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' B' ' 26' ' ' LEU . 23.4 Cg_endo -65.82 -28.31 51.18 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.51 2.14 . . . . 0.0 112.224 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' B' ' 25' ' ' PRO . 37.6 tp -45.73 -40.54 9.54 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.34 -44.53 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 71.0 t -49.94 -47.39 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.91 . . . . 0.0 108.774 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.69 78.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.237 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.38 -56.27 15.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -0.875 . . . . 0.0 109.832 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.41 -37.83 76.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -0.945 . . . . 0.0 110.018 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 18.4 mt -69.26 -42.97 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.107 -0.995 . . . . 0.0 109.191 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 mt -56.4 -34.46 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.242 -0.911 . . . . 0.0 108.783 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.33 -43.41 38.44 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 68.1 mt -60.38 -31.94 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.295 -1.12 . . . . 0.0 109.305 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.97 -66.52 0.6 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 109.248 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -44.96 -41.7 7.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 109.924 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.0 tp -62.7 -68.37 0.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.5 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 6.1 mt -46.93 -31.44 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.316 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -60.2 3.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.86 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . 0.404 ' NE1' ' OD2' ' A' ' 44' ' ' ASP . 37.7 t-105 -48.75 -43.94 38.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 109.664 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 25.8 mt -64.53 -40.01 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.99 . . . . 0.0 108.922 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 tp -56.48 -35.76 68.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.571 -0.706 . . . . 0.0 110.368 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.8 -22.98 27.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.071 -1.018 . . . . 0.0 110.382 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.478 ' C ' ' H ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -76.13 -27.97 57.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.912 -1.117 . . . . 0.0 110.517 -179.204 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -51.86 -11.47 0.15 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.6 -1.312 . . . . 0.0 108.99 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.478 ' H ' ' C ' ' B' ' 45' ' ' ARG . 24.6 t80 -67.28 126.45 29.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.493 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -147.95 -90.54 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.92 . . . . 0.0 109.425 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.407 ' O ' ' OG ' ' B' ' 50' ' ' SER . 1.8 pttt -61.85 -149.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.181 -0.949 . . . . 0.0 109.393 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' B' ' 49' ' ' LYS . 48.8 p 45.99 56.67 5.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 109.612 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 12.4 mt -92.74 -28.95 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.263 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.68 -25.6 4.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.403 -0.811 . . . . 0.0 109.788 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.461 ' O ' ' CG ' ' B' ' 57' ' ' HIS . 30.4 mtt180 -68.52 -38.33 80.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.765 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -71.37 -35.15 70.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.027 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -65.8 -53.1 44.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.691 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -65.23 -30.43 71.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.885 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . 0.461 ' CG ' ' O ' ' B' ' 53' ' ' ARG . 1.7 m-70 -68.04 -41.77 81.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.147 -0.971 . . . . 0.0 109.437 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.75 -66.2 1.69 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.74 108.24 6.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -1.144 . . . . 0.0 109.27 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.898 -1.048 . . . . 0.0 109.409 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.62 160.78 32.03 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.171 -0.956 . . . . 0.0 109.407 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' C' ' 26' ' ' LEU . 13.5 Cg_endo -60.05 -23.69 74.07 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.625 2.216 . . . . 0.0 112.2 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' C' ' 25' ' ' PRO . 39.9 tp -45.72 -42.08 11.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.294 -0.878 . . . . 0.0 108.86 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 46.9 t -70.0 -44.16 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.376 -0.828 . . . . 0.0 108.784 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 69.9 t -50.17 -47.63 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 0.0 108.918 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.06 86.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.567 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.62 -55.27 21.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 109.591 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.62 -36.76 67.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 109.83 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 25.9 mt -72.36 -42.64 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.511 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.1 mt -55.01 -34.26 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.12 -0.987 . . . . 0.0 108.805 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.8 -44.05 21.06 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 64.2 mt -58.35 -29.73 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.17 -1.194 . . . . 0.0 109.421 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.15 -59.42 2.75 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.235 -0.915 . . . . 0.0 109.015 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -47.24 -38.84 13.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.703 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.2 tp -68.68 -67.66 0.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.574 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.5 mt -46.09 -28.02 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 0.0 109.418 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 mt -69.95 -60.45 2.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.409 -0.807 . . . . 0.0 109.823 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -47.02 -43.61 19.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 6.4 mt -70.75 -40.44 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.112 -0.992 . . . . 0.0 109.326 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 57.9 tp -60.51 -35.5 76.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.339 -0.851 . . . . 0.0 110.091 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . 0.408 ' OD2' ' NC ' ' C' ' 399' ' ' RIM . 14.7 m-20 -87.54 -19.24 28.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.116 -0.99 . . . . 0.0 110.167 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' C' ' 47' ' ' PHE . 3.7 mmt180 -84.65 -20.88 30.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.027 -1.046 . . . . 0.0 111.119 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' C' ' 45' ' ' ARG . 38.8 mt -46.35 -17.73 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.825 -1.172 . . . . 0.0 109.108 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' C' ' 45' ' ' ARG . 22.6 m-85 -93.08 79.25 4.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.264 -0.897 . . . . 0.0 109.319 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -83.77 -57.36 3.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.33 -0.856 . . . . 0.0 109.476 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -76.94 -139.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.36 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 46.1 m 52.78 61.35 3.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.442 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 61.1 mt -95.33 -26.01 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.865 . . . . 0.0 109.518 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -58.81 -22.72 59.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.267 -0.895 . . . . 0.0 109.835 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . 0.517 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 0.0 OUTLIER -67.37 -42.32 83.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.83 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -71.01 -38.9 72.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.289 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -62.83 -45.97 90.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.28 -0.888 . . . . 0.0 109.071 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -69.15 -27.33 65.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.833 . . . . 0.0 109.62 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . 0.517 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 51.3 m170 -69.39 -38.54 78.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 0.0 109.188 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.6 -59.83 5.01 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mt -72.67 176.04 5.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -1.162 . . . . 0.0 109.496 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . 0.585 ' N ' ' CD ' ' C' ' 60' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.371 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' D' ' 26' ' ' LEU . 7.1 p30 -169.0 68.09 0.67 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.366 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -47.24 -9.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.754 2.302 . . . . 0.0 112.29 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' D' ' 24' ' ' ASP . 33.9 tp -47.48 -46.84 27.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.169 -0.957 . . . . 0.0 108.979 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.72 -45.79 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.262 -0.899 . . . . 0.0 108.728 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 66.2 t -48.45 -48.73 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -0.879 . . . . 0.0 108.881 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.81 -34.92 79.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.37 -0.831 . . . . 0.0 109.305 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.56 -56.37 12.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.0 109.755 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 2.5 m -55.65 -35.04 65.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 109.809 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 16.4 mt -73.89 -42.99 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.155 -0.966 . . . . 0.0 109.586 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 19.4 mt -55.14 -34.7 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.075 -1.016 . . . . 0.0 108.733 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.71 -44.83 37.68 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 56.6 mt -57.21 -35.02 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -1.134 . . . . 0.0 109.026 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -67.11 0.48 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.377 -0.827 . . . . 0.0 108.848 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -47.13 -37.95 10.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.378 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 59.3 tp -61.48 -70.7 0.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.23 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mt -49.35 -24.08 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.921 . . . . 0.0 109.577 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.54 -60.68 2.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -0.891 . . . . 0.0 109.759 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -52.26 -46.54 65.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.092 -1.005 . . . . 0.0 109.53 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 54.9 mt -62.63 -55.02 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.179 -0.95 . . . . 0.0 108.878 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 42.3 tp -47.93 -37.59 14.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.542 -0.724 . . . . 0.0 109.744 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.448 ' OD2' ' NC ' ' D' ' 499' ' ' RIM . 65.7 m-20 -73.72 -28.44 61.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.144 -0.972 . . . . 0.0 109.544 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.37 -20.57 54.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.195 -0.941 . . . . 0.0 110.423 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -80.34 -8.84 59.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.777 -1.202 . . . . 0.0 108.968 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -141.38 100.22 3.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.444 -0.785 . . . . 0.0 109.125 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -151.68 5.68 0.45 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.188 -0.945 . . . . 0.0 109.618 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . 0.403 ' CG ' ' H ' ' D' ' 50' ' ' SER . 43.1 tttt -76.61 -140.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.447 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.403 ' H ' ' CG ' ' D' ' 49' ' ' LYS . 15.3 m 47.37 76.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.872 . . . . 0.0 109.486 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 24.2 mt -99.75 -23.94 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.437 -0.789 . . . . 0.0 109.442 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . 0.401 ' CG ' ' N ' ' D' ' 53' ' ' ARG . 25.6 p90 -57.95 -33.31 68.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.338 -0.851 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . 0.48 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 23.0 ptt180 -65.16 -30.72 71.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -75.12 -34.01 61.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.296 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.9 -44.23 64.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -0.826 . . . . 0.0 109.902 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -72.76 -27.74 62.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.14 -0.975 . . . . 0.0 109.525 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . 0.48 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 0.7 OUTLIER -70.24 -42.52 72.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.913 . . . . 0.0 109.251 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.45 -64.36 2.77 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 1.7 tt -56.43 108.58 0.5 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -1.179 . . . . 0.0 109.551 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.469 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' RIM . . . . . 0.514 ' NC ' ' OD1' ' A' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 299' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 399' ' ' RIM . . . . . 0.408 ' NC ' ' OD2' ' C' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 499' ' ' RIM . . . . . 0.448 ' NC ' ' OD2' ' D' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.547 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.9 p30 -174.18 49.31 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.332 -0.855 . . . . 0.0 109.45 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.7 Cg_endo -55.64 -17.89 18.86 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.813 2.342 . . . . 0.0 112.381 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 22.9 tp -46.25 -43.26 15.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 109.008 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 t -69.34 -45.67 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.328 -0.858 . . . . 0.0 108.888 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.4 t -48.97 -48.5 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.91 . . . . 0.0 109.015 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.95 -35.99 82.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.34 -0.85 . . . . 0.0 109.422 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.02 -56.48 14.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.903 . . . . 0.0 109.737 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -36.82 65.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.236 -0.915 . . . . 0.0 109.923 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.8 mt -72.35 -40.94 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.133 -0.98 . . . . 0.0 109.496 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.1 mt -56.36 -34.12 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.059 -1.025 . . . . 0.0 108.675 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.99 -44.19 24.64 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.7 mt -58.89 -30.86 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.154 -1.204 . . . . 0.0 109.226 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.77 -66.76 0.62 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.286 -0.884 . . . . 0.0 109.059 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -46.12 -37.95 7.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.706 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.2 tp -64.14 -70.24 0.23 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 109.382 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.3 mt -47.32 -35.25 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 0.0 109.693 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mt -63.95 -63.23 1.21 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 109.934 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -45.41 -47.94 13.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.29 -46.77 94.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.395 -0.816 . . . . 0.0 108.916 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.07 -50.02 29.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.582 -0.699 . . . . 0.0 109.327 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.68 -30.78 71.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.392 -0.817 . . . . 0.0 110.289 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -69.25 -26.93 65.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.902 -1.124 . . . . 0.0 110.39 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -71.52 -32.71 68.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.649 -1.282 . . . . 0.0 109.47 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -67.15 -88.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.033 -1.042 . . . . 0.0 109.559 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.2 -168.39 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.1 tttt 48.25 -152.41 0.11 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.142 -0.974 . . . . 0.0 109.271 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.7 p 45.22 59.41 3.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 109.773 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 mt -98.69 -22.95 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 0.0 109.606 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -55.61 -25.3 38.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.971 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.463 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 6.6 ptt180 -67.7 -40.21 84.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.124 -0.985 . . . . 0.0 109.977 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.439 ' N ' ' CG ' ' A' ' 53' ' ' ARG . 54.9 m-85 -71.35 -36.7 71.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.028 -1.045 . . . . 0.0 109.404 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -63.41 -44.74 93.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -0.899 . . . . 0.0 109.219 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -70.28 -28.1 64.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 109.625 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.463 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 20.1 m170 -66.06 -42.29 89.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -0.947 . . . . 0.0 109.272 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.82 -63.4 2.87 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 mt -70.98 119.51 15.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -1.161 . . . . 0.0 109.368 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.4 mttt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.441 -179.949 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' B' ' 26' ' ' LEU . 19.1 t70 50.97 67.36 4.38 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.523 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -46.1 -11.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.673 2.248 . . . . 0.0 112.19 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' B' ' 24' ' ' ASP . 43.6 tp -47.23 -48.25 24.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 108.991 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 45.7 t -67.56 -44.47 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.305 -0.872 . . . . 0.0 108.903 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 77.8 t -49.23 -48.55 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.264 -0.897 . . . . 0.0 109.019 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.7 78.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.912 . . . . 0.0 109.339 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.24 -57.71 6.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 0.0 109.927 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.92 -36.49 62.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 109.806 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 24.0 mt -72.31 -41.63 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 109.424 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 21.9 mt -55.43 -34.82 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.156 -0.965 . . . . 0.0 108.73 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.29 -45.26 31.33 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 47.9 mt -54.97 -37.99 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.199 -1.177 . . . . 0.0 109.496 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.31 -58.31 3.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.173 -0.955 . . . . 0.0 108.818 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -46.8 -41.36 15.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -0.86 . . . . 0.0 109.6 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 51.3 tp -65.78 -70.02 0.26 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.783 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mt -46.57 -26.64 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 109.684 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.484 ' CD2' HNC2 ' B' ' 299' ' ' RIM . 6.0 mt -70.19 -62.82 1.24 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.99 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -48.19 -47.74 35.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.069 -1.02 . . . . 0.0 109.674 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.473 ' O ' ' N ' ' B' ' 45' ' ' ARG . 68.0 mt -63.9 -61.35 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.132 -0.98 . . . . 0.0 109.336 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 60.5 tp -43.74 -42.37 5.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.687 -0.633 . . . . 0.0 109.784 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.496 ' OD2' ' NC ' ' B' ' 299' ' ' RIM . 35.7 m-20 -69.32 -28.97 66.71 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.257 -0.902 . . . . 0.0 109.469 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' B' ' 42' ' ' ILE . 11.0 mmm180 -78.23 -16.69 57.59 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.218 -0.926 . . . . 0.0 110.105 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -88.8 -9.54 51.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.851 -1.156 . . . . 0.0 109.07 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -47.72 -23.89 0.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.64 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . 0.463 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 2.1 t80 -47.91 106.88 0.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.598 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -160.09 -41.03 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 109.558 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.49 121.96 5.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.189 -0.944 . . . . 0.0 109.598 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 mt -102.72 -24.05 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.568 -0.707 . . . . 0.0 109.286 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' B' ' 52' ' ' TYR . 5.8 p90 -52.3 -28.27 18.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . 0.479 ' O ' ' CG ' ' B' ' 57' ' ' HIS . 7.4 mtt-85 -63.02 -42.56 99.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.978 -1.076 . . . . 0.0 109.564 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -68.18 -35.23 77.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 109.392 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.03 -55.73 15.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.127 -0.983 . . . . 0.0 108.951 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -56.83 -32.18 65.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.381 -0.825 . . . . 0.0 109.562 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . 0.479 ' CG ' ' O ' ' B' ' 53' ' ' ARG . 3.2 m-70 -64.3 -61.16 2.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 109.274 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.55 -59.53 9.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mt -80.06 81.53 6.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.364 -1.08 . . . . 0.0 109.658 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.347 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.551 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 2.3 p30 -165.5 48.84 0.2 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 109.406 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 11.0 Cg_endo -57.01 -14.18 13.75 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.808 2.339 . . . . 0.0 112.083 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 33.7 tp -47.34 -44.32 23.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 108.993 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 36.1 t -69.92 -45.16 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.113 -0.992 . . . . 0.0 108.77 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 54.6 t -49.75 -48.53 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 108.977 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.03 -32.99 74.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 109.376 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.96 -54.96 19.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.913 . . . . 0.0 109.698 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' SER . . . . . 0.401 ' H ' ' HG ' ' C' ' 31' ' ' SER . 0.7 OUTLIER -58.36 -37.37 75.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.972 . . . . 0.0 109.937 -179.652 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 20.5 mt -70.74 -42.27 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.107 -0.996 . . . . 0.0 109.118 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 23.1 mt -55.86 -33.67 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.191 -0.943 . . . . 0.0 108.555 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.08 -44.73 28.6 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 55.2 mt -57.26 -31.99 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.188 -1.184 . . . . 0.0 109.422 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.82 -64.28 1.0 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 108.988 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -45.61 -43.11 11.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.372 -0.83 . . . . 0.0 109.717 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 44.4 tp -60.77 -68.67 0.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 109.508 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.0 mt -47.45 -30.7 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.218 -0.926 . . . . 0.0 109.516 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mt -68.86 -65.61 0.68 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -0.949 . . . . 0.0 109.811 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . 0.414 ' CH2' ' NE ' ' C' ' 45' ' ' ARG . 19.5 t-105 -45.16 -49.38 12.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.858 . . . . 0.0 109.882 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 76.0 mt -61.7 -54.44 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.049 -1.032 . . . . 0.0 109.1 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 60.3 tp -47.91 -44.54 29.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 109.567 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' C' ' 44' ' ' ASP . 0.2 OUTLIER -67.33 -27.99 67.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.784 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.414 ' NE ' ' CH2' ' C' ' 41' ' ' TRP . 0.9 OUTLIER -75.98 -24.11 55.34 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.14 -0.975 . . . . 0.0 110.43 -179.428 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.4 mt -79.44 -25.53 41.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.759 -1.213 . . . . 0.0 109.224 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -56.42 95.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 109.733 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -156.96 -59.32 0.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.772 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . 0.429 ' CG ' ' H ' ' C' ' 50' ' ' SER . 21.8 tttp 54.3 -138.17 1.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.109 -0.994 . . . . 0.0 109.066 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' SER . . . . . 0.429 ' H ' ' CG ' ' C' ' 49' ' ' LYS . 1.8 t -78.68 170.94 15.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.102 -0.999 . . . . 0.0 109.036 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 9.9 mt -100.87 -26.23 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 0.0 109.802 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.82 -26.03 5.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.942 . . . . 0.0 110.038 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . 0.496 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 11.2 mmt180 -68.48 -43.79 76.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.938 -1.101 . . . . 0.0 109.735 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . 0.458 ' O ' ' CD1' ' D' ' 51' ' ' ILE . 8.0 m-85 -63.75 -36.98 85.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.928 . . . . 0.0 108.779 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.86 -53.73 51.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.469 -0.769 . . . . 0.0 109.158 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -61.6 -33.01 73.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.437 -0.789 . . . . 0.0 109.545 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 2.6 m-70 -59.44 -58.3 9.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 108.936 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.74 -59.99 7.97 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 49.6 mt -71.95 175.66 5.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.344 -1.092 . . . . 0.0 109.213 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.428 179.853 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.332 0.587 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.98 161.09 47.99 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.305 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' D' ' 26' ' ' LEU . 18.6 Cg_endo -63.1 -24.1 73.29 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.496 2.131 . . . . 0.0 112.1 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' D' ' 25' ' ' PRO . 45.3 tp -45.95 -42.63 13.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 108.675 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.9 t -69.76 -44.17 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.292 -0.88 . . . . 0.0 108.806 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 69.9 t -51.4 -50.74 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.061 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.46 -34.53 77.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.745 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.56 -54.55 22.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 109.664 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 2.5 m -57.23 -35.35 69.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -0.953 . . . . 0.0 109.657 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 13.9 mt -72.93 -44.5 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 0.0 109.377 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 30.8 mt -53.87 -35.42 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.133 -0.98 . . . . 0.0 108.735 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.52 -44.39 41.09 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 65.4 mt -59.34 -43.09 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.241 -1.152 . . . . 0.0 109.208 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.13 -62.64 1.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 109.024 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -45.14 -40.28 6.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.391 -0.818 . . . . 0.0 110.139 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 55.7 tp -65.79 -65.3 0.69 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.115 -0.99 . . . . 0.0 109.571 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 9.8 mt -49.65 -29.48 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.918 . . . . 0.0 109.711 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 6.1 mt -70.09 -56.78 6.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 109.555 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -47.38 -48.37 25.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.307 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 7.2 mt -65.75 -43.3 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.127 -0.983 . . . . 0.0 108.89 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 tp -52.01 -44.63 64.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.428 -0.795 . . . . 0.0 109.921 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.527 ' OD2' ' NC ' ' D' ' 499' ' ' RIM . 99.7 m-20 -76.24 -24.69 54.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 110.239 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.482 ' O ' ' N ' ' D' ' 47' ' ' PHE . 0.0 OUTLIER -88.69 -3.99 58.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 111.071 -178.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' D' ' 45' ' ' ARG . 27.3 mt -33.93 -35.04 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.696 -0.627 . . . . 0.0 110.449 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . 0.482 ' N ' ' O ' ' D' ' 45' ' ' ARG . 1.8 t80 -169.18 131.03 1.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.92 . . . . 0.0 109.276 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -166.57 97.9 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.112 -0.993 . . . . 0.0 109.708 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -160.58 -25.87 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.254 -0.904 . . . . 0.0 109.457 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t -48.02 110.19 0.3 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . 0.458 ' CD1' ' O ' ' C' ' 54' ' ' PHE . 4.1 mt -84.23 -17.81 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.289 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.83 -37.42 70.31 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.201 -0.937 . . . . 0.0 110.862 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . 0.5 ' O ' ' ND1' ' D' ' 57' ' ' HIS . 78.8 mtm180 -78.16 -41.1 35.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.266 -1.521 . . . . 0.0 111.007 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' D' ' 54' ' ' PHE . 8.3 t80 -71.34 -44.84 64.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.079 -1.013 . . . . 0.0 110.542 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.21 -24.29 47.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.036 -1.04 . . . . 0.0 110.792 -178.73 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . 0.572 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 88.3 tt0 -80.14 -28.89 38.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.597 -1.314 . . . . 0.0 108.017 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' D' ' 53' ' ' ARG . 11.8 m170 -70.37 -47.07 62.63 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.78 -61.15 6.76 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.35 140.1 55.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.328 -1.101 . . . . 0.0 109.427 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 57.0 tttm . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.477 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 299' ' ' RIM . . . . . 0.496 ' NC ' ' OD2' ' B' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 399' ' ' RIM . . . . . 0.464 ' NC ' ' CG ' ' C' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 499' ' ' RIM . . . . . 0.527 ' NC ' ' OD2' ' D' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.361 0.601 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 26' ' ' LEU . 8.2 m-20 -162.53 67.5 1.92 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.36 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -47.22 -10.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.904 2.403 . . . . 0.0 112.411 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 24' ' ' ASP . 36.7 tp -46.87 -45.55 20.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.13 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 t -70.21 -45.56 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.93 . . . . 0.0 108.715 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.0 t -48.58 -48.26 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.285 -0.884 . . . . 0.0 108.908 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.58 81.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.381 -0.825 . . . . 0.0 109.309 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.05 -55.48 21.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.337 -0.852 . . . . 0.0 109.729 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.16 -37.0 71.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.966 . . . . 0.0 110.005 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.6 mt -71.58 -42.13 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.145 -0.972 . . . . 0.0 109.438 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 14.8 mt -56.67 -33.29 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.153 -0.967 . . . . 0.0 108.703 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.55 -43.59 29.47 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.0 mt -56.96 -32.23 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.287 -1.125 . . . . 0.0 109.363 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.26 -61.97 1.64 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.136 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -48.6 -39.17 22.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.354 -0.841 . . . . 0.0 109.728 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -66.41 -67.43 0.45 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.919 . . . . 0.0 109.602 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.7 mt -47.3 -27.55 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.529 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mt -67.9 -65.62 0.67 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.272 -0.893 . . . . 0.0 109.823 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.412 ' CH2' ' NE ' ' A' ' 45' ' ' ARG . 24.7 t-105 -48.03 -45.98 32.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.728 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.3 mt -61.6 -54.34 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.157 -0.964 . . . . 0.0 108.894 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.5 tp -47.13 -44.37 21.52 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.579 -0.7 . . . . 0.0 109.638 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.527 ' OD2' ' NC ' ' A' ' 199' ' ' RIM . 1.9 m-20 -69.88 -26.16 64.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.222 -0.923 . . . . 0.0 110.089 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.412 ' NE ' ' CH2' ' A' ' 41' ' ' TRP . 0.2 OUTLIER -77.22 -23.42 51.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.978 -1.076 . . . . 0.0 110.387 -179.513 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.1 mt -77.77 -21.14 52.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.8 -1.188 . . . . 0.0 108.956 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 63.27 154.02 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.908 . . . . 0.0 109.39 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -158.65 43.56 0.27 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -0.876 . . . . 0.0 109.379 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.539 ' CD ' ' H ' ' A' ' 50' ' ' SER . 0.6 OUTLIER -163.34 -148.37 0.13 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 109.156 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.539 ' H ' ' CD ' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -132.85 166.26 22.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 0.0 109.368 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.2 mt -99.33 -44.0 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.38 -0.825 . . . . 0.0 109.642 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.423 ' OH ' ' OG ' ' A' ' 50' ' ' SER . 17.3 p90 -56.35 -24.41 43.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.959 . . . . 0.0 109.495 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -69.13 -44.23 72.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.969 . . . . 0.0 109.287 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -64.3 -29.67 70.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.223 -0.923 . . . . 0.0 109.115 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -72.63 -70.23 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.835 . . . . 0.0 109.332 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -46.23 -28.42 1.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 109.518 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -67.4 -61.98 1.64 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.18 -0.95 . . . . 0.0 109.618 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -50.7 -53.12 26.93 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.0 mt -68.72 100.49 1.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -1.186 . . . . 0.0 109.641 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 tttm . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.369 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.443 ' O ' ' O ' ' B' ' 24' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' B' ' 23' ' ' SER . 0.1 OUTLIER 57.38 160.91 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.344 -0.848 . . . . 0.0 109.445 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.36 -22.18 53.05 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.398 2.066 . . . . 0.0 112.017 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 37.1 tp -46.58 -43.87 17.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 108.653 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.43 -42.54 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.36 -0.837 . . . . 0.0 108.889 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 73.9 t -51.34 -50.19 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 109.018 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.83 85.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.311 -0.868 . . . . 0.0 109.38 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.64 -55.28 24.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.73 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' SER . . . . . 0.41 ' H ' ' HG ' ' B' ' 31' ' ' SER . 0.9 OUTLIER -56.56 -37.0 69.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.714 -179.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 24.5 mt -71.61 -39.74 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.158 -0.963 . . . . 0.0 109.526 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 34.0 mt -58.37 -34.23 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.157 -0.965 . . . . 0.0 108.742 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.88 -41.86 32.19 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 79.4 mt -62.74 -36.46 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.32 -1.106 . . . . 0.0 109.119 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.79 -62.47 1.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.023 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -46.42 -40.59 12.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 109.684 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 59.2 tp -63.19 -70.48 0.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.777 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 8.4 mt -47.0 -33.34 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.485 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mt -64.45 -58.69 5.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.425 -0.797 . . . . 0.0 109.535 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -46.28 -44.79 16.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 109.65 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 11.1 mt -70.53 -33.6 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.117 -0.989 . . . . 0.0 109.446 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 tp -59.11 -43.86 91.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 110.203 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.514 ' OD2' ' NC ' ' B' ' 299' ' ' RIM . 38.5 m-20 -82.54 -22.76 34.84 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 110.514 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -82.05 -16.22 50.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.89 -1.131 . . . . 0.0 111.006 -179.212 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' B' ' 48' ' ' PHE . 21.9 mt -44.58 -19.16 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.904 -1.122 . . . . 0.0 109.472 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' B' ' 45' ' ' ARG . 93.7 t80 -49.77 97.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.122 -0.987 . . . . 0.0 109.355 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . 0.426 ' N ' ' O ' ' B' ' 46' ' ' LEU . 58.6 t80 -168.54 65.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.882 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.439 ' CG ' ' H ' ' B' ' 50' ' ' SER . 14.3 pttt -158.81 -107.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.83 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.439 ' H ' ' CG ' ' B' ' 49' ' ' LYS . 41.4 t -80.76 129.17 34.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 109.957 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 32.8 mt -106.04 -32.09 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.633 -0.667 . . . . 0.0 109.438 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -46.48 -27.78 1.2 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 0.0 109.934 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 43.4 mtt-85 -65.91 -41.93 90.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.119 -0.988 . . . . 0.0 109.69 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -68.4 -33.51 74.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 109.7 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.14 -46.67 76.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.946 . . . . 0.0 109.377 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -69.56 -33.87 73.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.608 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -64.37 -33.62 76.26 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.159 -0.963 . . . . 0.0 108.756 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.04 -63.9 2.01 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mt -55.42 126.34 24.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -1.159 . . . . 0.0 109.105 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.35 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.486 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 67.2 m-20 51.17 52.32 11.89 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.652 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 11.6 Cg_endo -58.36 -16.4 28.61 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.666 2.244 . . . . 0.0 112.254 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 31.4 tp -46.23 -44.44 16.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.214 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 40.4 t -69.16 -44.56 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.258 -0.901 . . . . 0.0 108.907 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -49.6 -49.14 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.153 -0.967 . . . . 0.0 108.96 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.55 -33.07 75.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.863 . . . . 0.0 109.27 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.08 -56.95 8.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 109.669 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.9 -35.46 69.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.887 . . . . 0.0 109.924 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 24.4 mt -72.78 -43.99 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 0.0 109.531 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 26.6 mt -54.83 -35.27 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.16 -0.963 . . . . 0.0 108.792 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.23 -44.75 42.55 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 58.1 mt -57.67 -27.22 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.273 -1.134 . . . . 0.0 109.203 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.93 -67.36 0.68 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.22 -0.925 . . . . 0.0 109.08 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -46.22 -43.17 15.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.491 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.88 -67.49 0.4 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 109.403 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -47.85 -28.75 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.326 -0.858 . . . . 0.0 109.864 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -67.92 -64.28 0.89 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.793 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . 0.519 ' CH2' ' NE ' ' C' ' 45' ' ' ARG . 30.5 t-105 -48.01 -45.58 31.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.22 -0.925 . . . . 0.0 109.634 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 82.7 mt -63.34 -48.53 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.174 -0.954 . . . . 0.0 108.936 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.7 tp -53.42 -33.28 53.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.635 -0.665 . . . . 0.0 110.126 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.3 -25.01 31.92 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.168 -0.958 . . . . 0.0 109.947 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.519 ' NE ' ' CH2' ' C' ' 41' ' ' TRP . 0.1 OUTLIER -75.36 -27.97 59.36 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.087 -1.008 . . . . 0.0 110.493 -179.311 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' C' ' 47' ' ' PHE . 9.8 mt -61.51 -30.71 70.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.612 -1.305 . . . . 0.0 108.946 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.408 ' O ' ' O ' ' C' ' 46' ' ' LEU . 54.8 m-85 -61.22 -111.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.101 -0.999 . . . . 0.0 108.833 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . 0.514 ' CG ' ' O ' ' C' ' 48' ' ' PHE . 8.6 t80 45.77 83.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -0.869 . . . . 0.0 109.667 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . 0.537 ' CD ' ' H ' ' C' ' 50' ' ' SER . 0.2 OUTLIER -85.07 -152.71 0.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.147 -0.97 . . . . 0.0 108.725 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' SER . . . . . 0.537 ' H ' ' CD ' ' C' ' 49' ' ' LYS . 0.2 OUTLIER -60.6 -173.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.84 -1.163 . . . . 0.0 109.436 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 45.5 mt -108.64 -27.66 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.59 -0.694 . . . . 0.0 109.272 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -36.29 70.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.996 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -65.83 -34.83 79.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.076 -1.015 . . . . 0.0 109.559 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -68.49 -35.98 78.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.391 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -69.99 -40.62 75.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.918 . . . . 0.0 109.478 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.48 -25.13 63.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 109.49 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.75 -46.5 45.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.195 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.43 -65.99 2.27 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mt -58.81 118.79 6.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -1.124 . . . . 0.0 109.73 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 11.5 tttm . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.602 -179.974 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 41.7 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' D' ' 24' ' ' ASP . 2.8 p-10 -165.51 68.17 1.21 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -46.14 -11.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.793 2.329 . . . . 0.0 112.34 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' D' ' 24' ' ' ASP . 34.2 tp -47.21 -46.3 23.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 109.212 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 43.9 t -69.48 -44.32 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 108.754 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 78.0 t -49.92 -48.08 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.348 -0.845 . . . . 0.0 109.054 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.2 -34.42 77.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 109.547 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.81 -55.4 17.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.649 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.37 -37.29 69.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.213 -0.929 . . . . 0.0 109.842 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 20.6 mt -71.58 -40.39 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.6 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 26.8 mt -57.71 -35.21 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 0.0 108.795 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.47 -42.69 47.65 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 74.6 mt -62.69 -30.49 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.362 -1.081 . . . . 0.0 109.45 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.53 -60.1 2.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 109.081 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -48.98 -40.57 31.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.959 . . . . 0.0 109.542 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.1 tp -62.9 -68.42 0.34 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.194 -0.942 . . . . 0.0 109.412 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 mt -47.15 -31.77 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.455 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt -68.26 -57.97 5.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.39 -0.819 . . . . 0.0 109.798 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -46.64 -44.52 18.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.403 -0.811 . . . . 0.0 109.621 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mt -72.25 -38.33 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.051 -1.031 . . . . 0.0 109.426 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 44.5 tp -57.85 -41.35 82.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.929 . . . . 0.0 110.106 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -82.64 -24.0 34.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.096 -1.003 . . . . 0.0 109.813 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' D' ' 47' ' ' PHE . 11.9 mmt180 -89.82 -1.66 58.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.171 -0.955 . . . . 0.0 110.83 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . 0.478 ' C ' ' O ' ' D' ' 45' ' ' ARG . 31.4 mt -31.99 -35.77 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.768 -0.583 . . . . 0.0 110.581 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' D' ' 45' ' ' ARG . 88.1 t80 -172.75 7.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.525 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.51 113.55 0.72 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.564 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -163.54 -37.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.377 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 44.5 m -54.53 134.94 46.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -0.85 . . . . 0.0 109.634 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 8.7 mt -104.06 -26.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.656 -0.652 . . . . 0.0 109.379 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -47.64 -42.05 23.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.871 . . . . 0.0 109.89 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -45.74 72.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 0.0 109.712 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -62.46 -36.48 82.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 109.591 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -63.27 -66.67 0.51 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.435 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -45.86 -34.91 4.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.347 -0.846 . . . . 0.0 109.863 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -63.55 -60.99 2.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.129 -0.982 . . . . 0.0 109.522 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -47.51 -59.77 5.71 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mt -70.11 118.53 13.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.274 -1.133 . . . . 0.0 109.577 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 24.1 mttm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.573 179.893 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' RIM . . . . . 0.527 ' NC ' ' OD2' ' A' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 299' ' ' RIM . . . . . 0.514 ' NC ' ' OD2' ' B' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 399' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 499' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -168.15 70.55 0.85 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.283 -0.886 . . . . 0.0 109.473 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.83 -11.85 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.66 2.24 . . . . 0.0 112.192 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 46.1 tp -47.96 -47.16 32.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.13 -0.981 . . . . 0.0 108.899 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.0 t -67.93 -44.22 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.321 -0.862 . . . . 0.0 108.878 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.9 t -49.34 -50.66 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 108.951 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.39 80.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.406 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.32 -57.41 9.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.654 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.21 -36.08 63.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 110.013 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.6 mt -73.12 -41.51 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.006 . . . . 0.0 109.703 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.27 -36.68 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.987 -1.07 . . . . 0.0 108.641 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.38 -44.28 42.77 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.9 mt -56.31 -39.05 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.03 -1.276 . . . . 0.0 109.387 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.83 -54.64 14.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.126 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -48.61 -42.88 35.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.838 . . . . 0.0 109.881 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.2 tp -67.16 -65.47 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 109.684 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.9 mt -46.65 -27.41 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 109.43 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.436 ' CD2' ' NC ' ' A' ' 199' ' ' RIM . 1.9 mt -69.48 -61.8 1.64 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.383 -0.823 . . . . 0.0 109.727 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.659 ' HE1' HNC1 ' D' ' 499' ' ' RIM . 55.8 t-105 -47.84 -46.04 30.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 0.0 109.413 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.2 mt -64.17 -55.7 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.197 -0.939 . . . . 0.0 109.135 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.2 tp -45.27 -43.7 10.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.583 -0.698 . . . . 0.0 110.313 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.04 -27.63 54.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.034 -1.041 . . . . 0.0 110.556 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -72.47 -22.24 61.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.793 -1.192 . . . . 0.0 110.487 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.3 mt -68.64 -12.06 60.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.657 -1.277 . . . . 0.0 108.986 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -82.5 137.86 34.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.331 -0.856 . . . . 0.0 109.183 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -151.07 174.9 12.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.148 -0.97 . . . . 0.0 109.513 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.429 ' CG ' ' H ' ' A' ' 50' ' ' SER . 15.3 tttp 47.37 -143.28 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.364 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.429 ' H ' ' CG ' ' A' ' 49' ' ' LYS . 18.8 p 51.48 42.25 29.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.478 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 mt -80.67 -31.02 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 109.158 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.557 ' CG ' ' N ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -46.08 -42.69 13.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.789 . . . . 0.0 109.887 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.557 ' N ' ' CG ' ' A' ' 52' ' ' TYR . 1.2 mtp180 -50.61 -61.84 1.95 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 0.0 110.665 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -70.63 -26.58 63.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.885 -1.134 . . . . 0.0 110.061 -179.076 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -46.41 80.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.904 -1.122 . . . . 0.0 109.371 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -76.39 -27.5 56.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.673 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -61.97 -50.56 71.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.211 -0.93 . . . . 0.0 109.317 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.81 -59.51 3.7 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.9 mt -64.53 -167.85 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -1.169 . . . . 0.0 109.853 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.054 -0.975 . . . . 0.0 109.421 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 92.0 p . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.517 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 6.0 m-20 -153.61 50.4 0.57 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 109.532 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 11.7 Cg_endo -57.97 -14.47 18.66 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.793 2.329 . . . . 0.0 112.066 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 33.3 tp -46.17 -45.82 16.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.36 -0.837 . . . . 0.0 109.255 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 36.0 t -69.19 -44.72 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.24 -0.913 . . . . 0.0 108.927 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 72.5 t -49.18 -49.11 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 109.096 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.73 -33.73 76.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.289 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.86 -56.8 9.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.337 -0.852 . . . . 0.0 109.825 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.83 -37.2 70.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.877 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 33.4 mt -71.25 -41.22 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.058 -1.026 . . . . 0.0 109.499 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 24.0 mt -57.08 -34.14 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 108.559 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.11 -43.94 24.82 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 53.9 mt -56.11 -35.29 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.177 -1.19 . . . . 0.0 109.235 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -61.53 1.73 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.22 -0.925 . . . . 0.0 109.073 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . 0.455 ' NE2' ' ND1' ' C' ' 37' ' ' HIS . 1.8 t-80 -46.83 -41.91 16.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 109.771 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -62.3 -69.75 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.166 -0.959 . . . . 0.0 109.591 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.3 mt -46.11 -38.26 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.34 -0.85 . . . . 0.0 109.36 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mt -59.37 -62.4 1.91 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.45 -0.781 . . . . 0.0 109.967 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -44.99 -49.38 11.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.424 -0.798 . . . . 0.0 109.649 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 34.1 mt -59.79 -48.61 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.12 -0.988 . . . . 0.0 108.52 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.62 -57.41 4.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.55 -0.719 . . . . 0.0 109.453 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.0 -31.34 68.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.848 . . . . 0.0 110.41 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.438 ' CA ' ' HE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -71.92 -23.43 61.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.873 -1.142 . . . . 0.0 110.471 -179.198 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.0 mt -75.93 -34.01 59.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.699 -1.251 . . . . 0.0 108.887 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -48.42 101.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.912 . . . . 0.0 109.435 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -163.5 -3.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 10.8 mtmm -67.21 -118.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.55 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 10.3 p -53.18 104.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.324 -0.86 . . . . 0.0 109.718 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 11.4 mt -102.21 -24.85 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.479 -0.763 . . . . 0.0 109.17 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -54.46 -24.94 22.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.854 . . . . 0.0 109.748 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 -65.87 -38.77 89.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.522 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -71.01 -36.65 72.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 109.166 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -69.46 -46.77 65.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.405 -0.809 . . . . 0.0 109.162 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -64.02 -27.88 69.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 108.933 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -69.38 -46.63 66.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.403 -0.811 . . . . 0.0 109.545 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.0 -61.22 6.0 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 73.0 mt -60.86 -178.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -1.127 . . . . 0.0 109.808 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.436 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' SER . . . . . 0.545 ' HG ' ' H ' ' C' ' 24' ' ' ASP . 2.9 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.545 ' H ' ' HG ' ' C' ' 23' ' ' SER . 20.2 t0 -168.94 65.38 0.6 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.899 . . . . 0.0 109.463 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -45.18 -11.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.749 2.299 . . . . 0.0 112.14 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' C' ' 24' ' ' ASP . 22.2 tp -47.69 -46.33 29.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.144 -0.972 . . . . 0.0 109.107 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 41.5 t -68.15 -44.93 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.213 -0.929 . . . . 0.0 108.581 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.2 t -50.03 -49.39 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.334 -0.854 . . . . 0.0 108.788 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.28 -30.19 71.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.355 -0.841 . . . . 0.0 109.288 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.96 -56.83 6.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.0 109.602 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.31 -36.97 66.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.947 . . . . 0.0 109.525 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 36.3 mt -72.71 -42.5 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.16 -0.963 . . . . 0.0 109.412 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 20.3 mt -55.88 -34.33 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.122 -0.986 . . . . 0.0 108.629 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.26 -45.33 31.28 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 65.4 mt -58.38 -34.66 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.277 -1.131 . . . . 0.0 108.993 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.98 -67.89 0.41 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 108.908 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . 0.455 ' ND1' ' NE2' ' B' ' 37' ' ' HIS . 4.3 t-80 -45.83 -36.82 5.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.813 . . . . 0.0 109.656 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.89 -69.61 0.28 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 109.517 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 7.9 mt -48.11 -30.12 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 109.751 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt -68.1 -63.56 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.109 -0.995 . . . . 0.0 109.718 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 -44.45 -48.69 10.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.338 -0.851 . . . . 0.0 110.06 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.89 -58.28 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.046 -1.034 . . . . 0.0 109.108 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 54.1 tp -45.12 -40.19 6.72 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.533 -0.73 . . . . 0.0 109.99 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . 0.46 ' CG ' ' NC ' ' C' ' 399' ' ' RIM . 0.4 OUTLIER -73.18 -28.39 62.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 109.638 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.423 ' HE ' ' CA ' ' C' ' 45' ' ' ARG . 0.0 OUTLIER -76.55 -18.76 58.51 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.212 -0.93 . . . . 0.0 110.196 -179.57 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' C' ' 47' ' ' PHE . 8.3 mt -83.93 -31.18 25.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.797 -1.189 . . . . 0.0 108.885 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.464 ' C ' ' CG ' ' C' ' 48' ' ' PHE . 2.4 m-85 -52.92 -174.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 109.652 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . 0.464 ' CG ' ' C ' ' C' ' 47' ' ' PHE . 0.8 OUTLIER 67.02 -66.51 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 0.0 109.811 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' C' ' 47' ' ' PHE . 10.8 tttp 52.33 -93.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.353 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' SER . . . . . 0.451 ' N ' ' O ' ' C' ' 48' ' ' PHE . 68.1 m -63.27 148.41 48.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.136 -0.977 . . . . 0.0 109.389 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 11.6 mt -103.31 -27.55 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.562 -0.711 . . . . 0.0 109.697 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -52.88 -18.66 2.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.934 . . . . 0.0 109.715 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . 0.49 ' O ' ' CD2' ' C' ' 57' ' ' HIS . 9.5 mtp180 -72.64 -42.16 64.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.865 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.7 -38.03 83.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.935 . . . . 0.0 109.37 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -64.15 -59.3 4.59 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.352 -0.843 . . . . 0.0 109.249 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -55.88 -29.4 59.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.547 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . 0.49 ' CD2' ' O ' ' C' ' 53' ' ' ARG . 10.9 m170 -69.01 -52.89 24.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.204 -0.935 . . . . 0.0 109.312 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.16 -63.93 4.0 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.71 105.17 3.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -1.187 . . . . 0.0 109.108 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.396 179.947 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.526 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 2.8 m-20 -155.81 49.85 0.45 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.527 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 11.0 Cg_endo -57.65 -7.13 2.86 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.768 2.312 . . . . 0.0 112.138 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 33.7 tp -49.23 -48.8 45.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 108.924 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 98.5 t -67.11 -44.87 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 108.724 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 73.5 t -48.67 -50.03 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 108.974 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.75 -33.8 76.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -0.856 . . . . 0.0 109.173 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.25 -57.55 8.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 109.635 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.35 -35.86 65.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.189 -0.944 . . . . 0.0 109.949 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 21.8 mt -72.94 -42.45 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.123 -0.985 . . . . 0.0 109.485 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 mt -55.04 -35.85 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.974 -1.079 . . . . 0.0 108.573 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.67 -45.14 46.4 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 57.9 mt -56.79 -37.74 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -1.171 . . . . 0.0 109.129 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' D' ' 37' ' ' HIS . 0.7 OUTLIER -66.4 -68.47 0.37 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.902 . . . . 0.0 109.342 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' D' ' 36' ' ' LEU . 1.6 t-80 -42.76 -33.18 0.7 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.438 -0.789 . . . . 0.0 110.161 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.3 tp -70.36 -71.21 0.25 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.947 . . . . 0.0 109.672 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mt -49.16 -29.4 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 109.498 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.64 -59.66 2.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.457 -0.777 . . . . 0.0 109.648 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 17.0 t-105 -45.1 -54.28 6.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.71 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.62 -46.45 79.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.204 -0.935 . . . . 0.0 108.867 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.53 -48.77 14.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.588 -0.695 . . . . 0.0 109.722 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.503 ' OD1' ' NC ' ' D' ' 499' ' ' RIM . 0.7 OUTLIER -66.97 -33.87 76.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -0.873 . . . . 0.0 110.184 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -68.34 -23.86 64.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.091 -1.006 . . . . 0.0 110.577 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -75.82 -34.37 60.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.663 -1.273 . . . . 0.0 109.089 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -52.58 115.78 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.4 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -172.11 132.77 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 0.0 109.486 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . 0.418 ' O ' ' OG ' ' D' ' 50' ' ' SER . 6.8 ttpt -154.27 -42.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 109.708 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' D' ' 49' ' ' LYS . 4.5 m -165.77 159.18 15.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.655 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 9.2 mt -103.97 -25.27 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.613 -0.679 . . . . 0.0 109.369 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -52.01 -19.04 1.63 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.328 -0.857 . . . . 0.0 109.852 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -71.63 -41.03 69.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.069 -1.019 . . . . 0.0 109.682 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -70.71 -32.48 69.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.096 -1.003 . . . . 0.0 109.148 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -68.37 -42.84 78.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.265 -0.897 . . . . 0.0 109.401 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -72.73 -28.2 62.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.287 -0.883 . . . . 0.0 109.288 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -66.21 -44.3 84.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 108.761 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.33 -63.36 3.81 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.5 125.62 24.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.349 -1.089 . . . . 0.0 109.233 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 61.2 mttt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.889 -1.053 . . . . 0.0 109.425 -179.906 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' RIM . . . . . 0.436 ' NC ' ' CD2' ' A' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 299' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 399' ' ' RIM . . . . . 0.46 ' NC ' ' CG ' ' C' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 499' ' ' RIM . . . . . 0.659 HNC1 ' HE1' ' A' ' 41' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.8 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 26' ' ' LEU . 1.3 m-20 49.32 69.29 2.78 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.451 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -47.99 -8.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.928 2.418 . . . . 0.0 112.476 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.469 ' H ' ' C ' ' A' ' 24' ' ' ASP . 36.4 tp -48.46 -47.48 38.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.099 -1.001 . . . . 0.0 108.923 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.2 t -67.54 -45.03 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.0 108.639 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.0 t -49.28 -46.8 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.5 81.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.241 -0.912 . . . . 0.0 109.228 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.64 -56.67 10.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 0.0 109.682 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -36.41 64.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.26 -0.9 . . . . 0.0 109.738 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.0 mt -72.7 -41.98 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 109.565 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 mt -56.13 -35.52 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.099 -1.001 . . . . 0.0 108.786 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.85 -44.99 45.48 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.3 mt -59.16 -33.9 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 121.297 -1.119 . . . . 0.0 109.376 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.56 -66.13 0.61 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.389 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -44.4 -45.39 8.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.325 -0.859 . . . . 0.0 110.235 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.5 tp -59.05 -66.07 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.097 -1.002 . . . . 0.0 109.598 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mt -48.8 -47.51 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.165 -0.96 . . . . 0.0 109.626 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 mt -56.45 -55.18 36.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 110.13 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -48.54 -49.54 35.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.038 -1.039 . . . . 0.0 109.691 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.3 mt -60.6 -57.27 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.244 -0.91 . . . . 0.0 109.126 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.0 tp -50.3 -21.56 1.44 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.675 -0.64 . . . . 0.0 110.247 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.415 ' CG ' HNC1 ' A' ' 199' ' ' RIM . 39.3 m-20 -90.77 -26.73 19.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.971 . . . . 0.0 110.009 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.65 ' NE ' HNC1 ' D' ' 499' ' ' RIM . 43.9 mtp85 -81.63 -21.87 37.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.163 -0.96 . . . . 0.0 110.721 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -69.16 -31.8 70.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.667 -1.271 . . . . 0.0 108.91 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -98.1 124.35 42.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.433 -0.792 . . . . 0.0 109.212 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -168.44 -8.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.143 -0.973 . . . . 0.0 109.878 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.545 ' CG ' ' H ' ' A' ' 50' ' ' SER . 1.3 tpmt? -72.95 -149.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.176 -0.953 . . . . 0.0 109.312 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.545 ' H ' ' CG ' ' A' ' 49' ' ' LYS . 59.0 p 46.33 71.61 0.29 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.56 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.7 mt -94.45 -25.16 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.559 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -61.23 -26.18 67.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 109.466 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -68.62 -37.6 79.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.079 -1.013 . . . . 0.0 109.359 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -74.19 -41.29 61.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.151 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -62.34 -42.98 99.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.335 -0.853 . . . . 0.0 109.405 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -73.61 -26.34 60.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.185 -0.947 . . . . 0.0 109.276 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.476 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 12.3 t-80 -69.91 -31.19 68.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.17 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.32 -63.68 1.77 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mt -57.94 112.13 1.39 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -1.183 . . . . 0.0 109.234 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.593 -179.869 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' B' ' 24' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.552 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 23.9 m-20 -151.34 49.27 0.56 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.462 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 9.8 Cg_endo -56.16 -10.96 5.09 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.724 2.282 . . . . 0.0 112.02 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 28.6 tp -47.01 -47.24 22.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.063 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 41.0 t -67.69 -45.3 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.887 . . . . 0.0 108.937 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -48.79 -48.9 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 108.994 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.43 -33.46 75.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.4 -0.813 . . . . 0.0 109.184 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.91 -58.01 6.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.675 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -55.22 -35.5 64.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.797 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 36.8 mt -73.45 -41.26 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.121 -0.987 . . . . 0.0 109.745 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 24.1 mt -55.98 -35.41 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.992 -1.068 . . . . 0.0 108.661 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.76 -45.4 34.79 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mt -55.26 -30.58 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.23 -1.159 . . . . 0.0 109.096 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.07 -65.64 0.82 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.228 -0.92 . . . . 0.0 109.055 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -46.48 -34.87 5.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.619 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.75 -71.24 0.22 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 109.469 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.9 mt -46.78 -37.41 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.324 -0.86 . . . . 0.0 109.397 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.7 tt -58.92 -62.91 1.53 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.489 -0.757 . . . . 0.0 109.662 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 10.9 t-105 -47.41 -52.44 16.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.828 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 57.0 mt -55.02 -48.19 76.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.989 -1.069 . . . . 0.0 108.681 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.11 -50.63 11.0 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.39 0.614 . . . . 0.0 109.476 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.469 ' CG ' HH11 ' C' ' 45' ' ' ARG . 37.7 m-20 -62.16 -32.68 73.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.342 -0.849 . . . . 0.0 109.521 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.507 ' CA ' ' HE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -72.39 -20.52 61.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.115 -0.99 . . . . 0.0 110.183 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -85.83 -34.3 21.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.699 -1.251 . . . . 0.0 108.961 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . 0.491 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 59.1 t80 -59.01 96.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.286 -0.884 . . . . 0.0 109.378 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' B' ' 47' ' ' PHE . 8.5 m-85 -165.9 97.82 0.64 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.688 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -150.41 -80.9 0.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.935 . . . . 0.0 109.552 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 16.4 m -80.4 106.14 12.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.937 . . . . 0.0 109.548 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 13.7 mt -92.29 -23.48 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.897 . . . . 0.0 109.562 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.428 ' CD1' ' C ' ' B' ' 52' ' ' TYR . 1.4 p90 -64.64 -17.09 63.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 109.214 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -43.87 64.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 109.783 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -68.63 -32.93 73.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.511 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -70.66 -44.3 67.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.692 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.99 -29.39 68.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 109.512 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -68.67 -47.79 65.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.877 . . . . 0.0 109.177 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.0 -64.31 3.48 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.22 120.63 8.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.292 -1.122 . . . . 0.0 109.469 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.485 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 74.0 m . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.297 0.57 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' C' ' 26' ' ' LEU . 25.4 t0 55.27 66.81 3.55 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.508 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -46.51 -11.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.717 2.278 . . . . 0.0 111.974 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' C' ' 24' ' ' ASP . 40.5 tp -47.49 -45.04 25.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.423 -0.798 . . . . 0.0 109.059 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 51.5 t -69.85 -45.19 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 108.755 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 78.9 t -48.45 -48.22 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -0.865 . . . . 0.0 108.846 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.5 -35.45 80.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.355 -0.841 . . . . 0.0 109.107 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.29 -57.36 10.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.46 -0.775 . . . . 0.0 109.851 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -56.42 -35.71 68.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.757 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.4 mt -71.47 -39.76 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.114 -0.991 . . . . 0.0 109.355 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 32.2 mt -58.15 -35.14 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.012 -1.055 . . . . 0.0 108.423 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.64 -45.15 54.86 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 75.3 mt -61.69 -23.06 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.298 -1.119 . . . . 0.0 108.73 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.1 -70.83 0.39 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.385 -0.822 . . . . 0.0 109.404 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -45.36 -37.05 4.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.312 -0.868 . . . . 0.0 109.676 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.93 -68.05 0.37 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 0.0 109.412 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 5.4 mt -51.98 -27.69 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.947 . . . . 0.0 109.584 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . 0.437 ' CD2' HNC1 ' C' ' 399' ' ' RIM . 0.5 OUTLIER -70.22 -61.49 1.76 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 0.0 109.598 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -46.91 -43.75 19.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 109.646 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 64.6 mt -67.68 -40.05 83.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.261 -0.899 . . . . 0.0 109.249 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 57.6 tp -58.68 -36.35 74.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.577 -0.702 . . . . 0.0 110.217 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -86.4 -20.44 28.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.106 -0.997 . . . . 0.0 110.158 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.469 HH11 ' CG ' ' B' ' 44' ' ' ASP . 1.6 mmp_? -78.45 -27.23 46.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.952 -1.093 . . . . 0.0 110.549 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -52.14 -12.9 0.27 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.563 -1.336 . . . . 0.0 108.864 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . 0.447 ' H ' ' C ' ' C' ' 45' ' ' ARG . 53.6 m-85 -93.13 101.75 14.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.887 . . . . 0.0 109.724 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -168.23 -20.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 0.0 109.559 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.74 -70.25 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.166 -0.959 . . . . 0.0 109.369 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 64.0 p -68.49 110.88 4.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.174 -0.954 . . . . 0.0 109.365 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 11.2 mt -105.95 -25.17 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.576 -0.703 . . . . 0.0 109.803 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -28.29 23.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.93 . . . . 0.0 109.752 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -65.91 -42.79 89.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 0.0 109.817 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -64.96 -34.96 79.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.309 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -63.69 -59.53 4.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.338 -0.851 . . . . 0.0 109.227 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -54.72 -31.01 57.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 109.732 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -65.73 -42.96 90.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -0.976 . . . . 0.0 109.335 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.13 -61.5 5.13 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 54.0 mt -74.91 156.8 35.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -1.147 . . . . 0.0 109.591 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.377 179.968 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.237 0.542 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' D' ' 26' ' ' LEU . 1.5 m-20 51.0 66.97 4.75 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.93 . . . . 0.0 109.617 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -46.44 -10.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.785 2.323 . . . . 0.0 112.353 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' D' ' 24' ' ' ASP . 26.3 tp -47.26 -45.89 24.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 109.079 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 39.0 t -69.29 -45.14 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.1 t -49.4 -48.92 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 108.78 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.93 -32.88 74.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.341 -0.85 . . . . 0.0 109.184 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.3 -56.89 10.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.388 -0.82 . . . . 0.0 109.741 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -56.1 -36.34 68.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.783 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.07 -40.54 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.114 -0.991 . . . . 0.0 109.395 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 25.0 mt -57.18 -34.06 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.124 -0.985 . . . . 0.0 108.543 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.46 -44.52 27.01 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 61.7 mt -57.9 -29.5 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.152 -1.204 . . . . 0.0 109.022 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.48 -66.62 0.67 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.427 -0.796 . . . . 0.0 109.252 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -46.53 -39.92 11.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.834 . . . . 0.0 109.927 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.7 -67.54 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.064 -1.022 . . . . 0.0 109.757 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mt -48.85 -40.48 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.152 -0.968 . . . . 0.0 109.541 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 tt -55.79 -55.4 32.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.844 . . . . 0.0 109.915 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -53.06 -48.69 67.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.074 -1.016 . . . . 0.0 110.077 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 68.2 mt -60.18 -49.48 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.107 -0.996 . . . . 0.0 109.152 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 tp -49.37 -40.29 35.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.497 -0.752 . . . . 0.0 110.093 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -74.01 -27.65 61.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.206 -0.934 . . . . 0.0 109.808 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.404 HH21 ' CE1' ' C' ' 399' ' ' RIM . 4.3 mmm180 -74.65 -24.25 58.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 110.494 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -74.48 -9.5 58.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.68 -1.262 . . . . 0.0 109.086 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -142.84 89.24 2.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.453 -0.779 . . . . 0.0 109.466 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . 0.415 ' O ' ' O ' ' D' ' 49' ' ' LYS . 2.7 t80 -151.76 -3.96 0.27 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 0.0 109.515 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' D' ' 48' ' ' PHE . 4.1 mtmt -63.02 -134.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.413 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.489 ' HG ' HH11 ' D' ' 53' ' ' ARG . 21.3 t 51.36 79.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 109.521 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 47.8 mt -95.74 -37.58 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.845 . . . . 0.0 109.334 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . 0.521 ' CD2' ' N ' ' D' ' 53' ' ' ARG . 21.2 p90 -52.23 -43.96 64.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.107 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . 0.521 ' N ' ' CD2' ' D' ' 52' ' ' TYR . 0.9 OUTLIER -62.84 -18.07 62.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 108.844 179.32 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -69.32 -46.86 66.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.367 -0.833 . . . . 0.0 109.128 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 1.1 m-85 -74.18 -52.96 10.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.062 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -49.2 -35.11 16.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.423 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . 0.496 ' CD2' ' O ' ' D' ' 53' ' ' ARG . 12.4 m170 -70.64 -57.69 4.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 109.642 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -50.46 -56.98 11.18 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 4.7 mt -70.91 124.01 23.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -1.127 . . . . 0.0 109.492 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 35.3 tttm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.461 179.834 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' RIM . . . . . 0.415 HNC1 ' CG ' ' A' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 299' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 399' ' ' RIM . . . . . 0.437 HNC1 ' CD2' ' C' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 499' ' ' RIM . . . . . 0.65 HNC1 ' NE ' ' A' ' 45' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 46.97 70.21 2.22 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.535 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.66 -11.16 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.638 2.225 . . . . 0.0 112.439 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.2 tp -47.43 -47.88 26.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.039 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.9 -44.99 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -0.841 . . . . 0.0 108.824 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -49.38 -47.76 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.269 -0.895 . . . . 0.0 108.718 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.36 83.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.622 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.33 -53.7 39.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -0.915 . . . . 0.0 109.61 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -37.3 71.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.794 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.4 mt -72.29 -41.52 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.144 -0.972 . . . . 0.0 109.563 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.3 mt -56.88 -35.2 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.013 -1.055 . . . . 0.0 108.693 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.5 -42.98 46.5 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.2 mt -62.18 -27.17 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.336 -1.097 . . . . 0.0 109.148 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.92 -63.63 1.13 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.363 -0.835 . . . . 0.0 108.982 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -45.8 -40.64 9.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 0.0 109.94 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -64.3 -67.66 0.41 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.587 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.2 mt -47.36 -35.63 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.279 -0.888 . . . . 0.0 109.106 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 43' ' ' LEU . 2.5 mt -62.34 -61.61 2.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.615 -0.678 . . . . 0.0 109.682 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -43.3 -46.46 6.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.613 -0.679 . . . . 0.0 109.796 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.3 mt -71.88 -28.05 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 108.985 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 40' ' ' LEU . 6.6 tp -63.75 -41.93 97.93 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.274 -0.891 . . . . 0.0 109.907 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -83.95 -23.59 31.04 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.293 -0.88 . . . . 0.0 109.813 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' PHE . 8.4 mmt85 -95.47 3.17 54.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.252 -0.905 . . . . 0.0 110.865 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.488 ' C ' ' O ' ' A' ' 45' ' ' ARG . 34.4 mt -31.17 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.783 -0.573 . . . . 0.0 110.816 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 45' ' ' ARG . 2.2 m-85 -171.9 -170.86 0.81 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.114 -0.991 . . . . 0.0 109.74 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.528 ' O ' ' N ' ' A' ' 50' ' ' SER . 3.3 p90 -137.88 -1.93 1.96 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.467 -0.77 . . . . 0.0 109.552 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp 47.99 -91.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.88 . . . . 0.0 109.525 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -148.13 177.63 9.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -0.882 . . . . 0.0 109.43 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 mt -102.35 -24.29 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.491 -0.756 . . . . 0.0 109.489 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -52.63 -21.35 3.84 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.223 -0.923 . . . . 0.0 109.448 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -67.47 -43.48 80.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.36 -0.837 . . . . 0.0 109.9 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -69.98 -39.55 75.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.973 . . . . 0.0 109.371 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -55.01 -51.5 66.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.348 -0.845 . . . . 0.0 109.641 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -71.23 -25.11 62.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.31 -0.869 . . . . 0.0 109.794 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -67.44 -37.59 83.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 0.0 109.611 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.25 -62.83 1.77 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.4 mt -72.26 84.85 1.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -1.215 . . . . 0.0 109.622 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 pttt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.421 179.804 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 34.6 p . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' B' ' 26' ' ' LEU . 5.7 m-20 -149.42 64.88 7.54 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.589 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -44.54 -9.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.972 2.448 . . . . 0.0 112.524 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' B' ' 24' ' ' ASP . 42.7 tp -47.34 -46.13 25.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.123 -0.985 . . . . 0.0 109.261 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 35.1 t -68.14 -45.13 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 108.924 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 78.2 t -48.38 -47.65 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.877 . . . . 0.0 109.138 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.54 -37.45 86.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.35 -0.844 . . . . 0.0 109.4 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.07 -55.9 21.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 109.569 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' SER . . . . . 0.427 ' H ' ' HG ' ' B' ' 31' ' ' SER . 2.1 m -56.31 -34.74 66.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 109.887 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.41 HG23 HD12 ' B' ' 32' ' ' ILE . 5.2 mt -72.83 -43.48 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.14 -0.975 . . . . 0.0 109.323 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 11.7 mt -54.59 -35.3 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.067 -1.02 . . . . 0.0 108.547 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.59 -44.18 50.4 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 59.3 mt -59.3 -34.67 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.269 -1.136 . . . . 0.0 109.468 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.33 -67.77 0.47 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -0.962 . . . . 0.0 109.226 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -44.29 -34.08 1.81 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.47 -0.768 . . . . 0.0 109.788 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 54.8 tp -70.18 -70.44 0.29 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 14.2 mt -47.24 -24.02 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.216 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.7 tt -71.76 -63.48 1.12 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 109.688 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 16.6 t-105 -48.65 -47.03 40.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.558 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 82.2 mt -57.11 -44.68 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.93 -54.47 9.99 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.496 0.665 . . . . 0.0 109.38 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.456 ' CG ' HH11 ' C' ' 45' ' ' ARG . 59.2 m-20 -61.82 -29.5 70.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.552 -0.717 . . . . 0.0 110.338 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -73.35 -24.32 60.33 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.949 -1.094 . . . . 0.0 110.871 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -75.0 -8.58 56.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.605 -1.309 . . . . 0.0 109.577 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -143.11 117.87 9.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.324 -0.86 . . . . 0.0 109.664 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -156.3 -3.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -0.873 . . . . 0.0 109.362 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -71.23 -146.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.601 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.513 ' O ' ' CE2' ' B' ' 54' ' ' PHE . 0.7 OUTLIER 46.92 72.27 0.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.364 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 22.1 mt -100.33 -24.42 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.405 -0.81 . . . . 0.0 109.532 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -70.79 -16.51 62.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.175 -0.953 . . . . 0.0 109.449 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -45.18 56.34 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . 0.513 ' CE2' ' O ' ' B' ' 50' ' ' SER . 4.6 m-85 -69.23 -30.96 69.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.349 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -69.49 -45.36 69.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 109.078 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -72.98 -29.18 62.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -0.858 . . . . 0.0 109.421 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -64.36 -60.04 3.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.232 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.98 -55.13 31.93 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.36 95.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.349 -1.089 . . . . 0.0 109.209 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 tttt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.459 -179.826 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' C' ' 26' ' ' LEU . 0.9 OUTLIER 50.9 70.37 2.04 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -47.36 -7.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.631 2.22 . . . . 0.0 112.313 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . 0.509 ' H ' ' C ' ' C' ' 24' ' ' ASP . 41.9 tp -49.31 -45.61 45.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.088 -1.007 . . . . 0.0 109.093 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.97 -45.53 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.067 -1.021 . . . . 0.0 108.534 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.5 t -49.28 -46.7 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.52 75.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.87 . . . . 0.0 109.285 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.07 -56.47 11.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.387 -0.82 . . . . 0.0 109.556 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.68 -37.27 68.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 109.559 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 12.2 mt -70.75 -40.34 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.517 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 26.2 mt -58.44 -35.31 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.054 -1.029 . . . . 0.0 108.79 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.56 -43.73 67.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.47 -27.19 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.45 -1.03 . . . . 0.0 108.999 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.5 tp -68.8 -68.89 0.36 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.0 109.111 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . 0.598 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 1.8 t-80 -45.97 -43.0 13.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 110.048 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 49.1 tp -58.39 -65.19 0.69 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.124 -0.985 . . . . 0.0 109.709 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.404 HD13 HG23 ' C' ' 39' ' ' ILE . 4.1 mt -49.09 -31.87 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.954 . . . . 0.0 109.523 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -70.31 -59.46 2.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.923 . . . . 0.0 110.277 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -48.83 -46.17 41.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.997 -1.064 . . . . 0.0 109.908 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 69.6 mt -64.88 -48.89 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.135 -0.978 . . . . 0.0 109.124 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 tp -54.46 -32.42 57.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.567 -0.708 . . . . 0.0 110.183 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' C' ' 44' ' ' ASP . 0.3 OUTLIER -84.54 -22.29 30.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.074 -1.016 . . . . 0.0 109.746 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . 0.456 HH11 ' CG ' ' B' ' 44' ' ' ASP . 0.2 OUTLIER -79.1 -25.09 43.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -0.936 . . . . 0.0 110.464 -179.236 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' C' ' 48' ' ' PHE . 10.5 mt -67.31 -31.2 71.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.706 -1.247 . . . . 0.0 108.893 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -47.45 98.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.943 . . . . 0.0 109.217 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . 0.429 ' N ' ' O ' ' C' ' 46' ' ' LEU . 2.5 t80 -162.05 18.66 0.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 109.341 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' C' ' 48' ' ' PHE . 1.5 pttm -61.11 -115.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.811 . . . . 0.0 109.647 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' SER . . . . . 0.403 ' H ' ' CG ' ' C' ' 49' ' ' LYS . 0.9 OUTLIER -87.26 148.59 25.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.664 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 18.5 mt -106.63 -24.23 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.648 -0.658 . . . . 0.0 109.407 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -52.39 -20.32 2.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.328 -0.857 . . . . 0.0 109.609 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -71.43 -41.8 69.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.18 -0.95 . . . . 0.0 109.578 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -67.14 -38.43 85.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 109.079 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -64.58 -64.62 0.83 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.407 -0.808 . . . . 0.0 109.146 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -50.52 -30.17 12.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.829 . . . . 0.0 109.855 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.79 -56.21 10.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.991 . . . . 0.0 109.571 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.4 -60.26 9.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.07 110.34 0.29 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -1.134 . . . . 0.0 109.426 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.46 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.6 p . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.436 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 1.5 m-20 47.64 54.66 15.94 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.229 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 17.3 Cg_endo -60.88 -11.34 17.57 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.566 2.177 . . . . 0.0 112.453 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 20.6 tp -47.64 -46.17 28.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 0.0 108.977 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.5 t -70.1 -45.2 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 108.647 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 78.8 t -49.23 -48.1 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.148 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.49 -34.8 78.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.865 . . . . 0.0 109.285 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.81 -55.87 16.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.966 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.3 -37.47 72.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.115 -0.991 . . . . 0.0 109.919 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . 0.4 HG21 HD11 ' D' ' 32' ' ' ILE . 19.8 mt -70.33 -39.2 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 109.261 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 22.5 mt -58.9 -34.59 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.116 -0.99 . . . . 0.0 108.617 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.18 -44.9 58.51 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 63.8 mt -60.47 -28.55 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.472 -1.016 . . . . 0.0 109.121 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.39 -66.4 0.66 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.34 -0.85 . . . . 0.0 109.049 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . 0.598 ' CE1' ' NE2' ' C' ' 37' ' ' HIS . 11.6 t-160 -47.28 -37.27 10.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.952 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 42.8 tp -68.27 -62.99 1.15 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.097 -1.002 . . . . 0.0 109.67 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mt -46.64 -40.76 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 109.324 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 mt -59.78 -60.45 3.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.454 -0.779 . . . . 0.0 110.322 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . 0.424 ' CZ2' ' CG ' ' D' ' 45' ' ' ARG . 20.6 t-105 -49.93 -46.26 51.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.004 -1.06 . . . . 0.0 110.025 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.31 -47.04 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.14 -0.975 . . . . 0.0 109.362 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 tp -53.92 -39.85 66.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.426 -0.796 . . . . 0.0 109.744 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.481 ' OD2' ' NC ' ' D' ' 499' ' ' RIM . 2.7 m-20 -74.35 -25.61 59.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.25 -0.906 . . . . 0.0 109.823 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.424 ' CG ' ' CZ2' ' D' ' 41' ' ' TRP . 0.6 OUTLIER -74.47 -28.54 61.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.987 -1.071 . . . . 0.0 110.486 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 mt -69.13 -24.67 64.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.708 -1.245 . . . . 0.0 109.12 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -86.05 77.41 9.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.491 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -162.72 3.76 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.341 -0.849 . . . . 0.0 109.182 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . 0.53 ' CG ' ' H ' ' D' ' 50' ' ' SER . 0.8 OUTLIER -62.47 -98.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.53 ' H ' ' CG ' ' D' ' 49' ' ' LYS . 49.0 p -46.65 129.51 11.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.631 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 15.3 mt -104.91 -29.84 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.557 -0.715 . . . . 0.0 109.109 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -26.1 6.02 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.214 -0.929 . . . . 0.0 109.459 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -66.69 -45.05 80.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.119 -0.988 . . . . 0.0 109.55 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -65.01 -36.41 84.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.2 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.51 -66.64 0.53 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.383 -0.823 . . . . 0.0 109.068 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -46.74 -30.85 2.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.551 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -68.89 -56.7 7.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.936 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.8 -60.42 9.05 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mt -59.1 107.65 0.57 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -1.201 . . . . 0.0 109.322 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 5.7 mmmm . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.274 -179.694 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 299' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 399' ' ' RIM . . . . . 0.463 ' NC ' ' CG ' ' C' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 499' ' ' RIM . . . . . 0.481 ' NC ' ' OD2' ' D' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.554 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 4.9 p-10 -171.2 48.82 0.11 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.455 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.9 Cg_endo -56.15 -16.87 18.23 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.912 2.408 . . . . 0.0 112.152 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.8 tp -46.22 -43.42 15.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.262 -0.899 . . . . 0.0 109.17 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.06 -44.93 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.234 -0.916 . . . . 0.0 108.924 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.2 t -49.68 -49.59 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.192 -0.942 . . . . 0.0 109.174 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.09 -34.45 78.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.321 -0.862 . . . . 0.0 109.482 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.32 -56.48 12.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 109.615 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.452 ' H ' ' HG ' ' A' ' 31' ' ' SER . 0.7 OUTLIER -55.44 -37.56 67.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.307 -0.87 . . . . 0.0 109.908 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.1 mt -72.21 -41.13 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.966 . . . . 0.0 109.589 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.2 mt -55.87 -34.82 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.098 -1.001 . . . . 0.0 108.485 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.08 -45.01 33.59 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.4 mt -59.62 -27.27 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.256 -1.143 . . . . 0.0 109.187 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.15 -65.91 0.79 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 109.212 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -45.18 -37.89 4.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.363 -0.835 . . . . 0.0 109.79 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.7 tp -66.12 -68.99 0.33 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.943 . . . . 0.0 109.671 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.8 mt -46.69 -36.42 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.445 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mt -66.46 -58.06 6.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.271 -0.893 . . . . 0.0 109.708 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -49.1 -48.04 44.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.758 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.4 mt -63.1 -49.08 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -0.929 . . . . 0.0 109.315 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.6 tp -51.41 -34.65 35.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.535 -0.728 . . . . 0.0 110.318 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.511 ' OD2' ' NC ' ' A' ' 199' ' ' RIM . 4.0 m-20 -84.44 -26.42 28.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.12 -0.988 . . . . 0.0 110.272 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -71.78 -29.38 64.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.073 -1.017 . . . . 0.0 110.685 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -59.37 -26.11 64.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.714 -1.241 . . . . 0.0 109.593 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -57.26 111.07 0.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.07 -1.019 . . . . 0.0 109.43 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.481 ' CD1' ' C ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -169.54 16.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.241 -0.912 . . . . 0.0 109.471 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 48' ' ' PHE . 45.5 mtpt -62.44 -133.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 109.443 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.56 146.79 54.08 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 109.673 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.2 mt -106.31 -21.71 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -58.05 -15.13 8.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.399 -0.813 . . . . 0.0 109.755 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -69.58 -40.72 76.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 109.774 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -72.86 -42.84 63.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.079 -1.013 . . . . 0.0 109.158 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -56.51 -46.18 80.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.171 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -71.7 -25.43 62.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -0.843 . . . . 0.0 109.317 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -69.77 -32.51 71.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.17 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.22 -62.89 2.02 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.8 mt -72.66 138.8 46.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.193 -1.181 . . . . 0.0 109.498 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.389 -179.874 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' B' ' 26' ' ' LEU . 19.9 t0 -158.66 64.27 2.69 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.873 . . . . 0.0 109.476 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -44.61 -10.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.766 2.31 . . . . 0.0 112.367 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' B' ' 24' ' ' ASP . 30.2 tp -47.35 -46.43 25.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.023 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.5 -45.83 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.197 -0.939 . . . . 0.0 108.804 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 63.3 t -48.26 -48.18 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -0.837 . . . . 0.0 109.026 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.72 -34.15 77.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.219 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.89 -57.41 8.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 109.749 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 2.3 m -55.18 -35.64 65.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.93 . . . . 0.0 109.786 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 19.8 mt -72.89 -41.28 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.098 -1.001 . . . . 0.0 109.567 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -56.11 -33.88 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.037 -1.039 . . . . 0.0 108.574 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.13 -44.83 22.01 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 59.5 mt -56.77 -31.76 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.274 -1.133 . . . . 0.0 109.182 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.68 -64.11 1.02 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.193 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -44.4 -40.5 5.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.413 -0.805 . . . . 0.0 110.123 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 50.8 tp -66.87 -67.27 0.46 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.975 . . . . 0.0 109.636 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 mt -47.33 -26.02 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 109.429 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.66 -68.05 0.44 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.322 -0.861 . . . . 0.0 110.039 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -44.51 -46.54 9.83 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.437 -0.789 . . . . 0.0 109.953 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 56.7 mt -59.29 -47.28 90.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.123 -0.986 . . . . 0.0 108.644 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.1 -54.01 11.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.481 -0.762 . . . . 0.0 108.985 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . 0.445 ' OD2' ' NC ' ' B' ' 299' ' ' RIM . 52.7 m-20 -60.25 -29.89 69.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.493 -0.754 . . . . 0.0 110.389 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -21.39 57.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.909 -1.12 . . . . 0.0 110.745 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -79.04 -33.71 44.48 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.532 -1.355 . . . . 0.0 108.952 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -61.49 122.61 15.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.848 . . . . 0.0 109.682 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -156.39 52.85 0.54 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.374 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.44 -80.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 109.456 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.499 ' CB ' ' CZ ' ' B' ' 52' ' ' TYR . 0.0 OUTLIER -155.81 166.57 33.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.436 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 11.5 mt -96.9 -34.89 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.303 -0.873 . . . . 0.0 109.842 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.499 ' CZ ' ' CB ' ' B' ' 50' ' ' SER . 19.6 p90 -62.66 -19.14 63.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.036 -1.04 . . . . 0.0 109.654 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.7 mmt85 -68.56 -45.22 72.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.537 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -66.27 -32.61 74.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.277 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -69.67 -59.94 2.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.0 109.18 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -53.73 -28.12 32.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.897 . . . . 0.0 109.822 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -71.56 -53.87 12.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.104 -0.997 . . . . 0.0 109.305 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.31 -62.25 6.04 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.98 108.24 0.57 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -1.105 . . . . 0.0 108.985 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 17.9 tttm . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.471 -179.837 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' C' ' 26' ' ' LEU . 15.9 m-20 -149.52 66.06 8.12 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -46.22 -10.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.875 2.383 . . . . 0.0 112.237 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . 0.489 ' H ' ' C ' ' C' ' 24' ' ' ASP . 49.3 tp -47.32 -46.57 25.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.237 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.58 -44.51 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.077 -1.014 . . . . 0.0 108.847 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 69.5 t -49.15 -49.48 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 108.904 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.61 74.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.218 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.48 -57.54 8.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 109.6 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.43 -37.14 67.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.088 -1.008 . . . . 0.0 109.873 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 24.3 mt -71.4 -41.85 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 0.0 109.454 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 23.1 mt -55.55 -34.86 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.089 -1.007 . . . . 0.0 108.544 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.83 -45.24 28.2 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 50.0 mt -55.36 -31.51 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.261 -1.14 . . . . 0.0 109.379 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.0 -57.69 3.74 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.271 -0.893 . . . . 0.0 109.019 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -50.33 -37.62 37.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.217 -0.927 . . . . 0.0 109.436 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -67.02 -69.01 0.33 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.273 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.4 mt -46.7 -26.44 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.275 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mt -69.61 -64.98 0.77 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -0.875 . . . . 0.0 109.655 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -45.41 -47.5 13.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.497 -0.752 . . . . 0.0 109.635 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 70.1 mt -63.73 -56.8 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.145 -0.972 . . . . 0.0 109.074 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.3 tp -44.7 -48.92 10.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.492 -0.755 . . . . 0.0 110.129 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.66 -25.81 65.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.15 -0.969 . . . . 0.0 110.416 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 11.7 mmt-85 -77.84 -21.1 51.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.887 -1.133 . . . . 0.0 110.536 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.1 mt -77.17 -14.43 59.78 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.697 -1.252 . . . . 0.0 108.956 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -76.55 -3.9 39.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.574 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . 0.407 ' O ' ' CG ' ' C' ' 48' ' ' PHE . 0.2 OUTLIER -79.52 112.79 17.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.976 . . . . 0.0 109.579 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . 0.491 ' CG ' ' H ' ' C' ' 50' ' ' SER . 4.5 pttp -163.22 -92.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.475 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' SER . . . . . 0.491 ' H ' ' CG ' ' C' ' 49' ' ' LYS . 28.4 t -77.55 138.03 38.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.4 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 11.1 mt -102.89 -20.28 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.536 -0.727 . . . . 0.0 109.112 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -30.6 26.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.263 -0.898 . . . . 0.0 109.683 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -62.7 -46.03 90.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 109.636 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . 0.408 ' O ' ' CD1' ' D' ' 51' ' ' ILE . 2.7 m-85 -63.78 -37.11 86.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.242 -0.911 . . . . 0.0 109.375 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.07 -63.36 1.17 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.25 -0.906 . . . . 0.0 109.147 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -46.77 -34.07 4.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.795 . . . . 0.0 109.673 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -65.62 -49.72 67.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 0.0 109.137 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.7 -60.81 8.07 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.53 105.84 17.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -1.14 . . . . 0.0 108.963 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.384 -179.99 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.42 160.64 40.4 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.251 -0.906 . . . . 0.0 109.296 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.02 -21.99 73.43 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.578 2.185 . . . . 0.0 112.373 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 51.5 tp -46.25 -43.64 15.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 108.664 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.6 -44.4 79.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.339 -0.85 . . . . 0.0 108.731 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 74.4 t -50.19 -49.43 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 108.703 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.56 -32.83 74.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.412 -0.805 . . . . 0.0 109.251 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.37 -56.67 9.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 109.783 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.67 -36.4 69.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 0.0 109.775 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 15.7 mt -71.65 -42.3 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 109.475 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 24.0 mt -56.13 -34.83 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -0.999 . . . . 0.0 108.617 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.28 -43.62 37.91 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 58.7 mt -58.0 -38.57 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.204 -1.174 . . . . 0.0 109.037 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.0 -66.26 0.57 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -0.884 . . . . 0.0 109.089 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -45.3 -36.65 4.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 0.0 109.83 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 44.1 tp -66.42 -70.0 0.27 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.095 -1.003 . . . . 0.0 109.407 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 9.9 mt -48.01 -25.15 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.361 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . 0.471 ' CD2' ' OD2' ' D' ' 44' ' ' ASP . 2.8 tt -72.74 -55.61 6.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.334 -0.854 . . . . 0.0 109.658 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -53.27 -50.92 63.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.094 -1.003 . . . . 0.0 109.568 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 23.1 mt -59.0 -55.0 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.091 -1.006 . . . . 0.0 108.739 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 35.9 tp -47.52 -37.2 11.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.422 -0.799 . . . . 0.0 109.72 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.472 ' OD2' ' NC ' ' D' ' 499' ' ' RIM . 94.6 m-20 -74.22 -26.05 60.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.223 -0.923 . . . . 0.0 109.67 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.503 ' CA ' ' HE ' ' D' ' 45' ' ' ARG . 0.0 OUTLIER -82.12 -17.67 45.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.126 -0.984 . . . . 0.0 110.732 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -82.26 -34.89 28.59 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.64 -1.287 . . . . 0.0 109.691 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . 0.607 ' CG ' ' N ' ' D' ' 48' ' ' PHE . 0.1 OUTLIER -101.53 -167.66 1.45 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.423 -0.798 . . . . 0.0 109.694 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . 0.607 ' N ' ' CG ' ' D' ' 47' ' ' PHE . 2.5 t80 77.76 30.39 0.47 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.505 -0.747 . . . . 0.0 109.541 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' D' ' 50' ' ' SER . 7.9 tptt -93.3 -148.32 0.25 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 109.28 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 50' ' ' SER . . . . . 0.429 ' O ' ' O ' ' D' ' 49' ' ' LYS . 1.2 m 54.75 102.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.469 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . 0.408 ' CD1' ' O ' ' C' ' 54' ' ' PHE . 11.8 mt -91.12 -19.52 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 109.16 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -31.4 70.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -0.909 . . . . 0.0 109.777 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -47.35 66.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 0.0 110.413 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . 0.479 ' CD1' ' O ' ' D' ' 54' ' ' PHE . 0.0 OUTLIER -69.75 -28.8 66.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.044 -1.035 . . . . 0.0 109.211 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.08 -58.28 7.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.367 -0.833 . . . . 0.0 109.609 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -68.88 -26.99 65.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.121 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -59.94 -61.01 2.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.986 -1.071 . . . . 0.0 109.098 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.7 -59.48 8.13 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.7 110.12 2.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -1.141 . . . . 0.0 109.611 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 2.8 pttp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.46 179.94 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' RIM . . . . . 0.511 ' NC ' ' OD2' ' A' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 299' ' ' RIM . . . . . 0.445 ' NC ' ' OD2' ' B' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 399' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 499' ' ' RIM . . . . . 0.472 ' NC ' ' OD2' ' D' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.299 0.571 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.14 161.52 52.03 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.319 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 26' ' ' LEU . 19.3 Cg_endo -61.72 -29.26 83.2 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.541 2.16 . . . . 0.0 112.055 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.409 ' C ' ' O ' ' A' ' 25' ' ' PRO . 40.8 tp -45.13 -40.45 7.01 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.7 t -69.25 -43.51 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.0 t -53.12 -51.8 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.13 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.38 -34.95 76.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.52 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.39 -53.51 42.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 109.591 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.508 ' H ' ' HG ' ' A' ' 31' ' ' SER . 0.8 OUTLIER -58.2 -37.44 74.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.859 -179.687 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.3 mt -71.41 -42.47 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.389 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.9 mt -55.28 -36.37 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 0.0 108.789 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.31 -42.79 56.44 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.3 mt -61.83 -46.53 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.235 -1.156 . . . . 0.0 109.269 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.45 -44.69 80.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 109.142 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -57.88 -56.08 26.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 109.482 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.3 tp -54.0 -59.97 3.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.913 . . . . 0.0 109.533 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.2 mt -47.52 -48.36 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.299 -0.876 . . . . 0.0 109.311 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mt -51.93 -59.31 4.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -45.14 -65.83 0.48 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.459 -0.776 . . . . 0.0 109.572 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mt -48.58 -37.74 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.125 -0.984 . . . . 0.0 109.278 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.1 -49.31 63.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.47 -0.769 . . . . 0.0 110.084 -179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.477 ' OD1' ' NC ' ' A' ' 199' ' ' RIM . 0.5 OUTLIER -76.67 -21.72 55.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.968 . . . . 0.0 110.401 -179.042 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 47' ' ' PHE . 12.9 mmt180 -91.68 -1.15 57.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.013 -1.054 . . . . 0.0 110.841 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 45' ' ' ARG . 29.7 mt -35.79 -30.61 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.525 -0.734 . . . . 0.0 110.192 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 45' ' ' ARG . 7.4 p90 -170.92 167.13 7.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.161 -0.962 . . . . 0.0 109.486 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -164.15 99.68 0.85 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.252 -0.905 . . . . 0.0 109.578 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 51' ' ' ILE . 10.1 ttmt -151.64 -44.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.166 -0.959 . . . . 0.0 109.405 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.9 t -60.15 80.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 109.369 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 49' ' ' LYS . 40.7 mt -92.43 -27.76 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.89 . . . . 0.0 109.557 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.51 -44.84 65.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.751 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.29 -45.12 62.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.088 -1.008 . . . . 0.0 109.454 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -61.97 -37.28 84.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.286 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.0 -34.7 78.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.115 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -70.21 -38.14 75.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.353 -0.842 . . . . 0.0 109.476 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -62.66 -54.41 39.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 0.0 109.324 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.53 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -54.17 -63.08 5.49 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 60' ' ' LYS . 7.7 mt -72.93 21.85 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -1.143 . . . . 0.0 109.741 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.53 ' H ' ' C ' ' A' ' 58' ' ' GLY . 65.9 mttm . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.546 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ASP . . . . . 0.533 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 1.5 p30 -153.35 50.05 0.55 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.88 . . . . 0.0 109.399 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 9.2 Cg_endo -55.59 -11.26 4.55 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.802 2.334 . . . . 0.0 112.248 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 43.6 tp -47.62 -45.85 28.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.152 -0.967 . . . . 0.0 109.094 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.57 -46.14 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.145 -0.972 . . . . 0.0 108.808 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 74.0 t -47.98 -48.27 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.892 . . . . 0.0 108.99 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.54 84.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.452 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.39 -57.34 8.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.261 -0.9 . . . . 0.0 109.801 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -53.93 -35.83 62.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 0.0 109.69 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 18.4 mt -72.65 -41.68 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.179 -0.951 . . . . 0.0 109.411 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 18.6 mt -55.25 -34.5 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.087 -1.008 . . . . 0.0 108.691 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.94 -44.77 23.23 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 51.6 mt -55.49 -34.87 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.072 -1.252 . . . . 0.0 109.326 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.46 -58.97 2.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 108.971 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' HIS . . . . . 0.602 ' NE2' ' ND1' ' C' ' 37' ' ' HIS . 2.3 t-80 -47.83 -37.4 13.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 0.0 109.716 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 52.6 tp -69.88 -67.74 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 0.0 109.466 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mt -47.04 -25.14 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 109.316 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mt -69.03 -63.43 1.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.642 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 41.8 t-105 -47.72 -46.69 29.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.399 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' B' ' 45' ' ' ARG . 72.3 mt -62.02 -61.4 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 108.906 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 57.6 tp -42.53 -47.73 5.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.762 -0.587 . . . . 0.0 110.096 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.72 -27.78 68.57 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' B' ' 42' ' ' ILE . 2.3 mmt180 -81.19 -14.97 57.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.099 -1.001 . . . . 0.0 110.333 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -88.83 -16.08 32.93 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.763 -1.211 . . . . 0.0 109.289 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -47.23 -77.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.326 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 45.11 74.72 0.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 109.769 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -96.65 -88.21 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 109.49 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' SER . . . . . 0.492 ' HG ' ' N ' ' B' ' 51' ' ' ILE . 2.1 t -148.51 148.98 30.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.388 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . 0.492 ' N ' ' HG ' ' B' ' 50' ' ' SER . 20.2 mt -96.37 -22.55 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.325 -0.859 . . . . 0.0 109.566 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -67.01 -20.7 65.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.592 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -70.31 -43.74 69.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.246 -0.909 . . . . 0.0 109.833 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -67.12 -34.76 78.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -0.956 . . . . 0.0 109.632 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -66.35 -43.65 85.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.201 -0.937 . . . . 0.0 109.302 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -68.78 -27.54 65.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.085 -1.009 . . . . 0.0 108.72 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -70.69 -38.41 73.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.447 -0.783 . . . . 0.0 109.501 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.96 -62.4 3.17 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 50.5 mt -72.39 136.43 46.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -1.083 . . . . 0.0 109.367 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 48.5 mttm . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.463 179.92 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' ASP . . . . . 0.505 ' C ' ' H ' ' C' ' 26' ' ' LEU . 0.2 OUTLIER -161.5 68.35 2.34 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.923 . . . . 0.0 109.571 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -46.4 -9.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.692 2.261 . . . . 0.0 112.105 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' LEU . . . . . 0.505 ' H ' ' C ' ' C' ' 24' ' ' ASP . 35.4 tp -47.2 -46.41 23.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 0.0 109.141 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 33.8 t -69.49 -45.19 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.191 -0.943 . . . . 0.0 108.631 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 71.6 t -49.32 -50.41 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.336 -0.853 . . . . 0.0 108.995 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.11 -30.9 71.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.363 -0.835 . . . . 0.0 109.228 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.74 -56.22 11.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 109.603 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.13 -37.55 74.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -0.946 . . . . 0.0 109.829 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 42.0 mt -71.02 -40.72 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 0.0 109.51 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 18.5 mt -58.53 -32.28 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.106 -0.996 . . . . 0.0 108.594 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.86 -44.03 26.01 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 52.4 mt -57.04 -31.46 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.301 -1.117 . . . . 0.0 109.186 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.25 -62.39 1.45 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 108.935 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' HIS . . . . . 0.602 ' ND1' ' NE2' ' B' ' 37' ' ' HIS . 10.5 t-80 -47.13 -34.46 6.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 109.586 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 40.2 tp -70.56 -66.77 0.56 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.661 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 5.8 mt -49.97 -26.19 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.623 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -72.38 -54.49 9.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.138 -0.976 . . . . 0.0 109.526 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -55.02 -49.08 72.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.722 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 59.4 mt -63.9 -55.14 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.203 -0.936 . . . . 0.0 109.117 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 40.1 tp -48.23 -40.37 24.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.794 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' C' ' 44' ' ' ASP . 4.5 m-20 -73.21 -25.84 60.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 109.843 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.64 -19.43 45.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.114 -0.991 . . . . 0.0 110.506 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -79.39 -32.22 42.99 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.631 -1.293 . . . . 0.0 109.109 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -92.31 103.47 15.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.437 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.55 -12.3 0.13 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.328 -0.857 . . . . 0.0 109.582 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -65.1 -156.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.187 -0.946 . . . . 0.0 109.304 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 60.6 p 45.91 76.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.956 -1.09 . . . . 0.0 109.656 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 10.8 mt -95.54 -27.68 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -59.4 -24.91 63.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.193 -0.942 . . . . 0.0 109.421 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -68.78 -37.19 79.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.421 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -72.2 -35.12 68.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 109.364 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -64.12 -56.51 14.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.792 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -65.11 -28.25 69.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.114 -0.991 . . . . 0.0 109.788 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -70.41 -43.74 69.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.431 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.86 -65.7 2.32 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.67 95.28 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -1.189 . . . . 0.0 109.054 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.326 -179.831 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 24' ' ' ASP . . . . . 0.46 ' C ' ' H ' ' D' ' 26' ' ' LEU . 27.8 t0 51.13 69.36 2.61 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.936 . . . . 0.0 109.394 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -47.32 -10.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.663 2.242 . . . . 0.0 112.134 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 26' ' ' LEU . . . . . 0.46 ' H ' ' C ' ' D' ' 24' ' ' ASP . 35.2 tp -47.88 -47.03 32.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.244 -0.91 . . . . 0.0 108.902 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 42.3 t -68.66 -44.71 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.106 -0.996 . . . . 0.0 108.63 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 78.3 t -49.24 -49.44 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 108.687 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.44 77.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.379 -0.826 . . . . 0.0 109.236 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.12 -56.85 10.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.343 -0.848 . . . . 0.0 109.734 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.82 -37.12 65.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.162 -0.961 . . . . 0.0 109.763 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 17.2 mt -71.5 -41.95 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.42 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 27.6 mt -55.24 -35.32 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 108.69 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.47 -45.3 47.44 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 72.2 mt -60.99 -24.26 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.291 -1.123 . . . . 0.0 109.037 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 17.2 tp -76.16 -70.53 0.44 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.464 -0.772 . . . . 0.0 109.231 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -45.52 -33.38 2.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.873 . . . . 0.0 109.715 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 56.6 tp -68.19 -66.27 0.59 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.179 -0.951 . . . . 0.0 109.49 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mt -52.43 -28.23 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.842 . . . . 0.0 109.659 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mt -76.24 -59.24 2.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.84 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -45.97 -52.01 12.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.283 -0.886 . . . . 0.0 109.841 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 42' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' D' ' 45' ' ' ARG . 66.9 mt -60.46 -57.63 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.154 -0.966 . . . . 0.0 109.018 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 59.2 tp -43.89 -44.69 7.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.62 -0.675 . . . . 0.0 109.81 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 44' ' ' ASP . . . . . 0.514 ' CG ' HNC1 ' D' ' 499' ' ' RIM . 0.6 OUTLIER -67.46 -29.86 69.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.164 -0.96 . . . . 0.0 109.652 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 45' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' D' ' 42' ' ' ILE . 4.0 mmt180 -77.22 -17.43 58.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.2 -0.938 . . . . 0.0 110.208 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 mt -85.7 -17.13 36.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.82 -1.175 . . . . 0.0 109.236 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.35 -6.66 4.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.195 -0.941 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -71.41 70.97 0.64 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.52 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -96.65 -100.27 0.18 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.422 -0.799 . . . . 0.0 109.52 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 3.4 m -76.18 130.99 39.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 109.783 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 28.9 mt -93.37 -30.67 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.898 . . . . 0.0 109.318 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -25.68 61.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.925 . . . . 0.0 109.923 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 53' ' ' ARG . . . . . 0.426 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 12.5 mmt85 -63.6 -41.26 98.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.123 -0.986 . . . . 0.0 109.669 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -71.15 -41.39 70.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.151 -0.968 . . . . 0.0 109.435 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -58.84 -41.81 87.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.332 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -26.87 61.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.259 -0.901 . . . . 0.0 109.26 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 57' ' ' HIS . . . . . 0.426 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 2.5 m-70 -67.47 -39.65 85.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 108.905 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.82 -63.35 2.74 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.08 159.75 2.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.251 -1.146 . . . . 0.0 109.605 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 17.7 mttp . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.448 -179.967 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' RIM . . . . . 0.477 ' NC ' ' OD1' ' A' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 299' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 399' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 499' ' ' RIM . . . . . 0.514 HNC1 ' CG ' ' D' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 2.7 m-20 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.3 Cg_endo -55.78 -15.54 13.17 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.714 2.276 . . . . 0.0 111.978 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.8 tp -46.29 -44.42 16.58 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.319 -0.863 . . . . 0.0 109.169 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.8 t -68.6 -45.26 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.273 -0.892 . . . . 0.0 108.997 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -48.93 -49.02 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.184 -0.947 . . . . 0.0 109.057 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.09 -34.47 78.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 0.0 109.387 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.74 -57.25 8.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 0.0 109.805 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.57 -36.14 66.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.733 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.7 mt -71.7 -42.51 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.338 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.4 mt -55.73 -34.63 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.128 -0.982 . . . . 0.0 108.511 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.09 -45.17 32.95 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.1 mt -55.67 -36.21 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.165 -1.197 . . . . 0.0 109.179 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.5 -61.91 1.67 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.353 -0.842 . . . . 0.0 109.236 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -45.15 -39.9 6.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.416 -0.802 . . . . 0.0 110.061 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -66.23 -69.49 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.141 -0.974 . . . . 0.0 109.843 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.8 mt -48.19 -27.4 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 0.0 109.739 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.425 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 7.4 mt -72.24 -60.37 2.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.928 . . . . 0.0 109.945 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 40.7 t-105 -48.1 -48.53 33.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.055 -1.028 . . . . 0.0 109.784 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 45' ' ' ARG . 66.6 mt -63.28 -59.89 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.08 -1.013 . . . . 0.0 109.336 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.3 tp -44.27 -40.66 5.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.572 -0.705 . . . . 0.0 109.821 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 1.7 m-20 -69.75 -31.31 69.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -0.964 . . . . 0.0 109.217 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.5 ' NH1' ' OD2' ' D' ' 44' ' ' ASP . 0.4 OUTLIER -75.4 -16.05 60.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 110.181 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -90.04 -12.06 39.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.872 -1.142 . . . . 0.0 109.22 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.487 ' O ' ' N ' ' A' ' 49' ' ' LYS . 17.6 t80 -78.0 -60.73 2.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 109.306 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -50.23 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 109.066 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 47' ' ' PHE . 30.8 mtpt -91.65 -82.43 0.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.915 . . . . 0.0 109.634 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.1 m -87.35 170.07 11.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.635 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.3 mt -105.46 -21.66 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.569 -0.707 . . . . 0.0 109.626 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -55.02 -20.87 10.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.182 -0.949 . . . . 0.0 109.8 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.433 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 7.6 mmm180 -70.94 -42.59 69.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.062 -1.024 . . . . 0.0 109.553 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -66.79 -35.23 79.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.227 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -65.25 -48.85 71.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -0.866 . . . . 0.0 109.19 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -63.2 -29.18 70.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.348 -0.845 . . . . 0.0 109.526 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.433 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 18.5 m80 -66.2 -52.34 48.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.263 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.22 -60.89 7.8 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.46 ' O ' ' CB ' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -50.28 118.8 3.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.377 -1.072 . . . . 0.0 109.458 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 59' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.479 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.298 0.57 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.516 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 48.5 m-20 -157.72 51.23 0.46 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.472 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 13.0 Cg_endo -59.23 -12.02 14.92 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.759 2.306 . . . . 0.0 112.345 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 58.2 tp -47.98 -46.71 32.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 108.958 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.71 -44.93 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.113 -0.992 . . . . 0.0 108.774 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 71.2 t -48.97 -49.71 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 108.931 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.38 -32.87 74.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -0.837 . . . . 0.0 109.136 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.91 -58.08 6.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 0.0 109.66 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.77 -35.28 63.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 109.697 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 16.7 mt -73.29 -41.86 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 0.0 109.745 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.474 HD13 HG13 ' C' ' 35' ' ' ILE . 21.9 mt -55.86 -35.57 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.005 -1.059 . . . . 0.0 108.822 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.34 -44.18 43.55 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 48.6 mt -56.05 -33.07 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.226 -1.161 . . . . 0.0 109.204 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -65.19 0.79 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 109.1 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' HIS . . . . . 0.598 ' HE2' ' CE1' ' C' ' 37' ' ' HIS . 3.4 t-80 -45.43 -38.13 5.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.412 -0.805 . . . . 0.0 109.748 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 54.9 tp -66.38 -67.86 0.42 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 109.503 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.8 mt -48.91 -25.89 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 109.518 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mt -71.5 -64.07 0.99 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.851 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -46.11 -47.1 17.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 0.0 109.647 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 51.7 mt -63.27 -55.46 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.087 -1.008 . . . . 0.0 108.909 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 39.5 tp -47.13 -41.19 17.09 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.51 -0.744 . . . . 0.0 109.661 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' B' ' 44' ' ' ASP . 0.3 OUTLIER -69.79 -30.26 67.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.707 -179.709 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.97 -19.71 58.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.07 -1.018 . . . . 0.0 110.47 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -82.97 -8.46 59.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.631 -1.293 . . . . 0.0 108.973 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -138.11 106.93 5.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.525 -0.734 . . . . 0.0 109.569 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' PHE . . . . . 0.409 ' H ' ' H ' ' B' ' 49' ' ' LYS . 28.5 t80 -171.15 3.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.216 -0.928 . . . . 0.0 109.556 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.409 ' H ' ' H ' ' B' ' 48' ' ' PHE . 14.2 mtpp -71.89 -142.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.905 . . . . 0.0 109.302 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 20.8 m 51.54 75.74 0.19 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.166 -0.959 . . . . 0.0 109.568 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 50.9 mt -99.36 -31.21 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.463 -0.773 . . . . 0.0 109.385 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.494 ' CE2' ' NH1' ' B' ' 53' ' ' ARG . 0.1 OUTLIER -61.02 -32.93 72.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.0 109.781 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.494 ' NH1' ' CE2' ' B' ' 52' ' ' TYR . 19.5 mmt-85 -64.42 -33.84 76.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.085 -1.009 . . . . 0.0 109.42 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -75.3 -42.15 55.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.873 . . . . 0.0 109.17 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -58.34 -40.53 82.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.856 . . . . 0.0 109.55 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -72.78 -67.61 0.55 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' HIS . . . . . 0.45 ' O ' ' ND1' ' B' ' 57' ' ' HIS . 23.0 t-80 -41.22 -30.06 0.15 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.616 -0.678 . . . . 0.0 110.208 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.28 -70.25 1.31 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mt -66.35 82.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -1.113 . . . . 0.0 109.516 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 58.8 tttm . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.403 179.855 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 55.1 m . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' C' ' 26' ' ' LEU . 3.2 m-20 57.64 65.33 3.52 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 109.647 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -45.22 -11.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.921 2.414 . . . . 0.0 112.535 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' C' ' 24' ' ' ASP . 24.2 tp -47.74 -46.11 29.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 108.975 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 45.5 t -67.19 -45.32 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 108.769 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 71.5 t -50.3 -51.64 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.363 -0.836 . . . . 0.0 109.008 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.32 -32.58 73.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.502 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.8 -55.27 18.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.53 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.13 -37.51 69.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.843 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 23.1 mt -71.89 -42.81 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.072 -1.017 . . . . 0.0 109.602 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.25 -36.39 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 108.551 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.95 -45.04 64.76 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 35' ' ' ILE . . . . . 0.474 HG13 HD13 ' B' ' 33' ' ' ILE . 63.5 mt -59.6 -41.59 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.347 -1.09 . . . . 0.0 108.832 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.77 -68.01 0.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.368 -0.832 . . . . 0.0 109.292 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 37' ' ' HIS . . . . . 0.598 ' CE1' ' HE2' ' B' ' 37' ' ' HIS . 2.3 t-80 -44.17 -39.95 4.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.389 -0.82 . . . . 0.0 110.24 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.76 -67.89 0.38 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.985 -1.072 . . . . 0.0 109.196 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 mt -47.67 -40.66 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.344 -0.847 . . . . 0.0 109.423 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mt -61.64 -54.31 44.54 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.45 -0.781 . . . . 0.0 109.581 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -46.31 -58.19 3.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.418 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.19 -47.8 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.055 -1.028 . . . . 0.0 109.339 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 6.3 tp -52.56 -27.52 17.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.417 -0.802 . . . . 0.0 110.43 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -91.03 -34.03 15.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.071 -1.018 . . . . 0.0 109.426 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' C' ' 47' ' ' PHE . 14.6 mmm180 -84.67 4.32 33.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.343 -0.848 . . . . 0.0 110.403 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.476 ' C ' ' O ' ' C' ' 45' ' ' ARG . 34.8 mt -31.0 -34.95 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 CA-C-O 121.273 0.559 . . . . 0.0 110.299 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.55 ' N ' ' O ' ' C' ' 45' ' ' ARG . 0.2 OUTLIER 68.2 102.04 0.05 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.714 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -104.16 162.67 12.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.557 -0.714 . . . . 0.0 109.211 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 49' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' C' ' 50' ' ' SER . 20.4 tptt -92.37 -150.14 0.26 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.168 -0.958 . . . . 0.0 109.767 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 50' ' ' SER . . . . . 0.412 ' O ' ' O ' ' C' ' 49' ' ' LYS . 8.2 m 47.06 92.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 109.843 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 mt -92.65 -31.61 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.213 -0.93 . . . . 0.0 109.446 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 52' ' ' TYR . . . . . 0.463 ' CD2' ' N ' ' C' ' 53' ' ' ARG . 50.9 p90 -48.45 -44.26 35.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.382 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 53' ' ' ARG . . . . . 0.463 ' N ' ' CD2' ' C' ' 52' ' ' TYR . 3.7 mtp85 -46.73 -50.52 17.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.306 -0.871 . . . . 0.0 109.954 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -61.7 -41.5 97.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.112 -0.993 . . . . 0.0 109.76 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -60.79 -35.57 76.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 109.266 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -73.52 -37.62 65.58 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.275 -0.891 . . . . 0.0 109.239 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -41.22 94.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.914 . . . . 0.0 109.189 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.42 -62.43 4.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 57.6 mt -85.24 -147.99 0.11 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -1.125 . . . . 0.0 109.316 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.442 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.95 161.38 77.8 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.339 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -65.1 -21.52 62.84 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.511 2.14 . . . . 0.0 112.097 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 54.2 tp -46.8 -43.87 18.74 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -69.76 -43.23 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.329 -0.857 . . . . 0.0 108.803 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 70.4 t -51.04 -48.55 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.069 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.35 -33.91 76.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 0.0 109.26 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.35 -57.02 9.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 109.674 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -56.1 -35.99 67.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.746 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 12.3 mt -71.69 -41.41 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.208 -0.933 . . . . 0.0 109.352 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -56.64 -35.17 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.942 . . . . 0.0 108.796 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.79 -43.67 50.1 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 57.2 mt -59.17 -30.34 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.333 -1.098 . . . . 0.0 109.478 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.75 -67.5 0.63 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -0.944 . . . . 0.0 109.405 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -44.11 -35.71 2.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.23 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 45.8 tp -71.42 -63.13 1.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.031 -1.043 . . . . 0.0 109.803 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.7 mt -50.93 -34.38 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.96 . . . . 0.0 109.599 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 40' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' D' ' 43' ' ' LEU . 1.2 mt -67.17 -64.81 0.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.36 -0.838 . . . . 0.0 110.273 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -44.76 -48.61 10.84 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.398 -0.814 . . . . 0.0 109.682 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 93.3 mt -59.63 -37.52 71.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 108.601 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' D' ' 40' ' ' LEU . 0.1 OUTLIER -57.7 -43.38 85.14 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.488 -0.757 . . . . 0.0 109.36 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 44' ' ' ASP . . . . . 0.5 ' OD2' ' NH1' ' A' ' 45' ' ' ARG . 7.0 m-20 -71.71 -26.82 62.65 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.381 -0.825 . . . . 0.0 110.182 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -28.36 58.31 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.829 -1.169 . . . . 0.0 110.981 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' D' ' 48' ' ' PHE . 7.7 mt -58.4 -12.31 3.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.525 -1.359 . . . . 0.0 109.179 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -73.95 17.09 0.18 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.14 -0.975 . . . . 0.0 109.114 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 48' ' ' PHE . . . . . 0.478 ' H ' ' C ' ' D' ' 46' ' ' LEU . 0.4 OUTLIER -46.66 155.2 0.26 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 109.56 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 15.8 tttm 64.23 -146.45 0.29 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 73.3 m 47.96 59.44 4.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 38.8 mt -95.06 -29.59 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.347 -0.846 . . . . 0.0 109.39 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -37.94 74.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.545 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 53' ' ' ARG . . . . . 0.472 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 5.9 mtm180 -61.51 -36.63 81.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.247 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -69.99 -37.92 75.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 0.0 109.258 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -63.39 -53.79 46.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 109.677 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -62.61 -29.13 70.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.748 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 57' ' ' HIS . . . . . 0.472 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 1.4 m-70 -67.48 -45.14 76.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 109.431 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.29 -60.71 6.78 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.1 -166.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -1.15 . . . . 0.0 109.712 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 61.1 tttm . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.923 -1.036 . . . . 0.0 109.669 -179.969 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 5.5 p-10 . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 120.889 0.376 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 11.2 Cg_endo -58.02 -17.87 33.17 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.509 2.139 . . . . 0.0 112.269 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.8 tp -47.2 -45.02 22.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.189 -0.945 . . . . 0.0 108.826 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.98 -44.52 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.241 -0.912 . . . . 0.0 108.802 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -49.86 -50.25 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.163 -0.96 . . . . 0.0 109.068 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.54 -33.69 76.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.322 -0.861 . . . . 0.0 109.514 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.57 -56.78 8.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 109.784 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 m -55.55 -34.65 64.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.705 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.4 mt -74.81 -43.7 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.118 -0.989 . . . . 0.0 109.725 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.8 mt -54.02 -35.91 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.021 -1.05 . . . . 0.0 108.618 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.06 -45.43 41.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.7 mt -57.65 -37.27 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.192 -1.181 . . . . 0.0 108.907 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.15 -68.74 0.33 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -0.85 . . . . 0.0 109.373 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -43.19 -42.26 4.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.431 -0.793 . . . . 0.0 110.263 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.7 tp -61.05 -67.66 0.38 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.106 -0.996 . . . . 0.0 109.569 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 mt -49.15 -44.1 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 109.513 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt -55.77 -58.39 8.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 109.987 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -46.43 -59.1 3.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.322 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.467 ' O ' ' N ' ' A' ' 45' ' ' ARG . 48.0 mt -51.17 -52.44 18.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.276 -0.89 . . . . 0.0 108.978 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 42' ' ' ILE . 0.1 OUTLIER -41.89 -57.21 2.47 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.426 0.631 . . . . 0.0 109.503 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -59.15 -27.7 65.89 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.328 -0.858 . . . . 0.0 109.624 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.467 ' N ' ' O ' ' A' ' 42' ' ' ILE . 2.7 mmp_? -81.52 -13.82 57.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.071 -1.018 . . . . 0.0 110.714 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 mt -88.65 -18.88 27.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.652 -1.28 . . . . 0.0 109.198 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.48 ' O ' ' CB ' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -141.79 166.29 25.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.301 -0.875 . . . . 0.0 109.518 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.48 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 2.4 t80 75.96 97.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.57 -0.706 . . . . 0.0 109.539 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 50' ' ' SER . 10.1 tttp -150.23 -135.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.109 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 49' ' ' LYS . 0.9 OUTLIER 68.14 117.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.957 . . . . 0.0 109.51 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 mt -97.69 -29.25 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 109.625 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.485 ' CG ' ' N ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -57.32 -38.82 74.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.97 . . . . 0.0 109.44 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.485 ' N ' ' CG ' ' A' ' 52' ' ' TYR . 1.4 mtt180 -57.65 -37.21 72.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.044 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -70.67 -39.98 73.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.844 . . . . 0.0 109.233 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -65.55 -34.08 77.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.125 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -75.02 -31.66 61.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.824 . . . . 0.0 109.613 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -68.92 -37.93 79.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.256 -0.902 . . . . 0.0 109.152 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.63 -64.41 2.6 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.7 mt -75.78 150.95 37.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -1.112 . . . . 0.0 109.538 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.449 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.265 0.555 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.15 160.67 39.18 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 109.271 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' B' ' 26' ' ' LEU . 18.7 Cg_endo -63.16 -24.5 72.8 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.557 2.171 . . . . 0.0 112.165 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' B' ' 25' ' ' PRO . 56.9 tp -45.63 -40.89 9.55 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 52.3 t -70.98 -44.75 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.345 -0.847 . . . . 0.0 108.809 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 74.4 t -49.54 -48.71 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 108.953 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.55 -34.73 78.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.362 -0.836 . . . . 0.0 109.223 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.26 -56.75 12.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 109.665 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.04 -36.71 68.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 109.966 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 29.8 mt -72.05 -40.06 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.095 -1.003 . . . . 0.0 109.686 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 30.6 mt -58.05 -35.23 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.013 -1.054 . . . . 0.0 108.751 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.14 -44.0 45.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 55.9 mt -57.8 -35.83 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.288 -1.125 . . . . 0.0 109.162 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.44 -65.96 0.61 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.279 -0.888 . . . . 0.0 109.056 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -45.5 -39.18 7.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.46 -0.775 . . . . 0.0 109.895 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.79 -69.3 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 0.0 109.786 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.4 mt -51.21 -23.84 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.113 -0.992 . . . . 0.0 109.269 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.494 HD23 ' C ' ' B' ' 40' ' ' LEU . 2.6 tt -68.67 -63.86 0.98 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.36 -0.837 . . . . 0.0 110.005 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 -52.34 -46.63 66.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.989 . . . . 0.0 109.907 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.95 -55.21 26.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.032 -1.042 . . . . 0.0 108.841 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 52.9 tp -46.8 -40.99 14.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.536 -0.728 . . . . 0.0 109.932 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.3 -25.32 61.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 109.865 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.6 -17.72 43.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.912 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -81.06 -27.78 35.57 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.631 -1.293 . . . . 0.0 109.338 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -147.46 116.93 7.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.223 -0.923 . . . . 0.0 109.668 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' PHE . . . . . 0.444 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 79.7 t80 -173.41 82.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 109.391 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -141.8 -129.97 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.43 -0.794 . . . . 0.0 109.176 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 7.4 t 49.57 84.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.419 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 27.5 mt -97.9 -26.78 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.272 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.574 ' CG ' ' N ' ' B' ' 53' ' ' ARG . 2.8 p90 -53.09 -40.26 63.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.453 -0.779 . . . . 0.0 110.362 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.574 ' N ' ' CG ' ' B' ' 52' ' ' TYR . 0.0 OUTLIER -64.91 -29.49 70.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.931 -1.106 . . . . 0.0 109.909 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -74.57 -41.44 60.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.143 -0.973 . . . . 0.0 109.414 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.44 -50.74 66.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.195 -0.941 . . . . 0.0 108.963 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.53 -32.56 71.6 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.303 -0.873 . . . . 0.0 109.12 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -61.37 -59.46 5.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.114 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.65 -58.07 12.33 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 56.4 mt -78.0 69.48 4.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.357 -1.084 . . . . 0.0 109.246 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.9 tptp . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.563 -179.811 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 37.6 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.313 0.578 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' C' ' 26' ' ' LEU . 2.0 m-20 48.81 64.81 8.02 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.754 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -46.06 -8.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.738 2.292 . . . . 0.0 112.435 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' C' ' 24' ' ' ASP . 39.0 tp -47.41 -45.91 25.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.163 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 32.8 t -67.84 -45.83 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 108.616 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -49.32 -49.26 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 109.013 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.01 -34.67 78.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.26 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.24 -55.53 15.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 109.701 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.86 -36.67 67.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.724 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 mt -72.34 -42.02 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 109.406 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.7 mt -54.76 -34.69 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.09 -1.006 . . . . 0.0 108.64 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.23 -44.28 23.19 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 59.9 mt -57.19 -32.38 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.184 -1.186 . . . . 0.0 108.971 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -71.27 -65.56 0.73 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 108.812 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -46.16 -38.24 7.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.815 . . . . 0.0 109.678 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.4 -69.95 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.216 -0.927 . . . . 0.0 109.696 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 15.7 mt -47.4 -25.45 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.16 -0.963 . . . . 0.0 109.398 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 5.9 mt -71.98 -61.05 1.93 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.482 -0.761 . . . . 0.0 109.755 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -47.79 -48.18 30.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.978 . . . . 0.0 109.61 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 42' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' C' ' 45' ' ' ARG . 53.4 mt -61.6 -59.8 3.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.193 -0.942 . . . . 0.0 108.826 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.4 tp -43.51 -44.6 6.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.756 -0.59 . . . . 0.0 109.913 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 44' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' C' ' 44' ' ' ASP . 0.7 OUTLIER -68.13 -27.25 66.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.22 -0.925 . . . . 0.0 109.64 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.464 ' N ' ' O ' ' C' ' 42' ' ' ILE . 14.0 mmt180 -82.6 -15.54 51.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.171 -0.955 . . . . 0.0 110.559 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 mt -86.58 -11.28 51.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.736 -1.227 . . . . 0.0 109.247 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -59.07 94.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.942 . . . . 0.0 109.156 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.51 ' O ' ' CG ' ' C' ' 48' ' ' PHE . 0.1 OUTLIER -162.89 6.99 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -50.57 -31.36 15.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 3.1 p -164.41 131.95 3.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 5.1 mt -82.18 -22.77 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 108.996 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -45.8 -39.72 8.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 0.0 109.96 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -53.01 -48.57 67.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.117 -0.989 . . . . 0.0 110.171 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' D' ' 51' ' ' ILE . 10.1 m-85 -62.37 -40.48 96.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.095 -1.003 . . . . 0.0 109.562 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -60.19 -58.39 8.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.851 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -57.0 -37.19 71.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -48.04 82.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.063 -1.023 . . . . 0.0 109.748 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.4 -59.54 9.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 6.9 mt -75.63 87.68 2.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -1.163 . . . . 0.0 109.4 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.46 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' D' ' 26' ' ' LEU . 15.4 m-20 51.15 66.68 5.08 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.393 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -46.16 -10.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.754 2.303 . . . . 0.0 112.092 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' D' ' 24' ' ' ASP . 44.9 tp -47.58 -47.6 28.42 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.223 -0.923 . . . . 0.0 109.016 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.27 -44.79 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 108.73 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -48.58 -49.5 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 108.904 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.26 -37.14 86.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.507 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -57.1 10.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.231 -0.918 . . . . 0.0 109.916 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.4 -36.72 64.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.224 -0.923 . . . . 0.0 109.81 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 26.9 mt -72.54 -41.69 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.166 -0.958 . . . . 0.0 109.453 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -55.92 -36.98 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 108.702 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.11 -45.16 57.71 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 47.2 mt -56.05 -38.88 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.204 -1.174 . . . . 0.0 109.286 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.72 -61.78 1.72 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -0.866 . . . . 0.0 109.137 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -46.57 -44.02 17.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.61 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.0 tp -60.07 -69.18 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mt -46.95 -25.25 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.891 . . . . 0.0 109.403 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 40' ' ' LEU . . . . . 0.444 ' CD2' ' OD2' ' D' ' 44' ' ' ASP . 1.5 tt -69.96 -64.12 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.895 . . . . 0.0 109.716 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 19.0 t-105 -47.26 -49.06 24.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 109.523 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 36.2 mt -61.16 -50.93 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.176 -0.953 . . . . 0.0 109.228 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 53.2 tp -50.88 -37.7 45.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.835 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 44' ' ' ASP . . . . . 0.444 ' OD2' ' CD2' ' D' ' 40' ' ' LEU . 73.2 m-20 -75.9 -28.41 58.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 109.625 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -71.56 -27.02 62.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.951 . . . . 0.0 110.569 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.4 mt -71.27 -16.08 62.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.69 -1.256 . . . . 0.0 109.112 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -82.92 -7.55 59.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.248 -0.908 . . . . 0.0 108.935 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 48' ' ' PHE . . . . . 0.445 ' O ' ' CB ' ' D' ' 49' ' ' LYS . 0.9 OUTLIER -87.7 -153.86 0.24 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.405 -0.809 . . . . 0.0 109.737 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 49' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' D' ' 48' ' ' PHE . 5.9 ttpt 74.14 -62.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.365 -0.834 . . . . 0.0 109.593 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.85 106.42 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.196 -0.94 . . . . 0.0 109.594 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 51' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' C' ' 54' ' ' PHE . 4.0 mt -87.78 -23.3 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.574 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 52' ' ' TYR . . . . . 0.468 ' CD1' ' C ' ' D' ' 52' ' ' TYR . 0.0 OUTLIER -62.79 -49.25 75.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.145 -0.972 . . . . 0.0 110.181 -179.348 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 53' ' ' ARG . . . . . 0.419 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 0.7 OUTLIER -71.6 -28.48 63.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.536 -1.353 . . . . 0.0 110.19 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -75.66 -54.91 6.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.086 -1.009 . . . . 0.0 111.089 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 55' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.1 OUTLIER -75.58 -18.29 59.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.957 -1.089 . . . . 0.0 110.583 -178.673 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 56' ' ' GLU . . . . . 0.526 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 2.2 tm-20 -84.5 -33.7 23.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.856 -1.152 . . . . 0.0 108.063 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 57' ' ' HIS . . . . . 0.419 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 0.5 OUTLIER -69.0 -38.6 79.36 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 58' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' D' ' 60' ' ' LYS . . . -69.78 -61.5 4.34 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.1 77.61 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -1.159 . . . . 0.0 109.556 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 60' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' D' ' 58' ' ' GLY . 50.9 tttt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.479 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 26' ' ' LEU . 8.6 m-20 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -45.82 -11.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.778 2.319 . . . . 0.0 112.27 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 24' ' ' ASP . 37.2 tp -46.65 -46.31 19.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.234 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.6 t -68.51 -44.78 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 108.974 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -49.15 -49.39 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 0.0 109.08 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.83 -35.04 79.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 109.355 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.41 -56.98 10.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.69 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.95 -36.98 68.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.194 -0.941 . . . . 0.0 109.866 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.8 mt -71.01 -40.91 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.107 -0.996 . . . . 0.0 109.441 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.9 mt -57.02 -36.05 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.141 -0.974 . . . . 0.0 108.59 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.29 -44.1 53.34 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.5 mt -61.81 -27.02 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.165 -1.197 . . . . 0.0 109.155 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.99 -66.6 0.65 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.333 -0.854 . . . . 0.0 109.441 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.31 -39.31 6.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 109.841 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.67 -69.0 0.3 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.419 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.5 mt -47.1 -34.34 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.514 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 mt -62.87 -55.8 22.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.464 -0.773 . . . . 0.0 109.943 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -52.03 -45.01 64.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mt -68.76 -28.29 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.108 -0.995 . . . . 0.0 109.279 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -61.69 -44.26 97.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.563 -179.653 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.507 ' OD1' ' NH2' ' B' ' 45' ' ' ARG . 2.6 m-20 -80.19 -24.45 40.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 109.97 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -93.31 0.97 57.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.122 -0.987 . . . . 0.0 111.25 -179.22 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.48 ' C ' ' O ' ' A' ' 45' ' ' ARG . 31.0 mt -31.3 -36.27 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.693 -0.63 . . . . 0.0 110.814 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 169.15 -10.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 109.267 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -46.21 103.8 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.383 -0.823 . . . . 0.0 109.42 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' CG ' ' H ' ' A' ' 50' ' ' SER . 12.6 tptm -145.44 -129.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.905 . . . . 0.0 109.713 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.428 ' H ' ' CG ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER 65.36 135.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.282 -0.886 . . . . 0.0 109.229 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.1 mt -102.17 -35.26 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.525 -0.735 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -35.39 69.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.612 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -64.24 -41.12 97.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 0.0 109.369 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -65.34 -29.11 69.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.434 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -75.34 -68.42 0.56 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.098 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -46.83 -31.27 2.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.243 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -69.85 -58.77 3.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.314 -0.866 . . . . 0.0 109.566 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.19 -60.45 9.0 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.08 97.17 1.44 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -1.1 . . . . 0.0 109.356 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.4 mttp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.511 -179.888 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 30.3 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' B' ' 26' ' ' LEU . 4.8 m-20 48.82 67.28 4.66 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.449 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -47.22 -9.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.763 2.309 . . . . 0.0 112.311 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' B' ' 24' ' ' ASP . 39.1 tp -47.22 -44.76 22.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.944 . . . . 0.0 108.871 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 38.7 t -68.66 -44.88 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 108.758 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.5 t -49.7 -50.62 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 109.176 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.39 -34.82 78.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 109.391 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.76 -55.99 14.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 109.685 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.72 -36.85 67.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 109.873 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 18.9 mt -72.42 -42.4 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.553 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 mt -55.85 -34.65 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.054 -1.029 . . . . 0.0 108.826 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.33 -43.89 36.55 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 67.7 mt -60.25 -26.29 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.243 -1.151 . . . . 0.0 109.234 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.58 -64.49 1.06 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.267 -0.896 . . . . 0.0 109.263 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -45.5 -43.56 11.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.4 tp -63.15 -64.57 0.87 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.311 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 8.2 mt -47.78 -28.36 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.471 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mt -67.44 -55.86 11.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 110.141 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -55.67 -39.72 71.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.944 . . . . 0.0 109.937 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 94.5 mt -70.58 -40.57 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.954 -1.091 . . . . 0.0 108.959 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 50.3 tp -57.51 -41.33 80.61 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.516 -0.74 . . . . 0.0 109.767 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.3 -23.73 43.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.154 -0.966 . . . . 0.0 109.84 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.507 ' NH2' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -89.01 -4.74 58.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.044 -1.035 . . . . 0.0 110.902 -179.19 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.497 ' C ' ' O ' ' B' ' 45' ' ' ARG . 28.0 mt -33.56 -35.9 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.693 -0.629 . . . . 0.0 110.166 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' B' ' 45' ' ' ARG . 3.3 t80 -172.59 136.08 0.73 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.943 . . . . 0.0 109.326 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' PHE . . . . . 0.413 ' CD2' ' O ' ' B' ' 47' ' ' PHE . 0.7 OUTLIER -167.85 98.58 0.46 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.216 -0.928 . . . . 0.0 109.43 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -141.79 -35.73 0.44 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 109.424 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 11.9 p -65.65 124.71 23.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.291 -0.88 . . . . 0.0 109.531 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 15.8 mt -111.39 -22.67 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.671 -0.643 . . . . 0.0 109.347 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -54.03 -21.43 8.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.663 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -69.87 -45.9 66.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.437 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -65.09 -34.4 78.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.476 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -65.65 -60.24 3.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 109.458 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -52.71 -30.96 35.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.459 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -62.63 -63.42 1.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 109.315 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.33 -59.29 9.77 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mt -50.77 143.96 9.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.358 -1.084 . . . . 0.0 109.683 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.5 mttm . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.33 179.854 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 50.9 p . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' C' ' 24' ' ' ASP . 1.7 p-10 -171.11 70.24 0.51 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.393 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.53 -9.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.814 2.343 . . . . 0.0 112.402 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' C' ' 24' ' ' ASP . 48.3 tp -47.76 -46.97 30.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.189 -0.944 . . . . 0.0 109.033 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.78 -45.47 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.238 -0.914 . . . . 0.0 108.759 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -48.46 -46.48 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 0.0 109.139 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.93 -36.87 83.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -0.929 . . . . 0.0 109.46 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.36 -55.13 27.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 109.388 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.08 -36.2 67.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.392 -0.818 . . . . 0.0 109.894 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 18.4 mt -72.98 -41.57 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.109 -0.994 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 21.1 mt -56.78 -34.79 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.074 -1.016 . . . . 0.0 108.614 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.11 -45.17 42.03 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 54.4 mt -57.13 -31.81 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.21 -1.171 . . . . 0.0 108.869 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.98 -64.62 0.87 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.456 -0.778 . . . . 0.0 109.055 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -46.25 -39.08 9.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.876 . . . . 0.0 109.72 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -63.09 -70.13 0.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.956 . . . . 0.0 109.545 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 3.9 mt -47.14 -37.92 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.319 -0.863 . . . . 0.0 109.401 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mt -61.42 -61.79 2.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.343 -0.848 . . . . 0.0 110.101 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -45.85 -49.48 15.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.366 -0.834 . . . . 0.0 109.578 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 64.7 mt -60.57 -44.44 96.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.166 -0.959 . . . . 0.0 108.9 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' C' ' 43' ' ' LEU . 0.1 OUTLIER -48.36 -55.28 11.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.536 -0.727 . . . . 0.0 109.583 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -64.4 -27.71 69.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 110.316 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -72.11 -25.25 61.67 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.861 -1.149 . . . . 0.0 110.798 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 47' ' ' PHE . 9.7 mt -68.95 -8.78 47.71 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.669 -1.27 . . . . 0.0 109.289 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' C' ' 49' ' ' LYS . 2.9 m-85 -47.23 -92.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -0.93 . . . . 0.0 109.35 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 46.09 19.63 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.762 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 49' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' C' ' 47' ' ' PHE . 16.4 mtpt -64.01 -148.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.153 -0.967 . . . . 0.0 109.483 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.7 162.83 14.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.174 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 13.4 mt -103.93 -22.76 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.536 -0.728 . . . . 0.0 109.442 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 52' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' C' ' 52' ' ' TYR . 6.5 t80 -63.55 -22.05 66.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.265 -0.897 . . . . 0.0 109.982 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -66.33 -46.99 74.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.072 -1.017 . . . . 0.0 110.0 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -66.02 -33.68 76.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 0.0 109.691 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -63.17 -58.65 6.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.378 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -57.14 -30.0 64.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 109.157 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -67.28 -45.83 75.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.298 -0.876 . . . . 0.0 109.127 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.25 -61.89 5.36 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 mt -48.7 140.08 8.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -1.153 . . . . 0.0 109.494 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.474 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.286 0.565 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.37 160.11 0.38 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.328 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 25' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' D' ' 26' ' ' LEU . 19.5 Cg_endo -61.83 -24.42 77.24 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.567 2.178 . . . . 0.0 112.206 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' D' ' 25' ' ' PRO . 56.2 tp -45.59 -41.02 9.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 108.775 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 33.5 t -70.26 -45.27 76.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.303 -0.873 . . . . 0.0 108.697 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 74.1 t -49.76 -49.1 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 108.95 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.37 -33.47 76.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.307 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.23 -56.17 14.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.663 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -37.12 69.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.228 -0.92 . . . . 0.0 109.858 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 20.6 mt -71.36 -41.67 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.076 -1.015 . . . . 0.0 109.426 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 17.3 mt -56.48 -33.94 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.071 -1.018 . . . . 0.0 108.566 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.58 -44.55 32.38 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 61.9 mt -58.41 -29.66 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.343 -1.092 . . . . 0.0 109.218 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.13 -67.07 0.6 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.0 109.097 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -46.82 -37.29 8.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 0.0 109.732 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 59.4 tp -65.09 -69.2 0.31 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.133 -0.98 . . . . 0.0 109.507 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.1 mt -49.2 -26.51 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.483 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 40' ' ' LEU . . . . . 0.488 ' C ' HD23 ' D' ' 40' ' ' LEU . 2.3 tt -67.64 -63.03 1.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.924 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 41' ' ' TRP . . . . . 0.507 ' CH2' ' NE ' ' D' ' 45' ' ' ARG . 24.7 t-105 -53.04 -43.87 66.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.984 -1.072 . . . . 0.0 109.666 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.75 -51.2 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.152 -0.967 . . . . 0.0 108.782 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 58.1 tp -50.06 -39.73 43.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.608 -0.683 . . . . 0.0 109.931 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.79 -24.43 55.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 109.911 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.507 ' NE ' ' CH2' ' D' ' 41' ' ' TRP . 0.6 OUTLIER -76.08 -25.24 55.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.106 -0.996 . . . . 0.0 110.21 -179.596 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -73.13 -28.88 62.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.796 -1.19 . . . . 0.0 109.338 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 47' ' ' PHE . . . . . 0.455 ' O ' ' CB ' ' D' ' 48' ' ' PHE . 7.5 m-85 -66.19 -170.4 0.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 48' ' ' PHE . . . . . 0.455 ' CB ' ' O ' ' D' ' 47' ' ' PHE . 2.4 t80 73.61 18.5 3.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 49' ' ' LYS . . . . . 0.485 ' CG ' ' H ' ' D' ' 50' ' ' SER . 0.0 OUTLIER -58.47 -97.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -0.869 . . . . 0.0 109.409 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.51 ' OG ' ' CZ ' ' D' ' 52' ' ' TYR . 1.1 t -57.76 139.52 53.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.44 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 19.8 mt -109.59 -26.83 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.661 -0.65 . . . . 0.0 109.522 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 52' ' ' TYR . . . . . 0.51 ' CZ ' ' OG ' ' D' ' 50' ' ' SER . 17.8 p90 -59.99 -43.82 94.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.93 . . . . 0.0 109.721 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 53' ' ' ARG . . . . . 0.407 ' N ' ' CD2' ' D' ' 52' ' ' TYR . 10.1 mtp85 -64.39 -35.93 82.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.089 -1.007 . . . . 0.0 109.339 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -63.48 -33.74 76.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.878 . . . . 0.0 109.334 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -71.21 -56.59 5.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -0.84 . . . . 0.0 109.215 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -51.56 -29.31 16.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.221 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -69.34 -55.79 9.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.913 . . . . 0.0 109.235 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -48.07 -57.17 8.16 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.73 121.6 13.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.345 -1.091 . . . . 0.0 109.445 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 23.6 tttt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.486 -179.981 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.532 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 5.1 m-20 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 12.8 Cg_endo -59.01 -12.67 16.09 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.744 2.296 . . . . 0.0 112.121 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.2 tp -47.22 -46.85 24.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 0.0 108.959 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.2 t -68.9 -44.74 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.34 -0.85 . . . . 0.0 108.792 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.3 t -49.36 -49.33 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.0 108.815 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.82 -33.39 75.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.374 -0.829 . . . . 0.0 109.35 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.52 -56.8 10.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.3 -0.875 . . . . 0.0 109.677 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.98 -37.34 68.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 109.891 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 27.7 mt -71.59 -41.36 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.136 -0.977 . . . . 0.0 109.474 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.1 mt -55.67 -34.79 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.175 -0.953 . . . . 0.0 108.458 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.26 -44.96 32.69 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.2 mt -56.84 -34.07 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.175 -1.191 . . . . 0.0 109.248 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.96 -63.61 1.03 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 109.086 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.96 -38.39 7.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.475 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.71 -70.97 0.2 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.872 . . . . 0.0 109.392 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 mt -46.79 -25.52 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.278 -0.889 . . . . 0.0 109.505 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -74.24 -55.5 5.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.704 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.5 t-105 -50.84 -48.52 59.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.96 . . . . 0.0 109.613 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mt -65.78 -57.53 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.291 -0.881 . . . . 0.0 109.398 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.6 tp -48.78 -27.95 3.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.541 -0.725 . . . . 0.0 110.525 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 2.3 m-20 -90.3 -26.97 19.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.012 -1.055 . . . . 0.0 109.961 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -73.12 -26.12 61.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.628 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 48' ' ' PHE . 9.0 mt -64.91 -9.81 24.06 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.795 -1.191 . . . . 0.0 109.552 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -66.82 76.61 0.12 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.1 -1.0 . . . . 0.0 109.514 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -156.9 21.01 0.32 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -126.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.54 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.0 m -48.55 125.91 10.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 0.0 109.421 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.3 mt -94.62 -24.86 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.817 . . . . 0.0 109.428 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.505 ' CD2' ' OE1' ' A' ' 56' ' ' GLU . 0.5 OUTLIER -60.6 -23.23 64.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.878 . . . . 0.0 109.592 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.457 ' O ' ' CG ' ' A' ' 57' ' ' HIS . 21.3 mtt180 -70.36 -37.47 74.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.088 -1.008 . . . . 0.0 109.665 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -71.93 -36.52 69.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.154 -0.966 . . . . 0.0 109.298 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -65.62 -46.42 79.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 0.0 109.793 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.505 ' OE1' ' CD2' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -70.56 -28.16 64.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.245 -0.909 . . . . 0.0 109.708 -179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.457 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 1.9 m-70 -67.28 -46.32 73.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 109.196 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.86 -65.16 2.56 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mt -59.1 145.34 42.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -1.136 . . . . 0.0 109.492 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.457 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.561 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 28.9 m-20 -152.21 48.5 0.47 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 109.612 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 10.5 Cg_endo -56.52 -15.06 14.45 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.794 2.33 . . . . 0.0 112.235 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' B' ' 26' ' ' LEU . 29.6 tp -46.5 -46.1 18.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.247 -0.908 . . . . 0.0 109.096 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.53 -44.39 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.231 -0.918 . . . . 0.0 108.967 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 74.5 t -50.73 -50.22 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.302 -0.874 . . . . 0.0 109.089 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.42 -36.56 82.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.53 -56.08 16.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.336 -0.852 . . . . 0.0 109.806 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.22 -36.77 66.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 109.707 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.19 -40.33 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.108 -0.995 . . . . 0.0 109.613 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.45 HD13 HG13 ' C' ' 35' ' ' ILE . 17.1 mt -56.8 -36.0 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.019 -1.051 . . . . 0.0 108.803 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.63 -43.29 44.33 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 86.2 mt -63.11 -21.27 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.35 -1.088 . . . . 0.0 108.908 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.55 -69.77 0.54 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.838 . . . . 0.0 109.218 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -46.55 -33.69 4.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.332 -0.855 . . . . 0.0 109.453 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.7 tp -68.11 -68.76 0.36 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.358 -0.839 . . . . 0.0 109.446 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -48.64 -33.33 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -0.925 . . . . 0.0 109.433 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.461 ' O ' HD23 ' B' ' 40' ' ' LEU . 2.1 tt -64.32 -54.74 28.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 109.444 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -48.83 -48.04 41.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.3 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 11.5 mt -66.27 -33.12 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.119 -0.988 . . . . 0.0 108.802 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -58.88 -34.5 71.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.507 -0.746 . . . . 0.0 110.316 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -87.71 -27.26 22.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.971 -1.081 . . . . 0.0 109.614 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -91.63 3.46 54.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 110.649 -179.481 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.481 ' C ' ' O ' ' B' ' 45' ' ' ARG . 34.1 mt -29.35 -37.02 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.976 -0.453 . . . . 0.0 110.915 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' B' ' 45' ' ' ARG . 0.4 OUTLIER -177.92 165.01 1.96 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.995 -1.066 . . . . 0.0 109.7 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -163.99 110.43 1.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.814 . . . . 0.0 109.432 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.586 ' N ' ' CD ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -144.02 -18.48 0.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.375 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.4 97.22 10.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.214 -0.929 . . . . 0.0 109.35 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 5.8 mt -93.33 -23.84 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.255 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -34.94 74.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.588 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 12.3 mtp180 -64.66 -32.58 74.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.869 . . . . 0.0 109.395 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -72.69 -42.63 64.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -0.892 . . . . 0.0 109.27 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -60.48 -39.7 88.61 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.385 -0.822 . . . . 0.0 109.015 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -71.77 -30.87 66.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.408 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -65.18 -48.95 71.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.27 -0.894 . . . . 0.0 109.066 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.9 -62.34 5.32 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 3.9 mt -58.98 138.08 57.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.353 -1.087 . . . . 0.0 109.272 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 16.0 tttm . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.52 -179.896 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.324 0.583 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 10.8 t0 -167.6 48.77 0.16 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.9 . . . . 0.0 109.197 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 25' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 2.9 Cg_endo -44.98 -19.77 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.778 2.319 . . . . 0.0 112.011 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 32.3 tp -45.85 -40.73 10.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.404 -0.81 . . . . 0.0 109.172 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.44 -45.19 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.866 . . . . 0.0 108.959 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 70.8 t -51.18 -49.88 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 108.973 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.89 -32.99 74.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.839 . . . . 0.0 109.249 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.36 -55.88 13.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.865 . . . . 0.0 109.47 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.93 -36.47 70.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.352 -0.843 . . . . 0.0 109.672 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 15.4 mt -71.45 -40.23 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.159 -0.963 . . . . 0.0 109.402 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.4 mt -58.03 -35.69 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.139 -0.976 . . . . 0.0 108.665 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.42 -43.23 62.57 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 35' ' ' ILE . . . . . 0.45 HG13 HD13 ' B' ' 33' ' ' ILE . 79.5 mt -63.76 -28.87 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.415 -1.05 . . . . 0.0 109.006 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.94 -58.86 4.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.412 -0.805 . . . . 0.0 108.98 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -54.36 -42.76 70.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.397 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 59.2 tp -58.81 -62.79 1.61 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.131 -0.98 . . . . 0.0 109.319 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mt -51.61 -40.98 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.215 -0.928 . . . . 0.0 109.495 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mt -60.86 -54.43 45.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.403 -0.81 . . . . 0.0 110.05 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -52.21 -44.61 64.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.366 -0.834 . . . . 0.0 109.813 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 36.4 mt -70.48 -28.17 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.236 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.82 -43.5 98.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.644 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.31 -24.6 32.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.111 -0.993 . . . . 0.0 109.688 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' C' ' 47' ' ' PHE . 1.6 mmt85 -89.42 -1.18 57.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.3 -0.875 . . . . 0.0 110.753 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.491 ' C ' ' O ' ' C' ' 45' ' ' ARG . 29.0 mt -31.16 -36.23 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.851 -0.531 . . . . 0.0 110.805 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' C' ' 45' ' ' ARG . 2.3 m-85 -169.16 85.22 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.116 -0.99 . . . . 0.0 109.801 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 46.32 -132.87 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 109.686 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -170.07 -140.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.88 . . . . 0.0 109.256 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 50' ' ' SER . . . . . 0.441 ' O ' ' CZ ' ' C' ' 54' ' ' PHE . 40.5 t -147.9 120.52 8.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.319 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 17.1 mt -86.79 -23.12 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.243 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -23.85 64.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.352 -0.842 . . . . 0.0 109.499 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -70.39 -45.49 65.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.132 -0.98 . . . . 0.0 109.956 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' C' ' 54' ' ' PHE . 0.7 OUTLIER -69.1 -43.14 75.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.007 -1.058 . . . . 0.0 109.069 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -55.95 -56.72 17.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.407 -0.808 . . . . 0.0 109.354 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -26.8 68.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.664 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 37.0 t60 -67.16 -47.5 70.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.225 -0.922 . . . . 0.0 109.131 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.28 -59.6 9.21 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 62.4 mt -69.09 147.86 50.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.325 -1.103 . . . . 0.0 109.791 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 15.3 mttp . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.626 179.709 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 23' ' ' SER . . . . . 0.404 ' O ' ' OD1' ' D' ' 24' ' ' ASP . 69.4 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' D' ' 26' ' ' LEU . 62.0 m-20 -151.68 68.0 7.47 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -46.95 -11.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.659 2.239 . . . . 0.0 112.187 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' D' ' 24' ' ' ASP . 36.9 tp -47.36 -46.32 25.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.023 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 80.6 t -67.67 -45.5 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 0.0 108.852 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 72.6 t -49.42 -47.4 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.897 . . . . 0.0 108.912 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.53 -34.2 77.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.412 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.41 -56.63 10.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.194 -0.941 . . . . 0.0 109.634 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.94 -35.67 66.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 0.0 109.91 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 18.9 mt -73.25 -43.73 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.133 -0.979 . . . . 0.0 109.561 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 20.6 mt -54.56 -34.42 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.177 -0.952 . . . . 0.0 108.655 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.55 -44.41 26.82 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 50.0 mt -55.59 -31.04 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.087 -1.243 . . . . 0.0 109.356 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.11 -63.02 1.36 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.299 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -45.87 -38.94 7.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.367 -0.833 . . . . 0.0 109.854 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 53.7 tp -68.12 -67.85 0.43 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.123 -0.985 . . . . 0.0 109.642 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -47.31 -25.68 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.659 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.88 -65.67 0.67 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 109.818 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 21.3 t-105 -48.9 -45.19 40.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.212 -0.93 . . . . 0.0 109.879 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 42' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' D' ' 45' ' ' ARG . 84.9 mt -63.32 -56.86 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.131 -0.981 . . . . 0.0 108.875 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 61.2 tp -46.26 -45.82 17.42 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.539 -0.726 . . . . 0.0 109.422 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.79 -26.7 67.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.357 -0.839 . . . . 0.0 109.771 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.512 ' CA ' ' HE ' ' D' ' 45' ' ' ARG . 0.0 OUTLIER -77.49 -21.15 53.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.13 -0.981 . . . . 0.0 110.151 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.1 mt -83.65 -34.13 25.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.776 -1.202 . . . . 0.0 108.926 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -95.43 118.09 31.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.458 -0.776 . . . . 0.0 109.389 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -158.85 -8.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.122 -0.986 . . . . 0.0 109.63 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.9 pttp -67.98 -152.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.191 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 11.4 p 44.09 59.53 3.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.334 -0.854 . . . . 0.0 109.65 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 12.4 mt -96.83 -22.89 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.338 -0.852 . . . . 0.0 109.606 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -67.73 -22.75 65.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.136 -0.977 . . . . 0.0 109.483 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 53' ' ' ARG . . . . . 0.435 ' O ' ' ND1' ' D' ' 57' ' ' HIS . 0.1 OUTLIER -69.93 -39.37 76.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 109.44 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -69.72 -37.62 76.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.92 . . . . 0.0 109.089 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.35 -43.69 96.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.341 -0.849 . . . . 0.0 109.288 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -68.99 -27.95 66.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.272 -0.892 . . . . 0.0 109.114 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 57' ' ' HIS . . . . . 0.435 ' ND1' ' O ' ' D' ' 53' ' ' ARG . 1.7 m-70 -67.37 -46.95 71.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.308 -0.87 . . . . 0.0 108.855 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.26 -60.99 7.38 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 114.81 6.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -1.061 . . . . 0.0 109.419 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.06 -0.972 . . . . 0.0 109.447 179.978 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 26' ' ' LEU . 13.3 m-20 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.123 0.487 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -45.72 -11.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.691 2.261 . . . . 0.0 112.076 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 24' ' ' ASP . 28.7 tp -47.37 -45.68 25.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.339 -0.851 . . . . 0.0 109.044 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.32 -45.64 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.288 -0.883 . . . . 0.0 108.803 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.5 t -49.53 -47.85 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.253 -0.904 . . . . 0.0 109.021 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.3 -33.58 76.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 109.339 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.18 -56.66 10.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.873 . . . . 0.0 109.685 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.95 -36.27 70.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.259 -0.9 . . . . 0.0 109.633 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.7 mt -70.87 -41.15 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 0.0 109.329 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.2 mt -57.48 -33.8 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.099 -1.001 . . . . 0.0 108.626 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.65 -44.38 39.92 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.1 mt -55.47 -34.98 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.321 -1.106 . . . . 0.0 109.097 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -68.82 -64.33 0.89 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.31 -0.869 . . . . 0.0 109.066 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.23 -41.01 8.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.445 -0.784 . . . . 0.0 110.072 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 35.4 tp -64.19 -68.04 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.111 -0.993 . . . . 0.0 109.6 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mt -47.9 -24.59 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.213 -0.93 . . . . 0.0 109.308 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.462 ' CD2' ' OD2' ' A' ' 44' ' ' ASP . 1.8 tt -71.35 -61.32 1.81 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 109.595 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 -51.16 -49.79 60.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.272 -0.892 . . . . 0.0 109.714 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 45' ' ' ARG . 80.6 mt -60.23 -56.32 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.006 -1.059 . . . . 0.0 108.969 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.3 tp -46.34 -42.15 14.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.477 -0.764 . . . . 0.0 109.578 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.462 ' OD2' ' CD2' ' A' ' 40' ' ' LEU . 72.9 m-20 -67.71 -28.19 67.45 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.21 -0.931 . . . . 0.0 109.276 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 42' ' ' ILE . 7.0 mmt-85 -80.11 -17.72 51.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 110.42 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -87.14 -35.08 18.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.693 -1.255 . . . . 0.0 109.002 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -99.5 -154.58 0.47 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.462 -0.774 . . . . 0.0 109.255 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 t80 66.56 114.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 50' ' ' SER . 5.3 ptmm? -169.8 -148.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.315 -0.866 . . . . 0.0 109.3 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 49' ' ' LYS . 17.0 m 50.98 97.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.9 mt -86.5 -24.42 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 109.067 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -59.23 -21.7 59.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.272 -0.892 . . . . 0.0 109.867 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.521 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 17.7 mmm180 -74.43 -44.09 53.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.91 -1.119 . . . . 0.0 109.744 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -73.71 -33.55 64.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.993 -1.067 . . . . 0.0 108.496 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -68.43 -52.12 36.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.351 -0.843 . . . . 0.0 109.861 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -71.17 -27.54 63.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.122 -0.986 . . . . 0.0 110.194 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 11.4 m170 -65.0 -52.91 53.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.966 -1.084 . . . . 0.0 109.124 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.05 -64.52 2.76 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.4 116.98 4.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.189 -1.183 . . . . 0.0 109.425 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.431 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.537 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 16.6 m-20 -159.96 50.22 0.34 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.212 -0.93 . . . . 0.0 109.376 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 12.3 Cg_endo -58.7 -15.8 27.79 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.928 2.418 . . . . 0.0 112.438 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 52.1 tp -47.22 -43.23 21.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.086 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.58 -45.25 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.91 . . . . 0.0 108.733 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 77.6 t -49.0 -46.34 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.282 -0.886 . . . . 0.0 108.989 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.95 -37.1 85.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 109.144 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.01 -55.37 29.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.339 -0.851 . . . . 0.0 109.651 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.0 -37.28 71.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 110.06 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 14.0 mt -70.84 -39.75 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.141 -0.974 . . . . 0.0 109.319 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 26.8 mt -57.77 -36.44 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.246 -0.909 . . . . 0.0 108.634 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.54 -44.55 63.6 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.2 -23.28 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.295 -1.12 . . . . 0.0 109.005 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.2 tp -76.78 -71.71 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.464 -0.773 . . . . 0.0 109.456 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' HIS . . . . . 0.47 ' CD2' ' ND1' ' C' ' 37' ' ' HIS . 2.9 t-80 -44.79 -35.42 2.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 109.774 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -66.58 -68.66 0.36 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.191 -0.943 . . . . 0.0 109.466 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 7.0 mt -48.69 -41.18 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.463 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.96 -61.72 2.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 110.066 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -46.82 -47.62 21.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.104 -0.998 . . . . 0.0 109.746 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 70.1 mt -62.0 -42.17 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.185 -0.947 . . . . 0.0 109.11 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.42 -43.39 64.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.625 -0.672 . . . . 0.0 109.918 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -77.83 -25.41 48.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.743 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -71.83 -30.47 65.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.84 -1.163 . . . . 0.0 110.614 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -55.85 -26.53 47.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.734 -1.228 . . . . 0.0 109.281 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.19 -166.17 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.071 -1.018 . . . . 0.0 109.255 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -134.36 -125.02 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.742 . . . . 0.0 109.358 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -149.74 -63.68 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 83.7 p -52.14 104.96 0.1 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.871 . . . . 0.0 109.493 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 10.7 mt -103.75 -20.18 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.435 -0.791 . . . . 0.0 109.355 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -57.51 -12.64 2.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.576 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -72.1 -42.17 66.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 109.724 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -70.09 -38.41 75.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.143 -0.973 . . . . 0.0 108.993 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -59.43 -47.91 83.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.512 -0.743 . . . . 0.0 109.593 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.8 -27.2 63.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.584 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -66.18 -50.48 63.74 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.885 . . . . 0.0 109.13 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.03 -63.54 3.77 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 7.2 mt -68.65 118.58 11.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -1.148 . . . . 0.0 109.511 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 mptt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.481 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.32 159.22 75.54 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 0.0 109.277 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -61.08 -20.35 67.34 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.36 2.04 . . . . 0.0 112.205 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 47.4 tp -47.22 -42.54 20.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.944 . . . . 0.0 108.581 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 35.0 t -69.09 -45.48 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 73.8 t -48.77 -47.55 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 108.853 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.86 -36.48 84.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.37 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.13 -57.27 10.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.393 -0.817 . . . . 0.0 109.832 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.48 -36.97 67.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.268 -0.895 . . . . 0.0 109.916 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 24.8 mt -70.99 -42.45 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.378 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.9 mt -55.41 -35.69 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 108.83 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.25 -45.22 40.44 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 51.5 mt -55.72 -30.27 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.157 -1.202 . . . . 0.0 109.066 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' C' ' 36' ' ' LEU . 0.2 OUTLIER -73.73 -64.01 1.09 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 109.069 179.656 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 37' ' ' HIS . . . . . 0.47 ' ND1' ' CD2' ' B' ' 37' ' ' HIS . 13.0 t-80 -43.4 -37.25 2.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.484 -0.76 . . . . 0.0 110.244 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' C' ' 38' ' ' LEU . 35.3 tp -71.99 -65.17 0.8 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.983 -1.073 . . . . 0.0 109.523 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.3 mt -46.94 -27.64 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.235 -0.916 . . . . 0.0 109.393 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.04 -63.24 1.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.338 -0.851 . . . . 0.0 109.688 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -45.94 -47.5 16.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 109.287 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 64.5 mt -58.49 -49.31 82.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.221 -0.924 . . . . 0.0 108.93 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.56 -50.43 13.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.653 -0.655 . . . . 0.0 109.411 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 44' ' ' ASP . . . . . 0.423 ' OD1' ' NH1' ' D' ' 45' ' ' ARG . 1.3 m-20 -62.76 -32.82 74.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.89 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -73.02 -19.12 61.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.07 -1.019 . . . . 0.0 110.416 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -83.75 -13.63 53.49 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.641 -1.287 . . . . 0.0 108.716 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.93 12.7 5.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 0.0 109.733 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.16 106.69 18.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.113 -0.992 . . . . 0.0 109.039 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -163.58 -90.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.152 -0.967 . . . . 0.0 109.72 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.34 103.61 0.25 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.913 . . . . 0.0 109.756 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 18.4 mt -90.99 -22.68 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.052 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.97 -23.42 66.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.026 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 53' ' ' ARG . . . . . 0.52 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 96.7 mtt180 -70.38 -36.51 74.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.068 -1.02 . . . . 0.0 110.125 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -72.35 -34.74 68.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.004 -1.06 . . . . 0.0 109.286 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.26 -45.8 79.29 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.338 -0.851 . . . . 0.0 109.679 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -71.6 -29.01 64.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.0 109.591 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 57' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 2.7 m-70 -64.58 -43.05 95.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 109.068 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.44 -61.61 4.09 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 mt -75.07 107.2 6.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -1.117 . . . . 0.0 109.57 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 14.9 tttt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.515 179.824 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.537 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 6.1 t70 66.21 48.4 0.56 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.353 -0.842 . . . . 0.0 109.595 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 25' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 0.9 OUTLIER -48.11 -19.72 1.81 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.634 2.223 . . . . 0.0 111.701 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 42.1 tp -46.26 -41.17 12.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.423 -0.798 . . . . 0.0 108.99 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 36.4 t -69.66 -45.67 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.237 -0.914 . . . . 0.0 108.795 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 77.5 t -49.2 -47.35 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 108.963 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.8 -34.33 77.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.873 . . . . 0.0 109.226 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.2 -55.44 18.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.849 . . . . 0.0 109.688 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -58.1 -36.21 72.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.324 -0.86 . . . . 0.0 109.892 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 25.7 mt -72.05 -42.52 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.145 -0.972 . . . . 0.0 109.438 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mt -56.2 -33.37 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.107 -0.996 . . . . 0.0 108.457 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.5 -44.78 25.84 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.85 -28.99 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.188 -1.184 . . . . 0.0 109.113 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.18 -65.33 0.76 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.335 -0.853 . . . . 0.0 108.883 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -45.75 -42.88 12.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.48 -0.763 . . . . 0.0 109.712 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.19 -67.79 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 0.0 109.558 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mt -47.13 -35.7 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.175 -0.953 . . . . 0.0 109.639 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mt -63.5 -57.39 10.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.937 . . . . 0.0 109.826 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -48.15 -45.38 33.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.04 -1.037 . . . . 0.0 109.472 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 67.4 mt -64.49 -50.17 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.156 -0.965 . . . . 0.0 109.012 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 14.3 tp -52.09 -37.14 53.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.638 -0.664 . . . . 0.0 110.39 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.67 -21.73 30.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.036 -1.04 . . . . 0.0 110.349 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.423 ' NH1' ' OD1' ' C' ' 44' ' ' ASP . 0.0 OUTLIER -76.09 -28.95 57.73 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.984 -1.073 . . . . 0.0 110.712 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.25 -10.98 1.46 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.687 -1.258 . . . . 0.0 109.171 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -77.04 120.49 22.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.165 -0.96 . . . . 0.0 109.407 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.34 178.78 8.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.39 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 49' ' ' LYS . . . . . 0.543 ' CD ' ' H ' ' D' ' 50' ' ' SER . 6.0 tmtt? 54.83 -153.67 0.31 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.088 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.543 ' H ' ' CD ' ' D' ' 49' ' ' LYS . 2.6 m 47.01 54.7 8.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.945 -1.097 . . . . 0.0 110.023 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 47.4 mt -97.47 -28.64 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 0.0 109.297 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.44 -32.96 67.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.339 -0.85 . . . . 0.0 109.455 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -63.56 -34.76 78.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.114 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -72.55 -38.88 67.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.286 -0.884 . . . . 0.0 109.108 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -62.29 -49.39 75.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.411 -0.806 . . . . 0.0 109.208 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -67.87 -26.22 65.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.338 -0.851 . . . . 0.0 109.424 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -68.91 -34.71 75.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.87 . . . . 0.0 109.119 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.19 -62.89 2.36 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 7.5 mt -59.93 116.6 4.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -1.132 . . . . 0.0 109.337 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.474 179.886 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 26' ' ' LEU . 28.0 t70 . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -44.72 -12.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.677 2.251 . . . . 0.0 112.234 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' A' ' 24' ' ' ASP . 38.8 tp -48.92 -43.22 39.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.018 -1.052 . . . . 0.0 108.8 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 t -68.39 -46.01 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.232 -0.918 . . . . 0.0 108.588 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.6 t -49.08 -47.17 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 0.0 108.876 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.11 -33.39 75.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.316 -0.865 . . . . 0.0 109.345 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.44 -57.24 6.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.313 -0.867 . . . . 0.0 109.727 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.71 -37.14 65.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.968 . . . . 0.0 109.429 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.5 mt -71.11 -41.15 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 0.0 109.124 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.3 mt -56.03 -34.03 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.119 -0.988 . . . . 0.0 108.524 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.9 -45.84 31.7 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.9 mt -60.55 -23.13 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.265 -1.138 . . . . 0.0 108.845 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.6 tp -76.69 -70.8 0.43 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.518 -0.739 . . . . 0.0 109.082 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.467 ' HE2' ' CE1' ' B' ' 37' ' ' HIS . 1.9 t-80 -47.31 -33.51 5.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 109.506 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.9 tp -66.59 -69.17 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 109.654 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 mt -48.45 -27.68 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.61 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.483 HD12 HD11 ' B' ' 38' ' ' LEU . 1.6 mt -68.61 -59.82 2.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -0.933 . . . . 0.0 109.914 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -53.36 -46.12 69.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.021 -1.049 . . . . 0.0 109.809 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 82.2 mt -61.78 -52.77 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.018 -1.051 . . . . 0.0 108.836 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.8 tp -51.25 -38.58 53.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.506 -0.746 . . . . 0.0 109.399 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 1.4 m-20 -72.38 -24.98 61.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 109.23 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.558 ' CA ' ' HE ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -77.96 -24.12 48.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.177 -0.952 . . . . 0.0 110.14 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.463 ' C ' ' H ' ' A' ' 48' ' ' PHE . 9.3 mt -80.17 -13.93 58.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.77 -1.206 . . . . 0.0 109.043 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -75.03 29.78 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.655 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.463 ' H ' ' C ' ' A' ' 46' ' ' LEU . 78.0 t80 -83.04 77.14 9.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.134 -0.979 . . . . 0.0 109.369 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -85.71 -128.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.459 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.98 168.48 10.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.337 -0.852 . . . . 0.0 109.489 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.0 mt -104.2 -23.11 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.487 -0.758 . . . . 0.0 109.324 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -60.15 -21.82 62.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.097 -1.002 . . . . 0.0 109.734 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.7 mtt85 -69.39 -43.48 73.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.176 -0.952 . . . . 0.0 109.26 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -64.96 -36.56 84.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.476 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -70.68 -61.64 1.69 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -48.39 -29.72 4.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.348 -0.845 . . . . 0.0 109.646 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -71.13 -53.3 15.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.198 -0.939 . . . . 0.0 109.512 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.05 -60.28 9.33 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.8 mt -77.65 81.65 4.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -1.139 . . . . 0.0 109.604 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.7 tttt . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.379 179.864 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.86 160.86 66.62 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.301 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' B' ' 26' ' ' LEU . 18.7 Cg_endo -63.7 -21.08 69.9 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.525 2.15 . . . . 0.0 112.301 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' B' ' 25' ' ' PRO . 48.9 tp -46.63 -43.67 17.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 108.686 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 37.3 t -69.54 -44.76 79.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.306 -0.871 . . . . 0.0 108.801 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -48.6 -46.63 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.878 . . . . 0.0 108.827 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.15 -39.06 92.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.393 -0.817 . . . . 0.0 109.155 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.86 -57.51 11.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.458 -0.776 . . . . 0.0 109.948 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.78 -37.07 63.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.096 -1.003 . . . . 0.0 109.758 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 20.6 mt -71.38 -38.49 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.152 -0.967 . . . . 0.0 109.468 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 29.8 mt -57.51 -36.27 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.087 -1.008 . . . . 0.0 108.582 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.89 -46.53 52.18 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 69.0 mt -59.64 -25.76 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.306 -1.114 . . . . 0.0 108.891 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 14.0 tp -75.63 -67.88 0.62 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' HIS . . . . . 0.467 ' CE1' ' HE2' ' A' ' 37' ' ' HIS . 1.4 t60 -42.59 -42.73 3.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.529 -0.732 . . . . 0.0 110.086 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.483 HD11 HD12 ' A' ' 40' ' ' LEU . 22.2 tp -64.37 -64.66 0.82 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.979 -1.076 . . . . 0.0 109.521 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 6.3 mt -48.02 -29.34 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.327 -0.858 . . . . 0.0 109.556 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 5.2 mt -75.98 -57.79 3.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.552 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -45.83 -54.97 7.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.365 -0.834 . . . . 0.0 109.663 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' B' ' 45' ' ' ARG . 58.5 mt -58.66 -60.38 2.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.155 -0.966 . . . . 0.0 109.036 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' B' ' 42' ' ' ILE . 57.3 tp -41.61 -38.84 1.46 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.674 -0.641 . . . . 0.0 110.347 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.74 -30.19 62.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.1 -1.0 . . . . 0.0 109.625 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' B' ' 42' ' ' ILE . 0.4 OUTLIER -80.9 -13.64 58.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.898 . . . . 0.0 110.596 -179.521 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -87.28 -33.15 19.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.661 -1.275 . . . . 0.0 109.015 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -63.62 -19.87 65.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 109.515 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.02 128.9 34.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.445 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.414 ' HB3' ' HZ3' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -167.29 -54.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 109.504 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 78.1 p -93.32 138.39 31.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.959 . . . . 0.0 109.525 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 30.0 mt -110.33 -27.43 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.698 -0.626 . . . . 0.0 109.859 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -33.08 56.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.154 -0.966 . . . . 0.0 110.267 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -67.54 -39.71 85.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.861 -1.149 . . . . 0.0 109.595 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -66.28 -33.87 76.73 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.324 -0.86 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -68.24 -52.08 38.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 109.384 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -60.99 -30.92 70.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.676 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.26 -57.64 5.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 0.0 109.722 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.02 -58.93 11.76 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 5.2 mt -70.08 148.18 49.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.184 -1.186 . . . . 0.0 109.365 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 6.1 tptm . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.404 -179.936 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.352 0.596 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.502 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 4.9 p30 -166.71 51.84 0.24 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.391 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 25' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 12.4 Cg_endo -59.2 -9.54 8.52 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.633 2.222 . . . . 0.0 111.922 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 41.3 tp -47.5 -46.05 26.9 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.34 -0.85 . . . . 0.0 108.873 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 29.2 t -69.15 -45.58 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.213 -0.929 . . . . 0.0 108.686 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -49.2 -50.46 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.87 . . . . 0.0 109.071 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.77 76.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.872 . . . . 0.0 109.222 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.64 -55.84 15.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.448 -0.782 . . . . 0.0 109.659 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -54.92 -36.46 65.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 109.688 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.7 mt -72.41 -40.62 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.225 -0.922 . . . . 0.0 109.531 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 33' ' ' ILE . . . . . 0.451 HD13 HG13 ' D' ' 35' ' ' ILE . 23.5 mt -56.27 -35.65 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.001 -1.062 . . . . 0.0 108.871 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.15 -42.72 35.1 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 58.0 mt -58.72 -36.84 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -1.158 . . . . 0.0 109.57 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.45 -60.97 1.99 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.183 -0.948 . . . . 0.0 109.305 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -44.34 -39.34 4.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 0.0 110.187 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 25.6 tp -69.22 -66.94 0.52 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 109.688 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mt -46.81 -27.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.311 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 40' ' ' LEU . . . . . 0.529 ' O ' HD23 ' C' ' 40' ' ' LEU . 2.4 tt -74.25 -52.42 12.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.359 -0.838 . . . . 0.0 109.762 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 41' ' ' TRP . . . . . 0.435 ' CH2' ' NE ' ' C' ' 45' ' ' ARG . 24.3 t-105 -58.31 -46.08 86.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -0.962 . . . . 0.0 109.46 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 69.6 mt -64.57 -39.24 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.144 -0.973 . . . . 0.0 109.185 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.12 -31.31 71.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.839 . . . . 0.0 109.678 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -82.81 -25.24 32.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 109.627 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.435 ' NE ' ' CH2' ' C' ' 41' ' ' TRP . 3.5 mmt-85 -79.27 -26.15 42.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 111.137 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' C' ' 48' ' ' PHE . 6.4 mt -55.86 -9.69 0.62 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.413 -1.429 . . . . 0.0 109.217 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.414 ' N ' ' C ' ' C' ' 45' ' ' ARG . 70.8 t80 -70.61 66.3 0.33 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 109.108 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' C' ' 46' ' ' LEU . 2.7 t80 -92.19 153.41 19.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.863 . . . . 0.0 109.797 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp 59.06 -150.47 0.44 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 109.474 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 6.2 t 47.06 59.9 3.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.935 . . . . 0.0 109.548 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 15.8 mt -102.01 -31.08 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.429 -0.795 . . . . 0.0 109.411 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 52' ' ' TYR . . . . . 0.434 ' CD1' ' C ' ' C' ' 52' ' ' TYR . 0.0 OUTLIER -55.25 -34.25 63.85 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.336 -0.853 . . . . 0.0 110.13 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -67.42 -36.74 81.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.098 -1.001 . . . . 0.0 109.472 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -68.78 -32.29 71.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -0.95 . . . . 0.0 108.808 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -68.95 -47.01 66.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.449 -0.782 . . . . 0.0 109.3 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -65.94 -27.28 68.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.277 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 57' ' ' HIS . . . . . 0.652 ' CD2' ' HZ2' ' D' ' 49' ' ' LYS . 82.3 t60 -71.18 -44.54 65.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.095 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.11 -63.3 4.67 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 41.1 mt -80.96 90.39 5.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.286 -1.126 . . . . 0.0 109.393 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 mttm . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.536 -179.846 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.24 0.543 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' D' ' 26' ' ' LEU . 11.1 m-20 -154.29 66.28 5.28 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.362 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -45.26 -11.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.738 2.292 . . . . 0.0 112.179 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' D' ' 24' ' ' ASP . 41.9 tp -47.61 -44.98 27.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.127 -0.983 . . . . 0.0 109.193 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.4 t -68.47 -44.99 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.22 -0.925 . . . . 0.0 108.812 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.3 t -49.12 -48.62 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 108.981 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.71 -33.19 75.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.327 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.36 -57.1 8.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.342 -0.849 . . . . 0.0 109.571 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.56 -37.09 70.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.812 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 16.2 mt -71.11 -43.11 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.155 -0.965 . . . . 0.0 109.52 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 27.2 mt -56.05 -35.11 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.071 -1.018 . . . . 0.0 108.681 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.95 -43.79 39.58 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 35' ' ' ILE . . . . . 0.451 HG13 HD13 ' C' ' 33' ' ' ILE . 78.6 mt -62.26 -26.45 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.304 -1.115 . . . . 0.0 108.869 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.49 -67.0 0.55 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.478 -0.764 . . . . 0.0 109.172 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -45.16 -47.27 12.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.35 -0.844 . . . . 0.0 109.954 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.2 tp -57.62 -63.54 1.2 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.166 -0.959 . . . . 0.0 109.614 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 10.3 mt -50.57 -36.1 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.122 -0.986 . . . . 0.0 109.558 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 mt -63.57 -57.54 9.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.798 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -47.24 -44.75 23.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.279 -0.888 . . . . 0.0 109.548 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 12.2 mt -69.38 -33.9 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 108.714 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -60.14 -42.15 94.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.438 -0.789 . . . . 0.0 109.936 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.97 -22.19 36.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 0.0 109.612 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' D' ' 47' ' ' PHE . 9.3 mmt180 -92.57 -0.71 57.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 0.0 110.875 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.482 ' C ' ' O ' ' D' ' 45' ' ' ARG . 32.8 mt -31.01 -36.16 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.658 -0.651 . . . . 0.0 110.832 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 47' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' D' ' 45' ' ' ARG . 0.2 OUTLIER 178.23 15.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.139 -0.976 . . . . 0.0 109.547 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -49.95 101.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.449 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 49' ' ' LYS . . . . . 0.652 ' HZ2' ' CD2' ' C' ' 57' ' ' HIS . 0.0 OUTLIER -150.6 -29.16 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.964 . . . . 0.0 109.626 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 15.2 p -51.34 120.42 5.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 0.0 109.318 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 15.8 mt -101.07 -29.37 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.492 -0.755 . . . . 0.0 109.721 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -34.48 60.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.186 -0.946 . . . . 0.0 109.897 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -63.64 -39.6 94.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 109.551 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -67.55 -37.82 83.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 0.0 109.44 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.29 -64.43 0.88 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.437 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -51.27 -31.47 21.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.124 -0.985 . . . . 0.0 109.528 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 57' ' ' HIS . . . . . 0.414 ' ND1' ' C ' ' D' ' 57' ' ' HIS . 14.1 t-80 -69.26 -53.98 17.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.159 -0.963 . . . . 0.0 109.541 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.97 -62.29 6.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 59' ' ' LEU . . . . . 0.453 HD13 ' C ' ' D' ' 59' ' ' LEU . 0.4 OUTLIER -55.35 109.94 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -1.13 . . . . 0.0 109.076 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 60' ' ' LYS . . . . . 0.432 ' N ' HD13 ' D' ' 59' ' ' LEU . 17.6 ttmt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.562 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.6 m-20 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.8 Cg_endo -55.12 -14.92 9.54 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.837 2.358 . . . . 0.0 112.266 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.9 tp -47.5 -44.28 25.35 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.201 -0.937 . . . . 0.0 109.091 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.8 t -68.21 -45.08 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.186 -0.946 . . . . 0.0 108.665 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.6 t -50.89 -48.12 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 0.0 109.009 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.02 -32.72 74.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 109.464 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.52 -55.14 12.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.329 -0.857 . . . . 0.0 109.626 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.94 -36.21 67.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.744 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.1 mt -73.35 -43.34 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.509 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.4 mt -54.34 -32.95 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.029 -1.044 . . . . 0.0 108.595 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.41 -45.33 14.54 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.0 mt -56.64 -36.68 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.148 -1.207 . . . . 0.0 109.483 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.39 -59.51 2.94 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.236 -0.915 . . . . 0.0 109.203 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -44.3 -44.81 8.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.342 -0.849 . . . . 0.0 110.02 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.53 -68.83 0.31 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.084 -1.01 . . . . 0.0 109.639 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 mt -45.44 -29.76 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.418 -0.801 . . . . 0.0 109.653 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 mt -68.57 -61.5 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.947 . . . . 0.0 109.543 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.494 ' NE1' ' OD2' ' D' ' 44' ' ' ASP . 54.8 t-105 -44.33 -46.04 9.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.548 -0.72 . . . . 0.0 109.633 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.5 mt -71.59 -33.09 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.086 -1.009 . . . . 0.0 109.559 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.9 tp -61.52 -43.12 99.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 109.972 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.52 -20.74 36.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 110.588 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 46' ' ' LEU . 8.6 mmt180 -85.92 -16.56 38.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.711 -1.243 . . . . 0.0 111.515 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 45' ' ' ARG . 20.7 mt -39.61 -34.55 0.24 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.01 -1.056 . . . . 0.0 110.171 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.548 ' CG ' ' O ' ' A' ' 47' ' ' PHE . 1.6 p90 -55.05 126.73 25.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.014 -1.054 . . . . 0.0 109.394 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -173.76 32.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 109.235 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -148.7 -76.64 0.16 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 109.556 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 p -55.15 85.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.94 . . . . 0.0 109.597 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.52 ' N ' ' O ' ' A' ' 49' ' ' LYS . 26.3 mt -89.76 -21.29 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.648 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.54 -21.47 62.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.965 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -67.36 -40.87 85.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.966 . . . . 0.0 109.943 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -71.39 -37.65 71.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 0.0 109.32 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -59.08 -51.38 70.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.233 -0.917 . . . . 0.0 109.192 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -67.69 -26.29 66.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 109.452 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -67.25 -42.01 84.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.18 -0.95 . . . . 0.0 109.198 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.04 -62.58 3.49 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mt -52.9 159.7 1.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.392 -1.063 . . . . 0.0 109.503 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.9 mttt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.498 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' B' ' 26' ' ' LEU . 6.9 m-20 -156.55 65.29 3.82 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.605 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -45.61 -9.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.773 2.315 . . . . 0.0 112.182 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' B' ' 24' ' ' ASP . 29.1 tp -47.27 -46.9 25.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.263 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.96 -45.21 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.225 -0.922 . . . . 0.0 108.89 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 73.0 t -48.98 -48.88 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 108.999 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.22 -34.01 77.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.364 -0.835 . . . . 0.0 109.461 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.46 -56.63 10.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.26 -0.9 . . . . 0.0 109.599 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.11 -37.0 68.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.586 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 16.8 mt -71.0 -41.08 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 21.1 mt -56.4 -33.91 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.174 -0.954 . . . . 0.0 108.645 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.67 -43.13 24.48 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 66.9 mt -59.14 -39.4 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.115 -1.226 . . . . 0.0 109.308 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.12 -63.8 1.0 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.952 . . . . 0.0 109.076 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.08 -49.77 11.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.435 -0.79 . . . . 0.0 109.761 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' B' ' 38' ' ' LEU . 48.9 tp -56.5 -65.19 0.65 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 109.618 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.8 mt -46.44 -40.03 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 0.0 109.538 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.67 -63.24 1.37 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 110.095 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -45.06 -48.25 11.82 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.374 -0.828 . . . . 0.0 109.854 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 79.3 mt -61.53 -47.78 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.212 -0.93 . . . . 0.0 109.07 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 13.3 tp -51.78 -39.59 58.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.537 -0.727 . . . . 0.0 110.137 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.31 -26.45 55.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 109.953 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.509 ' CA ' ' HE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -73.58 -27.95 61.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.056 -1.027 . . . . 0.0 110.464 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -65.96 -31.06 71.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.688 -1.258 . . . . 0.0 109.179 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' B' ' 48' ' ' PHE . 60.3 t80 -78.19 -103.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 109.313 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' PHE . . . . . 0.48 ' N ' ' CG ' ' B' ' 47' ' ' PHE . 2.7 t80 48.04 -154.97 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.925 . . . . 0.0 109.747 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 6.6 tttt 68.73 -153.8 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.3 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' SER . . . . . 0.525 ' O ' ' CE2' ' B' ' 54' ' ' PHE . 13.8 m 44.77 75.53 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.215 -0.928 . . . . 0.0 109.401 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 27.3 mt -90.7 -20.25 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.15 -0.969 . . . . 0.0 109.712 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -20.97 58.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 0.0 109.581 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -71.49 -42.92 67.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 110.046 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' PHE . . . . . 0.525 ' CE2' ' O ' ' B' ' 50' ' ' SER . 4.0 m-85 -70.58 -35.08 72.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.059 -1.026 . . . . 0.0 109.492 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -63.55 -45.56 89.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.19 -0.944 . . . . 0.0 109.279 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -71.49 -25.49 62.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.514 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -65.97 -53.07 43.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.091 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.02 -60.52 7.12 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.12 148.96 16.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -1.168 . . . . 0.0 109.439 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 33.1 tttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.391 179.929 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.55 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 4.2 p30 -175.09 49.16 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.346 -0.846 . . . . 0.0 109.432 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 25' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 10.6 Cg_endo -56.34 -12.32 7.79 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.941 2.427 . . . . 0.0 112.249 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 35.5 tp -47.71 -44.65 27.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.129 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 38.6 t -68.99 -45.18 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.179 -0.95 . . . . 0.0 108.674 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.8 t -49.69 -49.19 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.0 108.889 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.17 -31.87 73.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.338 -0.851 . . . . 0.0 109.254 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.15 -57.27 7.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 109.686 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -55.68 -36.27 66.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.666 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.5 mt -71.79 -38.98 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.979 . . . . 0.0 109.548 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 23.7 mt -59.38 -35.51 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.015 -1.053 . . . . 0.0 108.73 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.47 -42.89 63.22 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 77.7 mt -63.63 -22.28 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.414 -1.05 . . . . 0.0 108.771 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.91 -70.84 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 37' ' ' HIS . . . . . 0.55 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 2.3 t-80 -45.92 -36.73 5.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.864 . . . . 0.0 109.67 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.95 -67.82 0.4 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.437 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 5.6 mt -48.54 -28.92 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.878 . . . . 0.0 109.672 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 mt -71.57 -59.79 2.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 110.01 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 51.9 t-105 -49.59 -47.75 49.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.084 -1.01 . . . . 0.0 109.811 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 73.2 mt -64.02 -58.74 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.102 -0.999 . . . . 0.0 109.273 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 59.2 tp -44.99 -54.46 6.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.47 -0.769 . . . . 0.0 109.679 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.79 -26.61 67.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.314 -0.867 . . . . 0.0 110.109 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.486 ' HE ' ' CA ' ' C' ' 45' ' ' ARG . 0.0 OUTLIER -79.19 -20.69 47.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.924 -1.11 . . . . 0.0 110.446 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -79.84 -32.14 40.56 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.701 -1.249 . . . . 0.0 109.058 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.451 ' O ' ' CB ' ' C' ' 48' ' ' PHE . 6.3 t80 -92.33 -144.91 0.21 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 0.0 109.31 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.451 ' CB ' ' O ' ' C' ' 47' ' ' PHE . 1.1 t80 72.38 106.31 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 109.441 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 49' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' C' ' 50' ' ' SER . 10.7 tttp -165.62 -154.03 0.19 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.366 -0.834 . . . . 0.0 109.094 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 50' ' ' SER . . . . . 0.42 ' O ' ' O ' ' C' ' 49' ' ' LYS . 34.6 m 42.55 91.14 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.333 -0.854 . . . . 0.0 109.917 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 10.3 mt -94.64 -19.09 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.411 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -67.53 -21.88 65.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.092 -1.005 . . . . 0.0 109.499 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -68.2 -42.33 80.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.895 . . . . 0.0 109.7 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 54' ' ' PHE . . . . . 0.428 ' HB3' HD11 ' D' ' 51' ' ' ILE . 1.5 m-85 -71.71 -45.13 62.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.112 -0.992 . . . . 0.0 109.036 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -54.29 -48.69 70.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 108.828 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -66.8 -26.95 67.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.397 -0.814 . . . . 0.0 109.032 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -66.95 -43.9 81.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.888 . . . . 0.0 108.746 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.47 -62.64 4.91 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.45 ' C ' HD13 ' C' ' 59' ' ' LEU . 0.5 OUTLIER -66.0 103.3 0.92 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -1.114 . . . . 0.0 108.925 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 31.9 tttm . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.079 -0.963 . . . . 0.0 109.542 179.97 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 66.1 p . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.472 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 2.6 m-20 53.21 52.8 10.82 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.243 -0.911 . . . . 0.0 109.441 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 25' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 11.2 Cg_endo -58.57 -13.7 18.34 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.542 2.161 . . . . 0.0 112.116 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' D' ' 26' ' ' LEU . 35.6 tp -48.0 -44.23 30.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.947 . . . . 0.0 108.901 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.58 -45.36 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.16 -0.962 . . . . 0.0 108.668 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 67.9 t -48.94 -47.7 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.847 . . . . 0.0 108.957 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.89 -35.07 79.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.336 -0.853 . . . . 0.0 109.166 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.86 -56.93 11.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.849 . . . . 0.0 109.708 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.87 -36.16 67.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.147 -0.971 . . . . 0.0 109.79 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 11.2 mt -71.63 -39.57 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.192 -0.942 . . . . 0.0 109.494 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 16.5 mt -58.67 -35.29 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.988 -1.07 . . . . 0.0 108.576 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.88 -43.73 57.67 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.86 -23.61 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.225 -1.162 . . . . 0.0 108.919 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.69 -70.21 0.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.866 . . . . 0.0 109.032 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 37' ' ' HIS . . . . . 0.55 ' CE1' ' NE2' ' C' ' 37' ' ' HIS . 9.8 t-80 -46.46 -35.64 5.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.913 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 57.3 tp -65.75 -63.02 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.117 -0.989 . . . . 0.0 109.564 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 6.8 mt -54.7 -32.82 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.522 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.03 -58.04 4.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.816 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 -46.45 -51.94 14.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.819 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.06 -53.58 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.008 -1.057 . . . . 0.0 108.883 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 54.9 tp -46.13 -44.05 15.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.464 -0.772 . . . . 0.0 109.895 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 44' ' ' ASP . . . . . 0.494 ' OD2' ' NE1' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -68.7 -28.18 66.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.775 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -79.2 -19.69 50.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 0.0 110.687 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.4 mt -80.9 -33.81 33.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.666 -1.271 . . . . 0.0 109.167 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -67.88 114.0 6.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.426 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -157.75 -155.14 0.48 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.153 -0.967 . . . . 0.0 109.597 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt 48.43 -153.5 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.36 -0.837 . . . . 0.0 109.243 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 94.4 p 43.1 65.34 0.98 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.36 -0.837 . . . . 0.0 109.65 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 51' ' ' ILE . . . . . 0.428 HD11 ' HB3' ' C' ' 54' ' ' PHE . 6.7 mt -89.96 -24.41 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 109.07 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.98 -27.92 65.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 109.893 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -71.94 -43.34 65.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.904 -1.122 . . . . 0.0 109.498 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -60.75 -37.03 80.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.383 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -68.57 -67.77 0.44 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.395 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -47.53 -40.16 18.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.893 . . . . 0.0 109.658 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -65.56 -54.37 28.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.305 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.83 -61.3 7.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.51 129.08 40.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -1.195 . . . . 0.0 109.413 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 37.8 tttp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.394 -179.9 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 26' ' ' LEU . 30.5 t0 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -46.06 -11.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.662 2.241 . . . . 0.0 112.031 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 24' ' ' ASP . 37.6 tp -47.78 -45.91 29.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.262 -0.899 . . . . 0.0 108.962 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.53 -45.29 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.207 -0.933 . . . . 0.0 108.721 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.3 t -49.12 -49.08 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 108.95 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.24 -32.55 74.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.316 -0.865 . . . . 0.0 109.157 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.81 -58.16 6.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.347 -0.845 . . . . 0.0 109.671 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.55 -36.85 67.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 109.743 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.4 mt -70.93 -39.74 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.361 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.3 mt -57.66 -34.51 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.027 -1.045 . . . . 0.0 108.415 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.96 -44.63 45.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.6 mt -57.0 -31.33 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.19 -1.182 . . . . 0.0 109.128 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.07 -64.69 0.86 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.305 -0.872 . . . . 0.0 109.208 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -44.96 -47.37 11.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.839 . . . . 0.0 110.223 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.8 tp -59.02 -63.92 1.13 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.997 -1.064 . . . . 0.0 109.693 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.3 mt -51.38 -25.74 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 109.601 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mt -74.74 -56.59 4.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.175 -0.953 . . . . 0.0 109.49 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -48.37 -51.3 27.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 109.377 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.75 -53.58 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.235 -0.916 . . . . 0.0 109.105 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.4 tp -46.49 -35.42 5.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.562 -0.711 . . . . 0.0 110.327 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 0.2 OUTLIER -79.2 -29.08 42.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.039 -1.038 . . . . 0.0 109.814 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.79 -19.48 57.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 0.0 110.873 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 47' ' ' PHE . 8.5 mt -77.6 -9.22 58.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.556 -1.34 . . . . 0.0 109.347 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.403 ' O ' ' O ' ' A' ' 46' ' ' LEU . 3.0 m-85 -47.41 -90.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 109.225 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 46.57 23.91 0.27 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 109.64 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -66.07 -144.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.495 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.3 m -80.51 141.48 35.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 109.629 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 mt -97.21 -32.19 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.514 -0.741 . . . . 0.0 109.432 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -56.2 -19.12 12.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -72.27 -41.04 67.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -0.987 . . . . 0.0 109.812 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -69.54 -33.3 72.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.088 -1.007 . . . . 0.0 109.377 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -69.7 -45.46 68.22 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.287 -0.883 . . . . 0.0 109.347 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -67.1 -27.05 67.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -69.12 -52.64 26.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.24 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.19 -60.56 8.73 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.1 mt -48.63 147.33 2.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.348 -1.089 . . . . 0.0 109.491 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.7 tttt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.35 179.829 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.51 162.68 28.98 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.279 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' B' ' 26' ' ' LEU . 23.4 Cg_endo -65.82 -28.31 51.18 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.51 2.14 . . . . 0.0 112.224 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' B' ' 25' ' ' PRO . 37.6 tp -45.73 -40.54 9.54 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.34 -44.53 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 71.0 t -49.94 -47.39 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.91 . . . . 0.0 108.774 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.69 78.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.237 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.38 -56.27 15.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -0.875 . . . . 0.0 109.832 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.41 -37.83 76.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -0.945 . . . . 0.0 110.018 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 18.4 mt -69.26 -42.97 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.107 -0.995 . . . . 0.0 109.191 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 mt -56.4 -34.46 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.242 -0.911 . . . . 0.0 108.783 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.33 -43.41 38.44 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 68.1 mt -60.38 -31.94 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.295 -1.12 . . . . 0.0 109.305 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.97 -66.52 0.6 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 109.248 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -44.96 -41.7 7.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 109.924 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.0 tp -62.7 -68.37 0.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.5 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 6.1 mt -46.93 -31.44 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.316 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -60.2 3.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.86 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' TRP . . . . . 0.404 ' NE1' ' OD2' ' A' ' 44' ' ' ASP . 37.7 t-105 -48.75 -43.94 38.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 109.664 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 25.8 mt -64.53 -40.01 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.99 . . . . 0.0 108.922 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 tp -56.48 -35.76 68.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.571 -0.706 . . . . 0.0 110.368 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.8 -22.98 27.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.071 -1.018 . . . . 0.0 110.382 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.483 ' CA ' ' HE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -76.13 -27.97 57.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.912 -1.117 . . . . 0.0 110.517 -179.204 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -51.86 -11.47 0.15 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.6 -1.312 . . . . 0.0 108.99 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.455 ' N ' ' O ' ' B' ' 45' ' ' ARG . 24.6 t80 -67.28 126.45 29.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.493 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -147.95 -90.54 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.92 . . . . 0.0 109.425 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -61.85 -149.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.181 -0.949 . . . . 0.0 109.393 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 48.8 p 45.99 56.67 5.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 109.612 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 12.4 mt -92.74 -28.95 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.263 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.68 -25.6 4.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.403 -0.811 . . . . 0.0 109.788 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.461 ' O ' ' CG ' ' B' ' 57' ' ' HIS . 30.4 mtt180 -68.52 -38.33 80.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.765 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -71.37 -35.15 70.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.027 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -65.8 -53.1 44.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.691 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -65.23 -30.43 71.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.885 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' HIS . . . . . 0.461 ' CG ' ' O ' ' B' ' 53' ' ' ARG . 1.7 m-70 -68.04 -41.77 81.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.147 -0.971 . . . . 0.0 109.437 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.75 -66.2 1.69 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' B' ' 59' ' ' LEU . 0.3 OUTLIER -73.74 108.24 6.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -1.144 . . . . 0.0 109.27 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.898 -1.048 . . . . 0.0 109.409 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.62 160.78 32.03 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.171 -0.956 . . . . 0.0 109.407 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' C' ' 26' ' ' LEU . 13.5 Cg_endo -60.05 -23.69 74.07 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.625 2.216 . . . . 0.0 112.2 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' C' ' 25' ' ' PRO . 39.9 tp -45.72 -42.08 11.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.294 -0.878 . . . . 0.0 108.86 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 46.9 t -70.0 -44.16 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.376 -0.828 . . . . 0.0 108.784 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 69.9 t -50.17 -47.63 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 0.0 108.918 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.06 86.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.567 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.62 -55.27 21.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 109.591 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.62 -36.76 67.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 109.83 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 25.9 mt -72.36 -42.64 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.511 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.1 mt -55.01 -34.26 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.12 -0.987 . . . . 0.0 108.805 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.8 -44.05 21.06 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 64.2 mt -58.35 -29.73 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.17 -1.194 . . . . 0.0 109.421 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.15 -59.42 2.75 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.235 -0.915 . . . . 0.0 109.015 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -47.24 -38.84 13.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.703 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.2 tp -68.68 -67.66 0.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.574 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.5 mt -46.09 -28.02 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 0.0 109.418 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 mt -69.95 -60.45 2.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.409 -0.807 . . . . 0.0 109.823 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -47.02 -43.61 19.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 42' ' ' ILE . . . . . 0.408 HD13 HG21 ' C' ' 42' ' ' ILE . 6.4 mt -70.75 -40.44 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.112 -0.992 . . . . 0.0 109.326 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 57.9 tp -60.51 -35.5 76.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.339 -0.851 . . . . 0.0 110.091 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -87.54 -19.24 28.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.116 -0.99 . . . . 0.0 110.167 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' C' ' 47' ' ' PHE . 3.7 mmt180 -84.65 -20.88 30.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.027 -1.046 . . . . 0.0 111.119 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' C' ' 45' ' ' ARG . 38.8 mt -46.35 -17.73 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.825 -1.172 . . . . 0.0 109.108 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' C' ' 45' ' ' ARG . 22.6 m-85 -93.08 79.25 4.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.264 -0.897 . . . . 0.0 109.319 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -83.77 -57.36 3.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.33 -0.856 . . . . 0.0 109.476 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -76.94 -139.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.36 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 46.1 m 52.78 61.35 3.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.442 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 61.1 mt -95.33 -26.01 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.865 . . . . 0.0 109.518 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -58.81 -22.72 59.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.267 -0.895 . . . . 0.0 109.835 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 53' ' ' ARG . . . . . 0.517 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 0.0 OUTLIER -67.37 -42.32 83.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.83 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -71.01 -38.9 72.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.289 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -62.83 -45.97 90.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.28 -0.888 . . . . 0.0 109.071 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -69.15 -27.33 65.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.833 . . . . 0.0 109.62 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 57' ' ' HIS . . . . . 0.517 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 2.4 m-70 -69.39 -38.54 78.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 0.0 109.188 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.6 -59.83 5.01 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mt -72.67 176.04 5.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -1.162 . . . . 0.0 109.496 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 60' ' ' LYS . . . . . 0.585 ' N ' ' CD ' ' C' ' 60' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.371 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' D' ' 26' ' ' LEU . 7.1 p30 -169.0 68.09 0.67 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.366 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -47.24 -9.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.754 2.302 . . . . 0.0 112.29 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' D' ' 24' ' ' ASP . 33.9 tp -47.48 -46.84 27.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.169 -0.957 . . . . 0.0 108.979 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.72 -45.79 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.262 -0.899 . . . . 0.0 108.728 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 66.2 t -48.45 -48.73 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -0.879 . . . . 0.0 108.881 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.81 -34.92 79.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.37 -0.831 . . . . 0.0 109.305 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.56 -56.37 12.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.0 109.755 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 2.5 m -55.65 -35.04 65.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 109.809 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 16.4 mt -73.89 -42.99 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.155 -0.966 . . . . 0.0 109.586 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 19.4 mt -55.14 -34.7 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.075 -1.016 . . . . 0.0 108.733 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.71 -44.83 37.68 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 56.6 mt -57.21 -35.02 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -1.134 . . . . 0.0 109.026 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -67.11 0.48 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.377 -0.827 . . . . 0.0 108.848 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -47.13 -37.95 10.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.378 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 59.3 tp -61.48 -70.7 0.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.23 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mt -49.35 -24.08 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.921 . . . . 0.0 109.577 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 40' ' ' LEU . . . . . 0.412 ' C ' HD23 ' D' ' 40' ' ' LEU . 1.7 tt -70.54 -60.68 2.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -0.891 . . . . 0.0 109.759 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -52.26 -46.54 65.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.092 -1.005 . . . . 0.0 109.53 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 54.9 mt -62.63 -55.02 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.179 -0.95 . . . . 0.0 108.878 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 42.3 tp -47.93 -37.59 14.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.542 -0.724 . . . . 0.0 109.744 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -73.72 -28.44 61.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.144 -0.972 . . . . 0.0 109.544 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.37 -20.57 54.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.195 -0.941 . . . . 0.0 110.423 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -80.34 -8.84 59.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.777 -1.202 . . . . 0.0 108.968 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -141.38 100.22 3.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.444 -0.785 . . . . 0.0 109.125 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -151.68 5.68 0.45 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.188 -0.945 . . . . 0.0 109.618 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -76.61 -140.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.447 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 15.3 m 47.37 76.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.872 . . . . 0.0 109.486 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 24.2 mt -99.75 -23.94 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.437 -0.789 . . . . 0.0 109.442 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 52' ' ' TYR . . . . . 0.401 ' CG ' ' N ' ' D' ' 53' ' ' ARG . 25.6 p90 -57.95 -33.31 68.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.338 -0.851 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 53' ' ' ARG . . . . . 0.48 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 23.0 ptt180 -65.16 -30.72 71.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -75.12 -34.01 61.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.296 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.9 -44.23 64.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -0.826 . . . . 0.0 109.902 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -72.76 -27.74 62.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.14 -0.975 . . . . 0.0 109.525 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 57' ' ' HIS . . . . . 0.48 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 0.7 OUTLIER -70.24 -42.52 72.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.913 . . . . 0.0 109.251 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.45 -64.36 2.77 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 59' ' ' LEU . . . . . 0.438 ' C ' HD23 ' D' ' 59' ' ' LEU . 1.7 tt -56.43 108.58 0.5 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -1.179 . . . . 0.0 109.551 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 60' ' ' LYS . . . . . 0.413 ' N ' HD23 ' D' ' 59' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.469 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.547 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.9 p30 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.7 Cg_endo -55.64 -17.89 18.86 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.813 2.342 . . . . 0.0 112.381 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 26' ' ' LEU . 22.9 tp -46.25 -43.26 15.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 109.008 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 t -69.34 -45.67 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.328 -0.858 . . . . 0.0 108.888 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.4 t -48.97 -48.5 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.91 . . . . 0.0 109.015 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.95 -35.99 82.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.34 -0.85 . . . . 0.0 109.422 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.02 -56.48 14.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.903 . . . . 0.0 109.737 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -36.82 65.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.236 -0.915 . . . . 0.0 109.923 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.8 mt -72.35 -40.94 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.133 -0.98 . . . . 0.0 109.496 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.1 mt -56.36 -34.12 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.059 -1.025 . . . . 0.0 108.675 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.99 -44.19 24.64 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.7 mt -58.89 -30.86 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.154 -1.204 . . . . 0.0 109.226 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.77 -66.76 0.62 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.286 -0.884 . . . . 0.0 109.059 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -46.12 -37.95 7.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.706 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.2 tp -64.14 -70.24 0.23 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 109.382 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.3 mt -47.32 -35.25 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 0.0 109.693 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mt -63.95 -63.23 1.21 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 109.934 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -45.41 -47.94 13.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.29 -46.77 94.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.395 -0.816 . . . . 0.0 108.916 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.07 -50.02 29.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.582 -0.699 . . . . 0.0 109.327 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.68 -30.78 71.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.392 -0.817 . . . . 0.0 110.289 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -69.25 -26.93 65.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.902 -1.124 . . . . 0.0 110.39 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -71.52 -32.71 68.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.649 -1.282 . . . . 0.0 109.47 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -67.15 -88.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.033 -1.042 . . . . 0.0 109.559 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.2 -168.39 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.1 tttt 48.25 -152.41 0.11 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.142 -0.974 . . . . 0.0 109.271 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.7 p 45.22 59.41 3.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 109.773 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 mt -98.69 -22.95 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 0.0 109.606 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -55.61 -25.3 38.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.971 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.463 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 6.6 ptt180 -67.7 -40.21 84.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.124 -0.985 . . . . 0.0 109.977 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.439 ' N ' ' CG ' ' A' ' 53' ' ' ARG . 54.9 m-85 -71.35 -36.7 71.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.028 -1.045 . . . . 0.0 109.404 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -63.41 -44.74 93.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -0.899 . . . . 0.0 109.219 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -70.28 -28.1 64.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 109.625 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.463 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 20.1 m170 -66.06 -42.29 89.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -0.947 . . . . 0.0 109.272 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.82 -63.4 2.87 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 mt -70.98 119.51 15.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -1.161 . . . . 0.0 109.368 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.4 mttt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.441 -179.949 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' B' ' 26' ' ' LEU . 19.1 t70 50.97 67.36 4.38 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.523 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -46.1 -11.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.673 2.248 . . . . 0.0 112.19 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' B' ' 24' ' ' ASP . 43.6 tp -47.23 -48.25 24.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 108.991 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 45.7 t -67.56 -44.47 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.305 -0.872 . . . . 0.0 108.903 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 77.8 t -49.23 -48.55 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.264 -0.897 . . . . 0.0 109.019 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.7 78.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.912 . . . . 0.0 109.339 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.24 -57.71 6.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 0.0 109.927 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.92 -36.49 62.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 109.806 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 24.0 mt -72.31 -41.63 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 109.424 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 21.9 mt -55.43 -34.82 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.156 -0.965 . . . . 0.0 108.73 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.29 -45.26 31.33 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 47.9 mt -54.97 -37.99 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.199 -1.177 . . . . 0.0 109.496 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.31 -58.31 3.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.173 -0.955 . . . . 0.0 108.818 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -46.8 -41.36 15.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -0.86 . . . . 0.0 109.6 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 51.3 tp -65.78 -70.02 0.26 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.783 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mt -46.57 -26.64 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 109.684 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 6.0 mt -70.19 -62.82 1.24 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.99 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -48.19 -47.74 35.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.069 -1.02 . . . . 0.0 109.674 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' B' ' 45' ' ' ARG . 68.0 mt -63.9 -61.35 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.132 -0.98 . . . . 0.0 109.336 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 60.5 tp -43.74 -42.37 5.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.687 -0.633 . . . . 0.0 109.784 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -69.32 -28.97 66.71 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.257 -0.902 . . . . 0.0 109.469 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' B' ' 42' ' ' ILE . 11.0 mmm180 -78.23 -16.69 57.59 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.218 -0.926 . . . . 0.0 110.105 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -88.8 -9.54 51.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.851 -1.156 . . . . 0.0 109.07 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -47.72 -23.89 0.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.64 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' PHE . . . . . 0.463 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 2.1 t80 -47.91 106.88 0.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.598 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -160.09 -41.03 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 109.558 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.49 121.96 5.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.189 -0.944 . . . . 0.0 109.598 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 mt -102.72 -24.05 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.568 -0.707 . . . . 0.0 109.286 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' B' ' 52' ' ' TYR . 5.8 p90 -52.3 -28.27 18.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ARG . . . . . 0.479 ' O ' ' CG ' ' B' ' 57' ' ' HIS . 7.4 mtt-85 -63.02 -42.56 99.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.978 -1.076 . . . . 0.0 109.564 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -68.18 -35.23 77.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 109.392 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.03 -55.73 15.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.127 -0.983 . . . . 0.0 108.951 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -56.83 -32.18 65.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.381 -0.825 . . . . 0.0 109.562 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' HIS . . . . . 0.479 ' CG ' ' O ' ' B' ' 53' ' ' ARG . 3.2 m-70 -64.3 -61.16 2.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 109.274 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.55 -59.53 9.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mt -80.06 81.53 6.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.364 -1.08 . . . . 0.0 109.658 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.347 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.551 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 2.3 p30 -165.5 48.84 0.2 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 109.406 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 25' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 11.0 Cg_endo -57.01 -14.18 13.75 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.808 2.339 . . . . 0.0 112.083 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 33.7 tp -47.34 -44.32 23.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 108.993 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 36.1 t -69.92 -45.16 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.113 -0.992 . . . . 0.0 108.77 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 54.6 t -49.75 -48.53 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 108.977 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.03 -32.99 74.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 109.376 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.96 -54.96 19.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.913 . . . . 0.0 109.698 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.36 -37.37 75.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.972 . . . . 0.0 109.937 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 20.5 mt -70.74 -42.27 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.107 -0.996 . . . . 0.0 109.118 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 33' ' ' ILE . . . . . 0.465 HD13 HG13 ' D' ' 35' ' ' ILE . 23.1 mt -55.86 -33.67 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.191 -0.943 . . . . 0.0 108.555 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.08 -44.73 28.6 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 55.2 mt -57.26 -31.99 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.188 -1.184 . . . . 0.0 109.422 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.82 -64.28 1.0 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 108.988 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -45.61 -43.11 11.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.372 -0.83 . . . . 0.0 109.717 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 44.4 tp -60.77 -68.67 0.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 109.508 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.0 mt -47.45 -30.7 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.218 -0.926 . . . . 0.0 109.516 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mt -68.86 -65.61 0.68 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -0.949 . . . . 0.0 109.811 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 41' ' ' TRP . . . . . 0.414 ' CH2' ' NE ' ' C' ' 45' ' ' ARG . 19.5 t-105 -45.16 -49.38 12.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.858 . . . . 0.0 109.882 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 76.0 mt -61.7 -54.44 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.049 -1.032 . . . . 0.0 109.1 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 60.3 tp -47.91 -44.54 29.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 109.567 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 44' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' C' ' 44' ' ' ASP . 0.2 OUTLIER -67.33 -27.99 67.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.784 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.414 ' NE ' ' CH2' ' C' ' 41' ' ' TRP . 0.9 OUTLIER -75.98 -24.11 55.34 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.14 -0.975 . . . . 0.0 110.43 -179.428 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.4 mt -79.44 -25.53 41.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.759 -1.213 . . . . 0.0 109.224 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -56.42 95.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 109.733 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -156.96 -59.32 0.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.772 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 tttp 54.3 -138.17 1.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.109 -0.994 . . . . 0.0 109.066 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 1.8 t -78.68 170.94 15.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.102 -0.999 . . . . 0.0 109.036 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 9.9 mt -100.87 -26.23 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 0.0 109.802 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.82 -26.03 5.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.942 . . . . 0.0 110.038 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 53' ' ' ARG . . . . . 0.496 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 11.2 mmt180 -68.48 -43.79 76.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.938 -1.101 . . . . 0.0 109.735 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 54' ' ' PHE . . . . . 0.458 ' O ' ' CD1' ' D' ' 51' ' ' ILE . 8.0 m-85 -63.75 -36.98 85.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.928 . . . . 0.0 108.779 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.86 -53.73 51.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.469 -0.769 . . . . 0.0 109.158 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -61.6 -33.01 73.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.437 -0.789 . . . . 0.0 109.545 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 57' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 2.6 m-70 -59.44 -58.3 9.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 108.936 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.74 -59.99 7.97 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 49.6 mt -71.95 175.66 5.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.344 -1.092 . . . . 0.0 109.213 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.428 179.853 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.332 0.587 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.98 161.09 47.99 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.305 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 25' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' D' ' 26' ' ' LEU . 18.6 Cg_endo -63.1 -24.1 73.29 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.496 2.131 . . . . 0.0 112.1 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' D' ' 25' ' ' PRO . 45.3 tp -45.95 -42.63 13.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 108.675 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.9 t -69.76 -44.17 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.292 -0.88 . . . . 0.0 108.806 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 69.9 t -51.4 -50.74 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.061 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.46 -34.53 77.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.745 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.56 -54.55 22.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 109.664 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 2.5 m -57.23 -35.35 69.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -0.953 . . . . 0.0 109.657 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 13.9 mt -72.93 -44.5 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 0.0 109.377 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 30.8 mt -53.87 -35.42 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.133 -0.98 . . . . 0.0 108.735 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.52 -44.39 41.09 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 35' ' ' ILE . . . . . 0.465 HG13 HD13 ' C' ' 33' ' ' ILE . 65.4 mt -59.34 -43.09 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.241 -1.152 . . . . 0.0 109.208 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.13 -62.64 1.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 109.024 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -45.14 -40.28 6.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.391 -0.818 . . . . 0.0 110.139 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 55.7 tp -65.79 -65.3 0.69 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.115 -0.99 . . . . 0.0 109.571 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 9.8 mt -49.65 -29.48 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.918 . . . . 0.0 109.711 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 6.1 mt -70.09 -56.78 6.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 109.555 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -47.38 -48.37 25.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.307 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 7.2 mt -65.75 -43.3 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.127 -0.983 . . . . 0.0 108.89 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 tp -52.01 -44.63 64.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.428 -0.795 . . . . 0.0 109.921 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -76.24 -24.69 54.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 110.239 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.482 ' O ' ' N ' ' D' ' 47' ' ' PHE . 0.0 OUTLIER -88.69 -3.99 58.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 111.071 -178.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' D' ' 45' ' ' ARG . 27.3 mt -33.93 -35.04 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.696 -0.627 . . . . 0.0 110.449 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 47' ' ' PHE . . . . . 0.482 ' N ' ' O ' ' D' ' 45' ' ' ARG . 1.8 t80 -169.18 131.03 1.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.92 . . . . 0.0 109.276 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -166.57 97.9 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.112 -0.993 . . . . 0.0 109.708 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -160.58 -25.87 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.254 -0.904 . . . . 0.0 109.457 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t -48.02 110.19 0.3 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 51' ' ' ILE . . . . . 0.458 ' CD1' ' O ' ' C' ' 54' ' ' PHE . 4.1 mt -84.23 -17.81 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.289 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.83 -37.42 70.31 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.201 -0.937 . . . . 0.0 110.862 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 53' ' ' ARG . . . . . 0.5 ' O ' ' ND1' ' D' ' 57' ' ' HIS . 78.8 mtm180 -78.16 -41.1 35.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.266 -1.521 . . . . 0.0 111.007 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 54' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' D' ' 54' ' ' PHE . 8.3 t80 -71.34 -44.84 64.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.079 -1.013 . . . . 0.0 110.542 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 55' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.21 -24.29 47.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.036 -1.04 . . . . 0.0 110.792 -178.73 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 56' ' ' GLU . . . . . 0.572 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 88.3 tt0 -80.14 -28.89 38.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.597 -1.314 . . . . 0.0 108.017 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 57' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' D' ' 53' ' ' ARG . 11.8 m170 -70.37 -47.07 62.63 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.78 -61.15 6.76 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.35 140.1 55.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.328 -1.101 . . . . 0.0 109.427 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 57.0 tttm . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.477 179.984 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 26' ' ' LEU . 8.2 m-20 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -47.22 -10.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.904 2.403 . . . . 0.0 112.411 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 24' ' ' ASP . 36.7 tp -46.87 -45.55 20.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.13 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 t -70.21 -45.56 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.93 . . . . 0.0 108.715 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.0 t -48.58 -48.26 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.285 -0.884 . . . . 0.0 108.908 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.58 81.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.381 -0.825 . . . . 0.0 109.309 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.05 -55.48 21.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.337 -0.852 . . . . 0.0 109.729 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.16 -37.0 71.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.966 . . . . 0.0 110.005 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.6 mt -71.58 -42.13 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.145 -0.972 . . . . 0.0 109.438 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.455 HD13 HG13 ' B' ' 35' ' ' ILE . 14.8 mt -56.67 -33.29 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.153 -0.967 . . . . 0.0 108.703 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.55 -43.59 29.47 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.0 mt -56.96 -32.23 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.287 -1.125 . . . . 0.0 109.363 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.26 -61.97 1.64 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.136 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -48.6 -39.17 22.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.354 -0.841 . . . . 0.0 109.728 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -66.41 -67.43 0.45 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.919 . . . . 0.0 109.602 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.7 mt -47.3 -27.55 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.529 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mt -67.9 -65.62 0.67 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.272 -0.893 . . . . 0.0 109.823 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.412 ' CH2' ' NE ' ' A' ' 45' ' ' ARG . 24.7 t-105 -48.03 -45.98 32.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.728 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.3 mt -61.6 -54.34 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.157 -0.964 . . . . 0.0 108.894 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.5 tp -47.13 -44.37 21.52 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.579 -0.7 . . . . 0.0 109.638 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.88 -26.16 64.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.222 -0.923 . . . . 0.0 110.089 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.412 ' NE ' ' CH2' ' A' ' 41' ' ' TRP . 0.2 OUTLIER -77.22 -23.42 51.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.978 -1.076 . . . . 0.0 110.387 -179.513 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.1 mt -77.77 -21.14 52.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.8 -1.188 . . . . 0.0 108.956 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 63.27 154.02 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.908 . . . . 0.0 109.39 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -158.65 43.56 0.27 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -0.876 . . . . 0.0 109.379 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.528 ' CD ' ' H ' ' A' ' 50' ' ' SER . 0.6 OUTLIER -163.34 -148.37 0.13 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 109.156 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.528 ' H ' ' CD ' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -132.85 166.26 22.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 0.0 109.368 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.2 mt -99.33 -44.0 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.38 -0.825 . . . . 0.0 109.642 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.432 ' HH ' ' HG ' ' A' ' 50' ' ' SER . 17.3 p90 -56.35 -24.41 43.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.959 . . . . 0.0 109.495 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -69.13 -44.23 72.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.969 . . . . 0.0 109.287 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -64.3 -29.67 70.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.223 -0.923 . . . . 0.0 109.115 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -72.63 -70.23 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.835 . . . . 0.0 109.332 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -46.23 -28.42 1.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 109.518 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -67.4 -61.98 1.64 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.18 -0.95 . . . . 0.0 109.618 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -50.7 -53.12 26.93 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.0 mt -68.72 100.49 1.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -1.186 . . . . 0.0 109.641 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 tttm . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.369 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.443 ' O ' ' O ' ' B' ' 24' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' B' ' 23' ' ' SER . 0.1 OUTLIER 57.38 160.91 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.344 -0.848 . . . . 0.0 109.445 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.36 -22.18 53.05 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.398 2.066 . . . . 0.0 112.017 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 37.1 tp -46.58 -43.87 17.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 108.653 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.43 -42.54 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.36 -0.837 . . . . 0.0 108.889 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 73.9 t -51.34 -50.19 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 109.018 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.83 85.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.311 -0.868 . . . . 0.0 109.38 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.64 -55.28 24.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.73 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.56 -37.0 69.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.714 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 24.5 mt -71.61 -39.74 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.158 -0.963 . . . . 0.0 109.526 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 34.0 mt -58.37 -34.23 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.157 -0.965 . . . . 0.0 108.742 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.88 -41.86 32.19 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.455 HG13 HD13 ' A' ' 33' ' ' ILE . 79.4 mt -62.74 -36.46 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.32 -1.106 . . . . 0.0 109.119 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.79 -62.47 1.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.023 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -46.42 -40.59 12.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 109.684 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 59.2 tp -63.19 -70.48 0.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.777 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 8.4 mt -47.0 -33.34 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.485 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mt -64.45 -58.69 5.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.425 -0.797 . . . . 0.0 109.535 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -46.28 -44.79 16.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 109.65 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 11.1 mt -70.53 -33.6 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.117 -0.989 . . . . 0.0 109.446 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 tp -59.11 -43.86 91.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 110.203 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -82.54 -22.76 34.84 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 110.514 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -82.05 -16.22 50.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.89 -1.131 . . . . 0.0 111.006 -179.212 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' B' ' 46' ' ' LEU . 21.9 mt -44.58 -19.16 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.904 -1.122 . . . . 0.0 109.472 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' B' ' 45' ' ' ARG . 93.7 t80 -49.77 97.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.122 -0.987 . . . . 0.0 109.355 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' PHE . . . . . 0.426 ' N ' ' O ' ' B' ' 46' ' ' LEU . 58.6 t80 -168.54 65.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.882 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.404 ' CG ' ' H ' ' B' ' 50' ' ' SER . 14.3 pttt -158.81 -107.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.83 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' SER . . . . . 0.404 ' H ' ' CG ' ' B' ' 49' ' ' LYS . 41.4 t -80.76 129.17 34.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 109.957 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 32.8 mt -106.04 -32.09 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.633 -0.667 . . . . 0.0 109.438 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -46.48 -27.78 1.2 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 0.0 109.934 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 43.4 mtt-85 -65.91 -41.93 90.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.119 -0.988 . . . . 0.0 109.69 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -68.4 -33.51 74.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 109.7 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.14 -46.67 76.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.946 . . . . 0.0 109.377 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -69.56 -33.87 73.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.608 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -64.37 -33.62 76.26 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.159 -0.963 . . . . 0.0 108.756 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.04 -63.9 2.01 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mt -55.42 126.34 24.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -1.159 . . . . 0.0 109.105 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.35 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.486 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 67.2 m-20 51.17 52.32 11.89 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.652 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 25' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 11.6 Cg_endo -58.36 -16.4 28.61 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.666 2.244 . . . . 0.0 112.254 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' C' ' 26' ' ' LEU . 31.4 tp -46.23 -44.44 16.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.214 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 40.4 t -69.16 -44.56 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.258 -0.901 . . . . 0.0 108.907 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -49.6 -49.14 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.153 -0.967 . . . . 0.0 108.96 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.55 -33.07 75.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.863 . . . . 0.0 109.27 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.08 -56.95 8.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 109.669 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.9 -35.46 69.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.887 . . . . 0.0 109.924 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 24.4 mt -72.78 -43.99 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 0.0 109.531 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' ILE . . . . . 0.455 HD13 HG13 ' D' ' 35' ' ' ILE . 26.6 mt -54.83 -35.27 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.16 -0.963 . . . . 0.0 108.792 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.23 -44.75 42.55 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 58.1 mt -57.67 -27.22 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.273 -1.134 . . . . 0.0 109.203 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.93 -67.36 0.68 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.22 -0.925 . . . . 0.0 109.08 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -46.22 -43.17 15.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.491 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.88 -67.49 0.4 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 109.403 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -47.85 -28.75 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.326 -0.858 . . . . 0.0 109.864 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -67.92 -64.28 0.89 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.793 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' TRP . . . . . 0.519 ' CH2' ' NE ' ' C' ' 45' ' ' ARG . 30.5 t-105 -48.01 -45.58 31.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.22 -0.925 . . . . 0.0 109.634 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 82.7 mt -63.34 -48.53 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.174 -0.954 . . . . 0.0 108.936 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.7 tp -53.42 -33.28 53.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.635 -0.665 . . . . 0.0 110.126 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.3 -25.01 31.92 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.168 -0.958 . . . . 0.0 109.947 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.519 ' NE ' ' CH2' ' C' ' 41' ' ' TRP . 0.1 OUTLIER -75.36 -27.97 59.36 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.087 -1.008 . . . . 0.0 110.493 -179.311 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' C' ' 47' ' ' PHE . 9.8 mt -61.51 -30.71 70.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.612 -1.305 . . . . 0.0 108.946 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.408 ' O ' ' O ' ' C' ' 46' ' ' LEU . 54.8 m-85 -61.22 -111.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.101 -0.999 . . . . 0.0 108.833 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.514 ' CG ' ' O ' ' C' ' 48' ' ' PHE . 8.6 t80 45.77 83.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -0.869 . . . . 0.0 109.667 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 49' ' ' LYS . . . . . 0.521 ' CD ' ' H ' ' C' ' 50' ' ' SER . 0.2 OUTLIER -85.07 -152.71 0.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.147 -0.97 . . . . 0.0 108.725 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 50' ' ' SER . . . . . 0.521 ' H ' ' CD ' ' C' ' 49' ' ' LYS . 0.2 OUTLIER -60.6 -173.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.84 -1.163 . . . . 0.0 109.436 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 45.5 mt -108.64 -27.66 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.59 -0.694 . . . . 0.0 109.272 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -36.29 70.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.996 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -65.83 -34.83 79.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.076 -1.015 . . . . 0.0 109.559 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -68.49 -35.98 78.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.391 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -69.99 -40.62 75.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.918 . . . . 0.0 109.478 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.48 -25.13 63.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 109.49 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.75 -46.5 45.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.195 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.43 -65.99 2.27 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mt -58.81 118.79 6.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -1.124 . . . . 0.0 109.73 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 11.5 tttm . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.602 -179.974 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 41.7 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' D' ' 24' ' ' ASP . 2.8 p-10 -165.51 68.17 1.21 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -46.14 -11.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.793 2.329 . . . . 0.0 112.34 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' D' ' 24' ' ' ASP . 34.2 tp -47.21 -46.3 23.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 109.212 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 43.9 t -69.48 -44.32 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 108.754 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 78.0 t -49.92 -48.08 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.348 -0.845 . . . . 0.0 109.054 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.2 -34.42 77.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 109.547 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.81 -55.4 17.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.649 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.37 -37.29 69.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.213 -0.929 . . . . 0.0 109.842 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 20.6 mt -71.58 -40.39 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.6 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 26.8 mt -57.71 -35.21 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 0.0 108.795 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.47 -42.69 47.65 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 35' ' ' ILE . . . . . 0.455 HG13 HD13 ' C' ' 33' ' ' ILE . 74.6 mt -62.69 -30.49 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.362 -1.081 . . . . 0.0 109.45 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.53 -60.1 2.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 109.081 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -48.98 -40.57 31.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.959 . . . . 0.0 109.542 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.1 tp -62.9 -68.42 0.34 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.194 -0.942 . . . . 0.0 109.412 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 mt -47.15 -31.77 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.455 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt -68.26 -57.97 5.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.39 -0.819 . . . . 0.0 109.798 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -46.64 -44.52 18.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.403 -0.811 . . . . 0.0 109.621 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mt -72.25 -38.33 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.051 -1.031 . . . . 0.0 109.426 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 44.5 tp -57.85 -41.35 82.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.929 . . . . 0.0 110.106 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -82.64 -24.0 34.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.096 -1.003 . . . . 0.0 109.813 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' D' ' 47' ' ' PHE . 11.9 mmt180 -89.82 -1.66 58.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.171 -0.955 . . . . 0.0 110.83 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 46' ' ' LEU . . . . . 0.478 ' C ' ' O ' ' D' ' 45' ' ' ARG . 31.4 mt -31.99 -35.77 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.768 -0.583 . . . . 0.0 110.581 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 47' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' D' ' 45' ' ' ARG . 88.1 t80 -172.75 7.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.525 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.51 113.55 0.72 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.564 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -163.54 -37.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.377 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 44.5 m -54.53 134.94 46.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -0.85 . . . . 0.0 109.634 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 8.7 mt -104.06 -26.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.656 -0.652 . . . . 0.0 109.379 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -47.64 -42.05 23.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.871 . . . . 0.0 109.89 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -45.74 72.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 0.0 109.712 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -62.46 -36.48 82.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 109.591 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -63.27 -66.67 0.51 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.435 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -45.86 -34.91 4.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.347 -0.846 . . . . 0.0 109.863 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -63.55 -60.99 2.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.129 -0.982 . . . . 0.0 109.522 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -47.51 -59.77 5.71 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mt -70.11 118.53 13.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.274 -1.133 . . . . 0.0 109.577 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 24.1 mttm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.573 179.893 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.83 -11.85 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.66 2.24 . . . . 0.0 112.192 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 26' ' ' LEU . 46.1 tp -47.96 -47.16 32.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.13 -0.981 . . . . 0.0 108.899 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.0 t -67.93 -44.22 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.321 -0.862 . . . . 0.0 108.878 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.9 t -49.34 -50.66 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 108.951 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.39 80.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.406 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.32 -57.41 9.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.654 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.21 -36.08 63.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 110.013 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.6 mt -73.12 -41.51 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.006 . . . . 0.0 109.703 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.27 -36.68 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.987 -1.07 . . . . 0.0 108.641 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.38 -44.28 42.77 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.9 mt -56.31 -39.05 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.03 -1.276 . . . . 0.0 109.387 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.83 -54.64 14.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.126 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -48.61 -42.88 35.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.838 . . . . 0.0 109.881 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.2 tp -67.16 -65.47 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 109.684 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.9 mt -46.65 -27.41 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 109.43 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mt -69.48 -61.8 1.64 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.383 -0.823 . . . . 0.0 109.727 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.476 ' NE1' ' OD2' ' D' ' 44' ' ' ASP . 55.8 t-105 -47.84 -46.04 30.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 0.0 109.413 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.2 mt -64.17 -55.7 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.197 -0.939 . . . . 0.0 109.135 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.2 tp -45.27 -43.7 10.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.583 -0.698 . . . . 0.0 110.313 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.04 -27.63 54.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.034 -1.041 . . . . 0.0 110.556 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -72.47 -22.24 61.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.793 -1.192 . . . . 0.0 110.487 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.3 mt -68.64 -12.06 60.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.657 -1.277 . . . . 0.0 108.986 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -82.5 137.86 34.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.331 -0.856 . . . . 0.0 109.183 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -151.07 174.9 12.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.148 -0.97 . . . . 0.0 109.513 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.402 ' CG ' ' H ' ' A' ' 50' ' ' SER . 15.3 tttp 47.37 -143.28 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.364 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.402 ' H ' ' CG ' ' A' ' 49' ' ' LYS . 18.8 p 51.48 42.25 29.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.478 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 mt -80.67 -31.02 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 109.158 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.557 ' CG ' ' N ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -46.08 -42.69 13.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.789 . . . . 0.0 109.887 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.557 ' N ' ' CG ' ' A' ' 52' ' ' TYR . 1.2 mtp180 -50.61 -61.84 1.95 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 0.0 110.665 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -70.63 -26.58 63.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.885 -1.134 . . . . 0.0 110.061 -179.076 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -46.41 80.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.904 -1.122 . . . . 0.0 109.371 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -76.39 -27.5 56.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.673 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -61.97 -50.56 71.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.211 -0.93 . . . . 0.0 109.317 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.81 -59.51 3.7 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.9 mt -64.53 -167.85 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -1.169 . . . . 0.0 109.853 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.054 -0.975 . . . . 0.0 109.421 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 92.0 p . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.517 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 6.0 m-20 -153.61 50.4 0.57 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 109.532 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 11.7 Cg_endo -57.97 -14.47 18.66 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.793 2.329 . . . . 0.0 112.066 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 33.3 tp -46.17 -45.82 16.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.36 -0.837 . . . . 0.0 109.255 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 36.0 t -69.19 -44.72 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.24 -0.913 . . . . 0.0 108.927 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 72.5 t -49.18 -49.11 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 109.096 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.73 -33.73 76.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.289 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.86 -56.8 9.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.337 -0.852 . . . . 0.0 109.825 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.83 -37.2 70.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.877 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 33.4 mt -71.25 -41.22 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.058 -1.026 . . . . 0.0 109.499 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 24.0 mt -57.08 -34.14 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 108.559 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.11 -43.94 24.82 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 53.9 mt -56.11 -35.29 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.177 -1.19 . . . . 0.0 109.235 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -61.53 1.73 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.22 -0.925 . . . . 0.0 109.073 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 37' ' ' HIS . . . . . 0.438 ' NE2' ' ND1' ' C' ' 37' ' ' HIS . 1.8 t-80 -46.83 -41.91 16.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 109.771 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -62.3 -69.75 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.166 -0.959 . . . . 0.0 109.591 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.3 mt -46.11 -38.26 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.34 -0.85 . . . . 0.0 109.36 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mt -59.37 -62.4 1.91 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.45 -0.781 . . . . 0.0 109.967 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -44.99 -49.38 11.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.424 -0.798 . . . . 0.0 109.649 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.407 HD13 HG21 ' B' ' 42' ' ' ILE . 34.1 mt -59.79 -48.61 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.12 -0.988 . . . . 0.0 108.52 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.62 -57.41 4.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.55 -0.719 . . . . 0.0 109.453 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.0 -31.34 68.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.848 . . . . 0.0 110.41 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.455 ' CA ' ' HE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -71.92 -23.43 61.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.873 -1.142 . . . . 0.0 110.471 -179.198 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.0 mt -75.93 -34.01 59.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.699 -1.251 . . . . 0.0 108.887 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -48.42 101.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.912 . . . . 0.0 109.435 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' PHE . . . . . 0.4 ' H ' ' H ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -163.5 -3.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.4 ' H ' ' H ' ' B' ' 48' ' ' PHE . 10.8 mtmm -67.21 -118.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.55 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 10.3 p -53.18 104.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.324 -0.86 . . . . 0.0 109.718 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 11.4 mt -102.21 -24.85 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.479 -0.763 . . . . 0.0 109.17 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -54.46 -24.94 22.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.854 . . . . 0.0 109.748 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 -65.87 -38.77 89.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.522 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -71.01 -36.65 72.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 109.166 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -69.46 -46.77 65.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.405 -0.809 . . . . 0.0 109.162 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -64.02 -27.88 69.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 108.933 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -69.38 -46.63 66.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.403 -0.811 . . . . 0.0 109.545 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.0 -61.22 6.0 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 73.0 mt -60.86 -178.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -1.127 . . . . 0.0 109.808 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.436 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' C' ' 26' ' ' LEU . 20.2 t0 -168.94 65.38 0.6 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.899 . . . . 0.0 109.463 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -45.18 -11.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.749 2.299 . . . . 0.0 112.14 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' C' ' 24' ' ' ASP . 22.2 tp -47.69 -46.33 29.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.144 -0.972 . . . . 0.0 109.107 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 41.5 t -68.15 -44.93 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.213 -0.929 . . . . 0.0 108.581 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.2 t -50.03 -49.39 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.334 -0.854 . . . . 0.0 108.788 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.28 -30.19 71.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.355 -0.841 . . . . 0.0 109.288 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.96 -56.83 6.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.0 109.602 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.31 -36.97 66.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.947 . . . . 0.0 109.525 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 36.3 mt -72.71 -42.5 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.16 -0.963 . . . . 0.0 109.412 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 20.3 mt -55.88 -34.33 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.122 -0.986 . . . . 0.0 108.629 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.26 -45.33 31.28 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 65.4 mt -58.38 -34.66 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.277 -1.131 . . . . 0.0 108.993 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.98 -67.89 0.41 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 108.908 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 37' ' ' HIS . . . . . 0.438 ' ND1' ' NE2' ' B' ' 37' ' ' HIS . 4.3 t-80 -45.83 -36.82 5.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.813 . . . . 0.0 109.656 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.89 -69.61 0.28 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 109.517 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 7.9 mt -48.11 -30.12 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 109.751 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 40' ' ' LEU . . . . . 0.408 HD12 HD11 ' D' ' 38' ' ' LEU . 2.3 mt -68.1 -63.56 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.109 -0.995 . . . . 0.0 109.718 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 -44.45 -48.69 10.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.338 -0.851 . . . . 0.0 110.06 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.89 -58.28 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.046 -1.034 . . . . 0.0 109.108 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 54.1 tp -45.12 -40.19 6.72 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.533 -0.73 . . . . 0.0 109.99 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 44' ' ' ASP . . . . . 0.42 ' O ' ' CE2' ' C' ' 48' ' ' PHE . 0.4 OUTLIER -73.18 -28.39 62.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 109.638 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.438 ' HE ' ' CA ' ' C' ' 45' ' ' ARG . 0.0 OUTLIER -76.55 -18.76 58.51 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.212 -0.93 . . . . 0.0 110.196 -179.57 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' C' ' 47' ' ' PHE . 8.3 mt -83.93 -31.18 25.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.797 -1.189 . . . . 0.0 108.885 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.464 ' C ' ' CG ' ' C' ' 48' ' ' PHE . 2.4 m-85 -52.92 -174.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 109.652 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.464 ' CG ' ' C ' ' C' ' 47' ' ' PHE . 0.8 OUTLIER 67.02 -66.51 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 0.0 109.811 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 49' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' C' ' 47' ' ' PHE . 10.8 tttp 52.33 -93.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.353 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 50' ' ' SER . . . . . 0.451 ' N ' ' O ' ' C' ' 48' ' ' PHE . 68.1 m -63.27 148.41 48.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.136 -0.977 . . . . 0.0 109.389 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 11.6 mt -103.31 -27.55 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.562 -0.711 . . . . 0.0 109.697 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -52.88 -18.66 2.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.934 . . . . 0.0 109.715 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -72.64 -42.16 64.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.865 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.7 -38.03 83.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.935 . . . . 0.0 109.37 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -64.15 -59.3 4.59 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.352 -0.843 . . . . 0.0 109.249 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -55.88 -29.4 59.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.547 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.01 -52.89 24.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.204 -0.935 . . . . 0.0 109.312 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.16 -63.93 4.0 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.461 ' C ' HD13 ' C' ' 59' ' ' LEU . 0.5 OUTLIER -70.71 105.17 3.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -1.187 . . . . 0.0 109.108 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.396 179.947 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.526 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 2.8 m-20 -155.81 49.85 0.45 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.527 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 25' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 11.0 Cg_endo -57.65 -7.13 2.86 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.768 2.312 . . . . 0.0 112.138 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' D' ' 26' ' ' LEU . 33.7 tp -49.23 -48.8 45.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 108.924 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 98.5 t -67.11 -44.87 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 108.724 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 73.5 t -48.67 -50.03 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 108.974 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.75 -33.8 76.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -0.856 . . . . 0.0 109.173 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.25 -57.55 8.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 109.635 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.35 -35.86 65.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.189 -0.944 . . . . 0.0 109.949 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 21.8 mt -72.94 -42.45 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.123 -0.985 . . . . 0.0 109.485 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 mt -55.04 -35.85 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.974 -1.079 . . . . 0.0 108.573 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.67 -45.14 46.4 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 57.9 mt -56.79 -37.74 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -1.171 . . . . 0.0 109.129 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' D' ' 37' ' ' HIS . 0.7 OUTLIER -66.4 -68.47 0.37 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.902 . . . . 0.0 109.342 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 37' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' D' ' 36' ' ' LEU . 1.6 t-80 -42.76 -33.18 0.7 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.438 -0.789 . . . . 0.0 110.161 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 38' ' ' LEU . . . . . 0.408 HD11 HD12 ' C' ' 40' ' ' LEU . 50.3 tp -70.36 -71.21 0.25 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.947 . . . . 0.0 109.672 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mt -49.16 -29.4 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 109.498 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.64 -59.66 2.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.457 -0.777 . . . . 0.0 109.648 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 17.0 t-105 -45.1 -54.28 6.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.71 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.62 -46.45 79.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.204 -0.935 . . . . 0.0 108.867 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.53 -48.77 14.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.588 -0.695 . . . . 0.0 109.722 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 44' ' ' ASP . . . . . 0.476 ' OD2' ' NE1' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -66.97 -33.87 76.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -0.873 . . . . 0.0 110.184 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -68.34 -23.86 64.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.091 -1.006 . . . . 0.0 110.577 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -75.82 -34.37 60.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.663 -1.273 . . . . 0.0 109.089 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -52.58 115.78 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.4 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -172.11 132.77 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 0.0 109.486 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -154.27 -42.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 109.708 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 4.5 m -165.77 159.18 15.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.655 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 9.2 mt -103.97 -25.27 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.613 -0.679 . . . . 0.0 109.369 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -52.01 -19.04 1.63 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.328 -0.857 . . . . 0.0 109.852 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -71.63 -41.03 69.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.069 -1.019 . . . . 0.0 109.682 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -70.71 -32.48 69.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.096 -1.003 . . . . 0.0 109.148 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -68.37 -42.84 78.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.265 -0.897 . . . . 0.0 109.401 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -72.73 -28.2 62.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.287 -0.883 . . . . 0.0 109.288 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.21 -44.3 84.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 108.761 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.33 -63.36 3.81 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.5 125.62 24.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.349 -1.089 . . . . 0.0 109.233 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 61.2 mttt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.889 -1.053 . . . . 0.0 109.425 -179.906 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 26' ' ' LEU . 1.3 m-20 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -47.99 -8.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.928 2.418 . . . . 0.0 112.476 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 24' ' ' ASP . 36.4 tp -48.46 -47.48 38.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.099 -1.001 . . . . 0.0 108.923 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.2 t -67.54 -45.03 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.0 108.639 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.0 t -49.28 -46.8 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.5 81.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.241 -0.912 . . . . 0.0 109.228 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.64 -56.67 10.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 0.0 109.682 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -36.41 64.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.26 -0.9 . . . . 0.0 109.738 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.0 mt -72.7 -41.98 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 109.565 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 mt -56.13 -35.52 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.099 -1.001 . . . . 0.0 108.786 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.85 -44.99 45.48 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.3 mt -59.16 -33.9 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 121.297 -1.119 . . . . 0.0 109.376 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.56 -66.13 0.61 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.389 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -44.4 -45.39 8.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.325 -0.859 . . . . 0.0 110.235 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.5 tp -59.05 -66.07 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.097 -1.002 . . . . 0.0 109.598 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mt -48.8 -47.51 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.165 -0.96 . . . . 0.0 109.626 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 mt -56.45 -55.18 36.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 110.13 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -48.54 -49.54 35.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.038 -1.039 . . . . 0.0 109.691 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.3 mt -60.6 -57.27 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.244 -0.91 . . . . 0.0 109.126 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.0 tp -50.3 -21.56 1.44 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.675 -0.64 . . . . 0.0 110.247 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -90.77 -26.73 19.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.971 . . . . 0.0 110.009 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.9 mtp85 -81.63 -21.87 37.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.163 -0.96 . . . . 0.0 110.721 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -69.16 -31.8 70.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.667 -1.271 . . . . 0.0 108.91 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -98.1 124.35 42.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.433 -0.792 . . . . 0.0 109.212 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -168.44 -8.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.143 -0.973 . . . . 0.0 109.878 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.525 ' CG ' ' H ' ' A' ' 50' ' ' SER . 1.3 tpmt? -72.95 -149.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.176 -0.953 . . . . 0.0 109.312 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.525 ' H ' ' CG ' ' A' ' 49' ' ' LYS . 59.0 p 46.33 71.61 0.29 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.56 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.7 mt -94.45 -25.16 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.559 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -61.23 -26.18 67.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 109.466 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -68.62 -37.6 79.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.079 -1.013 . . . . 0.0 109.359 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -74.19 -41.29 61.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.151 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -62.34 -42.98 99.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.335 -0.853 . . . . 0.0 109.405 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -73.61 -26.34 60.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.185 -0.947 . . . . 0.0 109.276 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.476 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 12.3 t-80 -69.91 -31.19 68.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.17 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.32 -63.68 1.77 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mt -57.94 112.13 1.39 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -1.183 . . . . 0.0 109.234 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.593 -179.869 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' B' ' 24' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.552 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 23.9 m-20 -151.34 49.27 0.56 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.462 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 9.8 Cg_endo -56.16 -10.96 5.09 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.724 2.282 . . . . 0.0 112.02 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 28.6 tp -47.01 -47.24 22.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.063 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 41.0 t -67.69 -45.3 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.887 . . . . 0.0 108.937 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -48.79 -48.9 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 108.994 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.43 -33.46 75.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.4 -0.813 . . . . 0.0 109.184 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.91 -58.01 6.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.675 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -55.22 -35.5 64.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.797 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 36.8 mt -73.45 -41.26 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.121 -0.987 . . . . 0.0 109.745 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 24.1 mt -55.98 -35.41 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.992 -1.068 . . . . 0.0 108.661 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.76 -45.4 34.79 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mt -55.26 -30.58 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.23 -1.159 . . . . 0.0 109.096 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.07 -65.64 0.82 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.228 -0.92 . . . . 0.0 109.055 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -46.48 -34.87 5.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.619 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.75 -71.24 0.22 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 109.469 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.9 mt -46.78 -37.41 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.324 -0.86 . . . . 0.0 109.397 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.439 HD23 ' C ' ' B' ' 40' ' ' LEU . 2.7 tt -58.92 -62.91 1.53 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.489 -0.757 . . . . 0.0 109.662 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 10.9 t-105 -47.41 -52.44 16.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.828 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 57.0 mt -55.02 -48.19 76.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.989 -1.069 . . . . 0.0 108.681 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.11 -50.63 11.0 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.39 0.614 . . . . 0.0 109.476 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' ASP . . . . . 0.483 ' CG ' HH11 ' C' ' 45' ' ' ARG . 37.7 m-20 -62.16 -32.68 73.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.342 -0.849 . . . . 0.0 109.521 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.522 ' CA ' ' HE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -72.39 -20.52 61.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.115 -0.99 . . . . 0.0 110.183 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -85.83 -34.3 21.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.699 -1.251 . . . . 0.0 108.961 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' PHE . . . . . 0.491 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 59.1 t80 -59.01 96.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.286 -0.884 . . . . 0.0 109.378 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 48' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' B' ' 47' ' ' PHE . 8.5 m-85 -165.9 97.82 0.64 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.688 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -150.41 -80.9 0.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.935 . . . . 0.0 109.552 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 16.4 m -80.4 106.14 12.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.937 . . . . 0.0 109.548 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 13.7 mt -92.29 -23.48 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.897 . . . . 0.0 109.562 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.428 ' CD1' ' C ' ' B' ' 52' ' ' TYR . 1.4 p90 -64.64 -17.09 63.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 109.214 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -43.87 64.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 109.783 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -68.63 -32.93 73.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.511 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -70.66 -44.3 67.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.692 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.99 -29.39 68.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 109.512 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -68.67 -47.79 65.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.877 . . . . 0.0 109.177 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.0 -64.31 3.48 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.22 120.63 8.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.292 -1.122 . . . . 0.0 109.469 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.485 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 74.0 m . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.297 0.57 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' C' ' 26' ' ' LEU . 25.4 t0 55.27 66.81 3.55 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.508 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -46.51 -11.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.717 2.278 . . . . 0.0 111.974 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' C' ' 24' ' ' ASP . 40.5 tp -47.49 -45.04 25.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.423 -0.798 . . . . 0.0 109.059 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 51.5 t -69.85 -45.19 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 108.755 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 78.9 t -48.45 -48.22 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -0.865 . . . . 0.0 108.846 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.5 -35.45 80.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.355 -0.841 . . . . 0.0 109.107 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.29 -57.36 10.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.46 -0.775 . . . . 0.0 109.851 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -56.42 -35.71 68.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.757 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.4 mt -71.47 -39.76 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.114 -0.991 . . . . 0.0 109.355 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 32.2 mt -58.15 -35.14 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.012 -1.055 . . . . 0.0 108.423 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.64 -45.15 54.86 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 75.3 mt -61.69 -23.06 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.298 -1.119 . . . . 0.0 108.73 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.1 -70.83 0.39 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.385 -0.822 . . . . 0.0 109.404 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -45.36 -37.05 4.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.312 -0.868 . . . . 0.0 109.676 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.93 -68.05 0.37 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 0.0 109.412 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 5.4 mt -51.98 -27.69 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.947 . . . . 0.0 109.584 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.22 -61.49 1.76 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 0.0 109.598 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -46.91 -43.75 19.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 109.646 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 64.6 mt -67.68 -40.05 83.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.261 -0.899 . . . . 0.0 109.249 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 57.6 tp -58.68 -36.35 74.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.577 -0.702 . . . . 0.0 110.217 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -86.4 -20.44 28.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.106 -0.997 . . . . 0.0 110.158 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.483 HH11 ' CG ' ' B' ' 44' ' ' ASP . 1.6 mmp_? -78.45 -27.23 46.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.952 -1.093 . . . . 0.0 110.549 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -52.14 -12.9 0.27 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.563 -1.336 . . . . 0.0 108.864 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 47' ' ' PHE . . . . . 0.431 ' N ' ' C ' ' C' ' 45' ' ' ARG . 53.6 m-85 -93.13 101.75 14.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.887 . . . . 0.0 109.724 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -168.23 -20.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 0.0 109.559 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.74 -70.25 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.166 -0.959 . . . . 0.0 109.369 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 64.0 p -68.49 110.88 4.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.174 -0.954 . . . . 0.0 109.365 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 11.2 mt -105.95 -25.17 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.576 -0.703 . . . . 0.0 109.803 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -28.29 23.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.93 . . . . 0.0 109.752 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -65.91 -42.79 89.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 0.0 109.817 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -64.96 -34.96 79.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.309 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -63.69 -59.53 4.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.338 -0.851 . . . . 0.0 109.227 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -54.72 -31.01 57.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 109.732 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.73 -42.96 90.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -0.976 . . . . 0.0 109.335 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.13 -61.5 5.13 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 54.0 mt -74.91 156.8 35.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -1.147 . . . . 0.0 109.591 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.377 179.968 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.237 0.542 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' D' ' 26' ' ' LEU . 1.5 m-20 51.0 66.97 4.75 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.93 . . . . 0.0 109.617 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -46.44 -10.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.785 2.323 . . . . 0.0 112.353 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' D' ' 24' ' ' ASP . 26.3 tp -47.26 -45.89 24.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 109.079 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 39.0 t -69.29 -45.14 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.1 t -49.4 -48.92 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 108.78 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.93 -32.88 74.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.341 -0.85 . . . . 0.0 109.184 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.3 -56.89 10.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.388 -0.82 . . . . 0.0 109.741 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -56.1 -36.34 68.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.783 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.07 -40.54 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.114 -0.991 . . . . 0.0 109.395 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 25.0 mt -57.18 -34.06 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.124 -0.985 . . . . 0.0 108.543 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.46 -44.52 27.01 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 61.7 mt -57.9 -29.5 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.152 -1.204 . . . . 0.0 109.022 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.48 -66.62 0.67 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.427 -0.796 . . . . 0.0 109.252 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -46.53 -39.92 11.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.834 . . . . 0.0 109.927 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.7 -67.54 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.064 -1.022 . . . . 0.0 109.757 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mt -48.85 -40.48 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.152 -0.968 . . . . 0.0 109.541 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 40' ' ' LEU . . . . . 0.537 ' O ' HD23 ' D' ' 40' ' ' LEU . 2.5 tt -55.79 -55.4 32.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.844 . . . . 0.0 109.915 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -53.06 -48.69 67.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.074 -1.016 . . . . 0.0 110.077 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 68.2 mt -60.18 -49.48 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.107 -0.996 . . . . 0.0 109.152 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 tp -49.37 -40.29 35.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.497 -0.752 . . . . 0.0 110.093 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -74.01 -27.65 61.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.206 -0.934 . . . . 0.0 109.808 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -74.65 -24.25 58.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 110.494 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -74.48 -9.5 58.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.68 -1.262 . . . . 0.0 109.086 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -142.84 89.24 2.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.453 -0.779 . . . . 0.0 109.466 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 48' ' ' PHE . . . . . 0.415 ' O ' ' O ' ' D' ' 49' ' ' LYS . 2.7 t80 -151.76 -3.96 0.27 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 0.0 109.515 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 49' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' D' ' 48' ' ' PHE . 4.1 mtmt -63.02 -134.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.413 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 21.3 t 51.36 79.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 109.521 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 47.8 mt -95.74 -37.58 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.845 . . . . 0.0 109.334 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 52' ' ' TYR . . . . . 0.521 ' CD2' ' N ' ' D' ' 53' ' ' ARG . 21.2 p90 -52.23 -43.96 64.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.107 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 53' ' ' ARG . . . . . 0.521 ' N ' ' CD2' ' D' ' 52' ' ' TYR . 0.9 OUTLIER -62.84 -18.07 62.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 108.844 179.32 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -69.32 -46.86 66.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.367 -0.833 . . . . 0.0 109.128 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 55' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 1.1 m-85 -74.18 -52.96 10.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.062 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -49.2 -35.11 16.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.423 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 57' ' ' HIS . . . . . 0.496 ' CD2' ' O ' ' D' ' 53' ' ' ARG . 12.4 m170 -70.64 -57.69 4.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 109.642 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -50.46 -56.98 11.18 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 4.7 mt -70.91 124.01 23.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -1.127 . . . . 0.0 109.492 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 35.3 tttm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.461 179.834 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.66 -11.16 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.638 2.225 . . . . 0.0 112.439 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.2 tp -47.43 -47.88 26.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.039 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.9 -44.99 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -0.841 . . . . 0.0 108.824 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -49.38 -47.76 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.269 -0.895 . . . . 0.0 108.718 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.36 83.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.622 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.33 -53.7 39.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -0.915 . . . . 0.0 109.61 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -37.3 71.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.794 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.4 mt -72.29 -41.52 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.144 -0.972 . . . . 0.0 109.563 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.3 mt -56.88 -35.2 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.013 -1.055 . . . . 0.0 108.693 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.5 -42.98 46.5 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.416 HG13 HD13 ' D' ' 33' ' ' ILE . 73.2 mt -62.18 -27.17 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.336 -1.097 . . . . 0.0 109.148 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.92 -63.63 1.13 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.363 -0.835 . . . . 0.0 108.982 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -45.8 -40.64 9.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 0.0 109.94 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -64.3 -67.66 0.41 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.587 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.2 mt -47.36 -35.63 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.279 -0.888 . . . . 0.0 109.106 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 43' ' ' LEU . 2.5 mt -62.34 -61.61 2.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.615 -0.678 . . . . 0.0 109.682 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -43.3 -46.46 6.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.613 -0.679 . . . . 0.0 109.796 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.3 mt -71.88 -28.05 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 108.985 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 40' ' ' LEU . 6.6 tp -63.75 -41.93 97.93 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.274 -0.891 . . . . 0.0 109.907 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -83.95 -23.59 31.04 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.293 -0.88 . . . . 0.0 109.813 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' PHE . 8.4 mmt85 -95.47 3.17 54.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.252 -0.905 . . . . 0.0 110.865 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.488 ' C ' ' O ' ' A' ' 45' ' ' ARG . 34.4 mt -31.17 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.783 -0.573 . . . . 0.0 110.816 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 45' ' ' ARG . 2.2 m-85 -171.9 -170.86 0.81 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.114 -0.991 . . . . 0.0 109.74 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.528 ' O ' ' N ' ' A' ' 50' ' ' SER . 3.3 p90 -137.88 -1.93 1.96 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.467 -0.77 . . . . 0.0 109.552 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp 47.99 -91.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.88 . . . . 0.0 109.525 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -148.13 177.63 9.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -0.882 . . . . 0.0 109.43 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 mt -102.35 -24.29 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.491 -0.756 . . . . 0.0 109.489 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -52.63 -21.35 3.84 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.223 -0.923 . . . . 0.0 109.448 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -67.47 -43.48 80.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.36 -0.837 . . . . 0.0 109.9 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -69.98 -39.55 75.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.973 . . . . 0.0 109.371 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -55.01 -51.5 66.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.348 -0.845 . . . . 0.0 109.641 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -71.23 -25.11 62.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.31 -0.869 . . . . 0.0 109.794 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -67.44 -37.59 83.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 0.0 109.611 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.25 -62.83 1.77 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.4 mt -72.26 84.85 1.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -1.215 . . . . 0.0 109.622 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 pttt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.421 179.804 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 34.6 p . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' B' ' 26' ' ' LEU . 5.7 m-20 -149.42 64.88 7.54 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.589 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -44.54 -9.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.972 2.448 . . . . 0.0 112.524 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' B' ' 24' ' ' ASP . 42.7 tp -47.34 -46.13 25.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.123 -0.985 . . . . 0.0 109.261 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 35.1 t -68.14 -45.13 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 108.924 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 78.2 t -48.38 -47.65 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.877 . . . . 0.0 109.138 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.54 -37.45 86.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.35 -0.844 . . . . 0.0 109.4 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.07 -55.9 21.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 109.569 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 2.1 m -56.31 -34.74 66.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 109.887 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.83 -43.48 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.14 -0.975 . . . . 0.0 109.323 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 11.7 mt -54.59 -35.3 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.067 -1.02 . . . . 0.0 108.547 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.59 -44.18 50.4 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 59.3 mt -59.3 -34.67 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.269 -1.136 . . . . 0.0 109.468 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.33 -67.77 0.47 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -0.962 . . . . 0.0 109.226 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -44.29 -34.08 1.81 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.47 -0.768 . . . . 0.0 109.788 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 54.8 tp -70.18 -70.44 0.29 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 14.2 mt -47.24 -24.02 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.216 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.424 HD23 ' C ' ' B' ' 40' ' ' LEU . 2.7 tt -71.76 -63.48 1.12 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 109.688 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 16.6 t-105 -48.65 -47.03 40.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.558 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 82.2 mt -57.11 -44.68 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.93 -54.47 9.99 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.496 0.665 . . . . 0.0 109.38 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' ASP . . . . . 0.471 ' CG ' HH11 ' C' ' 45' ' ' ARG . 59.2 m-20 -61.82 -29.5 70.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.552 -0.717 . . . . 0.0 110.338 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -73.35 -24.32 60.33 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.949 -1.094 . . . . 0.0 110.871 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -75.0 -8.58 56.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.605 -1.309 . . . . 0.0 109.577 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -143.11 117.87 9.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.324 -0.86 . . . . 0.0 109.664 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -156.3 -3.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -0.873 . . . . 0.0 109.362 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -71.23 -146.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.601 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' SER . . . . . 0.513 ' O ' ' CE2' ' B' ' 54' ' ' PHE . 0.7 OUTLIER 46.92 72.27 0.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.364 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 22.1 mt -100.33 -24.42 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.405 -0.81 . . . . 0.0 109.532 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -70.79 -16.51 62.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.175 -0.953 . . . . 0.0 109.449 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -45.18 56.34 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' PHE . . . . . 0.513 ' CE2' ' O ' ' B' ' 50' ' ' SER . 4.6 m-85 -69.23 -30.96 69.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.349 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -69.49 -45.36 69.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 109.078 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -72.98 -29.18 62.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -0.858 . . . . 0.0 109.421 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -64.36 -60.04 3.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.232 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.98 -55.13 31.93 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' LEU . . . . . 0.451 HD13 ' C ' ' B' ' 59' ' ' LEU . 0.4 OUTLIER -63.36 95.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.349 -1.089 . . . . 0.0 109.209 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 tttt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.459 -179.826 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' C' ' 26' ' ' LEU . 0.9 OUTLIER 50.9 70.37 2.04 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -47.36 -7.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.631 2.22 . . . . 0.0 112.313 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' C' ' 24' ' ' ASP . 41.9 tp -49.31 -45.61 45.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.088 -1.007 . . . . 0.0 109.093 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.97 -45.53 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.067 -1.021 . . . . 0.0 108.534 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.5 t -49.28 -46.7 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.52 75.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.87 . . . . 0.0 109.285 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.07 -56.47 11.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.387 -0.82 . . . . 0.0 109.556 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.68 -37.27 68.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 109.559 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 12.2 mt -70.75 -40.34 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.517 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 26.2 mt -58.44 -35.31 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.054 -1.029 . . . . 0.0 108.79 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.56 -43.73 67.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.47 -27.19 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.45 -1.03 . . . . 0.0 108.999 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.5 tp -68.8 -68.89 0.36 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.0 109.111 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 37' ' ' HIS . . . . . 0.598 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 1.8 t-80 -45.97 -43.0 13.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 110.048 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 49.1 tp -58.39 -65.19 0.69 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.124 -0.985 . . . . 0.0 109.709 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 4.1 mt -49.09 -31.87 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.954 . . . . 0.0 109.523 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -70.31 -59.46 2.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.923 . . . . 0.0 110.277 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -48.83 -46.17 41.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.997 -1.064 . . . . 0.0 109.908 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 69.6 mt -64.88 -48.89 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.135 -0.978 . . . . 0.0 109.124 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 tp -54.46 -32.42 57.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.567 -0.708 . . . . 0.0 110.183 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 44' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' C' ' 44' ' ' ASP . 0.3 OUTLIER -84.54 -22.29 30.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.074 -1.016 . . . . 0.0 109.746 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.471 HH11 ' CG ' ' B' ' 44' ' ' ASP . 0.2 OUTLIER -79.1 -25.09 43.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -0.936 . . . . 0.0 110.464 -179.236 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 46' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' C' ' 48' ' ' PHE . 10.5 mt -67.31 -31.2 71.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.706 -1.247 . . . . 0.0 108.893 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -47.45 98.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.943 . . . . 0.0 109.217 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.429 ' N ' ' O ' ' C' ' 46' ' ' LEU . 2.5 t80 -162.05 18.66 0.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 109.341 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 49' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' C' ' 48' ' ' PHE . 1.5 pttm -61.11 -115.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.811 . . . . 0.0 109.647 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.26 148.59 25.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.664 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 18.5 mt -106.63 -24.23 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.648 -0.658 . . . . 0.0 109.407 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -52.39 -20.32 2.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.328 -0.857 . . . . 0.0 109.609 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -71.43 -41.8 69.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.18 -0.95 . . . . 0.0 109.578 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -67.14 -38.43 85.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 109.079 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -64.58 -64.62 0.83 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.407 -0.808 . . . . 0.0 109.146 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -50.52 -30.17 12.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.829 . . . . 0.0 109.855 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.79 -56.21 10.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.991 . . . . 0.0 109.571 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.4 -60.26 9.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.07 110.34 0.29 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -1.134 . . . . 0.0 109.426 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.46 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.6 p . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.436 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 1.5 m-20 47.64 54.66 15.94 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.229 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 25' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 17.3 Cg_endo -60.88 -11.34 17.57 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.566 2.177 . . . . 0.0 112.453 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 20.6 tp -47.64 -46.17 28.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 0.0 108.977 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.5 t -70.1 -45.2 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 108.647 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 78.8 t -49.23 -48.1 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.148 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.49 -34.8 78.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.865 . . . . 0.0 109.285 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.81 -55.87 16.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.966 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.3 -37.47 72.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.115 -0.991 . . . . 0.0 109.919 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 19.8 mt -70.33 -39.2 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 109.261 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 33' ' ' ILE . . . . . 0.416 HD13 HG13 ' A' ' 35' ' ' ILE . 22.5 mt -58.9 -34.59 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.116 -0.99 . . . . 0.0 108.617 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.18 -44.9 58.51 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 63.8 mt -60.47 -28.55 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.472 -1.016 . . . . 0.0 109.121 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.39 -66.4 0.66 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.34 -0.85 . . . . 0.0 109.049 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 37' ' ' HIS . . . . . 0.598 ' CE1' ' NE2' ' C' ' 37' ' ' HIS . 11.6 t-160 -47.28 -37.27 10.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.952 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 42.8 tp -68.27 -62.99 1.15 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.097 -1.002 . . . . 0.0 109.67 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mt -46.64 -40.76 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 109.324 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 mt -59.78 -60.45 3.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.454 -0.779 . . . . 0.0 110.322 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 41' ' ' TRP . . . . . 0.424 ' CZ2' ' CG ' ' D' ' 45' ' ' ARG . 20.6 t-105 -49.93 -46.26 51.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.004 -1.06 . . . . 0.0 110.025 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.31 -47.04 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.14 -0.975 . . . . 0.0 109.362 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 tp -53.92 -39.85 66.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.426 -0.796 . . . . 0.0 109.744 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.35 -25.61 59.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.25 -0.906 . . . . 0.0 109.823 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.424 ' CG ' ' CZ2' ' D' ' 41' ' ' TRP . 0.6 OUTLIER -74.47 -28.54 61.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.987 -1.071 . . . . 0.0 110.486 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 mt -69.13 -24.67 64.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.708 -1.245 . . . . 0.0 109.12 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -86.05 77.41 9.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.491 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -162.72 3.76 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.341 -0.849 . . . . 0.0 109.182 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 49' ' ' LYS . . . . . 0.499 ' CG ' ' H ' ' D' ' 50' ' ' SER . 0.8 OUTLIER -62.47 -98.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.499 ' H ' ' CG ' ' D' ' 49' ' ' LYS . 49.0 p -46.65 129.51 11.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.631 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 15.3 mt -104.91 -29.84 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.557 -0.715 . . . . 0.0 109.109 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -26.1 6.02 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.214 -0.929 . . . . 0.0 109.459 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -66.69 -45.05 80.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.119 -0.988 . . . . 0.0 109.55 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -65.01 -36.41 84.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.2 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.51 -66.64 0.53 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.383 -0.823 . . . . 0.0 109.068 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -46.74 -30.85 2.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.551 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -68.89 -56.7 7.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.936 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.8 -60.42 9.05 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mt -59.1 107.65 0.57 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -1.201 . . . . 0.0 109.322 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 60' ' ' LYS . . . . . 0.425 ' HB3' ' HZ3' ' D' ' 60' ' ' LYS . 5.7 mmmm . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.274 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.554 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 4.9 p-10 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.9 Cg_endo -56.15 -16.87 18.23 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.912 2.408 . . . . 0.0 112.152 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.8 tp -46.22 -43.42 15.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.262 -0.899 . . . . 0.0 109.17 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.06 -44.93 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.234 -0.916 . . . . 0.0 108.924 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.2 t -49.68 -49.59 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.192 -0.942 . . . . 0.0 109.174 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.09 -34.45 78.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.321 -0.862 . . . . 0.0 109.482 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.32 -56.48 12.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 109.615 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.44 -37.56 67.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.307 -0.87 . . . . 0.0 109.908 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.1 mt -72.21 -41.13 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.966 . . . . 0.0 109.589 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.2 mt -55.87 -34.82 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.098 -1.001 . . . . 0.0 108.485 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.08 -45.01 33.59 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.4 mt -59.62 -27.27 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.256 -1.143 . . . . 0.0 109.187 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.15 -65.91 0.79 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 109.212 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -45.18 -37.89 4.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.363 -0.835 . . . . 0.0 109.79 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.7 tp -66.12 -68.99 0.33 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.943 . . . . 0.0 109.671 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.8 mt -46.69 -36.42 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.445 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mt -66.46 -58.06 6.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.271 -0.893 . . . . 0.0 109.708 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -49.1 -48.04 44.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.758 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.4 mt -63.1 -49.08 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -0.929 . . . . 0.0 109.315 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.6 tp -51.41 -34.65 35.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.535 -0.728 . . . . 0.0 110.318 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 4.0 m-20 -84.44 -26.42 28.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.12 -0.988 . . . . 0.0 110.272 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -71.78 -29.38 64.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.073 -1.017 . . . . 0.0 110.685 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -59.37 -26.11 64.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.714 -1.241 . . . . 0.0 109.593 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -57.26 111.07 0.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.07 -1.019 . . . . 0.0 109.43 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.481 ' CD1' ' C ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -169.54 16.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.241 -0.912 . . . . 0.0 109.471 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 48' ' ' PHE . 45.5 mtpt -62.44 -133.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 109.443 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.56 146.79 54.08 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 109.673 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.2 mt -106.31 -21.71 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -58.05 -15.13 8.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.399 -0.813 . . . . 0.0 109.755 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -69.58 -40.72 76.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 109.774 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -72.86 -42.84 63.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.079 -1.013 . . . . 0.0 109.158 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -56.51 -46.18 80.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.171 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -71.7 -25.43 62.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -0.843 . . . . 0.0 109.317 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -69.77 -32.51 71.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.17 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.22 -62.89 2.02 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.8 mt -72.66 138.8 46.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.193 -1.181 . . . . 0.0 109.498 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.389 -179.874 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' B' ' 26' ' ' LEU . 19.9 t0 -158.66 64.27 2.69 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.873 . . . . 0.0 109.476 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -44.61 -10.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.766 2.31 . . . . 0.0 112.367 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' B' ' 24' ' ' ASP . 30.2 tp -47.35 -46.43 25.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.023 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.5 -45.83 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.197 -0.939 . . . . 0.0 108.804 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 63.3 t -48.26 -48.18 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -0.837 . . . . 0.0 109.026 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.72 -34.15 77.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.219 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.89 -57.41 8.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 109.749 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 2.3 m -55.18 -35.64 65.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.93 . . . . 0.0 109.786 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 19.8 mt -72.89 -41.28 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.098 -1.001 . . . . 0.0 109.567 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -56.11 -33.88 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.037 -1.039 . . . . 0.0 108.574 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.13 -44.83 22.01 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 59.5 mt -56.77 -31.76 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.274 -1.133 . . . . 0.0 109.182 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.68 -64.11 1.02 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.193 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -44.4 -40.5 5.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.413 -0.805 . . . . 0.0 110.123 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 50.8 tp -66.87 -67.27 0.46 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.975 . . . . 0.0 109.636 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 mt -47.33 -26.02 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 109.429 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.66 -68.05 0.44 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.322 -0.861 . . . . 0.0 110.039 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -44.51 -46.54 9.83 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.437 -0.789 . . . . 0.0 109.953 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 56.7 mt -59.29 -47.28 90.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.123 -0.986 . . . . 0.0 108.644 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.1 -54.01 11.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.481 -0.762 . . . . 0.0 108.985 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -60.25 -29.89 69.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.493 -0.754 . . . . 0.0 110.389 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -21.39 57.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.909 -1.12 . . . . 0.0 110.745 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -79.04 -33.71 44.48 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.532 -1.355 . . . . 0.0 108.952 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -61.49 122.61 15.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.848 . . . . 0.0 109.682 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -156.39 52.85 0.54 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.374 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.44 -80.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 109.456 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 50' ' ' SER . . . . . 0.499 ' CB ' ' CZ ' ' B' ' 52' ' ' TYR . 0.0 OUTLIER -155.81 166.57 33.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.436 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 11.5 mt -96.9 -34.89 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.303 -0.873 . . . . 0.0 109.842 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.499 ' CZ ' ' CB ' ' B' ' 50' ' ' SER . 19.6 p90 -62.66 -19.14 63.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.036 -1.04 . . . . 0.0 109.654 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.7 mmt85 -68.56 -45.22 72.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.537 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -66.27 -32.61 74.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.277 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -69.67 -59.94 2.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.0 109.18 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -53.73 -28.12 32.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.897 . . . . 0.0 109.822 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -71.56 -53.87 12.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.104 -0.997 . . . . 0.0 109.305 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.31 -62.25 6.04 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' LEU . . . . . 0.442 HD13 ' C ' ' B' ' 59' ' ' LEU . 0.4 OUTLIER -57.98 108.24 0.57 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -1.105 . . . . 0.0 108.985 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.407 ' N ' HD13 ' B' ' 59' ' ' LEU . 17.9 tttm . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.471 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' C' ' 26' ' ' LEU . 15.9 m-20 -149.52 66.06 8.12 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -46.22 -10.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.875 2.383 . . . . 0.0 112.237 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' C' ' 24' ' ' ASP . 49.3 tp -47.32 -46.57 25.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.237 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.58 -44.51 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.077 -1.014 . . . . 0.0 108.847 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 69.5 t -49.15 -49.48 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 108.904 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.61 74.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.218 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.48 -57.54 8.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 109.6 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.43 -37.14 67.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.088 -1.008 . . . . 0.0 109.873 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 24.3 mt -71.4 -41.85 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 0.0 109.454 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 23.1 mt -55.55 -34.86 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.089 -1.007 . . . . 0.0 108.544 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.83 -45.24 28.2 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 50.0 mt -55.36 -31.51 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.261 -1.14 . . . . 0.0 109.379 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.0 -57.69 3.74 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.271 -0.893 . . . . 0.0 109.019 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -50.33 -37.62 37.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.217 -0.927 . . . . 0.0 109.436 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -67.02 -69.01 0.33 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.273 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.4 mt -46.7 -26.44 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.275 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mt -69.61 -64.98 0.77 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -0.875 . . . . 0.0 109.655 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -45.41 -47.5 13.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.497 -0.752 . . . . 0.0 109.635 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 70.1 mt -63.73 -56.8 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.145 -0.972 . . . . 0.0 109.074 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.3 tp -44.7 -48.92 10.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.492 -0.755 . . . . 0.0 110.129 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.66 -25.81 65.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.15 -0.969 . . . . 0.0 110.416 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 11.7 mmt-85 -77.84 -21.1 51.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.887 -1.133 . . . . 0.0 110.536 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.1 mt -77.17 -14.43 59.78 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.697 -1.252 . . . . 0.0 108.956 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -76.55 -3.9 39.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.574 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 48' ' ' PHE . . . . . 0.407 ' O ' ' CG ' ' C' ' 48' ' ' PHE . 0.2 OUTLIER -79.52 112.79 17.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.976 . . . . 0.0 109.579 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 49' ' ' LYS . . . . . 0.454 ' CG ' ' H ' ' C' ' 50' ' ' SER . 4.5 pttp -163.22 -92.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.475 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 50' ' ' SER . . . . . 0.454 ' H ' ' CG ' ' C' ' 49' ' ' LYS . 28.4 t -77.55 138.03 38.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.4 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 11.1 mt -102.89 -20.28 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.536 -0.727 . . . . 0.0 109.112 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -30.6 26.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.263 -0.898 . . . . 0.0 109.683 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -62.7 -46.03 90.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 109.636 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 54' ' ' PHE . . . . . 0.408 ' O ' ' CD1' ' D' ' 51' ' ' ILE . 2.7 m-85 -63.78 -37.11 86.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.242 -0.911 . . . . 0.0 109.375 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.07 -63.36 1.17 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.25 -0.906 . . . . 0.0 109.147 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -46.77 -34.07 4.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.795 . . . . 0.0 109.673 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -65.62 -49.72 67.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 0.0 109.137 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.7 -60.81 8.07 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.45 ' C ' HD13 ' C' ' 59' ' ' LEU . 0.4 OUTLIER -88.53 105.84 17.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -1.14 . . . . 0.0 108.963 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.384 -179.99 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.42 160.64 40.4 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.251 -0.906 . . . . 0.0 109.296 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.02 -21.99 73.43 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.578 2.185 . . . . 0.0 112.373 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 51.5 tp -46.25 -43.64 15.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 108.664 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.6 -44.4 79.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.339 -0.85 . . . . 0.0 108.731 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 74.4 t -50.19 -49.43 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 108.703 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.56 -32.83 74.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.412 -0.805 . . . . 0.0 109.251 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.37 -56.67 9.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 109.783 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.67 -36.4 69.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 0.0 109.775 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 15.7 mt -71.65 -42.3 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 109.475 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 24.0 mt -56.13 -34.83 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -0.999 . . . . 0.0 108.617 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.28 -43.62 37.91 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 58.7 mt -58.0 -38.57 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.204 -1.174 . . . . 0.0 109.037 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' D' ' 36' ' ' LEU . 0.2 OUTLIER -65.0 -66.26 0.57 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -0.884 . . . . 0.0 109.089 179.669 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -45.3 -36.65 4.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 0.0 109.83 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 44.1 tp -66.42 -70.0 0.27 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.095 -1.003 . . . . 0.0 109.407 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 9.9 mt -48.01 -25.15 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.361 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 40' ' ' LEU . . . . . 0.534 ' O ' HD23 ' D' ' 40' ' ' LEU . 2.8 tt -72.74 -55.61 6.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.334 -0.854 . . . . 0.0 109.658 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -53.27 -50.92 63.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.094 -1.003 . . . . 0.0 109.568 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 23.1 mt -59.0 -55.0 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.091 -1.006 . . . . 0.0 108.739 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 35.9 tp -47.52 -37.2 11.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.422 -0.799 . . . . 0.0 109.72 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 44' ' ' ASP . . . . . 0.471 ' OD2' ' CD2' ' D' ' 40' ' ' LEU . 94.6 m-20 -74.22 -26.05 60.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.223 -0.923 . . . . 0.0 109.67 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.524 ' CA ' ' HE ' ' D' ' 45' ' ' ARG . 0.0 OUTLIER -82.12 -17.67 45.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.126 -0.984 . . . . 0.0 110.732 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -82.26 -34.89 28.59 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.64 -1.287 . . . . 0.0 109.691 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 47' ' ' PHE . . . . . 0.607 ' CG ' ' N ' ' D' ' 48' ' ' PHE . 0.1 OUTLIER -101.53 -167.66 1.45 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.423 -0.798 . . . . 0.0 109.694 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 48' ' ' PHE . . . . . 0.607 ' N ' ' CG ' ' D' ' 47' ' ' PHE . 2.5 t80 77.76 30.39 0.47 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.505 -0.747 . . . . 0.0 109.541 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 49' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' D' ' 50' ' ' SER . 7.9 tptt -93.3 -148.32 0.25 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 109.28 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 50' ' ' SER . . . . . 0.429 ' O ' ' O ' ' D' ' 49' ' ' LYS . 1.2 m 54.75 102.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.469 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 51' ' ' ILE . . . . . 0.408 ' CD1' ' O ' ' C' ' 54' ' ' PHE . 11.8 mt -91.12 -19.52 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 109.16 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -31.4 70.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -0.909 . . . . 0.0 109.777 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -47.35 66.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 0.0 110.413 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 54' ' ' PHE . . . . . 0.479 ' CD1' ' O ' ' D' ' 54' ' ' PHE . 0.0 OUTLIER -69.75 -28.8 66.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.044 -1.035 . . . . 0.0 109.211 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.08 -58.28 7.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.367 -0.833 . . . . 0.0 109.609 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -68.88 -26.99 65.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.121 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -59.94 -61.01 2.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.986 -1.071 . . . . 0.0 109.098 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.7 -59.48 8.13 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.7 110.12 2.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -1.141 . . . . 0.0 109.611 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 2.8 pttp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.46 179.94 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 26' ' ' LEU . 19.3 Cg_endo -61.72 -29.26 83.2 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.541 2.16 . . . . 0.0 112.055 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 26' ' ' LEU . 40.8 tp -45.13 -40.45 7.01 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.7 t -69.25 -43.51 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.0 t -53.12 -51.8 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.13 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.38 -34.95 76.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.52 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.39 -53.51 42.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 109.591 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.2 -37.44 74.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.859 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.3 mt -71.41 -42.47 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.389 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.9 mt -55.28 -36.37 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 0.0 108.789 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.31 -42.79 56.44 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.3 mt -61.83 -46.53 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.235 -1.156 . . . . 0.0 109.269 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.45 -44.69 80.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 109.142 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.404 ' CE1' ' HE2' ' D' ' 37' ' ' HIS . 3.4 t-80 -57.88 -56.08 26.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 109.482 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.3 tp -54.0 -59.97 3.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.913 . . . . 0.0 109.533 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.2 mt -47.52 -48.36 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.299 -0.876 . . . . 0.0 109.311 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mt -51.93 -59.31 4.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -45.14 -65.83 0.48 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.459 -0.776 . . . . 0.0 109.572 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mt -48.58 -37.74 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.125 -0.984 . . . . 0.0 109.278 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -52.1 -49.31 63.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.47 -0.769 . . . . 0.0 110.084 -179.331 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.67 -21.72 55.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.968 . . . . 0.0 110.401 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 47' ' ' PHE . 12.9 mmt180 -91.68 -1.15 57.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.013 -1.054 . . . . 0.0 110.841 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 45' ' ' ARG . 29.7 mt -35.79 -30.61 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.525 -0.734 . . . . 0.0 110.192 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 45' ' ' ARG . 7.4 p90 -170.92 167.13 7.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.161 -0.962 . . . . 0.0 109.486 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -164.15 99.68 0.85 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.252 -0.905 . . . . 0.0 109.578 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 51' ' ' ILE . 10.1 ttmt -151.64 -44.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.166 -0.959 . . . . 0.0 109.405 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.9 t -60.15 80.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 109.369 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 49' ' ' LYS . 40.7 mt -92.43 -27.76 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.89 . . . . 0.0 109.557 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.51 -44.84 65.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.751 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.29 -45.12 62.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.088 -1.008 . . . . 0.0 109.454 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -61.97 -37.28 84.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.286 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.0 -34.7 78.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.115 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -70.21 -38.14 75.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.353 -0.842 . . . . 0.0 109.476 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -62.66 -54.41 39.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 0.0 109.324 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -54.17 -63.08 5.49 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 60' ' ' LYS . 7.7 mt -72.93 21.85 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -1.143 . . . . 0.0 109.741 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.488 ' H ' ' C ' ' A' ' 58' ' ' GLY . 65.9 mttm . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.546 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ASP . . . . . 0.533 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 1.5 p30 -153.35 50.05 0.55 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.88 . . . . 0.0 109.399 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 9.2 Cg_endo -55.59 -11.26 4.55 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.802 2.334 . . . . 0.0 112.248 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 43.6 tp -47.62 -45.85 28.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.152 -0.967 . . . . 0.0 109.094 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.57 -46.14 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.145 -0.972 . . . . 0.0 108.808 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 74.0 t -47.98 -48.27 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.892 . . . . 0.0 108.99 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.54 84.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.452 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.39 -57.34 8.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.261 -0.9 . . . . 0.0 109.801 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -53.93 -35.83 62.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 0.0 109.69 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 18.4 mt -72.65 -41.68 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.179 -0.951 . . . . 0.0 109.411 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 18.6 mt -55.25 -34.5 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.087 -1.008 . . . . 0.0 108.691 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.94 -44.77 23.23 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 51.6 mt -55.49 -34.87 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.072 -1.252 . . . . 0.0 109.326 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.46 -58.97 2.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 108.971 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 37' ' ' HIS . . . . . 0.602 ' NE2' ' ND1' ' C' ' 37' ' ' HIS . 2.3 t-80 -47.83 -37.4 13.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 0.0 109.716 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 52.6 tp -69.88 -67.74 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 0.0 109.466 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mt -47.04 -25.14 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 109.316 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mt -69.03 -63.43 1.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.642 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 41.8 t-105 -47.72 -46.69 29.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.399 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' B' ' 45' ' ' ARG . 72.3 mt -62.02 -61.4 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 108.906 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 57.6 tp -42.53 -47.73 5.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.762 -0.587 . . . . 0.0 110.096 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.72 -27.78 68.57 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' B' ' 42' ' ' ILE . 2.3 mmt180 -81.19 -14.97 57.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.099 -1.001 . . . . 0.0 110.333 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -88.83 -16.08 32.93 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.763 -1.211 . . . . 0.0 109.289 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -47.23 -77.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.326 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 45.11 74.72 0.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 109.769 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -96.65 -88.21 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 109.49 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 2.1 t -148.51 148.98 30.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.388 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 20.2 mt -96.37 -22.55 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.325 -0.859 . . . . 0.0 109.566 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -67.01 -20.7 65.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.592 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -70.31 -43.74 69.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.246 -0.909 . . . . 0.0 109.833 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -67.12 -34.76 78.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -0.956 . . . . 0.0 109.632 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -66.35 -43.65 85.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.201 -0.937 . . . . 0.0 109.302 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -68.78 -27.54 65.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.085 -1.009 . . . . 0.0 108.72 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -70.69 -38.41 73.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.447 -0.783 . . . . 0.0 109.501 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.96 -62.4 3.17 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 50.5 mt -72.39 136.43 46.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -1.083 . . . . 0.0 109.367 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 48.5 mttm . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.463 179.92 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 24' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' C' ' 26' ' ' LEU . 0.2 OUTLIER -161.5 68.35 2.34 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.923 . . . . 0.0 109.571 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -46.4 -9.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.692 2.261 . . . . 0.0 112.105 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 26' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' C' ' 24' ' ' ASP . 35.4 tp -47.2 -46.41 23.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 0.0 109.141 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 33.8 t -69.49 -45.19 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.191 -0.943 . . . . 0.0 108.631 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 71.6 t -49.32 -50.41 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.336 -0.853 . . . . 0.0 108.995 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.11 -30.9 71.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.363 -0.835 . . . . 0.0 109.228 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.74 -56.22 11.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 109.603 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.13 -37.55 74.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -0.946 . . . . 0.0 109.829 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 42.0 mt -71.02 -40.72 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 0.0 109.51 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 18.5 mt -58.53 -32.28 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.106 -0.996 . . . . 0.0 108.594 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.86 -44.03 26.01 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 52.4 mt -57.04 -31.46 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.301 -1.117 . . . . 0.0 109.186 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.25 -62.39 1.45 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 108.935 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 37' ' ' HIS . . . . . 0.602 ' ND1' ' NE2' ' B' ' 37' ' ' HIS . 10.5 t-80 -47.13 -34.46 6.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 109.586 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 40.2 tp -70.56 -66.77 0.56 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.661 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 5.8 mt -49.97 -26.19 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.623 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -72.38 -54.49 9.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.138 -0.976 . . . . 0.0 109.526 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -55.02 -49.08 72.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.722 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 59.4 mt -63.9 -55.14 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.203 -0.936 . . . . 0.0 109.117 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 40.1 tp -48.23 -40.37 24.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.794 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 44' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' C' ' 44' ' ' ASP . 4.5 m-20 -73.21 -25.84 60.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 109.843 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 45' ' ' ARG . . . . . 0.418 ' HA ' ' HE ' ' C' ' 45' ' ' ARG . 0.1 OUTLIER -80.64 -19.43 45.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.114 -0.991 . . . . 0.0 110.506 -179.393 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -79.39 -32.22 42.99 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.631 -1.293 . . . . 0.0 109.109 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -92.31 103.47 15.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.437 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.55 -12.3 0.13 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.328 -0.857 . . . . 0.0 109.582 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -65.1 -156.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.187 -0.946 . . . . 0.0 109.304 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 60.6 p 45.91 76.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.956 -1.09 . . . . 0.0 109.656 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 10.8 mt -95.54 -27.68 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -59.4 -24.91 63.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.193 -0.942 . . . . 0.0 109.421 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -68.78 -37.19 79.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.421 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -72.2 -35.12 68.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 109.364 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -64.12 -56.51 14.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.792 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -65.11 -28.25 69.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.114 -0.991 . . . . 0.0 109.788 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -70.41 -43.74 69.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.431 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.86 -65.7 2.32 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 59' ' ' LEU . . . . . 0.45 ' C ' HD13 ' C' ' 59' ' ' LEU . 0.4 OUTLIER -63.67 95.28 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -1.189 . . . . 0.0 109.054 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.326 -179.831 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 24' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' D' ' 26' ' ' LEU . 27.8 t0 51.13 69.36 2.61 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.936 . . . . 0.0 109.394 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -47.32 -10.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.663 2.242 . . . . 0.0 112.134 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 26' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' D' ' 24' ' ' ASP . 35.2 tp -47.88 -47.03 32.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.244 -0.91 . . . . 0.0 108.902 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 42.3 t -68.66 -44.71 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.106 -0.996 . . . . 0.0 108.63 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 78.3 t -49.24 -49.44 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 108.687 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.44 77.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.379 -0.826 . . . . 0.0 109.236 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.12 -56.85 10.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.343 -0.848 . . . . 0.0 109.734 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.82 -37.12 65.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.162 -0.961 . . . . 0.0 109.763 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 17.2 mt -71.5 -41.95 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.42 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 27.6 mt -55.24 -35.32 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 108.69 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.47 -45.3 47.44 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 72.2 mt -60.99 -24.26 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.291 -1.123 . . . . 0.0 109.037 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 17.2 tp -76.16 -70.53 0.44 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.464 -0.772 . . . . 0.0 109.231 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 37' ' ' HIS . . . . . 0.404 ' HE2' ' CE1' ' A' ' 37' ' ' HIS . 2.0 t-80 -45.52 -33.38 2.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.873 . . . . 0.0 109.715 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 56.6 tp -68.19 -66.27 0.59 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.179 -0.951 . . . . 0.0 109.49 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mt -52.43 -28.23 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.842 . . . . 0.0 109.659 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mt -76.24 -59.24 2.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.84 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -45.97 -52.01 12.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.283 -0.886 . . . . 0.0 109.841 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 42' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' D' ' 45' ' ' ARG . 66.9 mt -60.46 -57.63 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.154 -0.966 . . . . 0.0 109.018 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 59.2 tp -43.89 -44.69 7.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.62 -0.675 . . . . 0.0 109.81 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 44' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' D' ' 44' ' ' ASP . 0.6 OUTLIER -67.46 -29.86 69.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.164 -0.96 . . . . 0.0 109.652 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 45' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' D' ' 42' ' ' ILE . 4.0 mmt180 -77.22 -17.43 58.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.2 -0.938 . . . . 0.0 110.208 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 mt -85.7 -17.13 36.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.82 -1.175 . . . . 0.0 109.236 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.35 -6.66 4.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.195 -0.941 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -71.41 70.97 0.64 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.52 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -96.65 -100.27 0.18 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.422 -0.799 . . . . 0.0 109.52 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 3.4 m -76.18 130.99 39.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 109.783 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 28.9 mt -93.37 -30.67 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.898 . . . . 0.0 109.318 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -25.68 61.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.925 . . . . 0.0 109.923 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 53' ' ' ARG . . . . . 0.426 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 12.5 mmt85 -63.6 -41.26 98.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.123 -0.986 . . . . 0.0 109.669 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -71.15 -41.39 70.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.151 -0.968 . . . . 0.0 109.435 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -58.84 -41.81 87.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.332 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -26.87 61.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.259 -0.901 . . . . 0.0 109.26 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 57' ' ' HIS . . . . . 0.426 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 2.5 m-70 -67.47 -39.65 85.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 108.905 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.82 -63.35 2.74 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.08 159.75 2.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.251 -1.146 . . . . 0.0 109.605 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 17.7 mttp . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.448 -179.967 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 2.7 m-20 57.11 49.28 3.67 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.53 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.3 Cg_endo -55.78 -15.54 13.17 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.714 2.276 . . . . 0.0 111.978 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.8 tp -46.29 -44.42 16.58 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.319 -0.863 . . . . 0.0 109.169 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.8 t -68.6 -45.26 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.273 -0.892 . . . . 0.0 108.997 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -48.93 -49.02 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.184 -0.947 . . . . 0.0 109.057 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.09 -34.47 78.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 0.0 109.387 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.74 -57.25 8.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 0.0 109.805 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.57 -36.14 66.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.733 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.7 mt -71.7 -42.51 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.338 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.4 mt -55.73 -34.63 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.128 -0.982 . . . . 0.0 108.511 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.09 -45.17 32.95 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.1 mt -55.67 -36.21 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.165 -1.197 . . . . 0.0 109.179 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.5 -61.91 1.67 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.353 -0.842 . . . . 0.0 109.236 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -45.15 -39.9 6.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.416 -0.802 . . . . 0.0 110.061 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -66.23 -69.49 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.141 -0.974 . . . . 0.0 109.843 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.8 mt -48.19 -27.4 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 0.0 109.739 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.425 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 7.4 mt -72.24 -60.37 2.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.928 . . . . 0.0 109.945 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 40.7 t-105 -48.1 -48.53 33.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.055 -1.028 . . . . 0.0 109.784 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 45' ' ' ARG . 66.6 mt -63.28 -59.89 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.08 -1.013 . . . . 0.0 109.336 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.3 tp -44.27 -40.66 5.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.572 -0.705 . . . . 0.0 109.821 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.514 ' OD2' ' NC ' ' A' ' 199' ' ' RIM . 1.7 m-20 -69.75 -31.31 69.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -0.964 . . . . 0.0 109.217 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.5 ' NH1' ' OD2' ' D' ' 44' ' ' ASP . 0.4 OUTLIER -75.4 -16.05 60.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 110.181 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -90.04 -12.06 39.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.872 -1.142 . . . . 0.0 109.22 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.487 ' O ' ' N ' ' A' ' 49' ' ' LYS . 17.6 t80 -78.0 -60.73 2.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 109.306 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -50.23 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 109.066 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 47' ' ' PHE . 30.8 mtpt -91.65 -82.43 0.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.915 . . . . 0.0 109.634 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.1 m -87.35 170.07 11.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.635 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.3 mt -105.46 -21.66 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.569 -0.707 . . . . 0.0 109.626 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -55.02 -20.87 10.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.182 -0.949 . . . . 0.0 109.8 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.433 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 7.6 mmm180 -70.94 -42.59 69.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.062 -1.024 . . . . 0.0 109.553 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -66.79 -35.23 79.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.227 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -65.25 -48.85 71.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -0.866 . . . . 0.0 109.19 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -63.2 -29.18 70.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.348 -0.845 . . . . 0.0 109.526 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.433 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 18.5 m80 -66.2 -52.34 48.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.263 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.22 -60.89 7.8 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.46 ' O ' ' CB ' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -50.28 118.8 3.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.377 -1.072 . . . . 0.0 109.458 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 59' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.479 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.298 0.57 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.516 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 48.5 m-20 -157.72 51.23 0.46 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.472 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 13.0 Cg_endo -59.23 -12.02 14.92 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.759 2.306 . . . . 0.0 112.345 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 58.2 tp -47.98 -46.71 32.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 108.958 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.71 -44.93 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.113 -0.992 . . . . 0.0 108.774 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 71.2 t -48.97 -49.71 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 108.931 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.38 -32.87 74.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -0.837 . . . . 0.0 109.136 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.91 -58.08 6.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 0.0 109.66 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.77 -35.28 63.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 109.697 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 16.7 mt -73.29 -41.86 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 0.0 109.745 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.474 HD13 HG13 ' C' ' 35' ' ' ILE . 21.9 mt -55.86 -35.57 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.005 -1.059 . . . . 0.0 108.822 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.34 -44.18 43.55 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 48.6 mt -56.05 -33.07 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.226 -1.161 . . . . 0.0 109.204 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -65.19 0.79 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 109.1 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' HIS . . . . . 0.598 ' HE2' ' CE1' ' C' ' 37' ' ' HIS . 3.4 t-80 -45.43 -38.13 5.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.412 -0.805 . . . . 0.0 109.748 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 54.9 tp -66.38 -67.86 0.42 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 109.503 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.8 mt -48.91 -25.89 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 109.518 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mt -71.5 -64.07 0.99 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.851 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -46.11 -47.1 17.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 0.0 109.647 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 51.7 mt -63.27 -55.46 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.087 -1.008 . . . . 0.0 108.909 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 39.5 tp -47.13 -41.19 17.09 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.51 -0.744 . . . . 0.0 109.661 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' B' ' 44' ' ' ASP . 0.3 OUTLIER -69.79 -30.26 67.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.707 -179.709 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.97 -19.71 58.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.07 -1.018 . . . . 0.0 110.47 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -82.97 -8.46 59.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.631 -1.293 . . . . 0.0 108.973 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -138.11 106.93 5.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.525 -0.734 . . . . 0.0 109.569 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' PHE . . . . . 0.409 ' H ' ' H ' ' B' ' 49' ' ' LYS . 28.5 t80 -171.15 3.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.216 -0.928 . . . . 0.0 109.556 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.409 ' H ' ' H ' ' B' ' 48' ' ' PHE . 14.2 mtpp -71.89 -142.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.905 . . . . 0.0 109.302 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 20.8 m 51.54 75.74 0.19 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.166 -0.959 . . . . 0.0 109.568 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 50.9 mt -99.36 -31.21 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.463 -0.773 . . . . 0.0 109.385 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.494 ' CE2' ' NH1' ' B' ' 53' ' ' ARG . 0.1 OUTLIER -61.02 -32.93 72.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.0 109.781 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.494 ' NH1' ' CE2' ' B' ' 52' ' ' TYR . 19.5 mmt-85 -64.42 -33.84 76.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.085 -1.009 . . . . 0.0 109.42 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -75.3 -42.15 55.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.873 . . . . 0.0 109.17 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -58.34 -40.53 82.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.856 . . . . 0.0 109.55 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -72.78 -67.61 0.55 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' HIS . . . . . 0.45 ' O ' ' ND1' ' B' ' 57' ' ' HIS . 23.0 t-80 -41.22 -30.06 0.15 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.616 -0.678 . . . . 0.0 110.208 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.28 -70.25 1.31 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mt -66.35 82.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -1.113 . . . . 0.0 109.516 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 58.8 tttm . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.403 179.855 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 55.1 m . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' C' ' 26' ' ' LEU . 3.2 m-20 57.64 65.33 3.52 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 109.647 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -45.22 -11.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.921 2.414 . . . . 0.0 112.535 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' C' ' 24' ' ' ASP . 24.2 tp -47.74 -46.11 29.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 108.975 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 45.5 t -67.19 -45.32 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 108.769 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 71.5 t -50.3 -51.64 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.363 -0.836 . . . . 0.0 109.008 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.32 -32.58 73.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.502 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.8 -55.27 18.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.53 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.13 -37.51 69.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.843 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 23.1 mt -71.89 -42.81 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.072 -1.017 . . . . 0.0 109.602 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.25 -36.39 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 108.551 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.95 -45.04 64.76 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 35' ' ' ILE . . . . . 0.474 HG13 HD13 ' B' ' 33' ' ' ILE . 63.5 mt -59.6 -41.59 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.347 -1.09 . . . . 0.0 108.832 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.77 -68.01 0.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.368 -0.832 . . . . 0.0 109.292 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 37' ' ' HIS . . . . . 0.598 ' CE1' ' HE2' ' B' ' 37' ' ' HIS . 2.3 t-80 -44.17 -39.95 4.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.389 -0.82 . . . . 0.0 110.24 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.76 -67.89 0.38 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.985 -1.072 . . . . 0.0 109.196 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 mt -47.67 -40.66 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.344 -0.847 . . . . 0.0 109.423 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mt -61.64 -54.31 44.54 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.45 -0.781 . . . . 0.0 109.581 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -46.31 -58.19 3.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.418 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.19 -47.8 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.055 -1.028 . . . . 0.0 109.339 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 6.3 tp -52.56 -27.52 17.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.417 -0.802 . . . . 0.0 110.43 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -91.03 -34.03 15.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.071 -1.018 . . . . 0.0 109.426 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.704 HH21 HNC2 ' B' ' 299' ' ' RIM . 14.6 mmm180 -84.67 4.32 33.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.343 -0.848 . . . . 0.0 110.403 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.476 ' C ' ' O ' ' C' ' 45' ' ' ARG . 34.8 mt -31.0 -34.95 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 CA-C-O 121.273 0.559 . . . . 0.0 110.299 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.55 ' N ' ' O ' ' C' ' 45' ' ' ARG . 0.2 OUTLIER 68.2 102.04 0.05 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.714 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -104.16 162.67 12.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.557 -0.714 . . . . 0.0 109.211 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' C' ' 50' ' ' SER . 20.4 tptt -92.37 -150.14 0.26 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.168 -0.958 . . . . 0.0 109.767 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 50' ' ' SER . . . . . 0.412 ' O ' ' O ' ' C' ' 49' ' ' LYS . 8.2 m 47.06 92.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 109.843 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 mt -92.65 -31.61 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.213 -0.93 . . . . 0.0 109.446 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 52' ' ' TYR . . . . . 0.463 ' CD2' ' N ' ' C' ' 53' ' ' ARG . 50.9 p90 -48.45 -44.26 35.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.382 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 53' ' ' ARG . . . . . 0.463 ' N ' ' CD2' ' C' ' 52' ' ' TYR . 3.7 mtp85 -46.73 -50.52 17.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.306 -0.871 . . . . 0.0 109.954 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -61.7 -41.5 97.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.112 -0.993 . . . . 0.0 109.76 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -60.79 -35.57 76.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 109.266 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -73.52 -37.62 65.58 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.275 -0.891 . . . . 0.0 109.239 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -41.22 94.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.914 . . . . 0.0 109.189 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.42 -62.43 4.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 57.6 mt -85.24 -147.99 0.11 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -1.125 . . . . 0.0 109.316 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.442 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.95 161.38 77.8 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.339 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -65.1 -21.52 62.84 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.511 2.14 . . . . 0.0 112.097 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 54.2 tp -46.8 -43.87 18.74 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -69.76 -43.23 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.329 -0.857 . . . . 0.0 108.803 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 70.4 t -51.04 -48.55 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.069 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.35 -33.91 76.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 0.0 109.26 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.35 -57.02 9.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 109.674 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -56.1 -35.99 67.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.746 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 12.3 mt -71.69 -41.41 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.208 -0.933 . . . . 0.0 109.352 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -56.64 -35.17 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.942 . . . . 0.0 108.796 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.79 -43.67 50.1 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 57.2 mt -59.17 -30.34 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.333 -1.098 . . . . 0.0 109.478 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.75 -67.5 0.63 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -0.944 . . . . 0.0 109.405 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -44.11 -35.71 2.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.23 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 45.8 tp -71.42 -63.13 1.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.031 -1.043 . . . . 0.0 109.803 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.7 mt -50.93 -34.38 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.96 . . . . 0.0 109.599 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' D' ' 43' ' ' LEU . 1.2 mt -67.17 -64.81 0.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.36 -0.838 . . . . 0.0 110.273 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -44.76 -48.61 10.84 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.398 -0.814 . . . . 0.0 109.682 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 93.3 mt -59.63 -37.52 71.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 108.601 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' D' ' 40' ' ' LEU . 0.1 OUTLIER -57.7 -43.38 85.14 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.488 -0.757 . . . . 0.0 109.36 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.5 ' OD2' ' NH1' ' A' ' 45' ' ' ARG . 7.0 m-20 -71.71 -26.82 62.65 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.381 -0.825 . . . . 0.0 110.182 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -28.36 58.31 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.829 -1.169 . . . . 0.0 110.981 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' D' ' 48' ' ' PHE . 7.7 mt -58.4 -12.31 3.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.525 -1.359 . . . . 0.0 109.179 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -73.95 17.09 0.18 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.14 -0.975 . . . . 0.0 109.114 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 48' ' ' PHE . . . . . 0.478 ' H ' ' C ' ' D' ' 46' ' ' LEU . 0.4 OUTLIER -46.66 155.2 0.26 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 109.56 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 15.8 tttm 64.23 -146.45 0.29 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 73.3 m 47.96 59.44 4.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 38.8 mt -95.06 -29.59 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.347 -0.846 . . . . 0.0 109.39 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -37.94 74.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.545 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 53' ' ' ARG . . . . . 0.472 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 5.9 mtm180 -61.51 -36.63 81.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.247 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -69.99 -37.92 75.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 0.0 109.258 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -63.39 -53.79 46.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 109.677 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -62.61 -29.13 70.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.748 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 57' ' ' HIS . . . . . 0.472 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 1.4 m-70 -67.48 -45.14 76.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 109.431 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.29 -60.71 6.78 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.1 -166.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -1.15 . . . . 0.0 109.712 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 61.1 tttm . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.923 -1.036 . . . . 0.0 109.669 -179.969 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 199' ' ' RIM . . . . . 0.514 ' NC ' ' OD2' ' A' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 299' ' ' RIM . . . . . 0.704 HNC2 HH21 ' C' ' 45' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 399' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 499' ' ' RIM . . . . . 0.403 ' NC ' HD22 ' D' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 24' ' ' ASP . 12.9 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' ' 24' ' ' ASP . 5.5 p-10 41.13 54.36 7.42 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.69 -0.631 . . . . 0.0 110.047 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 11.2 Cg_endo -58.02 -17.87 33.17 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.509 2.139 . . . . 0.0 112.269 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.8 tp -47.2 -45.02 22.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.189 -0.945 . . . . 0.0 108.826 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.98 -44.52 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.241 -0.912 . . . . 0.0 108.802 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -49.86 -50.25 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.163 -0.96 . . . . 0.0 109.068 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.54 -33.69 76.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.322 -0.861 . . . . 0.0 109.514 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.57 -56.78 8.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 109.784 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 m -55.55 -34.65 64.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.705 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.4 mt -74.81 -43.7 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.118 -0.989 . . . . 0.0 109.725 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.8 mt -54.02 -35.91 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.021 -1.05 . . . . 0.0 108.618 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.06 -45.43 41.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.7 mt -57.65 -37.27 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.192 -1.181 . . . . 0.0 108.907 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.15 -68.74 0.33 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -0.85 . . . . 0.0 109.373 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -43.19 -42.26 4.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.431 -0.793 . . . . 0.0 110.263 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.7 tp -61.05 -67.66 0.38 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.106 -0.996 . . . . 0.0 109.569 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 mt -49.15 -44.1 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 109.513 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.662 HD22 ' NC ' ' A' ' 199' ' ' RIM . 2.3 mt -55.77 -58.39 8.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 109.987 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -46.43 -59.1 3.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.322 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.467 ' O ' ' N ' ' A' ' 45' ' ' ARG . 48.0 mt -51.17 -52.44 18.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.276 -0.89 . . . . 0.0 108.978 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 42' ' ' ILE . 0.1 OUTLIER -41.89 -57.21 2.47 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.426 0.631 . . . . 0.0 109.503 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.451 ' OD2' ' NC ' ' A' ' 199' ' ' RIM . 12.8 m-20 -59.15 -27.7 65.89 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.328 -0.858 . . . . 0.0 109.624 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.467 ' N ' ' O ' ' A' ' 42' ' ' ILE . 2.7 mmp_? -81.52 -13.82 57.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.071 -1.018 . . . . 0.0 110.714 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 mt -88.65 -18.88 27.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.652 -1.28 . . . . 0.0 109.198 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.48 ' O ' ' CB ' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -141.79 166.29 25.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.301 -0.875 . . . . 0.0 109.518 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.48 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 2.4 t80 75.96 97.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.57 -0.706 . . . . 0.0 109.539 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 50' ' ' SER . 10.1 tttp -150.23 -135.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.109 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 49' ' ' LYS . 0.9 OUTLIER 68.14 117.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.957 . . . . 0.0 109.51 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 mt -97.69 -29.25 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 109.625 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.485 ' CG ' ' N ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -57.32 -38.82 74.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.97 . . . . 0.0 109.44 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.485 ' N ' ' CG ' ' A' ' 52' ' ' TYR . 1.4 mtt180 -57.65 -37.21 72.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.044 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -70.67 -39.98 73.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.844 . . . . 0.0 109.233 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -65.55 -34.08 77.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.125 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -75.02 -31.66 61.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.824 . . . . 0.0 109.613 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -68.92 -37.93 79.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.256 -0.902 . . . . 0.0 109.152 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.63 -64.41 2.6 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.7 mt -75.78 150.95 37.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -1.112 . . . . 0.0 109.538 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.449 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.265 0.555 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.15 160.67 39.18 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 109.271 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' B' ' 26' ' ' LEU . 18.7 Cg_endo -63.16 -24.5 72.8 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.557 2.171 . . . . 0.0 112.165 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' B' ' 25' ' ' PRO . 56.9 tp -45.63 -40.89 9.55 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 52.3 t -70.98 -44.75 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.345 -0.847 . . . . 0.0 108.809 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 74.4 t -49.54 -48.71 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 108.953 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.55 -34.73 78.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.362 -0.836 . . . . 0.0 109.223 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.26 -56.75 12.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 109.665 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.04 -36.71 68.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 109.966 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 29.8 mt -72.05 -40.06 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.095 -1.003 . . . . 0.0 109.686 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 30.6 mt -58.05 -35.23 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.013 -1.054 . . . . 0.0 108.751 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.14 -44.0 45.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 55.9 mt -57.8 -35.83 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.288 -1.125 . . . . 0.0 109.162 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.44 -65.96 0.61 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.279 -0.888 . . . . 0.0 109.056 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -45.5 -39.18 7.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.46 -0.775 . . . . 0.0 109.895 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.79 -69.3 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 0.0 109.786 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.4 mt -51.21 -23.84 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.113 -0.992 . . . . 0.0 109.269 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.494 HD23 ' C ' ' B' ' 40' ' ' LEU . 2.6 tt -68.67 -63.86 0.98 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.36 -0.837 . . . . 0.0 110.005 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 -52.34 -46.63 66.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.989 . . . . 0.0 109.907 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.95 -55.21 26.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.032 -1.042 . . . . 0.0 108.841 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 52.9 tp -46.8 -40.99 14.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.536 -0.728 . . . . 0.0 109.932 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.509 ' OD2' ' NC ' ' B' ' 299' ' ' RIM . 1.2 m-20 -72.3 -25.32 61.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 109.865 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.6 -17.72 43.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.912 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -81.06 -27.78 35.57 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.631 -1.293 . . . . 0.0 109.338 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -147.46 116.93 7.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.223 -0.923 . . . . 0.0 109.668 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' PHE . . . . . 0.444 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 79.7 t80 -173.41 82.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 109.391 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -141.8 -129.97 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.43 -0.794 . . . . 0.0 109.176 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 7.4 t 49.57 84.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.419 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 27.5 mt -97.9 -26.78 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.272 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.574 ' CG ' ' N ' ' B' ' 53' ' ' ARG . 2.8 p90 -53.09 -40.26 63.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.453 -0.779 . . . . 0.0 110.362 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.574 ' N ' ' CG ' ' B' ' 52' ' ' TYR . 0.0 OUTLIER -64.91 -29.49 70.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.931 -1.106 . . . . 0.0 109.909 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -74.57 -41.44 60.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.143 -0.973 . . . . 0.0 109.414 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.44 -50.74 66.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.195 -0.941 . . . . 0.0 108.963 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.53 -32.56 71.6 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.303 -0.873 . . . . 0.0 109.12 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -61.37 -59.46 5.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.114 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.65 -58.07 12.33 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 56.4 mt -78.0 69.48 4.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.357 -1.084 . . . . 0.0 109.246 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.9 tptp . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.563 -179.811 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 37.6 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.313 0.578 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' C' ' 26' ' ' LEU . 2.0 m-20 48.81 64.81 8.02 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.754 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -46.06 -8.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.738 2.292 . . . . 0.0 112.435 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' C' ' 24' ' ' ASP . 39.0 tp -47.41 -45.91 25.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.163 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 32.8 t -67.84 -45.83 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 108.616 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -49.32 -49.26 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 109.013 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.01 -34.67 78.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.26 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.24 -55.53 15.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 109.701 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.86 -36.67 67.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.724 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 mt -72.34 -42.02 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 109.406 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.7 mt -54.76 -34.69 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.09 -1.006 . . . . 0.0 108.64 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.23 -44.28 23.19 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 59.9 mt -57.19 -32.38 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.184 -1.186 . . . . 0.0 108.971 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -71.27 -65.56 0.73 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 108.812 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -46.16 -38.24 7.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.815 . . . . 0.0 109.678 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.4 -69.95 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.216 -0.927 . . . . 0.0 109.696 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 15.7 mt -47.4 -25.45 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.16 -0.963 . . . . 0.0 109.398 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 5.9 mt -71.98 -61.05 1.93 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.482 -0.761 . . . . 0.0 109.755 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -47.79 -48.18 30.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.978 . . . . 0.0 109.61 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 42' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' C' ' 45' ' ' ARG . 53.4 mt -61.6 -59.8 3.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.193 -0.942 . . . . 0.0 108.826 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.4 tp -43.51 -44.6 6.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.756 -0.59 . . . . 0.0 109.913 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 44' ' ' ASP . . . . . 0.478 ' CG ' HNC2 ' C' ' 399' ' ' RIM . 0.7 OUTLIER -68.13 -27.25 66.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.22 -0.925 . . . . 0.0 109.64 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.464 ' N ' ' O ' ' C' ' 42' ' ' ILE . 14.0 mmt180 -82.6 -15.54 51.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.171 -0.955 . . . . 0.0 110.559 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 mt -86.58 -11.28 51.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.736 -1.227 . . . . 0.0 109.247 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -59.07 94.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.942 . . . . 0.0 109.156 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.51 ' O ' ' CG ' ' C' ' 48' ' ' PHE . 0.1 OUTLIER -162.89 6.99 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -50.57 -31.36 15.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 3.1 p -164.41 131.95 3.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 5.1 mt -82.18 -22.77 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 108.996 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -45.8 -39.72 8.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 0.0 109.96 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -53.01 -48.57 67.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.117 -0.989 . . . . 0.0 110.171 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' D' ' 51' ' ' ILE . 10.1 m-85 -62.37 -40.48 96.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.095 -1.003 . . . . 0.0 109.562 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -60.19 -58.39 8.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.851 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -57.0 -37.19 71.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -48.04 82.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.063 -1.023 . . . . 0.0 109.748 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.4 -59.54 9.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 6.9 mt -75.63 87.68 2.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -1.163 . . . . 0.0 109.4 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.46 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' D' ' 26' ' ' LEU . 15.4 m-20 51.15 66.68 5.08 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.393 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -46.16 -10.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.754 2.303 . . . . 0.0 112.092 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' D' ' 24' ' ' ASP . 44.9 tp -47.58 -47.6 28.42 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.223 -0.923 . . . . 0.0 109.016 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.27 -44.79 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 108.73 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -48.58 -49.5 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 108.904 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.26 -37.14 86.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.507 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -57.1 10.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.231 -0.918 . . . . 0.0 109.916 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.4 -36.72 64.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.224 -0.923 . . . . 0.0 109.81 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 26.9 mt -72.54 -41.69 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.166 -0.958 . . . . 0.0 109.453 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -55.92 -36.98 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 108.702 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.11 -45.16 57.71 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 47.2 mt -56.05 -38.88 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.204 -1.174 . . . . 0.0 109.286 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.72 -61.78 1.72 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -0.866 . . . . 0.0 109.137 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -46.57 -44.02 17.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.61 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.0 tp -60.07 -69.18 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mt -46.95 -25.25 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.891 . . . . 0.0 109.403 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.444 ' CD2' ' OD2' ' D' ' 44' ' ' ASP . 1.5 tt -69.96 -64.12 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.895 . . . . 0.0 109.716 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 19.0 t-105 -47.26 -49.06 24.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 109.523 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 36.2 mt -61.16 -50.93 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.176 -0.953 . . . . 0.0 109.228 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 53.2 tp -50.88 -37.7 45.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.835 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.476 ' OD2' ' NC ' ' D' ' 499' ' ' RIM . 73.2 m-20 -75.9 -28.41 58.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 109.625 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -71.56 -27.02 62.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.951 . . . . 0.0 110.569 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.4 mt -71.27 -16.08 62.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.69 -1.256 . . . . 0.0 109.112 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -82.92 -7.55 59.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.248 -0.908 . . . . 0.0 108.935 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 48' ' ' PHE . . . . . 0.445 ' O ' ' CB ' ' D' ' 49' ' ' LYS . 0.9 OUTLIER -87.7 -153.86 0.24 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.405 -0.809 . . . . 0.0 109.737 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 49' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' D' ' 48' ' ' PHE . 5.9 ttpt 74.14 -62.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.365 -0.834 . . . . 0.0 109.593 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.85 106.42 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.196 -0.94 . . . . 0.0 109.594 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 51' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' C' ' 54' ' ' PHE . 4.0 mt -87.78 -23.3 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.574 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 52' ' ' TYR . . . . . 0.468 ' CD1' ' C ' ' D' ' 52' ' ' TYR . 0.0 OUTLIER -62.79 -49.25 75.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.145 -0.972 . . . . 0.0 110.181 -179.348 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 53' ' ' ARG . . . . . 0.419 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 0.7 OUTLIER -71.6 -28.48 63.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.536 -1.353 . . . . 0.0 110.19 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -75.66 -54.91 6.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.086 -1.009 . . . . 0.0 111.089 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.1 OUTLIER -75.58 -18.29 59.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.957 -1.089 . . . . 0.0 110.583 -178.673 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 56' ' ' GLU . . . . . 0.526 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 2.2 tm-20 -84.5 -33.7 23.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.856 -1.152 . . . . 0.0 108.063 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 57' ' ' HIS . . . . . 0.419 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 0.5 OUTLIER -69.0 -38.6 79.36 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 58' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' D' ' 60' ' ' LYS . . . -69.78 -61.5 4.34 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.1 77.61 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -1.159 . . . . 0.0 109.556 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 60' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' D' ' 58' ' ' GLY . 50.9 tttt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.479 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' RIM . . . . . 0.662 ' NC ' HD22 ' A' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 299' ' ' RIM . . . . . 0.509 ' NC ' ' OD2' ' B' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 399' ' ' RIM . . . . . 0.478 HNC2 ' CG ' ' C' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 499' ' ' RIM . . . . . 0.476 ' NC ' ' OD2' ' D' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.0 p . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 26' ' ' LEU . 8.6 m-20 -152.4 66.72 6.54 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 109.363 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -45.82 -11.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.778 2.319 . . . . 0.0 112.27 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 24' ' ' ASP . 37.2 tp -46.65 -46.31 19.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.234 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.6 t -68.51 -44.78 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 108.974 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -49.15 -49.39 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 0.0 109.08 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.83 -35.04 79.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 109.355 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.41 -56.98 10.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.69 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.95 -36.98 68.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.194 -0.941 . . . . 0.0 109.866 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.8 mt -71.01 -40.91 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.107 -0.996 . . . . 0.0 109.441 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.9 mt -57.02 -36.05 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.141 -0.974 . . . . 0.0 108.59 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.29 -44.1 53.34 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.5 mt -61.81 -27.02 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.165 -1.197 . . . . 0.0 109.155 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.99 -66.6 0.65 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.333 -0.854 . . . . 0.0 109.441 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.31 -39.31 6.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 109.841 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.67 -69.0 0.3 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.419 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.5 mt -47.1 -34.34 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.514 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 mt -62.87 -55.8 22.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.464 -0.773 . . . . 0.0 109.943 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -52.03 -45.01 64.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mt -68.76 -28.29 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.108 -0.995 . . . . 0.0 109.279 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -61.69 -44.26 97.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.563 -179.653 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.507 ' OD1' ' NH2' ' B' ' 45' ' ' ARG . 2.6 m-20 -80.19 -24.45 40.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 109.97 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -93.31 0.97 57.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.122 -0.987 . . . . 0.0 111.25 -179.22 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.48 ' C ' ' O ' ' A' ' 45' ' ' ARG . 31.0 mt -31.3 -36.27 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.693 -0.63 . . . . 0.0 110.814 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 169.15 -10.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 109.267 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -46.21 103.8 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.383 -0.823 . . . . 0.0 109.42 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' CG ' ' H ' ' A' ' 50' ' ' SER . 12.6 tptm -145.44 -129.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.905 . . . . 0.0 109.713 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.428 ' H ' ' CG ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER 65.36 135.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.282 -0.886 . . . . 0.0 109.229 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.1 mt -102.17 -35.26 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.525 -0.735 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -35.39 69.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.612 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -64.24 -41.12 97.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 0.0 109.369 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -65.34 -29.11 69.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.434 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -75.34 -68.42 0.56 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.098 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -46.83 -31.27 2.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.243 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -69.85 -58.77 3.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.314 -0.866 . . . . 0.0 109.566 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.19 -60.45 9.0 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.08 97.17 1.44 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -1.1 . . . . 0.0 109.356 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.4 mttp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.511 -179.888 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 30.3 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' B' ' 26' ' ' LEU . 4.8 m-20 48.82 67.28 4.66 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.449 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -47.22 -9.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.763 2.309 . . . . 0.0 112.311 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' B' ' 24' ' ' ASP . 39.1 tp -47.22 -44.76 22.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.944 . . . . 0.0 108.871 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 38.7 t -68.66 -44.88 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 108.758 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.5 t -49.7 -50.62 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 109.176 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.39 -34.82 78.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 109.391 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.76 -55.99 14.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 109.685 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.72 -36.85 67.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 109.873 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 18.9 mt -72.42 -42.4 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.553 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 mt -55.85 -34.65 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.054 -1.029 . . . . 0.0 108.826 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.33 -43.89 36.55 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 67.7 mt -60.25 -26.29 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.243 -1.151 . . . . 0.0 109.234 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.58 -64.49 1.06 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.267 -0.896 . . . . 0.0 109.263 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -45.5 -43.56 11.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.4 tp -63.15 -64.57 0.87 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.311 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 8.2 mt -47.78 -28.36 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.471 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.675 HD22 HNC1 ' B' ' 299' ' ' RIM . 2.2 mt -67.44 -55.86 11.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 110.141 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -55.67 -39.72 71.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.944 . . . . 0.0 109.937 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 94.5 mt -70.58 -40.57 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.954 -1.091 . . . . 0.0 108.959 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 50.3 tp -57.51 -41.33 80.61 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.516 -0.74 . . . . 0.0 109.767 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.3 -23.73 43.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.154 -0.966 . . . . 0.0 109.84 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.507 ' NH2' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -89.01 -4.74 58.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.044 -1.035 . . . . 0.0 110.902 -179.19 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.497 ' C ' ' O ' ' B' ' 45' ' ' ARG . 28.0 mt -33.56 -35.9 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.693 -0.629 . . . . 0.0 110.166 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' B' ' 45' ' ' ARG . 3.3 t80 -172.59 136.08 0.73 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.943 . . . . 0.0 109.326 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' PHE . . . . . 0.413 ' CD2' ' O ' ' B' ' 47' ' ' PHE . 0.7 OUTLIER -167.85 98.58 0.46 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.216 -0.928 . . . . 0.0 109.43 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -141.79 -35.73 0.44 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 109.424 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 11.9 p -65.65 124.71 23.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.291 -0.88 . . . . 0.0 109.531 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 15.8 mt -111.39 -22.67 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.671 -0.643 . . . . 0.0 109.347 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -54.03 -21.43 8.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.663 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -69.87 -45.9 66.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.437 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -65.09 -34.4 78.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.476 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -65.65 -60.24 3.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 109.458 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -52.71 -30.96 35.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.459 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -62.63 -63.42 1.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 109.315 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.33 -59.29 9.77 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mt -50.77 143.96 9.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.358 -1.084 . . . . 0.0 109.683 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.5 mttm . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.33 179.854 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 50.9 p . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' C' ' 24' ' ' ASP . 1.7 p-10 -171.11 70.24 0.51 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.393 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.53 -9.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.814 2.343 . . . . 0.0 112.402 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' C' ' 24' ' ' ASP . 48.3 tp -47.76 -46.97 30.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.189 -0.944 . . . . 0.0 109.033 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.78 -45.47 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.238 -0.914 . . . . 0.0 108.759 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -48.46 -46.48 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 0.0 109.139 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.93 -36.87 83.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -0.929 . . . . 0.0 109.46 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.36 -55.13 27.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 109.388 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.08 -36.2 67.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.392 -0.818 . . . . 0.0 109.894 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 18.4 mt -72.98 -41.57 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.109 -0.994 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 21.1 mt -56.78 -34.79 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.074 -1.016 . . . . 0.0 108.614 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.11 -45.17 42.03 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 54.4 mt -57.13 -31.81 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.21 -1.171 . . . . 0.0 108.869 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.98 -64.62 0.87 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.456 -0.778 . . . . 0.0 109.055 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -46.25 -39.08 9.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.876 . . . . 0.0 109.72 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -63.09 -70.13 0.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.956 . . . . 0.0 109.545 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 3.9 mt -47.14 -37.92 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.319 -0.863 . . . . 0.0 109.401 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' LEU . . . . . 0.55 HD22 HNC1 ' C' ' 399' ' ' RIM . 4.0 mt -61.42 -61.79 2.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.343 -0.848 . . . . 0.0 110.101 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -45.85 -49.48 15.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.366 -0.834 . . . . 0.0 109.578 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 64.7 mt -60.57 -44.44 96.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.166 -0.959 . . . . 0.0 108.9 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' C' ' 43' ' ' LEU . 0.1 OUTLIER -48.36 -55.28 11.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.536 -0.727 . . . . 0.0 109.583 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 44' ' ' ASP . . . . . 0.514 ' OD1' ' NC ' ' C' ' 399' ' ' RIM . 7.8 m-20 -64.4 -27.71 69.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 110.316 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -72.11 -25.25 61.67 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.861 -1.149 . . . . 0.0 110.798 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 47' ' ' PHE . 9.7 mt -68.95 -8.78 47.71 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.669 -1.27 . . . . 0.0 109.289 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' C' ' 49' ' ' LYS . 2.9 m-85 -47.23 -92.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -0.93 . . . . 0.0 109.35 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 46.09 19.63 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.762 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 49' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' C' ' 47' ' ' PHE . 16.4 mtpt -64.01 -148.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.153 -0.967 . . . . 0.0 109.483 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.7 162.83 14.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.174 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 13.4 mt -103.93 -22.76 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.536 -0.728 . . . . 0.0 109.442 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 52' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' C' ' 52' ' ' TYR . 6.5 t80 -63.55 -22.05 66.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.265 -0.897 . . . . 0.0 109.982 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -66.33 -46.99 74.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.072 -1.017 . . . . 0.0 110.0 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -66.02 -33.68 76.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 0.0 109.691 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -63.17 -58.65 6.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.378 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -57.14 -30.0 64.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 109.157 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -67.28 -45.83 75.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.298 -0.876 . . . . 0.0 109.127 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.25 -61.89 5.36 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 mt -48.7 140.08 8.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -1.153 . . . . 0.0 109.494 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.474 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.286 0.565 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.37 160.11 0.38 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.328 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 25' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' D' ' 26' ' ' LEU . 19.5 Cg_endo -61.83 -24.42 77.24 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.567 2.178 . . . . 0.0 112.206 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' D' ' 25' ' ' PRO . 56.2 tp -45.59 -41.02 9.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 108.775 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 33.5 t -70.26 -45.27 76.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.303 -0.873 . . . . 0.0 108.697 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 74.1 t -49.76 -49.1 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 108.95 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.37 -33.47 76.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.307 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.23 -56.17 14.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.663 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -37.12 69.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.228 -0.92 . . . . 0.0 109.858 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 20.6 mt -71.36 -41.67 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.076 -1.015 . . . . 0.0 109.426 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 17.3 mt -56.48 -33.94 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.071 -1.018 . . . . 0.0 108.566 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.58 -44.55 32.38 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 61.9 mt -58.41 -29.66 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.343 -1.092 . . . . 0.0 109.218 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.13 -67.07 0.6 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.0 109.097 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -46.82 -37.29 8.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 0.0 109.732 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 59.4 tp -65.09 -69.2 0.31 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.133 -0.98 . . . . 0.0 109.507 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.1 mt -49.2 -26.51 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.483 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.488 ' C ' HD23 ' D' ' 40' ' ' LEU . 2.3 tt -67.64 -63.03 1.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.924 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 41' ' ' TRP . . . . . 0.507 ' CH2' ' NE ' ' D' ' 45' ' ' ARG . 24.7 t-105 -53.04 -43.87 66.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.984 -1.072 . . . . 0.0 109.666 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.75 -51.2 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.152 -0.967 . . . . 0.0 108.782 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 58.1 tp -50.06 -39.73 43.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.608 -0.683 . . . . 0.0 109.931 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.731 ' CG ' HNC2 ' D' ' 499' ' ' RIM . 0.5 OUTLIER -75.79 -24.43 55.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 109.911 -179.603 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.507 ' NE ' ' CH2' ' D' ' 41' ' ' TRP . 0.6 OUTLIER -76.08 -25.24 55.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.106 -0.996 . . . . 0.0 110.21 -179.596 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -73.13 -28.88 62.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.796 -1.19 . . . . 0.0 109.338 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 47' ' ' PHE . . . . . 0.455 ' O ' ' CB ' ' D' ' 48' ' ' PHE . 7.5 m-85 -66.19 -170.4 0.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 48' ' ' PHE . . . . . 0.455 ' CB ' ' O ' ' D' ' 47' ' ' PHE . 2.4 t80 73.61 18.5 3.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 49' ' ' LYS . . . . . 0.485 ' CG ' ' H ' ' D' ' 50' ' ' SER . 0.0 OUTLIER -58.47 -97.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -0.869 . . . . 0.0 109.409 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.51 ' OG ' ' CZ ' ' D' ' 52' ' ' TYR . 1.1 t -57.76 139.52 53.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.44 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 19.8 mt -109.59 -26.83 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.661 -0.65 . . . . 0.0 109.522 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 52' ' ' TYR . . . . . 0.51 ' CZ ' ' OG ' ' D' ' 50' ' ' SER . 17.8 p90 -59.99 -43.82 94.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.93 . . . . 0.0 109.721 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 53' ' ' ARG . . . . . 0.407 ' N ' ' CD2' ' D' ' 52' ' ' TYR . 10.1 mtp85 -64.39 -35.93 82.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.089 -1.007 . . . . 0.0 109.339 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -63.48 -33.74 76.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.878 . . . . 0.0 109.334 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -71.21 -56.59 5.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -0.84 . . . . 0.0 109.215 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -51.56 -29.31 16.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.221 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -69.34 -55.79 9.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.913 . . . . 0.0 109.235 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -48.07 -57.17 8.16 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.73 121.6 13.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.345 -1.091 . . . . 0.0 109.445 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 23.6 tttt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.486 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 199' ' ' RIM . . . . . 0.441 ' NC ' ' OD2' ' A' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 299' ' ' RIM . . . . . 0.675 HNC1 HD22 ' B' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 399' ' ' RIM . . . . . 0.55 HNC1 HD22 ' C' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 499' ' ' RIM . . . . . 0.731 HNC2 ' CG ' ' D' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.5 p . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.532 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 5.1 m-20 -154.68 49.51 0.46 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.182 -0.949 . . . . 0.0 109.644 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 12.8 Cg_endo -59.01 -12.67 16.09 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.744 2.296 . . . . 0.0 112.121 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.2 tp -47.22 -46.85 24.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 0.0 108.959 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.2 t -68.9 -44.74 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.34 -0.85 . . . . 0.0 108.792 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.3 t -49.36 -49.33 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.0 108.815 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.82 -33.39 75.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.374 -0.829 . . . . 0.0 109.35 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.52 -56.8 10.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.3 -0.875 . . . . 0.0 109.677 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.98 -37.34 68.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 109.891 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 27.7 mt -71.59 -41.36 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.136 -0.977 . . . . 0.0 109.474 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.1 mt -55.67 -34.79 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.175 -0.953 . . . . 0.0 108.458 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.26 -44.96 32.69 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.2 mt -56.84 -34.07 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.175 -1.191 . . . . 0.0 109.248 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.96 -63.61 1.03 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 109.086 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.96 -38.39 7.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.475 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.71 -70.97 0.2 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.872 . . . . 0.0 109.392 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 mt -46.79 -25.52 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.278 -0.889 . . . . 0.0 109.505 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -74.24 -55.5 5.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.704 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.5 t-105 -50.84 -48.52 59.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.96 . . . . 0.0 109.613 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mt -65.78 -57.53 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.291 -0.881 . . . . 0.0 109.398 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.6 tp -48.78 -27.95 3.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.541 -0.725 . . . . 0.0 110.525 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.511 ' OD2' ' NC ' ' A' ' 199' ' ' RIM . 2.3 m-20 -90.3 -26.97 19.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.012 -1.055 . . . . 0.0 109.961 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -73.12 -26.12 61.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.628 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 48' ' ' PHE . 9.0 mt -64.91 -9.81 24.06 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.795 -1.191 . . . . 0.0 109.552 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -66.82 76.61 0.12 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.1 -1.0 . . . . 0.0 109.514 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -156.9 21.01 0.32 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -126.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.54 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.0 m -48.55 125.91 10.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 0.0 109.421 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.3 mt -94.62 -24.86 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.817 . . . . 0.0 109.428 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.505 ' CD2' ' OE1' ' A' ' 56' ' ' GLU . 0.5 OUTLIER -60.6 -23.23 64.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.878 . . . . 0.0 109.592 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.457 ' O ' ' CG ' ' A' ' 57' ' ' HIS . 21.3 mtt180 -70.36 -37.47 74.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.088 -1.008 . . . . 0.0 109.665 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -71.93 -36.52 69.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.154 -0.966 . . . . 0.0 109.298 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -65.62 -46.42 79.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 0.0 109.793 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.505 ' OE1' ' CD2' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -70.56 -28.16 64.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.245 -0.909 . . . . 0.0 109.708 -179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.457 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 1.9 m-70 -67.28 -46.32 73.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 109.196 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.86 -65.16 2.56 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mt -59.1 145.34 42.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -1.136 . . . . 0.0 109.492 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.457 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.561 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 28.9 m-20 -152.21 48.5 0.47 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 109.612 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 10.5 Cg_endo -56.52 -15.06 14.45 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.794 2.33 . . . . 0.0 112.235 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' B' ' 26' ' ' LEU . 29.6 tp -46.5 -46.1 18.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.247 -0.908 . . . . 0.0 109.096 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.53 -44.39 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.231 -0.918 . . . . 0.0 108.967 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 74.5 t -50.73 -50.22 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.302 -0.874 . . . . 0.0 109.089 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.42 -36.56 82.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.53 -56.08 16.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.336 -0.852 . . . . 0.0 109.806 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.22 -36.77 66.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 109.707 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.19 -40.33 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.108 -0.995 . . . . 0.0 109.613 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.45 HD13 HG13 ' C' ' 35' ' ' ILE . 17.1 mt -56.8 -36.0 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.019 -1.051 . . . . 0.0 108.803 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.63 -43.29 44.33 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 86.2 mt -63.11 -21.27 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.35 -1.088 . . . . 0.0 108.908 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.55 -69.77 0.54 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.838 . . . . 0.0 109.218 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -46.55 -33.69 4.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.332 -0.855 . . . . 0.0 109.453 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.7 tp -68.11 -68.76 0.36 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.358 -0.839 . . . . 0.0 109.446 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -48.64 -33.33 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -0.925 . . . . 0.0 109.433 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.461 ' O ' HD23 ' B' ' 40' ' ' LEU . 2.1 tt -64.32 -54.74 28.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 109.444 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -48.83 -48.04 41.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.3 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 11.5 mt -66.27 -33.12 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.119 -0.988 . . . . 0.0 108.802 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -58.88 -34.5 71.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.507 -0.746 . . . . 0.0 110.316 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -87.71 -27.26 22.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.971 -1.081 . . . . 0.0 109.614 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -91.63 3.46 54.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 110.649 -179.481 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.481 ' C ' ' O ' ' B' ' 45' ' ' ARG . 34.1 mt -29.35 -37.02 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.976 -0.453 . . . . 0.0 110.915 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' B' ' 45' ' ' ARG . 0.4 OUTLIER -177.92 165.01 1.96 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.995 -1.066 . . . . 0.0 109.7 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -163.99 110.43 1.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.814 . . . . 0.0 109.432 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.586 ' N ' ' CD ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -144.02 -18.48 0.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.375 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.4 97.22 10.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.214 -0.929 . . . . 0.0 109.35 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 5.8 mt -93.33 -23.84 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.255 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -34.94 74.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.588 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 12.3 mtp180 -64.66 -32.58 74.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.869 . . . . 0.0 109.395 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -72.69 -42.63 64.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -0.892 . . . . 0.0 109.27 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -60.48 -39.7 88.61 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.385 -0.822 . . . . 0.0 109.015 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -71.77 -30.87 66.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.408 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -65.18 -48.95 71.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.27 -0.894 . . . . 0.0 109.066 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.9 -62.34 5.32 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 3.9 mt -58.98 138.08 57.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.353 -1.087 . . . . 0.0 109.272 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 16.0 tttm . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.52 -179.896 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.324 0.583 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 10.8 t0 -167.6 48.77 0.16 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.9 . . . . 0.0 109.197 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 25' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 2.9 Cg_endo -44.98 -19.77 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.778 2.319 . . . . 0.0 112.011 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 32.3 tp -45.85 -40.73 10.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.404 -0.81 . . . . 0.0 109.172 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.44 -45.19 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.866 . . . . 0.0 108.959 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 70.8 t -51.18 -49.88 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 108.973 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.89 -32.99 74.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.839 . . . . 0.0 109.249 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.36 -55.88 13.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.865 . . . . 0.0 109.47 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.93 -36.47 70.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.352 -0.843 . . . . 0.0 109.672 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 15.4 mt -71.45 -40.23 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.159 -0.963 . . . . 0.0 109.402 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.4 mt -58.03 -35.69 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.139 -0.976 . . . . 0.0 108.665 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.42 -43.23 62.57 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 35' ' ' ILE . . . . . 0.45 HG13 HD13 ' B' ' 33' ' ' ILE . 79.5 mt -63.76 -28.87 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.415 -1.05 . . . . 0.0 109.006 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.94 -58.86 4.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.412 -0.805 . . . . 0.0 108.98 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -54.36 -42.76 70.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.397 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 59.2 tp -58.81 -62.79 1.61 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.131 -0.98 . . . . 0.0 109.319 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mt -51.61 -40.98 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.215 -0.928 . . . . 0.0 109.495 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 40' ' ' LEU . . . . . 0.784 HD22 HNC1 ' C' ' 399' ' ' RIM . 2.6 mt -60.86 -54.43 45.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.403 -0.81 . . . . 0.0 110.05 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -52.21 -44.61 64.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.366 -0.834 . . . . 0.0 109.813 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 36.4 mt -70.48 -28.17 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.236 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.82 -43.5 98.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.644 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.31 -24.6 32.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.111 -0.993 . . . . 0.0 109.688 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' C' ' 47' ' ' PHE . 1.6 mmt85 -89.42 -1.18 57.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.3 -0.875 . . . . 0.0 110.753 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.491 ' C ' ' O ' ' C' ' 45' ' ' ARG . 29.0 mt -31.16 -36.23 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.851 -0.531 . . . . 0.0 110.805 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' C' ' 45' ' ' ARG . 2.3 m-85 -169.16 85.22 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.116 -0.99 . . . . 0.0 109.801 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 46.32 -132.87 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 109.686 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -170.07 -140.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.88 . . . . 0.0 109.256 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 50' ' ' SER . . . . . 0.441 ' O ' ' CZ ' ' C' ' 54' ' ' PHE . 40.5 t -147.9 120.52 8.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.319 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 17.1 mt -86.79 -23.12 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.243 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -23.85 64.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.352 -0.842 . . . . 0.0 109.499 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -70.39 -45.49 65.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.132 -0.98 . . . . 0.0 109.956 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 54' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' C' ' 54' ' ' PHE . 0.7 OUTLIER -69.1 -43.14 75.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.007 -1.058 . . . . 0.0 109.069 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -55.95 -56.72 17.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.407 -0.808 . . . . 0.0 109.354 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -26.8 68.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.664 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 37.0 t60 -67.16 -47.5 70.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.225 -0.922 . . . . 0.0 109.131 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.28 -59.6 9.21 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 62.4 mt -69.09 147.86 50.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.325 -1.103 . . . . 0.0 109.791 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 15.3 mttp . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.626 179.709 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 23' ' ' SER . . . . . 0.404 ' O ' ' OD1' ' D' ' 24' ' ' ASP . 69.4 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' D' ' 26' ' ' LEU . 62.0 m-20 -151.68 68.0 7.47 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -46.95 -11.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.659 2.239 . . . . 0.0 112.187 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' D' ' 24' ' ' ASP . 36.9 tp -47.36 -46.32 25.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.023 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 80.6 t -67.67 -45.5 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 0.0 108.852 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 72.6 t -49.42 -47.4 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.897 . . . . 0.0 108.912 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.53 -34.2 77.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.412 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.41 -56.63 10.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.194 -0.941 . . . . 0.0 109.634 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.94 -35.67 66.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 0.0 109.91 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 18.9 mt -73.25 -43.73 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.133 -0.979 . . . . 0.0 109.561 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 20.6 mt -54.56 -34.42 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.177 -0.952 . . . . 0.0 108.655 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.55 -44.41 26.82 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 50.0 mt -55.59 -31.04 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.087 -1.243 . . . . 0.0 109.356 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.11 -63.02 1.36 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.299 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -45.87 -38.94 7.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.367 -0.833 . . . . 0.0 109.854 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 53.7 tp -68.12 -67.85 0.43 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.123 -0.985 . . . . 0.0 109.642 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -47.31 -25.68 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.659 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.443 HD22 HNC1 ' D' ' 499' ' ' RIM . 4.3 mt -68.88 -65.67 0.67 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 109.818 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 21.3 t-105 -48.9 -45.19 40.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.212 -0.93 . . . . 0.0 109.879 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 42' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' D' ' 45' ' ' ARG . 84.9 mt -63.32 -56.86 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.131 -0.981 . . . . 0.0 108.875 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 61.2 tp -46.26 -45.82 17.42 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.539 -0.726 . . . . 0.0 109.422 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.79 -26.7 67.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.357 -0.839 . . . . 0.0 109.771 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.512 ' CA ' ' HE ' ' D' ' 45' ' ' ARG . 0.0 OUTLIER -77.49 -21.15 53.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.13 -0.981 . . . . 0.0 110.151 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.1 mt -83.65 -34.13 25.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.776 -1.202 . . . . 0.0 108.926 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -95.43 118.09 31.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.458 -0.776 . . . . 0.0 109.389 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -158.85 -8.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.122 -0.986 . . . . 0.0 109.63 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.9 pttp -67.98 -152.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.191 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 11.4 p 44.09 59.53 3.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.334 -0.854 . . . . 0.0 109.65 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 12.4 mt -96.83 -22.89 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.338 -0.852 . . . . 0.0 109.606 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -67.73 -22.75 65.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.136 -0.977 . . . . 0.0 109.483 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 53' ' ' ARG . . . . . 0.435 ' O ' ' ND1' ' D' ' 57' ' ' HIS . 0.1 OUTLIER -69.93 -39.37 76.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 109.44 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -69.72 -37.62 76.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.92 . . . . 0.0 109.089 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.35 -43.69 96.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.341 -0.849 . . . . 0.0 109.288 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -68.99 -27.95 66.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.272 -0.892 . . . . 0.0 109.114 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 57' ' ' HIS . . . . . 0.435 ' ND1' ' O ' ' D' ' 53' ' ' ARG . 1.7 m-70 -67.37 -46.95 71.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.308 -0.87 . . . . 0.0 108.855 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.26 -60.99 7.38 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 114.81 6.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -1.061 . . . . 0.0 109.419 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.06 -0.972 . . . . 0.0 109.447 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 199' ' ' RIM . . . . . 0.515 ' HA2' ' CB ' ' B' ' 45' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 299' ' ' RIM . . . . . 0.409 ' HA2' ' CB ' ' C' ' 45' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 399' ' ' RIM . . . . . 0.784 HNC1 HD22 ' C' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 499' ' ' RIM . . . . . 0.443 HNC1 HD22 ' D' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 26' ' ' LEU . 13.3 m-20 56.23 65.3 4.31 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.693 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -45.72 -11.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.691 2.261 . . . . 0.0 112.076 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 24' ' ' ASP . 28.7 tp -47.37 -45.68 25.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.339 -0.851 . . . . 0.0 109.044 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.32 -45.64 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.288 -0.883 . . . . 0.0 108.803 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.5 t -49.53 -47.85 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.253 -0.904 . . . . 0.0 109.021 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.3 -33.58 76.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 109.339 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.18 -56.66 10.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.873 . . . . 0.0 109.685 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.95 -36.27 70.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.259 -0.9 . . . . 0.0 109.633 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.7 mt -70.87 -41.15 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 0.0 109.329 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.2 mt -57.48 -33.8 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.099 -1.001 . . . . 0.0 108.626 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.65 -44.38 39.92 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.1 mt -55.47 -34.98 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.321 -1.106 . . . . 0.0 109.097 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -68.82 -64.33 0.89 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.31 -0.869 . . . . 0.0 109.066 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.23 -41.01 8.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.445 -0.784 . . . . 0.0 110.072 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 35.4 tp -64.19 -68.04 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.111 -0.993 . . . . 0.0 109.6 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mt -47.9 -24.59 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.213 -0.93 . . . . 0.0 109.308 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.462 ' CD2' ' OD2' ' A' ' 44' ' ' ASP . 1.8 tt -71.35 -61.32 1.81 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 109.595 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 -51.16 -49.79 60.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.272 -0.892 . . . . 0.0 109.714 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 45' ' ' ARG . 80.6 mt -60.23 -56.32 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.006 -1.059 . . . . 0.0 108.969 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.3 tp -46.34 -42.15 14.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.477 -0.764 . . . . 0.0 109.578 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.48 ' OD2' ' NC ' ' A' ' 199' ' ' RIM . 72.9 m-20 -67.71 -28.19 67.45 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.21 -0.931 . . . . 0.0 109.276 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 42' ' ' ILE . 7.0 mmt-85 -80.11 -17.72 51.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 110.42 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -87.14 -35.08 18.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.693 -1.255 . . . . 0.0 109.002 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -99.5 -154.58 0.47 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.462 -0.774 . . . . 0.0 109.255 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 t80 66.56 114.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 50' ' ' SER . 5.3 ptmm? -169.8 -148.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.315 -0.866 . . . . 0.0 109.3 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 49' ' ' LYS . 17.0 m 50.98 97.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.9 mt -86.5 -24.42 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 109.067 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -59.23 -21.7 59.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.272 -0.892 . . . . 0.0 109.867 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.521 ' O ' ' CD2' ' A' ' 57' ' ' HIS . 17.7 mmm180 -74.43 -44.09 53.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.91 -1.119 . . . . 0.0 109.744 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -73.71 -33.55 64.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.993 -1.067 . . . . 0.0 108.496 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -68.43 -52.12 36.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.351 -0.843 . . . . 0.0 109.861 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -71.17 -27.54 63.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.122 -0.986 . . . . 0.0 110.194 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 53' ' ' ARG . 11.4 m170 -65.0 -52.91 53.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.966 -1.084 . . . . 0.0 109.124 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.05 -64.52 2.76 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.4 116.98 4.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.189 -1.183 . . . . 0.0 109.425 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.431 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.537 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 16.6 m-20 -159.96 50.22 0.34 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.212 -0.93 . . . . 0.0 109.376 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 12.3 Cg_endo -58.7 -15.8 27.79 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.928 2.418 . . . . 0.0 112.438 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 52.1 tp -47.22 -43.23 21.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.086 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.58 -45.25 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.91 . . . . 0.0 108.733 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 77.6 t -49.0 -46.34 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.282 -0.886 . . . . 0.0 108.989 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.95 -37.1 85.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 109.144 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.01 -55.37 29.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.339 -0.851 . . . . 0.0 109.651 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.0 -37.28 71.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 110.06 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 14.0 mt -70.84 -39.75 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.141 -0.974 . . . . 0.0 109.319 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 26.8 mt -57.77 -36.44 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.246 -0.909 . . . . 0.0 108.634 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.54 -44.55 63.6 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.2 -23.28 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.295 -1.12 . . . . 0.0 109.005 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.2 tp -76.78 -71.71 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.464 -0.773 . . . . 0.0 109.456 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' HIS . . . . . 0.47 ' CD2' ' ND1' ' C' ' 37' ' ' HIS . 2.9 t-80 -44.79 -35.42 2.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 109.774 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -66.58 -68.66 0.36 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.191 -0.943 . . . . 0.0 109.466 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 7.0 mt -48.69 -41.18 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.463 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.664 HD22 ' NC ' ' B' ' 299' ' ' RIM . 2.5 mt -60.96 -61.72 2.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 110.066 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -46.82 -47.62 21.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.104 -0.998 . . . . 0.0 109.746 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 70.1 mt -62.0 -42.17 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.185 -0.947 . . . . 0.0 109.11 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.42 -43.39 64.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.625 -0.672 . . . . 0.0 109.918 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.505 ' OD2' ' NC ' ' B' ' 299' ' ' RIM . 6.7 m-20 -77.83 -25.41 48.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.743 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.542 ' NE ' ' NC ' ' A' ' 199' ' ' RIM . 9.6 mmm180 -71.83 -30.47 65.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.84 -1.163 . . . . 0.0 110.614 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -55.85 -26.53 47.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.734 -1.228 . . . . 0.0 109.281 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.19 -166.17 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.071 -1.018 . . . . 0.0 109.255 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -134.36 -125.02 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.742 . . . . 0.0 109.358 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -149.74 -63.68 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 83.7 p -52.14 104.96 0.1 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.871 . . . . 0.0 109.493 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 10.7 mt -103.75 -20.18 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.435 -0.791 . . . . 0.0 109.355 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -57.51 -12.64 2.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.576 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -72.1 -42.17 66.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 109.724 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -70.09 -38.41 75.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.143 -0.973 . . . . 0.0 108.993 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -59.43 -47.91 83.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.512 -0.743 . . . . 0.0 109.593 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.8 -27.2 63.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.584 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -66.18 -50.48 63.74 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.885 . . . . 0.0 109.13 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.03 -63.54 3.77 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 7.2 mt -68.65 118.58 11.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -1.148 . . . . 0.0 109.511 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 mptt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.481 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.32 159.22 75.54 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 0.0 109.277 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -61.08 -20.35 67.34 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.36 2.04 . . . . 0.0 112.205 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 47.4 tp -47.22 -42.54 20.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.944 . . . . 0.0 108.581 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 35.0 t -69.09 -45.48 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 73.8 t -48.77 -47.55 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 108.853 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.86 -36.48 84.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.37 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.13 -57.27 10.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.393 -0.817 . . . . 0.0 109.832 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.48 -36.97 67.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.268 -0.895 . . . . 0.0 109.916 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 24.8 mt -70.99 -42.45 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.378 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.9 mt -55.41 -35.69 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 108.83 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.25 -45.22 40.44 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 51.5 mt -55.72 -30.27 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.157 -1.202 . . . . 0.0 109.066 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' C' ' 36' ' ' LEU . 0.2 OUTLIER -73.73 -64.01 1.09 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 109.069 179.656 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 37' ' ' HIS . . . . . 0.47 ' ND1' ' CD2' ' B' ' 37' ' ' HIS . 13.0 t-80 -43.4 -37.25 2.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.484 -0.76 . . . . 0.0 110.244 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' C' ' 38' ' ' LEU . 35.3 tp -71.99 -65.17 0.8 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.983 -1.073 . . . . 0.0 109.523 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.3 mt -46.94 -27.64 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.235 -0.916 . . . . 0.0 109.393 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 40' ' ' LEU . . . . . 0.456 HD21 ' NC ' ' C' ' 399' ' ' RIM . 1.3 tt -72.04 -63.24 1.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.338 -0.851 . . . . 0.0 109.688 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -45.94 -47.5 16.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 109.287 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 64.5 mt -58.49 -49.31 82.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.221 -0.924 . . . . 0.0 108.93 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.56 -50.43 13.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.653 -0.655 . . . . 0.0 109.411 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 44' ' ' ASP . . . . . 0.434 ' OD2' ' NC ' ' C' ' 399' ' ' RIM . 1.3 m-20 -62.76 -32.82 74.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.89 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -73.02 -19.12 61.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.07 -1.019 . . . . 0.0 110.416 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -83.75 -13.63 53.49 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.641 -1.287 . . . . 0.0 108.716 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.93 12.7 5.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 0.0 109.733 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.16 106.69 18.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.113 -0.992 . . . . 0.0 109.039 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -163.58 -90.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.152 -0.967 . . . . 0.0 109.72 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.34 103.61 0.25 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.913 . . . . 0.0 109.756 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 18.4 mt -90.99 -22.68 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.052 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.97 -23.42 66.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.026 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 53' ' ' ARG . . . . . 0.52 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 96.7 mtt180 -70.38 -36.51 74.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.068 -1.02 . . . . 0.0 110.125 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -72.35 -34.74 68.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.004 -1.06 . . . . 0.0 109.286 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.26 -45.8 79.29 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.338 -0.851 . . . . 0.0 109.679 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -71.6 -29.01 64.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.0 109.591 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 57' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 2.7 m-70 -64.58 -43.05 95.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 109.068 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.44 -61.61 4.09 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 mt -75.07 107.2 6.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -1.117 . . . . 0.0 109.57 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 14.9 tttt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.515 179.824 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.537 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 6.1 t70 66.21 48.4 0.56 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.353 -0.842 . . . . 0.0 109.595 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 25' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 0.9 OUTLIER -48.11 -19.72 1.81 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.634 2.223 . . . . 0.0 111.701 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 42.1 tp -46.26 -41.17 12.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.423 -0.798 . . . . 0.0 108.99 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 36.4 t -69.66 -45.67 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.237 -0.914 . . . . 0.0 108.795 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 77.5 t -49.2 -47.35 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 108.963 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.8 -34.33 77.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.873 . . . . 0.0 109.226 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.2 -55.44 18.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.849 . . . . 0.0 109.688 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -58.1 -36.21 72.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.324 -0.86 . . . . 0.0 109.892 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 25.7 mt -72.05 -42.52 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.145 -0.972 . . . . 0.0 109.438 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mt -56.2 -33.37 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.107 -0.996 . . . . 0.0 108.457 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.5 -44.78 25.84 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.85 -28.99 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.188 -1.184 . . . . 0.0 109.113 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.18 -65.33 0.76 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.335 -0.853 . . . . 0.0 108.883 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -45.75 -42.88 12.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.48 -0.763 . . . . 0.0 109.712 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.19 -67.79 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 0.0 109.558 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mt -47.13 -35.7 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.175 -0.953 . . . . 0.0 109.639 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.587 HD22 ' NC ' ' D' ' 499' ' ' RIM . 4.0 mt -63.5 -57.39 10.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.937 . . . . 0.0 109.826 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -48.15 -45.38 33.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.04 -1.037 . . . . 0.0 109.472 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 67.4 mt -64.49 -50.17 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.156 -0.965 . . . . 0.0 109.012 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 14.3 tp -52.09 -37.14 53.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.638 -0.664 . . . . 0.0 110.39 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.67 -21.73 30.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.036 -1.04 . . . . 0.0 110.349 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.423 ' NH1' ' OD1' ' C' ' 44' ' ' ASP . 0.0 OUTLIER -76.09 -28.95 57.73 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.984 -1.073 . . . . 0.0 110.712 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.25 -10.98 1.46 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.687 -1.258 . . . . 0.0 109.171 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -77.04 120.49 22.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.165 -0.96 . . . . 0.0 109.407 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.34 178.78 8.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.39 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 49' ' ' LYS . . . . . 0.543 ' CD ' ' H ' ' D' ' 50' ' ' SER . 6.0 tmtt? 54.83 -153.67 0.31 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.088 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.543 ' H ' ' CD ' ' D' ' 49' ' ' LYS . 2.6 m 47.01 54.7 8.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.945 -1.097 . . . . 0.0 110.023 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 47.4 mt -97.47 -28.64 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 0.0 109.297 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.44 -32.96 67.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.339 -0.85 . . . . 0.0 109.455 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -63.56 -34.76 78.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.114 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -72.55 -38.88 67.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.286 -0.884 . . . . 0.0 109.108 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -62.29 -49.39 75.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.411 -0.806 . . . . 0.0 109.208 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -67.87 -26.22 65.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.338 -0.851 . . . . 0.0 109.424 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -68.91 -34.71 75.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.87 . . . . 0.0 109.119 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.19 -62.89 2.36 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 7.5 mt -59.93 116.6 4.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -1.132 . . . . 0.0 109.337 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.474 179.886 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 199' ' ' RIM . . . . . 0.542 ' NC ' ' NE ' ' B' ' 45' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 299' ' ' RIM . . . . . 0.664 ' NC ' HD22 ' B' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 399' ' ' RIM . . . . . 0.456 ' NC ' HD21 ' C' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 499' ' ' RIM . . . . . 0.587 ' NC ' HD22 ' D' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 26' ' ' LEU . 28.0 t70 52.4 65.01 6.64 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.446 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -44.72 -12.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.677 2.251 . . . . 0.0 112.234 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' A' ' 24' ' ' ASP . 38.8 tp -48.92 -43.22 39.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.018 -1.052 . . . . 0.0 108.8 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 t -68.39 -46.01 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.232 -0.918 . . . . 0.0 108.588 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.6 t -49.08 -47.17 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 0.0 108.876 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.11 -33.39 75.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.316 -0.865 . . . . 0.0 109.345 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.44 -57.24 6.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.313 -0.867 . . . . 0.0 109.727 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.71 -37.14 65.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.968 . . . . 0.0 109.429 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.5 mt -71.11 -41.15 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 0.0 109.124 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.3 mt -56.03 -34.03 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.119 -0.988 . . . . 0.0 108.524 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.9 -45.84 31.7 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.9 mt -60.55 -23.13 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.265 -1.138 . . . . 0.0 108.845 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.6 tp -76.69 -70.8 0.43 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.518 -0.739 . . . . 0.0 109.082 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.467 ' HE2' ' CE1' ' B' ' 37' ' ' HIS . 1.9 t-80 -47.31 -33.51 5.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 109.506 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.9 tp -66.59 -69.17 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 109.654 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 mt -48.45 -27.68 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.61 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.483 HD12 HD11 ' B' ' 38' ' ' LEU . 1.6 mt -68.61 -59.82 2.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -0.933 . . . . 0.0 109.914 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -53.36 -46.12 69.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.021 -1.049 . . . . 0.0 109.809 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 82.2 mt -61.78 -52.77 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.018 -1.051 . . . . 0.0 108.836 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.8 tp -51.25 -38.58 53.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.506 -0.746 . . . . 0.0 109.399 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 1.4 m-20 -72.38 -24.98 61.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 109.23 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.558 ' CA ' ' HE ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -77.96 -24.12 48.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.177 -0.952 . . . . 0.0 110.14 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.463 ' C ' ' H ' ' A' ' 48' ' ' PHE . 9.3 mt -80.17 -13.93 58.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.77 -1.206 . . . . 0.0 109.043 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -75.03 29.78 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.655 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.463 ' H ' ' C ' ' A' ' 46' ' ' LEU . 78.0 t80 -83.04 77.14 9.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.134 -0.979 . . . . 0.0 109.369 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -85.71 -128.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.459 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.98 168.48 10.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.337 -0.852 . . . . 0.0 109.489 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.0 mt -104.2 -23.11 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.487 -0.758 . . . . 0.0 109.324 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -60.15 -21.82 62.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.097 -1.002 . . . . 0.0 109.734 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.7 mtt85 -69.39 -43.48 73.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.176 -0.952 . . . . 0.0 109.26 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -64.96 -36.56 84.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.476 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -70.68 -61.64 1.69 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -48.39 -29.72 4.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.348 -0.845 . . . . 0.0 109.646 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -71.13 -53.3 15.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.198 -0.939 . . . . 0.0 109.512 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.05 -60.28 9.33 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.8 mt -77.65 81.65 4.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -1.139 . . . . 0.0 109.604 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.7 tttt . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.379 179.864 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.86 160.86 66.62 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.301 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' B' ' 26' ' ' LEU . 18.7 Cg_endo -63.7 -21.08 69.9 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.525 2.15 . . . . 0.0 112.301 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' B' ' 25' ' ' PRO . 48.9 tp -46.63 -43.67 17.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 108.686 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 37.3 t -69.54 -44.76 79.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.306 -0.871 . . . . 0.0 108.801 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -48.6 -46.63 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.878 . . . . 0.0 108.827 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.15 -39.06 92.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.393 -0.817 . . . . 0.0 109.155 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.86 -57.51 11.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.458 -0.776 . . . . 0.0 109.948 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.78 -37.07 63.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.096 -1.003 . . . . 0.0 109.758 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 20.6 mt -71.38 -38.49 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.152 -0.967 . . . . 0.0 109.468 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 29.8 mt -57.51 -36.27 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.087 -1.008 . . . . 0.0 108.582 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.89 -46.53 52.18 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 69.0 mt -59.64 -25.76 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.306 -1.114 . . . . 0.0 108.891 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 14.0 tp -75.63 -67.88 0.62 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' HIS . . . . . 0.467 ' CE1' ' HE2' ' A' ' 37' ' ' HIS . 1.4 t60 -42.59 -42.73 3.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.529 -0.732 . . . . 0.0 110.086 179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.483 HD11 HD12 ' A' ' 40' ' ' LEU . 22.2 tp -64.37 -64.66 0.82 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.979 -1.076 . . . . 0.0 109.521 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 6.3 mt -48.02 -29.34 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.327 -0.858 . . . . 0.0 109.556 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 5.2 mt -75.98 -57.79 3.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.552 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -45.83 -54.97 7.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.365 -0.834 . . . . 0.0 109.663 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' B' ' 45' ' ' ARG . 58.5 mt -58.66 -60.38 2.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.155 -0.966 . . . . 0.0 109.036 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' B' ' 42' ' ' ILE . 57.3 tp -41.61 -38.84 1.46 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.674 -0.641 . . . . 0.0 110.347 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.441 ' CG ' HNC1 ' B' ' 299' ' ' RIM . 1.0 OUTLIER -73.74 -30.19 62.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.1 -1.0 . . . . 0.0 109.625 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' B' ' 42' ' ' ILE . 0.4 OUTLIER -80.9 -13.64 58.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.898 . . . . 0.0 110.596 -179.521 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -87.28 -33.15 19.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.661 -1.275 . . . . 0.0 109.015 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -63.62 -19.87 65.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 109.515 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.02 128.9 34.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.445 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.414 ' HZ3' ' HB3' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -167.29 -54.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 109.504 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 78.1 p -93.32 138.39 31.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.959 . . . . 0.0 109.525 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 30.0 mt -110.33 -27.43 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.698 -0.626 . . . . 0.0 109.859 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -33.08 56.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.154 -0.966 . . . . 0.0 110.267 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -67.54 -39.71 85.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.861 -1.149 . . . . 0.0 109.595 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -66.28 -33.87 76.73 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.324 -0.86 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -68.24 -52.08 38.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 109.384 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -60.99 -30.92 70.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.676 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.26 -57.64 5.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 0.0 109.722 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.02 -58.93 11.76 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 5.2 mt -70.08 148.18 49.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.184 -1.186 . . . . 0.0 109.365 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 6.1 tptm . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.404 -179.936 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.352 0.596 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.502 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 4.9 p30 -166.71 51.84 0.24 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.391 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 25' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 12.4 Cg_endo -59.2 -9.54 8.52 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.633 2.222 . . . . 0.0 111.922 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 41.3 tp -47.5 -46.05 26.9 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.34 -0.85 . . . . 0.0 108.873 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 29.2 t -69.15 -45.58 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.213 -0.929 . . . . 0.0 108.686 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -49.2 -50.46 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.87 . . . . 0.0 109.071 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.77 76.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.872 . . . . 0.0 109.222 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.64 -55.84 15.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.448 -0.782 . . . . 0.0 109.659 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -54.92 -36.46 65.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 109.688 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.7 mt -72.41 -40.62 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.225 -0.922 . . . . 0.0 109.531 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 33' ' ' ILE . . . . . 0.451 HD13 HG13 ' D' ' 35' ' ' ILE . 23.5 mt -56.27 -35.65 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.001 -1.062 . . . . 0.0 108.871 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.15 -42.72 35.1 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 58.0 mt -58.72 -36.84 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -1.158 . . . . 0.0 109.57 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.45 -60.97 1.99 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.183 -0.948 . . . . 0.0 109.305 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -44.34 -39.34 4.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 0.0 110.187 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 25.6 tp -69.22 -66.94 0.52 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 109.688 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mt -46.81 -27.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.311 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 40' ' ' LEU . . . . . 0.529 ' O ' HD23 ' C' ' 40' ' ' LEU . 2.4 tt -74.25 -52.42 12.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.359 -0.838 . . . . 0.0 109.762 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 41' ' ' TRP . . . . . 0.435 ' CH2' ' NE ' ' C' ' 45' ' ' ARG . 24.3 t-105 -58.31 -46.08 86.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -0.962 . . . . 0.0 109.46 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 69.6 mt -64.57 -39.24 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.144 -0.973 . . . . 0.0 109.185 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.12 -31.31 71.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.839 . . . . 0.0 109.678 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -82.81 -25.24 32.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 109.627 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.435 ' NE ' ' CH2' ' C' ' 41' ' ' TRP . 3.5 mmt-85 -79.27 -26.15 42.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 111.137 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' C' ' 48' ' ' PHE . 6.4 mt -55.86 -9.69 0.62 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.413 -1.429 . . . . 0.0 109.217 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.414 ' N ' ' C ' ' C' ' 45' ' ' ARG . 70.8 t80 -70.61 66.3 0.33 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 109.108 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' C' ' 46' ' ' LEU . 2.7 t80 -92.19 153.41 19.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.863 . . . . 0.0 109.797 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp 59.06 -150.47 0.44 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 109.474 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 6.2 t 47.06 59.9 3.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.935 . . . . 0.0 109.548 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 15.8 mt -102.01 -31.08 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.429 -0.795 . . . . 0.0 109.411 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 52' ' ' TYR . . . . . 0.434 ' CD1' ' C ' ' C' ' 52' ' ' TYR . 0.0 OUTLIER -55.25 -34.25 63.85 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.336 -0.853 . . . . 0.0 110.13 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -67.42 -36.74 81.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.098 -1.001 . . . . 0.0 109.472 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -68.78 -32.29 71.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -0.95 . . . . 0.0 108.808 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -68.95 -47.01 66.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.449 -0.782 . . . . 0.0 109.3 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -65.94 -27.28 68.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.277 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' HIS . . . . . 0.652 ' CD2' ' HZ2' ' D' ' 49' ' ' LYS . 82.3 t60 -71.18 -44.54 65.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.095 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.11 -63.3 4.67 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 41.1 mt -80.96 90.39 5.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.286 -1.126 . . . . 0.0 109.393 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 mttm . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.536 -179.846 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.24 0.543 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' D' ' 26' ' ' LEU . 11.1 m-20 -154.29 66.28 5.28 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.362 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -45.26 -11.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.738 2.292 . . . . 0.0 112.179 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' D' ' 24' ' ' ASP . 41.9 tp -47.61 -44.98 27.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.127 -0.983 . . . . 0.0 109.193 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.4 t -68.47 -44.99 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.22 -0.925 . . . . 0.0 108.812 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.3 t -49.12 -48.62 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 108.981 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.71 -33.19 75.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.327 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.36 -57.1 8.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.342 -0.849 . . . . 0.0 109.571 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.56 -37.09 70.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.812 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 16.2 mt -71.11 -43.11 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.155 -0.965 . . . . 0.0 109.52 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 27.2 mt -56.05 -35.11 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.071 -1.018 . . . . 0.0 108.681 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.95 -43.79 39.58 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 35' ' ' ILE . . . . . 0.451 HG13 HD13 ' C' ' 33' ' ' ILE . 78.6 mt -62.26 -26.45 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.304 -1.115 . . . . 0.0 108.869 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.49 -67.0 0.55 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.478 -0.764 . . . . 0.0 109.172 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -45.16 -47.27 12.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.35 -0.844 . . . . 0.0 109.954 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.2 tp -57.62 -63.54 1.2 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.166 -0.959 . . . . 0.0 109.614 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 10.3 mt -50.57 -36.1 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.122 -0.986 . . . . 0.0 109.558 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.609 HD22 HNC1 ' D' ' 499' ' ' RIM . 4.6 mt -63.57 -57.54 9.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.798 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -47.24 -44.75 23.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.279 -0.888 . . . . 0.0 109.548 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 12.2 mt -69.38 -33.9 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 108.714 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -60.14 -42.15 94.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.438 -0.789 . . . . 0.0 109.936 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.501 ' OD1' ' NC ' ' D' ' 499' ' ' RIM . 0.7 OUTLIER -81.97 -22.19 36.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 0.0 109.612 -179.821 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' D' ' 47' ' ' PHE . 9.3 mmt180 -92.57 -0.71 57.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 0.0 110.875 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.482 ' C ' ' O ' ' D' ' 45' ' ' ARG . 32.8 mt -31.01 -36.16 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.658 -0.651 . . . . 0.0 110.832 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 47' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' D' ' 45' ' ' ARG . 0.2 OUTLIER 178.23 15.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.139 -0.976 . . . . 0.0 109.547 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -49.95 101.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.449 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 49' ' ' LYS . . . . . 0.652 ' HZ2' ' CD2' ' C' ' 57' ' ' HIS . 0.0 OUTLIER -150.6 -29.16 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.964 . . . . 0.0 109.626 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 15.2 p -51.34 120.42 5.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 0.0 109.318 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 15.8 mt -101.07 -29.37 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.492 -0.755 . . . . 0.0 109.721 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -34.48 60.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.186 -0.946 . . . . 0.0 109.897 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -63.64 -39.6 94.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 109.551 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -67.55 -37.82 83.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 0.0 109.44 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.29 -64.43 0.88 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.437 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -51.27 -31.47 21.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.124 -0.985 . . . . 0.0 109.528 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 57' ' ' HIS . . . . . 0.414 ' ND1' ' C ' ' D' ' 57' ' ' HIS . 14.1 t-80 -69.26 -53.98 17.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.159 -0.963 . . . . 0.0 109.541 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.97 -62.29 6.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 59' ' ' LEU . . . . . 0.453 HD13 ' C ' ' D' ' 59' ' ' LEU . 0.4 OUTLIER -55.35 109.94 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -1.13 . . . . 0.0 109.076 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 60' ' ' LYS . . . . . 0.432 ' N ' HD13 ' D' ' 59' ' ' LEU . 17.6 ttmt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.562 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 299' ' ' RIM . . . . . 0.441 HNC1 ' CG ' ' B' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 399' ' ' RIM . . . . . 0.402 ' NC ' HD21 ' C' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 499' ' ' RIM . . . . . 0.609 HNC1 HD22 ' D' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.6 m-20 58.23 49.66 3.25 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 109.449 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.8 Cg_endo -55.12 -14.92 9.54 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.837 2.358 . . . . 0.0 112.266 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.9 tp -47.5 -44.28 25.35 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.201 -0.937 . . . . 0.0 109.091 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.8 t -68.21 -45.08 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.186 -0.946 . . . . 0.0 108.665 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.6 t -50.89 -48.12 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 0.0 109.009 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.02 -32.72 74.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 109.464 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.52 -55.14 12.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.329 -0.857 . . . . 0.0 109.626 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.94 -36.21 67.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.744 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.1 mt -73.35 -43.34 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.509 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.4 mt -54.34 -32.95 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.029 -1.044 . . . . 0.0 108.595 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.41 -45.33 14.54 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.0 mt -56.64 -36.68 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.148 -1.207 . . . . 0.0 109.483 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.39 -59.51 2.94 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.236 -0.915 . . . . 0.0 109.203 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -44.3 -44.81 8.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.342 -0.849 . . . . 0.0 110.02 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.53 -68.83 0.31 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.084 -1.01 . . . . 0.0 109.639 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 mt -45.44 -29.76 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.418 -0.801 . . . . 0.0 109.653 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 mt -68.57 -61.5 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.947 . . . . 0.0 109.543 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.494 ' NE1' ' OD2' ' D' ' 44' ' ' ASP . 54.8 t-105 -44.33 -46.04 9.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.548 -0.72 . . . . 0.0 109.633 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.5 mt -71.59 -33.09 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.086 -1.009 . . . . 0.0 109.559 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.9 tp -61.52 -43.12 99.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 109.972 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.52 -20.74 36.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 110.588 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 46' ' ' LEU . 8.6 mmt180 -85.92 -16.56 38.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.711 -1.243 . . . . 0.0 111.515 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 45' ' ' ARG . 20.7 mt -39.61 -34.55 0.24 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.01 -1.056 . . . . 0.0 110.171 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.548 ' CG ' ' O ' ' A' ' 47' ' ' PHE . 1.6 p90 -55.05 126.73 25.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.014 -1.054 . . . . 0.0 109.394 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -173.76 32.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 109.235 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -148.7 -76.64 0.16 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 109.556 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 p -55.15 85.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.94 . . . . 0.0 109.597 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.52 ' N ' ' O ' ' A' ' 49' ' ' LYS . 26.3 mt -89.76 -21.29 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.648 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.54 -21.47 62.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.965 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -67.36 -40.87 85.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.966 . . . . 0.0 109.943 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -71.39 -37.65 71.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 0.0 109.32 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -59.08 -51.38 70.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.233 -0.917 . . . . 0.0 109.192 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -67.69 -26.29 66.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 109.452 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -67.25 -42.01 84.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.18 -0.95 . . . . 0.0 109.198 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.04 -62.58 3.49 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mt -52.9 159.7 1.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.392 -1.063 . . . . 0.0 109.503 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.9 mttt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.498 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' B' ' 26' ' ' LEU . 6.9 m-20 -156.55 65.29 3.82 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.605 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -45.61 -9.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.773 2.315 . . . . 0.0 112.182 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' B' ' 24' ' ' ASP . 29.1 tp -47.27 -46.9 25.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.263 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.96 -45.21 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.225 -0.922 . . . . 0.0 108.89 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 73.0 t -48.98 -48.88 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 108.999 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.22 -34.01 77.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.364 -0.835 . . . . 0.0 109.461 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.46 -56.63 10.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.26 -0.9 . . . . 0.0 109.599 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.11 -37.0 68.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.586 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 16.8 mt -71.0 -41.08 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 21.1 mt -56.4 -33.91 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.174 -0.954 . . . . 0.0 108.645 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.67 -43.13 24.48 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 66.9 mt -59.14 -39.4 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.115 -1.226 . . . . 0.0 109.308 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.12 -63.8 1.0 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.952 . . . . 0.0 109.076 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.08 -49.77 11.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.435 -0.79 . . . . 0.0 109.761 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' B' ' 38' ' ' LEU . 48.9 tp -56.5 -65.19 0.65 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 109.618 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.8 mt -46.44 -40.03 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 0.0 109.538 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.67 -63.24 1.37 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 110.095 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -45.06 -48.25 11.82 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.374 -0.828 . . . . 0.0 109.854 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.457 HG12 HNC1 ' A' ' 199' ' ' RIM . 79.3 mt -61.53 -47.78 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.212 -0.93 . . . . 0.0 109.07 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 13.3 tp -51.78 -39.59 58.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.537 -0.727 . . . . 0.0 110.137 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.583 ' CG ' HNC2 ' B' ' 299' ' ' RIM . 1.7 m-20 -76.31 -26.45 55.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 109.953 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.509 ' CA ' ' HE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -73.58 -27.95 61.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.056 -1.027 . . . . 0.0 110.464 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -65.96 -31.06 71.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.688 -1.258 . . . . 0.0 109.179 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' B' ' 48' ' ' PHE . 60.3 t80 -78.19 -103.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 109.313 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' PHE . . . . . 0.48 ' N ' ' CG ' ' B' ' 47' ' ' PHE . 2.7 t80 48.04 -154.97 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.925 . . . . 0.0 109.747 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 6.6 tttt 68.73 -153.8 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.3 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.525 ' O ' ' CE2' ' B' ' 54' ' ' PHE . 13.8 m 44.77 75.53 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.215 -0.928 . . . . 0.0 109.401 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 27.3 mt -90.7 -20.25 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.15 -0.969 . . . . 0.0 109.712 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -20.97 58.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 0.0 109.581 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -71.49 -42.92 67.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 110.046 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' PHE . . . . . 0.525 ' CE2' ' O ' ' B' ' 50' ' ' SER . 4.0 m-85 -70.58 -35.08 72.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.059 -1.026 . . . . 0.0 109.492 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -63.55 -45.56 89.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.19 -0.944 . . . . 0.0 109.279 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -71.49 -25.49 62.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.514 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -65.97 -53.07 43.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.091 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.02 -60.52 7.12 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.12 148.96 16.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -1.168 . . . . 0.0 109.439 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 33.1 tttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.391 179.929 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.55 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 4.2 p30 -175.09 49.16 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.346 -0.846 . . . . 0.0 109.432 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 25' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 10.6 Cg_endo -56.34 -12.32 7.79 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.941 2.427 . . . . 0.0 112.249 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 35.5 tp -47.71 -44.65 27.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.129 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 38.6 t -68.99 -45.18 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.179 -0.95 . . . . 0.0 108.674 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.8 t -49.69 -49.19 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.0 108.889 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.17 -31.87 73.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.338 -0.851 . . . . 0.0 109.254 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.15 -57.27 7.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 109.686 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -55.68 -36.27 66.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.666 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.5 mt -71.79 -38.98 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.979 . . . . 0.0 109.548 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 23.7 mt -59.38 -35.51 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.015 -1.053 . . . . 0.0 108.73 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.47 -42.89 63.22 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 77.7 mt -63.63 -22.28 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.414 -1.05 . . . . 0.0 108.771 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.91 -70.84 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 37' ' ' HIS . . . . . 0.55 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 2.3 t-80 -45.92 -36.73 5.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.864 . . . . 0.0 109.67 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.95 -67.82 0.4 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.437 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 5.6 mt -48.54 -28.92 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.878 . . . . 0.0 109.672 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 mt -71.57 -59.79 2.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 110.01 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 51.9 t-105 -49.59 -47.75 49.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.084 -1.01 . . . . 0.0 109.811 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 73.2 mt -64.02 -58.74 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.102 -0.999 . . . . 0.0 109.273 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 59.2 tp -44.99 -54.46 6.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.47 -0.769 . . . . 0.0 109.679 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.79 -26.61 67.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.314 -0.867 . . . . 0.0 110.109 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.486 ' HE ' ' CA ' ' C' ' 45' ' ' ARG . 0.0 OUTLIER -79.19 -20.69 47.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.924 -1.11 . . . . 0.0 110.446 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -79.84 -32.14 40.56 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.701 -1.249 . . . . 0.0 109.058 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.451 ' O ' ' CB ' ' C' ' 48' ' ' PHE . 6.3 t80 -92.33 -144.91 0.21 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 0.0 109.31 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.451 ' CB ' ' O ' ' C' ' 47' ' ' PHE . 1.1 t80 72.38 106.31 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 109.441 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 49' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' C' ' 50' ' ' SER . 10.7 tttp -165.62 -154.03 0.19 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.366 -0.834 . . . . 0.0 109.094 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 50' ' ' SER . . . . . 0.42 ' O ' ' O ' ' C' ' 49' ' ' LYS . 34.6 m 42.55 91.14 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.333 -0.854 . . . . 0.0 109.917 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 10.3 mt -94.64 -19.09 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.411 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -67.53 -21.88 65.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.092 -1.005 . . . . 0.0 109.499 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -68.2 -42.33 80.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.895 . . . . 0.0 109.7 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 54' ' ' PHE . . . . . 0.428 ' HB3' HD11 ' D' ' 51' ' ' ILE . 1.5 m-85 -71.71 -45.13 62.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.112 -0.992 . . . . 0.0 109.036 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -54.29 -48.69 70.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 108.828 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -66.8 -26.95 67.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.397 -0.814 . . . . 0.0 109.032 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -66.95 -43.9 81.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.888 . . . . 0.0 108.746 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.47 -62.64 4.91 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.45 ' C ' HD13 ' C' ' 59' ' ' LEU . 0.5 OUTLIER -66.0 103.3 0.92 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -1.114 . . . . 0.0 108.925 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 31.9 tttm . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.079 -0.963 . . . . 0.0 109.542 179.97 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 66.1 p . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.472 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 2.6 m-20 53.21 52.8 10.82 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.243 -0.911 . . . . 0.0 109.441 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 25' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 11.2 Cg_endo -58.57 -13.7 18.34 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.542 2.161 . . . . 0.0 112.116 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' D' ' 26' ' ' LEU . 35.6 tp -48.0 -44.23 30.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.947 . . . . 0.0 108.901 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.58 -45.36 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.16 -0.962 . . . . 0.0 108.668 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 67.9 t -48.94 -47.7 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.847 . . . . 0.0 108.957 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.89 -35.07 79.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.336 -0.853 . . . . 0.0 109.166 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.86 -56.93 11.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.849 . . . . 0.0 109.708 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.87 -36.16 67.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.147 -0.971 . . . . 0.0 109.79 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 11.2 mt -71.63 -39.57 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.192 -0.942 . . . . 0.0 109.494 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 16.5 mt -58.67 -35.29 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.988 -1.07 . . . . 0.0 108.576 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.88 -43.73 57.67 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.86 -23.61 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.225 -1.162 . . . . 0.0 108.919 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.69 -70.21 0.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.866 . . . . 0.0 109.032 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 37' ' ' HIS . . . . . 0.55 ' CE1' ' NE2' ' C' ' 37' ' ' HIS . 9.8 t-80 -46.46 -35.64 5.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.913 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 57.3 tp -65.75 -63.02 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.117 -0.989 . . . . 0.0 109.564 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 6.8 mt -54.7 -32.82 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.522 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.573 HD21 HNC2 ' D' ' 499' ' ' RIM . 0.6 OUTLIER -69.03 -58.04 4.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.816 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 -46.45 -51.94 14.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.819 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 42' ' ' ILE . . . . . 0.578 HG12 HNC1 ' C' ' 399' ' ' RIM . 71.1 mt -60.06 -53.58 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.008 -1.057 . . . . 0.0 108.883 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 54.9 tp -46.13 -44.05 15.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.464 -0.772 . . . . 0.0 109.895 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.494 ' OD2' ' NE1' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -68.7 -28.18 66.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.775 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -79.2 -19.69 50.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 0.0 110.687 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.4 mt -80.9 -33.81 33.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.666 -1.271 . . . . 0.0 109.167 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -67.88 114.0 6.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.426 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -157.75 -155.14 0.48 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.153 -0.967 . . . . 0.0 109.597 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt 48.43 -153.5 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.36 -0.837 . . . . 0.0 109.243 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 94.4 p 43.1 65.34 0.98 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.36 -0.837 . . . . 0.0 109.65 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 51' ' ' ILE . . . . . 0.428 HD11 ' HB3' ' C' ' 54' ' ' PHE . 6.7 mt -89.96 -24.41 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 109.07 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.98 -27.92 65.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 109.893 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -71.94 -43.34 65.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.904 -1.122 . . . . 0.0 109.498 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -60.75 -37.03 80.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.383 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -68.57 -67.77 0.44 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.395 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -47.53 -40.16 18.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.893 . . . . 0.0 109.658 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -65.56 -54.37 28.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.305 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.83 -61.3 7.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.51 129.08 40.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -1.195 . . . . 0.0 109.413 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 37.8 tttp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.394 -179.9 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 199' ' ' RIM . . . . . 0.457 HNC1 HG12 ' B' ' 42' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 299' ' ' RIM . . . . . 0.583 HNC2 ' CG ' ' B' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 399' ' ' RIM . . . . . 0.578 HNC1 HG12 ' D' ' 42' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 499' ' ' RIM . . . . . 0.573 HNC2 HD21 ' D' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.275 0.559 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 26' ' ' LEU . 30.5 t0 52.77 66.84 4.42 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.166 -0.959 . . . . 0.0 109.516 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -46.06 -11.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.662 2.241 . . . . 0.0 112.031 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 24' ' ' ASP . 37.6 tp -47.78 -45.91 29.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.262 -0.899 . . . . 0.0 108.962 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.53 -45.29 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.207 -0.933 . . . . 0.0 108.721 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.3 t -49.12 -49.08 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 108.95 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.24 -32.55 74.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.316 -0.865 . . . . 0.0 109.157 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.81 -58.16 6.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.347 -0.845 . . . . 0.0 109.671 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.55 -36.85 67.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 109.743 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.4 mt -70.93 -39.74 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.361 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.3 mt -57.66 -34.51 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.027 -1.045 . . . . 0.0 108.415 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.96 -44.63 45.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.6 mt -57.0 -31.33 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.19 -1.182 . . . . 0.0 109.128 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.07 -64.69 0.86 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.305 -0.872 . . . . 0.0 109.208 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -44.96 -47.37 11.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.839 . . . . 0.0 110.223 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.8 tp -59.02 -63.92 1.13 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.997 -1.064 . . . . 0.0 109.693 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.3 mt -51.38 -25.74 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 109.601 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.571 HD22 HNC1 ' A' ' 199' ' ' RIM . 1.4 mt -74.74 -56.59 4.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.175 -0.953 . . . . 0.0 109.49 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -48.37 -51.3 27.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 109.377 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.75 -53.58 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.235 -0.916 . . . . 0.0 109.105 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.4 tp -46.49 -35.42 5.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.562 -0.711 . . . . 0.0 110.327 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.514 ' OD1' ' NC ' ' A' ' 199' ' ' RIM . 0.2 OUTLIER -79.2 -29.08 42.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.039 -1.038 . . . . 0.0 109.814 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.79 -19.48 57.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 0.0 110.873 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 47' ' ' PHE . 8.5 mt -77.6 -9.22 58.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.556 -1.34 . . . . 0.0 109.347 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.403 ' O ' ' O ' ' A' ' 46' ' ' LEU . 3.0 m-85 -47.41 -90.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 109.225 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 46.57 23.91 0.27 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 109.64 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -66.07 -144.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.495 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.3 m -80.51 141.48 35.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 109.629 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 mt -97.21 -32.19 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.514 -0.741 . . . . 0.0 109.432 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -56.2 -19.12 12.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -72.27 -41.04 67.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -0.987 . . . . 0.0 109.812 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -69.54 -33.3 72.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.088 -1.007 . . . . 0.0 109.377 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -69.7 -45.46 68.22 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.287 -0.883 . . . . 0.0 109.347 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -67.1 -27.05 67.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -69.12 -52.64 26.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.24 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.19 -60.56 8.73 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.1 mt -48.63 147.33 2.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.348 -1.089 . . . . 0.0 109.491 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.7 tttt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.35 179.829 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.51 162.68 28.98 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.279 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' B' ' 26' ' ' LEU . 23.4 Cg_endo -65.82 -28.31 51.18 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.51 2.14 . . . . 0.0 112.224 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' B' ' 25' ' ' PRO . 37.6 tp -45.73 -40.54 9.54 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.34 -44.53 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 71.0 t -49.94 -47.39 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.91 . . . . 0.0 108.774 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.69 78.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.237 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.38 -56.27 15.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -0.875 . . . . 0.0 109.832 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.41 -37.83 76.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -0.945 . . . . 0.0 110.018 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 18.4 mt -69.26 -42.97 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.107 -0.995 . . . . 0.0 109.191 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 mt -56.4 -34.46 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.242 -0.911 . . . . 0.0 108.783 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.33 -43.41 38.44 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 68.1 mt -60.38 -31.94 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.295 -1.12 . . . . 0.0 109.305 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.97 -66.52 0.6 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 109.248 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -44.96 -41.7 7.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 109.924 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.0 tp -62.7 -68.37 0.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.5 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 6.1 mt -46.93 -31.44 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.316 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.671 HD21 ' NC ' ' B' ' 299' ' ' RIM . 0.5 OUTLIER -64.24 -60.2 3.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.86 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 41' ' ' TRP . . . . . 0.404 ' NE1' ' OD2' ' A' ' 44' ' ' ASP . 37.7 t-105 -48.75 -43.94 38.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 109.664 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 25.8 mt -64.53 -40.01 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.99 . . . . 0.0 108.922 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 tp -56.48 -35.76 68.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.571 -0.706 . . . . 0.0 110.368 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.8 -22.98 27.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.071 -1.018 . . . . 0.0 110.382 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.483 ' CA ' ' HE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -76.13 -27.97 57.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.912 -1.117 . . . . 0.0 110.517 -179.204 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -51.86 -11.47 0.15 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.6 -1.312 . . . . 0.0 108.99 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.455 ' N ' ' O ' ' B' ' 45' ' ' ARG . 24.6 t80 -67.28 126.45 29.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.493 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -147.95 -90.54 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.92 . . . . 0.0 109.425 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -61.85 -149.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.181 -0.949 . . . . 0.0 109.393 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 48.8 p 45.99 56.67 5.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 109.612 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 12.4 mt -92.74 -28.95 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.263 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.68 -25.6 4.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.403 -0.811 . . . . 0.0 109.788 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.461 ' O ' ' CG ' ' B' ' 57' ' ' HIS . 30.4 mtt180 -68.52 -38.33 80.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.765 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -71.37 -35.15 70.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.027 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -65.8 -53.1 44.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.691 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -65.23 -30.43 71.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.885 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' HIS . . . . . 0.461 ' CG ' ' O ' ' B' ' 53' ' ' ARG . 1.7 m-70 -68.04 -41.77 81.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.147 -0.971 . . . . 0.0 109.437 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.75 -66.2 1.69 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' B' ' 59' ' ' LEU . 0.3 OUTLIER -73.74 108.24 6.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -1.144 . . . . 0.0 109.27 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.898 -1.048 . . . . 0.0 109.409 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.62 160.78 32.03 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.171 -0.956 . . . . 0.0 109.407 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' C' ' 26' ' ' LEU . 13.5 Cg_endo -60.05 -23.69 74.07 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.625 2.216 . . . . 0.0 112.2 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' C' ' 25' ' ' PRO . 39.9 tp -45.72 -42.08 11.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.294 -0.878 . . . . 0.0 108.86 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 46.9 t -70.0 -44.16 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.376 -0.828 . . . . 0.0 108.784 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 69.9 t -50.17 -47.63 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 0.0 108.918 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.06 86.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.567 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.62 -55.27 21.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 109.591 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.62 -36.76 67.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 109.83 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 25.9 mt -72.36 -42.64 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.511 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.1 mt -55.01 -34.26 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.12 -0.987 . . . . 0.0 108.805 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.8 -44.05 21.06 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 64.2 mt -58.35 -29.73 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.17 -1.194 . . . . 0.0 109.421 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.15 -59.42 2.75 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.235 -0.915 . . . . 0.0 109.015 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -47.24 -38.84 13.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.703 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.2 tp -68.68 -67.66 0.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.574 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.5 mt -46.09 -28.02 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 0.0 109.418 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 mt -69.95 -60.45 2.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.409 -0.807 . . . . 0.0 109.823 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -47.02 -43.61 19.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 42' ' ' ILE . . . . . 0.408 HD13 HG21 ' C' ' 42' ' ' ILE . 6.4 mt -70.75 -40.44 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.112 -0.992 . . . . 0.0 109.326 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 57.9 tp -60.51 -35.5 76.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.339 -0.851 . . . . 0.0 110.091 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 44' ' ' ASP . . . . . 0.408 ' OD2' ' NC ' ' C' ' 399' ' ' RIM . 14.7 m-20 -87.54 -19.24 28.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.116 -0.99 . . . . 0.0 110.167 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' C' ' 47' ' ' PHE . 3.7 mmt180 -84.65 -20.88 30.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.027 -1.046 . . . . 0.0 111.119 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' C' ' 45' ' ' ARG . 38.8 mt -46.35 -17.73 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.825 -1.172 . . . . 0.0 109.108 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' C' ' 45' ' ' ARG . 22.6 m-85 -93.08 79.25 4.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.264 -0.897 . . . . 0.0 109.319 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -83.77 -57.36 3.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.33 -0.856 . . . . 0.0 109.476 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -76.94 -139.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.36 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 46.1 m 52.78 61.35 3.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.442 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 61.1 mt -95.33 -26.01 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.865 . . . . 0.0 109.518 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -58.81 -22.72 59.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.267 -0.895 . . . . 0.0 109.835 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 53' ' ' ARG . . . . . 0.517 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 0.0 OUTLIER -67.37 -42.32 83.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.83 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -71.01 -38.9 72.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.289 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -62.83 -45.97 90.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.28 -0.888 . . . . 0.0 109.071 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -69.15 -27.33 65.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.833 . . . . 0.0 109.62 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 57' ' ' HIS . . . . . 0.517 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 2.4 m-70 -69.39 -38.54 78.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 0.0 109.188 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.6 -59.83 5.01 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mt -72.67 176.04 5.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -1.162 . . . . 0.0 109.496 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 60' ' ' LYS . . . . . 0.585 ' N ' ' CD ' ' C' ' 60' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.371 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' D' ' 26' ' ' LEU . 7.1 p30 -169.0 68.09 0.67 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.366 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -47.24 -9.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.754 2.302 . . . . 0.0 112.29 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' D' ' 24' ' ' ASP . 33.9 tp -47.48 -46.84 27.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.169 -0.957 . . . . 0.0 108.979 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.72 -45.79 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.262 -0.899 . . . . 0.0 108.728 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 66.2 t -48.45 -48.73 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -0.879 . . . . 0.0 108.881 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.81 -34.92 79.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.37 -0.831 . . . . 0.0 109.305 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.56 -56.37 12.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.0 109.755 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 2.5 m -55.65 -35.04 65.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 109.809 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 16.4 mt -73.89 -42.99 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.155 -0.966 . . . . 0.0 109.586 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 19.4 mt -55.14 -34.7 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.075 -1.016 . . . . 0.0 108.733 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.71 -44.83 37.68 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 56.6 mt -57.21 -35.02 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -1.134 . . . . 0.0 109.026 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -67.11 0.48 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.377 -0.827 . . . . 0.0 108.848 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -47.13 -37.95 10.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.378 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 59.3 tp -61.48 -70.7 0.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.23 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mt -49.35 -24.08 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.921 . . . . 0.0 109.577 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.412 ' C ' HD23 ' D' ' 40' ' ' LEU . 1.7 tt -70.54 -60.68 2.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -0.891 . . . . 0.0 109.759 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -52.26 -46.54 65.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.092 -1.005 . . . . 0.0 109.53 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 42' ' ' ILE . . . . . 0.403 HG23 ' HA1' ' C' ' 399' ' ' RIM . 54.9 mt -62.63 -55.02 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.179 -0.95 . . . . 0.0 108.878 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 42.3 tp -47.93 -37.59 14.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.542 -0.724 . . . . 0.0 109.744 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.448 ' OD2' ' NC ' ' D' ' 499' ' ' RIM . 65.7 m-20 -73.72 -28.44 61.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.144 -0.972 . . . . 0.0 109.544 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.37 -20.57 54.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.195 -0.941 . . . . 0.0 110.423 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -80.34 -8.84 59.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.777 -1.202 . . . . 0.0 108.968 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -141.38 100.22 3.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.444 -0.785 . . . . 0.0 109.125 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -151.68 5.68 0.45 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.188 -0.945 . . . . 0.0 109.618 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -76.61 -140.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.447 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 15.3 m 47.37 76.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.872 . . . . 0.0 109.486 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 24.2 mt -99.75 -23.94 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.437 -0.789 . . . . 0.0 109.442 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 52' ' ' TYR . . . . . 0.401 ' CG ' ' N ' ' D' ' 53' ' ' ARG . 25.6 p90 -57.95 -33.31 68.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.338 -0.851 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 53' ' ' ARG . . . . . 0.48 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 23.0 ptt180 -65.16 -30.72 71.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -75.12 -34.01 61.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.296 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.9 -44.23 64.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -0.826 . . . . 0.0 109.902 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -72.76 -27.74 62.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.14 -0.975 . . . . 0.0 109.525 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 57' ' ' HIS . . . . . 0.48 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 0.7 OUTLIER -70.24 -42.52 72.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.913 . . . . 0.0 109.251 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.45 -64.36 2.77 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 59' ' ' LEU . . . . . 0.438 ' C ' HD23 ' D' ' 59' ' ' LEU . 1.7 tt -56.43 108.58 0.5 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -1.179 . . . . 0.0 109.551 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 60' ' ' LYS . . . . . 0.413 ' N ' HD23 ' D' ' 59' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.469 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' RIM . . . . . 0.571 HNC1 HD22 ' A' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 299' ' ' RIM . . . . . 0.671 ' NC ' HD21 ' B' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 399' ' ' RIM . . . . . 0.408 ' NC ' ' OD2' ' C' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 499' ' ' RIM . . . . . 0.448 ' NC ' ' OD2' ' D' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.547 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.9 p30 -174.18 49.31 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.332 -0.855 . . . . 0.0 109.45 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.7 Cg_endo -55.64 -17.89 18.86 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.813 2.342 . . . . 0.0 112.381 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 26' ' ' LEU . 22.9 tp -46.25 -43.26 15.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 109.008 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 t -69.34 -45.67 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.328 -0.858 . . . . 0.0 108.888 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.4 t -48.97 -48.5 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.91 . . . . 0.0 109.015 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.95 -35.99 82.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.34 -0.85 . . . . 0.0 109.422 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.02 -56.48 14.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.903 . . . . 0.0 109.737 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -36.82 65.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.236 -0.915 . . . . 0.0 109.923 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.8 mt -72.35 -40.94 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.133 -0.98 . . . . 0.0 109.496 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.1 mt -56.36 -34.12 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.059 -1.025 . . . . 0.0 108.675 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.99 -44.19 24.64 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.7 mt -58.89 -30.86 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.154 -1.204 . . . . 0.0 109.226 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.77 -66.76 0.62 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.286 -0.884 . . . . 0.0 109.059 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -46.12 -37.95 7.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.706 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.2 tp -64.14 -70.24 0.23 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 109.382 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.3 mt -47.32 -35.25 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 0.0 109.693 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.645 HD22 ' NC ' ' A' ' 199' ' ' RIM . 2.1 mt -63.95 -63.23 1.21 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 109.934 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -45.41 -47.94 13.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.29 -46.77 94.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.395 -0.816 . . . . 0.0 108.916 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.07 -50.02 29.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.582 -0.699 . . . . 0.0 109.327 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.68 -30.78 71.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.392 -0.817 . . . . 0.0 110.289 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -69.25 -26.93 65.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.902 -1.124 . . . . 0.0 110.39 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -71.52 -32.71 68.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.649 -1.282 . . . . 0.0 109.47 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -67.15 -88.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.033 -1.042 . . . . 0.0 109.559 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.2 -168.39 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.1 tttt 48.25 -152.41 0.11 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.142 -0.974 . . . . 0.0 109.271 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.7 p 45.22 59.41 3.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 109.773 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 mt -98.69 -22.95 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 0.0 109.606 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -55.61 -25.3 38.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.971 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.463 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 6.6 ptt180 -67.7 -40.21 84.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.124 -0.985 . . . . 0.0 109.977 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.439 ' N ' ' CG ' ' A' ' 53' ' ' ARG . 54.9 m-85 -71.35 -36.7 71.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.028 -1.045 . . . . 0.0 109.404 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -63.41 -44.74 93.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -0.899 . . . . 0.0 109.219 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -70.28 -28.1 64.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 109.625 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.463 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 20.1 m170 -66.06 -42.29 89.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -0.947 . . . . 0.0 109.272 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.82 -63.4 2.87 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 mt -70.98 119.51 15.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -1.161 . . . . 0.0 109.368 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.4 mttt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.441 -179.949 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' B' ' 26' ' ' LEU . 19.1 t70 50.97 67.36 4.38 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.523 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -46.1 -11.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.673 2.248 . . . . 0.0 112.19 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' B' ' 24' ' ' ASP . 43.6 tp -47.23 -48.25 24.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 108.991 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 45.7 t -67.56 -44.47 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.305 -0.872 . . . . 0.0 108.903 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 77.8 t -49.23 -48.55 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.264 -0.897 . . . . 0.0 109.019 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.7 78.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.912 . . . . 0.0 109.339 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.24 -57.71 6.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 0.0 109.927 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.92 -36.49 62.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 109.806 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 24.0 mt -72.31 -41.63 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 109.424 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 21.9 mt -55.43 -34.82 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.156 -0.965 . . . . 0.0 108.73 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.29 -45.26 31.33 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 47.9 mt -54.97 -37.99 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.199 -1.177 . . . . 0.0 109.496 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.31 -58.31 3.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.173 -0.955 . . . . 0.0 108.818 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -46.8 -41.36 15.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -0.86 . . . . 0.0 109.6 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 51.3 tp -65.78 -70.02 0.26 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.783 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mt -46.57 -26.64 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 109.684 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 6.0 mt -70.19 -62.82 1.24 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.99 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -48.19 -47.74 35.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.069 -1.02 . . . . 0.0 109.674 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' B' ' 45' ' ' ARG . 68.0 mt -63.9 -61.35 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.132 -0.98 . . . . 0.0 109.336 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 60.5 tp -43.74 -42.37 5.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.687 -0.633 . . . . 0.0 109.784 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.496 ' OD2' ' NC ' ' B' ' 299' ' ' RIM . 35.7 m-20 -69.32 -28.97 66.71 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.257 -0.902 . . . . 0.0 109.469 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' B' ' 42' ' ' ILE . 11.0 mmm180 -78.23 -16.69 57.59 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.218 -0.926 . . . . 0.0 110.105 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -88.8 -9.54 51.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.851 -1.156 . . . . 0.0 109.07 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -47.72 -23.89 0.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.64 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' PHE . . . . . 0.463 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 2.1 t80 -47.91 106.88 0.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.598 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -160.09 -41.03 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 109.558 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.49 121.96 5.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.189 -0.944 . . . . 0.0 109.598 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 mt -102.72 -24.05 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.568 -0.707 . . . . 0.0 109.286 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' B' ' 52' ' ' TYR . 5.8 p90 -52.3 -28.27 18.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.479 ' O ' ' CG ' ' B' ' 57' ' ' HIS . 7.4 mtt-85 -63.02 -42.56 99.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.978 -1.076 . . . . 0.0 109.564 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -68.18 -35.23 77.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 109.392 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.03 -55.73 15.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.127 -0.983 . . . . 0.0 108.951 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -56.83 -32.18 65.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.381 -0.825 . . . . 0.0 109.562 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' HIS . . . . . 0.479 ' CG ' ' O ' ' B' ' 53' ' ' ARG . 3.2 m-70 -64.3 -61.16 2.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 109.274 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.55 -59.53 9.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mt -80.06 81.53 6.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.364 -1.08 . . . . 0.0 109.658 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.347 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.551 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 2.3 p30 -165.5 48.84 0.2 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 109.406 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 25' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 11.0 Cg_endo -57.01 -14.18 13.75 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.808 2.339 . . . . 0.0 112.083 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 33.7 tp -47.34 -44.32 23.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 108.993 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 36.1 t -69.92 -45.16 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.113 -0.992 . . . . 0.0 108.77 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 54.6 t -49.75 -48.53 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 108.977 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.03 -32.99 74.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 109.376 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.96 -54.96 19.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.913 . . . . 0.0 109.698 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.36 -37.37 75.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.972 . . . . 0.0 109.937 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 20.5 mt -70.74 -42.27 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.107 -0.996 . . . . 0.0 109.118 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 33' ' ' ILE . . . . . 0.465 HD13 HG13 ' D' ' 35' ' ' ILE . 23.1 mt -55.86 -33.67 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.191 -0.943 . . . . 0.0 108.555 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.08 -44.73 28.6 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 55.2 mt -57.26 -31.99 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.188 -1.184 . . . . 0.0 109.422 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.82 -64.28 1.0 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 108.988 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -45.61 -43.11 11.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.372 -0.83 . . . . 0.0 109.717 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 44.4 tp -60.77 -68.67 0.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 109.508 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.0 mt -47.45 -30.7 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.218 -0.926 . . . . 0.0 109.516 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mt -68.86 -65.61 0.68 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -0.949 . . . . 0.0 109.811 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 41' ' ' TRP . . . . . 0.414 ' CH2' ' NE ' ' C' ' 45' ' ' ARG . 19.5 t-105 -45.16 -49.38 12.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.858 . . . . 0.0 109.882 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 42' ' ' ILE . . . . . 0.568 HG23 ' HA3' ' B' ' 299' ' ' RIM . 76.0 mt -61.7 -54.44 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.049 -1.032 . . . . 0.0 109.1 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 60.3 tp -47.91 -44.54 29.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 109.567 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 44' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' C' ' 44' ' ' ASP . 0.2 OUTLIER -67.33 -27.99 67.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.784 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.414 ' NE ' ' CH2' ' C' ' 41' ' ' TRP . 0.9 OUTLIER -75.98 -24.11 55.34 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.14 -0.975 . . . . 0.0 110.43 -179.428 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.4 mt -79.44 -25.53 41.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.759 -1.213 . . . . 0.0 109.224 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -56.42 95.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 109.733 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -156.96 -59.32 0.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.772 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 tttp 54.3 -138.17 1.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.109 -0.994 . . . . 0.0 109.066 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 1.8 t -78.68 170.94 15.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.102 -0.999 . . . . 0.0 109.036 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 9.9 mt -100.87 -26.23 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 0.0 109.802 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.82 -26.03 5.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.942 . . . . 0.0 110.038 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 53' ' ' ARG . . . . . 0.496 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 11.2 mmt180 -68.48 -43.79 76.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.938 -1.101 . . . . 0.0 109.735 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 54' ' ' PHE . . . . . 0.458 ' O ' ' CD1' ' D' ' 51' ' ' ILE . 8.0 m-85 -63.75 -36.98 85.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.928 . . . . 0.0 108.779 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.86 -53.73 51.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.469 -0.769 . . . . 0.0 109.158 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -61.6 -33.01 73.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.437 -0.789 . . . . 0.0 109.545 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 2.6 m-70 -59.44 -58.3 9.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 108.936 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.74 -59.99 7.97 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 49.6 mt -71.95 175.66 5.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.344 -1.092 . . . . 0.0 109.213 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.428 179.853 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.332 0.587 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.98 161.09 47.99 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.305 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 25' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' D' ' 26' ' ' LEU . 18.6 Cg_endo -63.1 -24.1 73.29 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.496 2.131 . . . . 0.0 112.1 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' D' ' 25' ' ' PRO . 45.3 tp -45.95 -42.63 13.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 108.675 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.9 t -69.76 -44.17 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.292 -0.88 . . . . 0.0 108.806 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 69.9 t -51.4 -50.74 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.061 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.46 -34.53 77.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.745 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.56 -54.55 22.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 109.664 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 2.5 m -57.23 -35.35 69.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -0.953 . . . . 0.0 109.657 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 13.9 mt -72.93 -44.5 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 0.0 109.377 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 30.8 mt -53.87 -35.42 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.133 -0.98 . . . . 0.0 108.735 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.52 -44.39 41.09 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 35' ' ' ILE . . . . . 0.465 HG13 HD13 ' C' ' 33' ' ' ILE . 65.4 mt -59.34 -43.09 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.241 -1.152 . . . . 0.0 109.208 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.13 -62.64 1.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 109.024 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -45.14 -40.28 6.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.391 -0.818 . . . . 0.0 110.139 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 55.7 tp -65.79 -65.3 0.69 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.115 -0.99 . . . . 0.0 109.571 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 9.8 mt -49.65 -29.48 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.918 . . . . 0.0 109.711 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 6.1 mt -70.09 -56.78 6.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 109.555 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -47.38 -48.37 25.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.307 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 7.2 mt -65.75 -43.3 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.127 -0.983 . . . . 0.0 108.89 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 tp -52.01 -44.63 64.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.428 -0.795 . . . . 0.0 109.921 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.527 ' OD2' ' NC ' ' D' ' 499' ' ' RIM . 99.7 m-20 -76.24 -24.69 54.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 110.239 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.482 ' O ' ' N ' ' D' ' 47' ' ' PHE . 0.0 OUTLIER -88.69 -3.99 58.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 111.071 -178.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' D' ' 45' ' ' ARG . 27.3 mt -33.93 -35.04 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.696 -0.627 . . . . 0.0 110.449 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 47' ' ' PHE . . . . . 0.482 ' N ' ' O ' ' D' ' 45' ' ' ARG . 1.8 t80 -169.18 131.03 1.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.92 . . . . 0.0 109.276 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -166.57 97.9 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.112 -0.993 . . . . 0.0 109.708 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -160.58 -25.87 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.254 -0.904 . . . . 0.0 109.457 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t -48.02 110.19 0.3 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 51' ' ' ILE . . . . . 0.458 ' CD1' ' O ' ' C' ' 54' ' ' PHE . 4.1 mt -84.23 -17.81 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.289 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.83 -37.42 70.31 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.201 -0.937 . . . . 0.0 110.862 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 53' ' ' ARG . . . . . 0.5 ' O ' ' ND1' ' D' ' 57' ' ' HIS . 78.8 mtm180 -78.16 -41.1 35.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.266 -1.521 . . . . 0.0 111.007 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 54' ' ' PHE . . . . . 0.459 ' CD1' ' C ' ' D' ' 54' ' ' PHE . 8.3 t80 -71.34 -44.84 64.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.079 -1.013 . . . . 0.0 110.542 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.21 -24.29 47.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.036 -1.04 . . . . 0.0 110.792 -178.73 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 56' ' ' GLU . . . . . 0.572 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 88.3 tt0 -80.14 -28.89 38.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.597 -1.314 . . . . 0.0 108.017 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 57' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' D' ' 53' ' ' ARG . 11.8 m170 -70.37 -47.07 62.63 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.78 -61.15 6.76 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.35 140.1 55.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.328 -1.101 . . . . 0.0 109.427 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 57.0 tttm . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.477 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 199' ' ' RIM . . . . . 0.645 ' NC ' HD22 ' A' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 299' ' ' RIM . . . . . 0.568 ' HA3' HG23 ' C' ' 42' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 399' ' ' RIM . . . . . 0.464 ' NC ' ' CG ' ' C' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 499' ' ' RIM . . . . . 0.527 ' NC ' ' OD2' ' D' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.361 0.601 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 26' ' ' LEU . 8.2 m-20 -162.53 67.5 1.92 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.36 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -47.22 -10.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.904 2.403 . . . . 0.0 112.411 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 24' ' ' ASP . 36.7 tp -46.87 -45.55 20.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.13 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 t -70.21 -45.56 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.93 . . . . 0.0 108.715 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.0 t -48.58 -48.26 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.285 -0.884 . . . . 0.0 108.908 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.58 81.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.381 -0.825 . . . . 0.0 109.309 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.05 -55.48 21.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.337 -0.852 . . . . 0.0 109.729 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.16 -37.0 71.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.966 . . . . 0.0 110.005 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.6 mt -71.58 -42.13 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.145 -0.972 . . . . 0.0 109.438 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.455 HD13 HG13 ' B' ' 35' ' ' ILE . 14.8 mt -56.67 -33.29 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.153 -0.967 . . . . 0.0 108.703 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.55 -43.59 29.47 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.0 mt -56.96 -32.23 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.287 -1.125 . . . . 0.0 109.363 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.26 -61.97 1.64 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.136 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -48.6 -39.17 22.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.354 -0.841 . . . . 0.0 109.728 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -66.41 -67.43 0.45 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.919 . . . . 0.0 109.602 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.7 mt -47.3 -27.55 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.529 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mt -67.9 -65.62 0.67 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.272 -0.893 . . . . 0.0 109.823 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.412 ' CH2' ' NE ' ' A' ' 45' ' ' ARG . 24.7 t-105 -48.03 -45.98 32.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.728 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.3 mt -61.6 -54.34 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.157 -0.964 . . . . 0.0 108.894 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.5 tp -47.13 -44.37 21.52 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.579 -0.7 . . . . 0.0 109.638 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.792 ' CG ' HNC2 ' A' ' 199' ' ' RIM . 1.9 m-20 -69.88 -26.16 64.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.222 -0.923 . . . . 0.0 110.089 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.412 ' NE ' ' CH2' ' A' ' 41' ' ' TRP . 0.2 OUTLIER -77.22 -23.42 51.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.978 -1.076 . . . . 0.0 110.387 -179.513 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.1 mt -77.77 -21.14 52.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.8 -1.188 . . . . 0.0 108.956 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 63.27 154.02 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.908 . . . . 0.0 109.39 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -158.65 43.56 0.27 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -0.876 . . . . 0.0 109.379 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.528 ' CD ' ' H ' ' A' ' 50' ' ' SER . 0.6 OUTLIER -163.34 -148.37 0.13 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 109.156 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.528 ' H ' ' CD ' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -132.85 166.26 22.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 0.0 109.368 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.2 mt -99.33 -44.0 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.38 -0.825 . . . . 0.0 109.642 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.432 ' HH ' ' HG ' ' A' ' 50' ' ' SER . 17.3 p90 -56.35 -24.41 43.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.959 . . . . 0.0 109.495 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -69.13 -44.23 72.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.969 . . . . 0.0 109.287 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -64.3 -29.67 70.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.223 -0.923 . . . . 0.0 109.115 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -72.63 -70.23 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.835 . . . . 0.0 109.332 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -46.23 -28.42 1.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 109.518 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -67.4 -61.98 1.64 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.18 -0.95 . . . . 0.0 109.618 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -50.7 -53.12 26.93 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.0 mt -68.72 100.49 1.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -1.186 . . . . 0.0 109.641 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 tttm . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.369 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.443 ' O ' ' O ' ' B' ' 24' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' B' ' 23' ' ' SER . 0.1 OUTLIER 57.38 160.91 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.344 -0.848 . . . . 0.0 109.445 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.36 -22.18 53.05 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.398 2.066 . . . . 0.0 112.017 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 37.1 tp -46.58 -43.87 17.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 108.653 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.43 -42.54 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.36 -0.837 . . . . 0.0 108.889 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 73.9 t -51.34 -50.19 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 109.018 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.83 85.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.311 -0.868 . . . . 0.0 109.38 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.64 -55.28 24.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.73 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.56 -37.0 69.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.714 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 24.5 mt -71.61 -39.74 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.158 -0.963 . . . . 0.0 109.526 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 34.0 mt -58.37 -34.23 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.157 -0.965 . . . . 0.0 108.742 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.88 -41.86 32.19 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.455 HG13 HD13 ' A' ' 33' ' ' ILE . 79.4 mt -62.74 -36.46 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.32 -1.106 . . . . 0.0 109.119 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.79 -62.47 1.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.023 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -46.42 -40.59 12.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 109.684 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 59.2 tp -63.19 -70.48 0.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.777 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 8.4 mt -47.0 -33.34 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.485 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mt -64.45 -58.69 5.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.425 -0.797 . . . . 0.0 109.535 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -46.28 -44.79 16.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 109.65 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 11.1 mt -70.53 -33.6 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.117 -0.989 . . . . 0.0 109.446 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 tp -59.11 -43.86 91.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 110.203 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.514 ' OD2' ' NC ' ' B' ' 299' ' ' RIM . 38.5 m-20 -82.54 -22.76 34.84 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 110.514 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -82.05 -16.22 50.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.89 -1.131 . . . . 0.0 111.006 -179.212 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' B' ' 46' ' ' LEU . 21.9 mt -44.58 -19.16 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.904 -1.122 . . . . 0.0 109.472 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' B' ' 45' ' ' ARG . 93.7 t80 -49.77 97.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.122 -0.987 . . . . 0.0 109.355 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' PHE . . . . . 0.426 ' N ' ' O ' ' B' ' 46' ' ' LEU . 58.6 t80 -168.54 65.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.882 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.404 ' CG ' ' H ' ' B' ' 50' ' ' SER . 14.3 pttt -158.81 -107.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.83 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.404 ' H ' ' CG ' ' B' ' 49' ' ' LYS . 41.4 t -80.76 129.17 34.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 109.957 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 32.8 mt -106.04 -32.09 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.633 -0.667 . . . . 0.0 109.438 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -46.48 -27.78 1.2 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 0.0 109.934 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 43.4 mtt-85 -65.91 -41.93 90.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.119 -0.988 . . . . 0.0 109.69 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -68.4 -33.51 74.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 109.7 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.14 -46.67 76.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.946 . . . . 0.0 109.377 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -69.56 -33.87 73.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.608 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -64.37 -33.62 76.26 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.159 -0.963 . . . . 0.0 108.756 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.04 -63.9 2.01 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mt -55.42 126.34 24.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -1.159 . . . . 0.0 109.105 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.35 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.486 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 67.2 m-20 51.17 52.32 11.89 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.652 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 25' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 11.6 Cg_endo -58.36 -16.4 28.61 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.666 2.244 . . . . 0.0 112.254 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' C' ' 26' ' ' LEU . 31.4 tp -46.23 -44.44 16.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.214 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 40.4 t -69.16 -44.56 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.258 -0.901 . . . . 0.0 108.907 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -49.6 -49.14 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.153 -0.967 . . . . 0.0 108.96 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.55 -33.07 75.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.863 . . . . 0.0 109.27 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.08 -56.95 8.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 109.669 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.9 -35.46 69.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.887 . . . . 0.0 109.924 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 24.4 mt -72.78 -43.99 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 0.0 109.531 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 33' ' ' ILE . . . . . 0.455 HD13 HG13 ' D' ' 35' ' ' ILE . 26.6 mt -54.83 -35.27 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.16 -0.963 . . . . 0.0 108.792 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.23 -44.75 42.55 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 58.1 mt -57.67 -27.22 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.273 -1.134 . . . . 0.0 109.203 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.93 -67.36 0.68 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.22 -0.925 . . . . 0.0 109.08 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -46.22 -43.17 15.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.491 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.88 -67.49 0.4 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 109.403 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -47.85 -28.75 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.326 -0.858 . . . . 0.0 109.864 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 40' ' ' LEU . . . . . 0.727 HD22 ' NC ' ' C' ' 399' ' ' RIM . 3.3 mt -67.92 -64.28 0.89 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.793 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 41' ' ' TRP . . . . . 0.519 ' CH2' ' NE ' ' C' ' 45' ' ' ARG . 30.5 t-105 -48.01 -45.58 31.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.22 -0.925 . . . . 0.0 109.634 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 82.7 mt -63.34 -48.53 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.174 -0.954 . . . . 0.0 108.936 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.7 tp -53.42 -33.28 53.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.635 -0.665 . . . . 0.0 110.126 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.3 -25.01 31.92 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.168 -0.958 . . . . 0.0 109.947 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.519 ' NE ' ' CH2' ' C' ' 41' ' ' TRP . 0.1 OUTLIER -75.36 -27.97 59.36 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.087 -1.008 . . . . 0.0 110.493 -179.311 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' C' ' 47' ' ' PHE . 9.8 mt -61.51 -30.71 70.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.612 -1.305 . . . . 0.0 108.946 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.408 ' O ' ' O ' ' C' ' 46' ' ' LEU . 54.8 m-85 -61.22 -111.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.101 -0.999 . . . . 0.0 108.833 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.514 ' CG ' ' O ' ' C' ' 48' ' ' PHE . 8.6 t80 45.77 83.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -0.869 . . . . 0.0 109.667 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 49' ' ' LYS . . . . . 0.521 ' CD ' ' H ' ' C' ' 50' ' ' SER . 0.2 OUTLIER -85.07 -152.71 0.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.147 -0.97 . . . . 0.0 108.725 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 50' ' ' SER . . . . . 0.521 ' H ' ' CD ' ' C' ' 49' ' ' LYS . 0.2 OUTLIER -60.6 -173.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.84 -1.163 . . . . 0.0 109.436 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 45.5 mt -108.64 -27.66 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.59 -0.694 . . . . 0.0 109.272 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -36.29 70.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.996 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -65.83 -34.83 79.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.076 -1.015 . . . . 0.0 109.559 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -68.49 -35.98 78.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.391 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -69.99 -40.62 75.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.918 . . . . 0.0 109.478 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.48 -25.13 63.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 109.49 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.75 -46.5 45.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.195 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.43 -65.99 2.27 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mt -58.81 118.79 6.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -1.124 . . . . 0.0 109.73 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 11.5 tttm . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.602 -179.974 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 41.7 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' D' ' 24' ' ' ASP . 2.8 p-10 -165.51 68.17 1.21 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -46.14 -11.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.793 2.329 . . . . 0.0 112.34 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' D' ' 24' ' ' ASP . 34.2 tp -47.21 -46.3 23.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 109.212 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 43.9 t -69.48 -44.32 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 108.754 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 78.0 t -49.92 -48.08 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.348 -0.845 . . . . 0.0 109.054 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.2 -34.42 77.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 109.547 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.81 -55.4 17.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.649 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.37 -37.29 69.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.213 -0.929 . . . . 0.0 109.842 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 20.6 mt -71.58 -40.39 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.6 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 26.8 mt -57.71 -35.21 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 0.0 108.795 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.47 -42.69 47.65 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 35' ' ' ILE . . . . . 0.455 HG13 HD13 ' C' ' 33' ' ' ILE . 74.6 mt -62.69 -30.49 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.362 -1.081 . . . . 0.0 109.45 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.53 -60.1 2.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 109.081 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -48.98 -40.57 31.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.959 . . . . 0.0 109.542 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.1 tp -62.9 -68.42 0.34 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.194 -0.942 . . . . 0.0 109.412 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 mt -47.15 -31.77 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.455 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.44 HD21 HNC2 ' D' ' 499' ' ' RIM . 2.3 mt -68.26 -57.97 5.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.39 -0.819 . . . . 0.0 109.798 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -46.64 -44.52 18.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.403 -0.811 . . . . 0.0 109.621 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mt -72.25 -38.33 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.051 -1.031 . . . . 0.0 109.426 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 44.5 tp -57.85 -41.35 82.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.929 . . . . 0.0 110.106 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -82.64 -24.0 34.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.096 -1.003 . . . . 0.0 109.813 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' D' ' 47' ' ' PHE . 11.9 mmt180 -89.82 -1.66 58.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.171 -0.955 . . . . 0.0 110.83 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 46' ' ' LEU . . . . . 0.478 ' C ' ' O ' ' D' ' 45' ' ' ARG . 31.4 mt -31.99 -35.77 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.768 -0.583 . . . . 0.0 110.581 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 47' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' D' ' 45' ' ' ARG . 88.1 t80 -172.75 7.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.525 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.51 113.55 0.72 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.564 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -163.54 -37.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.377 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 44.5 m -54.53 134.94 46.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -0.85 . . . . 0.0 109.634 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 8.7 mt -104.06 -26.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.656 -0.652 . . . . 0.0 109.379 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -47.64 -42.05 23.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.871 . . . . 0.0 109.89 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -45.74 72.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 0.0 109.712 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -62.46 -36.48 82.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 109.591 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -63.27 -66.67 0.51 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.435 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -45.86 -34.91 4.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.347 -0.846 . . . . 0.0 109.863 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -63.55 -60.99 2.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.129 -0.982 . . . . 0.0 109.522 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -47.51 -59.77 5.71 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mt -70.11 118.53 13.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.274 -1.133 . . . . 0.0 109.577 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 24.1 mttm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.573 179.893 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 199' ' ' RIM . . . . . 0.792 HNC2 ' CG ' ' A' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 299' ' ' RIM . . . . . 0.514 ' NC ' ' OD2' ' B' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 399' ' ' RIM . . . . . 0.727 ' NC ' HD22 ' C' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 499' ' ' RIM . . . . . 0.44 HNC2 HD21 ' D' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -168.15 70.55 0.85 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.283 -0.886 . . . . 0.0 109.473 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.83 -11.85 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.66 2.24 . . . . 0.0 112.192 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 26' ' ' LEU . 46.1 tp -47.96 -47.16 32.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.13 -0.981 . . . . 0.0 108.899 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.0 t -67.93 -44.22 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.321 -0.862 . . . . 0.0 108.878 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.9 t -49.34 -50.66 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 108.951 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.39 80.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.406 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.32 -57.41 9.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.654 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.21 -36.08 63.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 110.013 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.6 mt -73.12 -41.51 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.006 . . . . 0.0 109.703 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.27 -36.68 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.987 -1.07 . . . . 0.0 108.641 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.38 -44.28 42.77 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.9 mt -56.31 -39.05 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.03 -1.276 . . . . 0.0 109.387 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.83 -54.64 14.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.126 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -48.61 -42.88 35.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.838 . . . . 0.0 109.881 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.2 tp -67.16 -65.47 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 109.684 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.9 mt -46.65 -27.41 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 109.43 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.537 HD21 HNC2 ' A' ' 199' ' ' RIM . 1.9 mt -69.48 -61.8 1.64 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.383 -0.823 . . . . 0.0 109.727 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.512 ' HE1' HNC1 ' D' ' 499' ' ' RIM . 55.8 t-105 -47.84 -46.04 30.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 0.0 109.413 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.2 mt -64.17 -55.7 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.197 -0.939 . . . . 0.0 109.135 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.2 tp -45.27 -43.7 10.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.583 -0.698 . . . . 0.0 110.313 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.04 -27.63 54.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.034 -1.041 . . . . 0.0 110.556 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -72.47 -22.24 61.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.793 -1.192 . . . . 0.0 110.487 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.3 mt -68.64 -12.06 60.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.657 -1.277 . . . . 0.0 108.986 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -82.5 137.86 34.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.331 -0.856 . . . . 0.0 109.183 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -151.07 174.9 12.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.148 -0.97 . . . . 0.0 109.513 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.402 ' CG ' ' H ' ' A' ' 50' ' ' SER . 15.3 tttp 47.37 -143.28 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.364 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.402 ' H ' ' CG ' ' A' ' 49' ' ' LYS . 18.8 p 51.48 42.25 29.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.478 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 mt -80.67 -31.02 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 109.158 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.557 ' CG ' ' N ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -46.08 -42.69 13.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.789 . . . . 0.0 109.887 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.557 ' N ' ' CG ' ' A' ' 52' ' ' TYR . 1.2 mtp180 -50.61 -61.84 1.95 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 0.0 110.665 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -70.63 -26.58 63.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.885 -1.134 . . . . 0.0 110.061 -179.076 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -46.41 80.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.904 -1.122 . . . . 0.0 109.371 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -76.39 -27.5 56.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.673 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -61.97 -50.56 71.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.211 -0.93 . . . . 0.0 109.317 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.81 -59.51 3.7 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.9 mt -64.53 -167.85 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -1.169 . . . . 0.0 109.853 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.054 -0.975 . . . . 0.0 109.421 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 92.0 p . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.517 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 6.0 m-20 -153.61 50.4 0.57 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 109.532 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 11.7 Cg_endo -57.97 -14.47 18.66 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.793 2.329 . . . . 0.0 112.066 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 33.3 tp -46.17 -45.82 16.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.36 -0.837 . . . . 0.0 109.255 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 36.0 t -69.19 -44.72 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.24 -0.913 . . . . 0.0 108.927 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 72.5 t -49.18 -49.11 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 109.096 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.73 -33.73 76.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.289 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.86 -56.8 9.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.337 -0.852 . . . . 0.0 109.825 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.83 -37.2 70.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.877 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 33.4 mt -71.25 -41.22 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.058 -1.026 . . . . 0.0 109.499 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 24.0 mt -57.08 -34.14 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 108.559 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.11 -43.94 24.82 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 53.9 mt -56.11 -35.29 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.177 -1.19 . . . . 0.0 109.235 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -61.53 1.73 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.22 -0.925 . . . . 0.0 109.073 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' HIS . . . . . 0.438 ' NE2' ' ND1' ' C' ' 37' ' ' HIS . 1.8 t-80 -46.83 -41.91 16.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 109.771 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -62.3 -69.75 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.166 -0.959 . . . . 0.0 109.591 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.3 mt -46.11 -38.26 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.34 -0.85 . . . . 0.0 109.36 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mt -59.37 -62.4 1.91 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.45 -0.781 . . . . 0.0 109.967 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -44.99 -49.38 11.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.424 -0.798 . . . . 0.0 109.649 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.407 HD13 HG21 ' B' ' 42' ' ' ILE . 34.1 mt -59.79 -48.61 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.12 -0.988 . . . . 0.0 108.52 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.62 -57.41 4.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.55 -0.719 . . . . 0.0 109.453 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.0 -31.34 68.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.848 . . . . 0.0 110.41 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.455 ' CA ' ' HE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -71.92 -23.43 61.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.873 -1.142 . . . . 0.0 110.471 -179.198 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.0 mt -75.93 -34.01 59.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.699 -1.251 . . . . 0.0 108.887 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -48.42 101.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.912 . . . . 0.0 109.435 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' PHE . . . . . 0.4 ' H ' ' H ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -163.5 -3.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.4 ' H ' ' H ' ' B' ' 48' ' ' PHE . 10.8 mtmm -67.21 -118.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.55 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 10.3 p -53.18 104.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.324 -0.86 . . . . 0.0 109.718 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 11.4 mt -102.21 -24.85 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.479 -0.763 . . . . 0.0 109.17 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -54.46 -24.94 22.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.854 . . . . 0.0 109.748 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 -65.87 -38.77 89.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.522 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -71.01 -36.65 72.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 109.166 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -69.46 -46.77 65.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.405 -0.809 . . . . 0.0 109.162 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -64.02 -27.88 69.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 108.933 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -69.38 -46.63 66.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.403 -0.811 . . . . 0.0 109.545 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.0 -61.22 6.0 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 73.0 mt -60.86 -178.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -1.127 . . . . 0.0 109.808 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.436 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' C' ' 26' ' ' LEU . 20.2 t0 -168.94 65.38 0.6 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.899 . . . . 0.0 109.463 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -45.18 -11.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.749 2.299 . . . . 0.0 112.14 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' C' ' 24' ' ' ASP . 22.2 tp -47.69 -46.33 29.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.144 -0.972 . . . . 0.0 109.107 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 41.5 t -68.15 -44.93 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.213 -0.929 . . . . 0.0 108.581 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.2 t -50.03 -49.39 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.334 -0.854 . . . . 0.0 108.788 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.28 -30.19 71.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.355 -0.841 . . . . 0.0 109.288 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.96 -56.83 6.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.0 109.602 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.31 -36.97 66.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.947 . . . . 0.0 109.525 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 36.3 mt -72.71 -42.5 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.16 -0.963 . . . . 0.0 109.412 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 20.3 mt -55.88 -34.33 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.122 -0.986 . . . . 0.0 108.629 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.26 -45.33 31.28 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 65.4 mt -58.38 -34.66 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.277 -1.131 . . . . 0.0 108.993 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.98 -67.89 0.41 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 108.908 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 37' ' ' HIS . . . . . 0.438 ' ND1' ' NE2' ' B' ' 37' ' ' HIS . 4.3 t-80 -45.83 -36.82 5.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.813 . . . . 0.0 109.656 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.89 -69.61 0.28 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 109.517 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 7.9 mt -48.11 -30.12 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 109.751 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 40' ' ' LEU . . . . . 0.408 HD12 HD11 ' D' ' 38' ' ' LEU . 2.3 mt -68.1 -63.56 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.109 -0.995 . . . . 0.0 109.718 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 -44.45 -48.69 10.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.338 -0.851 . . . . 0.0 110.06 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 42' ' ' ILE . . . . . 0.681 HG12 HNC1 ' B' ' 299' ' ' RIM . 54.2 mt -63.89 -58.28 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.046 -1.034 . . . . 0.0 109.108 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 54.1 tp -45.12 -40.19 6.72 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.533 -0.73 . . . . 0.0 109.99 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 44' ' ' ASP . . . . . 0.46 ' CG ' ' NC ' ' C' ' 399' ' ' RIM . 0.4 OUTLIER -73.18 -28.39 62.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 109.638 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.438 ' HE ' ' CA ' ' C' ' 45' ' ' ARG . 0.0 OUTLIER -76.55 -18.76 58.51 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.212 -0.93 . . . . 0.0 110.196 -179.57 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' C' ' 47' ' ' PHE . 8.3 mt -83.93 -31.18 25.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.797 -1.189 . . . . 0.0 108.885 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.464 ' C ' ' CG ' ' C' ' 48' ' ' PHE . 2.4 m-85 -52.92 -174.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 109.652 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.464 ' CG ' ' C ' ' C' ' 47' ' ' PHE . 0.8 OUTLIER 67.02 -66.51 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 0.0 109.811 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 49' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' C' ' 47' ' ' PHE . 10.8 tttp 52.33 -93.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.353 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 50' ' ' SER . . . . . 0.451 ' N ' ' O ' ' C' ' 48' ' ' PHE . 68.1 m -63.27 148.41 48.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.136 -0.977 . . . . 0.0 109.389 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 11.6 mt -103.31 -27.55 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.562 -0.711 . . . . 0.0 109.697 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -52.88 -18.66 2.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.934 . . . . 0.0 109.715 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -72.64 -42.16 64.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.865 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.7 -38.03 83.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.935 . . . . 0.0 109.37 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -64.15 -59.3 4.59 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.352 -0.843 . . . . 0.0 109.249 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -55.88 -29.4 59.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.547 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.01 -52.89 24.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.204 -0.935 . . . . 0.0 109.312 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.16 -63.93 4.0 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.461 ' C ' HD13 ' C' ' 59' ' ' LEU . 0.5 OUTLIER -70.71 105.17 3.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -1.187 . . . . 0.0 109.108 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.396 179.947 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.526 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 2.8 m-20 -155.81 49.85 0.45 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.527 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 25' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 11.0 Cg_endo -57.65 -7.13 2.86 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.768 2.312 . . . . 0.0 112.138 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' D' ' 26' ' ' LEU . 33.7 tp -49.23 -48.8 45.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 108.924 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 98.5 t -67.11 -44.87 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 108.724 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 73.5 t -48.67 -50.03 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 108.974 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.75 -33.8 76.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -0.856 . . . . 0.0 109.173 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.25 -57.55 8.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 109.635 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.35 -35.86 65.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.189 -0.944 . . . . 0.0 109.949 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 21.8 mt -72.94 -42.45 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.123 -0.985 . . . . 0.0 109.485 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 mt -55.04 -35.85 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.974 -1.079 . . . . 0.0 108.573 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.67 -45.14 46.4 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 57.9 mt -56.79 -37.74 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -1.171 . . . . 0.0 109.129 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' D' ' 37' ' ' HIS . 0.7 OUTLIER -66.4 -68.47 0.37 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.902 . . . . 0.0 109.342 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 37' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' D' ' 36' ' ' LEU . 1.6 t-80 -42.76 -33.18 0.7 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.438 -0.789 . . . . 0.0 110.161 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 38' ' ' LEU . . . . . 0.408 HD11 HD12 ' C' ' 40' ' ' LEU . 50.3 tp -70.36 -71.21 0.25 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.947 . . . . 0.0 109.672 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mt -49.16 -29.4 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 109.498 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.434 HD21 ' CE1' ' D' ' 499' ' ' RIM . 1.6 tt -72.64 -59.66 2.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.457 -0.777 . . . . 0.0 109.648 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 17.0 t-105 -45.1 -54.28 6.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.71 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.62 -46.45 79.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.204 -0.935 . . . . 0.0 108.867 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.53 -48.77 14.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.588 -0.695 . . . . 0.0 109.722 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.503 ' OD1' ' NC ' ' D' ' 499' ' ' RIM . 0.7 OUTLIER -66.97 -33.87 76.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -0.873 . . . . 0.0 110.184 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -68.34 -23.86 64.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.091 -1.006 . . . . 0.0 110.577 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -75.82 -34.37 60.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.663 -1.273 . . . . 0.0 109.089 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -52.58 115.78 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.4 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -172.11 132.77 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 0.0 109.486 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -154.27 -42.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 109.708 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 4.5 m -165.77 159.18 15.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.655 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 9.2 mt -103.97 -25.27 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.613 -0.679 . . . . 0.0 109.369 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -52.01 -19.04 1.63 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.328 -0.857 . . . . 0.0 109.852 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -71.63 -41.03 69.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.069 -1.019 . . . . 0.0 109.682 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -70.71 -32.48 69.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.096 -1.003 . . . . 0.0 109.148 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -68.37 -42.84 78.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.265 -0.897 . . . . 0.0 109.401 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -72.73 -28.2 62.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.287 -0.883 . . . . 0.0 109.288 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.21 -44.3 84.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 108.761 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.33 -63.36 3.81 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.5 125.62 24.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.349 -1.089 . . . . 0.0 109.233 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 61.2 mttt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.889 -1.053 . . . . 0.0 109.425 -179.906 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 199' ' ' RIM . . . . . 0.537 HNC2 HD21 ' A' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 299' ' ' RIM . . . . . 0.681 HNC1 HG12 ' C' ' 42' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 399' ' ' RIM . . . . . 0.46 ' NC ' ' CG ' ' C' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 499' ' ' RIM . . . . . 0.512 HNC1 ' HE1' ' A' ' 41' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.8 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 26' ' ' LEU . 1.3 m-20 49.32 69.29 2.78 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.451 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -47.99 -8.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.928 2.418 . . . . 0.0 112.476 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 24' ' ' ASP . 36.4 tp -48.46 -47.48 38.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.099 -1.001 . . . . 0.0 108.923 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.2 t -67.54 -45.03 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.0 108.639 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.0 t -49.28 -46.8 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.5 81.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.241 -0.912 . . . . 0.0 109.228 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.64 -56.67 10.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 0.0 109.682 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -36.41 64.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.26 -0.9 . . . . 0.0 109.738 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.0 mt -72.7 -41.98 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 109.565 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 mt -56.13 -35.52 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.099 -1.001 . . . . 0.0 108.786 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.85 -44.99 45.48 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.3 mt -59.16 -33.9 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 121.297 -1.119 . . . . 0.0 109.376 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.56 -66.13 0.61 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.389 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -44.4 -45.39 8.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.325 -0.859 . . . . 0.0 110.235 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.5 tp -59.05 -66.07 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.097 -1.002 . . . . 0.0 109.598 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mt -48.8 -47.51 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.165 -0.96 . . . . 0.0 109.626 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.73 HD22 ' NC ' ' A' ' 199' ' ' RIM . 3.1 mt -56.45 -55.18 36.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 110.13 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -48.54 -49.54 35.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.038 -1.039 . . . . 0.0 109.691 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.3 mt -60.6 -57.27 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.244 -0.91 . . . . 0.0 109.126 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.0 tp -50.3 -21.56 1.44 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.675 -0.64 . . . . 0.0 110.247 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.45 ' CG ' HNC2 ' A' ' 199' ' ' RIM . 39.3 m-20 -90.77 -26.73 19.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.971 . . . . 0.0 110.009 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.595 ' NE ' ' NC ' ' D' ' 499' ' ' RIM . 43.9 mtp85 -81.63 -21.87 37.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.163 -0.96 . . . . 0.0 110.721 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -69.16 -31.8 70.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.667 -1.271 . . . . 0.0 108.91 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -98.1 124.35 42.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.433 -0.792 . . . . 0.0 109.212 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -168.44 -8.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.143 -0.973 . . . . 0.0 109.878 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.525 ' CG ' ' H ' ' A' ' 50' ' ' SER . 1.3 tpmt? -72.95 -149.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.176 -0.953 . . . . 0.0 109.312 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.525 ' H ' ' CG ' ' A' ' 49' ' ' LYS . 59.0 p 46.33 71.61 0.29 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.56 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.7 mt -94.45 -25.16 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.559 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -61.23 -26.18 67.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 109.466 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -68.62 -37.6 79.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.079 -1.013 . . . . 0.0 109.359 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -74.19 -41.29 61.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.151 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -62.34 -42.98 99.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.335 -0.853 . . . . 0.0 109.405 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -73.61 -26.34 60.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.185 -0.947 . . . . 0.0 109.276 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.476 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 12.3 t-80 -69.91 -31.19 68.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.17 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.32 -63.68 1.77 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mt -57.94 112.13 1.39 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -1.183 . . . . 0.0 109.234 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.593 -179.869 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' B' ' 24' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.552 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 23.9 m-20 -151.34 49.27 0.56 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.462 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 9.8 Cg_endo -56.16 -10.96 5.09 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.724 2.282 . . . . 0.0 112.02 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 28.6 tp -47.01 -47.24 22.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.063 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 41.0 t -67.69 -45.3 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.887 . . . . 0.0 108.937 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -48.79 -48.9 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 108.994 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.43 -33.46 75.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.4 -0.813 . . . . 0.0 109.184 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.91 -58.01 6.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.675 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -55.22 -35.5 64.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.797 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 36.8 mt -73.45 -41.26 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.121 -0.987 . . . . 0.0 109.745 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 24.1 mt -55.98 -35.41 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.992 -1.068 . . . . 0.0 108.661 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.76 -45.4 34.79 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mt -55.26 -30.58 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.23 -1.159 . . . . 0.0 109.096 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.07 -65.64 0.82 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.228 -0.92 . . . . 0.0 109.055 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -46.48 -34.87 5.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.619 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.75 -71.24 0.22 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 109.469 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.9 mt -46.78 -37.41 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.324 -0.86 . . . . 0.0 109.397 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.458 HD21 ' NC ' ' B' ' 299' ' ' RIM . 2.7 tt -58.92 -62.91 1.53 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.489 -0.757 . . . . 0.0 109.662 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 10.9 t-105 -47.41 -52.44 16.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.828 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 57.0 mt -55.02 -48.19 76.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.989 -1.069 . . . . 0.0 108.681 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.11 -50.63 11.0 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.39 0.614 . . . . 0.0 109.476 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.483 ' CG ' HH11 ' C' ' 45' ' ' ARG . 37.7 m-20 -62.16 -32.68 73.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.342 -0.849 . . . . 0.0 109.521 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.522 ' CA ' ' HE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -72.39 -20.52 61.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.115 -0.99 . . . . 0.0 110.183 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -85.83 -34.3 21.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.699 -1.251 . . . . 0.0 108.961 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' PHE . . . . . 0.491 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 59.1 t80 -59.01 96.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.286 -0.884 . . . . 0.0 109.378 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' B' ' 47' ' ' PHE . 8.5 m-85 -165.9 97.82 0.64 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.688 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -150.41 -80.9 0.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.935 . . . . 0.0 109.552 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 16.4 m -80.4 106.14 12.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.937 . . . . 0.0 109.548 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 13.7 mt -92.29 -23.48 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.897 . . . . 0.0 109.562 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.428 ' CD1' ' C ' ' B' ' 52' ' ' TYR . 1.4 p90 -64.64 -17.09 63.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 109.214 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -43.87 64.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 109.783 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -68.63 -32.93 73.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.511 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -70.66 -44.3 67.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.692 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.99 -29.39 68.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 109.512 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -68.67 -47.79 65.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.877 . . . . 0.0 109.177 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.0 -64.31 3.48 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.22 120.63 8.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.292 -1.122 . . . . 0.0 109.469 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.485 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 74.0 m . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.297 0.57 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' C' ' 26' ' ' LEU . 25.4 t0 55.27 66.81 3.55 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.508 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -46.51 -11.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.717 2.278 . . . . 0.0 111.974 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' C' ' 24' ' ' ASP . 40.5 tp -47.49 -45.04 25.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.423 -0.798 . . . . 0.0 109.059 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 51.5 t -69.85 -45.19 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 108.755 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 78.9 t -48.45 -48.22 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -0.865 . . . . 0.0 108.846 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.5 -35.45 80.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.355 -0.841 . . . . 0.0 109.107 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.29 -57.36 10.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.46 -0.775 . . . . 0.0 109.851 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -56.42 -35.71 68.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.757 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.4 mt -71.47 -39.76 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.114 -0.991 . . . . 0.0 109.355 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 32.2 mt -58.15 -35.14 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.012 -1.055 . . . . 0.0 108.423 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.64 -45.15 54.86 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 75.3 mt -61.69 -23.06 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.298 -1.119 . . . . 0.0 108.73 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.1 -70.83 0.39 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.385 -0.822 . . . . 0.0 109.404 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -45.36 -37.05 4.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.312 -0.868 . . . . 0.0 109.676 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.93 -68.05 0.37 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 0.0 109.412 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 5.4 mt -51.98 -27.69 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.947 . . . . 0.0 109.584 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 40' ' ' LEU . . . . . 0.591 HD21 ' NC ' ' C' ' 399' ' ' RIM . 0.5 OUTLIER -70.22 -61.49 1.76 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 0.0 109.598 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -46.91 -43.75 19.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 109.646 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 64.6 mt -67.68 -40.05 83.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.261 -0.899 . . . . 0.0 109.249 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 57.6 tp -58.68 -36.35 74.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.577 -0.702 . . . . 0.0 110.217 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -86.4 -20.44 28.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.106 -0.997 . . . . 0.0 110.158 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.483 HH11 ' CG ' ' B' ' 44' ' ' ASP . 1.6 mmp_? -78.45 -27.23 46.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.952 -1.093 . . . . 0.0 110.549 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -52.14 -12.9 0.27 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.563 -1.336 . . . . 0.0 108.864 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 47' ' ' PHE . . . . . 0.431 ' N ' ' C ' ' C' ' 45' ' ' ARG . 53.6 m-85 -93.13 101.75 14.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.887 . . . . 0.0 109.724 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -168.23 -20.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 0.0 109.559 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.74 -70.25 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.166 -0.959 . . . . 0.0 109.369 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 64.0 p -68.49 110.88 4.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.174 -0.954 . . . . 0.0 109.365 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 11.2 mt -105.95 -25.17 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.576 -0.703 . . . . 0.0 109.803 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -28.29 23.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.93 . . . . 0.0 109.752 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -65.91 -42.79 89.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 0.0 109.817 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -64.96 -34.96 79.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.309 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -63.69 -59.53 4.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.338 -0.851 . . . . 0.0 109.227 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -54.72 -31.01 57.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 109.732 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -65.73 -42.96 90.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -0.976 . . . . 0.0 109.335 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.13 -61.5 5.13 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 54.0 mt -74.91 156.8 35.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -1.147 . . . . 0.0 109.591 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.377 179.968 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.237 0.542 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' D' ' 26' ' ' LEU . 1.5 m-20 51.0 66.97 4.75 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.93 . . . . 0.0 109.617 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -46.44 -10.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.785 2.323 . . . . 0.0 112.353 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' D' ' 24' ' ' ASP . 26.3 tp -47.26 -45.89 24.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 109.079 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 39.0 t -69.29 -45.14 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.1 t -49.4 -48.92 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 108.78 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.93 -32.88 74.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.341 -0.85 . . . . 0.0 109.184 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.3 -56.89 10.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.388 -0.82 . . . . 0.0 109.741 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -56.1 -36.34 68.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.783 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.07 -40.54 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.114 -0.991 . . . . 0.0 109.395 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 25.0 mt -57.18 -34.06 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.124 -0.985 . . . . 0.0 108.543 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.46 -44.52 27.01 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 61.7 mt -57.9 -29.5 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.152 -1.204 . . . . 0.0 109.022 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.48 -66.62 0.67 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.427 -0.796 . . . . 0.0 109.252 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -46.53 -39.92 11.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.834 . . . . 0.0 109.927 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.7 -67.54 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.064 -1.022 . . . . 0.0 109.757 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mt -48.85 -40.48 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.152 -0.968 . . . . 0.0 109.541 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.537 ' O ' HD23 ' D' ' 40' ' ' LEU . 2.5 tt -55.79 -55.4 32.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.844 . . . . 0.0 109.915 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -53.06 -48.69 67.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.074 -1.016 . . . . 0.0 110.077 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 42' ' ' ILE . . . . . 0.554 HG12 HNC1 ' C' ' 399' ' ' RIM . 68.2 mt -60.18 -49.48 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.107 -0.996 . . . . 0.0 109.152 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 tp -49.37 -40.29 35.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.497 -0.752 . . . . 0.0 110.093 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -74.01 -27.65 61.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.206 -0.934 . . . . 0.0 109.808 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.461 ' HE ' ' HA1' ' C' ' 399' ' ' RIM . 4.3 mmm180 -74.65 -24.25 58.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 110.494 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -74.48 -9.5 58.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.68 -1.262 . . . . 0.0 109.086 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -142.84 89.24 2.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.453 -0.779 . . . . 0.0 109.466 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 48' ' ' PHE . . . . . 0.415 ' O ' ' O ' ' D' ' 49' ' ' LYS . 2.7 t80 -151.76 -3.96 0.27 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 0.0 109.515 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 49' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' D' ' 48' ' ' PHE . 4.1 mtmt -63.02 -134.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.413 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 21.3 t 51.36 79.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 109.521 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 47.8 mt -95.74 -37.58 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.845 . . . . 0.0 109.334 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 52' ' ' TYR . . . . . 0.521 ' CD2' ' N ' ' D' ' 53' ' ' ARG . 21.2 p90 -52.23 -43.96 64.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.107 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 53' ' ' ARG . . . . . 0.521 ' N ' ' CD2' ' D' ' 52' ' ' TYR . 0.9 OUTLIER -62.84 -18.07 62.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 108.844 179.32 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -69.32 -46.86 66.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.367 -0.833 . . . . 0.0 109.128 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 55' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 1.1 m-85 -74.18 -52.96 10.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.062 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -49.2 -35.11 16.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.423 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 57' ' ' HIS . . . . . 0.496 ' CD2' ' O ' ' D' ' 53' ' ' ARG . 12.4 m170 -70.64 -57.69 4.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 109.642 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -50.46 -56.98 11.18 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 4.7 mt -70.91 124.01 23.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -1.127 . . . . 0.0 109.492 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 35.3 tttm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.461 179.834 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 199' ' ' RIM . . . . . 0.73 ' NC ' HD22 ' A' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 299' ' ' RIM . . . . . 0.458 ' NC ' HD21 ' B' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 399' ' ' RIM . . . . . 0.591 ' NC ' HD21 ' C' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 499' ' ' RIM . . . . . 0.595 ' NC ' ' NE ' ' A' ' 45' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 46.97 70.21 2.22 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.535 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.66 -11.16 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.638 2.225 . . . . 0.0 112.439 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.2 tp -47.43 -47.88 26.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.039 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.9 -44.99 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -0.841 . . . . 0.0 108.824 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -49.38 -47.76 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.269 -0.895 . . . . 0.0 108.718 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.36 83.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.622 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.33 -53.7 39.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -0.915 . . . . 0.0 109.61 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -37.3 71.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.794 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.4 mt -72.29 -41.52 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.144 -0.972 . . . . 0.0 109.563 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.3 mt -56.88 -35.2 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.013 -1.055 . . . . 0.0 108.693 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.5 -42.98 46.5 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.416 HG13 HD13 ' D' ' 33' ' ' ILE . 73.2 mt -62.18 -27.17 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.336 -1.097 . . . . 0.0 109.148 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.92 -63.63 1.13 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.363 -0.835 . . . . 0.0 108.982 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -45.8 -40.64 9.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 0.0 109.94 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -64.3 -67.66 0.41 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.587 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.2 mt -47.36 -35.63 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.279 -0.888 . . . . 0.0 109.106 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 43' ' ' LEU . 2.5 mt -62.34 -61.61 2.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.615 -0.678 . . . . 0.0 109.682 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -43.3 -46.46 6.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.613 -0.679 . . . . 0.0 109.796 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.3 mt -71.88 -28.05 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 108.985 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 40' ' ' LEU . 6.6 tp -63.75 -41.93 97.93 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.274 -0.891 . . . . 0.0 109.907 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -83.95 -23.59 31.04 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.293 -0.88 . . . . 0.0 109.813 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' PHE . 8.4 mmt85 -95.47 3.17 54.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.252 -0.905 . . . . 0.0 110.865 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.488 ' C ' ' O ' ' A' ' 45' ' ' ARG . 34.4 mt -31.17 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.783 -0.573 . . . . 0.0 110.816 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 45' ' ' ARG . 2.2 m-85 -171.9 -170.86 0.81 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.114 -0.991 . . . . 0.0 109.74 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.528 ' O ' ' N ' ' A' ' 50' ' ' SER . 3.3 p90 -137.88 -1.93 1.96 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.467 -0.77 . . . . 0.0 109.552 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp 47.99 -91.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.88 . . . . 0.0 109.525 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -148.13 177.63 9.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -0.882 . . . . 0.0 109.43 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 mt -102.35 -24.29 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.491 -0.756 . . . . 0.0 109.489 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -52.63 -21.35 3.84 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.223 -0.923 . . . . 0.0 109.448 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -67.47 -43.48 80.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.36 -0.837 . . . . 0.0 109.9 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -69.98 -39.55 75.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.973 . . . . 0.0 109.371 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -55.01 -51.5 66.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.348 -0.845 . . . . 0.0 109.641 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -71.23 -25.11 62.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.31 -0.869 . . . . 0.0 109.794 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -67.44 -37.59 83.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 0.0 109.611 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.25 -62.83 1.77 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.4 mt -72.26 84.85 1.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -1.215 . . . . 0.0 109.622 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 pttt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.421 179.804 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 34.6 p . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' B' ' 26' ' ' LEU . 5.7 m-20 -149.42 64.88 7.54 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.589 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -44.54 -9.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.972 2.448 . . . . 0.0 112.524 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' B' ' 24' ' ' ASP . 42.7 tp -47.34 -46.13 25.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.123 -0.985 . . . . 0.0 109.261 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 35.1 t -68.14 -45.13 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 108.924 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 78.2 t -48.38 -47.65 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.877 . . . . 0.0 109.138 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.54 -37.45 86.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.35 -0.844 . . . . 0.0 109.4 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.07 -55.9 21.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 109.569 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 2.1 m -56.31 -34.74 66.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 109.887 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.83 -43.48 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.14 -0.975 . . . . 0.0 109.323 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 11.7 mt -54.59 -35.3 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.067 -1.02 . . . . 0.0 108.547 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.59 -44.18 50.4 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 59.3 mt -59.3 -34.67 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.269 -1.136 . . . . 0.0 109.468 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.33 -67.77 0.47 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -0.962 . . . . 0.0 109.226 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -44.29 -34.08 1.81 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.47 -0.768 . . . . 0.0 109.788 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 54.8 tp -70.18 -70.44 0.29 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 14.2 mt -47.24 -24.02 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.216 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.424 HD23 ' C ' ' B' ' 40' ' ' LEU . 2.7 tt -71.76 -63.48 1.12 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 109.688 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 16.6 t-105 -48.65 -47.03 40.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.558 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 82.2 mt -57.11 -44.68 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.93 -54.47 9.99 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.496 0.665 . . . . 0.0 109.38 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.471 ' CG ' HH11 ' C' ' 45' ' ' ARG . 59.2 m-20 -61.82 -29.5 70.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.552 -0.717 . . . . 0.0 110.338 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -73.35 -24.32 60.33 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.949 -1.094 . . . . 0.0 110.871 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -75.0 -8.58 56.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.605 -1.309 . . . . 0.0 109.577 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -143.11 117.87 9.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.324 -0.86 . . . . 0.0 109.664 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -156.3 -3.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -0.873 . . . . 0.0 109.362 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -71.23 -146.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.601 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.513 ' O ' ' CE2' ' B' ' 54' ' ' PHE . 0.7 OUTLIER 46.92 72.27 0.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.364 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 22.1 mt -100.33 -24.42 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.405 -0.81 . . . . 0.0 109.532 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -70.79 -16.51 62.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.175 -0.953 . . . . 0.0 109.449 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -45.18 56.34 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' PHE . . . . . 0.513 ' CE2' ' O ' ' B' ' 50' ' ' SER . 4.6 m-85 -69.23 -30.96 69.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.349 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -69.49 -45.36 69.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 109.078 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -72.98 -29.18 62.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -0.858 . . . . 0.0 109.421 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -64.36 -60.04 3.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.232 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.98 -55.13 31.93 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.451 HD13 ' C ' ' B' ' 59' ' ' LEU . 0.4 OUTLIER -63.36 95.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.349 -1.089 . . . . 0.0 109.209 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 tttt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.459 -179.826 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' C' ' 26' ' ' LEU . 0.9 OUTLIER 50.9 70.37 2.04 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -47.36 -7.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.631 2.22 . . . . 0.0 112.313 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' C' ' 24' ' ' ASP . 41.9 tp -49.31 -45.61 45.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.088 -1.007 . . . . 0.0 109.093 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.97 -45.53 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.067 -1.021 . . . . 0.0 108.534 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.5 t -49.28 -46.7 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.52 75.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.87 . . . . 0.0 109.285 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.07 -56.47 11.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.387 -0.82 . . . . 0.0 109.556 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.68 -37.27 68.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 109.559 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 12.2 mt -70.75 -40.34 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.517 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 26.2 mt -58.44 -35.31 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.054 -1.029 . . . . 0.0 108.79 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.56 -43.73 67.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.47 -27.19 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.45 -1.03 . . . . 0.0 108.999 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.5 tp -68.8 -68.89 0.36 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.0 109.111 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 37' ' ' HIS . . . . . 0.598 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 1.8 t-80 -45.97 -43.0 13.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 110.048 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 49.1 tp -58.39 -65.19 0.69 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.124 -0.985 . . . . 0.0 109.709 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 4.1 mt -49.09 -31.87 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.954 . . . . 0.0 109.523 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -70.31 -59.46 2.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.923 . . . . 0.0 110.277 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -48.83 -46.17 41.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.997 -1.064 . . . . 0.0 109.908 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 69.6 mt -64.88 -48.89 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.135 -0.978 . . . . 0.0 109.124 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 tp -54.46 -32.42 57.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.567 -0.708 . . . . 0.0 110.183 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 44' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' C' ' 44' ' ' ASP . 0.3 OUTLIER -84.54 -22.29 30.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.074 -1.016 . . . . 0.0 109.746 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.471 HH11 ' CG ' ' B' ' 44' ' ' ASP . 0.2 OUTLIER -79.1 -25.09 43.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -0.936 . . . . 0.0 110.464 -179.236 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 46' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' C' ' 48' ' ' PHE . 10.5 mt -67.31 -31.2 71.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.706 -1.247 . . . . 0.0 108.893 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -47.45 98.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.943 . . . . 0.0 109.217 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.429 ' N ' ' O ' ' C' ' 46' ' ' LEU . 2.5 t80 -162.05 18.66 0.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 109.341 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 49' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' C' ' 48' ' ' PHE . 1.5 pttm -61.11 -115.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.811 . . . . 0.0 109.647 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.26 148.59 25.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.664 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 18.5 mt -106.63 -24.23 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.648 -0.658 . . . . 0.0 109.407 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -52.39 -20.32 2.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.328 -0.857 . . . . 0.0 109.609 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -71.43 -41.8 69.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.18 -0.95 . . . . 0.0 109.578 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -67.14 -38.43 85.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 109.079 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -64.58 -64.62 0.83 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.407 -0.808 . . . . 0.0 109.146 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -50.52 -30.17 12.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.829 . . . . 0.0 109.855 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.79 -56.21 10.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.991 . . . . 0.0 109.571 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.4 -60.26 9.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.07 110.34 0.29 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -1.134 . . . . 0.0 109.426 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.46 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.6 p . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.436 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 1.5 m-20 47.64 54.66 15.94 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.229 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 25' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 17.3 Cg_endo -60.88 -11.34 17.57 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.566 2.177 . . . . 0.0 112.453 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 20.6 tp -47.64 -46.17 28.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 0.0 108.977 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.5 t -70.1 -45.2 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 108.647 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 78.8 t -49.23 -48.1 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.148 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.49 -34.8 78.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.865 . . . . 0.0 109.285 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.81 -55.87 16.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.966 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.3 -37.47 72.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.115 -0.991 . . . . 0.0 109.919 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 19.8 mt -70.33 -39.2 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 109.261 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 33' ' ' ILE . . . . . 0.416 HD13 HG13 ' A' ' 35' ' ' ILE . 22.5 mt -58.9 -34.59 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.116 -0.99 . . . . 0.0 108.617 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.18 -44.9 58.51 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 63.8 mt -60.47 -28.55 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.472 -1.016 . . . . 0.0 109.121 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.39 -66.4 0.66 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.34 -0.85 . . . . 0.0 109.049 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 37' ' ' HIS . . . . . 0.598 ' CE1' ' NE2' ' C' ' 37' ' ' HIS . 11.6 t-160 -47.28 -37.27 10.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.952 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 42.8 tp -68.27 -62.99 1.15 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.097 -1.002 . . . . 0.0 109.67 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mt -46.64 -40.76 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 109.324 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.551 HD22 HNC1 ' D' ' 499' ' ' RIM . 1.8 mt -59.78 -60.45 3.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.454 -0.779 . . . . 0.0 110.322 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 41' ' ' TRP . . . . . 0.424 ' CZ2' ' CG ' ' D' ' 45' ' ' ARG . 20.6 t-105 -49.93 -46.26 51.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.004 -1.06 . . . . 0.0 110.025 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.31 -47.04 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.14 -0.975 . . . . 0.0 109.362 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 tp -53.92 -39.85 66.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.426 -0.796 . . . . 0.0 109.744 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.644 ' CG ' HNC2 ' D' ' 499' ' ' RIM . 2.7 m-20 -74.35 -25.61 59.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.25 -0.906 . . . . 0.0 109.823 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.424 ' CG ' ' CZ2' ' D' ' 41' ' ' TRP . 0.6 OUTLIER -74.47 -28.54 61.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.987 -1.071 . . . . 0.0 110.486 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 mt -69.13 -24.67 64.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.708 -1.245 . . . . 0.0 109.12 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -86.05 77.41 9.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.491 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -162.72 3.76 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.341 -0.849 . . . . 0.0 109.182 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 49' ' ' LYS . . . . . 0.499 ' CG ' ' H ' ' D' ' 50' ' ' SER . 0.8 OUTLIER -62.47 -98.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.499 ' H ' ' CG ' ' D' ' 49' ' ' LYS . 49.0 p -46.65 129.51 11.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.631 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 15.3 mt -104.91 -29.84 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.557 -0.715 . . . . 0.0 109.109 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -26.1 6.02 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.214 -0.929 . . . . 0.0 109.459 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -66.69 -45.05 80.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.119 -0.988 . . . . 0.0 109.55 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -65.01 -36.41 84.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.2 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.51 -66.64 0.53 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.383 -0.823 . . . . 0.0 109.068 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -46.74 -30.85 2.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.551 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -68.89 -56.7 7.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.936 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.8 -60.42 9.05 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mt -59.1 107.65 0.57 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -1.201 . . . . 0.0 109.322 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 60' ' ' LYS . . . . . 0.425 ' HB3' ' HZ3' ' D' ' 60' ' ' LYS . 5.7 mmmm . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.274 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 299' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 399' ' ' RIM . . . . . 0.463 ' NC ' ' CG ' ' C' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 499' ' ' RIM . . . . . 0.644 HNC2 ' CG ' ' D' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.554 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 4.9 p-10 -171.2 48.82 0.11 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.455 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.9 Cg_endo -56.15 -16.87 18.23 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.912 2.408 . . . . 0.0 112.152 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.8 tp -46.22 -43.42 15.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.262 -0.899 . . . . 0.0 109.17 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.06 -44.93 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.234 -0.916 . . . . 0.0 108.924 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.2 t -49.68 -49.59 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.192 -0.942 . . . . 0.0 109.174 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.09 -34.45 78.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.321 -0.862 . . . . 0.0 109.482 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.32 -56.48 12.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 109.615 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.44 -37.56 67.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.307 -0.87 . . . . 0.0 109.908 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.1 mt -72.21 -41.13 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.966 . . . . 0.0 109.589 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.2 mt -55.87 -34.82 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.098 -1.001 . . . . 0.0 108.485 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.08 -45.01 33.59 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.4 mt -59.62 -27.27 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.256 -1.143 . . . . 0.0 109.187 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.15 -65.91 0.79 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 109.212 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -45.18 -37.89 4.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.363 -0.835 . . . . 0.0 109.79 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.7 tp -66.12 -68.99 0.33 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.943 . . . . 0.0 109.671 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.8 mt -46.69 -36.42 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.445 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.68 HD22 ' NC ' ' A' ' 199' ' ' RIM . 4.3 mt -66.46 -58.06 6.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.271 -0.893 . . . . 0.0 109.708 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -49.1 -48.04 44.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.758 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.4 mt -63.1 -49.08 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -0.929 . . . . 0.0 109.315 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.6 tp -51.41 -34.65 35.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.535 -0.728 . . . . 0.0 110.318 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.511 ' OD2' ' NC ' ' A' ' 199' ' ' RIM . 4.0 m-20 -84.44 -26.42 28.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.12 -0.988 . . . . 0.0 110.272 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -71.78 -29.38 64.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.073 -1.017 . . . . 0.0 110.685 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -59.37 -26.11 64.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.714 -1.241 . . . . 0.0 109.593 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -57.26 111.07 0.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.07 -1.019 . . . . 0.0 109.43 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.481 ' CD1' ' C ' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -169.54 16.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.241 -0.912 . . . . 0.0 109.471 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 48' ' ' PHE . 45.5 mtpt -62.44 -133.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 109.443 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.56 146.79 54.08 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 109.673 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.2 mt -106.31 -21.71 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -58.05 -15.13 8.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.399 -0.813 . . . . 0.0 109.755 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -69.58 -40.72 76.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 109.774 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -72.86 -42.84 63.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.079 -1.013 . . . . 0.0 109.158 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -56.51 -46.18 80.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.171 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -71.7 -25.43 62.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -0.843 . . . . 0.0 109.317 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -69.77 -32.51 71.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.17 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.22 -62.89 2.02 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.8 mt -72.66 138.8 46.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.193 -1.181 . . . . 0.0 109.498 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.389 -179.874 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' B' ' 26' ' ' LEU . 19.9 t0 -158.66 64.27 2.69 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.873 . . . . 0.0 109.476 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -44.61 -10.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.766 2.31 . . . . 0.0 112.367 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' B' ' 24' ' ' ASP . 30.2 tp -47.35 -46.43 25.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.023 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.5 -45.83 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.197 -0.939 . . . . 0.0 108.804 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 63.3 t -48.26 -48.18 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -0.837 . . . . 0.0 109.026 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.72 -34.15 77.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.219 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.89 -57.41 8.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 109.749 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 2.3 m -55.18 -35.64 65.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.93 . . . . 0.0 109.786 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 19.8 mt -72.89 -41.28 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.098 -1.001 . . . . 0.0 109.567 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -56.11 -33.88 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.037 -1.039 . . . . 0.0 108.574 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.13 -44.83 22.01 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 59.5 mt -56.77 -31.76 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.274 -1.133 . . . . 0.0 109.182 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.68 -64.11 1.02 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.193 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -44.4 -40.5 5.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.413 -0.805 . . . . 0.0 110.123 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 50.8 tp -66.87 -67.27 0.46 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.975 . . . . 0.0 109.636 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 mt -47.33 -26.02 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 109.429 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.524 HD21 HE31 ' B' ' 299' ' ' RIM . 0.6 OUTLIER -69.66 -68.05 0.44 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.322 -0.861 . . . . 0.0 110.039 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -44.51 -46.54 9.83 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.437 -0.789 . . . . 0.0 109.953 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 56.7 mt -59.29 -47.28 90.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.123 -0.986 . . . . 0.0 108.644 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.1 -54.01 11.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.481 -0.762 . . . . 0.0 108.985 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' ASP . . . . . 0.485 ' CG ' HNC2 ' B' ' 299' ' ' RIM . 52.7 m-20 -60.25 -29.89 69.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.493 -0.754 . . . . 0.0 110.389 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.402 HH12 HE21 ' A' ' 199' ' ' RIM . 0.0 OUTLIER -75.95 -21.39 57.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.909 -1.12 . . . . 0.0 110.745 -179.157 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -79.04 -33.71 44.48 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.532 -1.355 . . . . 0.0 108.952 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -61.49 122.61 15.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.848 . . . . 0.0 109.682 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -156.39 52.85 0.54 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.374 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.44 -80.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 109.456 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 50' ' ' SER . . . . . 0.499 ' CB ' ' CZ ' ' B' ' 52' ' ' TYR . 0.0 OUTLIER -155.81 166.57 33.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.436 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 11.5 mt -96.9 -34.89 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.303 -0.873 . . . . 0.0 109.842 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.499 ' CZ ' ' CB ' ' B' ' 50' ' ' SER . 19.6 p90 -62.66 -19.14 63.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.036 -1.04 . . . . 0.0 109.654 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.7 mmt85 -68.56 -45.22 72.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.537 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -66.27 -32.61 74.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.277 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -69.67 -59.94 2.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.0 109.18 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -53.73 -28.12 32.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.897 . . . . 0.0 109.822 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -71.56 -53.87 12.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.104 -0.997 . . . . 0.0 109.305 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.31 -62.25 6.04 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' LEU . . . . . 0.442 HD13 ' C ' ' B' ' 59' ' ' LEU . 0.4 OUTLIER -57.98 108.24 0.57 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -1.105 . . . . 0.0 108.985 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.407 ' N ' HD13 ' B' ' 59' ' ' LEU . 17.9 tttm . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.471 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' C' ' 26' ' ' LEU . 15.9 m-20 -149.52 66.06 8.12 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -46.22 -10.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.875 2.383 . . . . 0.0 112.237 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' C' ' 24' ' ' ASP . 49.3 tp -47.32 -46.57 25.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.237 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.58 -44.51 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.077 -1.014 . . . . 0.0 108.847 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 69.5 t -49.15 -49.48 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 108.904 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.61 74.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.218 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.48 -57.54 8.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 109.6 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.43 -37.14 67.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.088 -1.008 . . . . 0.0 109.873 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 24.3 mt -71.4 -41.85 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 0.0 109.454 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 23.1 mt -55.55 -34.86 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.089 -1.007 . . . . 0.0 108.544 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.83 -45.24 28.2 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 50.0 mt -55.36 -31.51 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.261 -1.14 . . . . 0.0 109.379 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.0 -57.69 3.74 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.271 -0.893 . . . . 0.0 109.019 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -50.33 -37.62 37.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.217 -0.927 . . . . 0.0 109.436 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -67.02 -69.01 0.33 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.273 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.4 mt -46.7 -26.44 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.275 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 40' ' ' LEU . . . . . 0.405 HD21 HNC2 ' C' ' 399' ' ' RIM . 3.0 mt -69.61 -64.98 0.77 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -0.875 . . . . 0.0 109.655 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -45.41 -47.5 13.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.497 -0.752 . . . . 0.0 109.635 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 70.1 mt -63.73 -56.8 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.145 -0.972 . . . . 0.0 109.074 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.3 tp -44.7 -48.92 10.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.492 -0.755 . . . . 0.0 110.129 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.66 -25.81 65.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.15 -0.969 . . . . 0.0 110.416 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 11.7 mmt-85 -77.84 -21.1 51.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.887 -1.133 . . . . 0.0 110.536 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.1 mt -77.17 -14.43 59.78 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.697 -1.252 . . . . 0.0 108.956 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -76.55 -3.9 39.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.574 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 48' ' ' PHE . . . . . 0.407 ' O ' ' CG ' ' C' ' 48' ' ' PHE . 0.2 OUTLIER -79.52 112.79 17.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.976 . . . . 0.0 109.579 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 49' ' ' LYS . . . . . 0.454 ' CG ' ' H ' ' C' ' 50' ' ' SER . 4.5 pttp -163.22 -92.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.475 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 50' ' ' SER . . . . . 0.454 ' H ' ' CG ' ' C' ' 49' ' ' LYS . 28.4 t -77.55 138.03 38.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.4 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 11.1 mt -102.89 -20.28 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.536 -0.727 . . . . 0.0 109.112 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -30.6 26.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.263 -0.898 . . . . 0.0 109.683 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -62.7 -46.03 90.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 109.636 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 54' ' ' PHE . . . . . 0.408 ' O ' ' CD1' ' D' ' 51' ' ' ILE . 2.7 m-85 -63.78 -37.11 86.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.242 -0.911 . . . . 0.0 109.375 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.07 -63.36 1.17 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.25 -0.906 . . . . 0.0 109.147 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -46.77 -34.07 4.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.795 . . . . 0.0 109.673 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -65.62 -49.72 67.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 0.0 109.137 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.7 -60.81 8.07 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.45 ' C ' HD13 ' C' ' 59' ' ' LEU . 0.4 OUTLIER -88.53 105.84 17.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -1.14 . . . . 0.0 108.963 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.384 -179.99 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.42 160.64 40.4 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.251 -0.906 . . . . 0.0 109.296 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.02 -21.99 73.43 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.578 2.185 . . . . 0.0 112.373 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 51.5 tp -46.25 -43.64 15.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 108.664 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.6 -44.4 79.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.339 -0.85 . . . . 0.0 108.731 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 74.4 t -50.19 -49.43 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 108.703 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.56 -32.83 74.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.412 -0.805 . . . . 0.0 109.251 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.37 -56.67 9.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 109.783 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.67 -36.4 69.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 0.0 109.775 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 15.7 mt -71.65 -42.3 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 109.475 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 24.0 mt -56.13 -34.83 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -0.999 . . . . 0.0 108.617 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.28 -43.62 37.91 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 58.7 mt -58.0 -38.57 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.204 -1.174 . . . . 0.0 109.037 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' D' ' 36' ' ' LEU . 0.2 OUTLIER -65.0 -66.26 0.57 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -0.884 . . . . 0.0 109.089 179.669 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -45.3 -36.65 4.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 0.0 109.83 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 44.1 tp -66.42 -70.0 0.27 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.095 -1.003 . . . . 0.0 109.407 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 9.9 mt -48.01 -25.15 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.361 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.534 ' O ' HD23 ' D' ' 40' ' ' LEU . 2.8 tt -72.74 -55.61 6.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.334 -0.854 . . . . 0.0 109.658 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -53.27 -50.92 63.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.094 -1.003 . . . . 0.0 109.568 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 23.1 mt -59.0 -55.0 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.091 -1.006 . . . . 0.0 108.739 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 35.9 tp -47.52 -37.2 11.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.422 -0.799 . . . . 0.0 109.72 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.472 ' OD2' ' NC ' ' D' ' 499' ' ' RIM . 94.6 m-20 -74.22 -26.05 60.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.223 -0.923 . . . . 0.0 109.67 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.524 ' CA ' ' HE ' ' D' ' 45' ' ' ARG . 0.0 OUTLIER -82.12 -17.67 45.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.126 -0.984 . . . . 0.0 110.732 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -82.26 -34.89 28.59 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.64 -1.287 . . . . 0.0 109.691 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 47' ' ' PHE . . . . . 0.607 ' CG ' ' N ' ' D' ' 48' ' ' PHE . 0.1 OUTLIER -101.53 -167.66 1.45 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.423 -0.798 . . . . 0.0 109.694 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 48' ' ' PHE . . . . . 0.607 ' N ' ' CG ' ' D' ' 47' ' ' PHE . 2.5 t80 77.76 30.39 0.47 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.505 -0.747 . . . . 0.0 109.541 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 49' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' D' ' 50' ' ' SER . 7.9 tptt -93.3 -148.32 0.25 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 109.28 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 50' ' ' SER . . . . . 0.429 ' O ' ' O ' ' D' ' 49' ' ' LYS . 1.2 m 54.75 102.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.469 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 51' ' ' ILE . . . . . 0.408 ' CD1' ' O ' ' C' ' 54' ' ' PHE . 11.8 mt -91.12 -19.52 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 109.16 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -31.4 70.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -0.909 . . . . 0.0 109.777 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -47.35 66.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 0.0 110.413 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 54' ' ' PHE . . . . . 0.479 ' CD1' ' O ' ' D' ' 54' ' ' PHE . 0.0 OUTLIER -69.75 -28.8 66.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.044 -1.035 . . . . 0.0 109.211 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.08 -58.28 7.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.367 -0.833 . . . . 0.0 109.609 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -68.88 -26.99 65.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.121 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -59.94 -61.01 2.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.986 -1.071 . . . . 0.0 109.098 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.7 -59.48 8.13 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.7 110.12 2.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -1.141 . . . . 0.0 109.611 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 2.8 pttp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.46 179.94 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 199' ' ' RIM . . . . . 0.68 ' NC ' HD22 ' A' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 299' ' ' RIM . . . . . 0.524 HE31 HD21 ' B' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 399' ' ' RIM . . . . . 0.405 HNC2 HD21 ' C' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 499' ' ' RIM . . . . . 0.472 ' NC ' ' OD2' ' D' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.299 0.571 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.14 161.52 52.03 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.319 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 26' ' ' LEU . 19.3 Cg_endo -61.72 -29.26 83.2 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.541 2.16 . . . . 0.0 112.055 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 26' ' ' LEU . 40.8 tp -45.13 -40.45 7.01 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.7 t -69.25 -43.51 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.0 t -53.12 -51.8 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.13 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.38 -34.95 76.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.52 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.39 -53.51 42.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 109.591 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.2 -37.44 74.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.859 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.3 mt -71.41 -42.47 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.389 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.9 mt -55.28 -36.37 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 0.0 108.789 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.31 -42.79 56.44 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.3 mt -61.83 -46.53 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.235 -1.156 . . . . 0.0 109.269 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.45 -44.69 80.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 109.142 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.404 ' CE1' ' HE2' ' D' ' 37' ' ' HIS . 3.4 t-80 -57.88 -56.08 26.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 109.482 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.3 tp -54.0 -59.97 3.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.913 . . . . 0.0 109.533 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.2 mt -47.52 -48.36 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.299 -0.876 . . . . 0.0 109.311 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mt -51.93 -59.31 4.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -45.14 -65.83 0.48 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.459 -0.776 . . . . 0.0 109.572 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mt -48.58 -37.74 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.125 -0.984 . . . . 0.0 109.278 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -52.1 -49.31 63.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.47 -0.769 . . . . 0.0 110.084 -179.331 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.463 ' OD1' ' NC ' ' A' ' 199' ' ' RIM . 0.5 OUTLIER -76.67 -21.72 55.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.968 . . . . 0.0 110.401 -179.042 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 47' ' ' PHE . 12.9 mmt180 -91.68 -1.15 57.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.013 -1.054 . . . . 0.0 110.841 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 45' ' ' ARG . 29.7 mt -35.79 -30.61 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.525 -0.734 . . . . 0.0 110.192 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 45' ' ' ARG . 7.4 p90 -170.92 167.13 7.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.161 -0.962 . . . . 0.0 109.486 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -164.15 99.68 0.85 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.252 -0.905 . . . . 0.0 109.578 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 51' ' ' ILE . 10.1 ttmt -151.64 -44.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.166 -0.959 . . . . 0.0 109.405 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.9 t -60.15 80.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 109.369 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 49' ' ' LYS . 40.7 mt -92.43 -27.76 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.89 . . . . 0.0 109.557 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.51 -44.84 65.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.751 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.29 -45.12 62.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.088 -1.008 . . . . 0.0 109.454 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -61.97 -37.28 84.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.286 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.0 -34.7 78.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.115 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -70.21 -38.14 75.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.353 -0.842 . . . . 0.0 109.476 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -62.66 -54.41 39.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 0.0 109.324 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -54.17 -63.08 5.49 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 60' ' ' LYS . 7.7 mt -72.93 21.85 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -1.143 . . . . 0.0 109.741 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.488 ' H ' ' C ' ' A' ' 58' ' ' GLY . 65.9 mttm . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.546 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ASP . . . . . 0.533 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 1.5 p30 -153.35 50.05 0.55 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.88 . . . . 0.0 109.399 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 9.2 Cg_endo -55.59 -11.26 4.55 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.802 2.334 . . . . 0.0 112.248 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 43.6 tp -47.62 -45.85 28.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.152 -0.967 . . . . 0.0 109.094 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.57 -46.14 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.145 -0.972 . . . . 0.0 108.808 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 74.0 t -47.98 -48.27 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.892 . . . . 0.0 108.99 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.54 84.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.452 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.39 -57.34 8.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.261 -0.9 . . . . 0.0 109.801 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -53.93 -35.83 62.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 0.0 109.69 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 18.4 mt -72.65 -41.68 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.179 -0.951 . . . . 0.0 109.411 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 18.6 mt -55.25 -34.5 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.087 -1.008 . . . . 0.0 108.691 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.94 -44.77 23.23 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 51.6 mt -55.49 -34.87 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.072 -1.252 . . . . 0.0 109.326 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.46 -58.97 2.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 108.971 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 37' ' ' HIS . . . . . 0.602 ' NE2' ' ND1' ' C' ' 37' ' ' HIS . 2.3 t-80 -47.83 -37.4 13.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 0.0 109.716 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 52.6 tp -69.88 -67.74 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 0.0 109.466 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mt -47.04 -25.14 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 109.316 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mt -69.03 -63.43 1.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.642 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 41.8 t-105 -47.72 -46.69 29.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.399 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' B' ' 45' ' ' ARG . 72.3 mt -62.02 -61.4 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 108.906 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 57.6 tp -42.53 -47.73 5.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.762 -0.587 . . . . 0.0 110.096 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.72 -27.78 68.57 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' B' ' 42' ' ' ILE . 2.3 mmt180 -81.19 -14.97 57.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.099 -1.001 . . . . 0.0 110.333 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -88.83 -16.08 32.93 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.763 -1.211 . . . . 0.0 109.289 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -47.23 -77.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.326 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 45.11 74.72 0.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 109.769 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -96.65 -88.21 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 109.49 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 2.1 t -148.51 148.98 30.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.388 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 20.2 mt -96.37 -22.55 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.325 -0.859 . . . . 0.0 109.566 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -67.01 -20.7 65.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.592 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -70.31 -43.74 69.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.246 -0.909 . . . . 0.0 109.833 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -67.12 -34.76 78.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -0.956 . . . . 0.0 109.632 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -66.35 -43.65 85.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.201 -0.937 . . . . 0.0 109.302 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -68.78 -27.54 65.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.085 -1.009 . . . . 0.0 108.72 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -70.69 -38.41 73.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.447 -0.783 . . . . 0.0 109.501 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.96 -62.4 3.17 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 50.5 mt -72.39 136.43 46.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -1.083 . . . . 0.0 109.367 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 48.5 mttm . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.463 179.92 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 24' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' C' ' 26' ' ' LEU . 0.2 OUTLIER -161.5 68.35 2.34 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.923 . . . . 0.0 109.571 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -46.4 -9.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.692 2.261 . . . . 0.0 112.105 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 26' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' C' ' 24' ' ' ASP . 35.4 tp -47.2 -46.41 23.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 0.0 109.141 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 33.8 t -69.49 -45.19 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.191 -0.943 . . . . 0.0 108.631 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 71.6 t -49.32 -50.41 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.336 -0.853 . . . . 0.0 108.995 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.11 -30.9 71.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.363 -0.835 . . . . 0.0 109.228 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.74 -56.22 11.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 109.603 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.13 -37.55 74.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -0.946 . . . . 0.0 109.829 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 42.0 mt -71.02 -40.72 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 0.0 109.51 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 18.5 mt -58.53 -32.28 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.106 -0.996 . . . . 0.0 108.594 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.86 -44.03 26.01 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 52.4 mt -57.04 -31.46 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.301 -1.117 . . . . 0.0 109.186 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.25 -62.39 1.45 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 108.935 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 37' ' ' HIS . . . . . 0.602 ' ND1' ' NE2' ' B' ' 37' ' ' HIS . 10.5 t-80 -47.13 -34.46 6.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 109.586 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 40.2 tp -70.56 -66.77 0.56 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.661 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 5.8 mt -49.97 -26.19 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.623 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -72.38 -54.49 9.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.138 -0.976 . . . . 0.0 109.526 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -55.02 -49.08 72.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.722 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 42' ' ' ILE . . . . . 0.498 HG12 HNC1 ' B' ' 299' ' ' RIM . 59.4 mt -63.9 -55.14 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.203 -0.936 . . . . 0.0 109.117 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 40.1 tp -48.23 -40.37 24.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.794 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 44' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' C' ' 44' ' ' ASP . 4.5 m-20 -73.21 -25.84 60.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 109.843 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 45' ' ' ARG . . . . . 0.418 ' HA ' ' HE ' ' C' ' 45' ' ' ARG . 0.1 OUTLIER -80.64 -19.43 45.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.114 -0.991 . . . . 0.0 110.506 -179.393 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -79.39 -32.22 42.99 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.631 -1.293 . . . . 0.0 109.109 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -92.31 103.47 15.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.437 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.55 -12.3 0.13 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.328 -0.857 . . . . 0.0 109.582 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -65.1 -156.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.187 -0.946 . . . . 0.0 109.304 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 60.6 p 45.91 76.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.956 -1.09 . . . . 0.0 109.656 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 10.8 mt -95.54 -27.68 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -59.4 -24.91 63.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.193 -0.942 . . . . 0.0 109.421 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -68.78 -37.19 79.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.421 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -72.2 -35.12 68.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 109.364 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -64.12 -56.51 14.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.792 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -65.11 -28.25 69.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.114 -0.991 . . . . 0.0 109.788 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -70.41 -43.74 69.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.431 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.86 -65.7 2.32 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 59' ' ' LEU . . . . . 0.45 ' C ' HD13 ' C' ' 59' ' ' LEU . 0.4 OUTLIER -63.67 95.28 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -1.189 . . . . 0.0 109.054 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.326 -179.831 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 24' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' D' ' 26' ' ' LEU . 27.8 t0 51.13 69.36 2.61 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.936 . . . . 0.0 109.394 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -47.32 -10.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.663 2.242 . . . . 0.0 112.134 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 26' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' D' ' 24' ' ' ASP . 35.2 tp -47.88 -47.03 32.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.244 -0.91 . . . . 0.0 108.902 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 42.3 t -68.66 -44.71 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.106 -0.996 . . . . 0.0 108.63 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 78.3 t -49.24 -49.44 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 108.687 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.44 77.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.379 -0.826 . . . . 0.0 109.236 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.12 -56.85 10.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.343 -0.848 . . . . 0.0 109.734 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.82 -37.12 65.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.162 -0.961 . . . . 0.0 109.763 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 17.2 mt -71.5 -41.95 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.42 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 27.6 mt -55.24 -35.32 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 108.69 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.47 -45.3 47.44 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 72.2 mt -60.99 -24.26 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.291 -1.123 . . . . 0.0 109.037 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 17.2 tp -76.16 -70.53 0.44 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.464 -0.772 . . . . 0.0 109.231 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 37' ' ' HIS . . . . . 0.404 ' HE2' ' CE1' ' A' ' 37' ' ' HIS . 2.0 t-80 -45.52 -33.38 2.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.873 . . . . 0.0 109.715 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 56.6 tp -68.19 -66.27 0.59 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.179 -0.951 . . . . 0.0 109.49 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mt -52.43 -28.23 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.842 . . . . 0.0 109.659 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 40' ' ' LEU . . . . . 0.742 HD22 ' NC ' ' D' ' 499' ' ' RIM . 2.1 mt -76.24 -59.24 2.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.84 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -45.97 -52.01 12.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.283 -0.886 . . . . 0.0 109.841 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 42' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' D' ' 45' ' ' ARG . 66.9 mt -60.46 -57.63 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.154 -0.966 . . . . 0.0 109.018 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 59.2 tp -43.89 -44.69 7.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.62 -0.675 . . . . 0.0 109.81 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 44' ' ' ASP . . . . . 0.517 ' CG ' HNC2 ' D' ' 499' ' ' RIM . 0.6 OUTLIER -67.46 -29.86 69.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.164 -0.96 . . . . 0.0 109.652 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 45' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' D' ' 42' ' ' ILE . 4.0 mmt180 -77.22 -17.43 58.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.2 -0.938 . . . . 0.0 110.208 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 mt -85.7 -17.13 36.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.82 -1.175 . . . . 0.0 109.236 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.35 -6.66 4.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.195 -0.941 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -71.41 70.97 0.64 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.52 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -96.65 -100.27 0.18 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.422 -0.799 . . . . 0.0 109.52 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 3.4 m -76.18 130.99 39.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 109.783 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 28.9 mt -93.37 -30.67 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.898 . . . . 0.0 109.318 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -25.68 61.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.925 . . . . 0.0 109.923 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 53' ' ' ARG . . . . . 0.426 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 12.5 mmt85 -63.6 -41.26 98.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.123 -0.986 . . . . 0.0 109.669 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -71.15 -41.39 70.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.151 -0.968 . . . . 0.0 109.435 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -58.84 -41.81 87.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.332 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -26.87 61.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.259 -0.901 . . . . 0.0 109.26 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 57' ' ' HIS . . . . . 0.426 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 2.5 m-70 -67.47 -39.65 85.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 108.905 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.82 -63.35 2.74 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.08 159.75 2.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.251 -1.146 . . . . 0.0 109.605 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 17.7 mttp . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.448 -179.967 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 199' ' ' RIM . . . . . 0.463 ' NC ' ' OD1' ' A' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 299' ' ' RIM . . . . . 0.498 HNC1 HG12 ' C' ' 42' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 399' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 499' ' ' RIM . . . . . 0.742 ' NC ' HD22 ' D' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 2.7 m-20 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.3 Cg_endo -55.78 -15.54 13.17 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.714 2.276 . . . . 0.0 111.978 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.8 tp -46.29 -44.42 16.58 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.319 -0.863 . . . . 0.0 109.169 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.8 t -68.6 -45.26 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.273 -0.892 . . . . 0.0 108.997 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -48.93 -49.02 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.184 -0.947 . . . . 0.0 109.057 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.09 -34.47 78.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 0.0 109.387 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.74 -57.25 8.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 0.0 109.805 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.57 -36.14 66.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.733 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.7 mt -71.7 -42.51 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.338 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.4 mt -55.73 -34.63 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.128 -0.982 . . . . 0.0 108.511 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.09 -45.17 32.95 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.1 mt -55.67 -36.21 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.165 -1.197 . . . . 0.0 109.179 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.5 -61.91 1.67 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.353 -0.842 . . . . 0.0 109.236 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -45.15 -39.9 6.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.416 -0.802 . . . . 0.0 110.061 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -66.23 -69.49 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.141 -0.974 . . . . 0.0 109.843 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.8 mt -48.19 -27.4 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 0.0 109.739 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.425 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 7.4 mt -72.24 -60.37 2.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.928 . . . . 0.0 109.945 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 40.7 t-105 -48.1 -48.53 33.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.055 -1.028 . . . . 0.0 109.784 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 45' ' ' ARG . 66.6 mt -63.28 -59.89 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.08 -1.013 . . . . 0.0 109.336 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.3 tp -44.27 -40.66 5.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.572 -0.705 . . . . 0.0 109.821 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 1.7 m-20 -69.75 -31.31 69.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -0.964 . . . . 0.0 109.217 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.5 ' NH1' ' OD2' ' D' ' 44' ' ' ASP . 0.4 OUTLIER -75.4 -16.05 60.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 110.181 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -90.04 -12.06 39.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.872 -1.142 . . . . 0.0 109.22 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.487 ' O ' ' N ' ' A' ' 49' ' ' LYS . 17.6 t80 -78.0 -60.73 2.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 109.306 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -50.23 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 109.066 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 47' ' ' PHE . 30.8 mtpt -91.65 -82.43 0.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.915 . . . . 0.0 109.634 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.1 m -87.35 170.07 11.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.635 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.3 mt -105.46 -21.66 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.569 -0.707 . . . . 0.0 109.626 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -55.02 -20.87 10.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.182 -0.949 . . . . 0.0 109.8 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.433 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 7.6 mmm180 -70.94 -42.59 69.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.062 -1.024 . . . . 0.0 109.553 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -66.79 -35.23 79.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.227 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -65.25 -48.85 71.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -0.866 . . . . 0.0 109.19 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -63.2 -29.18 70.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.348 -0.845 . . . . 0.0 109.526 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.433 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 18.5 m80 -66.2 -52.34 48.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.263 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.22 -60.89 7.8 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.46 ' O ' ' CB ' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -50.28 118.8 3.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.377 -1.072 . . . . 0.0 109.458 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 59' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.479 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.298 0.57 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.516 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 48.5 m-20 -157.72 51.23 0.46 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.472 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 13.0 Cg_endo -59.23 -12.02 14.92 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.759 2.306 . . . . 0.0 112.345 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 58.2 tp -47.98 -46.71 32.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 108.958 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.71 -44.93 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.113 -0.992 . . . . 0.0 108.774 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 71.2 t -48.97 -49.71 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 108.931 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.38 -32.87 74.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -0.837 . . . . 0.0 109.136 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.91 -58.08 6.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 0.0 109.66 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.77 -35.28 63.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 109.697 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 16.7 mt -73.29 -41.86 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 0.0 109.745 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.474 HD13 HG13 ' C' ' 35' ' ' ILE . 21.9 mt -55.86 -35.57 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.005 -1.059 . . . . 0.0 108.822 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.34 -44.18 43.55 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 48.6 mt -56.05 -33.07 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.226 -1.161 . . . . 0.0 109.204 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -65.19 0.79 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 109.1 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . 0.598 ' HE2' ' CE1' ' C' ' 37' ' ' HIS . 3.4 t-80 -45.43 -38.13 5.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.412 -0.805 . . . . 0.0 109.748 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 54.9 tp -66.38 -67.86 0.42 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 109.503 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.8 mt -48.91 -25.89 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 109.518 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mt -71.5 -64.07 0.99 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.851 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -46.11 -47.1 17.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 0.0 109.647 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 51.7 mt -63.27 -55.46 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.087 -1.008 . . . . 0.0 108.909 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 39.5 tp -47.13 -41.19 17.09 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.51 -0.744 . . . . 0.0 109.661 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' B' ' 44' ' ' ASP . 0.3 OUTLIER -69.79 -30.26 67.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.707 -179.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.97 -19.71 58.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.07 -1.018 . . . . 0.0 110.47 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -82.97 -8.46 59.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.631 -1.293 . . . . 0.0 108.973 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -138.11 106.93 5.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.525 -0.734 . . . . 0.0 109.569 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . 0.409 ' H ' ' H ' ' B' ' 49' ' ' LYS . 28.5 t80 -171.15 3.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.216 -0.928 . . . . 0.0 109.556 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.409 ' H ' ' H ' ' B' ' 48' ' ' PHE . 14.2 mtpp -71.89 -142.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.905 . . . . 0.0 109.302 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 20.8 m 51.54 75.74 0.19 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.166 -0.959 . . . . 0.0 109.568 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 50.9 mt -99.36 -31.21 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.463 -0.773 . . . . 0.0 109.385 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.494 ' CE2' ' NH1' ' B' ' 53' ' ' ARG . 0.1 OUTLIER -61.02 -32.93 72.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.0 109.781 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.494 ' NH1' ' CE2' ' B' ' 52' ' ' TYR . 19.5 mmt-85 -64.42 -33.84 76.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.085 -1.009 . . . . 0.0 109.42 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -75.3 -42.15 55.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.873 . . . . 0.0 109.17 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -58.34 -40.53 82.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.856 . . . . 0.0 109.55 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -72.78 -67.61 0.55 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . 0.45 ' ND1' ' O ' ' B' ' 57' ' ' HIS . 23.0 t-80 -41.22 -30.06 0.15 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.616 -0.678 . . . . 0.0 110.208 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.28 -70.25 1.31 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mt -66.35 82.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -1.113 . . . . 0.0 109.516 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 58.8 tttm . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.403 179.855 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 55.1 m . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' C' ' 26' ' ' LEU . 3.2 m-20 57.64 65.33 3.52 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 109.647 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -45.22 -11.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.921 2.414 . . . . 0.0 112.535 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' C' ' 24' ' ' ASP . 24.2 tp -47.74 -46.11 29.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 108.975 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 45.5 t -67.19 -45.32 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 108.769 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 71.5 t -50.3 -51.64 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.363 -0.836 . . . . 0.0 109.008 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.32 -32.58 73.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.502 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.8 -55.27 18.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.53 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.13 -37.51 69.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.843 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 23.1 mt -71.89 -42.81 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.072 -1.017 . . . . 0.0 109.602 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.25 -36.39 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 108.551 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.95 -45.04 64.76 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . 0.474 HG13 HD13 ' B' ' 33' ' ' ILE . 63.5 mt -59.6 -41.59 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.347 -1.09 . . . . 0.0 108.832 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.77 -68.01 0.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.368 -0.832 . . . . 0.0 109.292 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . 0.598 ' CE1' ' HE2' ' B' ' 37' ' ' HIS . 2.3 t-80 -44.17 -39.95 4.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.389 -0.82 . . . . 0.0 110.24 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.76 -67.89 0.38 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.985 -1.072 . . . . 0.0 109.196 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 mt -47.67 -40.66 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.344 -0.847 . . . . 0.0 109.423 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mt -61.64 -54.31 44.54 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.45 -0.781 . . . . 0.0 109.581 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -46.31 -58.19 3.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.418 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.19 -47.8 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.055 -1.028 . . . . 0.0 109.339 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 6.3 tp -52.56 -27.52 17.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.417 -0.802 . . . . 0.0 110.43 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -91.03 -34.03 15.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.071 -1.018 . . . . 0.0 109.426 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.55 ' O ' ' N ' ' C' ' 47' ' ' PHE . 14.6 mmm180 -84.67 4.32 33.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.343 -0.848 . . . . 0.0 110.403 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.476 ' C ' ' O ' ' C' ' 45' ' ' ARG . 34.8 mt -31.0 -34.95 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 CA-C-O 121.273 0.559 . . . . 0.0 110.299 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.55 ' N ' ' O ' ' C' ' 45' ' ' ARG . 0.2 OUTLIER 68.2 102.04 0.05 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.714 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -104.16 162.67 12.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.557 -0.714 . . . . 0.0 109.211 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' C' ' 50' ' ' SER . 20.4 tptt -92.37 -150.14 0.26 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.168 -0.958 . . . . 0.0 109.767 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . 0.412 ' O ' ' O ' ' C' ' 49' ' ' LYS . 8.2 m 47.06 92.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 109.843 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 mt -92.65 -31.61 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.213 -0.93 . . . . 0.0 109.446 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . 0.463 ' CD2' ' N ' ' C' ' 53' ' ' ARG . 50.9 p90 -48.45 -44.26 35.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.382 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . 0.463 ' N ' ' CD2' ' C' ' 52' ' ' TYR . 3.7 mtp85 -46.73 -50.52 17.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.306 -0.871 . . . . 0.0 109.954 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -61.7 -41.5 97.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.112 -0.993 . . . . 0.0 109.76 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -60.79 -35.57 76.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 109.266 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -73.52 -37.62 65.58 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.275 -0.891 . . . . 0.0 109.239 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -41.22 94.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.914 . . . . 0.0 109.189 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.42 -62.43 4.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 57.6 mt -85.24 -147.99 0.11 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -1.125 . . . . 0.0 109.316 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.442 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.95 161.38 77.8 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.339 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -65.1 -21.52 62.84 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.511 2.14 . . . . 0.0 112.097 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 54.2 tp -46.8 -43.87 18.74 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -69.76 -43.23 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.329 -0.857 . . . . 0.0 108.803 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 70.4 t -51.04 -48.55 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.069 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.35 -33.91 76.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 0.0 109.26 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.35 -57.02 9.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 109.674 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -56.1 -35.99 67.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.746 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 12.3 mt -71.69 -41.41 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.208 -0.933 . . . . 0.0 109.352 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -56.64 -35.17 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.942 . . . . 0.0 108.796 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.79 -43.67 50.1 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 57.2 mt -59.17 -30.34 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.333 -1.098 . . . . 0.0 109.478 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.75 -67.5 0.63 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -0.944 . . . . 0.0 109.405 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -44.11 -35.71 2.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.23 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 45.8 tp -71.42 -63.13 1.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.031 -1.043 . . . . 0.0 109.803 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.7 mt -50.93 -34.38 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.96 . . . . 0.0 109.599 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' D' ' 43' ' ' LEU . 1.2 mt -67.17 -64.81 0.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.36 -0.838 . . . . 0.0 110.273 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -44.76 -48.61 10.84 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.398 -0.814 . . . . 0.0 109.682 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 93.3 mt -59.63 -37.52 71.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 108.601 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' D' ' 40' ' ' LEU . 0.1 OUTLIER -57.7 -43.38 85.14 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.488 -0.757 . . . . 0.0 109.36 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . 0.5 ' OD2' ' NH1' ' A' ' 45' ' ' ARG . 7.0 m-20 -71.71 -26.82 62.65 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.381 -0.825 . . . . 0.0 110.182 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -28.36 58.31 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.829 -1.169 . . . . 0.0 110.981 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' D' ' 48' ' ' PHE . 7.7 mt -58.4 -12.31 3.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.525 -1.359 . . . . 0.0 109.179 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -73.95 17.09 0.18 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.14 -0.975 . . . . 0.0 109.114 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . 0.478 ' H ' ' C ' ' D' ' 46' ' ' LEU . 0.4 OUTLIER -46.66 155.2 0.26 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 109.56 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 15.8 tttm 64.23 -146.45 0.29 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 73.3 m 47.96 59.44 4.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 38.8 mt -95.06 -29.59 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.347 -0.846 . . . . 0.0 109.39 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -37.94 74.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.545 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . 0.472 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 5.9 mtm180 -61.51 -36.63 81.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.247 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -69.99 -37.92 75.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 0.0 109.258 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -63.39 -53.79 46.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 109.677 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -62.61 -29.13 70.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.748 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . 0.472 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 1.4 m-70 -67.48 -45.14 76.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 109.431 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.29 -60.71 6.78 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.1 -166.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -1.15 . . . . 0.0 109.712 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 61.1 tttm . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.923 -1.036 . . . . 0.0 109.669 -179.969 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.419 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 5.5 p-10 . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 120.889 0.376 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 11.2 Cg_endo -58.02 -17.87 33.17 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.509 2.139 . . . . 0.0 112.269 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.8 tp -47.2 -45.02 22.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.189 -0.945 . . . . 0.0 108.826 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.98 -44.52 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.241 -0.912 . . . . 0.0 108.802 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -49.86 -50.25 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.163 -0.96 . . . . 0.0 109.068 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.54 -33.69 76.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.322 -0.861 . . . . 0.0 109.514 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.57 -56.78 8.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 109.784 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 m -55.55 -34.65 64.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.705 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.4 mt -74.81 -43.7 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.118 -0.989 . . . . 0.0 109.725 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.8 mt -54.02 -35.91 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.021 -1.05 . . . . 0.0 108.618 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.06 -45.43 41.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.7 mt -57.65 -37.27 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.192 -1.181 . . . . 0.0 108.907 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.15 -68.74 0.33 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -0.85 . . . . 0.0 109.373 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -43.19 -42.26 4.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.431 -0.793 . . . . 0.0 110.263 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.7 tp -61.05 -67.66 0.38 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.106 -0.996 . . . . 0.0 109.569 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 mt -49.15 -44.1 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 109.513 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt -55.77 -58.39 8.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 109.987 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -46.43 -59.1 3.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.322 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.467 ' O ' ' N ' ' A' ' 45' ' ' ARG . 48.0 mt -51.17 -52.44 18.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.276 -0.89 . . . . 0.0 108.978 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 42' ' ' ILE . 0.1 OUTLIER -41.89 -57.21 2.47 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.426 0.631 . . . . 0.0 109.503 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -59.15 -27.7 65.89 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.328 -0.858 . . . . 0.0 109.624 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.467 ' N ' ' O ' ' A' ' 42' ' ' ILE . 2.7 mmp_? -81.52 -13.82 57.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.071 -1.018 . . . . 0.0 110.714 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 mt -88.65 -18.88 27.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.652 -1.28 . . . . 0.0 109.198 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.48 ' O ' ' CB ' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -141.79 166.29 25.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.301 -0.875 . . . . 0.0 109.518 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.48 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 2.4 t80 75.96 97.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.57 -0.706 . . . . 0.0 109.539 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 50' ' ' SER . 10.1 tttp -150.23 -135.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.109 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 49' ' ' LYS . 0.9 OUTLIER 68.14 117.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.957 . . . . 0.0 109.51 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 mt -97.69 -29.25 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 109.625 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.485 ' CG ' ' N ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -57.32 -38.82 74.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.97 . . . . 0.0 109.44 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.485 ' N ' ' CG ' ' A' ' 52' ' ' TYR . 1.4 mtt180 -57.65 -37.21 72.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.044 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -70.67 -39.98 73.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.844 . . . . 0.0 109.233 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -65.55 -34.08 77.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.125 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -75.02 -31.66 61.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.824 . . . . 0.0 109.613 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -68.92 -37.93 79.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.256 -0.902 . . . . 0.0 109.152 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.63 -64.41 2.6 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.7 mt -75.78 150.95 37.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -1.112 . . . . 0.0 109.538 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.449 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.265 0.555 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.15 160.67 39.18 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 109.271 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' B' ' 26' ' ' LEU . 18.7 Cg_endo -63.16 -24.5 72.8 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.557 2.171 . . . . 0.0 112.165 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' B' ' 25' ' ' PRO . 56.9 tp -45.63 -40.89 9.55 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 52.3 t -70.98 -44.75 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.345 -0.847 . . . . 0.0 108.809 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 74.4 t -49.54 -48.71 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 108.953 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.55 -34.73 78.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.362 -0.836 . . . . 0.0 109.223 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.26 -56.75 12.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 109.665 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.04 -36.71 68.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 109.966 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 29.8 mt -72.05 -40.06 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.095 -1.003 . . . . 0.0 109.686 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 30.6 mt -58.05 -35.23 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.013 -1.054 . . . . 0.0 108.751 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.14 -44.0 45.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 55.9 mt -57.8 -35.83 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.288 -1.125 . . . . 0.0 109.162 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.44 -65.96 0.61 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.279 -0.888 . . . . 0.0 109.056 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -45.5 -39.18 7.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.46 -0.775 . . . . 0.0 109.895 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.79 -69.3 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 0.0 109.786 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.4 mt -51.21 -23.84 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.113 -0.992 . . . . 0.0 109.269 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.494 ' C ' HD23 ' B' ' 40' ' ' LEU . 2.6 tt -68.67 -63.86 0.98 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.36 -0.837 . . . . 0.0 110.005 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 -52.34 -46.63 66.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.989 . . . . 0.0 109.907 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.95 -55.21 26.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.032 -1.042 . . . . 0.0 108.841 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 52.9 tp -46.8 -40.99 14.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.536 -0.728 . . . . 0.0 109.932 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.3 -25.32 61.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 109.865 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.6 -17.72 43.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.912 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -81.06 -27.78 35.57 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.631 -1.293 . . . . 0.0 109.338 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -147.46 116.93 7.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.223 -0.923 . . . . 0.0 109.668 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . 0.444 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 79.7 t80 -173.41 82.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 109.391 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -141.8 -129.97 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.43 -0.794 . . . . 0.0 109.176 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 7.4 t 49.57 84.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.419 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 27.5 mt -97.9 -26.78 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.272 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.574 ' CG ' ' N ' ' B' ' 53' ' ' ARG . 2.8 p90 -53.09 -40.26 63.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.453 -0.779 . . . . 0.0 110.362 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.574 ' N ' ' CG ' ' B' ' 52' ' ' TYR . 0.0 OUTLIER -64.91 -29.49 70.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.931 -1.106 . . . . 0.0 109.909 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -74.57 -41.44 60.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.143 -0.973 . . . . 0.0 109.414 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.44 -50.74 66.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.195 -0.941 . . . . 0.0 108.963 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.53 -32.56 71.6 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.303 -0.873 . . . . 0.0 109.12 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -61.37 -59.46 5.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.114 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.65 -58.07 12.33 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 56.4 mt -78.0 69.48 4.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.357 -1.084 . . . . 0.0 109.246 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.9 tptp . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.563 -179.811 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 37.6 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.313 0.578 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' C' ' 26' ' ' LEU . 2.0 m-20 48.81 64.81 8.02 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.754 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -46.06 -8.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.738 2.292 . . . . 0.0 112.435 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' C' ' 24' ' ' ASP . 39.0 tp -47.41 -45.91 25.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.163 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 32.8 t -67.84 -45.83 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 108.616 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -49.32 -49.26 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 109.013 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.01 -34.67 78.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.26 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.24 -55.53 15.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 109.701 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.86 -36.67 67.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.724 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 mt -72.34 -42.02 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 109.406 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.7 mt -54.76 -34.69 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.09 -1.006 . . . . 0.0 108.64 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.23 -44.28 23.19 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 59.9 mt -57.19 -32.38 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.184 -1.186 . . . . 0.0 108.971 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -71.27 -65.56 0.73 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 108.812 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -46.16 -38.24 7.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.815 . . . . 0.0 109.678 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.4 -69.95 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.216 -0.927 . . . . 0.0 109.696 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 15.7 mt -47.4 -25.45 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.16 -0.963 . . . . 0.0 109.398 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 5.9 mt -71.98 -61.05 1.93 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.482 -0.761 . . . . 0.0 109.755 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -47.79 -48.18 30.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.978 . . . . 0.0 109.61 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' C' ' 45' ' ' ARG . 53.4 mt -61.6 -59.8 3.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.193 -0.942 . . . . 0.0 108.826 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.4 tp -43.51 -44.6 6.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.756 -0.59 . . . . 0.0 109.913 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' C' ' 44' ' ' ASP . 0.7 OUTLIER -68.13 -27.25 66.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.22 -0.925 . . . . 0.0 109.64 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.464 ' N ' ' O ' ' C' ' 42' ' ' ILE . 14.0 mmt180 -82.6 -15.54 51.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.171 -0.955 . . . . 0.0 110.559 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 mt -86.58 -11.28 51.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.736 -1.227 . . . . 0.0 109.247 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -59.07 94.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.942 . . . . 0.0 109.156 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.51 ' O ' ' CG ' ' C' ' 48' ' ' PHE . 0.1 OUTLIER -162.89 6.99 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -50.57 -31.36 15.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 3.1 p -164.41 131.95 3.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 5.1 mt -82.18 -22.77 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 108.996 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -45.8 -39.72 8.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 0.0 109.96 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -53.01 -48.57 67.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.117 -0.989 . . . . 0.0 110.171 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' D' ' 51' ' ' ILE . 10.1 m-85 -62.37 -40.48 96.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.095 -1.003 . . . . 0.0 109.562 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -60.19 -58.39 8.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.851 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -57.0 -37.19 71.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -48.04 82.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.063 -1.023 . . . . 0.0 109.748 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.4 -59.54 9.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 6.9 mt -75.63 87.68 2.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -1.163 . . . . 0.0 109.4 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.46 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' D' ' 26' ' ' LEU . 15.4 m-20 51.15 66.68 5.08 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.393 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -46.16 -10.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.754 2.303 . . . . 0.0 112.092 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' D' ' 24' ' ' ASP . 44.9 tp -47.58 -47.6 28.42 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.223 -0.923 . . . . 0.0 109.016 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.27 -44.79 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 108.73 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -48.58 -49.5 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 108.904 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.26 -37.14 86.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.507 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -57.1 10.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.231 -0.918 . . . . 0.0 109.916 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.4 -36.72 64.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.224 -0.923 . . . . 0.0 109.81 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 26.9 mt -72.54 -41.69 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.166 -0.958 . . . . 0.0 109.453 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -55.92 -36.98 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 108.702 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.11 -45.16 57.71 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 47.2 mt -56.05 -38.88 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.204 -1.174 . . . . 0.0 109.286 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.72 -61.78 1.72 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -0.866 . . . . 0.0 109.137 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -46.57 -44.02 17.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.61 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.0 tp -60.07 -69.18 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mt -46.95 -25.25 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.891 . . . . 0.0 109.403 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . 0.444 ' CD2' ' OD2' ' D' ' 44' ' ' ASP . 1.5 tt -69.96 -64.12 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.895 . . . . 0.0 109.716 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 19.0 t-105 -47.26 -49.06 24.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 109.523 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 36.2 mt -61.16 -50.93 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.176 -0.953 . . . . 0.0 109.228 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 53.2 tp -50.88 -37.7 45.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.835 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . 0.444 ' OD2' ' CD2' ' D' ' 40' ' ' LEU . 73.2 m-20 -75.9 -28.41 58.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 109.625 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -71.56 -27.02 62.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.951 . . . . 0.0 110.569 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.4 mt -71.27 -16.08 62.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.69 -1.256 . . . . 0.0 109.112 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -82.92 -7.55 59.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.248 -0.908 . . . . 0.0 108.935 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . 0.445 ' O ' ' CB ' ' D' ' 49' ' ' LYS . 0.9 OUTLIER -87.7 -153.86 0.24 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.405 -0.809 . . . . 0.0 109.737 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' D' ' 48' ' ' PHE . 5.9 ttpt 74.14 -62.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.365 -0.834 . . . . 0.0 109.593 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.85 106.42 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.196 -0.94 . . . . 0.0 109.594 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' C' ' 54' ' ' PHE . 4.0 mt -87.78 -23.3 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.574 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . 0.468 ' CD1' ' C ' ' D' ' 52' ' ' TYR . 0.0 OUTLIER -62.79 -49.25 75.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.145 -0.972 . . . . 0.0 110.181 -179.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . 0.419 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 0.7 OUTLIER -71.6 -28.48 63.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.536 -1.353 . . . . 0.0 110.19 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -75.66 -54.91 6.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.086 -1.009 . . . . 0.0 111.089 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.1 OUTLIER -75.58 -18.29 59.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.957 -1.089 . . . . 0.0 110.583 -178.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . 0.526 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 2.2 tm-20 -84.5 -33.7 23.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.856 -1.152 . . . . 0.0 108.063 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . 0.419 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 0.5 OUTLIER -69.0 -38.6 79.36 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' D' ' 60' ' ' LYS . . . -69.78 -61.5 4.34 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.1 77.61 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -1.159 . . . . 0.0 109.556 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' D' ' 58' ' ' GLY . 50.9 tttt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.479 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 26' ' ' LEU . 8.6 m-20 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -45.82 -11.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.778 2.319 . . . . 0.0 112.27 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 24' ' ' ASP . 37.2 tp -46.65 -46.31 19.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.234 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.6 t -68.51 -44.78 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 108.974 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -49.15 -49.39 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 0.0 109.08 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.83 -35.04 79.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 109.355 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.41 -56.98 10.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.69 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.95 -36.98 68.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.194 -0.941 . . . . 0.0 109.866 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.8 mt -71.01 -40.91 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.107 -0.996 . . . . 0.0 109.441 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.9 mt -57.02 -36.05 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.141 -0.974 . . . . 0.0 108.59 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.29 -44.1 53.34 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.5 mt -61.81 -27.02 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.165 -1.197 . . . . 0.0 109.155 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.99 -66.6 0.65 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.333 -0.854 . . . . 0.0 109.441 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.31 -39.31 6.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 109.841 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.67 -69.0 0.3 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.419 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.5 mt -47.1 -34.34 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.514 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 mt -62.87 -55.8 22.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.464 -0.773 . . . . 0.0 109.943 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -52.03 -45.01 64.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mt -68.76 -28.29 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.108 -0.995 . . . . 0.0 109.279 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -61.69 -44.26 97.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.563 -179.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.507 ' OD1' ' NH2' ' B' ' 45' ' ' ARG . 2.6 m-20 -80.19 -24.45 40.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 109.97 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -93.31 0.97 57.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.122 -0.987 . . . . 0.0 111.25 -179.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.48 ' C ' ' O ' ' A' ' 45' ' ' ARG . 31.0 mt -31.3 -36.27 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.693 -0.63 . . . . 0.0 110.814 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.524 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 169.15 -10.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 109.267 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -46.21 103.8 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.383 -0.823 . . . . 0.0 109.42 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' CG ' ' H ' ' A' ' 50' ' ' SER . 12.6 tptm -145.44 -129.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.905 . . . . 0.0 109.713 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.428 ' H ' ' CG ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER 65.36 135.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.282 -0.886 . . . . 0.0 109.229 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.1 mt -102.17 -35.26 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.525 -0.735 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -35.39 69.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.612 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -64.24 -41.12 97.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 0.0 109.369 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -65.34 -29.11 69.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.434 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -75.34 -68.42 0.56 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.098 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -46.83 -31.27 2.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.243 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -69.85 -58.77 3.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.314 -0.866 . . . . 0.0 109.566 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.19 -60.45 9.0 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.08 97.17 1.44 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -1.1 . . . . 0.0 109.356 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.4 mttp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.511 -179.888 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 30.3 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' B' ' 26' ' ' LEU . 4.8 m-20 48.82 67.28 4.66 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.449 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -47.22 -9.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.763 2.309 . . . . 0.0 112.311 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' B' ' 24' ' ' ASP . 39.1 tp -47.22 -44.76 22.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.944 . . . . 0.0 108.871 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 38.7 t -68.66 -44.88 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 108.758 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.5 t -49.7 -50.62 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 109.176 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.39 -34.82 78.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 109.391 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.76 -55.99 14.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 109.685 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.72 -36.85 67.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 109.873 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 18.9 mt -72.42 -42.4 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.553 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 mt -55.85 -34.65 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.054 -1.029 . . . . 0.0 108.826 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.33 -43.89 36.55 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 67.7 mt -60.25 -26.29 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.243 -1.151 . . . . 0.0 109.234 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.58 -64.49 1.06 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.267 -0.896 . . . . 0.0 109.263 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -45.5 -43.56 11.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.4 tp -63.15 -64.57 0.87 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.311 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 8.2 mt -47.78 -28.36 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.471 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.2 mt -67.44 -55.86 11.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 110.141 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -55.67 -39.72 71.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.944 . . . . 0.0 109.937 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 94.5 mt -70.58 -40.57 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.954 -1.091 . . . . 0.0 108.959 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 50.3 tp -57.51 -41.33 80.61 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.516 -0.74 . . . . 0.0 109.767 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.3 -23.73 43.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.154 -0.966 . . . . 0.0 109.84 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.507 ' NH2' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -89.01 -4.74 58.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.044 -1.035 . . . . 0.0 110.902 -179.19 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.497 ' C ' ' O ' ' B' ' 45' ' ' ARG . 28.0 mt -33.56 -35.9 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.693 -0.629 . . . . 0.0 110.166 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' B' ' 45' ' ' ARG . 3.3 t80 -172.59 136.08 0.73 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.943 . . . . 0.0 109.326 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . 0.413 ' CD2' ' O ' ' B' ' 47' ' ' PHE . 0.7 OUTLIER -167.85 98.58 0.46 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.216 -0.928 . . . . 0.0 109.43 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -141.79 -35.73 0.44 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 109.424 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 11.9 p -65.65 124.71 23.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.291 -0.88 . . . . 0.0 109.531 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 15.8 mt -111.39 -22.67 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.671 -0.643 . . . . 0.0 109.347 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -54.03 -21.43 8.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.663 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -69.87 -45.9 66.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.437 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -65.09 -34.4 78.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.476 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -65.65 -60.24 3.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 109.458 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -52.71 -30.96 35.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.459 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -62.63 -63.42 1.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 109.315 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.33 -59.29 9.77 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mt -50.77 143.96 9.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.358 -1.084 . . . . 0.0 109.683 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.5 mttm . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.33 179.854 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 50.9 p . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' C' ' 24' ' ' ASP . 1.7 p-10 -171.11 70.24 0.51 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.393 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.53 -9.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.814 2.343 . . . . 0.0 112.402 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' C' ' 24' ' ' ASP . 48.3 tp -47.76 -46.97 30.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.189 -0.944 . . . . 0.0 109.033 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.78 -45.47 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.238 -0.914 . . . . 0.0 108.759 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -48.46 -46.48 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 0.0 109.139 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.93 -36.87 83.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -0.929 . . . . 0.0 109.46 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.36 -55.13 27.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 109.388 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.08 -36.2 67.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.392 -0.818 . . . . 0.0 109.894 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 18.4 mt -72.98 -41.57 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.109 -0.994 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 21.1 mt -56.78 -34.79 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.074 -1.016 . . . . 0.0 108.614 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.11 -45.17 42.03 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 54.4 mt -57.13 -31.81 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.21 -1.171 . . . . 0.0 108.869 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.98 -64.62 0.87 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.456 -0.778 . . . . 0.0 109.055 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -46.25 -39.08 9.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.876 . . . . 0.0 109.72 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -63.09 -70.13 0.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.956 . . . . 0.0 109.545 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 3.9 mt -47.14 -37.92 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.319 -0.863 . . . . 0.0 109.401 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mt -61.42 -61.79 2.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.343 -0.848 . . . . 0.0 110.101 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -45.85 -49.48 15.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.366 -0.834 . . . . 0.0 109.578 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 64.7 mt -60.57 -44.44 96.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.166 -0.959 . . . . 0.0 108.9 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' C' ' 43' ' ' LEU . 0.1 OUTLIER -48.36 -55.28 11.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.536 -0.727 . . . . 0.0 109.583 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -64.4 -27.71 69.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 110.316 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -72.11 -25.25 61.67 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.861 -1.149 . . . . 0.0 110.798 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 47' ' ' PHE . 9.7 mt -68.95 -8.78 47.71 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.669 -1.27 . . . . 0.0 109.289 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' C' ' 49' ' ' LYS . 2.9 m-85 -47.23 -92.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -0.93 . . . . 0.0 109.35 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 46.09 19.63 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.762 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' C' ' 47' ' ' PHE . 16.4 mtpt -64.01 -148.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.153 -0.967 . . . . 0.0 109.483 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.7 162.83 14.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.174 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 13.4 mt -103.93 -22.76 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.536 -0.728 . . . . 0.0 109.442 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' C' ' 52' ' ' TYR . 6.5 t80 -63.55 -22.05 66.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.265 -0.897 . . . . 0.0 109.982 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -66.33 -46.99 74.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.072 -1.017 . . . . 0.0 110.0 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -66.02 -33.68 76.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 0.0 109.691 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -63.17 -58.65 6.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.378 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -57.14 -30.0 64.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 109.157 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -67.28 -45.83 75.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.298 -0.876 . . . . 0.0 109.127 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.25 -61.89 5.36 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 mt -48.7 140.08 8.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -1.153 . . . . 0.0 109.494 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.474 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.286 0.565 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.37 160.11 0.38 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.328 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' D' ' 26' ' ' LEU . 19.5 Cg_endo -61.83 -24.42 77.24 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.567 2.178 . . . . 0.0 112.206 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' D' ' 25' ' ' PRO . 56.2 tp -45.59 -41.02 9.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 108.775 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 33.5 t -70.26 -45.27 76.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.303 -0.873 . . . . 0.0 108.697 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 74.1 t -49.76 -49.1 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 108.95 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.37 -33.47 76.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.307 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.23 -56.17 14.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.663 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -37.12 69.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.228 -0.92 . . . . 0.0 109.858 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 20.6 mt -71.36 -41.67 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.076 -1.015 . . . . 0.0 109.426 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 17.3 mt -56.48 -33.94 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.071 -1.018 . . . . 0.0 108.566 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.58 -44.55 32.38 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 61.9 mt -58.41 -29.66 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.343 -1.092 . . . . 0.0 109.218 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.13 -67.07 0.6 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.0 109.097 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -46.82 -37.29 8.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 0.0 109.732 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 59.4 tp -65.09 -69.2 0.31 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.133 -0.98 . . . . 0.0 109.507 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.1 mt -49.2 -26.51 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.483 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . 0.488 HD23 ' C ' ' D' ' 40' ' ' LEU . 2.3 tt -67.64 -63.03 1.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.924 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . 0.507 ' CH2' ' NE ' ' D' ' 45' ' ' ARG . 24.7 t-105 -53.04 -43.87 66.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.984 -1.072 . . . . 0.0 109.666 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.75 -51.2 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.152 -0.967 . . . . 0.0 108.782 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 58.1 tp -50.06 -39.73 43.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.608 -0.683 . . . . 0.0 109.931 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.79 -24.43 55.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 109.911 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.507 ' NE ' ' CH2' ' D' ' 41' ' ' TRP . 0.6 OUTLIER -76.08 -25.24 55.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.106 -0.996 . . . . 0.0 110.21 -179.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -73.13 -28.88 62.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.796 -1.19 . . . . 0.0 109.338 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . 0.455 ' O ' ' CB ' ' D' ' 48' ' ' PHE . 7.5 m-85 -66.19 -170.4 0.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . 0.455 ' CB ' ' O ' ' D' ' 47' ' ' PHE . 2.4 t80 73.61 18.5 3.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . 0.485 ' CG ' ' H ' ' D' ' 50' ' ' SER . 0.0 OUTLIER -58.47 -97.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -0.869 . . . . 0.0 109.409 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.51 ' OG ' ' CZ ' ' D' ' 52' ' ' TYR . 1.1 t -57.76 139.52 53.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.44 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 19.8 mt -109.59 -26.83 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.661 -0.65 . . . . 0.0 109.522 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . 0.51 ' CZ ' ' OG ' ' D' ' 50' ' ' SER . 17.8 p90 -59.99 -43.82 94.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.93 . . . . 0.0 109.721 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . 0.407 ' N ' ' CD2' ' D' ' 52' ' ' TYR . 10.1 mtp85 -64.39 -35.93 82.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.089 -1.007 . . . . 0.0 109.339 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -63.48 -33.74 76.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.878 . . . . 0.0 109.334 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -71.21 -56.59 5.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -0.84 . . . . 0.0 109.215 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -51.56 -29.31 16.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.221 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -69.34 -55.79 9.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.913 . . . . 0.0 109.235 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -48.07 -57.17 8.16 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.73 121.6 13.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.345 -1.091 . . . . 0.0 109.445 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 23.6 tttt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.486 -179.981 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.532 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 5.1 m-20 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 12.8 Cg_endo -59.01 -12.67 16.09 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.744 2.296 . . . . 0.0 112.121 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.2 tp -47.22 -46.85 24.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 0.0 108.959 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.2 t -68.9 -44.74 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.34 -0.85 . . . . 0.0 108.792 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.3 t -49.36 -49.33 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.0 108.815 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.82 -33.39 75.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.374 -0.829 . . . . 0.0 109.35 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.52 -56.8 10.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.3 -0.875 . . . . 0.0 109.677 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.98 -37.34 68.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 109.891 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 27.7 mt -71.59 -41.36 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.136 -0.977 . . . . 0.0 109.474 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.1 mt -55.67 -34.79 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.175 -0.953 . . . . 0.0 108.458 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.26 -44.96 32.69 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.2 mt -56.84 -34.07 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.175 -1.191 . . . . 0.0 109.248 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.96 -63.61 1.03 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 109.086 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.96 -38.39 7.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.475 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.71 -70.97 0.2 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.872 . . . . 0.0 109.392 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 mt -46.79 -25.52 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.278 -0.889 . . . . 0.0 109.505 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -74.24 -55.5 5.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.704 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.5 t-105 -50.84 -48.52 59.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.96 . . . . 0.0 109.613 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mt -65.78 -57.53 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.291 -0.881 . . . . 0.0 109.398 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.6 tp -48.78 -27.95 3.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.541 -0.725 . . . . 0.0 110.525 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.484 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 2.3 m-20 -90.3 -26.97 19.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.012 -1.055 . . . . 0.0 109.961 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -73.12 -26.12 61.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.628 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 48' ' ' PHE . 9.0 mt -64.91 -9.81 24.06 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.795 -1.191 . . . . 0.0 109.552 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -66.82 76.61 0.12 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.1 -1.0 . . . . 0.0 109.514 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -156.9 21.01 0.32 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -126.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.54 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.0 m -48.55 125.91 10.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 0.0 109.421 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.3 mt -94.62 -24.86 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.817 . . . . 0.0 109.428 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.505 ' CD2' ' OE1' ' A' ' 56' ' ' GLU . 0.5 OUTLIER -60.6 -23.23 64.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.878 . . . . 0.0 109.592 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.457 ' O ' ' CG ' ' A' ' 57' ' ' HIS . 21.3 mtt180 -70.36 -37.47 74.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.088 -1.008 . . . . 0.0 109.665 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -71.93 -36.52 69.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.154 -0.966 . . . . 0.0 109.298 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -65.62 -46.42 79.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 0.0 109.793 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.505 ' OE1' ' CD2' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -70.56 -28.16 64.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.245 -0.909 . . . . 0.0 109.708 -179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.457 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 1.9 m-70 -67.28 -46.32 73.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 109.196 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.86 -65.16 2.56 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mt -59.1 145.34 42.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -1.136 . . . . 0.0 109.492 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.457 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.561 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 28.9 m-20 -152.21 48.5 0.47 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 109.612 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 10.5 Cg_endo -56.52 -15.06 14.45 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.794 2.33 . . . . 0.0 112.235 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' B' ' 26' ' ' LEU . 29.6 tp -46.5 -46.1 18.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.247 -0.908 . . . . 0.0 109.096 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.53 -44.39 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.231 -0.918 . . . . 0.0 108.967 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 74.5 t -50.73 -50.22 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.302 -0.874 . . . . 0.0 109.089 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.42 -36.56 82.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.53 -56.08 16.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.336 -0.852 . . . . 0.0 109.806 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.22 -36.77 66.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 109.707 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.19 -40.33 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.108 -0.995 . . . . 0.0 109.613 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.45 HD13 HG13 ' C' ' 35' ' ' ILE . 17.1 mt -56.8 -36.0 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.019 -1.051 . . . . 0.0 108.803 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.63 -43.29 44.33 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 86.2 mt -63.11 -21.27 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.35 -1.088 . . . . 0.0 108.908 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.55 -69.77 0.54 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.838 . . . . 0.0 109.218 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -46.55 -33.69 4.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.332 -0.855 . . . . 0.0 109.453 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.7 tp -68.11 -68.76 0.36 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.358 -0.839 . . . . 0.0 109.446 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -48.64 -33.33 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -0.925 . . . . 0.0 109.433 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.461 HD23 ' O ' ' B' ' 40' ' ' LEU . 2.1 tt -64.32 -54.74 28.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 109.444 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -48.83 -48.04 41.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.3 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 11.5 mt -66.27 -33.12 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.119 -0.988 . . . . 0.0 108.802 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -58.88 -34.5 71.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.507 -0.746 . . . . 0.0 110.316 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -87.71 -27.26 22.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.971 -1.081 . . . . 0.0 109.614 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -91.63 3.46 54.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 110.649 -179.481 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.481 ' C ' ' O ' ' B' ' 45' ' ' ARG . 34.1 mt -29.35 -37.02 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.976 -0.453 . . . . 0.0 110.915 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' B' ' 45' ' ' ARG . 0.4 OUTLIER -177.92 165.01 1.96 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.995 -1.066 . . . . 0.0 109.7 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -163.99 110.43 1.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.814 . . . . 0.0 109.432 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.586 ' N ' ' CD ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -144.02 -18.48 0.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.375 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.4 97.22 10.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.214 -0.929 . . . . 0.0 109.35 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 5.8 mt -93.33 -23.84 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.255 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -34.94 74.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.588 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 12.3 mtp180 -64.66 -32.58 74.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.869 . . . . 0.0 109.395 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -72.69 -42.63 64.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -0.892 . . . . 0.0 109.27 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -60.48 -39.7 88.61 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.385 -0.822 . . . . 0.0 109.015 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -71.77 -30.87 66.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.408 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -65.18 -48.95 71.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.27 -0.894 . . . . 0.0 109.066 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.9 -62.34 5.32 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 3.9 mt -58.98 138.08 57.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.353 -1.087 . . . . 0.0 109.272 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 16.0 tttm . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.52 -179.896 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.324 0.583 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 10.8 t0 -167.6 48.77 0.16 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.9 . . . . 0.0 109.197 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 2.9 Cg_endo -44.98 -19.77 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.778 2.319 . . . . 0.0 112.011 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 32.3 tp -45.85 -40.73 10.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.404 -0.81 . . . . 0.0 109.172 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.44 -45.19 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.866 . . . . 0.0 108.959 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 70.8 t -51.18 -49.88 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 108.973 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.89 -32.99 74.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.839 . . . . 0.0 109.249 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.36 -55.88 13.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.865 . . . . 0.0 109.47 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.93 -36.47 70.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.352 -0.843 . . . . 0.0 109.672 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 15.4 mt -71.45 -40.23 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.159 -0.963 . . . . 0.0 109.402 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.4 mt -58.03 -35.69 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.139 -0.976 . . . . 0.0 108.665 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.42 -43.23 62.57 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . 0.45 HG13 HD13 ' B' ' 33' ' ' ILE . 79.5 mt -63.76 -28.87 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.415 -1.05 . . . . 0.0 109.006 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.94 -58.86 4.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.412 -0.805 . . . . 0.0 108.98 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -54.36 -42.76 70.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.397 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 59.2 tp -58.81 -62.79 1.61 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.131 -0.98 . . . . 0.0 109.319 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mt -51.61 -40.98 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.215 -0.928 . . . . 0.0 109.495 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 2.6 mt -60.86 -54.43 45.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.403 -0.81 . . . . 0.0 110.05 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -52.21 -44.61 64.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.366 -0.834 . . . . 0.0 109.813 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 36.4 mt -70.48 -28.17 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.236 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.82 -43.5 98.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.644 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.31 -24.6 32.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.111 -0.993 . . . . 0.0 109.688 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' C' ' 47' ' ' PHE . 1.6 mmt85 -89.42 -1.18 57.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.3 -0.875 . . . . 0.0 110.753 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.491 ' C ' ' O ' ' C' ' 45' ' ' ARG . 29.0 mt -31.16 -36.23 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.851 -0.531 . . . . 0.0 110.805 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' C' ' 45' ' ' ARG . 2.3 m-85 -169.16 85.22 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.116 -0.99 . . . . 0.0 109.801 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 46.32 -132.87 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 109.686 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -170.07 -140.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.88 . . . . 0.0 109.256 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . 0.441 ' O ' ' CZ ' ' C' ' 54' ' ' PHE . 40.5 t -147.9 120.52 8.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.319 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 17.1 mt -86.79 -23.12 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.243 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -23.85 64.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.352 -0.842 . . . . 0.0 109.499 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -70.39 -45.49 65.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.132 -0.98 . . . . 0.0 109.956 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' C' ' 54' ' ' PHE . 0.7 OUTLIER -69.1 -43.14 75.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.007 -1.058 . . . . 0.0 109.069 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -55.95 -56.72 17.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.407 -0.808 . . . . 0.0 109.354 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -26.8 68.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.664 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 37.0 t60 -67.16 -47.5 70.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.225 -0.922 . . . . 0.0 109.131 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.28 -59.6 9.21 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 62.4 mt -69.09 147.86 50.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.325 -1.103 . . . . 0.0 109.791 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 15.3 mttp . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.626 179.709 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . 0.404 ' O ' ' OD1' ' D' ' 24' ' ' ASP . 69.4 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' D' ' 26' ' ' LEU . 62.0 m-20 -151.68 68.0 7.47 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -46.95 -11.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.659 2.239 . . . . 0.0 112.187 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' D' ' 24' ' ' ASP . 36.9 tp -47.36 -46.32 25.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.023 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 80.6 t -67.67 -45.5 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 0.0 108.852 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 72.6 t -49.42 -47.4 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.897 . . . . 0.0 108.912 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.53 -34.2 77.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.412 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.41 -56.63 10.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.194 -0.941 . . . . 0.0 109.634 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.94 -35.67 66.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 0.0 109.91 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 18.9 mt -73.25 -43.73 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.133 -0.979 . . . . 0.0 109.561 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 20.6 mt -54.56 -34.42 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.177 -0.952 . . . . 0.0 108.655 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.55 -44.41 26.82 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 50.0 mt -55.59 -31.04 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.087 -1.243 . . . . 0.0 109.356 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.11 -63.02 1.36 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.299 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -45.87 -38.94 7.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.367 -0.833 . . . . 0.0 109.854 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 53.7 tp -68.12 -67.85 0.43 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.123 -0.985 . . . . 0.0 109.642 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -47.31 -25.68 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.659 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mt -68.88 -65.67 0.67 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 109.818 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 21.3 t-105 -48.9 -45.19 40.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.212 -0.93 . . . . 0.0 109.879 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' D' ' 45' ' ' ARG . 84.9 mt -63.32 -56.86 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.131 -0.981 . . . . 0.0 108.875 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 61.2 tp -46.26 -45.82 17.42 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.539 -0.726 . . . . 0.0 109.422 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.79 -26.7 67.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.357 -0.839 . . . . 0.0 109.771 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.512 ' CA ' ' HE ' ' D' ' 45' ' ' ARG . 0.0 OUTLIER -77.49 -21.15 53.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.13 -0.981 . . . . 0.0 110.151 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.1 mt -83.65 -34.13 25.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.776 -1.202 . . . . 0.0 108.926 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -95.43 118.09 31.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.458 -0.776 . . . . 0.0 109.389 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -158.85 -8.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.122 -0.986 . . . . 0.0 109.63 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.9 pttp -67.98 -152.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.191 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 11.4 p 44.09 59.53 3.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.334 -0.854 . . . . 0.0 109.65 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 12.4 mt -96.83 -22.89 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.338 -0.852 . . . . 0.0 109.606 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -67.73 -22.75 65.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.136 -0.977 . . . . 0.0 109.483 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . 0.435 ' O ' ' ND1' ' D' ' 57' ' ' HIS . 0.1 OUTLIER -69.93 -39.37 76.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 109.44 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -69.72 -37.62 76.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.92 . . . . 0.0 109.089 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.35 -43.69 96.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.341 -0.849 . . . . 0.0 109.288 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -68.99 -27.95 66.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.272 -0.892 . . . . 0.0 109.114 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . 0.435 ' ND1' ' O ' ' D' ' 53' ' ' ARG . 1.7 m-70 -67.37 -46.95 71.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.308 -0.87 . . . . 0.0 108.855 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.26 -60.99 7.38 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 114.81 6.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -1.061 . . . . 0.0 109.419 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.06 -0.972 . . . . 0.0 109.447 179.978 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 26' ' ' LEU . 13.3 m-20 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.123 0.487 . . . . 0.0 109.693 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -45.72 -11.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.691 2.261 . . . . 0.0 112.076 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 24' ' ' ASP . 28.7 tp -47.37 -45.68 25.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.339 -0.851 . . . . 0.0 109.044 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.32 -45.64 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.288 -0.883 . . . . 0.0 108.803 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.5 t -49.53 -47.85 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.253 -0.904 . . . . 0.0 109.021 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.3 -33.58 76.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 109.339 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.18 -56.66 10.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.873 . . . . 0.0 109.685 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.95 -36.27 70.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.259 -0.9 . . . . 0.0 109.633 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.7 mt -70.87 -41.15 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 0.0 109.329 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.2 mt -57.48 -33.8 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.099 -1.001 . . . . 0.0 108.626 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.65 -44.38 39.92 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.1 mt -55.47 -34.98 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.321 -1.106 . . . . 0.0 109.097 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -68.82 -64.33 0.89 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.31 -0.869 . . . . 0.0 109.066 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.23 -41.01 8.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.445 -0.784 . . . . 0.0 110.072 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 35.4 tp -64.19 -68.04 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.111 -0.993 . . . . 0.0 109.6 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mt -47.9 -24.59 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.213 -0.93 . . . . 0.0 109.308 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.462 ' CD2' ' OD2' ' A' ' 44' ' ' ASP . 1.8 tt -71.35 -61.32 1.81 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 109.595 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 -51.16 -49.79 60.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.272 -0.892 . . . . 0.0 109.714 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 45' ' ' ARG . 80.6 mt -60.23 -56.32 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.006 -1.059 . . . . 0.0 108.969 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.3 tp -46.34 -42.15 14.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.477 -0.764 . . . . 0.0 109.578 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.462 ' OD2' ' CD2' ' A' ' 40' ' ' LEU . 72.9 m-20 -67.71 -28.19 67.45 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.21 -0.931 . . . . 0.0 109.276 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 42' ' ' ILE . 7.0 mmt-85 -80.11 -17.72 51.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 110.42 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -87.14 -35.08 18.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.693 -1.255 . . . . 0.0 109.002 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -99.5 -154.58 0.47 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.462 -0.774 . . . . 0.0 109.255 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 t80 66.56 114.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 50' ' ' SER . 5.3 ptmm? -169.8 -148.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.315 -0.866 . . . . 0.0 109.3 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 49' ' ' LYS . 17.0 m 50.98 97.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.9 mt -86.5 -24.42 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 109.067 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -59.23 -21.7 59.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.272 -0.892 . . . . 0.0 109.867 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' A' ' 57' ' ' HIS . 17.7 mmm180 -74.43 -44.09 53.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.91 -1.119 . . . . 0.0 109.744 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -73.71 -33.55 64.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.993 -1.067 . . . . 0.0 108.496 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -68.43 -52.12 36.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.351 -0.843 . . . . 0.0 109.861 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -71.17 -27.54 63.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.122 -0.986 . . . . 0.0 110.194 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.521 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 11.4 m170 -65.0 -52.91 53.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.966 -1.084 . . . . 0.0 109.124 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.05 -64.52 2.76 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.4 116.98 4.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.189 -1.183 . . . . 0.0 109.425 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.431 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.537 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 16.6 m-20 -159.96 50.22 0.34 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.212 -0.93 . . . . 0.0 109.376 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 12.3 Cg_endo -58.7 -15.8 27.79 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.928 2.418 . . . . 0.0 112.438 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 52.1 tp -47.22 -43.23 21.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.086 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.58 -45.25 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.91 . . . . 0.0 108.733 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 77.6 t -49.0 -46.34 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.282 -0.886 . . . . 0.0 108.989 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.95 -37.1 85.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 109.144 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.01 -55.37 29.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.339 -0.851 . . . . 0.0 109.651 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.0 -37.28 71.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 110.06 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 14.0 mt -70.84 -39.75 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.141 -0.974 . . . . 0.0 109.319 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 26.8 mt -57.77 -36.44 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.246 -0.909 . . . . 0.0 108.634 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.54 -44.55 63.6 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.2 -23.28 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.295 -1.12 . . . . 0.0 109.005 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.2 tp -76.78 -71.71 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.464 -0.773 . . . . 0.0 109.456 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . 0.47 ' CD2' ' ND1' ' C' ' 37' ' ' HIS . 2.9 t-80 -44.79 -35.42 2.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 109.774 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -66.58 -68.66 0.36 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.191 -0.943 . . . . 0.0 109.466 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 7.0 mt -48.69 -41.18 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.463 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.96 -61.72 2.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 110.066 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -46.82 -47.62 21.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.104 -0.998 . . . . 0.0 109.746 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 70.1 mt -62.0 -42.17 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.185 -0.947 . . . . 0.0 109.11 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.42 -43.39 64.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.625 -0.672 . . . . 0.0 109.918 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -77.83 -25.41 48.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.743 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 -71.83 -30.47 65.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.84 -1.163 . . . . 0.0 110.614 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -55.85 -26.53 47.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.734 -1.228 . . . . 0.0 109.281 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.19 -166.17 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.071 -1.018 . . . . 0.0 109.255 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -134.36 -125.02 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.742 . . . . 0.0 109.358 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -149.74 -63.68 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 83.7 p -52.14 104.96 0.1 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.871 . . . . 0.0 109.493 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 10.7 mt -103.75 -20.18 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.435 -0.791 . . . . 0.0 109.355 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -57.51 -12.64 2.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.576 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -72.1 -42.17 66.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 109.724 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -70.09 -38.41 75.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.143 -0.973 . . . . 0.0 108.993 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -59.43 -47.91 83.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.512 -0.743 . . . . 0.0 109.593 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.8 -27.2 63.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.584 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -66.18 -50.48 63.74 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.885 . . . . 0.0 109.13 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.03 -63.54 3.77 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 7.2 mt -68.65 118.58 11.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -1.148 . . . . 0.0 109.511 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 mptt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.481 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.32 159.22 75.54 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 0.0 109.277 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -61.08 -20.35 67.34 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.36 2.04 . . . . 0.0 112.205 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 47.4 tp -47.22 -42.54 20.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.944 . . . . 0.0 108.581 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 35.0 t -69.09 -45.48 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 73.8 t -48.77 -47.55 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 108.853 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.86 -36.48 84.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.37 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.13 -57.27 10.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.393 -0.817 . . . . 0.0 109.832 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.48 -36.97 67.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.268 -0.895 . . . . 0.0 109.916 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 24.8 mt -70.99 -42.45 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.378 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.9 mt -55.41 -35.69 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 108.83 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.25 -45.22 40.44 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 51.5 mt -55.72 -30.27 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.157 -1.202 . . . . 0.0 109.066 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.405 ' HA ' HD22 ' C' ' 36' ' ' LEU . 0.2 OUTLIER -73.73 -64.01 1.09 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 109.069 179.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . 0.47 ' ND1' ' CD2' ' B' ' 37' ' ' HIS . 13.0 t-80 -43.4 -37.25 2.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.484 -0.76 . . . . 0.0 110.244 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' C' ' 38' ' ' LEU . 35.3 tp -71.99 -65.17 0.8 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.983 -1.073 . . . . 0.0 109.523 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.3 mt -46.94 -27.64 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.235 -0.916 . . . . 0.0 109.393 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 tt -72.04 -63.24 1.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.338 -0.851 . . . . 0.0 109.688 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -45.94 -47.5 16.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 109.287 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 64.5 mt -58.49 -49.31 82.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.221 -0.924 . . . . 0.0 108.93 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.56 -50.43 13.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.653 -0.655 . . . . 0.0 109.411 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . 0.423 ' OD1' ' NH1' ' D' ' 45' ' ' ARG . 1.3 m-20 -62.76 -32.82 74.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.89 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -73.02 -19.12 61.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.07 -1.019 . . . . 0.0 110.416 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -83.75 -13.63 53.49 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.641 -1.287 . . . . 0.0 108.716 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.93 12.7 5.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 0.0 109.733 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.16 106.69 18.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.113 -0.992 . . . . 0.0 109.039 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -163.58 -90.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.152 -0.967 . . . . 0.0 109.72 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.34 103.61 0.25 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.913 . . . . 0.0 109.756 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 18.4 mt -90.99 -22.68 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.052 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.97 -23.42 66.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.026 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . 0.52 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 96.7 mtt180 -70.38 -36.51 74.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.068 -1.02 . . . . 0.0 110.125 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -72.35 -34.74 68.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.004 -1.06 . . . . 0.0 109.286 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.26 -45.8 79.29 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.338 -0.851 . . . . 0.0 109.679 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -71.6 -29.01 64.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.0 109.591 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 2.7 m-70 -64.58 -43.05 95.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 109.068 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.44 -61.61 4.09 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 mt -75.07 107.2 6.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -1.117 . . . . 0.0 109.57 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 14.9 tttt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.515 179.824 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.537 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 6.1 t70 66.21 48.4 0.56 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.353 -0.842 . . . . 0.0 109.595 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 0.9 OUTLIER -48.11 -19.72 1.81 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.634 2.223 . . . . 0.0 111.701 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 42.1 tp -46.26 -41.17 12.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.423 -0.798 . . . . 0.0 108.99 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 36.4 t -69.66 -45.67 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.237 -0.914 . . . . 0.0 108.795 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 77.5 t -49.2 -47.35 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 108.963 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.8 -34.33 77.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.873 . . . . 0.0 109.226 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.2 -55.44 18.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.849 . . . . 0.0 109.688 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -58.1 -36.21 72.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.324 -0.86 . . . . 0.0 109.892 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 25.7 mt -72.05 -42.52 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.145 -0.972 . . . . 0.0 109.438 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mt -56.2 -33.37 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.107 -0.996 . . . . 0.0 108.457 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.5 -44.78 25.84 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.85 -28.99 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.188 -1.184 . . . . 0.0 109.113 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.18 -65.33 0.76 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.335 -0.853 . . . . 0.0 108.883 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -45.75 -42.88 12.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.48 -0.763 . . . . 0.0 109.712 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.19 -67.79 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 0.0 109.558 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mt -47.13 -35.7 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.175 -0.953 . . . . 0.0 109.639 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mt -63.5 -57.39 10.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.937 . . . . 0.0 109.826 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -48.15 -45.38 33.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.04 -1.037 . . . . 0.0 109.472 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 67.4 mt -64.49 -50.17 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.156 -0.965 . . . . 0.0 109.012 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 14.3 tp -52.09 -37.14 53.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.638 -0.664 . . . . 0.0 110.39 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.67 -21.73 30.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.036 -1.04 . . . . 0.0 110.349 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.423 ' NH1' ' OD1' ' C' ' 44' ' ' ASP . 0.0 OUTLIER -76.09 -28.95 57.73 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.984 -1.073 . . . . 0.0 110.712 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.25 -10.98 1.46 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.687 -1.258 . . . . 0.0 109.171 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -77.04 120.49 22.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.165 -0.96 . . . . 0.0 109.407 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.34 178.78 8.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.39 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . 0.543 ' CD ' ' H ' ' D' ' 50' ' ' SER . 6.0 tmtt? 54.83 -153.67 0.31 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.088 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.543 ' H ' ' CD ' ' D' ' 49' ' ' LYS . 2.6 m 47.01 54.7 8.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.945 -1.097 . . . . 0.0 110.023 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 47.4 mt -97.47 -28.64 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 0.0 109.297 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.44 -32.96 67.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.339 -0.85 . . . . 0.0 109.455 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -63.56 -34.76 78.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.114 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -72.55 -38.88 67.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.286 -0.884 . . . . 0.0 109.108 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -62.29 -49.39 75.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.411 -0.806 . . . . 0.0 109.208 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -67.87 -26.22 65.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.338 -0.851 . . . . 0.0 109.424 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -68.91 -34.71 75.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.87 . . . . 0.0 109.119 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.19 -62.89 2.36 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 7.5 mt -59.93 116.6 4.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -1.132 . . . . 0.0 109.337 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.474 179.886 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 26' ' ' LEU . 28.0 t70 . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -44.72 -12.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.677 2.251 . . . . 0.0 112.234 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' A' ' 24' ' ' ASP . 38.8 tp -48.92 -43.22 39.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.018 -1.052 . . . . 0.0 108.8 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 t -68.39 -46.01 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.232 -0.918 . . . . 0.0 108.588 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.6 t -49.08 -47.17 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 0.0 108.876 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.11 -33.39 75.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.316 -0.865 . . . . 0.0 109.345 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.44 -57.24 6.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.313 -0.867 . . . . 0.0 109.727 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.71 -37.14 65.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.968 . . . . 0.0 109.429 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.5 mt -71.11 -41.15 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 0.0 109.124 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.3 mt -56.03 -34.03 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.119 -0.988 . . . . 0.0 108.524 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.9 -45.84 31.7 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.9 mt -60.55 -23.13 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.265 -1.138 . . . . 0.0 108.845 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.6 tp -76.69 -70.8 0.43 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.518 -0.739 . . . . 0.0 109.082 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -47.31 -33.51 5.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 109.506 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.9 tp -66.59 -69.17 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 109.654 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 mt -48.45 -27.68 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.61 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.483 HD12 HD11 ' B' ' 38' ' ' LEU . 1.6 mt -68.61 -59.82 2.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -0.933 . . . . 0.0 109.914 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -53.36 -46.12 69.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.021 -1.049 . . . . 0.0 109.809 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 82.2 mt -61.78 -52.77 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.018 -1.051 . . . . 0.0 108.836 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.8 tp -51.25 -38.58 53.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.506 -0.746 . . . . 0.0 109.399 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 1.4 m-20 -72.38 -24.98 61.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 109.23 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.558 ' CA ' ' HE ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -77.96 -24.12 48.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.177 -0.952 . . . . 0.0 110.14 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.463 ' C ' ' H ' ' A' ' 48' ' ' PHE . 9.3 mt -80.17 -13.93 58.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.77 -1.206 . . . . 0.0 109.043 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -75.03 29.78 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.655 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.463 ' H ' ' C ' ' A' ' 46' ' ' LEU . 78.0 t80 -83.04 77.14 9.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.134 -0.979 . . . . 0.0 109.369 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -85.71 -128.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.459 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.98 168.48 10.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.337 -0.852 . . . . 0.0 109.489 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.0 mt -104.2 -23.11 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.487 -0.758 . . . . 0.0 109.324 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -60.15 -21.82 62.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.097 -1.002 . . . . 0.0 109.734 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.7 mtt85 -69.39 -43.48 73.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.176 -0.952 . . . . 0.0 109.26 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -64.96 -36.56 84.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.476 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -70.68 -61.64 1.69 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -48.39 -29.72 4.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.348 -0.845 . . . . 0.0 109.646 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -71.13 -53.3 15.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.198 -0.939 . . . . 0.0 109.512 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.05 -60.28 9.33 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.8 mt -77.65 81.65 4.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -1.139 . . . . 0.0 109.604 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.7 tttt . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.379 179.864 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.86 160.86 66.62 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.301 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' B' ' 26' ' ' LEU . 18.7 Cg_endo -63.7 -21.08 69.9 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.525 2.15 . . . . 0.0 112.301 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' B' ' 25' ' ' PRO . 48.9 tp -46.63 -43.67 17.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 108.686 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 37.3 t -69.54 -44.76 79.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.306 -0.871 . . . . 0.0 108.801 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -48.6 -46.63 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.878 . . . . 0.0 108.827 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.15 -39.06 92.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.393 -0.817 . . . . 0.0 109.155 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.86 -57.51 11.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.458 -0.776 . . . . 0.0 109.948 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.78 -37.07 63.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.096 -1.003 . . . . 0.0 109.758 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 20.6 mt -71.38 -38.49 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.152 -0.967 . . . . 0.0 109.468 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 29.8 mt -57.51 -36.27 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.087 -1.008 . . . . 0.0 108.582 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.89 -46.53 52.18 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 69.0 mt -59.64 -25.76 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.306 -1.114 . . . . 0.0 108.891 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 14.0 tp -75.63 -67.88 0.62 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -42.59 -42.73 3.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.529 -0.732 . . . . 0.0 110.086 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.483 HD11 HD12 ' A' ' 40' ' ' LEU . 22.2 tp -64.37 -64.66 0.82 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.979 -1.076 . . . . 0.0 109.521 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 6.3 mt -48.02 -29.34 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.327 -0.858 . . . . 0.0 109.556 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 5.2 mt -75.98 -57.79 3.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.552 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -45.83 -54.97 7.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.365 -0.834 . . . . 0.0 109.663 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' B' ' 45' ' ' ARG . 58.5 mt -58.66 -60.38 2.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.155 -0.966 . . . . 0.0 109.036 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' B' ' 42' ' ' ILE . 57.3 tp -41.61 -38.84 1.46 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.674 -0.641 . . . . 0.0 110.347 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.74 -30.19 62.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.1 -1.0 . . . . 0.0 109.625 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' B' ' 42' ' ' ILE . 0.4 OUTLIER -80.9 -13.64 58.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.898 . . . . 0.0 110.596 -179.521 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -87.28 -33.15 19.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.661 -1.275 . . . . 0.0 109.015 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -63.62 -19.87 65.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 109.515 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.02 128.9 34.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.445 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.414 ' HB3' ' HZ3' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -167.29 -54.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 109.504 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 78.1 p -93.32 138.39 31.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.959 . . . . 0.0 109.525 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 30.0 mt -110.33 -27.43 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.698 -0.626 . . . . 0.0 109.859 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -33.08 56.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.154 -0.966 . . . . 0.0 110.267 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -67.54 -39.71 85.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.861 -1.149 . . . . 0.0 109.595 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -66.28 -33.87 76.73 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.324 -0.86 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -68.24 -52.08 38.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 109.384 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -60.99 -30.92 70.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.676 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.26 -57.64 5.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 0.0 109.722 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.02 -58.93 11.76 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 5.2 mt -70.08 148.18 49.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.184 -1.186 . . . . 0.0 109.365 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 6.1 tptm . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.404 -179.936 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.352 0.596 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.502 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 4.9 p30 -166.71 51.84 0.24 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.391 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 12.4 Cg_endo -59.2 -9.54 8.52 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.633 2.222 . . . . 0.0 111.922 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 41.3 tp -47.5 -46.05 26.9 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.34 -0.85 . . . . 0.0 108.873 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 29.2 t -69.15 -45.58 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.213 -0.929 . . . . 0.0 108.686 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -49.2 -50.46 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.87 . . . . 0.0 109.071 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.77 76.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.872 . . . . 0.0 109.222 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.64 -55.84 15.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.448 -0.782 . . . . 0.0 109.659 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -54.92 -36.46 65.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 109.688 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.7 mt -72.41 -40.62 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.225 -0.922 . . . . 0.0 109.531 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . 0.451 HD13 HG13 ' D' ' 35' ' ' ILE . 23.5 mt -56.27 -35.65 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.001 -1.062 . . . . 0.0 108.871 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.15 -42.72 35.1 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 58.0 mt -58.72 -36.84 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -1.158 . . . . 0.0 109.57 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.45 -60.97 1.99 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.183 -0.948 . . . . 0.0 109.305 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -44.34 -39.34 4.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 0.0 110.187 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 25.6 tp -69.22 -66.94 0.52 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 109.688 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mt -46.81 -27.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.311 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . 0.529 HD23 ' O ' ' C' ' 40' ' ' LEU . 2.4 tt -74.25 -52.42 12.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.359 -0.838 . . . . 0.0 109.762 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . 0.435 ' CH2' ' NE ' ' C' ' 45' ' ' ARG . 24.3 t-105 -58.31 -46.08 86.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -0.962 . . . . 0.0 109.46 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 69.6 mt -64.57 -39.24 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.144 -0.973 . . . . 0.0 109.185 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.12 -31.31 71.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.839 . . . . 0.0 109.678 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -82.81 -25.24 32.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 109.627 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.435 ' NE ' ' CH2' ' C' ' 41' ' ' TRP . 3.5 mmt-85 -79.27 -26.15 42.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 111.137 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' C' ' 48' ' ' PHE . 6.4 mt -55.86 -9.69 0.62 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.413 -1.429 . . . . 0.0 109.217 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.414 ' N ' ' C ' ' C' ' 45' ' ' ARG . 70.8 t80 -70.61 66.3 0.33 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 109.108 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' C' ' 46' ' ' LEU . 2.7 t80 -92.19 153.41 19.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.863 . . . . 0.0 109.797 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp 59.06 -150.47 0.44 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 109.474 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 6.2 t 47.06 59.9 3.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.935 . . . . 0.0 109.548 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 15.8 mt -102.01 -31.08 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.429 -0.795 . . . . 0.0 109.411 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . 0.434 ' CD1' ' C ' ' C' ' 52' ' ' TYR . 0.0 OUTLIER -55.25 -34.25 63.85 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.336 -0.853 . . . . 0.0 110.13 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -67.42 -36.74 81.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.098 -1.001 . . . . 0.0 109.472 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -68.78 -32.29 71.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -0.95 . . . . 0.0 108.808 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -68.95 -47.01 66.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.449 -0.782 . . . . 0.0 109.3 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -65.94 -27.28 68.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.277 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . 0.652 ' CD2' ' HZ2' ' D' ' 49' ' ' LYS . 82.3 t60 -71.18 -44.54 65.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.095 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.11 -63.3 4.67 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 41.1 mt -80.96 90.39 5.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.286 -1.126 . . . . 0.0 109.393 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 mttm . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.536 -179.846 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.24 0.543 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' D' ' 26' ' ' LEU . 11.1 m-20 -154.29 66.28 5.28 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.362 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -45.26 -11.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.738 2.292 . . . . 0.0 112.179 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' D' ' 24' ' ' ASP . 41.9 tp -47.61 -44.98 27.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.127 -0.983 . . . . 0.0 109.193 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.4 t -68.47 -44.99 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.22 -0.925 . . . . 0.0 108.812 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.3 t -49.12 -48.62 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 108.981 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.71 -33.19 75.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.327 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.36 -57.1 8.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.342 -0.849 . . . . 0.0 109.571 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.56 -37.09 70.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.812 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 16.2 mt -71.11 -43.11 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.155 -0.965 . . . . 0.0 109.52 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 27.2 mt -56.05 -35.11 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.071 -1.018 . . . . 0.0 108.681 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.95 -43.79 39.58 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . 0.451 HG13 HD13 ' C' ' 33' ' ' ILE . 78.6 mt -62.26 -26.45 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.304 -1.115 . . . . 0.0 108.869 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.49 -67.0 0.55 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.478 -0.764 . . . . 0.0 109.172 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -45.16 -47.27 12.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.35 -0.844 . . . . 0.0 109.954 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.2 tp -57.62 -63.54 1.2 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.166 -0.959 . . . . 0.0 109.614 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 10.3 mt -50.57 -36.1 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.122 -0.986 . . . . 0.0 109.558 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 4.6 mt -63.57 -57.54 9.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.798 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -47.24 -44.75 23.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.279 -0.888 . . . . 0.0 109.548 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 12.2 mt -69.38 -33.9 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 108.714 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -60.14 -42.15 94.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.438 -0.789 . . . . 0.0 109.936 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.97 -22.19 36.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 0.0 109.612 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' D' ' 47' ' ' PHE . 9.3 mmt180 -92.57 -0.71 57.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 0.0 110.875 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.482 ' C ' ' O ' ' D' ' 45' ' ' ARG . 32.8 mt -31.01 -36.16 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.658 -0.651 . . . . 0.0 110.832 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' D' ' 45' ' ' ARG . 0.2 OUTLIER 178.23 15.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.139 -0.976 . . . . 0.0 109.547 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -49.95 101.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.449 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . 0.652 ' HZ2' ' CD2' ' C' ' 57' ' ' HIS . 0.0 OUTLIER -150.6 -29.16 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.964 . . . . 0.0 109.626 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 15.2 p -51.34 120.42 5.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 0.0 109.318 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 15.8 mt -101.07 -29.37 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.492 -0.755 . . . . 0.0 109.721 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -34.48 60.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.186 -0.946 . . . . 0.0 109.897 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -63.64 -39.6 94.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 109.551 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -67.55 -37.82 83.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 0.0 109.44 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.29 -64.43 0.88 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.437 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -51.27 -31.47 21.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.124 -0.985 . . . . 0.0 109.528 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . 0.414 ' C ' ' ND1' ' D' ' 57' ' ' HIS . 14.1 t-80 -69.26 -53.98 17.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.159 -0.963 . . . . 0.0 109.541 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.97 -62.29 6.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . 0.453 ' C ' HD13 ' D' ' 59' ' ' LEU . 0.4 OUTLIER -55.35 109.94 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -1.13 . . . . 0.0 109.076 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . 0.432 ' N ' HD13 ' D' ' 59' ' ' LEU . 17.6 ttmt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.562 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.6 m-20 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.8 Cg_endo -55.12 -14.92 9.54 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.837 2.358 . . . . 0.0 112.266 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.9 tp -47.5 -44.28 25.35 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.201 -0.937 . . . . 0.0 109.091 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.8 t -68.21 -45.08 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.186 -0.946 . . . . 0.0 108.665 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.6 t -50.89 -48.12 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 0.0 109.009 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.02 -32.72 74.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 109.464 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.52 -55.14 12.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.329 -0.857 . . . . 0.0 109.626 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.94 -36.21 67.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.744 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.1 mt -73.35 -43.34 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.509 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.4 mt -54.34 -32.95 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.029 -1.044 . . . . 0.0 108.595 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.41 -45.33 14.54 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.0 mt -56.64 -36.68 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.148 -1.207 . . . . 0.0 109.483 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.39 -59.51 2.94 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.236 -0.915 . . . . 0.0 109.203 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -44.3 -44.81 8.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.342 -0.849 . . . . 0.0 110.02 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.53 -68.83 0.31 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.084 -1.01 . . . . 0.0 109.639 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 mt -45.44 -29.76 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.418 -0.801 . . . . 0.0 109.653 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 mt -68.57 -61.5 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.947 . . . . 0.0 109.543 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.494 ' NE1' ' OD2' ' D' ' 44' ' ' ASP . 54.8 t-105 -44.33 -46.04 9.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.548 -0.72 . . . . 0.0 109.633 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.5 mt -71.59 -33.09 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.086 -1.009 . . . . 0.0 109.559 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.9 tp -61.52 -43.12 99.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 109.972 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.52 -20.74 36.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 110.588 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 46' ' ' LEU . 8.6 mmt180 -85.92 -16.56 38.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.711 -1.243 . . . . 0.0 111.515 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 45' ' ' ARG . 20.7 mt -39.61 -34.55 0.24 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.01 -1.056 . . . . 0.0 110.171 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.548 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 1.6 p90 -55.05 126.73 25.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.014 -1.054 . . . . 0.0 109.394 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -173.76 32.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 109.235 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -148.7 -76.64 0.16 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 109.556 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 p -55.15 85.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.94 . . . . 0.0 109.597 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.52 ' N ' ' O ' ' A' ' 49' ' ' LYS . 26.3 mt -89.76 -21.29 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.648 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.54 -21.47 62.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.965 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -67.36 -40.87 85.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.966 . . . . 0.0 109.943 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -71.39 -37.65 71.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 0.0 109.32 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -59.08 -51.38 70.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.233 -0.917 . . . . 0.0 109.192 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -67.69 -26.29 66.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 109.452 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -67.25 -42.01 84.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.18 -0.95 . . . . 0.0 109.198 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.04 -62.58 3.49 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mt -52.9 159.7 1.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.392 -1.063 . . . . 0.0 109.503 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.9 mttt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.498 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' B' ' 26' ' ' LEU . 6.9 m-20 -156.55 65.29 3.82 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.605 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -45.61 -9.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.773 2.315 . . . . 0.0 112.182 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' B' ' 24' ' ' ASP . 29.1 tp -47.27 -46.9 25.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.263 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.96 -45.21 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.225 -0.922 . . . . 0.0 108.89 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 73.0 t -48.98 -48.88 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 108.999 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.22 -34.01 77.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.364 -0.835 . . . . 0.0 109.461 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.46 -56.63 10.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.26 -0.9 . . . . 0.0 109.599 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.11 -37.0 68.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.586 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 16.8 mt -71.0 -41.08 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 21.1 mt -56.4 -33.91 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.174 -0.954 . . . . 0.0 108.645 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.67 -43.13 24.48 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 66.9 mt -59.14 -39.4 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.115 -1.226 . . . . 0.0 109.308 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.12 -63.8 1.0 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.952 . . . . 0.0 109.076 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.08 -49.77 11.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.435 -0.79 . . . . 0.0 109.761 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' B' ' 38' ' ' LEU . 48.9 tp -56.5 -65.19 0.65 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 109.618 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.8 mt -46.44 -40.03 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 0.0 109.538 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.67 -63.24 1.37 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 110.095 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -45.06 -48.25 11.82 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.374 -0.828 . . . . 0.0 109.854 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 79.3 mt -61.53 -47.78 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.212 -0.93 . . . . 0.0 109.07 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 13.3 tp -51.78 -39.59 58.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.537 -0.727 . . . . 0.0 110.137 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -76.31 -26.45 55.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 109.953 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.509 ' CA ' ' HE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -73.58 -27.95 61.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.056 -1.027 . . . . 0.0 110.464 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -65.96 -31.06 71.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.688 -1.258 . . . . 0.0 109.179 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' B' ' 48' ' ' PHE . 60.3 t80 -78.19 -103.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 109.313 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . 0.48 ' N ' ' CG ' ' B' ' 47' ' ' PHE . 2.7 t80 48.04 -154.97 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.925 . . . . 0.0 109.747 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 6.6 tttt 68.73 -153.8 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.3 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . 0.525 ' O ' ' CE2' ' B' ' 54' ' ' PHE . 13.8 m 44.77 75.53 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.215 -0.928 . . . . 0.0 109.401 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 27.3 mt -90.7 -20.25 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.15 -0.969 . . . . 0.0 109.712 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -20.97 58.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 0.0 109.581 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -71.49 -42.92 67.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 110.046 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . 0.525 ' CE2' ' O ' ' B' ' 50' ' ' SER . 4.0 m-85 -70.58 -35.08 72.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.059 -1.026 . . . . 0.0 109.492 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -63.55 -45.56 89.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.19 -0.944 . . . . 0.0 109.279 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -71.49 -25.49 62.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.514 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -65.97 -53.07 43.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.091 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.02 -60.52 7.12 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.12 148.96 16.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -1.168 . . . . 0.0 109.439 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 33.1 tttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.391 179.929 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.55 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 4.2 p30 -175.09 49.16 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.346 -0.846 . . . . 0.0 109.432 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 10.6 Cg_endo -56.34 -12.32 7.79 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.941 2.427 . . . . 0.0 112.249 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 35.5 tp -47.71 -44.65 27.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.129 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 38.6 t -68.99 -45.18 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.179 -0.95 . . . . 0.0 108.674 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.8 t -49.69 -49.19 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.0 108.889 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.17 -31.87 73.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.338 -0.851 . . . . 0.0 109.254 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.15 -57.27 7.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 109.686 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -55.68 -36.27 66.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.666 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.5 mt -71.79 -38.98 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.979 . . . . 0.0 109.548 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 23.7 mt -59.38 -35.51 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.015 -1.053 . . . . 0.0 108.73 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.47 -42.89 63.22 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 77.7 mt -63.63 -22.28 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.414 -1.05 . . . . 0.0 108.771 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.91 -70.84 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . 0.55 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 2.3 t-80 -45.92 -36.73 5.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.864 . . . . 0.0 109.67 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.95 -67.82 0.4 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.437 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 5.6 mt -48.54 -28.92 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.878 . . . . 0.0 109.672 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 mt -71.57 -59.79 2.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 110.01 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 51.9 t-105 -49.59 -47.75 49.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.084 -1.01 . . . . 0.0 109.811 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 73.2 mt -64.02 -58.74 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.102 -0.999 . . . . 0.0 109.273 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 59.2 tp -44.99 -54.46 6.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.47 -0.769 . . . . 0.0 109.679 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.79 -26.61 67.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.314 -0.867 . . . . 0.0 110.109 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.486 ' HE ' ' CA ' ' C' ' 45' ' ' ARG . 0.0 OUTLIER -79.19 -20.69 47.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.924 -1.11 . . . . 0.0 110.446 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -79.84 -32.14 40.56 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.701 -1.249 . . . . 0.0 109.058 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.451 ' O ' ' CB ' ' C' ' 48' ' ' PHE . 6.3 t80 -92.33 -144.91 0.21 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 0.0 109.31 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.451 ' CB ' ' O ' ' C' ' 47' ' ' PHE . 1.1 t80 72.38 106.31 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 109.441 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' C' ' 50' ' ' SER . 10.7 tttp -165.62 -154.03 0.19 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.366 -0.834 . . . . 0.0 109.094 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . 0.42 ' O ' ' O ' ' C' ' 49' ' ' LYS . 34.6 m 42.55 91.14 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.333 -0.854 . . . . 0.0 109.917 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 10.3 mt -94.64 -19.09 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.411 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -67.53 -21.88 65.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.092 -1.005 . . . . 0.0 109.499 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -68.2 -42.33 80.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.895 . . . . 0.0 109.7 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . 0.428 ' HB3' HD11 ' D' ' 51' ' ' ILE . 1.5 m-85 -71.71 -45.13 62.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.112 -0.992 . . . . 0.0 109.036 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -54.29 -48.69 70.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 108.828 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -66.8 -26.95 67.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.397 -0.814 . . . . 0.0 109.032 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -66.95 -43.9 81.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.888 . . . . 0.0 108.746 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.47 -62.64 4.91 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.45 ' C ' HD13 ' C' ' 59' ' ' LEU . 0.5 OUTLIER -66.0 103.3 0.92 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -1.114 . . . . 0.0 108.925 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 31.9 tttm . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.079 -0.963 . . . . 0.0 109.542 179.97 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 66.1 p . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.472 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 2.6 m-20 53.21 52.8 10.82 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.243 -0.911 . . . . 0.0 109.441 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 11.2 Cg_endo -58.57 -13.7 18.34 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.542 2.161 . . . . 0.0 112.116 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' D' ' 26' ' ' LEU . 35.6 tp -48.0 -44.23 30.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.947 . . . . 0.0 108.901 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.58 -45.36 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.16 -0.962 . . . . 0.0 108.668 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 67.9 t -48.94 -47.7 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.847 . . . . 0.0 108.957 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.89 -35.07 79.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.336 -0.853 . . . . 0.0 109.166 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.86 -56.93 11.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.849 . . . . 0.0 109.708 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.87 -36.16 67.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.147 -0.971 . . . . 0.0 109.79 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 11.2 mt -71.63 -39.57 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.192 -0.942 . . . . 0.0 109.494 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 16.5 mt -58.67 -35.29 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.988 -1.07 . . . . 0.0 108.576 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.88 -43.73 57.67 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.86 -23.61 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.225 -1.162 . . . . 0.0 108.919 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.69 -70.21 0.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.866 . . . . 0.0 109.032 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . 0.55 ' CE1' ' NE2' ' C' ' 37' ' ' HIS . 9.8 t-80 -46.46 -35.64 5.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.913 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 57.3 tp -65.75 -63.02 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.117 -0.989 . . . . 0.0 109.564 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 6.8 mt -54.7 -32.82 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.522 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.03 -58.04 4.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.816 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 -46.45 -51.94 14.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.819 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.06 -53.58 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.008 -1.057 . . . . 0.0 108.883 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 54.9 tp -46.13 -44.05 15.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.464 -0.772 . . . . 0.0 109.895 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . 0.494 ' OD2' ' NE1' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -68.7 -28.18 66.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.775 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -79.2 -19.69 50.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 0.0 110.687 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.4 mt -80.9 -33.81 33.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.666 -1.271 . . . . 0.0 109.167 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -67.88 114.0 6.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.426 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -157.75 -155.14 0.48 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.153 -0.967 . . . . 0.0 109.597 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt 48.43 -153.5 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.36 -0.837 . . . . 0.0 109.243 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 94.4 p 43.1 65.34 0.98 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.36 -0.837 . . . . 0.0 109.65 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . 0.428 HD11 ' HB3' ' C' ' 54' ' ' PHE . 6.7 mt -89.96 -24.41 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 109.07 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.98 -27.92 65.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 109.893 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -71.94 -43.34 65.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.904 -1.122 . . . . 0.0 109.498 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -60.75 -37.03 80.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.383 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -68.57 -67.77 0.44 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.395 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -47.53 -40.16 18.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.893 . . . . 0.0 109.658 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -65.56 -54.37 28.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.305 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.83 -61.3 7.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.51 129.08 40.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -1.195 . . . . 0.0 109.413 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 37.8 tttp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.394 -179.9 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 26' ' ' LEU . 30.5 t0 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -46.06 -11.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.662 2.241 . . . . 0.0 112.031 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 24' ' ' ASP . 37.6 tp -47.78 -45.91 29.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.262 -0.899 . . . . 0.0 108.962 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.53 -45.29 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.207 -0.933 . . . . 0.0 108.721 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.3 t -49.12 -49.08 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 108.95 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.24 -32.55 74.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.316 -0.865 . . . . 0.0 109.157 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.81 -58.16 6.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.347 -0.845 . . . . 0.0 109.671 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.55 -36.85 67.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 109.743 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.4 mt -70.93 -39.74 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.361 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.3 mt -57.66 -34.51 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.027 -1.045 . . . . 0.0 108.415 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.96 -44.63 45.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.6 mt -57.0 -31.33 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.19 -1.182 . . . . 0.0 109.128 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.07 -64.69 0.86 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.305 -0.872 . . . . 0.0 109.208 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -44.96 -47.37 11.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.839 . . . . 0.0 110.223 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.8 tp -59.02 -63.92 1.13 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.997 -1.064 . . . . 0.0 109.693 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.3 mt -51.38 -25.74 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 109.601 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mt -74.74 -56.59 4.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.175 -0.953 . . . . 0.0 109.49 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -48.37 -51.3 27.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 109.377 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.75 -53.58 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.235 -0.916 . . . . 0.0 109.105 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.4 tp -46.49 -35.42 5.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.562 -0.711 . . . . 0.0 110.327 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 0.2 OUTLIER -79.2 -29.08 42.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.039 -1.038 . . . . 0.0 109.814 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.79 -19.48 57.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 0.0 110.873 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 47' ' ' PHE . 8.5 mt -77.6 -9.22 58.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.556 -1.34 . . . . 0.0 109.347 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.403 ' O ' ' O ' ' A' ' 46' ' ' LEU . 3.0 m-85 -47.41 -90.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 109.225 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 46.57 23.91 0.27 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 109.64 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -66.07 -144.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.495 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.3 m -80.51 141.48 35.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 109.629 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 mt -97.21 -32.19 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.514 -0.741 . . . . 0.0 109.432 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -56.2 -19.12 12.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -72.27 -41.04 67.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -0.987 . . . . 0.0 109.812 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -69.54 -33.3 72.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.088 -1.007 . . . . 0.0 109.377 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -69.7 -45.46 68.22 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.287 -0.883 . . . . 0.0 109.347 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -67.1 -27.05 67.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -69.12 -52.64 26.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.24 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.19 -60.56 8.73 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.1 mt -48.63 147.33 2.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.348 -1.089 . . . . 0.0 109.491 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.7 tttt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.35 179.829 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.51 162.68 28.98 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.279 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' B' ' 26' ' ' LEU . 23.4 Cg_endo -65.82 -28.31 51.18 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.51 2.14 . . . . 0.0 112.224 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' B' ' 25' ' ' PRO . 37.6 tp -45.73 -40.54 9.54 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.34 -44.53 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 71.0 t -49.94 -47.39 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.91 . . . . 0.0 108.774 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.69 78.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.237 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.38 -56.27 15.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -0.875 . . . . 0.0 109.832 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.41 -37.83 76.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -0.945 . . . . 0.0 110.018 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 18.4 mt -69.26 -42.97 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.107 -0.995 . . . . 0.0 109.191 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 mt -56.4 -34.46 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.242 -0.911 . . . . 0.0 108.783 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.33 -43.41 38.44 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 68.1 mt -60.38 -31.94 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.295 -1.12 . . . . 0.0 109.305 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.97 -66.52 0.6 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 109.248 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -44.96 -41.7 7.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 109.924 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.0 tp -62.7 -68.37 0.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.5 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 6.1 mt -46.93 -31.44 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.316 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.24 -60.2 3.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.86 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . 0.404 ' NE1' ' OD2' ' A' ' 44' ' ' ASP . 37.7 t-105 -48.75 -43.94 38.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 109.664 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 25.8 mt -64.53 -40.01 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.99 . . . . 0.0 108.922 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 tp -56.48 -35.76 68.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.571 -0.706 . . . . 0.0 110.368 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.8 -22.98 27.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.071 -1.018 . . . . 0.0 110.382 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.483 ' CA ' ' HE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -76.13 -27.97 57.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.912 -1.117 . . . . 0.0 110.517 -179.204 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -51.86 -11.47 0.15 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.6 -1.312 . . . . 0.0 108.99 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.455 ' N ' ' O ' ' B' ' 45' ' ' ARG . 24.6 t80 -67.28 126.45 29.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.493 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -147.95 -90.54 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.92 . . . . 0.0 109.425 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -61.85 -149.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.181 -0.949 . . . . 0.0 109.393 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 48.8 p 45.99 56.67 5.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 109.612 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 12.4 mt -92.74 -28.95 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.263 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.68 -25.6 4.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.403 -0.811 . . . . 0.0 109.788 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.461 ' O ' ' CG ' ' B' ' 57' ' ' HIS . 30.4 mtt180 -68.52 -38.33 80.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.765 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -71.37 -35.15 70.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.027 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -65.8 -53.1 44.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.691 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -65.23 -30.43 71.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.885 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . 0.461 ' CG ' ' O ' ' B' ' 53' ' ' ARG . 1.7 m-70 -68.04 -41.77 81.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.147 -0.971 . . . . 0.0 109.437 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.75 -66.2 1.69 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' B' ' 59' ' ' LEU . 0.3 OUTLIER -73.74 108.24 6.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -1.144 . . . . 0.0 109.27 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.898 -1.048 . . . . 0.0 109.409 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.62 160.78 32.03 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.171 -0.956 . . . . 0.0 109.407 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' C' ' 26' ' ' LEU . 13.5 Cg_endo -60.05 -23.69 74.07 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.625 2.216 . . . . 0.0 112.2 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' C' ' 25' ' ' PRO . 39.9 tp -45.72 -42.08 11.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.294 -0.878 . . . . 0.0 108.86 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 46.9 t -70.0 -44.16 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.376 -0.828 . . . . 0.0 108.784 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 69.9 t -50.17 -47.63 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 0.0 108.918 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.06 86.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.567 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.62 -55.27 21.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 109.591 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.62 -36.76 67.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 109.83 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 25.9 mt -72.36 -42.64 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.511 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.1 mt -55.01 -34.26 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.12 -0.987 . . . . 0.0 108.805 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.8 -44.05 21.06 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 64.2 mt -58.35 -29.73 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.17 -1.194 . . . . 0.0 109.421 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.15 -59.42 2.75 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.235 -0.915 . . . . 0.0 109.015 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -47.24 -38.84 13.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.703 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.2 tp -68.68 -67.66 0.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.574 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.5 mt -46.09 -28.02 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 0.0 109.418 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 mt -69.95 -60.45 2.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.409 -0.807 . . . . 0.0 109.823 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -47.02 -43.61 19.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . 0.408 HD13 HG21 ' C' ' 42' ' ' ILE . 6.4 mt -70.75 -40.44 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.112 -0.992 . . . . 0.0 109.326 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 57.9 tp -60.51 -35.5 76.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.339 -0.851 . . . . 0.0 110.091 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -87.54 -19.24 28.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.116 -0.99 . . . . 0.0 110.167 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' C' ' 47' ' ' PHE . 3.7 mmt180 -84.65 -20.88 30.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.027 -1.046 . . . . 0.0 111.119 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' C' ' 45' ' ' ARG . 38.8 mt -46.35 -17.73 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.825 -1.172 . . . . 0.0 109.108 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' C' ' 45' ' ' ARG . 22.6 m-85 -93.08 79.25 4.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.264 -0.897 . . . . 0.0 109.319 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -83.77 -57.36 3.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.33 -0.856 . . . . 0.0 109.476 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -76.94 -139.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.36 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 46.1 m 52.78 61.35 3.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.442 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 61.1 mt -95.33 -26.01 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.865 . . . . 0.0 109.518 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -58.81 -22.72 59.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.267 -0.895 . . . . 0.0 109.835 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . 0.517 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 0.0 OUTLIER -67.37 -42.32 83.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.83 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -71.01 -38.9 72.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.289 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -62.83 -45.97 90.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.28 -0.888 . . . . 0.0 109.071 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -69.15 -27.33 65.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.833 . . . . 0.0 109.62 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . 0.517 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 51.3 m170 -69.39 -38.54 78.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 0.0 109.188 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.6 -59.83 5.01 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mt -72.67 176.04 5.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -1.162 . . . . 0.0 109.496 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . 0.585 ' N ' ' CD ' ' C' ' 60' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.371 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' D' ' 26' ' ' LEU . 7.1 p30 -169.0 68.09 0.67 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.366 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -47.24 -9.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.754 2.302 . . . . 0.0 112.29 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' D' ' 24' ' ' ASP . 33.9 tp -47.48 -46.84 27.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.169 -0.957 . . . . 0.0 108.979 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.72 -45.79 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.262 -0.899 . . . . 0.0 108.728 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 66.2 t -48.45 -48.73 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -0.879 . . . . 0.0 108.881 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.81 -34.92 79.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.37 -0.831 . . . . 0.0 109.305 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.56 -56.37 12.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.0 109.755 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 2.5 m -55.65 -35.04 65.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 109.809 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 16.4 mt -73.89 -42.99 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.155 -0.966 . . . . 0.0 109.586 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 19.4 mt -55.14 -34.7 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.075 -1.016 . . . . 0.0 108.733 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.71 -44.83 37.68 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 56.6 mt -57.21 -35.02 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -1.134 . . . . 0.0 109.026 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -67.11 0.48 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.377 -0.827 . . . . 0.0 108.848 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -47.13 -37.95 10.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.378 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 59.3 tp -61.48 -70.7 0.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.23 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mt -49.35 -24.08 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.921 . . . . 0.0 109.577 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . 0.412 HD23 ' C ' ' D' ' 40' ' ' LEU . 1.7 tt -70.54 -60.68 2.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -0.891 . . . . 0.0 109.759 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -52.26 -46.54 65.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.092 -1.005 . . . . 0.0 109.53 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 54.9 mt -62.63 -55.02 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.179 -0.95 . . . . 0.0 108.878 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 42.3 tp -47.93 -37.59 14.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.542 -0.724 . . . . 0.0 109.744 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -73.72 -28.44 61.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.144 -0.972 . . . . 0.0 109.544 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.37 -20.57 54.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.195 -0.941 . . . . 0.0 110.423 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -80.34 -8.84 59.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.777 -1.202 . . . . 0.0 108.968 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -141.38 100.22 3.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.444 -0.785 . . . . 0.0 109.125 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -151.68 5.68 0.45 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.188 -0.945 . . . . 0.0 109.618 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -76.61 -140.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.447 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 15.3 m 47.37 76.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.872 . . . . 0.0 109.486 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 24.2 mt -99.75 -23.94 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.437 -0.789 . . . . 0.0 109.442 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . 0.401 ' CG ' ' N ' ' D' ' 53' ' ' ARG . 25.6 p90 -57.95 -33.31 68.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.338 -0.851 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . 0.48 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 23.0 ptt180 -65.16 -30.72 71.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -75.12 -34.01 61.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.296 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.9 -44.23 64.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -0.826 . . . . 0.0 109.902 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -72.76 -27.74 62.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.14 -0.975 . . . . 0.0 109.525 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . 0.48 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 0.7 OUTLIER -70.24 -42.52 72.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.913 . . . . 0.0 109.251 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.45 -64.36 2.77 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . 0.438 HD23 ' C ' ' D' ' 59' ' ' LEU . 1.7 tt -56.43 108.58 0.5 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -1.179 . . . . 0.0 109.551 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . 0.413 ' N ' HD23 ' D' ' 59' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.469 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.547 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.9 p30 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.7 Cg_endo -55.64 -17.89 18.86 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.813 2.342 . . . . 0.0 112.381 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 26' ' ' LEU . 22.9 tp -46.25 -43.26 15.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 109.008 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 t -69.34 -45.67 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.328 -0.858 . . . . 0.0 108.888 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.4 t -48.97 -48.5 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.91 . . . . 0.0 109.015 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.95 -35.99 82.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.34 -0.85 . . . . 0.0 109.422 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.02 -56.48 14.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.903 . . . . 0.0 109.737 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -36.82 65.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.236 -0.915 . . . . 0.0 109.923 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.8 mt -72.35 -40.94 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.133 -0.98 . . . . 0.0 109.496 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.1 mt -56.36 -34.12 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.059 -1.025 . . . . 0.0 108.675 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.99 -44.19 24.64 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.7 mt -58.89 -30.86 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.154 -1.204 . . . . 0.0 109.226 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.77 -66.76 0.62 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.286 -0.884 . . . . 0.0 109.059 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -46.12 -37.95 7.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.706 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.2 tp -64.14 -70.24 0.23 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 109.382 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.3 mt -47.32 -35.25 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 0.0 109.693 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mt -63.95 -63.23 1.21 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 109.934 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -45.41 -47.94 13.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.29 -46.77 94.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.395 -0.816 . . . . 0.0 108.916 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.07 -50.02 29.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.582 -0.699 . . . . 0.0 109.327 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.68 -30.78 71.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.392 -0.817 . . . . 0.0 110.289 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -69.25 -26.93 65.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.902 -1.124 . . . . 0.0 110.39 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -71.52 -32.71 68.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.649 -1.282 . . . . 0.0 109.47 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -67.15 -88.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.033 -1.042 . . . . 0.0 109.559 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.2 -168.39 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.1 tttt 48.25 -152.41 0.11 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.142 -0.974 . . . . 0.0 109.271 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.7 p 45.22 59.41 3.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 109.773 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 mt -98.69 -22.95 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 0.0 109.606 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -55.61 -25.3 38.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.971 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.463 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 6.6 ptt180 -67.7 -40.21 84.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.124 -0.985 . . . . 0.0 109.977 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.439 ' N ' ' CG ' ' A' ' 53' ' ' ARG . 54.9 m-85 -71.35 -36.7 71.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.028 -1.045 . . . . 0.0 109.404 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -63.41 -44.74 93.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -0.899 . . . . 0.0 109.219 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -70.28 -28.1 64.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 109.625 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.463 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 20.1 m170 -66.06 -42.29 89.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -0.947 . . . . 0.0 109.272 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.82 -63.4 2.87 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 mt -70.98 119.51 15.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -1.161 . . . . 0.0 109.368 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.4 mttt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.441 -179.949 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' B' ' 26' ' ' LEU . 19.1 t70 50.97 67.36 4.38 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.523 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -46.1 -11.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.673 2.248 . . . . 0.0 112.19 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' B' ' 24' ' ' ASP . 43.6 tp -47.23 -48.25 24.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 108.991 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 45.7 t -67.56 -44.47 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.305 -0.872 . . . . 0.0 108.903 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 77.8 t -49.23 -48.55 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.264 -0.897 . . . . 0.0 109.019 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.7 78.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.912 . . . . 0.0 109.339 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.24 -57.71 6.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 0.0 109.927 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.92 -36.49 62.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 109.806 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 24.0 mt -72.31 -41.63 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 109.424 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 21.9 mt -55.43 -34.82 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.156 -0.965 . . . . 0.0 108.73 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.29 -45.26 31.33 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 47.9 mt -54.97 -37.99 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.199 -1.177 . . . . 0.0 109.496 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.31 -58.31 3.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.173 -0.955 . . . . 0.0 108.818 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -46.8 -41.36 15.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -0.86 . . . . 0.0 109.6 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 51.3 tp -65.78 -70.02 0.26 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.783 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mt -46.57 -26.64 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 109.684 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 6.0 mt -70.19 -62.82 1.24 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.99 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -48.19 -47.74 35.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.069 -1.02 . . . . 0.0 109.674 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' B' ' 45' ' ' ARG . 68.0 mt -63.9 -61.35 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.132 -0.98 . . . . 0.0 109.336 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 60.5 tp -43.74 -42.37 5.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.687 -0.633 . . . . 0.0 109.784 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -69.32 -28.97 66.71 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.257 -0.902 . . . . 0.0 109.469 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' B' ' 42' ' ' ILE . 11.0 mmm180 -78.23 -16.69 57.59 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.218 -0.926 . . . . 0.0 110.105 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -88.8 -9.54 51.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.851 -1.156 . . . . 0.0 109.07 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -47.72 -23.89 0.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.64 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . 0.463 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 2.1 t80 -47.91 106.88 0.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.598 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -160.09 -41.03 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 109.558 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.49 121.96 5.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.189 -0.944 . . . . 0.0 109.598 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 mt -102.72 -24.05 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.568 -0.707 . . . . 0.0 109.286 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' B' ' 52' ' ' TYR . 5.8 p90 -52.3 -28.27 18.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . 0.479 ' O ' ' CG ' ' B' ' 57' ' ' HIS . 7.4 mtt-85 -63.02 -42.56 99.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.978 -1.076 . . . . 0.0 109.564 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -68.18 -35.23 77.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 109.392 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.03 -55.73 15.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.127 -0.983 . . . . 0.0 108.951 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -56.83 -32.18 65.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.381 -0.825 . . . . 0.0 109.562 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . 0.479 ' CG ' ' O ' ' B' ' 53' ' ' ARG . 3.2 m-70 -64.3 -61.16 2.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 109.274 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.55 -59.53 9.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mt -80.06 81.53 6.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.364 -1.08 . . . . 0.0 109.658 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.347 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.551 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 2.3 p30 -165.5 48.84 0.2 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 109.406 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 11.0 Cg_endo -57.01 -14.18 13.75 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.808 2.339 . . . . 0.0 112.083 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 33.7 tp -47.34 -44.32 23.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 108.993 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 36.1 t -69.92 -45.16 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.113 -0.992 . . . . 0.0 108.77 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 54.6 t -49.75 -48.53 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 108.977 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.03 -32.99 74.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 109.376 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.96 -54.96 19.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.913 . . . . 0.0 109.698 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.36 -37.37 75.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.972 . . . . 0.0 109.937 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 20.5 mt -70.74 -42.27 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.107 -0.996 . . . . 0.0 109.118 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . 0.465 HD13 HG13 ' D' ' 35' ' ' ILE . 23.1 mt -55.86 -33.67 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.191 -0.943 . . . . 0.0 108.555 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.08 -44.73 28.6 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 55.2 mt -57.26 -31.99 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.188 -1.184 . . . . 0.0 109.422 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.82 -64.28 1.0 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 108.988 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -45.61 -43.11 11.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.372 -0.83 . . . . 0.0 109.717 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 44.4 tp -60.77 -68.67 0.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 109.508 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.0 mt -47.45 -30.7 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.218 -0.926 . . . . 0.0 109.516 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mt -68.86 -65.61 0.68 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -0.949 . . . . 0.0 109.811 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . 0.414 ' CH2' ' NE ' ' C' ' 45' ' ' ARG . 19.5 t-105 -45.16 -49.38 12.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.858 . . . . 0.0 109.882 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 76.0 mt -61.7 -54.44 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.049 -1.032 . . . . 0.0 109.1 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 60.3 tp -47.91 -44.54 29.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 109.567 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' C' ' 44' ' ' ASP . 0.2 OUTLIER -67.33 -27.99 67.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.784 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.414 ' NE ' ' CH2' ' C' ' 41' ' ' TRP . 0.9 OUTLIER -75.98 -24.11 55.34 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.14 -0.975 . . . . 0.0 110.43 -179.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.4 mt -79.44 -25.53 41.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.759 -1.213 . . . . 0.0 109.224 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -56.42 95.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 109.733 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -156.96 -59.32 0.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.772 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 tttp 54.3 -138.17 1.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.109 -0.994 . . . . 0.0 109.066 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 1.8 t -78.68 170.94 15.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.102 -0.999 . . . . 0.0 109.036 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 9.9 mt -100.87 -26.23 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 0.0 109.802 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.82 -26.03 5.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.942 . . . . 0.0 110.038 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . 0.496 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 11.2 mmt180 -68.48 -43.79 76.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.938 -1.101 . . . . 0.0 109.735 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . 0.458 ' O ' ' CD1' ' D' ' 51' ' ' ILE . 8.0 m-85 -63.75 -36.98 85.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.928 . . . . 0.0 108.779 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.86 -53.73 51.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.469 -0.769 . . . . 0.0 109.158 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -61.6 -33.01 73.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.437 -0.789 . . . . 0.0 109.545 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 2.6 m-70 -59.44 -58.3 9.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 108.936 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.74 -59.99 7.97 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 49.6 mt -71.95 175.66 5.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.344 -1.092 . . . . 0.0 109.213 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.428 179.853 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.332 0.587 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.98 161.09 47.99 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.305 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' D' ' 26' ' ' LEU . 18.6 Cg_endo -63.1 -24.1 73.29 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.496 2.131 . . . . 0.0 112.1 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' D' ' 25' ' ' PRO . 45.3 tp -45.95 -42.63 13.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 108.675 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.9 t -69.76 -44.17 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.292 -0.88 . . . . 0.0 108.806 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 69.9 t -51.4 -50.74 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.061 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.46 -34.53 77.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.745 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.56 -54.55 22.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 109.664 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 2.5 m -57.23 -35.35 69.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -0.953 . . . . 0.0 109.657 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 13.9 mt -72.93 -44.5 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 0.0 109.377 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 30.8 mt -53.87 -35.42 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.133 -0.98 . . . . 0.0 108.735 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.52 -44.39 41.09 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . 0.465 HG13 HD13 ' C' ' 33' ' ' ILE . 65.4 mt -59.34 -43.09 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.241 -1.152 . . . . 0.0 109.208 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.13 -62.64 1.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 109.024 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -45.14 -40.28 6.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.391 -0.818 . . . . 0.0 110.139 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 55.7 tp -65.79 -65.3 0.69 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.115 -0.99 . . . . 0.0 109.571 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 9.8 mt -49.65 -29.48 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.918 . . . . 0.0 109.711 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 6.1 mt -70.09 -56.78 6.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 109.555 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -47.38 -48.37 25.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.307 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 7.2 mt -65.75 -43.3 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.127 -0.983 . . . . 0.0 108.89 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 tp -52.01 -44.63 64.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.428 -0.795 . . . . 0.0 109.921 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -76.24 -24.69 54.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 110.239 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.482 ' O ' ' N ' ' D' ' 47' ' ' PHE . 0.0 OUTLIER -88.69 -3.99 58.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 111.071 -178.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' D' ' 45' ' ' ARG . 27.3 mt -33.93 -35.04 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.696 -0.627 . . . . 0.0 110.449 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . 0.482 ' N ' ' O ' ' D' ' 45' ' ' ARG . 1.8 t80 -169.18 131.03 1.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.92 . . . . 0.0 109.276 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -166.57 97.9 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.112 -0.993 . . . . 0.0 109.708 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -160.58 -25.87 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.254 -0.904 . . . . 0.0 109.457 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t -48.02 110.19 0.3 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . 0.458 ' CD1' ' O ' ' C' ' 54' ' ' PHE . 4.1 mt -84.23 -17.81 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.289 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.83 -37.42 70.31 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.201 -0.937 . . . . 0.0 110.862 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . 0.5 ' O ' ' ND1' ' D' ' 57' ' ' HIS . 78.8 mtm180 -78.16 -41.1 35.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.266 -1.521 . . . . 0.0 111.007 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . 0.459 ' C ' ' CD1' ' D' ' 54' ' ' PHE . 8.3 t80 -71.34 -44.84 64.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.079 -1.013 . . . . 0.0 110.542 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.21 -24.29 47.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.036 -1.04 . . . . 0.0 110.792 -178.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . 0.572 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 88.3 tt0 -80.14 -28.89 38.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.597 -1.314 . . . . 0.0 108.017 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' D' ' 53' ' ' ARG . 11.8 m170 -70.37 -47.07 62.63 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.78 -61.15 6.76 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.35 140.1 55.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.328 -1.101 . . . . 0.0 109.427 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 57.0 tttm . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.477 179.984 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 26' ' ' LEU . 8.2 m-20 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -47.22 -10.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.904 2.403 . . . . 0.0 112.411 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 24' ' ' ASP . 36.7 tp -46.87 -45.55 20.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.13 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 t -70.21 -45.56 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.93 . . . . 0.0 108.715 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.0 t -48.58 -48.26 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.285 -0.884 . . . . 0.0 108.908 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.58 81.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.381 -0.825 . . . . 0.0 109.309 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.05 -55.48 21.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.337 -0.852 . . . . 0.0 109.729 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.16 -37.0 71.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.966 . . . . 0.0 110.005 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.6 mt -71.58 -42.13 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.145 -0.972 . . . . 0.0 109.438 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.455 HD13 HG13 ' B' ' 35' ' ' ILE . 14.8 mt -56.67 -33.29 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.153 -0.967 . . . . 0.0 108.703 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.55 -43.59 29.47 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.0 mt -56.96 -32.23 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.287 -1.125 . . . . 0.0 109.363 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.26 -61.97 1.64 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.136 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -48.6 -39.17 22.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.354 -0.841 . . . . 0.0 109.728 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -66.41 -67.43 0.45 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.919 . . . . 0.0 109.602 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.7 mt -47.3 -27.55 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.529 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mt -67.9 -65.62 0.67 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.272 -0.893 . . . . 0.0 109.823 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.412 ' CH2' ' NE ' ' A' ' 45' ' ' ARG . 24.7 t-105 -48.03 -45.98 32.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.728 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.3 mt -61.6 -54.34 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.157 -0.964 . . . . 0.0 108.894 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.5 tp -47.13 -44.37 21.52 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.579 -0.7 . . . . 0.0 109.638 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.88 -26.16 64.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.222 -0.923 . . . . 0.0 110.089 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.412 ' NE ' ' CH2' ' A' ' 41' ' ' TRP . 0.2 OUTLIER -77.22 -23.42 51.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.978 -1.076 . . . . 0.0 110.387 -179.513 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.1 mt -77.77 -21.14 52.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.8 -1.188 . . . . 0.0 108.956 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 63.27 154.02 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.908 . . . . 0.0 109.39 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -158.65 43.56 0.27 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -0.876 . . . . 0.0 109.379 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.528 ' CD ' ' H ' ' A' ' 50' ' ' SER . 0.6 OUTLIER -163.34 -148.37 0.13 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 109.156 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.528 ' H ' ' CD ' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -132.85 166.26 22.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 0.0 109.368 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.2 mt -99.33 -44.0 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.38 -0.825 . . . . 0.0 109.642 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.432 ' HH ' ' HG ' ' A' ' 50' ' ' SER . 17.3 p90 -56.35 -24.41 43.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.959 . . . . 0.0 109.495 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -69.13 -44.23 72.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.969 . . . . 0.0 109.287 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -64.3 -29.67 70.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.223 -0.923 . . . . 0.0 109.115 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -72.63 -70.23 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.835 . . . . 0.0 109.332 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -46.23 -28.42 1.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 109.518 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -67.4 -61.98 1.64 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.18 -0.95 . . . . 0.0 109.618 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -50.7 -53.12 26.93 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.0 mt -68.72 100.49 1.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -1.186 . . . . 0.0 109.641 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 tttm . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.369 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.443 ' O ' ' O ' ' B' ' 24' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' B' ' 23' ' ' SER . 0.1 OUTLIER 57.38 160.91 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.344 -0.848 . . . . 0.0 109.445 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.36 -22.18 53.05 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.398 2.066 . . . . 0.0 112.017 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 37.1 tp -46.58 -43.87 17.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 108.653 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.43 -42.54 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.36 -0.837 . . . . 0.0 108.889 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 73.9 t -51.34 -50.19 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 109.018 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.83 85.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.311 -0.868 . . . . 0.0 109.38 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.64 -55.28 24.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.73 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.56 -37.0 69.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.714 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 24.5 mt -71.61 -39.74 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.158 -0.963 . . . . 0.0 109.526 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 34.0 mt -58.37 -34.23 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.157 -0.965 . . . . 0.0 108.742 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.88 -41.86 32.19 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.455 HG13 HD13 ' A' ' 33' ' ' ILE . 79.4 mt -62.74 -36.46 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.32 -1.106 . . . . 0.0 109.119 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.79 -62.47 1.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.023 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -46.42 -40.59 12.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 109.684 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 59.2 tp -63.19 -70.48 0.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.777 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 8.4 mt -47.0 -33.34 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.485 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mt -64.45 -58.69 5.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.425 -0.797 . . . . 0.0 109.535 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -46.28 -44.79 16.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 109.65 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 11.1 mt -70.53 -33.6 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.117 -0.989 . . . . 0.0 109.446 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 tp -59.11 -43.86 91.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 110.203 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -82.54 -22.76 34.84 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 110.514 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -82.05 -16.22 50.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.89 -1.131 . . . . 0.0 111.006 -179.212 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' B' ' 46' ' ' LEU . 21.9 mt -44.58 -19.16 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.904 -1.122 . . . . 0.0 109.472 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' B' ' 45' ' ' ARG . 93.7 t80 -49.77 97.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.122 -0.987 . . . . 0.0 109.355 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . 0.426 ' N ' ' O ' ' B' ' 46' ' ' LEU . 58.6 t80 -168.54 65.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.882 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.404 ' CG ' ' H ' ' B' ' 50' ' ' SER . 14.3 pttt -158.81 -107.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.83 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . 0.404 ' H ' ' CG ' ' B' ' 49' ' ' LYS . 41.4 t -80.76 129.17 34.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 109.957 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 32.8 mt -106.04 -32.09 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.633 -0.667 . . . . 0.0 109.438 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -46.48 -27.78 1.2 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 0.0 109.934 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 43.4 mtt-85 -65.91 -41.93 90.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.119 -0.988 . . . . 0.0 109.69 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -68.4 -33.51 74.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 109.7 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.14 -46.67 76.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.946 . . . . 0.0 109.377 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -69.56 -33.87 73.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.608 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -64.37 -33.62 76.26 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.159 -0.963 . . . . 0.0 108.756 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.04 -63.9 2.01 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mt -55.42 126.34 24.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -1.159 . . . . 0.0 109.105 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.35 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.486 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 67.2 m-20 51.17 52.32 11.89 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.652 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 11.6 Cg_endo -58.36 -16.4 28.61 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.666 2.244 . . . . 0.0 112.254 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' C' ' 26' ' ' LEU . 31.4 tp -46.23 -44.44 16.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.214 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 40.4 t -69.16 -44.56 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.258 -0.901 . . . . 0.0 108.907 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -49.6 -49.14 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.153 -0.967 . . . . 0.0 108.96 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.55 -33.07 75.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.863 . . . . 0.0 109.27 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.08 -56.95 8.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 109.669 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.9 -35.46 69.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.887 . . . . 0.0 109.924 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 24.4 mt -72.78 -43.99 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 0.0 109.531 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . 0.455 HD13 HG13 ' D' ' 35' ' ' ILE . 26.6 mt -54.83 -35.27 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.16 -0.963 . . . . 0.0 108.792 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.23 -44.75 42.55 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 58.1 mt -57.67 -27.22 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.273 -1.134 . . . . 0.0 109.203 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.93 -67.36 0.68 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.22 -0.925 . . . . 0.0 109.08 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -46.22 -43.17 15.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.491 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.88 -67.49 0.4 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 109.403 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -47.85 -28.75 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.326 -0.858 . . . . 0.0 109.864 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -67.92 -64.28 0.89 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.793 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . 0.519 ' CH2' ' NE ' ' C' ' 45' ' ' ARG . 30.5 t-105 -48.01 -45.58 31.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.22 -0.925 . . . . 0.0 109.634 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 82.7 mt -63.34 -48.53 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.174 -0.954 . . . . 0.0 108.936 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.7 tp -53.42 -33.28 53.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.635 -0.665 . . . . 0.0 110.126 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.3 -25.01 31.92 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.168 -0.958 . . . . 0.0 109.947 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.519 ' NE ' ' CH2' ' C' ' 41' ' ' TRP . 0.1 OUTLIER -75.36 -27.97 59.36 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.087 -1.008 . . . . 0.0 110.493 -179.311 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' C' ' 47' ' ' PHE . 9.8 mt -61.51 -30.71 70.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.612 -1.305 . . . . 0.0 108.946 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.408 ' O ' ' O ' ' C' ' 46' ' ' LEU . 54.8 m-85 -61.22 -111.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.101 -0.999 . . . . 0.0 108.833 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.514 ' CG ' ' O ' ' C' ' 48' ' ' PHE . 8.6 t80 45.77 83.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -0.869 . . . . 0.0 109.667 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . 0.521 ' CD ' ' H ' ' C' ' 50' ' ' SER . 0.2 OUTLIER -85.07 -152.71 0.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.147 -0.97 . . . . 0.0 108.725 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . 0.521 ' H ' ' CD ' ' C' ' 49' ' ' LYS . 0.2 OUTLIER -60.6 -173.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.84 -1.163 . . . . 0.0 109.436 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 45.5 mt -108.64 -27.66 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.59 -0.694 . . . . 0.0 109.272 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -36.29 70.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.996 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -65.83 -34.83 79.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.076 -1.015 . . . . 0.0 109.559 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -68.49 -35.98 78.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.391 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -69.99 -40.62 75.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.918 . . . . 0.0 109.478 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.48 -25.13 63.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 109.49 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.75 -46.5 45.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.195 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.43 -65.99 2.27 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mt -58.81 118.79 6.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -1.124 . . . . 0.0 109.73 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 11.5 tttm . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.602 -179.974 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 41.7 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' D' ' 24' ' ' ASP . 2.8 p-10 -165.51 68.17 1.21 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -46.14 -11.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.793 2.329 . . . . 0.0 112.34 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' D' ' 24' ' ' ASP . 34.2 tp -47.21 -46.3 23.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 109.212 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 43.9 t -69.48 -44.32 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 108.754 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 78.0 t -49.92 -48.08 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.348 -0.845 . . . . 0.0 109.054 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.2 -34.42 77.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 109.547 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.81 -55.4 17.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.649 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.37 -37.29 69.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.213 -0.929 . . . . 0.0 109.842 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 20.6 mt -71.58 -40.39 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.6 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 26.8 mt -57.71 -35.21 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 0.0 108.795 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.47 -42.69 47.65 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . 0.455 HG13 HD13 ' C' ' 33' ' ' ILE . 74.6 mt -62.69 -30.49 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.362 -1.081 . . . . 0.0 109.45 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.53 -60.1 2.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 109.081 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -48.98 -40.57 31.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.959 . . . . 0.0 109.542 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.1 tp -62.9 -68.42 0.34 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.194 -0.942 . . . . 0.0 109.412 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 mt -47.15 -31.77 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.455 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.3 mt -68.26 -57.97 5.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.39 -0.819 . . . . 0.0 109.798 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -46.64 -44.52 18.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.403 -0.811 . . . . 0.0 109.621 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mt -72.25 -38.33 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.051 -1.031 . . . . 0.0 109.426 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 44.5 tp -57.85 -41.35 82.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.929 . . . . 0.0 110.106 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -82.64 -24.0 34.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.096 -1.003 . . . . 0.0 109.813 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' D' ' 47' ' ' PHE . 11.9 mmt180 -89.82 -1.66 58.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.171 -0.955 . . . . 0.0 110.83 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . 0.478 ' C ' ' O ' ' D' ' 45' ' ' ARG . 31.4 mt -31.99 -35.77 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.768 -0.583 . . . . 0.0 110.581 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' D' ' 45' ' ' ARG . 88.1 t80 -172.75 7.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.525 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.51 113.55 0.72 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.564 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -163.54 -37.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.377 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 44.5 m -54.53 134.94 46.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -0.85 . . . . 0.0 109.634 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 8.7 mt -104.06 -26.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.656 -0.652 . . . . 0.0 109.379 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -47.64 -42.05 23.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.871 . . . . 0.0 109.89 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -45.74 72.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 0.0 109.712 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -62.46 -36.48 82.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 109.591 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -63.27 -66.67 0.51 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.435 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -45.86 -34.91 4.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.347 -0.846 . . . . 0.0 109.863 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -63.55 -60.99 2.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.129 -0.982 . . . . 0.0 109.522 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -47.51 -59.77 5.71 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mt -70.11 118.53 13.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.274 -1.133 . . . . 0.0 109.577 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 24.1 mttm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.573 179.893 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.83 -11.85 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.66 2.24 . . . . 0.0 112.192 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 26' ' ' LEU . 46.1 tp -47.96 -47.16 32.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.13 -0.981 . . . . 0.0 108.899 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.0 t -67.93 -44.22 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.321 -0.862 . . . . 0.0 108.878 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.9 t -49.34 -50.66 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 108.951 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.39 80.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.406 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.32 -57.41 9.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.654 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.21 -36.08 63.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 110.013 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.6 mt -73.12 -41.51 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.006 . . . . 0.0 109.703 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.27 -36.68 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.987 -1.07 . . . . 0.0 108.641 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.38 -44.28 42.77 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.9 mt -56.31 -39.05 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.03 -1.276 . . . . 0.0 109.387 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.83 -54.64 14.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.126 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -48.61 -42.88 35.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.838 . . . . 0.0 109.881 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.2 tp -67.16 -65.47 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 109.684 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.9 mt -46.65 -27.41 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 109.43 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mt -69.48 -61.8 1.64 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.383 -0.823 . . . . 0.0 109.727 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.476 ' NE1' ' OD2' ' D' ' 44' ' ' ASP . 55.8 t-105 -47.84 -46.04 30.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 0.0 109.413 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.2 mt -64.17 -55.7 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.197 -0.939 . . . . 0.0 109.135 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.2 tp -45.27 -43.7 10.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.583 -0.698 . . . . 0.0 110.313 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.04 -27.63 54.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.034 -1.041 . . . . 0.0 110.556 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -72.47 -22.24 61.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.793 -1.192 . . . . 0.0 110.487 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.3 mt -68.64 -12.06 60.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.657 -1.277 . . . . 0.0 108.986 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -82.5 137.86 34.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.331 -0.856 . . . . 0.0 109.183 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -151.07 174.9 12.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.148 -0.97 . . . . 0.0 109.513 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.402 ' CG ' ' H ' ' A' ' 50' ' ' SER . 15.3 tttp 47.37 -143.28 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.364 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.402 ' H ' ' CG ' ' A' ' 49' ' ' LYS . 18.8 p 51.48 42.25 29.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.478 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 mt -80.67 -31.02 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 109.158 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.557 ' CG ' ' N ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -46.08 -42.69 13.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.789 . . . . 0.0 109.887 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.557 ' N ' ' CG ' ' A' ' 52' ' ' TYR . 1.2 mtp180 -50.61 -61.84 1.95 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 0.0 110.665 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -70.63 -26.58 63.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.885 -1.134 . . . . 0.0 110.061 -179.076 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -46.41 80.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.904 -1.122 . . . . 0.0 109.371 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -76.39 -27.5 56.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.673 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -61.97 -50.56 71.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.211 -0.93 . . . . 0.0 109.317 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.81 -59.51 3.7 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.9 mt -64.53 -167.85 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -1.169 . . . . 0.0 109.853 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.054 -0.975 . . . . 0.0 109.421 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 92.0 p . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.517 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 6.0 m-20 -153.61 50.4 0.57 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 109.532 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 11.7 Cg_endo -57.97 -14.47 18.66 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.793 2.329 . . . . 0.0 112.066 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 33.3 tp -46.17 -45.82 16.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.36 -0.837 . . . . 0.0 109.255 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 36.0 t -69.19 -44.72 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.24 -0.913 . . . . 0.0 108.927 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 72.5 t -49.18 -49.11 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 109.096 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.73 -33.73 76.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.289 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.86 -56.8 9.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.337 -0.852 . . . . 0.0 109.825 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.83 -37.2 70.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.877 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 33.4 mt -71.25 -41.22 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.058 -1.026 . . . . 0.0 109.499 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 24.0 mt -57.08 -34.14 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 108.559 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.11 -43.94 24.82 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 53.9 mt -56.11 -35.29 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.177 -1.19 . . . . 0.0 109.235 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -61.53 1.73 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.22 -0.925 . . . . 0.0 109.073 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . 0.438 ' NE2' ' ND1' ' C' ' 37' ' ' HIS . 1.8 t-80 -46.83 -41.91 16.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 109.771 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -62.3 -69.75 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.166 -0.959 . . . . 0.0 109.591 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.3 mt -46.11 -38.26 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.34 -0.85 . . . . 0.0 109.36 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mt -59.37 -62.4 1.91 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.45 -0.781 . . . . 0.0 109.967 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -44.99 -49.38 11.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.424 -0.798 . . . . 0.0 109.649 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.407 HD13 HG21 ' B' ' 42' ' ' ILE . 34.1 mt -59.79 -48.61 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.12 -0.988 . . . . 0.0 108.52 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.62 -57.41 4.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.55 -0.719 . . . . 0.0 109.453 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.0 -31.34 68.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.848 . . . . 0.0 110.41 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.455 ' CA ' ' HE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -71.92 -23.43 61.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.873 -1.142 . . . . 0.0 110.471 -179.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.0 mt -75.93 -34.01 59.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.699 -1.251 . . . . 0.0 108.887 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -48.42 101.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.912 . . . . 0.0 109.435 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . 0.4 ' H ' ' H ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -163.5 -3.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.4 ' H ' ' H ' ' B' ' 48' ' ' PHE . 10.8 mtmm -67.21 -118.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.55 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 10.3 p -53.18 104.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.324 -0.86 . . . . 0.0 109.718 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 11.4 mt -102.21 -24.85 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.479 -0.763 . . . . 0.0 109.17 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -54.46 -24.94 22.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.854 . . . . 0.0 109.748 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 -65.87 -38.77 89.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.522 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -71.01 -36.65 72.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 109.166 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -69.46 -46.77 65.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.405 -0.809 . . . . 0.0 109.162 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -64.02 -27.88 69.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 108.933 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -69.38 -46.63 66.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.403 -0.811 . . . . 0.0 109.545 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.0 -61.22 6.0 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 73.0 mt -60.86 -178.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -1.127 . . . . 0.0 109.808 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.436 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' C' ' 26' ' ' LEU . 20.2 t0 -168.94 65.38 0.6 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.899 . . . . 0.0 109.463 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -45.18 -11.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.749 2.299 . . . . 0.0 112.14 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' C' ' 24' ' ' ASP . 22.2 tp -47.69 -46.33 29.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.144 -0.972 . . . . 0.0 109.107 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 41.5 t -68.15 -44.93 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.213 -0.929 . . . . 0.0 108.581 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.2 t -50.03 -49.39 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.334 -0.854 . . . . 0.0 108.788 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.28 -30.19 71.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.355 -0.841 . . . . 0.0 109.288 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.96 -56.83 6.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.0 109.602 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.31 -36.97 66.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.947 . . . . 0.0 109.525 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 36.3 mt -72.71 -42.5 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.16 -0.963 . . . . 0.0 109.412 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 20.3 mt -55.88 -34.33 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.122 -0.986 . . . . 0.0 108.629 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.26 -45.33 31.28 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 65.4 mt -58.38 -34.66 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.277 -1.131 . . . . 0.0 108.993 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.98 -67.89 0.41 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 108.908 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . 0.438 ' ND1' ' NE2' ' B' ' 37' ' ' HIS . 4.3 t-80 -45.83 -36.82 5.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.813 . . . . 0.0 109.656 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.89 -69.61 0.28 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 109.517 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 7.9 mt -48.11 -30.12 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 109.751 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . 0.408 HD12 HD11 ' D' ' 38' ' ' LEU . 2.3 mt -68.1 -63.56 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.109 -0.995 . . . . 0.0 109.718 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 -44.45 -48.69 10.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.338 -0.851 . . . . 0.0 110.06 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 54.2 mt -63.89 -58.28 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.046 -1.034 . . . . 0.0 109.108 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 54.1 tp -45.12 -40.19 6.72 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.533 -0.73 . . . . 0.0 109.99 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . 0.42 ' O ' ' CE2' ' C' ' 48' ' ' PHE . 0.4 OUTLIER -73.18 -28.39 62.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 109.638 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.438 ' HE ' ' CA ' ' C' ' 45' ' ' ARG . 0.0 OUTLIER -76.55 -18.76 58.51 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.212 -0.93 . . . . 0.0 110.196 -179.57 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' C' ' 47' ' ' PHE . 8.3 mt -83.93 -31.18 25.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.797 -1.189 . . . . 0.0 108.885 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.464 ' C ' ' CG ' ' C' ' 48' ' ' PHE . 2.4 m-85 -52.92 -174.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 109.652 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.464 ' CG ' ' C ' ' C' ' 47' ' ' PHE . 0.8 OUTLIER 67.02 -66.51 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 0.0 109.811 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' C' ' 47' ' ' PHE . 10.8 tttp 52.33 -93.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.353 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . 0.451 ' N ' ' O ' ' C' ' 48' ' ' PHE . 68.1 m -63.27 148.41 48.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.136 -0.977 . . . . 0.0 109.389 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 11.6 mt -103.31 -27.55 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.562 -0.711 . . . . 0.0 109.697 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -52.88 -18.66 2.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.934 . . . . 0.0 109.715 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . 0.49 ' O ' ' CD2' ' C' ' 57' ' ' HIS . 9.5 mtp180 -72.64 -42.16 64.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.865 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.7 -38.03 83.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.935 . . . . 0.0 109.37 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -64.15 -59.3 4.59 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.352 -0.843 . . . . 0.0 109.249 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -55.88 -29.4 59.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.547 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . 0.49 ' CD2' ' O ' ' C' ' 53' ' ' ARG . 10.9 m170 -69.01 -52.89 24.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.204 -0.935 . . . . 0.0 109.312 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.16 -63.93 4.0 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.461 ' C ' HD13 ' C' ' 59' ' ' LEU . 0.5 OUTLIER -70.71 105.17 3.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -1.187 . . . . 0.0 109.108 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.396 179.947 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.526 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 2.8 m-20 -155.81 49.85 0.45 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.527 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 11.0 Cg_endo -57.65 -7.13 2.86 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.768 2.312 . . . . 0.0 112.138 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' D' ' 26' ' ' LEU . 33.7 tp -49.23 -48.8 45.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 108.924 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 98.5 t -67.11 -44.87 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 108.724 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 73.5 t -48.67 -50.03 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 108.974 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.75 -33.8 76.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -0.856 . . . . 0.0 109.173 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.25 -57.55 8.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 109.635 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.35 -35.86 65.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.189 -0.944 . . . . 0.0 109.949 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 21.8 mt -72.94 -42.45 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.123 -0.985 . . . . 0.0 109.485 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 mt -55.04 -35.85 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.974 -1.079 . . . . 0.0 108.573 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.67 -45.14 46.4 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 57.9 mt -56.79 -37.74 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -1.171 . . . . 0.0 109.129 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' D' ' 37' ' ' HIS . 0.7 OUTLIER -66.4 -68.47 0.37 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.902 . . . . 0.0 109.342 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' D' ' 36' ' ' LEU . 1.6 t-80 -42.76 -33.18 0.7 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.438 -0.789 . . . . 0.0 110.161 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . 0.408 HD11 HD12 ' C' ' 40' ' ' LEU . 50.3 tp -70.36 -71.21 0.25 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.947 . . . . 0.0 109.672 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mt -49.16 -29.4 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 109.498 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 tt -72.64 -59.66 2.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.457 -0.777 . . . . 0.0 109.648 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 17.0 t-105 -45.1 -54.28 6.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.71 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.62 -46.45 79.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.204 -0.935 . . . . 0.0 108.867 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.53 -48.77 14.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.588 -0.695 . . . . 0.0 109.722 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . 0.476 ' OD2' ' NE1' ' A' ' 41' ' ' TRP . 0.7 OUTLIER -66.97 -33.87 76.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -0.873 . . . . 0.0 110.184 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -68.34 -23.86 64.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.091 -1.006 . . . . 0.0 110.577 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -75.82 -34.37 60.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.663 -1.273 . . . . 0.0 109.089 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -52.58 115.78 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.4 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -172.11 132.77 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 0.0 109.486 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -154.27 -42.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 109.708 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 4.5 m -165.77 159.18 15.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.655 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 9.2 mt -103.97 -25.27 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.613 -0.679 . . . . 0.0 109.369 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -52.01 -19.04 1.63 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.328 -0.857 . . . . 0.0 109.852 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -71.63 -41.03 69.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.069 -1.019 . . . . 0.0 109.682 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -70.71 -32.48 69.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.096 -1.003 . . . . 0.0 109.148 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -68.37 -42.84 78.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.265 -0.897 . . . . 0.0 109.401 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -72.73 -28.2 62.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.287 -0.883 . . . . 0.0 109.288 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -66.21 -44.3 84.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 108.761 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.33 -63.36 3.81 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.5 125.62 24.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.349 -1.089 . . . . 0.0 109.233 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 61.2 mttt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.889 -1.053 . . . . 0.0 109.425 -179.906 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 26' ' ' LEU . 1.3 m-20 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -47.99 -8.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.928 2.418 . . . . 0.0 112.476 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 24' ' ' ASP . 36.4 tp -48.46 -47.48 38.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.099 -1.001 . . . . 0.0 108.923 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.2 t -67.54 -45.03 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.0 108.639 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.0 t -49.28 -46.8 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.5 81.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.241 -0.912 . . . . 0.0 109.228 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.64 -56.67 10.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 0.0 109.682 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -36.41 64.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.26 -0.9 . . . . 0.0 109.738 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.0 mt -72.7 -41.98 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 109.565 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 mt -56.13 -35.52 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.099 -1.001 . . . . 0.0 108.786 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.85 -44.99 45.48 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.3 mt -59.16 -33.9 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 121.297 -1.119 . . . . 0.0 109.376 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.56 -66.13 0.61 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.389 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -44.4 -45.39 8.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.325 -0.859 . . . . 0.0 110.235 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.5 tp -59.05 -66.07 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.097 -1.002 . . . . 0.0 109.598 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mt -48.8 -47.51 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.165 -0.96 . . . . 0.0 109.626 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 mt -56.45 -55.18 36.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 110.13 -179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -48.54 -49.54 35.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.038 -1.039 . . . . 0.0 109.691 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.3 mt -60.6 -57.27 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.244 -0.91 . . . . 0.0 109.126 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.0 tp -50.3 -21.56 1.44 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.675 -0.64 . . . . 0.0 110.247 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -90.77 -26.73 19.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.971 . . . . 0.0 110.009 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 43.9 mtp85 -81.63 -21.87 37.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.163 -0.96 . . . . 0.0 110.721 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -69.16 -31.8 70.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.667 -1.271 . . . . 0.0 108.91 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -98.1 124.35 42.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.433 -0.792 . . . . 0.0 109.212 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -168.44 -8.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.143 -0.973 . . . . 0.0 109.878 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.525 ' CG ' ' H ' ' A' ' 50' ' ' SER . 1.3 tpmt? -72.95 -149.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.176 -0.953 . . . . 0.0 109.312 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.525 ' H ' ' CG ' ' A' ' 49' ' ' LYS . 59.0 p 46.33 71.61 0.29 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.56 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.7 mt -94.45 -25.16 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.559 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -61.23 -26.18 67.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 109.466 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -68.62 -37.6 79.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.079 -1.013 . . . . 0.0 109.359 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -74.19 -41.29 61.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.151 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -62.34 -42.98 99.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.335 -0.853 . . . . 0.0 109.405 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -73.61 -26.34 60.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.185 -0.947 . . . . 0.0 109.276 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.476 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 12.3 t-80 -69.91 -31.19 68.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.17 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.32 -63.68 1.77 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mt -57.94 112.13 1.39 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -1.183 . . . . 0.0 109.234 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.593 -179.869 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' B' ' 24' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.552 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 23.9 m-20 -151.34 49.27 0.56 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.462 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 9.8 Cg_endo -56.16 -10.96 5.09 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.724 2.282 . . . . 0.0 112.02 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 28.6 tp -47.01 -47.24 22.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.063 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 41.0 t -67.69 -45.3 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.887 . . . . 0.0 108.937 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -48.79 -48.9 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 108.994 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.43 -33.46 75.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.4 -0.813 . . . . 0.0 109.184 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.91 -58.01 6.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.675 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -55.22 -35.5 64.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.797 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 36.8 mt -73.45 -41.26 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.121 -0.987 . . . . 0.0 109.745 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 24.1 mt -55.98 -35.41 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.992 -1.068 . . . . 0.0 108.661 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.76 -45.4 34.79 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mt -55.26 -30.58 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.23 -1.159 . . . . 0.0 109.096 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.07 -65.64 0.82 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.228 -0.92 . . . . 0.0 109.055 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -46.48 -34.87 5.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.619 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.75 -71.24 0.22 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 109.469 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.9 mt -46.78 -37.41 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.324 -0.86 . . . . 0.0 109.397 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.439 ' C ' HD23 ' B' ' 40' ' ' LEU . 2.7 tt -58.92 -62.91 1.53 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.489 -0.757 . . . . 0.0 109.662 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 10.9 t-105 -47.41 -52.44 16.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.828 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 57.0 mt -55.02 -48.19 76.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.989 -1.069 . . . . 0.0 108.681 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.11 -50.63 11.0 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.39 0.614 . . . . 0.0 109.476 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.483 ' CG ' HH11 ' C' ' 45' ' ' ARG . 37.7 m-20 -62.16 -32.68 73.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.342 -0.849 . . . . 0.0 109.521 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.522 ' CA ' ' HE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -72.39 -20.52 61.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.115 -0.99 . . . . 0.0 110.183 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -85.83 -34.3 21.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.699 -1.251 . . . . 0.0 108.961 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . 0.491 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 59.1 t80 -59.01 96.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.286 -0.884 . . . . 0.0 109.378 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' B' ' 47' ' ' PHE . 8.5 m-85 -165.9 97.82 0.64 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.688 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -150.41 -80.9 0.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.935 . . . . 0.0 109.552 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 16.4 m -80.4 106.14 12.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.937 . . . . 0.0 109.548 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 13.7 mt -92.29 -23.48 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.897 . . . . 0.0 109.562 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.428 ' CD1' ' C ' ' B' ' 52' ' ' TYR . 1.4 p90 -64.64 -17.09 63.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 109.214 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -43.87 64.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 109.783 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -68.63 -32.93 73.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.511 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -70.66 -44.3 67.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.692 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.99 -29.39 68.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 109.512 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -68.67 -47.79 65.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.877 . . . . 0.0 109.177 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.0 -64.31 3.48 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.22 120.63 8.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.292 -1.122 . . . . 0.0 109.469 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.485 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 74.0 m . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.297 0.57 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' C' ' 26' ' ' LEU . 25.4 t0 55.27 66.81 3.55 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.508 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -46.51 -11.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.717 2.278 . . . . 0.0 111.974 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' C' ' 24' ' ' ASP . 40.5 tp -47.49 -45.04 25.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.423 -0.798 . . . . 0.0 109.059 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 51.5 t -69.85 -45.19 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 108.755 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 78.9 t -48.45 -48.22 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -0.865 . . . . 0.0 108.846 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.5 -35.45 80.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.355 -0.841 . . . . 0.0 109.107 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.29 -57.36 10.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.46 -0.775 . . . . 0.0 109.851 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -56.42 -35.71 68.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.757 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.4 mt -71.47 -39.76 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.114 -0.991 . . . . 0.0 109.355 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 32.2 mt -58.15 -35.14 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.012 -1.055 . . . . 0.0 108.423 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.64 -45.15 54.86 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 75.3 mt -61.69 -23.06 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.298 -1.119 . . . . 0.0 108.73 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.1 -70.83 0.39 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.385 -0.822 . . . . 0.0 109.404 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -45.36 -37.05 4.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.312 -0.868 . . . . 0.0 109.676 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.93 -68.05 0.37 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 0.0 109.412 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 5.4 mt -51.98 -27.69 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.947 . . . . 0.0 109.584 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.22 -61.49 1.76 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 0.0 109.598 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -46.91 -43.75 19.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 109.646 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 64.6 mt -67.68 -40.05 83.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.261 -0.899 . . . . 0.0 109.249 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 57.6 tp -58.68 -36.35 74.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.577 -0.702 . . . . 0.0 110.217 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -86.4 -20.44 28.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.106 -0.997 . . . . 0.0 110.158 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.483 HH11 ' CG ' ' B' ' 44' ' ' ASP . 1.6 mmp_? -78.45 -27.23 46.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.952 -1.093 . . . . 0.0 110.549 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -52.14 -12.9 0.27 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.563 -1.336 . . . . 0.0 108.864 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . 0.431 ' N ' ' C ' ' C' ' 45' ' ' ARG . 53.6 m-85 -93.13 101.75 14.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.887 . . . . 0.0 109.724 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -168.23 -20.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 0.0 109.559 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.74 -70.25 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.166 -0.959 . . . . 0.0 109.369 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 64.0 p -68.49 110.88 4.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.174 -0.954 . . . . 0.0 109.365 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 11.2 mt -105.95 -25.17 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.576 -0.703 . . . . 0.0 109.803 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -28.29 23.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.93 . . . . 0.0 109.752 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -65.91 -42.79 89.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 0.0 109.817 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -64.96 -34.96 79.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.309 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -63.69 -59.53 4.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.338 -0.851 . . . . 0.0 109.227 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -54.72 -31.01 57.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 109.732 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -65.73 -42.96 90.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -0.976 . . . . 0.0 109.335 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.13 -61.5 5.13 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 54.0 mt -74.91 156.8 35.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -1.147 . . . . 0.0 109.591 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.377 179.968 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.237 0.542 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' D' ' 26' ' ' LEU . 1.5 m-20 51.0 66.97 4.75 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.93 . . . . 0.0 109.617 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -46.44 -10.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.785 2.323 . . . . 0.0 112.353 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' D' ' 24' ' ' ASP . 26.3 tp -47.26 -45.89 24.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 109.079 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 39.0 t -69.29 -45.14 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.1 t -49.4 -48.92 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 108.78 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.93 -32.88 74.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.341 -0.85 . . . . 0.0 109.184 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.3 -56.89 10.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.388 -0.82 . . . . 0.0 109.741 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -56.1 -36.34 68.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.783 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.07 -40.54 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.114 -0.991 . . . . 0.0 109.395 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 25.0 mt -57.18 -34.06 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.124 -0.985 . . . . 0.0 108.543 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.46 -44.52 27.01 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 61.7 mt -57.9 -29.5 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.152 -1.204 . . . . 0.0 109.022 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.48 -66.62 0.67 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.427 -0.796 . . . . 0.0 109.252 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -46.53 -39.92 11.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.834 . . . . 0.0 109.927 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.7 -67.54 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.064 -1.022 . . . . 0.0 109.757 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mt -48.85 -40.48 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.152 -0.968 . . . . 0.0 109.541 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . 0.537 HD23 ' O ' ' D' ' 40' ' ' LEU . 2.5 tt -55.79 -55.4 32.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.844 . . . . 0.0 109.915 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -53.06 -48.69 67.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.074 -1.016 . . . . 0.0 110.077 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 68.2 mt -60.18 -49.48 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.107 -0.996 . . . . 0.0 109.152 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 tp -49.37 -40.29 35.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.497 -0.752 . . . . 0.0 110.093 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -74.01 -27.65 61.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.206 -0.934 . . . . 0.0 109.808 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -74.65 -24.25 58.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 110.494 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -74.48 -9.5 58.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.68 -1.262 . . . . 0.0 109.086 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -142.84 89.24 2.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.453 -0.779 . . . . 0.0 109.466 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . 0.415 ' O ' ' O ' ' D' ' 49' ' ' LYS . 2.7 t80 -151.76 -3.96 0.27 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 0.0 109.515 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' D' ' 48' ' ' PHE . 4.1 mtmt -63.02 -134.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.413 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 21.3 t 51.36 79.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 109.521 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 47.8 mt -95.74 -37.58 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.845 . . . . 0.0 109.334 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . 0.521 ' CD2' ' N ' ' D' ' 53' ' ' ARG . 21.2 p90 -52.23 -43.96 64.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.107 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . 0.521 ' N ' ' CD2' ' D' ' 52' ' ' TYR . 0.9 OUTLIER -62.84 -18.07 62.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 108.844 179.32 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -69.32 -46.86 66.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.367 -0.833 . . . . 0.0 109.128 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' D' ' 55' ' ' PHE . 1.1 m-85 -74.18 -52.96 10.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.062 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -49.2 -35.11 16.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.423 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . 0.496 ' CD2' ' O ' ' D' ' 53' ' ' ARG . 12.4 m170 -70.64 -57.69 4.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 109.642 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -50.46 -56.98 11.18 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 4.7 mt -70.91 124.01 23.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -1.127 . . . . 0.0 109.492 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 35.3 tttm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.461 179.834 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.66 -11.16 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.638 2.225 . . . . 0.0 112.439 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.2 tp -47.43 -47.88 26.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.039 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.9 -44.99 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -0.841 . . . . 0.0 108.824 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -49.38 -47.76 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.269 -0.895 . . . . 0.0 108.718 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.36 83.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.622 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.33 -53.7 39.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -0.915 . . . . 0.0 109.61 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -37.3 71.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.794 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.4 mt -72.29 -41.52 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.144 -0.972 . . . . 0.0 109.563 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.3 mt -56.88 -35.2 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.013 -1.055 . . . . 0.0 108.693 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.5 -42.98 46.5 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.416 HG13 HD13 ' D' ' 33' ' ' ILE . 73.2 mt -62.18 -27.17 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.336 -1.097 . . . . 0.0 109.148 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.92 -63.63 1.13 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.363 -0.835 . . . . 0.0 108.982 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -45.8 -40.64 9.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 0.0 109.94 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -64.3 -67.66 0.41 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.587 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.2 mt -47.36 -35.63 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.279 -0.888 . . . . 0.0 109.106 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 43' ' ' LEU . 2.5 mt -62.34 -61.61 2.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.615 -0.678 . . . . 0.0 109.682 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -43.3 -46.46 6.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.613 -0.679 . . . . 0.0 109.796 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.3 mt -71.88 -28.05 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 108.985 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 40' ' ' LEU . 6.6 tp -63.75 -41.93 97.93 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.274 -0.891 . . . . 0.0 109.907 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -83.95 -23.59 31.04 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.293 -0.88 . . . . 0.0 109.813 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' PHE . 8.4 mmt85 -95.47 3.17 54.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.252 -0.905 . . . . 0.0 110.865 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.488 ' C ' ' O ' ' A' ' 45' ' ' ARG . 34.4 mt -31.17 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.783 -0.573 . . . . 0.0 110.816 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 45' ' ' ARG . 2.2 m-85 -171.9 -170.86 0.81 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.114 -0.991 . . . . 0.0 109.74 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.528 ' O ' ' N ' ' A' ' 50' ' ' SER . 3.3 p90 -137.88 -1.93 1.96 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.467 -0.77 . . . . 0.0 109.552 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp 47.99 -91.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.88 . . . . 0.0 109.525 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -148.13 177.63 9.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -0.882 . . . . 0.0 109.43 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 mt -102.35 -24.29 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.491 -0.756 . . . . 0.0 109.489 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -52.63 -21.35 3.84 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.223 -0.923 . . . . 0.0 109.448 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -67.47 -43.48 80.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.36 -0.837 . . . . 0.0 109.9 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -69.98 -39.55 75.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.973 . . . . 0.0 109.371 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -55.01 -51.5 66.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.348 -0.845 . . . . 0.0 109.641 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -71.23 -25.11 62.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.31 -0.869 . . . . 0.0 109.794 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -67.44 -37.59 83.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 0.0 109.611 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.25 -62.83 1.77 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.4 mt -72.26 84.85 1.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -1.215 . . . . 0.0 109.622 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 pttt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.421 179.804 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 34.6 p . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' B' ' 26' ' ' LEU . 5.7 m-20 -149.42 64.88 7.54 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.589 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -44.54 -9.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.972 2.448 . . . . 0.0 112.524 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' B' ' 24' ' ' ASP . 42.7 tp -47.34 -46.13 25.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.123 -0.985 . . . . 0.0 109.261 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 35.1 t -68.14 -45.13 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 108.924 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 78.2 t -48.38 -47.65 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.877 . . . . 0.0 109.138 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.54 -37.45 86.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.35 -0.844 . . . . 0.0 109.4 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.07 -55.9 21.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 109.569 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 2.1 m -56.31 -34.74 66.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 109.887 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.83 -43.48 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.14 -0.975 . . . . 0.0 109.323 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 11.7 mt -54.59 -35.3 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.067 -1.02 . . . . 0.0 108.547 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.59 -44.18 50.4 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 59.3 mt -59.3 -34.67 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.269 -1.136 . . . . 0.0 109.468 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.33 -67.77 0.47 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -0.962 . . . . 0.0 109.226 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -44.29 -34.08 1.81 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.47 -0.768 . . . . 0.0 109.788 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 54.8 tp -70.18 -70.44 0.29 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 14.2 mt -47.24 -24.02 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.216 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.424 ' C ' HD23 ' B' ' 40' ' ' LEU . 2.7 tt -71.76 -63.48 1.12 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 109.688 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 16.6 t-105 -48.65 -47.03 40.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.558 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 82.2 mt -57.11 -44.68 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.93 -54.47 9.99 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.496 0.665 . . . . 0.0 109.38 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . 0.471 ' CG ' HH11 ' C' ' 45' ' ' ARG . 59.2 m-20 -61.82 -29.5 70.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.552 -0.717 . . . . 0.0 110.338 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -73.35 -24.32 60.33 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.949 -1.094 . . . . 0.0 110.871 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -75.0 -8.58 56.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.605 -1.309 . . . . 0.0 109.577 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -143.11 117.87 9.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.324 -0.86 . . . . 0.0 109.664 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -156.3 -3.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -0.873 . . . . 0.0 109.362 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -71.23 -146.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.601 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . 0.513 ' O ' ' CE2' ' B' ' 54' ' ' PHE . 0.7 OUTLIER 46.92 72.27 0.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.364 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 22.1 mt -100.33 -24.42 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.405 -0.81 . . . . 0.0 109.532 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -70.79 -16.51 62.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.175 -0.953 . . . . 0.0 109.449 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -45.18 56.34 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . 0.513 ' CE2' ' O ' ' B' ' 50' ' ' SER . 4.6 m-85 -69.23 -30.96 69.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.349 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -69.49 -45.36 69.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 109.078 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -72.98 -29.18 62.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -0.858 . . . . 0.0 109.421 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -64.36 -60.04 3.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.232 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.98 -55.13 31.93 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . 0.451 HD13 ' C ' ' B' ' 59' ' ' LEU . 0.4 OUTLIER -63.36 95.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.349 -1.089 . . . . 0.0 109.209 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 tttt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.459 -179.826 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' C' ' 26' ' ' LEU . 0.9 OUTLIER 50.9 70.37 2.04 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -47.36 -7.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.631 2.22 . . . . 0.0 112.313 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' C' ' 24' ' ' ASP . 41.9 tp -49.31 -45.61 45.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.088 -1.007 . . . . 0.0 109.093 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.97 -45.53 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.067 -1.021 . . . . 0.0 108.534 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.5 t -49.28 -46.7 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.52 75.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.87 . . . . 0.0 109.285 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.07 -56.47 11.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.387 -0.82 . . . . 0.0 109.556 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.68 -37.27 68.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 109.559 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 12.2 mt -70.75 -40.34 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.517 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 26.2 mt -58.44 -35.31 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.054 -1.029 . . . . 0.0 108.79 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.56 -43.73 67.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.47 -27.19 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.45 -1.03 . . . . 0.0 108.999 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.5 tp -68.8 -68.89 0.36 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.0 109.111 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . 0.598 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 1.8 t-80 -45.97 -43.0 13.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 110.048 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 49.1 tp -58.39 -65.19 0.69 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.124 -0.985 . . . . 0.0 109.709 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 4.1 mt -49.09 -31.87 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.954 . . . . 0.0 109.523 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -70.31 -59.46 2.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.923 . . . . 0.0 110.277 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -48.83 -46.17 41.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.997 -1.064 . . . . 0.0 109.908 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 69.6 mt -64.88 -48.89 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.135 -0.978 . . . . 0.0 109.124 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 tp -54.46 -32.42 57.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.567 -0.708 . . . . 0.0 110.183 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' C' ' 44' ' ' ASP . 0.3 OUTLIER -84.54 -22.29 30.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.074 -1.016 . . . . 0.0 109.746 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.471 HH11 ' CG ' ' B' ' 44' ' ' ASP . 0.2 OUTLIER -79.1 -25.09 43.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -0.936 . . . . 0.0 110.464 -179.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' C' ' 48' ' ' PHE . 10.5 mt -67.31 -31.2 71.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.706 -1.247 . . . . 0.0 108.893 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -47.45 98.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.943 . . . . 0.0 109.217 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.429 ' N ' ' O ' ' C' ' 46' ' ' LEU . 2.5 t80 -162.05 18.66 0.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 109.341 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' C' ' 48' ' ' PHE . 1.5 pttm -61.11 -115.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.811 . . . . 0.0 109.647 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.26 148.59 25.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.664 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 18.5 mt -106.63 -24.23 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.648 -0.658 . . . . 0.0 109.407 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -52.39 -20.32 2.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.328 -0.857 . . . . 0.0 109.609 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -71.43 -41.8 69.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.18 -0.95 . . . . 0.0 109.578 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -67.14 -38.43 85.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 109.079 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -64.58 -64.62 0.83 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.407 -0.808 . . . . 0.0 109.146 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -50.52 -30.17 12.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.829 . . . . 0.0 109.855 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.79 -56.21 10.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.991 . . . . 0.0 109.571 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.4 -60.26 9.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.07 110.34 0.29 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -1.134 . . . . 0.0 109.426 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.46 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.6 p . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.436 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 1.5 m-20 47.64 54.66 15.94 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.229 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 17.3 Cg_endo -60.88 -11.34 17.57 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.566 2.177 . . . . 0.0 112.453 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 20.6 tp -47.64 -46.17 28.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 0.0 108.977 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.5 t -70.1 -45.2 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 108.647 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 78.8 t -49.23 -48.1 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.148 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.49 -34.8 78.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.865 . . . . 0.0 109.285 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.81 -55.87 16.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.966 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.3 -37.47 72.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.115 -0.991 . . . . 0.0 109.919 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 19.8 mt -70.33 -39.2 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 109.261 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . 0.416 HD13 HG13 ' A' ' 35' ' ' ILE . 22.5 mt -58.9 -34.59 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.116 -0.99 . . . . 0.0 108.617 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.18 -44.9 58.51 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 63.8 mt -60.47 -28.55 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.472 -1.016 . . . . 0.0 109.121 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.39 -66.4 0.66 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.34 -0.85 . . . . 0.0 109.049 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . 0.598 ' CE1' ' NE2' ' C' ' 37' ' ' HIS . 11.6 t-160 -47.28 -37.27 10.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.952 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 42.8 tp -68.27 -62.99 1.15 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.097 -1.002 . . . . 0.0 109.67 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mt -46.64 -40.76 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 109.324 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 1.8 mt -59.78 -60.45 3.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.454 -0.779 . . . . 0.0 110.322 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . 0.424 ' CZ2' ' CG ' ' D' ' 45' ' ' ARG . 20.6 t-105 -49.93 -46.26 51.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.004 -1.06 . . . . 0.0 110.025 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.31 -47.04 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.14 -0.975 . . . . 0.0 109.362 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 tp -53.92 -39.85 66.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.426 -0.796 . . . . 0.0 109.744 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.35 -25.61 59.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.25 -0.906 . . . . 0.0 109.823 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.424 ' CG ' ' CZ2' ' D' ' 41' ' ' TRP . 0.6 OUTLIER -74.47 -28.54 61.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.987 -1.071 . . . . 0.0 110.486 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 mt -69.13 -24.67 64.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.708 -1.245 . . . . 0.0 109.12 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -86.05 77.41 9.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.491 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -162.72 3.76 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.341 -0.849 . . . . 0.0 109.182 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . 0.499 ' CG ' ' H ' ' D' ' 50' ' ' SER . 0.8 OUTLIER -62.47 -98.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.499 ' H ' ' CG ' ' D' ' 49' ' ' LYS . 49.0 p -46.65 129.51 11.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.631 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 15.3 mt -104.91 -29.84 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.557 -0.715 . . . . 0.0 109.109 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -26.1 6.02 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.214 -0.929 . . . . 0.0 109.459 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -66.69 -45.05 80.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.119 -0.988 . . . . 0.0 109.55 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -65.01 -36.41 84.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.2 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.51 -66.64 0.53 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.383 -0.823 . . . . 0.0 109.068 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -46.74 -30.85 2.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.551 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -68.89 -56.7 7.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.936 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.8 -60.42 9.05 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mt -59.1 107.65 0.57 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -1.201 . . . . 0.0 109.322 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . 0.425 ' HB3' ' HZ3' ' D' ' 60' ' ' LYS . 5.7 mmmm . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.274 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.554 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 4.9 p-10 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.9 Cg_endo -56.15 -16.87 18.23 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.912 2.408 . . . . 0.0 112.152 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.8 tp -46.22 -43.42 15.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.262 -0.899 . . . . 0.0 109.17 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.06 -44.93 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.234 -0.916 . . . . 0.0 108.924 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.2 t -49.68 -49.59 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.192 -0.942 . . . . 0.0 109.174 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.09 -34.45 78.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.321 -0.862 . . . . 0.0 109.482 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.32 -56.48 12.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 109.615 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.44 -37.56 67.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.307 -0.87 . . . . 0.0 109.908 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.1 mt -72.21 -41.13 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.966 . . . . 0.0 109.589 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.2 mt -55.87 -34.82 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.098 -1.001 . . . . 0.0 108.485 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.08 -45.01 33.59 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.4 mt -59.62 -27.27 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.256 -1.143 . . . . 0.0 109.187 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.15 -65.91 0.79 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 109.212 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -45.18 -37.89 4.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.363 -0.835 . . . . 0.0 109.79 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.7 tp -66.12 -68.99 0.33 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.943 . . . . 0.0 109.671 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.8 mt -46.69 -36.42 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.445 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.3 mt -66.46 -58.06 6.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.271 -0.893 . . . . 0.0 109.708 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -49.1 -48.04 44.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.758 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.4 mt -63.1 -49.08 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -0.929 . . . . 0.0 109.315 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.6 tp -51.41 -34.65 35.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.535 -0.728 . . . . 0.0 110.318 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.439 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 4.0 m-20 -84.44 -26.42 28.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.12 -0.988 . . . . 0.0 110.272 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -71.78 -29.38 64.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.073 -1.017 . . . . 0.0 110.685 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -59.37 -26.11 64.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.714 -1.241 . . . . 0.0 109.593 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -57.26 111.07 0.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.07 -1.019 . . . . 0.0 109.43 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.481 ' C ' ' CD1' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -169.54 16.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.241 -0.912 . . . . 0.0 109.471 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 48' ' ' PHE . 45.5 mtpt -62.44 -133.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 109.443 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.56 146.79 54.08 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 109.673 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.2 mt -106.31 -21.71 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -58.05 -15.13 8.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.399 -0.813 . . . . 0.0 109.755 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -69.58 -40.72 76.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 109.774 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -72.86 -42.84 63.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.079 -1.013 . . . . 0.0 109.158 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -56.51 -46.18 80.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.171 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -71.7 -25.43 62.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -0.843 . . . . 0.0 109.317 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -69.77 -32.51 71.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.17 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.22 -62.89 2.02 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.8 mt -72.66 138.8 46.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.193 -1.181 . . . . 0.0 109.498 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.389 -179.874 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' B' ' 26' ' ' LEU . 19.9 t0 -158.66 64.27 2.69 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.873 . . . . 0.0 109.476 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -44.61 -10.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.766 2.31 . . . . 0.0 112.367 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' B' ' 24' ' ' ASP . 30.2 tp -47.35 -46.43 25.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.023 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.5 -45.83 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.197 -0.939 . . . . 0.0 108.804 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 63.3 t -48.26 -48.18 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -0.837 . . . . 0.0 109.026 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.72 -34.15 77.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.219 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.89 -57.41 8.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 109.749 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 2.3 m -55.18 -35.64 65.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.93 . . . . 0.0 109.786 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 19.8 mt -72.89 -41.28 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.098 -1.001 . . . . 0.0 109.567 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -56.11 -33.88 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.037 -1.039 . . . . 0.0 108.574 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.13 -44.83 22.01 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 59.5 mt -56.77 -31.76 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.274 -1.133 . . . . 0.0 109.182 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.68 -64.11 1.02 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.193 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -44.4 -40.5 5.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.413 -0.805 . . . . 0.0 110.123 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 50.8 tp -66.87 -67.27 0.46 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.975 . . . . 0.0 109.636 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 mt -47.33 -26.02 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 109.429 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.66 -68.05 0.44 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.322 -0.861 . . . . 0.0 110.039 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -44.51 -46.54 9.83 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.437 -0.789 . . . . 0.0 109.953 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 56.7 mt -59.29 -47.28 90.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.123 -0.986 . . . . 0.0 108.644 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.1 -54.01 11.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.481 -0.762 . . . . 0.0 108.985 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -60.25 -29.89 69.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.493 -0.754 . . . . 0.0 110.389 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.95 -21.39 57.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.909 -1.12 . . . . 0.0 110.745 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -79.04 -33.71 44.48 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.532 -1.355 . . . . 0.0 108.952 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -61.49 122.61 15.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.848 . . . . 0.0 109.682 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -156.39 52.85 0.54 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.374 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.44 -80.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 109.456 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . 0.499 ' CB ' ' CZ ' ' B' ' 52' ' ' TYR . 0.0 OUTLIER -155.81 166.57 33.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.436 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 11.5 mt -96.9 -34.89 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.303 -0.873 . . . . 0.0 109.842 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.499 ' CZ ' ' CB ' ' B' ' 50' ' ' SER . 19.6 p90 -62.66 -19.14 63.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.036 -1.04 . . . . 0.0 109.654 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.7 mmt85 -68.56 -45.22 72.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.537 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -66.27 -32.61 74.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.277 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -69.67 -59.94 2.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.0 109.18 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -53.73 -28.12 32.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.897 . . . . 0.0 109.822 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -71.56 -53.87 12.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.104 -0.997 . . . . 0.0 109.305 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.31 -62.25 6.04 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . 0.442 HD13 ' C ' ' B' ' 59' ' ' LEU . 0.4 OUTLIER -57.98 108.24 0.57 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -1.105 . . . . 0.0 108.985 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.407 ' N ' HD13 ' B' ' 59' ' ' LEU . 17.9 tttm . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.471 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' C' ' 26' ' ' LEU . 15.9 m-20 -149.52 66.06 8.12 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -46.22 -10.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.875 2.383 . . . . 0.0 112.237 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' C' ' 24' ' ' ASP . 49.3 tp -47.32 -46.57 25.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.237 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.58 -44.51 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.077 -1.014 . . . . 0.0 108.847 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 69.5 t -49.15 -49.48 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 108.904 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.61 74.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.218 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.48 -57.54 8.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 109.6 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.43 -37.14 67.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.088 -1.008 . . . . 0.0 109.873 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 24.3 mt -71.4 -41.85 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 0.0 109.454 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 23.1 mt -55.55 -34.86 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.089 -1.007 . . . . 0.0 108.544 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.83 -45.24 28.2 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 50.0 mt -55.36 -31.51 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.261 -1.14 . . . . 0.0 109.379 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.0 -57.69 3.74 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.271 -0.893 . . . . 0.0 109.019 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -50.33 -37.62 37.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.217 -0.927 . . . . 0.0 109.436 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -67.02 -69.01 0.33 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.273 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.4 mt -46.7 -26.44 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.275 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mt -69.61 -64.98 0.77 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -0.875 . . . . 0.0 109.655 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -45.41 -47.5 13.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.497 -0.752 . . . . 0.0 109.635 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 70.1 mt -63.73 -56.8 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.145 -0.972 . . . . 0.0 109.074 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.3 tp -44.7 -48.92 10.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.492 -0.755 . . . . 0.0 110.129 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.66 -25.81 65.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.15 -0.969 . . . . 0.0 110.416 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 11.7 mmt-85 -77.84 -21.1 51.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.887 -1.133 . . . . 0.0 110.536 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.1 mt -77.17 -14.43 59.78 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.697 -1.252 . . . . 0.0 108.956 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -76.55 -3.9 39.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.574 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . 0.407 ' O ' ' CG ' ' C' ' 48' ' ' PHE . 0.2 OUTLIER -79.52 112.79 17.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.976 . . . . 0.0 109.579 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . 0.454 ' CG ' ' H ' ' C' ' 50' ' ' SER . 4.5 pttp -163.22 -92.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.475 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . 0.454 ' H ' ' CG ' ' C' ' 49' ' ' LYS . 28.4 t -77.55 138.03 38.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.4 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 11.1 mt -102.89 -20.28 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.536 -0.727 . . . . 0.0 109.112 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -30.6 26.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.263 -0.898 . . . . 0.0 109.683 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -62.7 -46.03 90.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 109.636 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . 0.408 ' O ' ' CD1' ' D' ' 51' ' ' ILE . 2.7 m-85 -63.78 -37.11 86.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.242 -0.911 . . . . 0.0 109.375 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.07 -63.36 1.17 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.25 -0.906 . . . . 0.0 109.147 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -46.77 -34.07 4.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.795 . . . . 0.0 109.673 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -65.62 -49.72 67.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 0.0 109.137 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.7 -60.81 8.07 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.45 ' C ' HD13 ' C' ' 59' ' ' LEU . 0.4 OUTLIER -88.53 105.84 17.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -1.14 . . . . 0.0 108.963 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.384 -179.99 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.42 160.64 40.4 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.251 -0.906 . . . . 0.0 109.296 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.02 -21.99 73.43 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.578 2.185 . . . . 0.0 112.373 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 51.5 tp -46.25 -43.64 15.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 108.664 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.6 -44.4 79.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.339 -0.85 . . . . 0.0 108.731 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 74.4 t -50.19 -49.43 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 108.703 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.56 -32.83 74.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.412 -0.805 . . . . 0.0 109.251 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.37 -56.67 9.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 109.783 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.67 -36.4 69.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 0.0 109.775 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 15.7 mt -71.65 -42.3 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 109.475 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 24.0 mt -56.13 -34.83 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -0.999 . . . . 0.0 108.617 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.28 -43.62 37.91 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 58.7 mt -58.0 -38.57 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.204 -1.174 . . . . 0.0 109.037 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' D' ' 36' ' ' LEU . 0.2 OUTLIER -65.0 -66.26 0.57 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -0.884 . . . . 0.0 109.089 179.669 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -45.3 -36.65 4.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 0.0 109.83 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 44.1 tp -66.42 -70.0 0.27 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.095 -1.003 . . . . 0.0 109.407 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 9.9 mt -48.01 -25.15 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.361 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . 0.534 HD23 ' O ' ' D' ' 40' ' ' LEU . 2.8 tt -72.74 -55.61 6.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.334 -0.854 . . . . 0.0 109.658 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -53.27 -50.92 63.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.094 -1.003 . . . . 0.0 109.568 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 23.1 mt -59.0 -55.0 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.091 -1.006 . . . . 0.0 108.739 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 35.9 tp -47.52 -37.2 11.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.422 -0.799 . . . . 0.0 109.72 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . 0.471 ' OD2' ' CD2' ' D' ' 40' ' ' LEU . 94.6 m-20 -74.22 -26.05 60.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.223 -0.923 . . . . 0.0 109.67 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.524 ' CA ' ' HE ' ' D' ' 45' ' ' ARG . 0.0 OUTLIER -82.12 -17.67 45.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.126 -0.984 . . . . 0.0 110.732 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -82.26 -34.89 28.59 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.64 -1.287 . . . . 0.0 109.691 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . 0.607 ' CG ' ' N ' ' D' ' 48' ' ' PHE . 0.1 OUTLIER -101.53 -167.66 1.45 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.423 -0.798 . . . . 0.0 109.694 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . 0.607 ' N ' ' CG ' ' D' ' 47' ' ' PHE . 2.5 t80 77.76 30.39 0.47 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.505 -0.747 . . . . 0.0 109.541 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' D' ' 50' ' ' SER . 7.9 tptt -93.3 -148.32 0.25 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 109.28 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . 0.429 ' O ' ' O ' ' D' ' 49' ' ' LYS . 1.2 m 54.75 102.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.469 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . 0.408 ' CD1' ' O ' ' C' ' 54' ' ' PHE . 11.8 mt -91.12 -19.52 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 109.16 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -31.4 70.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -0.909 . . . . 0.0 109.777 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -47.35 66.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 0.0 110.413 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . 0.479 ' O ' ' CD1' ' D' ' 54' ' ' PHE . 0.0 OUTLIER -69.75 -28.8 66.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.044 -1.035 . . . . 0.0 109.211 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.08 -58.28 7.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.367 -0.833 . . . . 0.0 109.609 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -68.88 -26.99 65.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.121 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -59.94 -61.01 2.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.986 -1.071 . . . . 0.0 109.098 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.7 -59.48 8.13 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.7 110.12 2.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -1.141 . . . . 0.0 109.611 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 2.8 pttp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.46 179.94 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 26' ' ' LEU . 19.3 Cg_endo -61.72 -29.26 83.2 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.541 2.16 . . . . 0.0 112.055 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 26' ' ' LEU . 40.8 tp -45.13 -40.45 7.01 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.7 t -69.25 -43.51 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.0 t -53.12 -51.8 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.13 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.38 -34.95 76.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.52 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.39 -53.51 42.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 109.591 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.2 -37.44 74.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.859 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.3 mt -71.41 -42.47 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.389 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.9 mt -55.28 -36.37 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 0.0 108.789 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.31 -42.79 56.44 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.3 mt -61.83 -46.53 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.235 -1.156 . . . . 0.0 109.269 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.45 -44.69 80.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 109.142 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -57.88 -56.08 26.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 109.482 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.3 tp -54.0 -59.97 3.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.913 . . . . 0.0 109.533 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.2 mt -47.52 -48.36 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.299 -0.876 . . . . 0.0 109.311 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mt -51.93 -59.31 4.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -45.14 -65.83 0.48 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.459 -0.776 . . . . 0.0 109.572 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mt -48.58 -37.74 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.125 -0.984 . . . . 0.0 109.278 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -52.1 -49.31 63.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.47 -0.769 . . . . 0.0 110.084 -179.331 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.67 -21.72 55.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.968 . . . . 0.0 110.401 -179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 47' ' ' PHE . 12.9 mmt180 -91.68 -1.15 57.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.013 -1.054 . . . . 0.0 110.841 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 45' ' ' ARG . 29.7 mt -35.79 -30.61 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.525 -0.734 . . . . 0.0 110.192 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 45' ' ' ARG . 7.4 p90 -170.92 167.13 7.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.161 -0.962 . . . . 0.0 109.486 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -164.15 99.68 0.85 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.252 -0.905 . . . . 0.0 109.578 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 51' ' ' ILE . 10.1 ttmt -151.64 -44.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.166 -0.959 . . . . 0.0 109.405 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.9 t -60.15 80.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 109.369 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 49' ' ' LYS . 40.7 mt -92.43 -27.76 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.89 . . . . 0.0 109.557 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.51 -44.84 65.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.751 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.29 -45.12 62.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.088 -1.008 . . . . 0.0 109.454 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -61.97 -37.28 84.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.286 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.0 -34.7 78.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.115 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -70.21 -38.14 75.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.353 -0.842 . . . . 0.0 109.476 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -62.66 -54.41 39.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 0.0 109.324 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -54.17 -63.08 5.49 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 60' ' ' LYS . 7.7 mt -72.93 21.85 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -1.143 . . . . 0.0 109.741 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.488 ' H ' ' C ' ' A' ' 58' ' ' GLY . 65.9 mttm . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.546 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ASP . . . . . 0.533 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 1.5 p30 -153.35 50.05 0.55 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.88 . . . . 0.0 109.399 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 9.2 Cg_endo -55.59 -11.26 4.55 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.802 2.334 . . . . 0.0 112.248 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 43.6 tp -47.62 -45.85 28.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.152 -0.967 . . . . 0.0 109.094 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.57 -46.14 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.145 -0.972 . . . . 0.0 108.808 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 74.0 t -47.98 -48.27 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.892 . . . . 0.0 108.99 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.54 84.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.452 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.39 -57.34 8.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.261 -0.9 . . . . 0.0 109.801 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -53.93 -35.83 62.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 0.0 109.69 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 18.4 mt -72.65 -41.68 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.179 -0.951 . . . . 0.0 109.411 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 18.6 mt -55.25 -34.5 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.087 -1.008 . . . . 0.0 108.691 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.94 -44.77 23.23 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 51.6 mt -55.49 -34.87 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.072 -1.252 . . . . 0.0 109.326 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.46 -58.97 2.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 108.971 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' HIS . . . . . 0.602 ' NE2' ' ND1' ' C' ' 37' ' ' HIS . 2.3 t-80 -47.83 -37.4 13.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 0.0 109.716 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 52.6 tp -69.88 -67.74 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 0.0 109.466 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mt -47.04 -25.14 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 109.316 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mt -69.03 -63.43 1.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.642 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 41.8 t-105 -47.72 -46.69 29.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.399 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' B' ' 45' ' ' ARG . 72.3 mt -62.02 -61.4 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 108.906 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 57.6 tp -42.53 -47.73 5.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.762 -0.587 . . . . 0.0 110.096 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.72 -27.78 68.57 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' B' ' 42' ' ' ILE . 2.3 mmt180 -81.19 -14.97 57.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.099 -1.001 . . . . 0.0 110.333 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -88.83 -16.08 32.93 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.763 -1.211 . . . . 0.0 109.289 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -47.23 -77.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.326 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 45.11 74.72 0.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 109.769 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -96.65 -88.21 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 109.49 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 2.1 t -148.51 148.98 30.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.388 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 20.2 mt -96.37 -22.55 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.325 -0.859 . . . . 0.0 109.566 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -67.01 -20.7 65.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.592 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -70.31 -43.74 69.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.246 -0.909 . . . . 0.0 109.833 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -67.12 -34.76 78.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -0.956 . . . . 0.0 109.632 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -66.35 -43.65 85.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.201 -0.937 . . . . 0.0 109.302 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -68.78 -27.54 65.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.085 -1.009 . . . . 0.0 108.72 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -70.69 -38.41 73.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.447 -0.783 . . . . 0.0 109.501 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.96 -62.4 3.17 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 50.5 mt -72.39 136.43 46.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -1.083 . . . . 0.0 109.367 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 48.5 mttm . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.463 179.92 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' C' ' 26' ' ' LEU . 0.2 OUTLIER -161.5 68.35 2.34 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.923 . . . . 0.0 109.571 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -46.4 -9.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.692 2.261 . . . . 0.0 112.105 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' C' ' 24' ' ' ASP . 35.4 tp -47.2 -46.41 23.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 0.0 109.141 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 33.8 t -69.49 -45.19 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.191 -0.943 . . . . 0.0 108.631 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 71.6 t -49.32 -50.41 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.336 -0.853 . . . . 0.0 108.995 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.11 -30.9 71.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.363 -0.835 . . . . 0.0 109.228 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.74 -56.22 11.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 109.603 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.13 -37.55 74.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -0.946 . . . . 0.0 109.829 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 42.0 mt -71.02 -40.72 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 0.0 109.51 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 18.5 mt -58.53 -32.28 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.106 -0.996 . . . . 0.0 108.594 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.86 -44.03 26.01 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 52.4 mt -57.04 -31.46 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.301 -1.117 . . . . 0.0 109.186 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.25 -62.39 1.45 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 108.935 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' HIS . . . . . 0.602 ' ND1' ' NE2' ' B' ' 37' ' ' HIS . 10.5 t-80 -47.13 -34.46 6.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 109.586 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 40.2 tp -70.56 -66.77 0.56 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.661 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 5.8 mt -49.97 -26.19 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.623 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -72.38 -54.49 9.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.138 -0.976 . . . . 0.0 109.526 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -55.02 -49.08 72.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.722 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 59.4 mt -63.9 -55.14 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.203 -0.936 . . . . 0.0 109.117 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 40.1 tp -48.23 -40.37 24.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.794 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' C' ' 44' ' ' ASP . 4.5 m-20 -73.21 -25.84 60.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 109.843 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' ARG . . . . . 0.418 ' HE ' ' HA ' ' C' ' 45' ' ' ARG . 0.1 OUTLIER -80.64 -19.43 45.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.114 -0.991 . . . . 0.0 110.506 -179.393 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -79.39 -32.22 42.99 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.631 -1.293 . . . . 0.0 109.109 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -92.31 103.47 15.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.437 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.55 -12.3 0.13 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.328 -0.857 . . . . 0.0 109.582 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -65.1 -156.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.187 -0.946 . . . . 0.0 109.304 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 60.6 p 45.91 76.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.956 -1.09 . . . . 0.0 109.656 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 10.8 mt -95.54 -27.68 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -59.4 -24.91 63.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.193 -0.942 . . . . 0.0 109.421 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -68.78 -37.19 79.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.421 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -72.2 -35.12 68.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 109.364 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -64.12 -56.51 14.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.792 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -65.11 -28.25 69.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.114 -0.991 . . . . 0.0 109.788 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -70.41 -43.74 69.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.431 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.86 -65.7 2.32 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 59' ' ' LEU . . . . . 0.45 ' C ' HD13 ' C' ' 59' ' ' LEU . 0.4 OUTLIER -63.67 95.28 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -1.189 . . . . 0.0 109.054 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.326 -179.831 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 24' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' D' ' 26' ' ' LEU . 27.8 t0 51.13 69.36 2.61 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.936 . . . . 0.0 109.394 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -47.32 -10.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.663 2.242 . . . . 0.0 112.134 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 26' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' D' ' 24' ' ' ASP . 35.2 tp -47.88 -47.03 32.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.244 -0.91 . . . . 0.0 108.902 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 42.3 t -68.66 -44.71 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.106 -0.996 . . . . 0.0 108.63 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 78.3 t -49.24 -49.44 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 108.687 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.44 77.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.379 -0.826 . . . . 0.0 109.236 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.12 -56.85 10.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.343 -0.848 . . . . 0.0 109.734 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.82 -37.12 65.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.162 -0.961 . . . . 0.0 109.763 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 17.2 mt -71.5 -41.95 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.42 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 27.6 mt -55.24 -35.32 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 108.69 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.47 -45.3 47.44 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 72.2 mt -60.99 -24.26 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.291 -1.123 . . . . 0.0 109.037 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 17.2 tp -76.16 -70.53 0.44 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.464 -0.772 . . . . 0.0 109.231 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -45.52 -33.38 2.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.873 . . . . 0.0 109.715 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 56.6 tp -68.19 -66.27 0.59 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.179 -0.951 . . . . 0.0 109.49 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mt -52.43 -28.23 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.842 . . . . 0.0 109.659 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mt -76.24 -59.24 2.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.84 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -45.97 -52.01 12.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.283 -0.886 . . . . 0.0 109.841 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 42' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' D' ' 45' ' ' ARG . 66.9 mt -60.46 -57.63 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.154 -0.966 . . . . 0.0 109.018 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 59.2 tp -43.89 -44.69 7.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.62 -0.675 . . . . 0.0 109.81 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 44' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' D' ' 44' ' ' ASP . 0.6 OUTLIER -67.46 -29.86 69.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.164 -0.96 . . . . 0.0 109.652 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 45' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' D' ' 42' ' ' ILE . 4.0 mmt180 -77.22 -17.43 58.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.2 -0.938 . . . . 0.0 110.208 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 mt -85.7 -17.13 36.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.82 -1.175 . . . . 0.0 109.236 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.35 -6.66 4.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.195 -0.941 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -71.41 70.97 0.64 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.52 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -96.65 -100.27 0.18 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.422 -0.799 . . . . 0.0 109.52 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 3.4 m -76.18 130.99 39.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 109.783 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 28.9 mt -93.37 -30.67 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.898 . . . . 0.0 109.318 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -25.68 61.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.925 . . . . 0.0 109.923 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 53' ' ' ARG . . . . . 0.426 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 12.5 mmt85 -63.6 -41.26 98.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.123 -0.986 . . . . 0.0 109.669 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -71.15 -41.39 70.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.151 -0.968 . . . . 0.0 109.435 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -58.84 -41.81 87.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.332 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -26.87 61.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.259 -0.901 . . . . 0.0 109.26 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 57' ' ' HIS . . . . . 0.426 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 2.5 m-70 -67.47 -39.65 85.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 108.905 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.82 -63.35 2.74 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.08 159.75 2.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.251 -1.146 . . . . 0.0 109.605 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 17.7 mttp . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.448 -179.967 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 2.7 m-20 57.11 49.28 3.67 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.53 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.3 Cg_endo -55.78 -15.54 13.17 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.714 2.276 . . . . 0.0 111.978 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 35.8 tp -46.29 -44.42 16.58 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.319 -0.863 . . . . 0.0 109.169 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.8 t -68.6 -45.26 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.273 -0.892 . . . . 0.0 108.997 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -48.93 -49.02 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.184 -0.947 . . . . 0.0 109.057 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.09 -34.47 78.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.87 . . . . 0.0 109.387 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.74 -57.25 8.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 0.0 109.805 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.57 -36.14 66.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.733 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.7 mt -71.7 -42.51 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.338 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.4 mt -55.73 -34.63 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.128 -0.982 . . . . 0.0 108.511 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.09 -45.17 32.95 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.1 mt -55.67 -36.21 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.165 -1.197 . . . . 0.0 109.179 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.5 -61.91 1.67 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.353 -0.842 . . . . 0.0 109.236 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -45.15 -39.9 6.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.416 -0.802 . . . . 0.0 110.061 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -66.23 -69.49 0.3 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.141 -0.974 . . . . 0.0 109.843 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.8 mt -48.19 -27.4 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.233 -0.917 . . . . 0.0 109.739 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.425 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 7.4 mt -72.24 -60.37 2.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.214 -0.928 . . . . 0.0 109.945 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 40.7 t-105 -48.1 -48.53 33.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.055 -1.028 . . . . 0.0 109.784 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' A' ' 45' ' ' ARG . 66.6 mt -63.28 -59.89 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.08 -1.013 . . . . 0.0 109.336 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.3 tp -44.27 -40.66 5.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.572 -0.705 . . . . 0.0 109.821 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.514 ' OD2' ' NC ' ' A' ' 199' ' ' RIM . 1.7 m-20 -69.75 -31.31 69.2 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.157 -0.964 . . . . 0.0 109.217 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.5 ' NH1' ' OD2' ' D' ' 44' ' ' ASP . 0.4 OUTLIER -75.4 -16.05 60.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 110.181 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -90.04 -12.06 39.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.872 -1.142 . . . . 0.0 109.22 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.487 ' O ' ' N ' ' A' ' 49' ' ' LYS . 17.6 t80 -78.0 -60.73 2.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.0 109.306 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -50.23 94.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 109.066 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.487 ' N ' ' O ' ' A' ' 47' ' ' PHE . 30.8 mtpt -91.65 -82.43 0.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.915 . . . . 0.0 109.634 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.1 m -87.35 170.07 11.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 109.635 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 13.3 mt -105.46 -21.66 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.569 -0.707 . . . . 0.0 109.626 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -55.02 -20.87 10.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.182 -0.949 . . . . 0.0 109.8 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.433 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 7.6 mmm180 -70.94 -42.59 69.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.062 -1.024 . . . . 0.0 109.553 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -66.79 -35.23 79.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.194 -0.941 . . . . 0.0 109.227 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -65.25 -48.85 71.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -0.866 . . . . 0.0 109.19 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -63.2 -29.18 70.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.348 -0.845 . . . . 0.0 109.526 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.433 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 18.5 m80 -66.2 -52.34 48.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.222 -0.924 . . . . 0.0 109.263 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -60.22 -60.89 7.8 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.46 ' O ' ' CB ' ' A' ' 60' ' ' LYS . 0.5 OUTLIER -50.28 118.8 3.2 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.377 -1.072 . . . . 0.0 109.458 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 59' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.479 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.298 0.57 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.516 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 48.5 m-20 -157.72 51.23 0.46 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.934 . . . . 0.0 109.472 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.516 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 13.0 Cg_endo -59.23 -12.02 14.92 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.759 2.306 . . . . 0.0 112.345 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 58.2 tp -47.98 -46.71 32.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 108.958 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.71 -44.93 85.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.113 -0.992 . . . . 0.0 108.774 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 71.2 t -48.97 -49.71 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 108.931 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.38 -32.87 74.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.36 -0.837 . . . . 0.0 109.136 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.91 -58.08 6.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 0.0 109.66 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.77 -35.28 63.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -0.873 . . . . 0.0 109.697 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 16.7 mt -73.29 -41.86 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 0.0 109.745 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.474 HD13 HG13 ' C' ' 35' ' ' ILE . 21.9 mt -55.86 -35.57 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.005 -1.059 . . . . 0.0 108.822 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.34 -44.18 43.55 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 48.6 mt -56.05 -33.07 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.226 -1.161 . . . . 0.0 109.204 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.68 -65.19 0.79 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.248 -0.907 . . . . 0.0 109.1 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . 0.598 ' HE2' ' CE1' ' C' ' 37' ' ' HIS . 3.4 t-80 -45.43 -38.13 5.76 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.412 -0.805 . . . . 0.0 109.748 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 54.9 tp -66.38 -67.86 0.42 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -0.901 . . . . 0.0 109.503 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.8 mt -48.91 -25.89 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.278 -0.889 . . . . 0.0 109.518 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mt -71.5 -64.07 0.99 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.851 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 15.5 t-105 -46.11 -47.1 17.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.278 -0.889 . . . . 0.0 109.647 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 51.7 mt -63.27 -55.46 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.087 -1.008 . . . . 0.0 108.909 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 39.5 tp -47.13 -41.19 17.09 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.51 -0.744 . . . . 0.0 109.661 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' B' ' 44' ' ' ASP . 0.3 OUTLIER -69.79 -30.26 67.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.707 -179.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.97 -19.71 58.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.07 -1.018 . . . . 0.0 110.47 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -82.97 -8.46 59.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.631 -1.293 . . . . 0.0 108.973 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -138.11 106.93 5.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.525 -0.734 . . . . 0.0 109.569 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . 0.409 ' H ' ' H ' ' B' ' 49' ' ' LYS . 28.5 t80 -171.15 3.91 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.216 -0.928 . . . . 0.0 109.556 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.409 ' H ' ' H ' ' B' ' 48' ' ' PHE . 14.2 mtpp -71.89 -142.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.905 . . . . 0.0 109.302 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 20.8 m 51.54 75.74 0.19 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.166 -0.959 . . . . 0.0 109.568 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 50.9 mt -99.36 -31.21 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.463 -0.773 . . . . 0.0 109.385 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.494 ' CE2' ' NH1' ' B' ' 53' ' ' ARG . 0.1 OUTLIER -61.02 -32.93 72.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.0 109.781 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.494 ' NH1' ' CE2' ' B' ' 52' ' ' TYR . 19.5 mmt-85 -64.42 -33.84 76.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.085 -1.009 . . . . 0.0 109.42 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -75.3 -42.15 55.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.304 -0.873 . . . . 0.0 109.17 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -58.34 -40.53 82.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.331 -0.856 . . . . 0.0 109.55 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -72.78 -67.61 0.55 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . 0.45 ' ND1' ' O ' ' B' ' 57' ' ' HIS . 23.0 t-80 -41.22 -30.06 0.15 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.616 -0.678 . . . . 0.0 110.208 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.28 -70.25 1.31 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mt -66.35 82.45 0.09 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -1.113 . . . . 0.0 109.516 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 58.8 tttm . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.403 179.855 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 55.1 m . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' C' ' 26' ' ' LEU . 3.2 m-20 57.64 65.33 3.52 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.258 -0.901 . . . . 0.0 109.647 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -45.22 -11.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.921 2.414 . . . . 0.0 112.535 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' C' ' 24' ' ' ASP . 24.2 tp -47.74 -46.11 29.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.185 -0.947 . . . . 0.0 108.975 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 45.5 t -67.19 -45.32 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 108.769 179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 71.5 t -50.3 -51.64 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.363 -0.836 . . . . 0.0 109.008 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.32 -32.58 73.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 109.502 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.8 -55.27 18.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.53 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.13 -37.51 69.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 109.843 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 23.1 mt -71.89 -42.81 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.072 -1.017 . . . . 0.0 109.602 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.25 -36.39 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 108.551 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -68.95 -45.04 64.76 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . 0.474 HG13 HD13 ' B' ' 33' ' ' ILE . 63.5 mt -59.6 -41.59 85.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.347 -1.09 . . . . 0.0 108.832 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.77 -68.01 0.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.368 -0.832 . . . . 0.0 109.292 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . 0.598 ' CE1' ' HE2' ' B' ' 37' ' ' HIS . 2.3 t-80 -44.17 -39.95 4.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.389 -0.82 . . . . 0.0 110.24 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.76 -67.89 0.38 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.985 -1.072 . . . . 0.0 109.196 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 13.6 mt -47.67 -40.66 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.344 -0.847 . . . . 0.0 109.423 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 1.3 mt -61.64 -54.31 44.54 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.45 -0.781 . . . . 0.0 109.581 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -46.31 -58.19 3.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.253 -0.904 . . . . 0.0 109.418 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.19 -47.8 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.055 -1.028 . . . . 0.0 109.339 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 6.3 tp -52.56 -27.52 17.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.417 -0.802 . . . . 0.0 110.43 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -91.03 -34.03 15.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.071 -1.018 . . . . 0.0 109.426 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.704 HH21 HNC2 ' B' ' 299' ' ' RIM . 14.6 mmm180 -84.67 4.32 33.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.343 -0.848 . . . . 0.0 110.403 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.476 ' C ' ' O ' ' C' ' 45' ' ' ARG . 34.8 mt -31.0 -34.95 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.378 0 CA-C-O 121.273 0.559 . . . . 0.0 110.299 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.55 ' N ' ' O ' ' C' ' 45' ' ' ARG . 0.2 OUTLIER 68.2 102.04 0.05 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.714 179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -104.16 162.67 12.98 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.557 -0.714 . . . . 0.0 109.211 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . 0.412 ' O ' ' O ' ' C' ' 50' ' ' SER . 20.4 tptt -92.37 -150.14 0.26 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.168 -0.958 . . . . 0.0 109.767 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . 0.412 ' O ' ' O ' ' C' ' 49' ' ' LYS . 8.2 m 47.06 92.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 109.843 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 mt -92.65 -31.61 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.213 -0.93 . . . . 0.0 109.446 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . 0.463 ' CD2' ' N ' ' C' ' 53' ' ' ARG . 50.9 p90 -48.45 -44.26 35.26 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.924 . . . . 0.0 109.382 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . 0.463 ' N ' ' CD2' ' C' ' 52' ' ' TYR . 3.7 mtp85 -46.73 -50.52 17.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.306 -0.871 . . . . 0.0 109.954 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -61.7 -41.5 97.69 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.112 -0.993 . . . . 0.0 109.76 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -60.79 -35.57 76.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 109.266 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -73.52 -37.62 65.58 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.275 -0.891 . . . . 0.0 109.239 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -60.59 -41.22 94.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.914 . . . . 0.0 109.189 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.42 -62.43 4.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 57.6 mt -85.24 -147.99 0.11 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -1.125 . . . . 0.0 109.316 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.442 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.95 161.38 77.8 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.339 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -65.1 -21.52 62.84 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.511 2.14 . . . . 0.0 112.097 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 54.2 tp -46.8 -43.87 18.74 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -69.76 -43.23 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.329 -0.857 . . . . 0.0 108.803 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 70.4 t -51.04 -48.55 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.247 -0.908 . . . . 0.0 109.069 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.35 -33.91 76.78 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 0.0 109.26 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.35 -57.02 9.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.358 -0.839 . . . . 0.0 109.674 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -56.1 -35.99 67.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.193 -0.942 . . . . 0.0 109.746 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 12.3 mt -71.69 -41.41 70.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.208 -0.933 . . . . 0.0 109.352 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -56.64 -35.17 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.192 -0.942 . . . . 0.0 108.796 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.79 -43.67 50.1 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 57.2 mt -59.17 -30.34 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.333 -1.098 . . . . 0.0 109.478 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.75 -67.5 0.63 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -0.944 . . . . 0.0 109.405 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -44.11 -35.71 2.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.23 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 45.8 tp -71.42 -63.13 1.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.031 -1.043 . . . . 0.0 109.803 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.7 mt -50.93 -34.38 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.165 -0.96 . . . . 0.0 109.599 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' D' ' 43' ' ' LEU . 1.2 mt -67.17 -64.81 0.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.36 -0.838 . . . . 0.0 110.273 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 15.8 t-105 -44.76 -48.61 10.84 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.398 -0.814 . . . . 0.0 109.682 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 93.3 mt -59.63 -37.52 71.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.19 -0.944 . . . . 0.0 108.601 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' D' ' 40' ' ' LEU . 0.1 OUTLIER -57.7 -43.38 85.14 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.488 -0.757 . . . . 0.0 109.36 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.5 ' OD2' ' NH1' ' A' ' 45' ' ' ARG . 7.0 m-20 -71.71 -26.82 62.65 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.381 -0.825 . . . . 0.0 110.182 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.8 -28.36 58.31 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.829 -1.169 . . . . 0.0 110.981 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.478 ' C ' ' H ' ' D' ' 48' ' ' PHE . 7.7 mt -58.4 -12.31 3.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.525 -1.359 . . . . 0.0 109.179 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -73.95 17.09 0.18 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.14 -0.975 . . . . 0.0 109.114 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . 0.478 ' H ' ' C ' ' D' ' 46' ' ' LEU . 0.4 OUTLIER -46.66 155.2 0.26 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 109.56 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 15.8 tttm 64.23 -146.45 0.29 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 73.3 m 47.96 59.44 4.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 109.482 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 38.8 mt -95.06 -29.59 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.347 -0.846 . . . . 0.0 109.39 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.64 -37.94 74.2 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.199 -0.938 . . . . 0.0 109.545 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . 0.472 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 5.9 mtm180 -61.51 -36.63 81.07 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.175 -0.953 . . . . 0.0 109.247 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -69.99 -37.92 75.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.237 -0.914 . . . . 0.0 109.258 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -63.39 -53.79 46.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.422 -0.799 . . . . 0.0 109.677 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -62.61 -29.13 70.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.289 -0.882 . . . . 0.0 109.748 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . 0.472 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 1.4 m-70 -67.48 -45.14 76.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.182 -0.949 . . . . 0.0 109.431 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.29 -60.71 6.78 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.1 -166.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -1.15 . . . . 0.0 109.712 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 61.1 tttm . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 117.923 -1.036 . . . . 0.0 109.669 -179.969 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' RIM . . . . . 0.514 ' NC ' ' OD2' ' A' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 299' ' ' RIM . . . . . 0.704 HNC2 HH21 ' C' ' 45' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 399' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 499' ' ' RIM . . . . . 0.403 ' NC ' HD22 ' D' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.413 ' O ' ' C ' ' A' ' 24' ' ' ASP . 12.9 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.419 ' O ' ' OD2' ' A' ' 24' ' ' ASP . 5.5 p-10 41.13 54.36 7.42 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.69 -0.631 . . . . 0.0 110.047 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 11.2 Cg_endo -58.02 -17.87 33.17 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.509 2.139 . . . . 0.0 112.269 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.8 tp -47.2 -45.02 22.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.189 -0.945 . . . . 0.0 108.826 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.3 t -67.98 -44.52 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.241 -0.912 . . . . 0.0 108.802 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -49.86 -50.25 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.163 -0.96 . . . . 0.0 109.068 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.54 -33.69 76.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.322 -0.861 . . . . 0.0 109.514 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.57 -56.78 8.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 109.784 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.0 m -55.55 -34.65 64.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.211 -0.931 . . . . 0.0 109.705 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.4 mt -74.81 -43.7 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.118 -0.989 . . . . 0.0 109.725 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.8 mt -54.02 -35.91 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.021 -1.05 . . . . 0.0 108.618 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.06 -45.43 41.2 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 62.7 mt -57.65 -37.27 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.192 -1.181 . . . . 0.0 108.907 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.15 -68.74 0.33 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -0.85 . . . . 0.0 109.373 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -43.19 -42.26 4.14 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.431 -0.793 . . . . 0.0 110.263 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.7 tp -61.05 -67.66 0.38 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.106 -0.996 . . . . 0.0 109.569 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 mt -49.15 -44.1 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -0.86 . . . . 0.0 109.513 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.662 HD22 ' NC ' ' A' ' 199' ' ' RIM . 2.3 mt -55.77 -58.39 8.05 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 109.987 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.1 t-105 -46.43 -59.1 3.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.188 -0.945 . . . . 0.0 109.322 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.467 ' O ' ' N ' ' A' ' 45' ' ' ARG . 48.0 mt -51.17 -52.44 18.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.276 -0.89 . . . . 0.0 108.978 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 42' ' ' ILE . 0.1 OUTLIER -41.89 -57.21 2.47 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.426 0.631 . . . . 0.0 109.503 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.451 ' OD2' ' NC ' ' A' ' 199' ' ' RIM . 12.8 m-20 -59.15 -27.7 65.89 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.328 -0.858 . . . . 0.0 109.624 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.467 ' N ' ' O ' ' A' ' 42' ' ' ILE . 2.7 mmp_? -81.52 -13.82 57.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.071 -1.018 . . . . 0.0 110.714 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 mt -88.65 -18.88 27.03 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.652 -1.28 . . . . 0.0 109.198 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.48 ' O ' ' CB ' ' A' ' 48' ' ' PHE . 0.1 OUTLIER -141.79 166.29 25.13 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.301 -0.875 . . . . 0.0 109.518 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.48 ' CB ' ' O ' ' A' ' 47' ' ' PHE . 2.4 t80 75.96 97.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.57 -0.706 . . . . 0.0 109.539 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.402 ' O ' ' CB ' ' A' ' 50' ' ' SER . 10.1 tttp -150.23 -135.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.109 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 49' ' ' LYS . 0.9 OUTLIER 68.14 117.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.168 -0.957 . . . . 0.0 109.51 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 mt -97.69 -29.25 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 109.625 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.485 ' CG ' ' N ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -57.32 -38.82 74.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.147 -0.97 . . . . 0.0 109.44 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.485 ' N ' ' CG ' ' A' ' 52' ' ' TYR . 1.4 mtt180 -57.65 -37.21 72.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.044 179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -70.67 -39.98 73.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.349 -0.844 . . . . 0.0 109.233 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -65.55 -34.08 77.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.125 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -75.02 -31.66 61.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.381 -0.824 . . . . 0.0 109.613 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 22.4 t60 -68.92 -37.93 79.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.256 -0.902 . . . . 0.0 109.152 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.63 -64.41 2.6 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.7 mt -75.78 150.95 37.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.31 -1.112 . . . . 0.0 109.538 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.449 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.265 0.555 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.15 160.67 39.18 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 109.271 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' B' ' 26' ' ' LEU . 18.7 Cg_endo -63.16 -24.5 72.8 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.557 2.171 . . . . 0.0 112.165 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' B' ' 25' ' ' PRO . 56.9 tp -45.63 -40.89 9.55 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 52.3 t -70.98 -44.75 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.345 -0.847 . . . . 0.0 108.809 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 74.4 t -49.54 -48.71 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 108.953 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.55 -34.73 78.92 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.362 -0.836 . . . . 0.0 109.223 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.26 -56.75 12.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 109.665 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.04 -36.71 68.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.232 -0.918 . . . . 0.0 109.966 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 29.8 mt -72.05 -40.06 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.095 -1.003 . . . . 0.0 109.686 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 30.6 mt -58.05 -35.23 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.013 -1.054 . . . . 0.0 108.751 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.14 -44.0 45.99 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 55.9 mt -57.8 -35.83 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.288 -1.125 . . . . 0.0 109.162 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.44 -65.96 0.61 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.279 -0.888 . . . . 0.0 109.056 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -45.5 -39.18 7.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.46 -0.775 . . . . 0.0 109.895 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.79 -69.3 0.27 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 0.0 109.786 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.4 mt -51.21 -23.84 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.113 -0.992 . . . . 0.0 109.269 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.494 ' C ' HD23 ' B' ' 40' ' ' LEU . 2.6 tt -68.67 -63.86 0.98 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.36 -0.837 . . . . 0.0 110.005 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 -52.34 -46.63 66.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.117 -0.989 . . . . 0.0 109.907 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 56.0 mt -60.95 -55.21 26.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.032 -1.042 . . . . 0.0 108.841 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 52.9 tp -46.8 -40.99 14.73 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.536 -0.728 . . . . 0.0 109.932 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.509 ' OD2' ' NC ' ' B' ' 299' ' ' RIM . 1.2 m-20 -72.3 -25.32 61.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 109.865 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -82.6 -17.72 43.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.912 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -81.06 -27.78 35.57 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.631 -1.293 . . . . 0.0 109.338 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -147.46 116.93 7.01 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.223 -0.923 . . . . 0.0 109.668 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . 0.444 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 79.7 t80 -173.41 82.76 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.337 -0.852 . . . . 0.0 109.391 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -141.8 -129.97 0.1 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.43 -0.794 . . . . 0.0 109.176 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 7.4 t 49.57 84.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.104 -0.997 . . . . 0.0 109.419 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 27.5 mt -97.9 -26.78 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.272 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.574 ' CG ' ' N ' ' B' ' 53' ' ' ARG . 2.8 p90 -53.09 -40.26 63.95 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.453 -0.779 . . . . 0.0 110.362 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.574 ' N ' ' CG ' ' B' ' 52' ' ' TYR . 0.0 OUTLIER -64.91 -29.49 70.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.931 -1.106 . . . . 0.0 109.909 -179.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -74.57 -41.44 60.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.143 -0.973 . . . . 0.0 109.414 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.44 -50.74 66.38 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.195 -0.941 . . . . 0.0 108.963 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.53 -32.56 71.6 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.303 -0.873 . . . . 0.0 109.12 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -61.37 -59.46 5.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.313 -0.867 . . . . 0.0 109.114 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.65 -58.07 12.33 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 56.4 mt -78.0 69.48 4.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.357 -1.084 . . . . 0.0 109.246 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 9.9 tptp . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.563 -179.811 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 37.6 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.313 0.578 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' C' ' 26' ' ' LEU . 2.0 m-20 48.81 64.81 8.02 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.754 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -46.06 -8.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.738 2.292 . . . . 0.0 112.435 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.506 ' N ' ' O ' ' C' ' 24' ' ' ASP . 39.0 tp -47.41 -45.91 25.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.183 -0.948 . . . . 0.0 109.163 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 32.8 t -67.84 -45.83 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.231 -0.918 . . . . 0.0 108.616 179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 72.4 t -49.32 -49.26 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.305 -0.872 . . . . 0.0 109.013 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.01 -34.67 78.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 109.26 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.24 -55.53 15.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.299 -0.876 . . . . 0.0 109.701 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.86 -36.67 67.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.897 . . . . 0.0 109.724 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 22.8 mt -72.34 -42.02 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.153 -0.967 . . . . 0.0 109.406 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.7 mt -54.76 -34.69 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.09 -1.006 . . . . 0.0 108.64 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.23 -44.28 23.19 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 59.9 mt -57.19 -32.38 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.184 -1.186 . . . . 0.0 108.971 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -71.27 -65.56 0.73 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 108.812 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -46.16 -38.24 7.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.815 . . . . 0.0 109.678 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 55.9 tp -66.4 -69.95 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.216 -0.927 . . . . 0.0 109.696 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 15.7 mt -47.4 -25.45 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.16 -0.963 . . . . 0.0 109.398 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 5.9 mt -71.98 -61.05 1.93 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.482 -0.761 . . . . 0.0 109.755 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -47.79 -48.18 30.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.978 . . . . 0.0 109.61 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' C' ' 45' ' ' ARG . 53.4 mt -61.6 -59.8 3.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.193 -0.942 . . . . 0.0 108.826 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.4 tp -43.51 -44.6 6.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.756 -0.59 . . . . 0.0 109.913 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . 0.478 ' CG ' HNC2 ' C' ' 399' ' ' RIM . 0.7 OUTLIER -68.13 -27.25 66.29 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.22 -0.925 . . . . 0.0 109.64 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.464 ' N ' ' O ' ' C' ' 42' ' ' ILE . 14.0 mmt180 -82.6 -15.54 51.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.171 -0.955 . . . . 0.0 110.559 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.7 mt -86.58 -11.28 51.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.736 -1.227 . . . . 0.0 109.247 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -59.07 94.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.942 . . . . 0.0 109.156 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.51 ' O ' ' CG ' ' C' ' 48' ' ' PHE . 0.1 OUTLIER -162.89 6.99 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.916 . . . . 0.0 109.503 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 9.1 ttpt -50.57 -31.36 15.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.25 -0.906 . . . . 0.0 109.477 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 3.1 p -164.41 131.95 3.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.607 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 5.1 mt -82.18 -22.77 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.294 -0.879 . . . . 0.0 108.996 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -45.8 -39.72 8.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 0.0 109.96 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -53.01 -48.57 67.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.117 -0.989 . . . . 0.0 110.171 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . 0.486 ' O ' ' CD1' ' D' ' 51' ' ' ILE . 10.1 m-85 -62.37 -40.48 96.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.095 -1.003 . . . . 0.0 109.562 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -60.19 -58.39 8.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.851 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -57.0 -37.19 71.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 110.221 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -48.04 82.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.063 -1.023 . . . . 0.0 109.748 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.4 -59.54 9.74 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 6.9 mt -75.63 87.68 2.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.223 -1.163 . . . . 0.0 109.4 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 17.9 mmtt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.46 -179.998 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' D' ' 26' ' ' LEU . 15.4 m-20 51.15 66.68 5.08 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.255 -0.903 . . . . 0.0 109.393 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -46.16 -10.45 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.754 2.303 . . . . 0.0 112.092 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' D' ' 24' ' ' ASP . 44.9 tp -47.58 -47.6 28.42 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.223 -0.923 . . . . 0.0 109.016 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.27 -44.79 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 108.73 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 75.3 t -48.58 -49.5 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.354 -0.841 . . . . 0.0 108.904 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.26 -37.14 86.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.877 . . . . 0.0 109.507 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.4 -57.1 10.26 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.231 -0.918 . . . . 0.0 109.916 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.4 -36.72 64.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.224 -0.923 . . . . 0.0 109.81 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 26.9 mt -72.54 -41.69 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.166 -0.958 . . . . 0.0 109.453 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -55.92 -36.98 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.092 -1.005 . . . . 0.0 108.702 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.11 -45.16 57.71 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.146 -1.582 . . . . 0.0 109.146 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 47.2 mt -56.05 -38.88 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.204 -1.174 . . . . 0.0 109.286 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.72 -61.78 1.72 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -0.866 . . . . 0.0 109.137 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -46.57 -44.02 17.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.61 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.0 tp -60.07 -69.18 0.23 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -0.915 . . . . 0.0 109.411 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mt -46.95 -25.25 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.275 -0.891 . . . . 0.0 109.403 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.444 ' CD2' ' OD2' ' D' ' 44' ' ' ASP . 1.5 tt -69.96 -64.12 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.895 . . . . 0.0 109.716 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 19.0 t-105 -47.26 -49.06 24.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 109.523 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 36.2 mt -61.16 -50.93 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.176 -0.953 . . . . 0.0 109.228 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 53.2 tp -50.88 -37.7 45.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.835 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.476 ' OD2' ' NC ' ' D' ' 499' ' ' RIM . 73.2 m-20 -75.9 -28.41 58.05 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.947 . . . . 0.0 109.625 -179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -71.56 -27.02 62.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.179 -0.951 . . . . 0.0 110.569 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.4 mt -71.27 -16.08 62.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.69 -1.256 . . . . 0.0 109.112 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -82.92 -7.55 59.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.248 -0.908 . . . . 0.0 108.935 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . 0.445 ' O ' ' CB ' ' D' ' 49' ' ' LYS . 0.9 OUTLIER -87.7 -153.86 0.24 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.405 -0.809 . . . . 0.0 109.737 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' D' ' 48' ' ' PHE . 5.9 ttpt 74.14 -62.81 0.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.365 -0.834 . . . . 0.0 109.593 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.85 106.42 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.196 -0.94 . . . . 0.0 109.594 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' C' ' 54' ' ' PHE . 4.0 mt -87.78 -23.3 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.574 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . 0.468 ' CD1' ' C ' ' D' ' 52' ' ' TYR . 0.0 OUTLIER -62.79 -49.25 75.71 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.145 -0.972 . . . . 0.0 110.181 -179.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . 0.419 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 0.7 OUTLIER -71.6 -28.48 63.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.536 -1.353 . . . . 0.0 110.19 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -75.66 -54.91 6.22 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.086 -1.009 . . . . 0.0 111.089 -178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.1 OUTLIER -75.58 -18.29 59.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.957 -1.089 . . . . 0.0 110.583 -178.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . 0.526 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 2.2 tm-20 -84.5 -33.7 23.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.856 -1.152 . . . . 0.0 108.063 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . 0.419 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 0.5 OUTLIER -69.0 -38.6 79.36 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' D' ' 60' ' ' LYS . . . -69.78 -61.5 4.34 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.1 77.61 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.229 -1.159 . . . . 0.0 109.556 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' D' ' 58' ' ' GLY . 50.9 tttt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.479 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' RIM . . . . . 0.662 ' NC ' HD22 ' A' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 299' ' ' RIM . . . . . 0.509 ' NC ' ' OD2' ' B' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 399' ' ' RIM . . . . . 0.478 HNC2 ' CG ' ' C' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 499' ' ' RIM . . . . . 0.476 ' NC ' ' OD2' ' D' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.0 p . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 26' ' ' LEU . 8.6 m-20 -152.4 66.72 6.54 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 109.363 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -45.82 -11.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.778 2.319 . . . . 0.0 112.27 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.489 ' N ' ' O ' ' A' ' 24' ' ' ASP . 37.2 tp -46.65 -46.31 19.83 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.234 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.6 t -68.51 -44.78 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.185 -0.947 . . . . 0.0 108.974 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -49.15 -49.39 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.237 -0.915 . . . . 0.0 109.08 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.83 -35.04 79.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 109.355 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.41 -56.98 10.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 0.0 109.69 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.95 -36.98 68.4 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.194 -0.941 . . . . 0.0 109.866 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.8 mt -71.01 -40.91 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.107 -0.996 . . . . 0.0 109.441 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.9 mt -57.02 -36.05 49.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.141 -0.974 . . . . 0.0 108.59 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.29 -44.1 53.34 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 74.5 mt -61.81 -27.02 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.165 -1.197 . . . . 0.0 109.155 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.99 -66.6 0.65 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.333 -0.854 . . . . 0.0 109.441 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.31 -39.31 6.53 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 109.841 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.67 -69.0 0.3 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.419 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.5 mt -47.1 -34.34 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.514 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 mt -62.87 -55.8 22.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.464 -0.773 . . . . 0.0 109.943 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 68.3 t-105 -52.03 -45.01 64.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mt -68.76 -28.29 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.108 -0.995 . . . . 0.0 109.279 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -61.69 -44.26 97.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.21 -0.931 . . . . 0.0 109.563 -179.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.507 ' OD1' ' NH2' ' B' ' 45' ' ' ARG . 2.6 m-20 -80.19 -24.45 40.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.218 -0.926 . . . . 0.0 109.97 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.521 ' O ' ' N ' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -93.31 0.97 57.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.122 -0.987 . . . . 0.0 111.25 -179.22 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.48 ' C ' ' O ' ' A' ' 45' ' ' ARG . 31.0 mt -31.3 -36.27 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.693 -0.63 . . . . 0.0 110.814 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.524 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 0.1 OUTLIER 169.15 -10.53 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 109.267 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -46.21 103.8 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.383 -0.823 . . . . 0.0 109.42 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' CG ' ' H ' ' A' ' 50' ' ' SER . 12.6 tptm -145.44 -129.08 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.251 -0.905 . . . . 0.0 109.713 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.428 ' H ' ' CG ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER 65.36 135.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.282 -0.886 . . . . 0.0 109.229 -179.758 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 49.1 mt -102.17 -35.26 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.525 -0.735 . . . . 0.0 109.5 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -35.39 69.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.612 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -64.24 -41.12 97.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 0.0 109.369 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -65.34 -29.11 69.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.236 -0.915 . . . . 0.0 109.434 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -75.34 -68.42 0.56 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.098 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -46.83 -31.27 2.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.243 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -69.85 -58.77 3.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.314 -0.866 . . . . 0.0 109.566 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.19 -60.45 9.0 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.08 97.17 1.44 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -1.1 . . . . 0.0 109.356 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.4 mttp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.511 -179.888 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 30.3 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' B' ' 26' ' ' LEU . 4.8 m-20 48.82 67.28 4.66 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 0.0 109.449 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -47.22 -9.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.763 2.309 . . . . 0.0 112.311 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' B' ' 24' ' ' ASP . 39.1 tp -47.22 -44.76 22.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.189 -0.944 . . . . 0.0 108.871 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 38.7 t -68.66 -44.88 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 0.0 108.758 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 76.5 t -49.7 -50.62 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 109.176 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.39 -34.82 78.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 109.391 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.76 -55.99 14.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.222 -0.924 . . . . 0.0 109.685 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.72 -36.85 67.66 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 109.873 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 18.9 mt -72.42 -42.4 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 0.0 109.553 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 mt -55.85 -34.65 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.054 -1.029 . . . . 0.0 108.826 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.33 -43.89 36.55 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 67.7 mt -60.25 -26.29 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.243 -1.151 . . . . 0.0 109.234 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.58 -64.49 1.06 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.267 -0.896 . . . . 0.0 109.263 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -45.5 -43.56 11.78 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 0.0 109.867 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.4 tp -63.15 -64.57 0.87 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.927 . . . . 0.0 109.311 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 8.2 mt -47.78 -28.36 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.471 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.675 HD22 HNC1 ' B' ' 299' ' ' RIM . 2.2 mt -67.44 -55.86 11.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.297 -0.877 . . . . 0.0 110.141 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -55.67 -39.72 71.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.944 . . . . 0.0 109.937 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 94.5 mt -70.58 -40.57 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.954 -1.091 . . . . 0.0 108.959 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 50.3 tp -57.51 -41.33 80.61 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.516 -0.74 . . . . 0.0 109.767 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -79.3 -23.73 43.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.154 -0.966 . . . . 0.0 109.84 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.507 ' NH2' ' OD1' ' A' ' 44' ' ' ASP . 0.1 OUTLIER -89.01 -4.74 58.32 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.044 -1.035 . . . . 0.0 110.902 -179.19 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.497 ' C ' ' O ' ' B' ' 45' ' ' ARG . 28.0 mt -33.56 -35.9 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.693 -0.629 . . . . 0.0 110.166 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.474 ' N ' ' O ' ' B' ' 45' ' ' ARG . 3.3 t80 -172.59 136.08 0.73 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.943 . . . . 0.0 109.326 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . 0.413 ' CD2' ' O ' ' B' ' 47' ' ' PHE . 0.7 OUTLIER -167.85 98.58 0.46 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.216 -0.928 . . . . 0.0 109.43 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -141.79 -35.73 0.44 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 0.0 109.424 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 11.9 p -65.65 124.71 23.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.291 -0.88 . . . . 0.0 109.531 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 15.8 mt -111.39 -22.67 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.671 -0.643 . . . . 0.0 109.347 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -54.03 -21.43 8.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 0.0 109.663 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -69.87 -45.9 66.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.437 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -65.09 -34.4 78.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.476 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -65.65 -60.24 3.11 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.923 . . . . 0.0 109.458 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -52.71 -30.96 35.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.222 -0.924 . . . . 0.0 109.459 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -62.63 -63.42 1.23 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.27 -0.894 . . . . 0.0 109.315 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -53.33 -59.29 9.77 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mt -50.77 143.96 9.02 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.358 -1.084 . . . . 0.0 109.683 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.5 mttm . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.33 179.854 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 50.9 p . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' C' ' 24' ' ' ASP . 1.7 p-10 -171.11 70.24 0.51 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.393 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.53 -9.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.814 2.343 . . . . 0.0 112.402 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.424 ' N ' ' O ' ' C' ' 24' ' ' ASP . 48.3 tp -47.76 -46.97 30.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.189 -0.944 . . . . 0.0 109.033 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 48.5 t -68.78 -45.47 80.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.238 -0.914 . . . . 0.0 108.759 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.6 t -48.46 -46.48 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.282 -0.886 . . . . 0.0 109.139 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.93 -36.87 83.2 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.213 -0.929 . . . . 0.0 109.46 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.36 -55.13 27.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 109.388 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.08 -36.2 67.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.392 -0.818 . . . . 0.0 109.894 -179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 18.4 mt -72.98 -41.57 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.109 -0.994 . . . . 0.0 109.721 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 21.1 mt -56.78 -34.79 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.074 -1.016 . . . . 0.0 108.614 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.11 -45.17 42.03 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.908 -1.677 . . . . 0.0 108.908 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 54.4 mt -57.13 -31.81 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.21 -1.171 . . . . 0.0 108.869 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.98 -64.62 0.87 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.456 -0.778 . . . . 0.0 109.055 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -46.25 -39.08 9.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.876 . . . . 0.0 109.72 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -63.09 -70.13 0.23 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.956 . . . . 0.0 109.545 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 3.9 mt -47.14 -37.92 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.319 -0.863 . . . . 0.0 109.401 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . 0.55 HD22 HNC1 ' C' ' 399' ' ' RIM . 4.0 mt -61.42 -61.79 2.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.343 -0.848 . . . . 0.0 110.101 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -45.85 -49.48 15.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.366 -0.834 . . . . 0.0 109.578 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 64.7 mt -60.57 -44.44 96.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.166 -0.959 . . . . 0.0 108.9 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' C' ' 43' ' ' LEU . 0.1 OUTLIER -48.36 -55.28 11.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.536 -0.727 . . . . 0.0 109.583 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . 0.514 ' OD1' ' NC ' ' C' ' 399' ' ' RIM . 7.8 m-20 -64.4 -27.71 69.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.302 -0.874 . . . . 0.0 110.316 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -72.11 -25.25 61.67 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.861 -1.149 . . . . 0.0 110.798 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 47' ' ' PHE . 9.7 mt -68.95 -8.78 47.71 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.669 -1.27 . . . . 0.0 109.289 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.446 ' O ' ' N ' ' C' ' 49' ' ' LYS . 2.9 m-85 -47.23 -92.93 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.212 -0.93 . . . . 0.0 109.35 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 46.09 19.63 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.762 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' C' ' 47' ' ' PHE . 16.4 mtpt -64.01 -148.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.153 -0.967 . . . . 0.0 109.483 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.7 162.83 14.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.212 -0.93 . . . . 0.0 109.174 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 13.4 mt -103.93 -22.76 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.536 -0.728 . . . . 0.0 109.442 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' C' ' 52' ' ' TYR . 6.5 t80 -63.55 -22.05 66.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.265 -0.897 . . . . 0.0 109.982 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -66.33 -46.99 74.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.072 -1.017 . . . . 0.0 110.0 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -66.02 -33.68 76.36 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.122 -0.986 . . . . 0.0 109.691 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -63.17 -58.65 6.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.378 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -57.14 -30.0 64.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 109.157 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -67.28 -45.83 75.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.298 -0.876 . . . . 0.0 109.127 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.25 -61.89 5.36 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 5.9 mt -48.7 140.08 8.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -1.153 . . . . 0.0 109.494 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 18.2 mtmm . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.474 -179.929 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.286 0.565 . . . . 0.0 109.521 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -47.37 160.11 0.38 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 0.0 109.328 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' D' ' 26' ' ' LEU . 19.5 Cg_endo -61.83 -24.42 77.24 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.567 2.178 . . . . 0.0 112.206 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' D' ' 25' ' ' PRO . 56.2 tp -45.59 -41.02 9.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.324 -0.86 . . . . 0.0 108.775 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 33.5 t -70.26 -45.27 76.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.303 -0.873 . . . . 0.0 108.697 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 74.1 t -49.76 -49.1 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.266 -0.896 . . . . 0.0 108.95 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.37 -33.47 76.03 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.316 -0.865 . . . . 0.0 109.307 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.23 -56.17 14.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.663 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.29 -37.12 69.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.228 -0.92 . . . . 0.0 109.858 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 20.6 mt -71.36 -41.67 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.076 -1.015 . . . . 0.0 109.426 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 17.3 mt -56.48 -33.94 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.071 -1.018 . . . . 0.0 108.566 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.58 -44.55 32.38 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.119 -1.592 . . . . 0.0 109.119 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 61.9 mt -58.41 -29.66 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.343 -1.092 . . . . 0.0 109.218 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -73.13 -67.07 0.6 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.0 109.097 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -46.82 -37.29 8.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 0.0 109.732 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 59.4 tp -65.09 -69.2 0.31 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.133 -0.98 . . . . 0.0 109.507 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.1 mt -49.2 -26.51 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.0 109.483 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.488 HD23 ' C ' ' D' ' 40' ' ' LEU . 2.3 tt -67.64 -63.03 1.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.924 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . 0.507 ' CH2' ' NE ' ' D' ' 45' ' ' ARG . 24.7 t-105 -53.04 -43.87 66.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.984 -1.072 . . . . 0.0 109.666 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 84.2 mt -61.75 -51.2 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.152 -0.967 . . . . 0.0 108.782 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 58.1 tp -50.06 -39.73 43.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.608 -0.683 . . . . 0.0 109.931 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.731 ' CG ' HNC2 ' D' ' 499' ' ' RIM . 0.5 OUTLIER -75.79 -24.43 55.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.207 -0.933 . . . . 0.0 109.911 -179.603 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.507 ' NE ' ' CH2' ' D' ' 41' ' ' TRP . 0.6 OUTLIER -76.08 -25.24 55.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.106 -0.996 . . . . 0.0 110.21 -179.596 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -73.13 -28.88 62.5 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.796 -1.19 . . . . 0.0 109.338 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . 0.455 ' O ' ' CB ' ' D' ' 48' ' ' PHE . 7.5 m-85 -66.19 -170.4 0.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.45 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . 0.455 ' CB ' ' O ' ' D' ' 47' ' ' PHE . 2.4 t80 73.61 18.5 3.5 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.855 . . . . 0.0 109.489 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . 0.485 ' CG ' ' H ' ' D' ' 50' ' ' SER . 0.0 OUTLIER -58.47 -97.78 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.31 -0.869 . . . . 0.0 109.409 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.51 ' OG ' ' CZ ' ' D' ' 52' ' ' TYR . 1.1 t -57.76 139.52 53.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.33 -0.856 . . . . 0.0 109.44 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 19.8 mt -109.59 -26.83 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.661 -0.65 . . . . 0.0 109.522 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . 0.51 ' CZ ' ' OG ' ' D' ' 50' ' ' SER . 17.8 p90 -59.99 -43.82 94.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.211 -0.93 . . . . 0.0 109.721 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . 0.407 ' N ' ' CD2' ' D' ' 52' ' ' TYR . 10.1 mtp85 -64.39 -35.93 82.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.089 -1.007 . . . . 0.0 109.339 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -63.48 -33.74 76.22 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.878 . . . . 0.0 109.334 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -71.21 -56.59 5.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.356 -0.84 . . . . 0.0 109.215 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -51.56 -29.31 16.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.221 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -69.34 -55.79 9.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.913 . . . . 0.0 109.235 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -48.07 -57.17 8.16 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.73 121.6 13.8 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.345 -1.091 . . . . 0.0 109.445 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 23.6 tttt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.486 -179.981 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' RIM . . . . . 0.441 ' NC ' ' OD2' ' A' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 299' ' ' RIM . . . . . 0.675 HNC1 HD22 ' B' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 399' ' ' RIM . . . . . 0.55 HNC1 HD22 ' C' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 499' ' ' RIM . . . . . 0.731 HNC2 ' CG ' ' D' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.5 p . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.532 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 5.1 m-20 -154.68 49.51 0.46 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.182 -0.949 . . . . 0.0 109.644 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 12.8 Cg_endo -59.01 -12.67 16.09 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.744 2.296 . . . . 0.0 112.121 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.2 tp -47.22 -46.85 24.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 0.0 108.959 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.2 t -68.9 -44.74 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.34 -0.85 . . . . 0.0 108.792 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.3 t -49.36 -49.33 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.257 -0.902 . . . . 0.0 108.815 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.82 -33.39 75.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.374 -0.829 . . . . 0.0 109.35 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.52 -56.8 10.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.3 -0.875 . . . . 0.0 109.677 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.98 -37.34 68.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 109.891 -179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 27.7 mt -71.59 -41.36 71.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.136 -0.977 . . . . 0.0 109.474 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.1 mt -55.67 -34.79 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.175 -0.953 . . . . 0.0 108.458 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.26 -44.96 32.69 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 56.2 mt -56.84 -34.07 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.175 -1.191 . . . . 0.0 109.248 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.96 -63.61 1.03 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 0.0 109.086 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.96 -38.39 7.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.39 -0.819 . . . . 0.0 109.475 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.71 -70.97 0.2 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.872 . . . . 0.0 109.392 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.4 mt -46.79 -25.52 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.278 -0.889 . . . . 0.0 109.505 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -74.24 -55.5 5.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.119 -0.988 . . . . 0.0 109.704 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.5 t-105 -50.84 -48.52 59.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.165 -0.96 . . . . 0.0 109.613 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.1 mt -65.78 -57.53 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.291 -0.881 . . . . 0.0 109.398 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.6 tp -48.78 -27.95 3.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.541 -0.725 . . . . 0.0 110.525 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.511 ' OD2' ' NC ' ' A' ' 199' ' ' RIM . 2.3 m-20 -90.3 -26.97 19.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.012 -1.055 . . . . 0.0 109.961 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -73.12 -26.12 61.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 110.628 -179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 48' ' ' PHE . 9.0 mt -64.91 -9.81 24.06 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.795 -1.191 . . . . 0.0 109.552 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -66.82 76.61 0.12 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.1 -1.0 . . . . 0.0 109.514 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -156.9 21.01 0.32 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 109.406 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.65 -126.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.54 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.0 m -48.55 125.91 10.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 0.0 109.421 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.3 mt -94.62 -24.86 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.394 -0.817 . . . . 0.0 109.428 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.505 ' CD2' ' OE1' ' A' ' 56' ' ' GLU . 0.5 OUTLIER -60.6 -23.23 64.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.878 . . . . 0.0 109.592 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.457 ' O ' ' CG ' ' A' ' 57' ' ' HIS . 21.3 mtt180 -70.36 -37.47 74.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.088 -1.008 . . . . 0.0 109.665 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -71.93 -36.52 69.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.154 -0.966 . . . . 0.0 109.298 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -65.62 -46.42 79.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 0.0 109.793 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.505 ' OE1' ' CD2' ' A' ' 52' ' ' TYR . 0.4 OUTLIER -70.56 -28.16 64.68 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.245 -0.909 . . . . 0.0 109.708 -179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.457 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 1.9 m-70 -67.28 -46.32 73.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.189 -0.944 . . . . 0.0 109.196 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.86 -65.16 2.56 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mt -59.1 145.34 42.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.269 -1.136 . . . . 0.0 109.492 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.04 -0.981 . . . . 0.0 109.457 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.561 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 28.9 m-20 -152.21 48.5 0.47 Allowed Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 109.612 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 10.5 Cg_endo -56.52 -15.06 14.45 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.794 2.33 . . . . 0.0 112.235 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' B' ' 26' ' ' LEU . 29.6 tp -46.5 -46.1 18.85 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.247 -0.908 . . . . 0.0 109.096 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.53 -44.39 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.231 -0.918 . . . . 0.0 108.967 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 74.5 t -50.73 -50.22 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.302 -0.874 . . . . 0.0 109.089 179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.42 -36.56 82.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.53 -56.08 16.41 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.336 -0.852 . . . . 0.0 109.806 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.22 -36.77 66.33 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.252 -0.905 . . . . 0.0 109.707 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.19 -40.33 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.108 -0.995 . . . . 0.0 109.613 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.45 HD13 HG13 ' C' ' 35' ' ' ILE . 17.1 mt -56.8 -36.0 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.019 -1.051 . . . . 0.0 108.803 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.63 -43.29 44.33 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 86.2 mt -63.11 -21.27 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.35 -1.088 . . . . 0.0 108.908 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.55 -69.77 0.54 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.36 -0.838 . . . . 0.0 109.218 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -46.55 -33.69 4.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.332 -0.855 . . . . 0.0 109.453 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.7 tp -68.11 -68.76 0.36 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.358 -0.839 . . . . 0.0 109.446 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -48.64 -33.33 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.22 -0.925 . . . . 0.0 109.433 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.461 HD23 ' O ' ' B' ' 40' ' ' LEU . 2.1 tt -64.32 -54.74 28.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 109.444 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -48.83 -48.04 41.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.201 -0.937 . . . . 0.0 109.3 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 11.5 mt -66.27 -33.12 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.119 -0.988 . . . . 0.0 108.802 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 tp -58.88 -34.5 71.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.507 -0.746 . . . . 0.0 110.316 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -87.71 -27.26 22.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.971 -1.081 . . . . 0.0 109.614 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -91.63 3.46 54.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 110.649 -179.481 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.481 ' C ' ' O ' ' B' ' 45' ' ' ARG . 34.1 mt -29.35 -37.02 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 O-C-N 121.976 -0.453 . . . . 0.0 110.915 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.538 ' N ' ' O ' ' B' ' 45' ' ' ARG . 0.4 OUTLIER -177.92 165.01 1.96 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.995 -1.066 . . . . 0.0 109.7 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -163.99 110.43 1.08 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.398 -0.814 . . . . 0.0 109.432 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.586 ' N ' ' CD ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -144.02 -18.48 0.58 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.306 -0.871 . . . . 0.0 109.375 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -93.4 97.22 10.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.214 -0.929 . . . . 0.0 109.35 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 5.8 mt -93.33 -23.84 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.255 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.99 -34.94 74.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.588 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 12.3 mtp180 -64.66 -32.58 74.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.309 -0.869 . . . . 0.0 109.395 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -72.69 -42.63 64.01 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.272 -0.892 . . . . 0.0 109.27 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -60.48 -39.7 88.61 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.385 -0.822 . . . . 0.0 109.015 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -71.77 -30.87 66.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.351 -0.843 . . . . 0.0 109.408 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -65.18 -48.95 71.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.27 -0.894 . . . . 0.0 109.066 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.9 -62.34 5.32 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.097 -1.601 . . . . 0.0 109.097 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 3.9 mt -58.98 138.08 57.64 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.353 -1.087 . . . . 0.0 109.272 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 16.0 tttm . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.905 -1.045 . . . . 0.0 109.52 -179.896 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.324 0.583 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 10.8 t0 -167.6 48.77 0.16 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.9 . . . . 0.0 109.197 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 2.9 Cg_endo -44.98 -19.77 0.33 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 122.778 2.319 . . . . 0.0 112.011 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 32.3 tp -45.85 -40.73 10.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.404 -0.81 . . . . 0.0 109.172 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.44 -45.19 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -0.866 . . . . 0.0 108.959 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 70.8 t -51.18 -49.88 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.303 -0.873 . . . . 0.0 108.973 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.89 -32.99 74.7 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.357 -0.839 . . . . 0.0 109.249 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.36 -55.88 13.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.315 -0.865 . . . . 0.0 109.47 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.93 -36.47 70.27 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.352 -0.843 . . . . 0.0 109.672 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 15.4 mt -71.45 -40.23 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.159 -0.963 . . . . 0.0 109.402 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.4 mt -58.03 -35.69 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.139 -0.976 . . . . 0.0 108.665 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.42 -43.23 62.57 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.845 -1.702 . . . . 0.0 108.845 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . 0.45 HG13 HD13 ' B' ' 33' ' ' ILE . 79.5 mt -63.76 -28.87 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.415 -1.05 . . . . 0.0 109.006 179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.94 -58.86 4.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.412 -0.805 . . . . 0.0 108.98 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -54.36 -42.76 70.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.316 -0.865 . . . . 0.0 109.397 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 59.2 tp -58.81 -62.79 1.61 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.131 -0.98 . . . . 0.0 109.319 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 mt -51.61 -40.98 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.215 -0.928 . . . . 0.0 109.495 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . 0.784 HD22 HNC1 ' C' ' 399' ' ' RIM . 2.6 mt -60.86 -54.43 45.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.403 -0.81 . . . . 0.0 110.05 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 66.8 t-105 -52.21 -44.61 64.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.366 -0.834 . . . . 0.0 109.813 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 36.4 mt -70.48 -28.17 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.257 -0.902 . . . . 0.0 109.236 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.82 -43.5 98.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.644 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.31 -24.6 32.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.111 -0.993 . . . . 0.0 109.688 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' C' ' 47' ' ' PHE . 1.6 mmt85 -89.42 -1.18 57.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.3 -0.875 . . . . 0.0 110.753 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.491 ' C ' ' O ' ' C' ' 45' ' ' ARG . 29.0 mt -31.16 -36.23 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.851 -0.531 . . . . 0.0 110.805 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.511 ' N ' ' O ' ' C' ' 45' ' ' ARG . 2.3 m-85 -169.16 85.22 0.15 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.116 -0.99 . . . . 0.0 109.801 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 46.32 -132.87 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.3 -0.875 . . . . 0.0 109.686 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -170.07 -140.22 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.88 . . . . 0.0 109.256 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . 0.441 ' O ' ' CZ ' ' C' ' 54' ' ' PHE . 40.5 t -147.9 120.52 8.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.319 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 17.1 mt -86.79 -23.12 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.255 -0.903 . . . . 0.0 109.243 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -23.85 64.17 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.352 -0.842 . . . . 0.0 109.499 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -70.39 -45.49 65.89 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.132 -0.98 . . . . 0.0 109.956 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' C' ' 54' ' ' PHE . 0.7 OUTLIER -69.1 -43.14 75.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.007 -1.058 . . . . 0.0 109.069 179.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -55.95 -56.72 17.36 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.407 -0.808 . . . . 0.0 109.354 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -26.8 68.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.664 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 37.0 t60 -67.16 -47.5 70.83 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.225 -0.922 . . . . 0.0 109.131 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.28 -59.6 9.21 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 62.4 mt -69.09 147.86 50.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.325 -1.103 . . . . 0.0 109.791 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 15.3 mttp . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.626 179.709 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . 0.404 ' O ' ' OD1' ' D' ' 24' ' ' ASP . 69.4 m . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' D' ' 26' ' ' LEU . 62.0 m-20 -151.68 68.0 7.47 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -46.95 -11.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.659 2.239 . . . . 0.0 112.187 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' D' ' 24' ' ' ASP . 36.9 tp -47.36 -46.32 25.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.023 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 80.6 t -67.67 -45.5 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.315 -0.866 . . . . 0.0 108.852 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 72.6 t -49.42 -47.4 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.897 . . . . 0.0 108.912 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.53 -34.2 77.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.412 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.41 -56.63 10.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.194 -0.941 . . . . 0.0 109.634 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.94 -35.67 66.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -0.882 . . . . 0.0 109.91 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 18.9 mt -73.25 -43.73 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.133 -0.979 . . . . 0.0 109.561 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 20.6 mt -54.56 -34.42 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.177 -0.952 . . . . 0.0 108.655 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.55 -44.41 26.82 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 50.0 mt -55.59 -31.04 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.087 -1.243 . . . . 0.0 109.356 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.11 -63.02 1.36 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.299 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 7.3 t-80 -45.87 -38.94 7.95 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.367 -0.833 . . . . 0.0 109.854 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 53.7 tp -68.12 -67.85 0.43 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.123 -0.985 . . . . 0.0 109.642 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -47.31 -25.68 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.659 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.443 HD22 HNC1 ' D' ' 499' ' ' RIM . 4.3 mt -68.88 -65.67 0.67 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 109.818 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 21.3 t-105 -48.9 -45.19 40.91 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.212 -0.93 . . . . 0.0 109.879 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' D' ' 45' ' ' ARG . 84.9 mt -63.32 -56.86 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.131 -0.981 . . . . 0.0 108.875 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 61.2 tp -46.26 -45.82 17.42 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.539 -0.726 . . . . 0.0 109.422 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.79 -26.7 67.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.357 -0.839 . . . . 0.0 109.771 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.512 ' CA ' ' HE ' ' D' ' 45' ' ' ARG . 0.0 OUTLIER -77.49 -21.15 53.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.13 -0.981 . . . . 0.0 110.151 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.1 mt -83.65 -34.13 25.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.776 -1.202 . . . . 0.0 108.926 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -95.43 118.09 31.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.458 -0.776 . . . . 0.0 109.389 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -158.85 -8.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.122 -0.986 . . . . 0.0 109.63 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 9.9 pttp -67.98 -152.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -0.919 . . . . 0.0 109.191 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 11.4 p 44.09 59.53 3.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.334 -0.854 . . . . 0.0 109.65 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 12.4 mt -96.83 -22.89 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.338 -0.852 . . . . 0.0 109.606 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -67.73 -22.75 65.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.136 -0.977 . . . . 0.0 109.483 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . 0.435 ' O ' ' ND1' ' D' ' 57' ' ' HIS . 0.1 OUTLIER -69.93 -39.37 76.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.178 -0.951 . . . . 0.0 109.44 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -69.72 -37.62 76.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.92 . . . . 0.0 109.089 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.35 -43.69 96.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.341 -0.849 . . . . 0.0 109.288 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -68.99 -27.95 66.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.272 -0.892 . . . . 0.0 109.114 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . 0.435 ' ND1' ' O ' ' D' ' 53' ' ' ARG . 1.7 m-70 -67.37 -46.95 71.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.308 -0.87 . . . . 0.0 108.855 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.26 -60.99 7.38 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.0 114.81 6.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.396 -1.061 . . . . 0.0 109.419 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.06 -0.972 . . . . 0.0 109.447 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' RIM . . . . . 0.515 ' HA2' ' CB ' ' B' ' 45' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 299' ' ' RIM . . . . . 0.409 ' HA2' ' CB ' ' C' ' 45' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 399' ' ' RIM . . . . . 0.784 HNC1 HD22 ' C' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 499' ' ' RIM . . . . . 0.443 HNC1 HD22 ' D' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.49 ' O ' ' N ' ' A' ' 26' ' ' LEU . 13.3 m-20 56.23 65.3 4.31 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.693 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -45.72 -11.38 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.691 2.261 . . . . 0.0 112.076 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 24' ' ' ASP . 28.7 tp -47.37 -45.68 25.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.339 -0.851 . . . . 0.0 109.044 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.5 t -69.32 -45.64 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.288 -0.883 . . . . 0.0 108.803 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 63.5 t -49.53 -47.85 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.253 -0.904 . . . . 0.0 109.021 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.3 -33.58 76.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.261 -0.899 . . . . 0.0 109.339 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.18 -56.66 10.24 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.873 . . . . 0.0 109.685 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.95 -36.27 70.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.259 -0.9 . . . . 0.0 109.633 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.7 mt -70.87 -41.15 77.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.214 -0.929 . . . . 0.0 109.329 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 19.2 mt -57.48 -33.8 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.099 -1.001 . . . . 0.0 108.626 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.65 -44.38 39.92 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 43.1 mt -55.47 -34.98 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.321 -1.106 . . . . 0.0 109.097 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -68.82 -64.33 0.89 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.31 -0.869 . . . . 0.0 109.066 179.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.23 -41.01 8.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.445 -0.784 . . . . 0.0 110.072 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 35.4 tp -64.19 -68.04 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.111 -0.993 . . . . 0.0 109.6 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mt -47.9 -24.59 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.213 -0.93 . . . . 0.0 109.308 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.462 ' CD2' ' OD2' ' A' ' 44' ' ' ASP . 1.8 tt -71.35 -61.32 1.81 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.287 -0.883 . . . . 0.0 109.595 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 -51.16 -49.79 60.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.272 -0.892 . . . . 0.0 109.714 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.425 ' O ' ' N ' ' A' ' 45' ' ' ARG . 80.6 mt -60.23 -56.32 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.006 -1.059 . . . . 0.0 108.969 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 40.3 tp -46.34 -42.15 14.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.477 -0.764 . . . . 0.0 109.578 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.48 ' OD2' ' NC ' ' A' ' 199' ' ' RIM . 72.9 m-20 -67.71 -28.19 67.45 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.21 -0.931 . . . . 0.0 109.276 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.425 ' N ' ' O ' ' A' ' 42' ' ' ILE . 7.0 mmt-85 -80.11 -17.72 51.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 110.42 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -87.14 -35.08 18.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.693 -1.255 . . . . 0.0 109.002 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -99.5 -154.58 0.47 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.462 -0.774 . . . . 0.0 109.255 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 t80 66.56 114.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.265 -0.897 . . . . 0.0 109.472 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 50' ' ' SER . 5.3 ptmm? -169.8 -148.65 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.315 -0.866 . . . . 0.0 109.3 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 49' ' ' LYS . 17.0 m 50.98 97.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.9 mt -86.5 -24.42 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.134 -0.979 . . . . 0.0 109.067 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -59.23 -21.7 59.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.272 -0.892 . . . . 0.0 109.867 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' A' ' 57' ' ' HIS . 17.7 mmm180 -74.43 -44.09 53.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.91 -1.119 . . . . 0.0 109.744 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.495 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -73.71 -33.55 64.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.993 -1.067 . . . . 0.0 108.496 179.606 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -68.43 -52.12 36.25 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.351 -0.843 . . . . 0.0 109.861 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -71.17 -27.54 63.61 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.122 -0.986 . . . . 0.0 110.194 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.521 ' CG ' ' O ' ' A' ' 53' ' ' ARG . 11.4 m170 -65.0 -52.91 53.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.966 -1.084 . . . . 0.0 109.124 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.05 -64.52 2.76 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.4 116.98 4.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.189 -1.183 . . . . 0.0 109.425 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 118.084 -0.96 . . . . 0.0 109.431 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.537 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 16.6 m-20 -159.96 50.22 0.34 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.212 -0.93 . . . . 0.0 109.376 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 12.3 Cg_endo -58.7 -15.8 27.79 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.928 2.418 . . . . 0.0 112.438 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 52.1 tp -47.22 -43.23 21.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.086 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.58 -45.25 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.91 . . . . 0.0 108.733 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 77.6 t -49.0 -46.34 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.282 -0.886 . . . . 0.0 108.989 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.95 -37.1 85.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 109.144 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.01 -55.37 29.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.339 -0.851 . . . . 0.0 109.651 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.0 -37.28 71.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.263 -0.898 . . . . 0.0 110.06 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 14.0 mt -70.84 -39.75 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.141 -0.974 . . . . 0.0 109.319 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 26.8 mt -57.77 -36.44 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.246 -0.909 . . . . 0.0 108.634 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.54 -44.55 63.6 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.2 -23.28 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.295 -1.12 . . . . 0.0 109.005 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 12.2 tp -76.78 -71.71 0.38 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.464 -0.773 . . . . 0.0 109.456 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . 0.47 ' CD2' ' ND1' ' C' ' 37' ' ' HIS . 2.9 t-80 -44.79 -35.42 2.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.277 -0.889 . . . . 0.0 109.774 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -66.58 -68.66 0.36 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.191 -0.943 . . . . 0.0 109.466 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 7.0 mt -48.69 -41.18 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.463 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.664 HD22 ' NC ' ' B' ' 299' ' ' RIM . 2.5 mt -60.96 -61.72 2.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 110.066 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -46.82 -47.62 21.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.104 -0.998 . . . . 0.0 109.746 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 70.1 mt -62.0 -42.17 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.185 -0.947 . . . . 0.0 109.11 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.42 -43.39 64.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.625 -0.672 . . . . 0.0 109.918 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.505 ' OD2' ' NC ' ' B' ' 299' ' ' RIM . 6.7 m-20 -77.83 -25.41 48.77 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.743 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.542 ' NE ' ' NC ' ' A' ' 199' ' ' RIM . 9.6 mmm180 -71.83 -30.47 65.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.84 -1.163 . . . . 0.0 110.614 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -55.85 -26.53 47.21 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.734 -1.228 . . . . 0.0 109.281 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 54.19 -166.17 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.071 -1.018 . . . . 0.0 109.255 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -134.36 -125.02 0.16 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.512 -0.742 . . . . 0.0 109.358 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -149.74 -63.68 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 109.449 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 83.7 p -52.14 104.96 0.1 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.871 . . . . 0.0 109.493 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 10.7 mt -103.75 -20.18 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.435 -0.791 . . . . 0.0 109.355 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 t80 -57.51 -12.64 2.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.576 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -72.1 -42.17 66.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 0.0 109.724 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -70.09 -38.41 75.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.143 -0.973 . . . . 0.0 108.993 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -59.43 -47.91 83.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.512 -0.743 . . . . 0.0 109.593 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -70.8 -27.2 63.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.263 -0.898 . . . . 0.0 109.584 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -66.18 -50.48 63.74 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.285 -0.885 . . . . 0.0 109.13 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.03 -63.54 3.77 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.326 -1.51 . . . . 0.0 109.326 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 7.2 mt -68.65 118.58 11.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -1.148 . . . . 0.0 109.511 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 10.8 mptt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.953 -1.022 . . . . 0.0 109.481 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.32 159.22 75.54 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.185 -0.947 . . . . 0.0 109.277 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -61.08 -20.35 67.34 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.36 2.04 . . . . 0.0 112.205 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 47.4 tp -47.22 -42.54 20.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.944 . . . . 0.0 108.581 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 35.0 t -69.09 -45.48 79.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 73.8 t -48.77 -47.55 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 108.853 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.86 -36.48 84.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.348 -0.845 . . . . 0.0 109.37 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.13 -57.27 10.07 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.393 -0.817 . . . . 0.0 109.832 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.48 -36.97 67.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.268 -0.895 . . . . 0.0 109.916 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 24.8 mt -70.99 -42.45 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.169 -0.957 . . . . 0.0 109.378 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.9 mt -55.41 -35.69 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.167 -0.958 . . . . 0.0 108.83 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.25 -45.22 40.44 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 51.5 mt -55.72 -30.27 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.157 -1.202 . . . . 0.0 109.066 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.405 ' HA ' HD22 ' C' ' 36' ' ' LEU . 0.2 OUTLIER -73.73 -64.01 1.09 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 109.069 179.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . 0.47 ' ND1' ' CD2' ' B' ' 37' ' ' HIS . 13.0 t-80 -43.4 -37.25 2.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.484 -0.76 . . . . 0.0 110.244 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' C' ' 38' ' ' LEU . 35.3 tp -71.99 -65.17 0.8 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.983 -1.073 . . . . 0.0 109.523 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.3 mt -46.94 -27.64 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.235 -0.916 . . . . 0.0 109.393 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . 0.456 HD21 ' NC ' ' C' ' 399' ' ' RIM . 1.3 tt -72.04 -63.24 1.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.338 -0.851 . . . . 0.0 109.688 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 14.7 t-105 -45.94 -47.5 16.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 109.287 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 64.5 mt -58.49 -49.31 82.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.221 -0.924 . . . . 0.0 108.93 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.56 -50.43 13.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.653 -0.655 . . . . 0.0 109.411 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . 0.434 ' OD2' ' NC ' ' C' ' 399' ' ' RIM . 1.3 m-20 -62.76 -32.82 74.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.278 -0.889 . . . . 0.0 109.89 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -73.02 -19.12 61.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.07 -1.019 . . . . 0.0 110.416 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -83.75 -13.63 53.49 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.641 -1.287 . . . . 0.0 108.716 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -83.93 12.7 5.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.239 -0.913 . . . . 0.0 109.733 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -87.16 106.69 18.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.113 -0.992 . . . . 0.0 109.039 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -163.58 -90.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.152 -0.967 . . . . 0.0 109.72 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.34 103.61 0.25 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.913 . . . . 0.0 109.756 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 18.4 mt -90.99 -22.68 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.221 -0.925 . . . . 0.0 109.052 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -61.97 -23.42 66.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 110.026 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . 0.52 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 96.7 mtt180 -70.38 -36.51 74.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.068 -1.02 . . . . 0.0 110.125 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -72.35 -34.74 68.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.004 -1.06 . . . . 0.0 109.286 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.26 -45.8 79.29 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.338 -0.851 . . . . 0.0 109.679 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -71.6 -29.01 64.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.0 109.591 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 2.7 m-70 -64.58 -43.05 95.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 109.068 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.44 -61.61 4.09 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 mt -75.07 107.2 6.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -1.117 . . . . 0.0 109.57 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 14.9 tttt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.515 179.824 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.537 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 6.1 t70 66.21 48.4 0.56 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.353 -0.842 . . . . 0.0 109.595 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 0.9 OUTLIER -48.11 -19.72 1.81 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.634 2.223 . . . . 0.0 111.701 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 42.1 tp -46.26 -41.17 12.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.423 -0.798 . . . . 0.0 108.99 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 36.4 t -69.66 -45.67 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.237 -0.914 . . . . 0.0 108.795 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 77.5 t -49.2 -47.35 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 108.963 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.8 -34.33 77.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.873 . . . . 0.0 109.226 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.2 -55.44 18.52 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.341 -0.849 . . . . 0.0 109.688 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -58.1 -36.21 72.56 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.324 -0.86 . . . . 0.0 109.892 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 25.7 mt -72.05 -42.52 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.145 -0.972 . . . . 0.0 109.438 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mt -56.2 -33.37 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.107 -0.996 . . . . 0.0 108.457 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.5 -44.78 25.84 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 75.8 mt -60.85 -28.99 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.188 -1.184 . . . . 0.0 109.113 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.18 -65.33 0.76 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.335 -0.853 . . . . 0.0 108.883 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -45.75 -42.88 12.5 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.48 -0.763 . . . . 0.0 109.712 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.4 tp -61.19 -67.79 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 0.0 109.558 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mt -47.13 -35.7 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.175 -0.953 . . . . 0.0 109.639 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.587 HD22 ' NC ' ' D' ' 499' ' ' RIM . 4.0 mt -63.5 -57.39 10.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.2 -0.937 . . . . 0.0 109.826 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 76.4 t-105 -48.15 -45.38 33.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.04 -1.037 . . . . 0.0 109.472 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 67.4 mt -64.49 -50.17 77.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.156 -0.965 . . . . 0.0 109.012 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 14.3 tp -52.09 -37.14 53.05 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.638 -0.664 . . . . 0.0 110.39 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.67 -21.73 30.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.036 -1.04 . . . . 0.0 110.349 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.423 ' NH1' ' OD1' ' C' ' 44' ' ' ASP . 0.0 OUTLIER -76.09 -28.95 57.73 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.984 -1.073 . . . . 0.0 110.712 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.6 mt -57.25 -10.98 1.46 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.687 -1.258 . . . . 0.0 109.171 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -77.04 120.49 22.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.165 -0.96 . . . . 0.0 109.407 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -149.34 178.78 8.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.39 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . 0.543 ' CD ' ' H ' ' D' ' 50' ' ' SER . 6.0 tmtt? 54.83 -153.67 0.31 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.234 -0.916 . . . . 0.0 109.088 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.543 ' H ' ' CD ' ' D' ' 49' ' ' LYS . 2.6 m 47.01 54.7 8.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.945 -1.097 . . . . 0.0 110.023 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 47.4 mt -97.47 -28.64 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.348 -0.845 . . . . 0.0 109.297 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.44 -32.96 67.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.339 -0.85 . . . . 0.0 109.455 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 12.2 mmt85 -63.56 -34.76 78.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.114 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -72.55 -38.88 67.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.286 -0.884 . . . . 0.0 109.108 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -62.29 -49.39 75.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.411 -0.806 . . . . 0.0 109.208 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -67.87 -26.22 65.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.338 -0.851 . . . . 0.0 109.424 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -68.91 -34.71 75.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.307 -0.87 . . . . 0.0 109.119 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -77.19 -62.89 2.36 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 7.5 mt -59.93 116.6 4.24 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -1.132 . . . . 0.0 109.337 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt . . . . . 0 N--CA 1.488 1.446 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.474 179.886 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' RIM . . . . . 0.542 ' NC ' ' NE ' ' B' ' 45' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 299' ' ' RIM . . . . . 0.664 ' NC ' HD22 ' B' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 399' ' ' RIM . . . . . 0.456 ' NC ' HD21 ' C' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 499' ' ' RIM . . . . . 0.587 ' NC ' HD22 ' D' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.498 ' O ' ' N ' ' A' ' 26' ' ' LEU . 28.0 t70 52.4 65.01 6.64 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.274 -0.891 . . . . 0.0 109.446 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -44.72 -12.43 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.677 2.251 . . . . 0.0 112.234 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' A' ' 24' ' ' ASP . 38.8 tp -48.92 -43.22 39.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.018 -1.052 . . . . 0.0 108.8 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.6 t -68.39 -46.01 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.232 -0.918 . . . . 0.0 108.588 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.6 t -49.08 -47.17 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.353 -0.842 . . . . 0.0 108.876 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.11 -33.39 75.68 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.316 -0.865 . . . . 0.0 109.345 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.44 -57.24 6.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.313 -0.867 . . . . 0.0 109.727 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.71 -37.14 65.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.152 -0.968 . . . . 0.0 109.429 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 13.5 mt -71.11 -41.15 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 0.0 109.124 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.3 mt -56.03 -34.03 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.119 -0.988 . . . . 0.0 108.524 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.9 -45.84 31.7 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.9 mt -60.55 -23.13 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.265 -1.138 . . . . 0.0 108.845 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 17.6 tp -76.69 -70.8 0.43 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.518 -0.739 . . . . 0.0 109.082 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -47.31 -33.51 5.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 109.506 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 50.9 tp -66.59 -69.17 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.282 -0.886 . . . . 0.0 109.654 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 mt -48.45 -27.68 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.61 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.483 HD12 HD11 ' B' ' 38' ' ' LEU . 1.6 mt -68.61 -59.82 2.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -0.933 . . . . 0.0 109.914 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 17.8 t-105 -53.36 -46.12 69.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.021 -1.049 . . . . 0.0 109.809 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 82.2 mt -61.78 -52.77 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.018 -1.051 . . . . 0.0 108.836 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.8 tp -51.25 -38.58 53.43 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.506 -0.746 . . . . 0.0 109.399 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.493 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 1.4 m-20 -72.38 -24.98 61.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 109.23 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.558 ' CA ' ' HE ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -77.96 -24.12 48.26 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.177 -0.952 . . . . 0.0 110.14 -179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.463 ' C ' ' H ' ' A' ' 48' ' ' PHE . 9.3 mt -80.17 -13.93 58.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.77 -1.206 . . . . 0.0 109.043 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -75.03 29.78 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.655 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.463 ' H ' ' C ' ' A' ' 46' ' ' LEU . 78.0 t80 -83.04 77.14 9.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.134 -0.979 . . . . 0.0 109.369 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -85.71 -128.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.459 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -93.98 168.48 10.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.337 -0.852 . . . . 0.0 109.489 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.0 mt -104.2 -23.11 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.487 -0.758 . . . . 0.0 109.324 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -60.15 -21.82 62.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.097 -1.002 . . . . 0.0 109.734 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.7 mtt85 -69.39 -43.48 73.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.176 -0.952 . . . . 0.0 109.26 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -64.96 -36.56 84.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.332 -0.855 . . . . 0.0 109.476 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -70.68 -61.64 1.69 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.268 -0.895 . . . . 0.0 109.306 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -48.39 -29.72 4.28 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.348 -0.845 . . . . 0.0 109.646 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -71.13 -53.3 15.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.198 -0.939 . . . . 0.0 109.512 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -57.05 -60.28 9.33 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.8 mt -77.65 81.65 4.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -1.139 . . . . 0.0 109.604 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 12.7 tttt . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.379 179.864 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.86 160.86 66.62 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.285 -0.884 . . . . 0.0 109.301 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' B' ' 26' ' ' LEU . 18.7 Cg_endo -63.7 -21.08 69.9 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.525 2.15 . . . . 0.0 112.301 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' B' ' 25' ' ' PRO . 48.9 tp -46.63 -43.67 17.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 108.686 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 37.3 t -69.54 -44.76 79.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.306 -0.871 . . . . 0.0 108.801 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -48.6 -46.63 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.878 . . . . 0.0 108.827 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.15 -39.06 92.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.393 -0.817 . . . . 0.0 109.155 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.86 -57.51 11.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.458 -0.776 . . . . 0.0 109.948 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -53.78 -37.07 63.1 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.096 -1.003 . . . . 0.0 109.758 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 20.6 mt -71.38 -38.49 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.152 -0.967 . . . . 0.0 109.468 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 29.8 mt -57.51 -36.27 52.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.087 -1.008 . . . . 0.0 108.582 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.89 -46.53 52.18 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 69.0 mt -59.64 -25.76 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.306 -1.114 . . . . 0.0 108.891 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 14.0 tp -75.63 -67.88 0.62 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 23.0 t-160 -42.59 -42.73 3.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.529 -0.732 . . . . 0.0 110.086 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.483 HD11 HD12 ' A' ' 40' ' ' LEU . 22.2 tp -64.37 -64.66 0.82 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.979 -1.076 . . . . 0.0 109.521 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 6.3 mt -48.02 -29.34 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.327 -0.858 . . . . 0.0 109.556 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 5.2 mt -75.98 -57.79 3.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 0.0 109.552 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.7 t-105 -45.83 -54.97 7.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.365 -0.834 . . . . 0.0 109.663 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' B' ' 45' ' ' ARG . 58.5 mt -58.66 -60.38 2.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.155 -0.966 . . . . 0.0 109.036 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.4 ' C ' ' O ' ' B' ' 42' ' ' ILE . 57.3 tp -41.61 -38.84 1.46 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.674 -0.641 . . . . 0.0 110.347 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.441 ' CG ' HNC1 ' B' ' 299' ' ' RIM . 1.0 OUTLIER -73.74 -30.19 62.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.1 -1.0 . . . . 0.0 109.625 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' B' ' 42' ' ' ILE . 0.4 OUTLIER -80.9 -13.64 58.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.262 -0.898 . . . . 0.0 110.596 -179.521 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -87.28 -33.15 19.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.661 -1.275 . . . . 0.0 109.015 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -63.62 -19.87 65.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 109.515 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.02 128.9 34.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.445 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.414 ' HB3' ' HZ3' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -167.29 -54.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.935 . . . . 0.0 109.504 179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 78.1 p -93.32 138.39 31.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.959 . . . . 0.0 109.525 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 30.0 mt -110.33 -27.43 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.698 -0.626 . . . . 0.0 109.859 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -33.08 56.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.154 -0.966 . . . . 0.0 110.267 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 23.3 mtp180 -67.54 -39.71 85.01 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.861 -1.149 . . . . 0.0 109.595 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -66.28 -33.87 76.73 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.324 -0.86 . . . . 0.0 109.436 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -68.24 -52.08 38.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 109.384 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -60.99 -30.92 70.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.258 -0.901 . . . . 0.0 109.676 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.26 -57.64 5.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.267 -0.895 . . . . 0.0 109.722 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.02 -58.93 11.76 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 5.2 mt -70.08 148.18 49.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.184 -1.186 . . . . 0.0 109.365 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 6.1 tptm . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.404 -179.936 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.352 0.596 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.502 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 4.9 p30 -166.71 51.84 0.24 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.391 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 12.4 Cg_endo -59.2 -9.54 8.52 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.633 2.222 . . . . 0.0 111.922 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 41.3 tp -47.5 -46.05 26.9 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.34 -0.85 . . . . 0.0 108.873 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 29.2 t -69.15 -45.58 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.213 -0.929 . . . . 0.0 108.686 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 75.5 t -49.2 -50.46 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -0.87 . . . . 0.0 109.071 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.77 76.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.872 . . . . 0.0 109.222 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.64 -55.84 15.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.448 -0.782 . . . . 0.0 109.659 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -54.92 -36.46 65.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.0 109.688 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.7 mt -72.41 -40.62 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.225 -0.922 . . . . 0.0 109.531 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . 0.451 HD13 HG13 ' D' ' 35' ' ' ILE . 23.5 mt -56.27 -35.65 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.001 -1.062 . . . . 0.0 108.871 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.15 -42.72 35.1 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 58.0 mt -58.72 -36.84 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -1.158 . . . . 0.0 109.57 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.45 -60.97 1.99 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.183 -0.948 . . . . 0.0 109.305 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -44.34 -39.34 4.53 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 0.0 110.187 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 25.6 tp -69.22 -66.94 0.52 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.07 -1.019 . . . . 0.0 109.688 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 5.5 mt -46.81 -27.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.299 -0.876 . . . . 0.0 109.311 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . 0.529 HD23 ' O ' ' C' ' 40' ' ' LEU . 2.4 tt -74.25 -52.42 12.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.359 -0.838 . . . . 0.0 109.762 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . 0.435 ' CH2' ' NE ' ' C' ' 45' ' ' ARG . 24.3 t-105 -58.31 -46.08 86.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -0.962 . . . . 0.0 109.46 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 69.6 mt -64.57 -39.24 84.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.144 -0.973 . . . . 0.0 109.185 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.0 tp -61.12 -31.31 71.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.839 . . . . 0.0 109.678 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -82.81 -25.24 32.87 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 109.627 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.435 ' NE ' ' CH2' ' C' ' 41' ' ' TRP . 3.5 mmt-85 -79.27 -26.15 42.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.281 -0.887 . . . . 0.0 111.137 -178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' C' ' 48' ' ' PHE . 6.4 mt -55.86 -9.69 0.62 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.413 -1.429 . . . . 0.0 109.217 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.414 ' N ' ' C ' ' C' ' 45' ' ' ARG . 70.8 t80 -70.61 66.3 0.33 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 109.108 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.417 ' N ' ' O ' ' C' ' 46' ' ' LEU . 2.7 t80 -92.19 153.41 19.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.863 . . . . 0.0 109.797 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp 59.06 -150.47 0.44 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 109.474 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 6.2 t 47.06 59.9 3.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.935 . . . . 0.0 109.548 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 15.8 mt -102.01 -31.08 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.429 -0.795 . . . . 0.0 109.411 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . 0.434 ' CD1' ' C ' ' C' ' 52' ' ' TYR . 0.0 OUTLIER -55.25 -34.25 63.85 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.336 -0.853 . . . . 0.0 110.13 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -67.42 -36.74 81.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.098 -1.001 . . . . 0.0 109.472 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -68.78 -32.29 71.93 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -0.95 . . . . 0.0 108.808 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -68.95 -47.01 66.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.449 -0.782 . . . . 0.0 109.3 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -65.94 -27.28 68.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.307 -0.871 . . . . 0.0 109.277 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . 0.652 ' CD2' ' HZ2' ' D' ' 49' ' ' LYS . 82.3 t60 -71.18 -44.54 65.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 0.0 109.095 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -63.11 -63.3 4.67 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 41.1 mt -80.96 90.39 5.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.286 -1.126 . . . . 0.0 109.393 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 mttm . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.536 -179.846 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 46.2 m . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.24 0.543 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' D' ' 26' ' ' LEU . 11.1 m-20 -154.29 66.28 5.28 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.898 . . . . 0.0 109.362 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -45.26 -11.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.738 2.292 . . . . 0.0 112.179 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.499 ' N ' ' O ' ' D' ' 24' ' ' ASP . 41.9 tp -47.61 -44.98 27.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.127 -0.983 . . . . 0.0 109.193 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.4 t -68.47 -44.99 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.22 -0.925 . . . . 0.0 108.812 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.3 t -49.12 -48.62 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.891 . . . . 0.0 108.981 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.71 -33.19 75.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.297 -0.877 . . . . 0.0 109.327 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.36 -57.1 8.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.342 -0.849 . . . . 0.0 109.571 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.56 -37.09 70.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.0 109.812 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 16.2 mt -71.11 -43.11 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.155 -0.965 . . . . 0.0 109.52 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 27.2 mt -56.05 -35.11 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.071 -1.018 . . . . 0.0 108.681 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.95 -43.79 39.58 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.874 -1.691 . . . . 0.0 108.874 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . 0.451 HG13 HD13 ' C' ' 33' ' ' ILE . 78.6 mt -62.26 -26.45 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.304 -1.115 . . . . 0.0 108.869 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.49 -67.0 0.55 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.478 -0.764 . . . . 0.0 109.172 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -45.16 -47.27 12.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.35 -0.844 . . . . 0.0 109.954 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.2 tp -57.62 -63.54 1.2 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.166 -0.959 . . . . 0.0 109.614 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 10.3 mt -50.57 -36.1 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.122 -0.986 . . . . 0.0 109.558 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.609 HD22 HNC1 ' D' ' 499' ' ' RIM . 4.6 mt -63.57 -57.54 9.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.798 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -47.24 -44.75 23.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.279 -0.888 . . . . 0.0 109.548 -179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 12.2 mt -69.38 -33.9 59.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 108.714 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 tp -60.14 -42.15 94.24 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.438 -0.789 . . . . 0.0 109.936 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.501 ' OD1' ' NC ' ' D' ' 499' ' ' RIM . 0.7 OUTLIER -81.97 -22.19 36.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 0.0 109.612 -179.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' D' ' 47' ' ' PHE . 9.3 mmt180 -92.57 -0.71 57.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.131 -0.981 . . . . 0.0 110.875 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.482 ' C ' ' O ' ' D' ' 45' ' ' ARG . 32.8 mt -31.01 -36.16 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.658 -0.651 . . . . 0.0 110.832 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' D' ' 45' ' ' ARG . 0.2 OUTLIER 178.23 15.72 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.139 -0.976 . . . . 0.0 109.547 -179.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -49.95 101.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.449 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . 0.652 ' HZ2' ' CD2' ' C' ' 57' ' ' HIS . 0.0 OUTLIER -150.6 -29.16 0.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.157 -0.964 . . . . 0.0 109.626 179.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 15.2 p -51.34 120.42 5.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 0.0 109.318 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 15.8 mt -101.07 -29.37 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.492 -0.755 . . . . 0.0 109.721 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -54.1 -34.48 60.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.186 -0.946 . . . . 0.0 109.897 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 1.6 mtp85 -63.64 -39.6 94.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.0 109.551 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -67.55 -37.82 83.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 0.0 109.44 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.29 -64.43 0.88 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.437 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -51.27 -31.47 21.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.124 -0.985 . . . . 0.0 109.528 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . 0.414 ' C ' ' ND1' ' D' ' 57' ' ' HIS . 14.1 t-80 -69.26 -53.98 17.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.159 -0.963 . . . . 0.0 109.541 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.97 -62.29 6.39 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . 0.453 ' C ' HD13 ' D' ' 59' ' ' LEU . 0.4 OUTLIER -55.35 109.94 0.62 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -1.13 . . . . 0.0 109.076 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . 0.432 ' N ' HD13 ' D' ' 59' ' ' LEU . 17.6 ttmt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.562 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 299' ' ' RIM . . . . . 0.441 HNC1 ' CG ' ' B' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 399' ' ' RIM . . . . . 0.402 ' NC ' HD21 ' C' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 499' ' ' RIM . . . . . 0.609 HNC1 HD22 ' D' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.6 m-20 58.23 49.66 3.25 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 109.449 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.8 Cg_endo -55.12 -14.92 9.54 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.837 2.358 . . . . 0.0 112.266 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 38.9 tp -47.5 -44.28 25.35 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.201 -0.937 . . . . 0.0 109.091 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.8 t -68.21 -45.08 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.186 -0.946 . . . . 0.0 108.665 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 76.6 t -50.89 -48.12 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.278 -0.889 . . . . 0.0 109.009 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.02 -32.72 74.58 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.325 -0.859 . . . . 0.0 109.464 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.52 -55.14 12.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.329 -0.857 . . . . 0.0 109.626 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.94 -36.21 67.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.744 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.1 mt -73.35 -43.34 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.509 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.4 mt -54.34 -32.95 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.029 -1.044 . . . . 0.0 108.595 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -76.41 -45.33 14.54 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 57.0 mt -56.64 -36.68 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.148 -1.207 . . . . 0.0 109.483 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.39 -59.51 2.94 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.236 -0.915 . . . . 0.0 109.203 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -44.3 -44.81 8.35 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.342 -0.849 . . . . 0.0 110.02 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -63.53 -68.83 0.31 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.084 -1.01 . . . . 0.0 109.639 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 mt -45.44 -29.76 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.418 -0.801 . . . . 0.0 109.653 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.1 mt -68.57 -61.5 1.8 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.947 . . . . 0.0 109.543 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.494 ' NE1' ' OD2' ' D' ' 44' ' ' ASP . 54.8 t-105 -44.33 -46.04 9.07 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.548 -0.72 . . . . 0.0 109.633 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.5 mt -71.59 -33.09 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.086 -1.009 . . . . 0.0 109.559 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.9 tp -61.52 -43.12 99.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 109.972 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.52 -20.74 36.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 110.588 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 46' ' ' LEU . 8.6 mmt180 -85.92 -16.56 38.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.711 -1.243 . . . . 0.0 111.515 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.452 ' C ' ' O ' ' A' ' 45' ' ' ARG . 20.7 mt -39.61 -34.55 0.24 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.01 -1.056 . . . . 0.0 110.171 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.548 ' O ' ' CG ' ' A' ' 47' ' ' PHE . 1.6 p90 -55.05 126.73 25.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.014 -1.054 . . . . 0.0 109.394 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -173.76 32.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.287 -0.883 . . . . 0.0 109.235 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.52 ' O ' ' N ' ' A' ' 51' ' ' ILE . 0.0 OUTLIER -148.7 -76.64 0.16 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -0.916 . . . . 0.0 109.556 -179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.3 p -55.15 85.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.197 -0.94 . . . . 0.0 109.597 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.52 ' N ' ' O ' ' A' ' 49' ' ' LYS . 26.3 mt -89.76 -21.29 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -0.883 . . . . 0.0 109.648 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -70.54 -21.47 62.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 109.965 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -67.36 -40.87 85.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.154 -0.966 . . . . 0.0 109.943 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -71.39 -37.65 71.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.087 -1.008 . . . . 0.0 109.32 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -59.08 -51.38 70.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.233 -0.917 . . . . 0.0 109.192 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -67.69 -26.29 66.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.301 -0.874 . . . . 0.0 109.452 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.4 t60 -67.25 -42.01 84.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.18 -0.95 . . . . 0.0 109.198 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.04 -62.58 3.49 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.8 mt -52.9 159.7 1.1 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.392 -1.063 . . . . 0.0 109.503 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 71.9 mttt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.059 -0.972 . . . . 0.0 109.498 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.524 ' O ' ' N ' ' B' ' 26' ' ' LEU . 6.9 m-20 -156.55 65.29 3.82 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.215 -0.928 . . . . 0.0 109.605 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -45.61 -9.51 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.773 2.315 . . . . 0.0 112.182 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.524 ' N ' ' O ' ' B' ' 24' ' ' ASP . 29.1 tp -47.27 -46.9 25.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.263 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 39.5 t -67.96 -45.21 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.225 -0.922 . . . . 0.0 108.89 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 73.0 t -48.98 -48.88 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 108.999 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.22 -34.01 77.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.364 -0.835 . . . . 0.0 109.461 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.46 -56.63 10.04 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.26 -0.9 . . . . 0.0 109.599 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.11 -37.0 68.81 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.286 -0.884 . . . . 0.0 109.586 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 16.8 mt -71.0 -41.08 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.303 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 21.1 mt -56.4 -33.91 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.174 -0.954 . . . . 0.0 108.645 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.67 -43.13 24.48 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 66.9 mt -59.14 -39.4 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.115 -1.226 . . . . 0.0 109.308 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.12 -63.8 1.0 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.176 -0.952 . . . . 0.0 109.076 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -45.08 -49.77 11.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.435 -0.79 . . . . 0.0 109.761 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' B' ' 38' ' ' LEU . 48.9 tp -56.5 -65.19 0.65 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.314 -0.866 . . . . 0.0 109.618 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 3.8 mt -46.44 -40.03 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -0.876 . . . . 0.0 109.538 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.67 -63.24 1.37 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 110.095 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 25.2 t-105 -45.06 -48.25 11.82 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.374 -0.828 . . . . 0.0 109.854 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.457 HG12 HNC1 ' A' ' 199' ' ' RIM . 79.3 mt -61.53 -47.78 91.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.212 -0.93 . . . . 0.0 109.07 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 13.3 tp -51.78 -39.59 58.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.537 -0.727 . . . . 0.0 110.137 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.583 ' CG ' HNC2 ' B' ' 299' ' ' RIM . 1.7 m-20 -76.31 -26.45 55.83 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 109.953 -179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.509 ' CA ' ' HE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -73.58 -27.95 61.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.056 -1.027 . . . . 0.0 110.464 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -65.96 -31.06 71.76 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.688 -1.258 . . . . 0.0 109.179 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' B' ' 48' ' ' PHE . 60.3 t80 -78.19 -103.5 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.905 . . . . 0.0 109.313 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . 0.48 ' N ' ' CG ' ' B' ' 47' ' ' PHE . 2.7 t80 48.04 -154.97 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.925 . . . . 0.0 109.747 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 6.6 tttt 68.73 -153.8 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.3 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.525 ' O ' ' CE2' ' B' ' 54' ' ' PHE . 13.8 m 44.77 75.53 0.1 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.215 -0.928 . . . . 0.0 109.401 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 27.3 mt -90.7 -20.25 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.15 -0.969 . . . . 0.0 109.712 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.45 -20.97 58.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 0.0 109.581 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 2.1 mtm180 -71.49 -42.92 67.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 110.046 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . 0.525 ' CE2' ' O ' ' B' ' 50' ' ' SER . 4.0 m-85 -70.58 -35.08 72.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.059 -1.026 . . . . 0.0 109.492 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -63.55 -45.56 89.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.19 -0.944 . . . . 0.0 109.279 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -71.49 -25.49 62.29 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.514 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -65.97 -53.07 43.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.091 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.02 -60.52 7.12 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 mt -56.12 148.96 16.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.214 -1.168 . . . . 0.0 109.439 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 33.1 tttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.391 179.929 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.55 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 4.2 p30 -175.09 49.16 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.346 -0.846 . . . . 0.0 109.432 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 10.6 Cg_endo -56.34 -12.32 7.79 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.941 2.427 . . . . 0.0 112.249 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 35.5 tp -47.71 -44.65 27.88 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.129 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 38.6 t -68.99 -45.18 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.179 -0.95 . . . . 0.0 108.674 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.8 t -49.69 -49.19 20.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.0 108.889 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.17 -31.87 73.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.338 -0.851 . . . . 0.0 109.254 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.15 -57.27 7.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 109.686 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -55.68 -36.27 66.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.224 -0.923 . . . . 0.0 109.666 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.5 mt -71.79 -38.98 67.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.134 -0.979 . . . . 0.0 109.548 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 23.7 mt -59.38 -35.51 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.015 -1.053 . . . . 0.0 108.73 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.47 -42.89 63.22 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.701 -1.76 . . . . 0.0 108.701 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 77.7 mt -63.63 -22.28 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.414 -1.05 . . . . 0.0 108.771 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.91 -70.84 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . 0.55 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 2.3 t-80 -45.92 -36.73 5.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -0.864 . . . . 0.0 109.67 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.95 -67.82 0.4 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.252 -0.905 . . . . 0.0 109.437 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 5.6 mt -48.54 -28.92 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.878 . . . . 0.0 109.672 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 5.4 mt -71.57 -59.79 2.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.268 -0.895 . . . . 0.0 110.01 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 51.9 t-105 -49.59 -47.75 49.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.084 -1.01 . . . . 0.0 109.811 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 73.2 mt -64.02 -58.74 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.102 -0.999 . . . . 0.0 109.273 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 59.2 tp -44.99 -54.46 6.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.47 -0.769 . . . . 0.0 109.679 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -60.79 -26.61 67.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.314 -0.867 . . . . 0.0 110.109 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.486 ' HE ' ' CA ' ' C' ' 45' ' ' ARG . 0.0 OUTLIER -79.19 -20.69 47.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.924 -1.11 . . . . 0.0 110.446 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 mt -79.84 -32.14 40.56 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.701 -1.249 . . . . 0.0 109.058 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.451 ' O ' ' CB ' ' C' ' 48' ' ' PHE . 6.3 t80 -92.33 -144.91 0.21 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.308 -0.87 . . . . 0.0 109.31 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.451 ' CB ' ' O ' ' C' ' 47' ' ' PHE . 1.1 t80 72.38 106.31 0.07 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 109.441 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . 0.42 ' O ' ' O ' ' C' ' 50' ' ' SER . 10.7 tttp -165.62 -154.03 0.19 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.366 -0.834 . . . . 0.0 109.094 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . 0.42 ' O ' ' O ' ' C' ' 49' ' ' LYS . 34.6 m 42.55 91.14 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.333 -0.854 . . . . 0.0 109.917 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 10.3 mt -94.64 -19.09 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.411 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -67.53 -21.88 65.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.092 -1.005 . . . . 0.0 109.499 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -68.2 -42.33 80.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.269 -0.895 . . . . 0.0 109.7 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . 0.428 ' HB3' HD11 ' D' ' 51' ' ' ILE . 1.5 m-85 -71.71 -45.13 62.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.112 -0.992 . . . . 0.0 109.036 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -54.29 -48.69 70.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.273 -0.892 . . . . 0.0 108.828 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 65.5 tt0 -66.8 -26.95 67.19 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.397 -0.814 . . . . 0.0 109.032 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -66.95 -43.9 81.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.28 -0.888 . . . . 0.0 108.746 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.47 -62.64 4.91 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.45 ' C ' HD13 ' C' ' 59' ' ' LEU . 0.5 OUTLIER -66.0 103.3 0.92 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -1.114 . . . . 0.0 108.925 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 31.9 tttm . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.079 -0.963 . . . . 0.0 109.542 179.97 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 66.1 p . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.472 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 2.6 m-20 53.21 52.8 10.82 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.243 -0.911 . . . . 0.0 109.441 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 11.2 Cg_endo -58.57 -13.7 18.34 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 122.542 2.161 . . . . 0.0 112.116 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' D' ' 26' ' ' LEU . 35.6 tp -48.0 -44.23 30.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.947 . . . . 0.0 108.901 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 39.5 t -69.58 -45.36 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.16 -0.962 . . . . 0.0 108.668 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 67.9 t -48.94 -47.7 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.344 -0.847 . . . . 0.0 108.957 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.89 -35.07 79.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.336 -0.853 . . . . 0.0 109.166 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.86 -56.93 11.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.341 -0.849 . . . . 0.0 109.708 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.87 -36.16 67.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.147 -0.971 . . . . 0.0 109.79 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 11.2 mt -71.63 -39.57 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.192 -0.942 . . . . 0.0 109.494 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 16.5 mt -58.67 -35.29 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 120.988 -1.07 . . . . 0.0 108.576 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.88 -43.73 57.67 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.86 -23.61 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.225 -1.162 . . . . 0.0 108.919 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.69 -70.21 0.44 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.866 . . . . 0.0 109.032 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . 0.55 ' CE1' ' NE2' ' C' ' 37' ' ' HIS . 9.8 t-80 -46.46 -35.64 5.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 0.0 109.913 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 57.3 tp -65.75 -63.02 1.19 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.117 -0.989 . . . . 0.0 109.564 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 6.8 mt -54.7 -32.82 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.522 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.573 HD21 HNC2 ' D' ' 499' ' ' RIM . 0.6 OUTLIER -69.03 -58.04 4.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.816 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 -46.45 -51.94 14.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.302 -0.874 . . . . 0.0 109.819 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . 0.578 HG12 HNC1 ' C' ' 399' ' ' RIM . 71.1 mt -60.06 -53.58 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.008 -1.057 . . . . 0.0 108.883 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 54.9 tp -46.13 -44.05 15.41 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.464 -0.772 . . . . 0.0 109.895 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.494 ' OD2' ' NE1' ' A' ' 41' ' ' TRP . 0.3 OUTLIER -68.7 -28.18 66.61 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.775 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -79.2 -19.69 50.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 0.0 110.687 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.4 mt -80.9 -33.81 33.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.666 -1.271 . . . . 0.0 109.167 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -67.88 114.0 6.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.309 -0.869 . . . . 0.0 109.426 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -157.75 -155.14 0.48 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.153 -0.967 . . . . 0.0 109.597 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt 48.43 -153.5 0.1 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.36 -0.837 . . . . 0.0 109.243 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 94.4 p 43.1 65.34 0.98 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.36 -0.837 . . . . 0.0 109.65 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . 0.428 HD11 ' HB3' ' C' ' 54' ' ' PHE . 6.7 mt -89.96 -24.41 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.223 -0.923 . . . . 0.0 109.07 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.98 -27.92 65.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.216 -0.927 . . . . 0.0 109.893 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -71.94 -43.34 65.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.904 -1.122 . . . . 0.0 109.498 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -60.75 -37.03 80.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.274 -0.891 . . . . 0.0 109.383 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -68.57 -67.77 0.44 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.287 -0.883 . . . . 0.0 109.395 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -47.53 -40.16 18.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.272 -0.893 . . . . 0.0 109.658 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -65.56 -54.37 28.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.305 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.83 -61.3 7.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.51 129.08 40.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.168 -1.195 . . . . 0.0 109.413 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 37.8 tttp . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.394 -179.9 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' RIM . . . . . 0.457 HNC1 HG12 ' B' ' 42' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 299' ' ' RIM . . . . . 0.583 HNC2 ' CG ' ' B' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 399' ' ' RIM . . . . . 0.578 HNC1 HG12 ' D' ' 42' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 499' ' ' RIM . . . . . 0.573 HNC2 HD21 ' D' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.275 0.559 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' A' ' 26' ' ' LEU . 30.5 t0 52.77 66.84 4.42 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.166 -0.959 . . . . 0.0 109.516 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -46.06 -11.55 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.662 2.241 . . . . 0.0 112.031 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 24' ' ' ASP . 37.6 tp -47.78 -45.91 29.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.262 -0.899 . . . . 0.0 108.962 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.1 t -68.53 -45.29 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.207 -0.933 . . . . 0.0 108.721 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.3 t -49.12 -49.08 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 108.95 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.24 -32.55 74.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.316 -0.865 . . . . 0.0 109.157 179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.81 -58.16 6.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.347 -0.845 . . . . 0.0 109.671 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.55 -36.85 67.24 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 0.0 109.743 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 17.4 mt -70.93 -39.74 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.183 -0.948 . . . . 0.0 109.361 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.3 mt -57.66 -34.51 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.027 -1.045 . . . . 0.0 108.415 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.96 -44.63 45.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 50.6 mt -57.0 -31.33 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.19 -1.182 . . . . 0.0 109.128 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.07 -64.69 0.86 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.305 -0.872 . . . . 0.0 109.208 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -44.96 -47.37 11.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.839 . . . . 0.0 110.223 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 40.8 tp -59.02 -63.92 1.13 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.997 -1.064 . . . . 0.0 109.693 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.3 mt -51.38 -25.74 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.231 -0.918 . . . . 0.0 109.601 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.571 HD22 HNC1 ' A' ' 199' ' ' RIM . 1.4 mt -74.74 -56.59 4.63 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.175 -0.953 . . . . 0.0 109.49 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -48.37 -51.3 27.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 0.0 109.377 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.75 -53.58 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.235 -0.916 . . . . 0.0 109.105 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 58.4 tp -46.49 -35.42 5.66 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.562 -0.711 . . . . 0.0 110.327 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.514 ' OD1' ' NC ' ' A' ' 199' ' ' RIM . 0.2 OUTLIER -79.2 -29.08 42.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.039 -1.038 . . . . 0.0 109.814 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.79 -19.48 57.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 0.0 110.873 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.403 ' O ' ' O ' ' A' ' 47' ' ' PHE . 8.5 mt -77.6 -9.22 58.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.556 -1.34 . . . . 0.0 109.347 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.403 ' O ' ' O ' ' A' ' 46' ' ' LEU . 3.0 m-85 -47.41 -90.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.269 -0.894 . . . . 0.0 109.225 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 46.57 23.91 0.27 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.191 -0.943 . . . . 0.0 109.64 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -66.07 -144.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.495 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.3 m -80.51 141.48 35.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.261 -0.899 . . . . 0.0 109.629 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 20.9 mt -97.21 -32.19 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.514 -0.741 . . . . 0.0 109.432 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -56.2 -19.12 12.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -72.27 -41.04 67.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.12 -0.987 . . . . 0.0 109.812 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -69.54 -33.3 72.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.088 -1.007 . . . . 0.0 109.377 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -69.7 -45.46 68.22 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.287 -0.883 . . . . 0.0 109.347 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -67.1 -27.05 67.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -69.12 -52.64 26.18 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.24 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.19 -60.56 8.73 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.1 mt -48.63 147.33 2.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.348 -1.089 . . . . 0.0 109.491 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.7 tttt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.929 -1.034 . . . . 0.0 109.35 179.829 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.51 162.68 28.98 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.279 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.415 ' O ' ' C ' ' B' ' 26' ' ' LEU . 23.4 Cg_endo -65.82 -28.31 51.18 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.51 2.14 . . . . 0.0 112.224 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.415 ' C ' ' O ' ' B' ' 25' ' ' PRO . 37.6 tp -45.73 -40.54 9.54 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -70.34 -44.53 77.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 71.0 t -49.94 -47.39 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.245 -0.91 . . . . 0.0 108.774 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.25 -34.69 78.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.276 -0.89 . . . . 0.0 109.237 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.38 -56.27 15.48 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.3 -0.875 . . . . 0.0 109.832 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.41 -37.83 76.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -0.945 . . . . 0.0 110.018 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 18.4 mt -69.26 -42.97 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.107 -0.995 . . . . 0.0 109.191 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 25.1 mt -56.4 -34.46 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.242 -0.911 . . . . 0.0 108.783 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.33 -43.41 38.44 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 68.1 mt -60.38 -31.94 49.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.295 -1.12 . . . . 0.0 109.305 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.97 -66.52 0.6 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 109.248 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -44.96 -41.7 7.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 109.924 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.0 tp -62.7 -68.37 0.34 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.919 . . . . 0.0 109.5 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 6.1 mt -46.93 -31.44 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.241 -0.912 . . . . 0.0 109.316 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.671 HD21 ' NC ' ' B' ' 299' ' ' RIM . 0.5 OUTLIER -64.24 -60.2 3.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.374 -0.829 . . . . 0.0 109.86 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . 0.404 ' NE1' ' OD2' ' A' ' 44' ' ' ASP . 37.7 t-105 -48.75 -43.94 38.1 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 109.664 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 25.8 mt -64.53 -40.01 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.99 . . . . 0.0 108.922 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 7.4 tp -56.48 -35.76 68.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.571 -0.706 . . . . 0.0 110.368 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.8 -22.98 27.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.071 -1.018 . . . . 0.0 110.382 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.483 ' CA ' ' HE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -76.13 -27.97 57.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.912 -1.117 . . . . 0.0 110.517 -179.204 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 mt -51.86 -11.47 0.15 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.6 -1.312 . . . . 0.0 108.99 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.455 ' N ' ' O ' ' B' ' 45' ' ' ARG . 24.6 t80 -67.28 126.45 29.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.493 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -147.95 -90.54 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.92 . . . . 0.0 109.425 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -61.85 -149.99 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.181 -0.949 . . . . 0.0 109.393 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 48.8 p 45.99 56.67 5.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.231 -0.918 . . . . 0.0 109.612 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 12.4 mt -92.74 -28.95 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.263 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.68 -25.6 4.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.403 -0.811 . . . . 0.0 109.788 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.461 ' O ' ' CG ' ' B' ' 57' ' ' HIS . 30.4 mtt180 -68.52 -38.33 80.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.765 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -71.37 -35.15 70.99 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.264 -0.897 . . . . 0.0 109.027 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -65.8 -53.1 44.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.691 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -65.23 -30.43 71.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 109.885 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . 0.461 ' CG ' ' O ' ' B' ' 53' ' ' ARG . 1.7 m-70 -68.04 -41.77 81.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.147 -0.971 . . . . 0.0 109.437 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.75 -66.2 1.69 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.426 HD22 ' HA ' ' B' ' 59' ' ' LEU . 0.3 OUTLIER -73.74 108.24 6.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.255 -1.144 . . . . 0.0 109.27 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 117.898 -1.048 . . . . 0.0 109.409 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -150.62 160.78 32.03 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.171 -0.956 . . . . 0.0 109.407 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' C' ' 26' ' ' LEU . 13.5 Cg_endo -60.05 -23.69 74.07 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.625 2.216 . . . . 0.0 112.2 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' C' ' 25' ' ' PRO . 39.9 tp -45.72 -42.08 11.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.294 -0.878 . . . . 0.0 108.86 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 46.9 t -70.0 -44.16 78.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.376 -0.828 . . . . 0.0 108.784 179.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 69.9 t -50.17 -47.63 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 0.0 108.918 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.21 -37.06 86.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -0.889 . . . . 0.0 109.567 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.62 -55.27 21.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.271 -0.893 . . . . 0.0 109.591 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.62 -36.76 67.33 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -0.9 . . . . 0.0 109.83 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 25.9 mt -72.36 -42.64 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.511 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 22.1 mt -55.01 -34.26 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.12 -0.987 . . . . 0.0 108.805 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.8 -44.05 21.06 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 64.2 mt -58.35 -29.73 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.17 -1.194 . . . . 0.0 109.421 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.15 -59.42 2.75 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.235 -0.915 . . . . 0.0 109.015 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -47.24 -38.84 13.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.703 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.2 tp -68.68 -67.66 0.45 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.574 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.5 mt -46.09 -28.02 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.34 -0.85 . . . . 0.0 109.418 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 mt -69.95 -60.45 2.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.409 -0.807 . . . . 0.0 109.823 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -47.02 -43.61 19.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . 0.408 HD13 HG21 ' C' ' 42' ' ' ILE . 6.4 mt -70.75 -40.44 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.112 -0.992 . . . . 0.0 109.326 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 57.9 tp -60.51 -35.5 76.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.339 -0.851 . . . . 0.0 110.091 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . 0.408 ' OD2' ' NC ' ' C' ' 399' ' ' RIM . 14.7 m-20 -87.54 -19.24 28.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.116 -0.99 . . . . 0.0 110.167 -179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' C' ' 47' ' ' PHE . 3.7 mmt180 -84.65 -20.88 30.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.027 -1.046 . . . . 0.0 111.119 -178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.408 ' C ' ' O ' ' C' ' 45' ' ' ARG . 38.8 mt -46.35 -17.73 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.825 -1.172 . . . . 0.0 109.108 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.508 ' N ' ' O ' ' C' ' 45' ' ' ARG . 22.6 m-85 -93.08 79.25 4.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.264 -0.897 . . . . 0.0 109.319 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -83.77 -57.36 3.25 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.33 -0.856 . . . . 0.0 109.476 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 10.8 ttmt -76.94 -139.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.314 -0.866 . . . . 0.0 109.36 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 46.1 m 52.78 61.35 3.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.442 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 61.1 mt -95.33 -26.01 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.315 -0.865 . . . . 0.0 109.518 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -58.81 -22.72 59.18 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.267 -0.895 . . . . 0.0 109.835 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . 0.517 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 0.0 OUTLIER -67.37 -42.32 83.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.198 -0.939 . . . . 0.0 109.83 -179.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -71.01 -38.9 72.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -0.934 . . . . 0.0 109.289 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -62.83 -45.97 90.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.28 -0.888 . . . . 0.0 109.071 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -69.15 -27.33 65.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.833 . . . . 0.0 109.62 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . 0.517 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 51.3 m170 -69.39 -38.54 78.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.236 -0.915 . . . . 0.0 109.188 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.6 -59.83 5.01 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mt -72.67 176.04 5.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.225 -1.162 . . . . 0.0 109.496 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . 0.585 ' N ' ' CD ' ' C' ' 60' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.371 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' D' ' 26' ' ' LEU . 7.1 p30 -169.0 68.09 0.67 Allowed Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.366 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_exo -47.24 -9.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.754 2.302 . . . . 0.0 112.29 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' D' ' 24' ' ' ASP . 33.9 tp -47.48 -46.84 27.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.169 -0.957 . . . . 0.0 108.979 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.72 -45.79 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.262 -0.899 . . . . 0.0 108.728 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 66.2 t -48.45 -48.73 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.294 -0.879 . . . . 0.0 108.881 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.81 -34.92 79.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.37 -0.831 . . . . 0.0 109.305 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.56 -56.37 12.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.0 109.755 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 2.5 m -55.65 -35.04 65.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 0.0 109.809 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 16.4 mt -73.89 -42.99 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.155 -0.966 . . . . 0.0 109.586 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 19.4 mt -55.14 -34.7 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.075 -1.016 . . . . 0.0 108.733 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.71 -44.83 37.68 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.111 -1.596 . . . . 0.0 109.111 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 56.6 mt -57.21 -35.02 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.272 -1.134 . . . . 0.0 109.026 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.22 -67.11 0.48 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.377 -0.827 . . . . 0.0 108.848 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -47.13 -37.95 10.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.378 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 59.3 tp -61.48 -70.7 0.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.279 -0.888 . . . . 0.0 109.23 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 10.4 mt -49.35 -24.08 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.921 . . . . 0.0 109.577 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.412 HD23 ' C ' ' D' ' 40' ' ' LEU . 1.7 tt -70.54 -60.68 2.12 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.275 -0.891 . . . . 0.0 109.759 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 17.7 t-105 -52.26 -46.54 65.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.092 -1.005 . . . . 0.0 109.53 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . 0.403 HG23 ' HA1' ' C' ' 399' ' ' RIM . 54.9 mt -62.63 -55.02 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.179 -0.95 . . . . 0.0 108.878 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 42.3 tp -47.93 -37.59 14.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.542 -0.724 . . . . 0.0 109.744 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.448 ' OD2' ' NC ' ' D' ' 499' ' ' RIM . 65.7 m-20 -73.72 -28.44 61.71 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.144 -0.972 . . . . 0.0 109.544 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.37 -20.57 54.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.195 -0.941 . . . . 0.0 110.423 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -80.34 -8.84 59.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.777 -1.202 . . . . 0.0 108.968 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -141.38 100.22 3.74 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.444 -0.785 . . . . 0.0 109.125 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -151.68 5.68 0.45 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.188 -0.945 . . . . 0.0 109.618 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -76.61 -140.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.447 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 15.3 m 47.37 76.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.304 -0.872 . . . . 0.0 109.486 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 24.2 mt -99.75 -23.94 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.437 -0.789 . . . . 0.0 109.442 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . 0.401 ' CG ' ' N ' ' D' ' 53' ' ' ARG . 25.6 p90 -57.95 -33.31 68.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.338 -0.851 . . . . 0.0 109.72 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . 0.48 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 23.0 ptt180 -65.16 -30.72 71.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.216 -0.928 . . . . 0.0 109.422 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -75.12 -34.01 61.64 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.296 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.9 -44.23 64.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.378 -0.826 . . . . 0.0 109.902 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -72.76 -27.74 62.2 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.14 -0.975 . . . . 0.0 109.525 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . 0.48 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 0.7 OUTLIER -70.24 -42.52 72.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.913 . . . . 0.0 109.251 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.45 -64.36 2.77 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . 0.438 HD23 ' C ' ' D' ' 59' ' ' LEU . 1.7 tt -56.43 108.58 0.5 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -1.179 . . . . 0.0 109.551 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . 0.413 ' N ' HD23 ' D' ' 59' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.469 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' RIM . . . . . 0.571 HNC1 HD22 ' A' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 299' ' ' RIM . . . . . 0.671 ' NC ' HD21 ' B' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 399' ' ' RIM . . . . . 0.408 ' NC ' ' OD2' ' C' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 499' ' ' RIM . . . . . 0.448 ' NC ' ' OD2' ' D' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.547 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.9 p30 -174.18 49.31 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.332 -0.855 . . . . 0.0 109.45 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.7 Cg_endo -55.64 -17.89 18.86 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.813 2.342 . . . . 0.0 112.381 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.429 HD12 ' HA ' ' A' ' 26' ' ' LEU . 22.9 tp -46.25 -43.26 15.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.329 -0.857 . . . . 0.0 109.008 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 t -69.34 -45.67 78.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.328 -0.858 . . . . 0.0 108.888 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 61.4 t -48.97 -48.5 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.91 . . . . 0.0 109.015 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.95 -35.99 82.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.34 -0.85 . . . . 0.0 109.422 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.02 -56.48 14.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.903 . . . . 0.0 109.737 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -36.82 65.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.236 -0.915 . . . . 0.0 109.923 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.8 mt -72.35 -40.94 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.133 -0.98 . . . . 0.0 109.496 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.1 mt -56.36 -34.12 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.059 -1.025 . . . . 0.0 108.675 179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.99 -44.19 24.64 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 66.7 mt -58.89 -30.86 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.154 -1.204 . . . . 0.0 109.226 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.77 -66.76 0.62 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.286 -0.884 . . . . 0.0 109.059 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -46.12 -37.95 7.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.856 . . . . 0.0 109.706 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 58.2 tp -64.14 -70.24 0.23 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 109.382 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.3 mt -47.32 -35.25 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 0.0 109.693 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.645 HD22 ' NC ' ' A' ' 199' ' ' RIM . 2.1 mt -63.95 -63.23 1.21 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 109.934 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -45.41 -47.94 13.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -0.873 . . . . 0.0 109.3 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.29 -46.77 94.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.395 -0.816 . . . . 0.0 108.916 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.07 -50.02 29.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.582 -0.699 . . . . 0.0 109.327 -179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.68 -30.78 71.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.392 -0.817 . . . . 0.0 110.289 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.2 mmt180 -69.25 -26.93 65.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.902 -1.124 . . . . 0.0 110.39 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -71.52 -32.71 68.48 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.649 -1.282 . . . . 0.0 109.47 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -67.15 -88.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.033 -1.042 . . . . 0.0 109.559 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 60.2 -168.39 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.1 tttt 48.25 -152.41 0.11 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.142 -0.974 . . . . 0.0 109.271 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.7 p 45.22 59.41 3.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.281 -0.887 . . . . 0.0 109.773 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 16.4 mt -98.69 -22.95 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 0.0 109.606 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -55.61 -25.3 38.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.971 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.463 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 6.6 ptt180 -67.7 -40.21 84.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.124 -0.985 . . . . 0.0 109.977 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.439 ' N ' ' CG ' ' A' ' 53' ' ' ARG . 54.9 m-85 -71.35 -36.7 71.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.028 -1.045 . . . . 0.0 109.404 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -63.41 -44.74 93.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.262 -0.899 . . . . 0.0 109.219 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -70.28 -28.1 64.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.266 -0.896 . . . . 0.0 109.625 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.463 ' ND1' ' O ' ' A' ' 53' ' ' ARG . 20.1 m170 -66.06 -42.29 89.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -0.947 . . . . 0.0 109.272 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.82 -63.4 2.87 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.0 mt -70.98 119.51 15.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.226 -1.161 . . . . 0.0 109.368 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.4 mttt . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.441 -179.949 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' B' ' 26' ' ' LEU . 19.1 t70 50.97 67.36 4.38 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.523 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -46.1 -11.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.673 2.248 . . . . 0.0 112.19 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' B' ' 24' ' ' ASP . 43.6 tp -47.23 -48.25 24.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 108.991 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 45.7 t -67.56 -44.47 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.305 -0.872 . . . . 0.0 108.903 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 77.8 t -49.23 -48.55 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.264 -0.897 . . . . 0.0 109.019 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.6 -34.7 78.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.912 . . . . 0.0 109.339 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.24 -57.71 6.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 0.0 109.927 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.92 -36.49 62.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 0.0 109.806 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 24.0 mt -72.31 -41.63 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.178 -0.951 . . . . 0.0 109.424 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 21.9 mt -55.43 -34.82 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.156 -0.965 . . . . 0.0 108.73 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.29 -45.26 31.33 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 47.9 mt -54.97 -37.99 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.199 -1.177 . . . . 0.0 109.496 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.31 -58.31 3.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.173 -0.955 . . . . 0.0 108.818 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 17.6 t-160 -46.8 -41.36 15.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -0.86 . . . . 0.0 109.6 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 51.3 tp -65.78 -70.02 0.26 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.27 -0.894 . . . . 0.0 109.783 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mt -46.57 -26.64 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -0.872 . . . . 0.0 109.684 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 6.0 mt -70.19 -62.82 1.24 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.207 -0.933 . . . . 0.0 109.99 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -48.19 -47.74 35.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.069 -1.02 . . . . 0.0 109.674 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.47 ' O ' ' N ' ' B' ' 45' ' ' ARG . 68.0 mt -63.9 -61.35 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.132 -0.98 . . . . 0.0 109.336 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 60.5 tp -43.74 -42.37 5.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.687 -0.633 . . . . 0.0 109.784 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.496 ' OD2' ' NC ' ' B' ' 299' ' ' RIM . 35.7 m-20 -69.32 -28.97 66.71 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.257 -0.902 . . . . 0.0 109.469 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' B' ' 42' ' ' ILE . 11.0 mmm180 -78.23 -16.69 57.59 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.218 -0.926 . . . . 0.0 110.105 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -88.8 -9.54 51.41 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.851 -1.156 . . . . 0.0 109.07 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -47.72 -23.89 0.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.64 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . 0.463 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 2.1 t80 -47.91 106.88 0.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.893 . . . . 0.0 109.598 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -160.09 -41.03 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 109.558 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.49 121.96 5.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.189 -0.944 . . . . 0.0 109.598 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 mt -102.72 -24.05 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.568 -0.707 . . . . 0.0 109.286 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' B' ' 52' ' ' TYR . 5.8 p90 -52.3 -28.27 18.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.348 -0.845 . . . . 0.0 109.957 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.479 ' O ' ' CG ' ' B' ' 57' ' ' HIS . 7.4 mtt-85 -63.02 -42.56 99.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.978 -1.076 . . . . 0.0 109.564 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -68.18 -35.23 77.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.179 -0.951 . . . . 0.0 109.392 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.03 -55.73 15.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.127 -0.983 . . . . 0.0 108.951 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -56.83 -32.18 65.5 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.381 -0.825 . . . . 0.0 109.562 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . 0.479 ' CG ' ' O ' ' B' ' 53' ' ' ARG . 3.2 m-70 -64.3 -61.16 2.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.957 . . . . 0.0 109.274 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -52.55 -59.53 9.0 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 4.3 mt -80.06 81.53 6.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.364 -1.08 . . . . 0.0 109.658 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.347 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.551 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 2.3 p30 -165.5 48.84 0.2 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 109.406 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . 0.551 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 11.0 Cg_endo -57.01 -14.18 13.75 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.808 2.339 . . . . 0.0 112.083 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . . . . . . . . . 33.7 tp -47.34 -44.32 23.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 108.993 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 36.1 t -69.92 -45.16 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.113 -0.992 . . . . 0.0 108.77 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 54.6 t -49.75 -48.53 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.871 . . . . 0.0 108.977 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.03 -32.99 74.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.309 -0.869 . . . . 0.0 109.376 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.96 -54.96 19.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.913 . . . . 0.0 109.698 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.36 -37.37 75.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.144 -0.972 . . . . 0.0 109.937 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 20.5 mt -70.74 -42.27 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.107 -0.996 . . . . 0.0 109.118 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . 0.465 HD13 HG13 ' D' ' 35' ' ' ILE . 23.1 mt -55.86 -33.67 35.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.191 -0.943 . . . . 0.0 108.555 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.08 -44.73 28.6 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 55.2 mt -57.26 -31.99 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.188 -1.184 . . . . 0.0 109.422 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.82 -64.28 1.0 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.255 -0.903 . . . . 0.0 108.988 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -45.61 -43.11 11.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.372 -0.83 . . . . 0.0 109.717 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 44.4 tp -60.77 -68.67 0.28 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 109.508 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.0 mt -47.45 -30.7 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.218 -0.926 . . . . 0.0 109.516 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 4.0 mt -68.86 -65.61 0.68 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.181 -0.949 . . . . 0.0 109.811 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . 0.414 ' CH2' ' NE ' ' C' ' 45' ' ' ARG . 19.5 t-105 -45.16 -49.38 12.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.328 -0.858 . . . . 0.0 109.882 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . 0.568 HG23 ' HA3' ' B' ' 299' ' ' RIM . 76.0 mt -61.7 -54.44 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.049 -1.032 . . . . 0.0 109.1 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 60.3 tp -47.91 -44.54 29.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.332 -0.855 . . . . 0.0 109.567 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' C' ' 44' ' ' ASP . 0.2 OUTLIER -67.33 -27.99 67.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.784 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.414 ' NE ' ' CH2' ' C' ' 41' ' ' TRP . 0.9 OUTLIER -75.98 -24.11 55.34 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.14 -0.975 . . . . 0.0 110.43 -179.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.4 mt -79.44 -25.53 41.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.759 -1.213 . . . . 0.0 109.224 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -56.42 95.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.186 -0.946 . . . . 0.0 109.733 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -156.96 -59.32 0.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.772 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 tttp 54.3 -138.17 1.13 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.109 -0.994 . . . . 0.0 109.066 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 1.8 t -78.68 170.94 15.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.102 -0.999 . . . . 0.0 109.036 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 9.9 mt -100.87 -26.23 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 0.0 109.802 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -50.82 -26.03 5.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.192 -0.942 . . . . 0.0 110.038 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . 0.496 ' O ' ' CG ' ' C' ' 57' ' ' HIS . 11.2 mmt180 -68.48 -43.79 76.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.938 -1.101 . . . . 0.0 109.735 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . 0.458 ' O ' ' CD1' ' D' ' 51' ' ' ILE . 8.0 m-85 -63.75 -36.98 85.65 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.928 . . . . 0.0 108.779 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -61.86 -53.73 51.77 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.469 -0.769 . . . . 0.0 109.158 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -61.6 -33.01 73.16 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.437 -0.789 . . . . 0.0 109.545 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' C' ' 53' ' ' ARG . 2.6 m-70 -59.44 -58.3 9.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 108.936 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -51.74 -59.99 7.97 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.171 -1.571 . . . . 0.0 109.171 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 49.6 mt -71.95 175.66 5.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.344 -1.092 . . . . 0.0 109.213 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 13.6 mtmt . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.05 -0.976 . . . . 0.0 109.428 179.853 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.332 0.587 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.98 161.09 47.99 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.22 -0.925 . . . . 0.0 109.305 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' D' ' 26' ' ' LEU . 18.6 Cg_endo -63.1 -24.1 73.29 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.496 2.131 . . . . 0.0 112.1 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' D' ' 25' ' ' PRO . 45.3 tp -45.95 -42.63 13.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 108.675 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.9 t -69.76 -44.17 79.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.292 -0.88 . . . . 0.0 108.806 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 69.9 t -51.4 -50.74 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 0.0 109.061 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.46 -34.53 77.96 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 109.745 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.56 -54.55 22.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -0.917 . . . . 0.0 109.664 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 2.5 m -57.23 -35.35 69.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.175 -0.953 . . . . 0.0 109.657 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 13.9 mt -72.93 -44.5 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 0.0 109.377 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 30.8 mt -53.87 -35.42 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.133 -0.98 . . . . 0.0 108.735 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.52 -44.39 41.09 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . 0.465 HG13 HD13 ' C' ' 33' ' ' ILE . 65.4 mt -59.34 -43.09 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.241 -1.152 . . . . 0.0 109.208 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.13 -62.64 1.68 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.143 -0.973 . . . . 0.0 109.024 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -45.14 -40.28 6.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.391 -0.818 . . . . 0.0 110.139 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 55.7 tp -65.79 -65.3 0.69 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.115 -0.99 . . . . 0.0 109.571 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 9.8 mt -49.65 -29.48 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.232 -0.918 . . . . 0.0 109.711 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . . . . . . . . . 6.1 mt -70.09 -56.78 6.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.145 -0.972 . . . . 0.0 109.555 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 48.7 t-105 -47.38 -48.37 25.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.0 109.307 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 7.2 mt -65.75 -43.3 93.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.127 -0.983 . . . . 0.0 108.89 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 tp -52.01 -44.63 64.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.428 -0.795 . . . . 0.0 109.921 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.527 ' OD2' ' NC ' ' D' ' 499' ' ' RIM . 99.7 m-20 -76.24 -24.69 54.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.166 -0.959 . . . . 0.0 110.239 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.482 ' O ' ' N ' ' D' ' 47' ' ' PHE . 0.0 OUTLIER -88.69 -3.99 58.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 111.071 -178.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.47 ' C ' ' O ' ' D' ' 45' ' ' ARG . 27.3 mt -33.93 -35.04 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.696 -0.627 . . . . 0.0 110.449 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . 0.482 ' N ' ' O ' ' D' ' 45' ' ' ARG . 1.8 t80 -169.18 131.03 1.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.229 -0.92 . . . . 0.0 109.276 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -166.57 97.9 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.112 -0.993 . . . . 0.0 109.708 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 7.0 ptmt -160.58 -25.87 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.254 -0.904 . . . . 0.0 109.457 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 8.0 t -48.02 110.19 0.3 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . 0.458 ' CD1' ' O ' ' C' ' 54' ' ' PHE . 4.1 mt -84.23 -17.81 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.247 -0.908 . . . . 0.0 109.289 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -71.83 -37.42 70.31 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.201 -0.937 . . . . 0.0 110.862 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . 0.5 ' O ' ' ND1' ' D' ' 57' ' ' HIS . 78.8 mtm180 -78.16 -41.1 35.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.266 -1.521 . . . . 0.0 111.007 -179.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . 0.459 ' C ' ' CD1' ' D' ' 54' ' ' PHE . 8.3 t80 -71.34 -44.84 64.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.079 -1.013 . . . . 0.0 110.542 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' D' ' 56' ' ' GLU . 0.0 OUTLIER -78.21 -24.29 47.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.036 -1.04 . . . . 0.0 110.792 -178.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . 0.572 ' N ' ' CD1' ' D' ' 55' ' ' PHE . 88.3 tt0 -80.14 -28.89 38.83 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.597 -1.314 . . . . 0.0 108.017 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' D' ' 53' ' ' ARG . 11.8 m170 -70.37 -47.07 62.63 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -62.78 -61.15 6.76 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 1.1 mt -68.35 140.1 55.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.328 -1.101 . . . . 0.0 109.427 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 57.0 tttm . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.477 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' RIM . . . . . 0.645 ' NC ' HD22 ' A' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 299' ' ' RIM . . . . . 0.568 ' HA3' HG23 ' C' ' 42' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 399' ' ' RIM . . . . . 0.464 ' NC ' ' CG ' ' C' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 499' ' ' RIM . . . . . 0.527 ' NC ' ' OD2' ' D' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.361 0.601 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 26' ' ' LEU . 8.2 m-20 -162.53 67.5 1.92 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.36 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -47.22 -10.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.904 2.403 . . . . 0.0 112.411 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 24' ' ' ASP . 36.7 tp -46.87 -45.55 20.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.13 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 t -70.21 -45.56 75.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.93 . . . . 0.0 108.715 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.0 t -48.58 -48.26 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.285 -0.884 . . . . 0.0 108.908 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.53 -35.58 81.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.381 -0.825 . . . . 0.0 109.309 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.05 -55.48 21.89 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.337 -0.852 . . . . 0.0 109.729 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.16 -37.0 71.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.155 -0.966 . . . . 0.0 110.005 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.6 mt -71.58 -42.13 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.145 -0.972 . . . . 0.0 109.438 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.455 HD13 HG13 ' B' ' 35' ' ' ILE . 14.8 mt -56.67 -33.29 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.153 -0.967 . . . . 0.0 108.703 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.55 -43.59 29.47 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.0 mt -56.96 -32.23 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.287 -1.125 . . . . 0.0 109.363 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.26 -61.97 1.64 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.136 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -48.6 -39.17 22.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.354 -0.841 . . . . 0.0 109.728 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 tp -66.41 -67.43 0.45 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.23 -0.919 . . . . 0.0 109.602 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 6.7 mt -47.3 -27.55 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.529 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 mt -67.9 -65.62 0.67 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.272 -0.893 . . . . 0.0 109.823 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.412 ' CH2' ' NE ' ' A' ' 45' ' ' ARG . 24.7 t-105 -48.03 -45.98 32.69 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.728 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 68.3 mt -61.6 -54.34 36.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.157 -0.964 . . . . 0.0 108.894 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.5 tp -47.13 -44.37 21.52 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.579 -0.7 . . . . 0.0 109.638 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.792 ' CG ' HNC2 ' A' ' 199' ' ' RIM . 1.9 m-20 -69.88 -26.16 64.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.222 -0.923 . . . . 0.0 110.089 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.412 ' NE ' ' CH2' ' A' ' 41' ' ' TRP . 0.2 OUTLIER -77.22 -23.42 51.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.978 -1.076 . . . . 0.0 110.387 -179.513 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.1 mt -77.77 -21.14 52.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.8 -1.188 . . . . 0.0 108.956 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.2 t80 63.27 154.02 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.248 -0.908 . . . . 0.0 109.39 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -158.65 43.56 0.27 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.299 -0.876 . . . . 0.0 109.379 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.528 ' CD ' ' H ' ' A' ' 50' ' ' SER . 0.6 OUTLIER -163.34 -148.37 0.13 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.929 . . . . 0.0 109.156 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.528 ' H ' ' CD ' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -132.85 166.26 22.7 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -0.909 . . . . 0.0 109.368 -179.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.2 mt -99.33 -44.0 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.38 -0.825 . . . . 0.0 109.642 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.432 ' HH ' ' HG ' ' A' ' 50' ' ' SER . 17.3 p90 -56.35 -24.41 43.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.959 . . . . 0.0 109.495 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -69.13 -44.23 72.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.969 . . . . 0.0 109.287 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -64.3 -29.67 70.75 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.223 -0.923 . . . . 0.0 109.115 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -72.63 -70.23 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.835 . . . . 0.0 109.332 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -46.23 -28.42 1.27 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.385 -0.822 . . . . 0.0 109.518 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 -67.4 -61.98 1.64 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.18 -0.95 . . . . 0.0 109.618 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -50.7 -53.12 26.93 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.679 -1.369 . . . . 0.0 109.679 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.0 mt -68.72 100.49 1.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.183 -1.186 . . . . 0.0 109.641 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 tttm . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.369 179.851 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.443 ' O ' ' O ' ' B' ' 24' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' B' ' 23' ' ' SER . 0.1 OUTLIER 57.38 160.91 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.344 -0.848 . . . . 0.0 109.445 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.36 -22.18 53.05 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.398 2.066 . . . . 0.0 112.017 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 37.1 tp -46.58 -43.87 17.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.269 -0.895 . . . . 0.0 108.653 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.43 -42.54 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.36 -0.837 . . . . 0.0 108.889 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 73.9 t -51.34 -50.19 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.181 -0.949 . . . . 0.0 109.018 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.62 -36.83 85.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.311 -0.868 . . . . 0.0 109.38 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.64 -55.28 24.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.34 -0.85 . . . . 0.0 109.73 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -56.56 -37.0 69.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.252 -0.905 . . . . 0.0 109.714 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 24.5 mt -71.61 -39.74 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.158 -0.963 . . . . 0.0 109.526 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 34.0 mt -58.37 -34.23 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.157 -0.965 . . . . 0.0 108.742 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.88 -41.86 32.19 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.455 HG13 HD13 ' A' ' 33' ' ' ILE . 79.4 mt -62.74 -36.46 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.32 -1.106 . . . . 0.0 109.119 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.79 -62.47 1.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.023 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -46.42 -40.59 12.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.275 -0.891 . . . . 0.0 109.684 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 59.2 tp -63.19 -70.48 0.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.237 -0.914 . . . . 0.0 109.777 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 8.4 mt -47.0 -33.34 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.485 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mt -64.45 -58.69 5.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.425 -0.797 . . . . 0.0 109.535 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 69.9 t-105 -46.28 -44.79 16.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 109.65 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 11.1 mt -70.53 -33.6 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.117 -0.989 . . . . 0.0 109.446 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 tp -59.11 -43.86 91.95 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.35 -0.844 . . . . 0.0 110.203 -179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.514 ' OD2' ' NC ' ' B' ' 299' ' ' RIM . 38.5 m-20 -82.54 -22.76 34.84 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.234 -0.916 . . . . 0.0 110.514 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' B' ' 47' ' ' PHE . 0.0 OUTLIER -82.05 -16.22 50.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.89 -1.131 . . . . 0.0 111.006 -179.212 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' B' ' 46' ' ' LEU . 21.9 mt -44.58 -19.16 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.904 -1.122 . . . . 0.0 109.472 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' B' ' 45' ' ' ARG . 93.7 t80 -49.77 97.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.122 -0.987 . . . . 0.0 109.355 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . 0.426 ' N ' ' O ' ' B' ' 46' ' ' LEU . 58.6 t80 -168.54 65.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.882 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.404 ' CG ' ' H ' ' B' ' 50' ' ' SER . 14.3 pttt -158.81 -107.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.83 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.404 ' H ' ' CG ' ' B' ' 49' ' ' LYS . 41.4 t -80.76 129.17 34.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 109.957 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 32.8 mt -106.04 -32.09 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.633 -0.667 . . . . 0.0 109.438 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -46.48 -27.78 1.2 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 0.0 109.934 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 43.4 mtt-85 -65.91 -41.93 90.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.119 -0.988 . . . . 0.0 109.69 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -68.4 -33.51 74.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 109.7 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -66.14 -46.67 76.67 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.946 . . . . 0.0 109.377 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -69.56 -33.87 73.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.608 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -64.37 -33.62 76.26 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.159 -0.963 . . . . 0.0 108.756 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.04 -63.9 2.01 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mt -55.42 126.34 24.72 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.229 -1.159 . . . . 0.0 109.105 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.941 -1.028 . . . . 0.0 109.35 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.486 ' N ' ' CD ' ' C' ' 25' ' ' PRO . 67.2 m-20 51.17 52.32 11.89 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 109.652 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' C' ' 24' ' ' ASP . 11.6 Cg_endo -58.36 -16.4 28.61 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.666 2.244 . . . . 0.0 112.254 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' C' ' 26' ' ' LEU . 31.4 tp -46.23 -44.44 16.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.214 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 40.4 t -69.16 -44.56 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.258 -0.901 . . . . 0.0 108.907 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -49.6 -49.14 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.153 -0.967 . . . . 0.0 108.96 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.55 -33.07 75.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.863 . . . . 0.0 109.27 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.08 -56.95 8.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.299 -0.876 . . . . 0.0 109.669 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.9 -35.46 69.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.28 -0.887 . . . . 0.0 109.924 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 24.4 mt -72.78 -43.99 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.124 -0.985 . . . . 0.0 109.531 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . 0.455 HD13 HG13 ' D' ' 35' ' ' ILE . 26.6 mt -54.83 -35.27 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.16 -0.963 . . . . 0.0 108.792 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.23 -44.75 42.55 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 58.1 mt -57.67 -27.22 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.273 -1.134 . . . . 0.0 109.203 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.93 -67.36 0.68 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.22 -0.925 . . . . 0.0 109.08 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 8.6 t-80 -46.22 -43.17 15.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.853 . . . . 0.0 109.491 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.88 -67.49 0.4 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.277 -0.889 . . . . 0.0 109.403 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -47.85 -28.75 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.326 -0.858 . . . . 0.0 109.864 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . 0.727 HD22 ' NC ' ' C' ' 399' ' ' RIM . 3.3 mt -67.92 -64.28 0.89 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.154 -0.966 . . . . 0.0 109.793 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . 0.519 ' CH2' ' NE ' ' C' ' 45' ' ' ARG . 30.5 t-105 -48.01 -45.58 31.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.22 -0.925 . . . . 0.0 109.634 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 82.7 mt -63.34 -48.53 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.174 -0.954 . . . . 0.0 108.936 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.7 tp -53.42 -33.28 53.33 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.635 -0.665 . . . . 0.0 110.126 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -83.3 -25.01 31.92 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.168 -0.958 . . . . 0.0 109.947 -179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.519 ' NE ' ' CH2' ' C' ' 41' ' ' TRP . 0.1 OUTLIER -75.36 -27.97 59.36 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.087 -1.008 . . . . 0.0 110.493 -179.311 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' C' ' 47' ' ' PHE . 9.8 mt -61.51 -30.71 70.8 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.612 -1.305 . . . . 0.0 108.946 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.408 ' O ' ' O ' ' C' ' 46' ' ' LEU . 54.8 m-85 -61.22 -111.06 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.101 -0.999 . . . . 0.0 108.833 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.514 ' CG ' ' O ' ' C' ' 48' ' ' PHE . 8.6 t80 45.77 83.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -0.869 . . . . 0.0 109.667 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . 0.521 ' CD ' ' H ' ' C' ' 50' ' ' SER . 0.2 OUTLIER -85.07 -152.71 0.15 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.147 -0.97 . . . . 0.0 108.725 179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . 0.521 ' H ' ' CD ' ' C' ' 49' ' ' LYS . 0.2 OUTLIER -60.6 -173.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.84 -1.163 . . . . 0.0 109.436 179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 45.5 mt -108.64 -27.66 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.59 -0.694 . . . . 0.0 109.272 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.3 -36.29 70.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.284 -0.885 . . . . 0.0 109.996 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -65.83 -34.83 79.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.076 -1.015 . . . . 0.0 109.559 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -68.49 -35.98 78.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.391 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -69.99 -40.62 75.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.918 . . . . 0.0 109.478 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.48 -25.13 63.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 109.49 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -73.75 -46.5 45.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.871 . . . . 0.0 109.195 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.43 -65.99 2.27 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 1.4 mt -58.81 118.79 6.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.289 -1.124 . . . . 0.0 109.73 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 11.5 tttm . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.602 -179.974 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 41.7 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.488 ' N ' ' OD1' ' D' ' 24' ' ' ASP . 2.8 p-10 -165.51 68.17 1.21 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_exo -46.14 -11.52 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.793 2.329 . . . . 0.0 112.34 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' D' ' 24' ' ' ASP . 34.2 tp -47.21 -46.3 23.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.224 -0.923 . . . . 0.0 109.212 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 43.9 t -69.48 -44.32 80.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.238 -0.914 . . . . 0.0 108.754 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 78.0 t -49.92 -48.08 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.348 -0.845 . . . . 0.0 109.054 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.2 -34.42 77.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.404 -0.81 . . . . 0.0 109.547 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.81 -55.4 17.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.26 -0.9 . . . . 0.0 109.649 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.37 -37.29 69.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.213 -0.929 . . . . 0.0 109.842 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 20.6 mt -71.58 -40.39 71.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.6 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 26.8 mt -57.71 -35.21 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.14 -0.975 . . . . 0.0 108.795 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.47 -42.69 47.65 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . 0.455 HG13 HD13 ' C' ' 33' ' ' ILE . 74.6 mt -62.69 -30.49 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.362 -1.081 . . . . 0.0 109.45 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.53 -60.1 2.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 109.081 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -48.98 -40.57 31.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.959 . . . . 0.0 109.542 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 58.1 tp -62.9 -68.42 0.34 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.194 -0.942 . . . . 0.0 109.412 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 7.1 mt -47.15 -31.77 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.305 -0.872 . . . . 0.0 109.455 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.44 HD21 HNC2 ' D' ' 499' ' ' RIM . 2.3 mt -68.26 -57.97 5.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.39 -0.819 . . . . 0.0 109.798 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -46.64 -44.52 18.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.403 -0.811 . . . . 0.0 109.621 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 mt -72.25 -38.33 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.051 -1.031 . . . . 0.0 109.426 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 44.5 tp -57.85 -41.35 82.16 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.929 . . . . 0.0 110.106 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -82.64 -24.0 34.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.096 -1.003 . . . . 0.0 109.813 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' D' ' 47' ' ' PHE . 11.9 mmt180 -89.82 -1.66 58.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.171 -0.955 . . . . 0.0 110.83 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . 0.478 ' C ' ' O ' ' D' ' 45' ' ' ARG . 31.4 mt -31.99 -35.77 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.768 -0.583 . . . . 0.0 110.581 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' D' ' 45' ' ' ARG . 88.1 t80 -172.75 7.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.525 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -47.51 113.55 0.72 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -0.947 . . . . 0.0 109.564 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 12.2 ttmt -163.54 -37.96 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.377 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 44.5 m -54.53 134.94 46.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -0.85 . . . . 0.0 109.634 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 8.7 mt -104.06 -26.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.656 -0.652 . . . . 0.0 109.379 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -47.64 -42.05 23.58 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.871 . . . . 0.0 109.89 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.24 -45.74 72.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.192 -0.943 . . . . 0.0 109.712 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -62.46 -36.48 82.57 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.202 -0.936 . . . . 0.0 109.591 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -63.27 -66.67 0.51 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.278 -0.889 . . . . 0.0 109.435 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -45.86 -34.91 4.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.347 -0.846 . . . . 0.0 109.863 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -63.55 -60.99 2.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.129 -0.982 . . . . 0.0 109.522 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -47.51 -59.77 5.71 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mt -70.11 118.53 13.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.274 -1.133 . . . . 0.0 109.577 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 24.1 mttm . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.573 179.893 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' RIM . . . . . 0.792 HNC2 ' CG ' ' A' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 299' ' ' RIM . . . . . 0.514 ' NC ' ' OD2' ' B' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 399' ' ' RIM . . . . . 0.727 ' NC ' HD22 ' C' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 499' ' ' RIM . . . . . 0.44 HNC2 HD21 ' D' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -168.15 70.55 0.85 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.283 -0.886 . . . . 0.0 109.473 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -48.83 -11.85 0.17 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.66 2.24 . . . . 0.0 112.192 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 26' ' ' LEU . 46.1 tp -47.96 -47.16 32.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.13 -0.981 . . . . 0.0 108.899 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.0 t -67.93 -44.22 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.321 -0.862 . . . . 0.0 108.878 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 77.9 t -49.34 -50.66 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 108.951 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.25 -35.39 80.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.882 . . . . 0.0 109.406 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.32 -57.41 9.47 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.231 -0.918 . . . . 0.0 109.654 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.21 -36.08 63.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 110.013 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.6 mt -73.12 -41.51 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.091 -1.006 . . . . 0.0 109.703 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 25.3 mt -55.27 -36.68 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 120.987 -1.07 . . . . 0.0 108.641 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.38 -44.28 42.77 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.9 mt -56.31 -39.05 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.03 -1.276 . . . . 0.0 109.387 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.83 -54.64 14.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.0 109.126 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 9.2 t-80 -48.61 -42.88 35.42 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.36 -0.838 . . . . 0.0 109.881 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.2 tp -67.16 -65.47 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 109.684 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.9 mt -46.65 -27.41 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 109.43 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.537 HD21 HNC2 ' A' ' 199' ' ' RIM . 1.9 mt -69.48 -61.8 1.64 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.383 -0.823 . . . . 0.0 109.727 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.512 ' HE1' HNC1 ' D' ' 499' ' ' RIM . 55.8 t-105 -47.84 -46.04 30.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.172 -0.955 . . . . 0.0 109.413 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 28.2 mt -64.17 -55.7 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.197 -0.939 . . . . 0.0 109.135 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.2 tp -45.27 -43.7 10.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.583 -0.698 . . . . 0.0 110.313 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -77.04 -27.63 54.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.034 -1.041 . . . . 0.0 110.556 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 mmm180 -72.47 -22.24 61.1 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.793 -1.192 . . . . 0.0 110.487 -179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.3 mt -68.64 -12.06 60.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.657 -1.277 . . . . 0.0 108.986 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -82.5 137.86 34.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.331 -0.856 . . . . 0.0 109.183 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -151.07 174.9 12.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.148 -0.97 . . . . 0.0 109.513 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.402 ' CG ' ' H ' ' A' ' 50' ' ' SER . 15.3 tttp 47.37 -143.28 0.38 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.303 -0.873 . . . . 0.0 109.364 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.402 ' H ' ' CG ' ' A' ' 49' ' ' LYS . 18.8 p 51.48 42.25 29.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.478 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 mt -80.67 -31.02 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 109.158 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.557 ' CG ' ' N ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -46.08 -42.69 13.88 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.438 -0.789 . . . . 0.0 109.887 -179.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.557 ' N ' ' CG ' ' A' ' 52' ' ' TYR . 1.2 mtp180 -50.61 -61.84 1.95 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.156 -0.965 . . . . 0.0 110.665 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.467 ' C ' ' CD1' ' A' ' 54' ' ' PHE . 0.0 OUTLIER -70.63 -26.58 63.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.885 -1.134 . . . . 0.0 110.061 -179.076 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.41 -46.41 80.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.904 -1.122 . . . . 0.0 109.371 179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -76.39 -27.5 56.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.673 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -61.97 -50.56 71.6 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.211 -0.93 . . . . 0.0 109.317 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.81 -59.51 3.7 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.9 mt -64.53 -167.85 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.213 -1.169 . . . . 0.0 109.853 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.054 -0.975 . . . . 0.0 109.421 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 92.0 p . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.517 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 6.0 m-20 -153.61 50.4 0.57 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 109.532 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 11.7 Cg_endo -57.97 -14.47 18.66 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.793 2.329 . . . . 0.0 112.066 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 33.3 tp -46.17 -45.82 16.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.36 -0.837 . . . . 0.0 109.255 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 36.0 t -69.19 -44.72 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.24 -0.913 . . . . 0.0 108.927 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 72.5 t -49.18 -49.11 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 109.096 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.73 -33.73 76.54 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.289 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.86 -56.8 9.94 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.337 -0.852 . . . . 0.0 109.825 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.83 -37.2 70.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 109.877 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 33.4 mt -71.25 -41.22 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.058 -1.026 . . . . 0.0 109.499 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 24.0 mt -57.08 -34.14 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.069 -1.019 . . . . 0.0 108.559 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.11 -43.94 24.82 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 53.9 mt -56.11 -35.29 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.177 -1.19 . . . . 0.0 109.235 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.77 -61.53 1.73 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.22 -0.925 . . . . 0.0 109.073 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . 0.438 ' NE2' ' ND1' ' C' ' 37' ' ' HIS . 1.8 t-80 -46.83 -41.91 16.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.228 -0.92 . . . . 0.0 109.771 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 58.5 tp -62.3 -69.75 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.166 -0.959 . . . . 0.0 109.591 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.3 mt -46.11 -38.26 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.34 -0.85 . . . . 0.0 109.36 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mt -59.37 -62.4 1.91 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.45 -0.781 . . . . 0.0 109.967 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 20.5 t-105 -44.99 -49.38 11.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.424 -0.798 . . . . 0.0 109.649 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.407 HD13 HG21 ' B' ' 42' ' ' ILE . 34.1 mt -59.79 -48.61 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.12 -0.988 . . . . 0.0 108.52 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.62 -57.41 4.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.55 -0.719 . . . . 0.0 109.453 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.0 -31.34 68.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.848 . . . . 0.0 110.41 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.455 ' CA ' ' HE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -71.92 -23.43 61.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.873 -1.142 . . . . 0.0 110.471 -179.198 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 10.0 mt -75.93 -34.01 59.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.699 -1.251 . . . . 0.0 108.887 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -48.42 101.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.912 . . . . 0.0 109.435 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . 0.4 ' H ' ' H ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -163.5 -3.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.236 -0.915 . . . . 0.0 109.491 -180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.4 ' H ' ' H ' ' B' ' 48' ' ' PHE . 10.8 mtmm -67.21 -118.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.55 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 10.3 p -53.18 104.08 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.324 -0.86 . . . . 0.0 109.718 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 11.4 mt -102.21 -24.85 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.479 -0.763 . . . . 0.0 109.17 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -54.46 -24.94 22.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.854 . . . . 0.0 109.748 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 23.4 mtt180 -65.87 -38.77 89.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.522 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -71.01 -36.65 72.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 109.166 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -69.46 -46.77 65.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.405 -0.809 . . . . 0.0 109.162 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -64.02 -27.88 69.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.254 -0.904 . . . . 0.0 108.933 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 44.3 t60 -69.38 -46.63 66.44 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.403 -0.811 . . . . 0.0 109.545 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -65.0 -61.22 6.0 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 73.0 mt -60.86 -178.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -1.127 . . . . 0.0 109.808 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.436 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' C' ' 26' ' ' LEU . 20.2 t0 -168.94 65.38 0.6 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.899 . . . . 0.0 109.463 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -45.18 -11.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.749 2.299 . . . . 0.0 112.14 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' C' ' 24' ' ' ASP . 22.2 tp -47.69 -46.33 29.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.144 -0.972 . . . . 0.0 109.107 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 41.5 t -68.15 -44.93 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.213 -0.929 . . . . 0.0 108.581 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.2 t -50.03 -49.39 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.334 -0.854 . . . . 0.0 108.788 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.28 -30.19 71.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.355 -0.841 . . . . 0.0 109.288 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.96 -56.83 6.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.0 109.602 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.31 -36.97 66.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.184 -0.947 . . . . 0.0 109.525 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 36.3 mt -72.71 -42.5 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.16 -0.963 . . . . 0.0 109.412 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 20.3 mt -55.88 -34.33 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.122 -0.986 . . . . 0.0 108.629 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.26 -45.33 31.28 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 65.4 mt -58.38 -34.66 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.277 -1.131 . . . . 0.0 108.993 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.98 -67.89 0.41 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 108.908 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . 0.438 ' ND1' ' NE2' ' B' ' 37' ' ' HIS . 4.3 t-80 -45.83 -36.82 5.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.398 -0.813 . . . . 0.0 109.656 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.5 tp -64.89 -69.61 0.28 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 0.0 109.517 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 7.9 mt -48.11 -30.12 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.947 . . . . 0.0 109.751 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . 0.408 HD12 HD11 ' D' ' 38' ' ' LEU . 2.3 mt -68.1 -63.56 1.04 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.109 -0.995 . . . . 0.0 109.718 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 -44.45 -48.69 10.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.338 -0.851 . . . . 0.0 110.06 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . 0.681 HG12 HNC1 ' B' ' 299' ' ' RIM . 54.2 mt -63.89 -58.28 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.046 -1.034 . . . . 0.0 109.108 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 54.1 tp -45.12 -40.19 6.72 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.533 -0.73 . . . . 0.0 109.99 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . 0.46 ' CG ' ' NC ' ' C' ' 399' ' ' RIM . 0.4 OUTLIER -73.18 -28.39 62.18 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.187 -0.946 . . . . 0.0 109.638 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.438 ' HE ' ' CA ' ' C' ' 45' ' ' ARG . 0.0 OUTLIER -76.55 -18.76 58.51 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.212 -0.93 . . . . 0.0 110.196 -179.57 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' C' ' 47' ' ' PHE . 8.3 mt -83.93 -31.18 25.76 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.797 -1.189 . . . . 0.0 108.885 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.464 ' C ' ' CG ' ' C' ' 48' ' ' PHE . 2.4 m-85 -52.92 -174.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 109.652 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.464 ' CG ' ' C ' ' C' ' 47' ' ' PHE . 0.8 OUTLIER 67.02 -66.51 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -0.785 . . . . 0.0 109.811 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' C' ' 47' ' ' PHE . 10.8 tttp 52.33 -93.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -0.913 . . . . 0.0 109.353 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . 0.451 ' N ' ' O ' ' C' ' 48' ' ' PHE . 68.1 m -63.27 148.41 48.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.136 -0.977 . . . . 0.0 109.389 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 11.6 mt -103.31 -27.55 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.562 -0.711 . . . . 0.0 109.697 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -52.88 -18.66 2.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.206 -0.934 . . . . 0.0 109.715 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . 0.49 ' O ' ' CD2' ' C' ' 57' ' ' HIS . 9.5 mtp180 -72.64 -42.16 64.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.19 -0.944 . . . . 0.0 109.865 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.7 -38.03 83.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.935 . . . . 0.0 109.37 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -64.15 -59.3 4.59 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.352 -0.843 . . . . 0.0 109.249 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -55.88 -29.4 59.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.547 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . 0.49 ' CD2' ' O ' ' C' ' 53' ' ' ARG . 10.9 m170 -69.01 -52.89 24.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.204 -0.935 . . . . 0.0 109.312 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.16 -63.93 4.0 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.461 ' C ' HD13 ' C' ' 59' ' ' LEU . 0.5 OUTLIER -70.71 105.17 3.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.182 -1.187 . . . . 0.0 109.108 179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.396 179.947 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 2.4 m . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.526 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 2.8 m-20 -155.81 49.85 0.45 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.527 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 11.0 Cg_endo -57.65 -7.13 2.86 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.768 2.312 . . . . 0.0 112.138 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' D' ' 26' ' ' LEU . 33.7 tp -49.23 -48.8 45.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.117 -0.989 . . . . 0.0 108.924 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 98.5 t -67.11 -44.87 87.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.232 -0.918 . . . . 0.0 108.724 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 73.5 t -48.67 -50.03 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 108.974 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.75 -33.8 76.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.331 -0.856 . . . . 0.0 109.173 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.25 -57.55 8.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.308 -0.87 . . . . 0.0 109.635 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.35 -35.86 65.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.189 -0.944 . . . . 0.0 109.949 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 21.8 mt -72.94 -42.45 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.123 -0.985 . . . . 0.0 109.485 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 mt -55.04 -35.85 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 120.974 -1.079 . . . . 0.0 108.573 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.67 -45.14 46.4 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 57.9 mt -56.79 -37.74 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.209 -1.171 . . . . 0.0 109.129 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.4 ' O ' ' C ' ' D' ' 37' ' ' HIS . 0.7 OUTLIER -66.4 -68.47 0.37 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.902 . . . . 0.0 109.342 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . 0.4 ' C ' ' O ' ' D' ' 36' ' ' LEU . 1.6 t-80 -42.76 -33.18 0.7 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.438 -0.789 . . . . 0.0 110.161 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . 0.408 HD11 HD12 ' C' ' 40' ' ' LEU . 50.3 tp -70.36 -71.21 0.25 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.184 -0.947 . . . . 0.0 109.672 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mt -49.16 -29.4 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.215 -0.928 . . . . 0.0 109.498 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.434 HD21 ' CE1' ' D' ' 499' ' ' RIM . 1.6 tt -72.64 -59.66 2.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.457 -0.777 . . . . 0.0 109.648 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 17.0 t-105 -45.1 -54.28 6.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.71 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 62.6 mt -55.62 -46.45 79.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.204 -0.935 . . . . 0.0 108.867 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.53 -48.77 14.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.588 -0.695 . . . . 0.0 109.722 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.503 ' OD1' ' NC ' ' D' ' 499' ' ' RIM . 0.7 OUTLIER -66.97 -33.87 76.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.303 -0.873 . . . . 0.0 110.184 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -68.34 -23.86 64.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.091 -1.006 . . . . 0.0 110.577 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 8.4 mt -75.82 -34.37 60.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.663 -1.273 . . . . 0.0 109.089 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -52.58 115.78 1.96 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -0.871 . . . . 0.0 109.4 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -172.11 132.77 0.67 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.217 -0.927 . . . . 0.0 109.486 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -154.27 -42.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 109.708 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 4.5 m -165.77 159.18 15.9 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.655 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 9.2 mt -103.97 -25.27 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.613 -0.679 . . . . 0.0 109.369 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -52.01 -19.04 1.63 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.328 -0.857 . . . . 0.0 109.852 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 38.5 mtt180 -71.63 -41.03 69.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.069 -1.019 . . . . 0.0 109.682 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -70.71 -32.48 69.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.096 -1.003 . . . . 0.0 109.148 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -68.37 -42.84 78.56 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.265 -0.897 . . . . 0.0 109.401 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -72.73 -28.2 62.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.287 -0.883 . . . . 0.0 109.288 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -66.21 -44.3 84.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 108.761 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.33 -63.36 3.81 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.5 125.62 24.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.349 -1.089 . . . . 0.0 109.233 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 61.2 mttt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.889 -1.053 . . . . 0.0 109.425 -179.906 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' RIM . . . . . 0.537 HNC2 HD21 ' A' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 299' ' ' RIM . . . . . 0.681 HNC1 HG12 ' C' ' 42' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 399' ' ' RIM . . . . . 0.46 ' NC ' ' CG ' ' C' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 499' ' ' RIM . . . . . 0.512 HNC1 ' HE1' ' A' ' 41' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.8 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 26' ' ' LEU . 1.3 m-20 49.32 69.29 2.78 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.451 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_exo -47.99 -8.53 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.928 2.418 . . . . 0.0 112.476 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.435 ' N ' ' O ' ' A' ' 24' ' ' ASP . 36.4 tp -48.46 -47.48 38.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.099 -1.001 . . . . 0.0 108.923 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.2 t -67.54 -45.03 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.0 108.639 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.0 t -49.28 -46.8 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.5 81.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.241 -0.912 . . . . 0.0 109.228 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.64 -56.67 10.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 0.0 109.682 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.76 -36.41 64.8 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.26 -0.9 . . . . 0.0 109.738 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 24.0 mt -72.7 -41.98 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 109.565 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.7 mt -56.13 -35.52 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.099 -1.001 . . . . 0.0 108.786 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.85 -44.99 45.48 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 64.3 mt -59.16 -33.9 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 121.297 -1.119 . . . . 0.0 109.376 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.56 -66.13 0.61 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 0.0 109.389 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -44.4 -45.39 8.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.325 -0.859 . . . . 0.0 110.235 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.5 tp -59.05 -66.07 0.56 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.097 -1.002 . . . . 0.0 109.598 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.9 mt -48.8 -47.51 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.165 -0.96 . . . . 0.0 109.626 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.73 HD22 ' NC ' ' A' ' 199' ' ' RIM . 3.1 mt -56.45 -55.18 36.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 110.13 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -48.54 -49.54 35.87 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.038 -1.039 . . . . 0.0 109.691 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 78.3 mt -60.6 -57.27 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.244 -0.91 . . . . 0.0 109.126 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.0 tp -50.3 -21.56 1.44 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.675 -0.64 . . . . 0.0 110.247 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.45 ' CG ' HNC2 ' A' ' 199' ' ' RIM . 39.3 m-20 -90.77 -26.73 19.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.147 -0.971 . . . . 0.0 110.009 -179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.595 ' NE ' ' NC ' ' D' ' 499' ' ' RIM . 43.9 mtp85 -81.63 -21.87 37.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.163 -0.96 . . . . 0.0 110.721 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -69.16 -31.8 70.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.667 -1.271 . . . . 0.0 108.91 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -98.1 124.35 42.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.433 -0.792 . . . . 0.0 109.212 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -168.44 -8.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.143 -0.973 . . . . 0.0 109.878 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.525 ' CG ' ' H ' ' A' ' 50' ' ' SER . 1.3 tpmt? -72.95 -149.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.176 -0.953 . . . . 0.0 109.312 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.525 ' H ' ' CG ' ' A' ' 49' ' ' LYS . 59.0 p 46.33 71.61 0.29 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.56 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 14.7 mt -94.45 -25.16 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.259 -0.9 . . . . 0.0 109.559 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -61.23 -26.18 67.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.164 -0.96 . . . . 0.0 109.466 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -68.62 -37.6 79.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.079 -1.013 . . . . 0.0 109.359 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -74.19 -41.29 61.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.151 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -62.34 -42.98 99.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.335 -0.853 . . . . 0.0 109.405 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -73.61 -26.34 60.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.185 -0.947 . . . . 0.0 109.276 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.476 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 12.3 t-80 -69.91 -31.19 68.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.306 -0.871 . . . . 0.0 109.17 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -82.32 -63.68 1.77 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.5 mt -57.94 112.13 1.39 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.188 -1.183 . . . . 0.0 109.234 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.593 -179.869 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.429 ' OG ' ' N ' ' B' ' 24' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.552 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 23.9 m-20 -151.34 49.27 0.56 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.276 -0.89 . . . . 0.0 109.462 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 9.8 Cg_endo -56.16 -10.96 5.09 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.724 2.282 . . . . 0.0 112.02 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 28.6 tp -47.01 -47.24 22.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.35 -0.844 . . . . 0.0 109.063 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 41.0 t -67.69 -45.3 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.28 -0.887 . . . . 0.0 108.937 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -48.79 -48.9 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.275 -0.891 . . . . 0.0 108.994 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.43 -33.46 75.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.4 -0.813 . . . . 0.0 109.184 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.91 -58.01 6.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.309 -0.869 . . . . 0.0 109.675 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -55.22 -35.5 64.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.797 -179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 36.8 mt -73.45 -41.26 56.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.121 -0.987 . . . . 0.0 109.745 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 24.1 mt -55.98 -35.41 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 120.992 -1.068 . . . . 0.0 108.661 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.76 -45.4 34.79 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 48.1 mt -55.26 -30.58 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.23 -1.159 . . . . 0.0 109.096 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.07 -65.64 0.82 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.228 -0.92 . . . . 0.0 109.055 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -46.48 -34.87 5.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.239 -0.913 . . . . 0.0 109.619 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -67.75 -71.24 0.22 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.136 -0.978 . . . . 0.0 109.469 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.9 mt -46.78 -37.41 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.324 -0.86 . . . . 0.0 109.397 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.458 HD21 ' NC ' ' B' ' 299' ' ' RIM . 2.7 tt -58.92 -62.91 1.53 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.489 -0.757 . . . . 0.0 109.662 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 10.9 t-105 -47.41 -52.44 16.82 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 109.828 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 57.0 mt -55.02 -48.19 76.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.989 -1.069 . . . . 0.0 108.681 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.11 -50.63 11.0 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.39 0.614 . . . . 0.0 109.476 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.483 ' CG ' HH11 ' C' ' 45' ' ' ARG . 37.7 m-20 -62.16 -32.68 73.32 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.342 -0.849 . . . . 0.0 109.521 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.522 ' CA ' ' HE ' ' B' ' 45' ' ' ARG . 0.0 OUTLIER -72.39 -20.52 61.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.115 -0.99 . . . . 0.0 110.183 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -85.83 -34.3 21.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.699 -1.251 . . . . 0.0 108.961 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . 0.491 ' O ' ' CD2' ' B' ' 48' ' ' PHE . 59.1 t80 -59.01 96.24 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.286 -0.884 . . . . 0.0 109.378 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' B' ' 47' ' ' PHE . 8.5 m-85 -165.9 97.82 0.64 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.255 -0.903 . . . . 0.0 109.688 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -150.41 -80.9 0.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.205 -0.935 . . . . 0.0 109.552 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 16.4 m -80.4 106.14 12.19 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.2 -0.937 . . . . 0.0 109.548 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 13.7 mt -92.29 -23.48 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.264 -0.897 . . . . 0.0 109.562 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.428 ' CD1' ' C ' ' B' ' 52' ' ' TYR . 1.4 p90 -64.64 -17.09 63.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.214 -0.929 . . . . 0.0 109.214 179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -43.87 64.32 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.264 -0.898 . . . . 0.0 109.783 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -68.63 -32.93 73.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.258 -0.901 . . . . 0.0 109.511 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -70.66 -44.3 67.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.343 -0.848 . . . . 0.0 109.692 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.99 -29.39 68.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.193 -0.942 . . . . 0.0 109.512 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -68.67 -47.79 65.59 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.877 . . . . 0.0 109.177 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.0 -64.31 3.48 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.22 120.63 8.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.292 -1.122 . . . . 0.0 109.469 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.485 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 74.0 m . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.297 0.57 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' C' ' 26' ' ' LEU . 25.4 t0 55.27 66.81 3.55 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.883 . . . . 0.0 109.508 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -46.51 -11.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.717 2.278 . . . . 0.0 111.974 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' C' ' 24' ' ' ASP . 40.5 tp -47.49 -45.04 25.94 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.423 -0.798 . . . . 0.0 109.059 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 51.5 t -69.85 -45.19 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 108.755 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 78.9 t -48.45 -48.22 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -0.865 . . . . 0.0 108.846 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.5 -35.45 80.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.355 -0.841 . . . . 0.0 109.107 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.29 -57.36 10.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.46 -0.775 . . . . 0.0 109.851 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m -56.42 -35.71 68.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.159 -0.963 . . . . 0.0 109.757 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 14.4 mt -71.47 -39.76 71.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.114 -0.991 . . . . 0.0 109.355 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 32.2 mt -58.15 -35.14 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.012 -1.055 . . . . 0.0 108.423 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.64 -45.15 54.86 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 108.646 -1.781 . . . . 0.0 108.646 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 75.3 mt -61.69 -23.06 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 O-C-N 121.298 -1.119 . . . . 0.0 108.73 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.1 -70.83 0.39 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.385 -0.822 . . . . 0.0 109.404 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -45.36 -37.05 4.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.312 -0.868 . . . . 0.0 109.676 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 57.6 tp -62.93 -68.05 0.37 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 0.0 109.412 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 5.4 mt -51.98 -27.69 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.947 . . . . 0.0 109.584 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . 0.591 HD21 ' NC ' ' C' ' 399' ' ' RIM . 0.5 OUTLIER -70.22 -61.49 1.76 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 0.0 109.598 -179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 76.2 t-105 -46.91 -43.75 19.16 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.261 -0.899 . . . . 0.0 109.646 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 64.6 mt -67.68 -40.05 83.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.261 -0.899 . . . . 0.0 109.249 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 57.6 tp -58.68 -36.35 74.05 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.577 -0.702 . . . . 0.0 110.217 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -86.4 -20.44 28.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.106 -0.997 . . . . 0.0 110.158 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.483 HH11 ' CG ' ' B' ' 44' ' ' ASP . 1.6 mmp_? -78.45 -27.23 46.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.952 -1.093 . . . . 0.0 110.549 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 7.9 mt -52.14 -12.9 0.27 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.563 -1.336 . . . . 0.0 108.864 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . 0.431 ' N ' ' C ' ' C' ' 45' ' ' ARG . 53.6 m-85 -93.13 101.75 14.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.28 -0.887 . . . . 0.0 109.724 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -168.23 -20.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 0.0 109.559 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.74 -70.25 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.166 -0.959 . . . . 0.0 109.369 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 64.0 p -68.49 110.88 4.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.174 -0.954 . . . . 0.0 109.365 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 11.2 mt -105.95 -25.17 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.576 -0.703 . . . . 0.0 109.803 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.99 -28.29 23.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.211 -0.93 . . . . 0.0 109.752 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 65.3 mtt180 -65.91 -42.79 89.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.138 -0.976 . . . . 0.0 109.817 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -64.96 -34.96 79.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.309 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -63.69 -59.53 4.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.338 -0.851 . . . . 0.0 109.227 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -54.72 -31.01 57.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 109.732 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 17.8 m170 -65.73 -42.96 90.42 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.139 -0.976 . . . . 0.0 109.335 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.13 -61.5 5.13 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 54.0 mt -74.91 156.8 35.98 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -1.147 . . . . 0.0 109.591 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.377 179.968 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.237 0.542 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' D' ' 26' ' ' LEU . 1.5 m-20 51.0 66.97 4.75 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.213 -0.93 . . . . 0.0 109.617 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -46.44 -10.98 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.785 2.323 . . . . 0.0 112.353 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' D' ' 24' ' ' ASP . 26.3 tp -47.26 -45.89 24.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.185 -0.947 . . . . 0.0 109.079 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 39.0 t -69.29 -45.14 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 71.1 t -49.4 -48.92 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.341 -0.849 . . . . 0.0 108.78 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.93 -32.88 74.81 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.341 -0.85 . . . . 0.0 109.184 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.3 -56.89 10.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.388 -0.82 . . . . 0.0 109.741 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -56.1 -36.34 68.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.204 -0.935 . . . . 0.0 109.783 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 26.0 mt -72.07 -40.54 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.114 -0.991 . . . . 0.0 109.395 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 25.0 mt -57.18 -34.06 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.124 -0.985 . . . . 0.0 108.543 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.46 -44.52 27.01 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 61.7 mt -57.9 -29.5 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.152 -1.204 . . . . 0.0 109.022 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.48 -66.62 0.67 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.427 -0.796 . . . . 0.0 109.252 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -46.53 -39.92 11.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -0.834 . . . . 0.0 109.927 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 57.7 tp -63.7 -67.54 0.42 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.064 -1.022 . . . . 0.0 109.757 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mt -48.85 -40.48 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.152 -0.968 . . . . 0.0 109.541 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.537 HD23 ' O ' ' D' ' 40' ' ' LEU . 2.5 tt -55.79 -55.4 32.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.349 -0.844 . . . . 0.0 109.915 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -53.06 -48.69 67.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.074 -1.016 . . . . 0.0 110.077 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . 0.554 HG12 HNC1 ' C' ' 399' ' ' RIM . 68.2 mt -60.18 -49.48 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.107 -0.996 . . . . 0.0 109.152 179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 6.7 tp -49.37 -40.29 35.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.497 -0.752 . . . . 0.0 110.093 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -74.01 -27.65 61.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.206 -0.934 . . . . 0.0 109.808 -179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.461 ' HE ' ' HA1' ' C' ' 399' ' ' RIM . 4.3 mmm180 -74.65 -24.25 58.79 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.118 -0.989 . . . . 0.0 110.494 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -74.48 -9.5 58.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.68 -1.262 . . . . 0.0 109.086 179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -142.84 89.24 2.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.453 -0.779 . . . . 0.0 109.466 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . 0.415 ' O ' ' O ' ' D' ' 49' ' ' LYS . 2.7 t80 -151.76 -3.96 0.27 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 0.0 109.515 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . 0.415 ' O ' ' O ' ' D' ' 48' ' ' PHE . 4.1 mtmt -63.02 -134.61 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -0.881 . . . . 0.0 109.413 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 21.3 t 51.36 79.25 0.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.209 -0.932 . . . . 0.0 109.521 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 47.8 mt -95.74 -37.58 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.845 . . . . 0.0 109.334 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . 0.521 ' CD2' ' N ' ' D' ' 53' ' ' ARG . 21.2 p90 -52.23 -43.96 64.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 109.107 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . 0.521 ' N ' ' CD2' ' D' ' 52' ' ' TYR . 0.9 OUTLIER -62.84 -18.07 62.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 108.844 179.32 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -69.32 -46.86 66.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.367 -0.833 . . . . 0.0 109.128 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' D' ' 55' ' ' PHE . 1.1 m-85 -74.18 -52.96 10.88 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.062 179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -49.2 -35.11 16.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.935 . . . . 0.0 109.423 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . 0.496 ' CD2' ' O ' ' D' ' 53' ' ' ARG . 12.4 m170 -70.64 -57.69 4.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.236 -0.915 . . . . 0.0 109.642 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -50.46 -56.98 11.18 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 4.7 mt -70.91 124.01 23.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.283 -1.127 . . . . 0.0 109.492 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 35.3 tttm . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.461 179.834 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' RIM . . . . . 0.73 ' NC ' HD22 ' A' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 299' ' ' RIM . . . . . 0.458 ' NC ' HD21 ' B' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 399' ' ' RIM . . . . . 0.591 ' NC ' HD21 ' C' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 499' ' ' RIM . . . . . 0.595 ' NC ' ' NE ' ' A' ' 45' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 46.97 70.21 2.22 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.535 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -48.66 -11.16 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.638 2.225 . . . . 0.0 112.439 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.2 tp -47.43 -47.88 26.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.039 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.9 -44.99 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.355 -0.841 . . . . 0.0 108.824 179.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.7 t -49.38 -47.76 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.269 -0.895 . . . . 0.0 108.718 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.36 83.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.622 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.33 -53.7 39.84 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.237 -0.915 . . . . 0.0 109.61 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.2 -37.3 71.98 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 109.794 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.4 mt -72.29 -41.52 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.144 -0.972 . . . . 0.0 109.563 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.3 mt -56.88 -35.2 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.013 -1.055 . . . . 0.0 108.693 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -72.5 -42.98 46.5 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.416 HG13 HD13 ' D' ' 33' ' ' ILE . 73.2 mt -62.18 -27.17 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.336 -1.097 . . . . 0.0 109.148 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.92 -63.63 1.13 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.363 -0.835 . . . . 0.0 108.982 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -45.8 -40.64 9.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.284 -0.885 . . . . 0.0 109.94 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.8 tp -64.3 -67.66 0.41 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.587 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 5.2 mt -47.36 -35.63 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.279 -0.888 . . . . 0.0 109.106 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 43' ' ' LEU . 2.5 mt -62.34 -61.61 2.34 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.615 -0.678 . . . . 0.0 109.682 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -43.3 -46.46 6.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.613 -0.679 . . . . 0.0 109.796 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.3 mt -71.88 -28.05 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.13 -0.981 . . . . 0.0 108.985 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 40' ' ' LEU . 6.6 tp -63.75 -41.93 97.93 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.274 -0.891 . . . . 0.0 109.907 -179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -83.95 -23.59 31.04 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.293 -0.88 . . . . 0.0 109.813 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' PHE . 8.4 mmt85 -95.47 3.17 54.5 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.252 -0.905 . . . . 0.0 110.865 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.488 ' C ' ' O ' ' A' ' 45' ' ' ARG . 34.4 mt -31.17 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.783 -0.573 . . . . 0.0 110.816 -179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 45' ' ' ARG . 2.2 m-85 -171.9 -170.86 0.81 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.114 -0.991 . . . . 0.0 109.74 -179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.528 ' O ' ' N ' ' A' ' 50' ' ' SER . 3.3 p90 -137.88 -1.93 1.96 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.467 -0.77 . . . . 0.0 109.552 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp 47.99 -91.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.88 . . . . 0.0 109.525 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.528 ' N ' ' O ' ' A' ' 48' ' ' PHE . 0.5 OUTLIER -148.13 177.63 9.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.289 -0.882 . . . . 0.0 109.43 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.7 mt -102.35 -24.29 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.491 -0.756 . . . . 0.0 109.489 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -52.63 -21.35 3.84 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.223 -0.923 . . . . 0.0 109.448 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 15.1 mtp180 -67.47 -43.48 80.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.36 -0.837 . . . . 0.0 109.9 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -69.98 -39.55 75.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.973 . . . . 0.0 109.371 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -55.01 -51.5 66.07 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.348 -0.845 . . . . 0.0 109.641 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -71.23 -25.11 62.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.31 -0.869 . . . . 0.0 109.794 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -67.44 -37.59 83.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 0.0 109.611 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -83.25 -62.83 1.77 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.4 mt -72.26 84.85 1.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.135 -1.215 . . . . 0.0 109.622 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 pttt . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.089 -0.958 . . . . 0.0 109.421 179.804 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 34.6 p . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.531 ' O ' ' N ' ' B' ' 26' ' ' LEU . 5.7 m-20 -149.42 64.88 7.54 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.589 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -44.54 -9.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.972 2.448 . . . . 0.0 112.524 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' B' ' 24' ' ' ASP . 42.7 tp -47.34 -46.13 25.3 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.123 -0.985 . . . . 0.0 109.261 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 35.1 t -68.14 -45.13 83.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 108.924 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 78.2 t -48.38 -47.65 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.296 -0.877 . . . . 0.0 109.138 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.54 -37.45 86.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.35 -0.844 . . . . 0.0 109.4 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.07 -55.9 21.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.944 . . . . 0.0 109.569 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 2.1 m -56.31 -34.74 66.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 109.887 -179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 5.2 mt -72.83 -43.48 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.14 -0.975 . . . . 0.0 109.323 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 11.7 mt -54.59 -35.3 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.067 -1.02 . . . . 0.0 108.547 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.59 -44.18 50.4 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 59.3 mt -59.3 -34.67 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.269 -1.136 . . . . 0.0 109.468 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.33 -67.77 0.47 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -0.962 . . . . 0.0 109.226 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -44.29 -34.08 1.81 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.47 -0.768 . . . . 0.0 109.788 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 54.8 tp -70.18 -70.44 0.29 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.464 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 14.2 mt -47.24 -24.02 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.216 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.424 ' C ' HD23 ' B' ' 40' ' ' LEU . 2.7 tt -71.76 -63.48 1.12 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 109.688 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 16.6 t-105 -48.65 -47.03 40.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.176 -0.952 . . . . 0.0 109.558 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 82.2 mt -57.11 -44.68 83.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.93 -54.47 9.99 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.496 0.665 . . . . 0.0 109.38 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.471 ' CG ' HH11 ' C' ' 45' ' ' ARG . 59.2 m-20 -61.82 -29.5 70.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.552 -0.717 . . . . 0.0 110.338 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -73.35 -24.32 60.33 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.949 -1.094 . . . . 0.0 110.871 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 9.0 mt -75.0 -8.58 56.92 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.605 -1.309 . . . . 0.0 109.577 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -143.11 117.87 9.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.324 -0.86 . . . . 0.0 109.664 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -156.3 -3.46 0.12 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -0.873 . . . . 0.0 109.362 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -71.23 -146.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.601 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.513 ' O ' ' CE2' ' B' ' 54' ' ' PHE . 0.7 OUTLIER 46.92 72.27 0.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.839 . . . . 0.0 109.364 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 22.1 mt -100.33 -24.42 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.405 -0.81 . . . . 0.0 109.532 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -70.79 -16.51 62.75 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.175 -0.953 . . . . 0.0 109.449 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -45.18 56.34 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.175 -0.953 . . . . 0.0 109.772 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . 0.513 ' CE2' ' O ' ' B' ' 50' ' ' SER . 4.6 m-85 -69.23 -30.96 69.22 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.201 -0.937 . . . . 0.0 109.349 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -69.49 -45.36 69.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 109.078 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -72.98 -29.18 62.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -0.858 . . . . 0.0 109.421 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 20.3 t-160 -64.36 -60.04 3.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 0.0 109.232 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.98 -55.13 31.93 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.451 HD13 ' C ' ' B' ' 59' ' ' LEU . 0.4 OUTLIER -63.36 95.78 0.1 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.349 -1.089 . . . . 0.0 109.209 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 tttt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.459 -179.826 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' C' ' 26' ' ' LEU . 0.9 OUTLIER 50.9 70.37 2.04 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 109.49 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -47.36 -7.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.631 2.22 . . . . 0.0 112.313 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.493 ' N ' ' O ' ' C' ' 24' ' ' ASP . 41.9 tp -49.31 -45.61 45.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.088 -1.007 . . . . 0.0 109.093 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.97 -45.53 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.067 -1.021 . . . . 0.0 108.534 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 74.5 t -49.28 -46.7 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.71 -33.52 75.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.87 . . . . 0.0 109.285 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.07 -56.47 11.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.387 -0.82 . . . . 0.0 109.556 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.68 -37.27 68.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.19 -0.944 . . . . 0.0 109.559 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 12.2 mt -70.75 -40.34 76.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.517 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 26.2 mt -58.44 -35.31 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.054 -1.029 . . . . 0.0 108.79 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -69.56 -43.73 67.23 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.47 -27.19 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.45 -1.03 . . . . 0.0 108.999 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 13.5 tp -68.8 -68.89 0.36 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.426 -0.796 . . . . 0.0 109.111 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . 0.598 ' NE2' ' CE1' ' D' ' 37' ' ' HIS . 1.8 t-80 -45.97 -43.0 13.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 110.048 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 49.1 tp -58.39 -65.19 0.69 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.124 -0.985 . . . . 0.0 109.709 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 4.1 mt -49.09 -31.87 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.174 -0.954 . . . . 0.0 109.523 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.3 mt -70.31 -59.46 2.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -0.923 . . . . 0.0 110.277 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 76.3 t-105 -48.83 -46.17 41.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.997 -1.064 . . . . 0.0 109.908 -179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 69.6 mt -64.88 -48.89 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.135 -0.978 . . . . 0.0 109.124 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 55.3 tp -54.46 -32.42 57.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.567 -0.708 . . . . 0.0 110.183 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' C' ' 44' ' ' ASP . 0.3 OUTLIER -84.54 -22.29 30.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.074 -1.016 . . . . 0.0 109.746 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.471 HH11 ' CG ' ' B' ' 44' ' ' ASP . 0.2 OUTLIER -79.1 -25.09 43.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -0.936 . . . . 0.0 110.464 -179.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' C' ' 48' ' ' PHE . 10.5 mt -67.31 -31.2 71.34 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.706 -1.247 . . . . 0.0 108.893 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -47.45 98.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.943 . . . . 0.0 109.217 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.429 ' N ' ' O ' ' C' ' 46' ' ' LEU . 2.5 t80 -162.05 18.66 0.1 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 109.341 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . 0.405 ' O ' ' O ' ' C' ' 48' ' ' PHE . 1.5 pttm -61.11 -115.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.811 . . . . 0.0 109.647 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.26 148.59 25.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -0.924 . . . . 0.0 109.664 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 18.5 mt -106.63 -24.23 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.648 -0.658 . . . . 0.0 109.407 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -52.39 -20.32 2.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.328 -0.857 . . . . 0.0 109.609 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -71.43 -41.8 69.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.18 -0.95 . . . . 0.0 109.578 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -67.14 -38.43 85.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.25 -0.906 . . . . 0.0 109.079 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -64.58 -64.62 0.83 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.407 -0.808 . . . . 0.0 109.146 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -50.52 -30.17 12.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.373 -0.829 . . . . 0.0 109.855 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -67.79 -56.21 10.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.114 -0.991 . . . . 0.0 109.571 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.4 -60.26 9.28 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.07 110.34 0.29 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.272 -1.134 . . . . 0.0 109.426 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.46 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 69.6 p . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.436 ' N ' ' CD ' ' D' ' 25' ' ' PRO . 1.5 m-20 47.64 54.66 15.94 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 109.229 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' D' ' 24' ' ' ASP . 17.3 Cg_endo -60.88 -11.34 17.57 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.566 2.177 . . . . 0.0 112.453 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 20.6 tp -47.64 -46.17 28.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 0.0 108.977 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 38.5 t -70.1 -45.2 76.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.202 -0.936 . . . . 0.0 108.647 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 78.8 t -49.23 -48.1 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.148 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.49 -34.8 78.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.317 -0.865 . . . . 0.0 109.285 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.81 -55.87 16.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.28 -0.888 . . . . 0.0 109.966 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -57.3 -37.47 72.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.115 -0.991 . . . . 0.0 109.919 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 19.8 mt -70.33 -39.2 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.111 -0.993 . . . . 0.0 109.261 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . 0.416 HD13 HG13 ' A' ' 35' ' ' ILE . 22.5 mt -58.9 -34.59 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.116 -0.99 . . . . 0.0 108.617 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.18 -44.9 58.51 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 63.8 mt -60.47 -28.55 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.472 -1.016 . . . . 0.0 109.121 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.39 -66.4 0.66 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.34 -0.85 . . . . 0.0 109.049 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . 0.598 ' CE1' ' NE2' ' C' ' 37' ' ' HIS . 11.6 t-160 -47.28 -37.27 10.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.367 -0.833 . . . . 0.0 109.952 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 42.8 tp -68.27 -62.99 1.15 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.097 -1.002 . . . . 0.0 109.67 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 5.0 mt -46.64 -40.76 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.278 -0.889 . . . . 0.0 109.324 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.551 HD22 HNC1 ' D' ' 499' ' ' RIM . 1.8 mt -59.78 -60.45 3.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.454 -0.779 . . . . 0.0 110.322 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . 0.424 ' CZ2' ' CG ' ' D' ' 45' ' ' ARG . 20.6 t-105 -49.93 -46.26 51.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.004 -1.06 . . . . 0.0 110.025 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.31 -47.04 94.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.14 -0.975 . . . . 0.0 109.362 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 tp -53.92 -39.85 66.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.426 -0.796 . . . . 0.0 109.744 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.644 ' CG ' HNC2 ' D' ' 499' ' ' RIM . 2.7 m-20 -74.35 -25.61 59.63 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.25 -0.906 . . . . 0.0 109.823 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.424 ' CG ' ' CZ2' ' D' ' 41' ' ' TRP . 0.6 OUTLIER -74.47 -28.54 61.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.987 -1.071 . . . . 0.0 110.486 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 10.1 mt -69.13 -24.67 64.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.708 -1.245 . . . . 0.0 109.12 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -86.05 77.41 9.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.491 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -162.72 3.76 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.341 -0.849 . . . . 0.0 109.182 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . 0.499 ' CG ' ' H ' ' D' ' 50' ' ' SER . 0.8 OUTLIER -62.47 -98.85 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -0.897 . . . . 0.0 109.546 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.499 ' H ' ' CG ' ' D' ' 49' ' ' LYS . 49.0 p -46.65 129.51 11.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.631 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 15.3 mt -104.91 -29.84 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.557 -0.715 . . . . 0.0 109.109 179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -51.1 -26.1 6.02 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.214 -0.929 . . . . 0.0 109.459 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -66.69 -45.05 80.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.119 -0.988 . . . . 0.0 109.55 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -65.01 -36.41 84.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.2 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -66.51 -66.64 0.53 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.383 -0.823 . . . . 0.0 109.068 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -46.74 -30.85 2.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.551 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -68.89 -56.7 7.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.203 -0.936 . . . . 0.0 109.508 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -56.8 -60.42 9.05 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mt -59.1 107.65 0.57 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -1.201 . . . . 0.0 109.322 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . 0.425 ' HB3' ' HZ3' ' D' ' 60' ' ' LYS . 5.7 mmmm . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.274 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 299' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 399' ' ' RIM . . . . . 0.463 ' NC ' ' CG ' ' C' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 499' ' ' RIM . . . . . 0.644 HNC2 ' CG ' ' D' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.554 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 4.9 p-10 -171.2 48.82 0.11 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.455 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' A' ' 24' ' ' ASP . 9.9 Cg_endo -56.15 -16.87 18.23 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.912 2.408 . . . . 0.0 112.152 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 29.8 tp -46.22 -43.42 15.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.262 -0.899 . . . . 0.0 109.17 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.06 -44.93 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.234 -0.916 . . . . 0.0 108.924 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.2 t -49.68 -49.59 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.192 -0.942 . . . . 0.0 109.174 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.09 -34.45 78.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.321 -0.862 . . . . 0.0 109.482 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.32 -56.48 12.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.192 -0.943 . . . . 0.0 109.615 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.44 -37.56 67.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.307 -0.87 . . . . 0.0 109.908 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.1 mt -72.21 -41.13 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.966 . . . . 0.0 109.589 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.2 mt -55.87 -34.82 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.098 -1.001 . . . . 0.0 108.485 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.08 -45.01 33.59 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.4 mt -59.62 -27.27 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.256 -1.143 . . . . 0.0 109.187 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.15 -65.91 0.79 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.338 -0.851 . . . . 0.0 109.212 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -45.18 -37.89 4.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.363 -0.835 . . . . 0.0 109.79 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.7 tp -66.12 -68.99 0.33 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.19 -0.943 . . . . 0.0 109.671 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.8 mt -46.69 -36.42 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.445 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.68 HD22 ' NC ' ' A' ' 199' ' ' RIM . 4.3 mt -66.46 -58.06 6.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.271 -0.893 . . . . 0.0 109.708 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 75.8 t-105 -49.1 -48.04 44.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.758 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.4 mt -63.1 -49.08 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -0.929 . . . . 0.0 109.315 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.6 tp -51.41 -34.65 35.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.535 -0.728 . . . . 0.0 110.318 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.511 ' OD2' ' NC ' ' A' ' 199' ' ' RIM . 4.0 m-20 -84.44 -26.42 28.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.12 -0.988 . . . . 0.0 110.272 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 -71.78 -29.38 64.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.073 -1.017 . . . . 0.0 110.685 -179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.3 mt -59.37 -26.11 64.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.714 -1.241 . . . . 0.0 109.593 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -57.26 111.07 0.97 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.07 -1.019 . . . . 0.0 109.43 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.481 ' C ' ' CD1' ' A' ' 48' ' ' PHE . 0.2 OUTLIER -169.54 16.56 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.241 -0.912 . . . . 0.0 109.471 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 48' ' ' PHE . 45.5 mtpt -62.44 -133.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.844 . . . . 0.0 109.443 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.56 146.79 54.08 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 109.673 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.2 mt -106.31 -21.71 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -58.05 -15.13 8.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.399 -0.813 . . . . 0.0 109.755 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -69.58 -40.72 76.55 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.256 -0.902 . . . . 0.0 109.774 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -72.86 -42.84 63.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.079 -1.013 . . . . 0.0 109.158 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -56.51 -46.18 80.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.171 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -71.7 -25.43 62.09 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.35 -0.843 . . . . 0.0 109.317 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 -69.77 -32.51 71.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.17 179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -80.22 -62.89 2.02 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.8 mt -72.66 138.8 46.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.193 -1.181 . . . . 0.0 109.498 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.389 -179.874 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' B' ' 26' ' ' LEU . 19.9 t0 -158.66 64.27 2.69 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.304 -0.873 . . . . 0.0 109.476 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -44.61 -10.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.766 2.31 . . . . 0.0 112.367 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.527 ' N ' ' O ' ' B' ' 24' ' ' ASP . 30.2 tp -47.35 -46.43 25.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.023 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.5 -45.83 81.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.197 -0.939 . . . . 0.0 108.804 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 63.3 t -48.26 -48.18 13.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.361 -0.837 . . . . 0.0 109.026 179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.72 -34.15 77.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.313 -0.867 . . . . 0.0 109.219 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.89 -57.41 8.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.377 -0.827 . . . . 0.0 109.749 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 2.3 m -55.18 -35.64 65.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.93 . . . . 0.0 109.786 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 19.8 mt -72.89 -41.28 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.098 -1.001 . . . . 0.0 109.567 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 25.4 mt -56.11 -33.88 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.037 -1.039 . . . . 0.0 108.574 179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.13 -44.83 22.01 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 59.5 mt -56.77 -31.76 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.274 -1.133 . . . . 0.0 109.182 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.68 -64.11 1.02 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.286 -0.884 . . . . 0.0 109.193 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -44.4 -40.5 5.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.413 -0.805 . . . . 0.0 110.123 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 50.8 tp -66.87 -67.27 0.46 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.975 . . . . 0.0 109.636 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 5.3 mt -47.33 -26.02 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 109.429 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.524 HD21 HE31 ' B' ' 299' ' ' RIM . 0.6 OUTLIER -69.66 -68.05 0.44 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.322 -0.861 . . . . 0.0 110.039 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -44.51 -46.54 9.83 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.437 -0.789 . . . . 0.0 109.953 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . . . . . . . . . 56.7 mt -59.29 -47.28 90.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.123 -0.986 . . . . 0.0 108.644 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -47.1 -54.01 11.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.481 -0.762 . . . . 0.0 108.985 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . 0.485 ' CG ' HNC2 ' B' ' 299' ' ' RIM . 52.7 m-20 -60.25 -29.89 69.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.493 -0.754 . . . . 0.0 110.389 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.402 HH12 HE21 ' A' ' 199' ' ' RIM . 0.0 OUTLIER -75.95 -21.39 57.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.909 -1.12 . . . . 0.0 110.745 -179.157 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -79.04 -33.71 44.48 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.532 -1.355 . . . . 0.0 108.952 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -61.49 122.61 15.63 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.344 -0.848 . . . . 0.0 109.682 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -156.39 52.85 0.54 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.278 -0.889 . . . . 0.0 109.374 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -48.44 -80.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.194 -0.941 . . . . 0.0 109.456 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . 0.499 ' CB ' ' CZ ' ' B' ' 52' ' ' TYR . 0.0 OUTLIER -155.81 166.57 33.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.436 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 11.5 mt -96.9 -34.89 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.303 -0.873 . . . . 0.0 109.842 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.499 ' CZ ' ' CB ' ' B' ' 50' ' ' SER . 19.6 p90 -62.66 -19.14 63.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.036 -1.04 . . . . 0.0 109.654 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.7 mmt85 -68.56 -45.22 72.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.175 -0.953 . . . . 0.0 109.537 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -66.27 -32.61 74.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -0.885 . . . . 0.0 109.277 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -69.67 -59.94 2.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.226 -0.921 . . . . 0.0 109.18 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -53.73 -28.12 32.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.897 . . . . 0.0 109.822 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -71.56 -53.87 12.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.104 -0.997 . . . . 0.0 109.305 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.31 -62.25 6.04 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . 0.442 HD13 ' C ' ' B' ' 59' ' ' LEU . 0.4 OUTLIER -57.98 108.24 0.57 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -1.105 . . . . 0.0 108.985 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.407 ' N ' HD13 ' B' ' 59' ' ' LEU . 17.9 tttm . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.471 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 41.9 t . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' C' ' 26' ' ' LEU . 15.9 m-20 -149.52 66.06 8.12 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.351 -0.843 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -46.22 -10.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.875 2.383 . . . . 0.0 112.237 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.482 ' N ' ' O ' ' C' ' 24' ' ' ASP . 49.3 tp -47.32 -46.57 25.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.237 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 53.0 t -68.58 -44.51 82.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.077 -1.014 . . . . 0.0 108.847 179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 69.5 t -49.15 -49.48 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 108.904 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.61 74.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.354 -0.841 . . . . 0.0 109.218 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.48 -57.54 8.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 109.6 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.43 -37.14 67.29 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.088 -1.008 . . . . 0.0 109.873 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 24.3 mt -71.4 -41.85 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.055 -1.028 . . . . 0.0 109.454 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 23.1 mt -55.55 -34.86 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.089 -1.007 . . . . 0.0 108.544 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.83 -45.24 28.2 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 50.0 mt -55.36 -31.51 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 O-C-N 121.261 -1.14 . . . . 0.0 109.379 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.0 -57.69 3.74 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.271 -0.893 . . . . 0.0 109.019 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -50.33 -37.62 37.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.217 -0.927 . . . . 0.0 109.436 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.7 tp -67.02 -69.01 0.33 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.196 -0.94 . . . . 0.0 109.273 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 6.4 mt -46.7 -26.44 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 0.0 109.275 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . 0.405 HD21 HNC2 ' C' ' 399' ' ' RIM . 3.0 mt -69.61 -64.98 0.77 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.301 -0.875 . . . . 0.0 109.655 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -45.41 -47.5 13.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.497 -0.752 . . . . 0.0 109.635 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . . . . . . . . . 70.1 mt -63.73 -56.8 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.145 -0.972 . . . . 0.0 109.074 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 58.3 tp -44.7 -48.92 10.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.492 -0.755 . . . . 0.0 110.129 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -68.66 -25.81 65.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.15 -0.969 . . . . 0.0 110.416 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . . . . . . . . . 11.7 mmt-85 -77.84 -21.1 51.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.887 -1.133 . . . . 0.0 110.536 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 9.1 mt -77.17 -14.43 59.78 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.697 -1.252 . . . . 0.0 108.956 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -76.55 -3.9 39.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.356 -0.84 . . . . 0.0 109.574 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . 0.407 ' O ' ' CG ' ' C' ' 48' ' ' PHE . 0.2 OUTLIER -79.52 112.79 17.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.138 -0.976 . . . . 0.0 109.579 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . 0.454 ' CG ' ' H ' ' C' ' 50' ' ' SER . 4.5 pttp -163.22 -92.49 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.207 -0.933 . . . . 0.0 109.475 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . 0.454 ' H ' ' CG ' ' C' ' 49' ' ' LYS . 28.4 t -77.55 138.03 38.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.4 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 11.1 mt -102.89 -20.28 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.536 -0.727 . . . . 0.0 109.112 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -52.07 -30.6 26.57 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.263 -0.898 . . . . 0.0 109.683 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -62.7 -46.03 90.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.182 -0.949 . . . . 0.0 109.636 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . 0.408 ' O ' ' CD1' ' D' ' 51' ' ' ILE . 2.7 m-85 -63.78 -37.11 86.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.242 -0.911 . . . . 0.0 109.375 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.07 -63.36 1.17 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.25 -0.906 . . . . 0.0 109.147 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -46.77 -34.07 4.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.427 -0.795 . . . . 0.0 109.673 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -65.62 -49.72 67.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.076 -1.015 . . . . 0.0 109.137 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -54.7 -60.81 8.07 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.45 ' C ' HD13 ' C' ' 59' ' ' LEU . 0.4 OUTLIER -88.53 105.84 17.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -1.14 . . . . 0.0 108.963 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.384 -179.99 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.42 160.64 40.4 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.251 -0.906 . . . . 0.0 109.296 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.02 -21.99 73.43 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.578 2.185 . . . . 0.0 112.373 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . . . . . . . . . 51.5 tp -46.25 -43.64 15.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 108.664 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 41.0 t -69.6 -44.4 79.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.339 -0.85 . . . . 0.0 108.731 179.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 74.4 t -50.19 -49.43 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 108.703 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.56 -32.83 74.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.412 -0.805 . . . . 0.0 109.251 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.37 -56.67 9.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 109.783 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -56.67 -36.4 69.53 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 0.0 109.775 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 15.7 mt -71.65 -42.3 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 109.475 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 24.0 mt -56.13 -34.83 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -0.999 . . . . 0.0 108.617 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -73.28 -43.62 37.91 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 58.7 mt -58.0 -38.57 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.204 -1.174 . . . . 0.0 109.037 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.418 HD22 ' HA ' ' D' ' 36' ' ' LEU . 0.2 OUTLIER -65.0 -66.26 0.57 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.286 -0.884 . . . . 0.0 109.089 179.669 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -45.3 -36.65 4.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.38 -0.825 . . . . 0.0 109.83 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 44.1 tp -66.42 -70.0 0.27 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.095 -1.003 . . . . 0.0 109.407 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 9.9 mt -48.01 -25.15 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.0 109.361 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.534 HD23 ' O ' ' D' ' 40' ' ' LEU . 2.8 tt -72.74 -55.61 6.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.334 -0.854 . . . . 0.0 109.658 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -53.27 -50.92 63.84 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.094 -1.003 . . . . 0.0 109.568 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . . . . . . . . . 23.1 mt -59.0 -55.0 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.091 -1.006 . . . . 0.0 108.739 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 35.9 tp -47.52 -37.2 11.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.422 -0.799 . . . . 0.0 109.72 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.472 ' OD2' ' NC ' ' D' ' 499' ' ' RIM . 94.6 m-20 -74.22 -26.05 60.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.223 -0.923 . . . . 0.0 109.67 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.524 ' CA ' ' HE ' ' D' ' 45' ' ' ARG . 0.0 OUTLIER -82.12 -17.67 45.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.126 -0.984 . . . . 0.0 110.732 -179.255 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 9.2 mt -82.26 -34.89 28.59 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.64 -1.287 . . . . 0.0 109.691 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . 0.607 ' CG ' ' N ' ' D' ' 48' ' ' PHE . 0.1 OUTLIER -101.53 -167.66 1.45 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.423 -0.798 . . . . 0.0 109.694 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . 0.607 ' N ' ' CG ' ' D' ' 47' ' ' PHE . 2.5 t80 77.76 30.39 0.47 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.505 -0.747 . . . . 0.0 109.541 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . 0.429 ' O ' ' O ' ' D' ' 50' ' ' SER . 7.9 tptt -93.3 -148.32 0.25 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 109.28 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . 0.429 ' O ' ' O ' ' D' ' 49' ' ' LYS . 1.2 m 54.75 102.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.24 -0.912 . . . . 0.0 109.469 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . 0.408 ' CD1' ' O ' ' C' ' 54' ' ' PHE . 11.8 mt -91.12 -19.52 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.21 -0.931 . . . . 0.0 109.16 179.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -31.4 70.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.246 -0.909 . . . . 0.0 109.777 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -47.35 66.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -0.918 . . . . 0.0 110.413 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . 0.479 ' O ' ' CD1' ' D' ' 54' ' ' PHE . 0.0 OUTLIER -69.75 -28.8 66.08 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.044 -1.035 . . . . 0.0 109.211 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.08 -58.28 7.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.367 -0.833 . . . . 0.0 109.609 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -68.88 -26.99 65.4 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.251 -0.906 . . . . 0.0 110.121 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -59.94 -61.01 2.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.986 -1.071 . . . . 0.0 109.098 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -64.7 -59.48 8.13 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.7 110.12 2.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -1.141 . . . . 0.0 109.611 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 2.8 pttp . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.46 179.94 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' RIM . . . . . 0.68 ' NC ' HD22 ' A' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 299' ' ' RIM . . . . . 0.524 HE31 HD21 ' B' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 399' ' ' RIM . . . . . 0.405 HNC2 HD21 ' C' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 499' ' ' RIM . . . . . 0.472 ' NC ' ' OD2' ' D' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.299 0.571 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.14 161.52 52.03 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.319 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 26' ' ' LEU . 19.3 Cg_endo -61.72 -29.26 83.2 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.541 2.16 . . . . 0.0 112.055 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 26' ' ' LEU . 40.8 tp -45.13 -40.45 7.01 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.7 t -69.25 -43.51 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 80.0 t -53.12 -51.8 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.13 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.38 -34.95 76.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.239 -0.913 . . . . 0.0 109.52 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.39 -53.51 42.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.261 -0.9 . . . . 0.0 109.591 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -58.2 -37.44 74.78 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.274 -0.891 . . . . 0.0 109.859 -179.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.3 mt -71.41 -42.47 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.389 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.9 mt -55.28 -36.37 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 0.0 108.789 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.31 -42.79 56.44 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.3 mt -61.83 -46.53 96.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.235 -1.156 . . . . 0.0 109.269 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.45 -44.69 80.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.094 -1.004 . . . . 0.0 109.142 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -57.88 -56.08 26.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 109.482 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 28.3 tp -54.0 -59.97 3.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.913 . . . . 0.0 109.533 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.2 mt -47.52 -48.36 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.299 -0.876 . . . . 0.0 109.311 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mt -51.93 -59.31 4.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -0.908 . . . . 0.0 109.571 179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -45.14 -65.83 0.48 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.459 -0.776 . . . . 0.0 109.572 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.0 mt -48.58 -37.74 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.125 -0.984 . . . . 0.0 109.278 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.459 HD13 ' O ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -52.1 -49.31 63.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.47 -0.769 . . . . 0.0 110.084 -179.331 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.463 ' OD1' ' NC ' ' A' ' 199' ' ' RIM . 0.5 OUTLIER -76.67 -21.72 55.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.15 -0.968 . . . . 0.0 110.401 -179.042 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.528 ' O ' ' N ' ' A' ' 47' ' ' PHE . 12.9 mmt180 -91.68 -1.15 57.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.013 -1.054 . . . . 0.0 110.841 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.466 ' C ' ' O ' ' A' ' 45' ' ' ARG . 29.7 mt -35.79 -30.61 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.525 -0.734 . . . . 0.0 110.192 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 45' ' ' ARG . 7.4 p90 -170.92 167.13 7.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.161 -0.962 . . . . 0.0 109.486 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -164.15 99.68 0.85 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.252 -0.905 . . . . 0.0 109.578 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.518 ' O ' ' N ' ' A' ' 51' ' ' ILE . 10.1 ttmt -151.64 -44.44 0.11 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.166 -0.959 . . . . 0.0 109.405 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.9 t -60.15 80.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.275 -0.891 . . . . 0.0 109.369 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 49' ' ' LYS . 40.7 mt -92.43 -27.76 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.89 . . . . 0.0 109.557 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -52.51 -44.84 65.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.751 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.29 -45.12 62.05 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.088 -1.008 . . . . 0.0 109.454 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -61.97 -37.28 84.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 109.286 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.0 -34.7 78.68 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.115 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -70.21 -38.14 75.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.353 -0.842 . . . . 0.0 109.476 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -62.66 -54.41 39.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 0.0 109.324 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.488 ' C ' ' H ' ' A' ' 60' ' ' LYS . . . -54.17 -63.08 5.49 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' A' ' 60' ' ' LYS . 7.7 mt -72.93 21.85 0.07 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -1.143 . . . . 0.0 109.741 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.488 ' H ' ' C ' ' A' ' 58' ' ' GLY . 65.9 mttm . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.546 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ASP . . . . . 0.533 ' N ' ' CD ' ' B' ' 25' ' ' PRO . 1.5 p30 -153.35 50.05 0.55 Allowed Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.88 . . . . 0.0 109.399 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' B' ' 24' ' ' ASP . 9.2 Cg_endo -55.59 -11.26 4.55 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.802 2.334 . . . . 0.0 112.248 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 43.6 tp -47.62 -45.85 28.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.152 -0.967 . . . . 0.0 109.094 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 30.4 t -67.57 -46.14 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.145 -0.972 . . . . 0.0 108.808 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 74.0 t -47.98 -48.27 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.892 . . . . 0.0 108.99 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.11 -36.54 84.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.298 -0.876 . . . . 0.0 109.452 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.39 -57.34 8.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.261 -0.9 . . . . 0.0 109.801 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' SER . . . . . . . . . . . . . 1.1 m -53.93 -35.83 62.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 0.0 109.69 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 18.4 mt -72.65 -41.68 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.179 -0.951 . . . . 0.0 109.411 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . . . . . . . . . 18.6 mt -55.25 -34.5 33.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.087 -1.008 . . . . 0.0 108.691 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.94 -44.77 23.23 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 51.6 mt -55.49 -34.87 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.072 -1.252 . . . . 0.0 109.326 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.46 -58.97 2.94 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.0 108.971 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' HIS . . . . . 0.602 ' NE2' ' ND1' ' C' ' 37' ' ' HIS . 2.3 t-80 -47.83 -37.4 13.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 0.0 109.716 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 52.6 tp -69.88 -67.74 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.13 -0.981 . . . . 0.0 109.466 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mt -47.04 -25.14 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.901 . . . . 0.0 109.316 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mt -69.03 -63.43 1.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.0 109.642 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' TRP . . . . . . . . . . . . . 41.8 t-105 -47.72 -46.69 29.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.399 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' ILE . . . . . 0.491 ' O ' ' N ' ' B' ' 45' ' ' ARG . 72.3 mt -62.02 -61.4 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.161 -0.962 . . . . 0.0 108.906 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 57.6 tp -42.53 -47.73 5.18 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.762 -0.587 . . . . 0.0 110.096 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.72 -27.78 68.57 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.247 -0.908 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' B' ' 42' ' ' ILE . 2.3 mmt180 -81.19 -14.97 57.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.099 -1.001 . . . . 0.0 110.333 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . . . . . . . . . 8.9 mt -88.83 -16.08 32.93 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.763 -1.211 . . . . 0.0 109.289 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -47.23 -77.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.248 -0.908 . . . . 0.0 109.326 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 45.11 74.72 0.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.271 -0.893 . . . . 0.0 109.769 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 16.0 tttt -96.65 -88.21 0.29 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 109.49 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' SER . . . . . . . . . . . . . 2.1 t -148.51 148.98 30.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.388 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . . . . . . . . . 20.2 mt -96.37 -22.55 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.325 -0.859 . . . . 0.0 109.566 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -67.01 -20.7 65.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 109.592 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.3 mmm180 -70.31 -43.74 69.72 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.246 -0.909 . . . . 0.0 109.833 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -67.12 -34.76 78.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.17 -0.956 . . . . 0.0 109.632 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -66.35 -43.65 85.47 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.201 -0.937 . . . . 0.0 109.302 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -68.78 -27.54 65.97 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.085 -1.009 . . . . 0.0 108.72 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -70.69 -38.41 73.69 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.447 -0.783 . . . . 0.0 109.501 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.96 -62.4 3.17 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 50.5 mt -72.39 136.43 46.1 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.36 -1.083 . . . . 0.0 109.367 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 48.5 mttm . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.463 179.92 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' C' ' 26' ' ' LEU . 0.2 OUTLIER -161.5 68.35 2.34 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.923 . . . . 0.0 109.571 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_exo -46.4 -9.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.692 2.261 . . . . 0.0 112.105 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' LEU . . . . . 0.494 ' N ' ' O ' ' C' ' 24' ' ' ASP . 35.4 tp -47.2 -46.41 23.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 0.0 109.141 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 33.8 t -69.49 -45.19 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.191 -0.943 . . . . 0.0 108.631 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 71.6 t -49.32 -50.41 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.336 -0.853 . . . . 0.0 108.995 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.11 -30.9 71.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.363 -0.835 . . . . 0.0 109.228 179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.74 -56.22 11.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 109.603 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.13 -37.55 74.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -0.946 . . . . 0.0 109.829 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' ILE . . . . . . . . . . . . . 42.0 mt -71.02 -40.72 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 0.0 109.51 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' ILE . . . . . . . . . . . . . 18.5 mt -58.53 -32.28 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.106 -0.996 . . . . 0.0 108.594 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.86 -44.03 26.01 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.131 -1.587 . . . . 0.0 109.131 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' ILE . . . . . . . . . . . . . 52.4 mt -57.04 -31.46 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.301 -1.117 . . . . 0.0 109.186 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.25 -62.39 1.45 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 108.935 179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' HIS . . . . . 0.602 ' ND1' ' NE2' ' B' ' 37' ' ' HIS . 10.5 t-80 -47.13 -34.46 6.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 109.586 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 40.2 tp -70.56 -66.77 0.56 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.263 -0.898 . . . . 0.0 109.661 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 5.8 mt -49.97 -26.19 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.623 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -72.38 -54.49 9.26 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.138 -0.976 . . . . 0.0 109.526 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' TRP . . . . . . . . . . . . . 29.8 t-105 -55.02 -49.08 72.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 0.0 109.722 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' ILE . . . . . 0.498 HG12 HNC1 ' B' ' 299' ' ' RIM . 59.4 mt -63.9 -55.14 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.203 -0.936 . . . . 0.0 109.117 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 40.1 tp -48.23 -40.37 24.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.794 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' ASP . . . . . 0.43 ' N ' ' OD1' ' C' ' 44' ' ' ASP . 4.5 m-20 -73.21 -25.84 60.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.191 -0.943 . . . . 0.0 109.843 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' ARG . . . . . 0.418 ' HE ' ' HA ' ' C' ' 45' ' ' ARG . 0.1 OUTLIER -80.64 -19.43 45.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.114 -0.991 . . . . 0.0 110.506 -179.393 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' LEU . . . . . . . . . . . . . 8.6 mt -79.39 -32.22 42.99 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.631 -1.293 . . . . 0.0 109.109 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -92.31 103.47 15.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.437 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.55 -12.3 0.13 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.328 -0.857 . . . . 0.0 109.582 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' LYS . . . . . . . . . . . . . 5.2 ptpt -65.1 -156.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.187 -0.946 . . . . 0.0 109.304 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' SER . . . . . . . . . . . . . 60.6 p 45.91 76.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.956 -1.09 . . . . 0.0 109.656 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' ILE . . . . . . . . . . . . . 10.8 mt -95.54 -27.68 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -59.4 -24.91 63.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.193 -0.942 . . . . 0.0 109.421 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' ARG . . . . . . . . . . . . . 26.0 mtm180 -68.78 -37.19 79.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.421 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -72.2 -35.12 68.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 0.0 109.364 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -64.12 -56.51 14.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.792 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -65.11 -28.25 69.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.114 -0.991 . . . . 0.0 109.788 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -70.41 -43.74 69.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.431 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.86 -65.7 2.32 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' LEU . . . . . 0.45 ' C ' HD13 ' C' ' 59' ' ' LEU . 0.4 OUTLIER -63.67 95.28 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -1.189 . . . . 0.0 109.054 -179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.326 -179.831 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 24' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' D' ' 26' ' ' LEU . 27.8 t0 51.13 69.36 2.61 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.203 -0.936 . . . . 0.0 109.394 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 25' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -47.32 -10.73 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.663 2.242 . . . . 0.0 112.134 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 26' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' D' ' 24' ' ' ASP . 35.2 tp -47.88 -47.03 32.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.244 -0.91 . . . . 0.0 108.902 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 42.3 t -68.66 -44.71 82.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.106 -0.996 . . . . 0.0 108.63 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 28' ' ' VAL . . . . . . . . . . . . . 78.3 t -49.24 -49.44 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.244 -0.91 . . . . 0.0 108.687 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.44 77.71 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.379 -0.826 . . . . 0.0 109.236 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.12 -56.85 10.55 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.343 -0.848 . . . . 0.0 109.734 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.82 -37.12 65.73 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.162 -0.961 . . . . 0.0 109.763 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 32' ' ' ILE . . . . . . . . . . . . . 17.2 mt -71.5 -41.95 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.42 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 33' ' ' ILE . . . . . . . . . . . . . 27.6 mt -55.24 -35.32 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -0.989 . . . . 0.0 108.69 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -71.47 -45.3 47.44 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 35' ' ' ILE . . . . . . . . . . . . . 72.2 mt -60.99 -24.26 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.291 -1.123 . . . . 0.0 109.037 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 17.2 tp -76.16 -70.53 0.44 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.464 -0.772 . . . . 0.0 109.231 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 37' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -45.52 -33.38 2.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.304 -0.873 . . . . 0.0 109.715 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 56.6 tp -68.19 -66.27 0.59 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.179 -0.951 . . . . 0.0 109.49 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.7 mt -52.43 -28.23 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.842 . . . . 0.0 109.659 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 40' ' ' LEU . . . . . 0.742 HD22 ' NC ' ' D' ' 499' ' ' RIM . 2.1 mt -76.24 -59.24 2.85 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.84 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 41' ' ' TRP . . . . . . . . . . . . . 25.8 t-105 -45.97 -52.01 12.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.283 -0.886 . . . . 0.0 109.841 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 42' ' ' ILE . . . . . 0.431 ' O ' ' N ' ' D' ' 45' ' ' ARG . 66.9 mt -60.46 -57.63 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.154 -0.966 . . . . 0.0 109.018 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 59.2 tp -43.89 -44.69 7.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.62 -0.675 . . . . 0.0 109.81 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 44' ' ' ASP . . . . . 0.517 ' CG ' HNC2 ' D' ' 499' ' ' RIM . 0.6 OUTLIER -67.46 -29.86 69.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.164 -0.96 . . . . 0.0 109.652 -179.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 45' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' D' ' 42' ' ' ILE . 4.0 mmt180 -77.22 -17.43 58.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.2 -0.938 . . . . 0.0 110.208 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 46' ' ' LEU . . . . . . . . . . . . . 8.5 mt -85.7 -17.13 36.87 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.82 -1.175 . . . . 0.0 109.236 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 47' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -63.35 -6.66 4.99 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.195 -0.941 . . . . 0.0 109.458 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 48' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -71.41 70.97 0.64 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.233 -0.917 . . . . 0.0 109.52 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 49' ' ' LYS . . . . . . . . . . . . . 25.3 mtpt -96.65 -100.27 0.18 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.422 -0.799 . . . . 0.0 109.52 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 50' ' ' SER . . . . . . . . . . . . . 3.4 m -76.18 130.99 39.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.313 -0.867 . . . . 0.0 109.783 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 51' ' ' ILE . . . . . . . . . . . . . 28.9 mt -93.37 -30.67 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.264 -0.898 . . . . 0.0 109.318 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 52' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -58.16 -25.68 61.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.925 . . . . 0.0 109.923 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 53' ' ' ARG . . . . . 0.426 ' O ' ' CG ' ' D' ' 57' ' ' HIS . 12.5 mmt85 -63.6 -41.26 98.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.123 -0.986 . . . . 0.0 109.669 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 54' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -71.15 -41.39 70.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.151 -0.968 . . . . 0.0 109.435 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 55' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -58.84 -41.81 87.81 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.332 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -26.87 61.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.259 -0.901 . . . . 0.0 109.26 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 57' ' ' HIS . . . . . 0.426 ' CG ' ' O ' ' D' ' 53' ' ' ARG . 2.5 m-70 -67.47 -39.65 85.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 108.905 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.82 -63.35 2.74 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 59' ' ' LEU . . . . . . . . . . . . . 80.0 mt -55.08 159.75 2.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.251 -1.146 . . . . 0.0 109.605 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 60' ' ' LYS . . . . . . . . . . . . . 17.7 mttp . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.448 -179.967 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' RIM . . . . . 0.463 ' NC ' ' OD1' ' A' ' 44' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 299' ' ' RIM . . . . . 0.498 HNC1 HG12 ' C' ' 42' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 399' ' ' RIM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 499' ' ' RIM . . . . . 0.742 ' NC ' HD22 ' D' ' 40' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_